PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jeffery, AN; Voss, LD; Metcalf, BS; Alba, S; Wilkin, TJ				Jeffery, AN; Voss, LD; Metcalf, BS; Alba, S; Wilkin, TJ			Parents' awareness of overweight in themselves and their children: cross sectional study within a cohort (EarlyBird 21)	BRITISH MEDICAL JOURNAL			English	Article									Derriford Hosp, Peninsula Med Sch, Plymouth PL6 8DH, Devon, England	Derriford Hospital; University of Plymouth	Jeffery, AN (corresponding author), Derriford Hosp, Peninsula Med Sch, Plymouth PL6 8DH, Devon, England.	alison.jeffery@pms.ac.uk						BUNDRED P, 2001, BRIT MED J, V10, P322; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; *NAT AUD OFF, 2001, TACKL OB ENGL; Saxena S, 2004, ARCH DIS CHILD, V89, P30; Voss LD, 2003, J PEDIATR ENDOCR MET, V16, P1211	5	170	171	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 1	2005	330	7481					23	24		10.1136/bmj.38315.451539.F7	http://dx.doi.org/10.1136/bmj.38315.451539.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15567804	Green Published, Bronze			2022-12-24	WOS:000226176700014
J	Maddison, P; Jones, J; Breslin, A; Bargon, C; Fleur, J; Lewis, R; McSweeney, L; Norgain, C; Smith, S; Thomas, C; Tillson, C				Maddison, P; Jones, J; Breslin, A; Bargon, C; Fleur, J; Lewis, R; McSweeney, L; Norgain, C; Smith, S; Thomas, C; Tillson, C			Improved access and targeting of musculoskeletal services in northwest Wales: targeted early access to musculoskeletal services (TEAMS) programme	BRITISH MEDICAL JOURNAL			English	Article								Problem The hospital based musculoskeletal service in northwest Wales was unable to cope with the demand for referrals from general practitioners. Waiting times were long, duplicate referrals to other departments were common, and general practitioners were reluctant to refer patients with common problems because of the perceived lack of service. Many referrals were made to the inappropriate specialty, especially orthopaedics. At least part of this problem was due to a lack of coordination between the four hospital departments providing musculoskeletal services and the emphasis on district general hospital based rather than community provision. Design Review over 18 months of impact of the targeted early access to musculoskeletal services (TEAMS) programme on accessibility to musculoskeletal services. Setting Northwest Wales. Key measures for improvement Number of patients referred and seen with musculoskeletal problems, waiting times, number of duplicate referrals, and surgery conversion rates in orthopaedic clinics. Strategies for change Establishing with central clinical triage a common pathway for all musculoskeletal referrals so that patients attend the appropriate department. A back pain pathway led by extended scope physiotherapists was developed, and general practitioners with special interests and extended. scope physiotherapists were trained to provide services for patients with uncomplicated musculoskeletal problems in the Community. Effects of change Over 18 months the number of referrals more than doubled. Despite this, waiting times for musculoskeletal services fell; this was noticeable for rheumatology and pain management. Duplicate referrals were abolished. Surgery conversion rates did not, however, change. Questionnaires from the clinics showed a high level of patient satisfaction. Lessons learnt Integration of hospital services that traditionally have worked in isolation can result in greatly improved access to musculoskeletal services. Community based multidisciplinary clinics run by specially trained general practitioners with special interests and extended scope physiotherapists are an effective way of managing patients with uncomplicated musculoskeletal problems and have been well received by patients and general practitioners. The huge unmet burden of need was reflected by the great increase in musculoskeletal referrals. Other approaches are needed to meet this, including better education of general practitioners and methods for identifying and modifying psychosocial risk factors for chronic pain at an early stage.	NW Wales NHS Trust, Bangor LL57 2PW, Gwynedd, Wales; Gwynedd Local Hlth Board, Eryldon, Caernarfon, Wales	Bangor University	Maddison, P (corresponding author), NW Wales NHS Trust, Bangor LL57 2PW, Gwynedd, Wales.	peter.maddison@nww-tr.wales.nhs.uk						BURTON AK, 1995, SPINE, V20, P722, DOI 10.1097/00007632-199503150-00014; Department of Health/Royal College of General Practitioners, 2002, IMPL SCHEM GEN PRACT; *JOINT HLTH SURV U, 1997, HLTH SURV ENGL 1995, V1; MCCORMICK A, 1995, MORBIDITY STAT GEN P; *WELSH OFF, 1998, BETT HLTH BETT WAL C	5	76	76	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1325	1327		10.1136/bmj.329.7478.1325	http://dx.doi.org/10.1136/bmj.329.7478.1325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15576743	Green Published			2022-12-24	WOS:000225657800021
J	Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpter, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, AH; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sutlivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A				Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpter, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, AH; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sutlivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A			The Opportunity Rover's Athena science investigation at Meridiani Planum, Mars	SCIENCE			English	Article							X-RAY SPECTROMETER; EXPLORATION ROVERS; MOSSBAUER SPECTROMETER; MICROSCOPIC IMAGER; TERRA-MERIDIANI; MINI-TES; ART.; HEMATITE; MISSION; CRATER	The Mars Exploration Rover Opportunity has investigated the landing site in Eagle crater and the nearby plains within Meridiani Planum. The soils consist of fine-grained basaltic sand and a surface tag of hematite-rich spherules, spherule fragments, and other granules. Wind ripples are common. Underlying the thin soil layer, and exposed within small impact craters and troughs, are flat-lying sedimentary rocks. These rocks are finely laminated, are rich in sulfur, and contain abundant sulfate salts. Small-scale cross-lamination in some locations provides evidence for deposition in flowing liquid water. We interpret the rocks to be a mixture of chemical and silicictastic sediments formed by episodic inundation by shallow surface water, followed by evaporation, exposure, and desiccation. Hematite-rich spherules are embedded in the rock and eroding from them. We interpret these spherules to be concretions formed by postdepositional diagenesis, again involving liquid water.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Ctr Etud Spatiale Rayonnements, Toulouse, France; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Max Planck Inst Aeron, Katlenburg Lindau, Germany; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Copenhagen, Niels Bohr Inst, Orsted Lab, DK-2100 Copenhagen, Denmark; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR, Inst Space Simulat, Cologne, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Space Sci Inst, Martinez, GA 30907 USA	Cornell University; Washington University (WUSTL); Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Copenhagen; Niels Bohr Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Moersch, Jeffrey E/F-7189-2010; Madsen, Morten Bo/D-2082-2011; Lemmon, Mark T/E-9983-2010; Lemmon, Mark/X-2333-2019; Smith, Michael/C-8875-2012; Farmer, Jack D/B-9343-2019	Moersch, Jeffrey E/0000-0003-3433-9419; Madsen, Morten Bo/0000-0001-8909-5111; Lemmon, Mark T/0000-0002-4504-5136; Lemmon, Mark/0000-0002-4504-5136; McLennan, Scott/0000-0003-4259-7178				[Anonymous], 1982, STRUCTURES SEQUENCES; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; ARVIDSON RE, 2004, SCIENCE, V306, P1760; BANIN A, 1992, MARS, P584; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207; Christensen PR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002233; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2000, J GEOPHYS RES, V105, P9632; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; Middleton G.V., 1984, SEPM SHORT COURSE 3, P401; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P680, DOI 10.2110/jsr.60.680; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	34	415	421	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1698	1703		10.1126/science.1106171	http://dx.doi.org/10.1126/science.1106171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576602				2022-12-24	WOS:000225630800034
J	Hien, TT; de Jong, M; Farrar, J				Hien, TT; de Jong, M; Farrar, J			Avian influenza - A challenge to global health care structures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							H5N1 INFLUENZA; VIRUSES		Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Oxford	Hien, TT (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.		Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746	5	70	82	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2363	2365		10.1056/NEJMp048267	http://dx.doi.org/10.1056/NEJMp048267			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575048				2022-12-24	WOS:000225429000001
J	Ricci, R; Sumara, G; Sumara, I; Rozenberg, I; Kurrer, M; Akhmedov, A; Hersberger, M; Eriksson, U; Eberli, FR; Becher, B; Boren, J; Chen, M; Cybulsky, MI; Moore, KJ; Freeman, MW; Wagner, EF; Matter, CM; Luscher, TF				Ricci, R; Sumara, G; Sumara, I; Rozenberg, I; Kurrer, M; Akhmedov, A; Hersberger, M; Eriksson, U; Eberli, FR; Becher, B; Boren, J; Chen, M; Cybulsky, MI; Moore, KJ; Freeman, MW; Wagner, EF; Matter, CM; Luscher, TF			Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis	SCIENCE			English	Article							VASCULAR PROLIFERATION; DEFICIENT MICE; ATHEROSCLEROSIS; DIFFERENTIATION; EXPRESSION; LDL; INFLAMMATION; ACTIVATION; ADHESION	In vitro studies suggest a role for c-Jun N-terminal kinases (JNKs) in proatherogenic cellular processes. We show that atherosclerosis-prone ApoE(-/-) mice simultaneously lacking JNK2 (ApoE(-/-) JNK2(-/-) mice), but not ApoE(-/-) JNK1(-/-) mice, developed less atherosclerosis than do ApoE(-/-) mice. Pharmacological inhibition of JNK activity efficiently reduced plaque formation. Macrophages lacking JNK2 displayed suppressed foam cell formation caused by defective uptake and degradation of modified lipoproteins and showed increased amounts of the modified lipoprotein-binding and -internalizing scavenger receptor A (SR-A), whose phosphorylation was markedly decreased. Macrophage-restricted deletion of JNK2 was sufficient to decrease atherogenesis. Thus, JNK2-dependent phosphorylation of SR-A promotes uptake of lipids in macrophages, thereby regulating foam cell formation, a critical step in atherogenesis.	Univ Zurich Hosp, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich Hosp, Div Cardiol, CH-8057 Zurich, Switzerland; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; ETH, Inst Biochem, CH-8093 Zurich, Switzerland; Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Neurol, Neuroimmunol Unit, CH-8091 Zurich, Switzerland; Univ Basel Hosp, Dept Res & Med A, CH-4031 Basel, Switzerland; Univ Gothenburg, Wallenberg Lab Cardiovasc Res, S-4345 Gothenburg, Sweden; Univ Toronto, Toronto Gen Res Inst, Toronto, ON, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Lipid Metab Unit, Boston, MA 02114 USA; Inst Mol Pathol, A-1030 Vienna, Austria	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Basel; University of Gothenburg; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harvard University; Harvard Medical School; Massachusetts General Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Ricci, R (corresponding author), Univ Zurich Hosp, Inst Physiol, CH-8057 Zurich, Switzerland.	romeo.ricci@cetll.biol.ethz.ca	Becher, Burkhard/ABE-4225-2020; Cybulsky, Myron I./AAD-6539-2019; Ricci, Romeo/K-3009-2013; Moore, Kathryn/ABE-6416-2020	Becher, Burkhard/0000-0002-1541-7867; Ricci, Romeo/0000-0002-9766-4369; Moore, Kathryn/0000-0003-2505-2547; Sumara, Grzegorz/0000-0003-1502-6265; Eriksson, Urs/0000-0003-1217-9696; Cybulsky, Myron/0000-0002-1696-2867; Sumara, Izabela/0000-0002-5968-3358; Wagner, Erwin F/0000-0001-7872-0196; Hersberger, Martin/0000-0002-4472-329X				Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dong ZM, 2000, CIRCULATION, V101, P2290, DOI 10.1161/01.CIR.101.19.2290; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Fong LG, 1999, J BIOL CHEM, V274, P36808, DOI 10.1074/jbc.274.51.36808; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gough PJ, 1998, J LIPID RES, V39, P531; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Han ZN, 2002, ARTHRITIS RHEUM, V46, P818, DOI 10.1002/art.10104; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Heider H, 2001, FEBS LETT, V505, P185, DOI 10.1016/S0014-5793(01)02819-8; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Whitman SC, 2002, J LIPID RES, V43, P1201, DOI 10.1194/jlr.M200116-JLR200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	27	218	232	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1558	1561		10.1126/science.1101909	http://dx.doi.org/10.1126/science.1101909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567863				2022-12-24	WOS:000225442700060
J	Maurer, M; Wedemeyer, J; Metz, M; Piliponsky, AM; Weller, K; Chatterjea, D; Clouthier, DE; Yanagisawa, MM; Tsai, M; Galli, SJ				Maurer, M; Wedemeyer, J; Metz, M; Piliponsky, AM; Weller, K; Chatterjea, D; Clouthier, DE; Yanagisawa, MM; Tsai, M; Galli, SJ			Mast cells promote homeostasis by limiting endothelin-1-induced toxicity	NATURE			English	Article							EMBRYONIC STEM-CELLS; ENDOTHELIAL-CELLS; KIT-LIGAND; IN-VITRO; MICE; RELEASE; PEPTIDE; SYSTEM; SEPSIS; PERITONITIS	Endothelin-1 (ET-1) is a 21-amino-acid peptide, derived from vascular endothelial cells, with potent vasoconstrictor activity(1). ET-1 has been implicated in diverse physiological or pathological processes(2,3), including the vascular changes associated with sepsis(2-5). However, the factors that regulate ET-1-associated toxicity during bacterial infections, or in other settings, are not fully understood(2-5). Both the pathology associated with certain allergic and autoimmune disorders(6,7), and optimal host defence against bacterial and parasitic infections(8-10) are mediated by mast cells. In vitro, mast cells can produce ET-1 (ref. 11), undergo ET-1-dependent and endothelin-A receptor (ETA)-dependent activation(12,13), and release proteases that degrade ET-1 (ref. 14). Although the potential relationships between mast cells and the ET-1 system thus may be complex, the importance of interactions between ET-1 and mast cells in vivo is obscure. Here we show that ETA-dependent mast-cell activation can diminish both ET-1 levels and ET-1-induced pathology in vivo, and also can contribute to optimal survival during acute bacterial peritonitis. These findings identify a new biological function for mast cells: promotion of homeostasis by limiting the toxicity associated with an endogenous mediator.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Mainz, Dept Dermatol, D-55101 Mainz, Germany; Humboldt Univ, Univ Hosp Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Hannover Med Sch, Ctr Internal Med, Dept Gastroenterol Hepatol & Endocrinol, D-30623 Hannover, Germany; Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; Univ Texas, SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Johannes Gutenberg University of Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stanford University; Hannover Medical School; University of Louisville; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Galli, SJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	sgalli@stanford.edu	Metz, Martin/M-5237-2013; Metz, Martin/B-8799-2009; Maurer, Marcus/ABG-2174-2020	Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Weller, Karsten/0000-0003-4437-0313; Tsai, Mindy/0000-0002-8421-4721				Ahn Gun Young, 1998, Journal of Dermatology (Tokyo), V25, P78; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; BOTOS M, 2002, CLIN SCI LOND S48, V103, pS31; Clouthier DE, 2003, DEV BIOL, V261, P506, DOI 10.1016/S0012-1606(03)00128-3; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GALLI SJ, 2004, INNATE IMMUNE RESPON, P111; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; KITAMURA Y, 1978, BLOOD, V52, P447; LUNDBLAD R, 1995, EUR J SURG, V161, P9; Maguire JJ, 2001, BRIT J PHARMACOL, V134, P1360, DOI 10.1038/sj.bjp.0704384; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Metsarinne KP, 2002, ARTERIOSCL THROM VAS, V22, P268, DOI 10.1161/hq0202.103994; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Opgenorth T J, 1995, Adv Pharmacol, V33, P1, DOI 10.1016/S1054-3589(08)60665-1; Ornan DA, 2000, BBA-MOL BASIS DIS, V1501, P211, DOI 10.1016/S0925-4439(00)00025-9; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V161, P1220, DOI 10.1016/0006-291X(89)91372-7; Szalay L, 1998, SHOCK, V10, P123, DOI 10.1097/00024382-199808000-00007; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; Tsai M, 2002, INT J HEMATOL, V75, P345, DOI 10.1007/BF02982122; Wanecek M, 2000, EUR J PHARMACOL, V407, P1, DOI 10.1016/S0014-2999(00)00675-0; YAMAMURA H, 1994, EUR J PHARMACOL, V265, P9, DOI 10.1016/0014-2999(94)90217-8; YAMAMURA H, 1995, EUR J PHARM-MOLEC PH, V288, P269; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	30	237	243	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					512	516		10.1038/nature03085	http://dx.doi.org/10.1038/nature03085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15543132				2022-12-24	WOS:000225322100049
J	Clayton, GM; Silverman, WR; Heginbotham, L; Morais-Cabral, JH				Clayton, GM; Silverman, WR; Heginbotham, L; Morais-Cabral, JH			Structural basis of ligand activation in a cyclic nucleotide regulated potassium channel	CELL			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASE; FUNCTIONAL RECONSTITUTION; MOLECULAR-BASIS; GATED CHANNELS; ALPHA SUBUNIT; CAMP; MECHANISM; REVEALS; DOMAINS	Here we describe the initial functional characterization of a cyclic nucleotide regulated ion channel from the bacterium Mesorhizobium loti and present two structures of its cyclic nucleotide binding domain, with and without cAMP. The domains are organized as dimers with the interface formed by the linker regions that connect the nucleotide binding pocket to the pore domain. Together, structural and functional data suggest the domains form two dimers on the cytoplasmic face of the channel. We propose a model for gating in which ligand binding alters the structural relationship within a dimer, directly affecting the position of the adjacent transmembrane helices.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Heginbotham, L (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	lise.heginbotham@yale.edu; joao.cabral@yale.edu	Silverman, William/AAE-4799-2019; Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047147] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47147] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; BACON DJ, 1998, J MOL GRAPHICS, V6, P219; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Nimigean CM, 2004, J GEN PHYSIOL, V124, P203, DOI 10.1085/jgp.200409133; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3	35	107	111	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					615	627		10.1016/j.cell.2004.10.030	http://dx.doi.org/10.1016/j.cell.2004.10.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550244	Bronze			2022-12-24	WOS:000225389500008
J	Beck, M; Forster, F; Ecke, M; Plitzko, JM; Melchior, F; Gerisch, G; Baumeister, W; Medalia, O				Beck, M; Forster, F; Ecke, M; Plitzko, JM; Melchior, F; Gerisch, G; Baumeister, W; Medalia, O			Nuclear pore complex structure and dynamics revealed by cryoelectron tomography	SCIENCE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; ARCHITECTURE; MICROSCOPY; IMPORT	Nuclear pore complexes (NPCs) are gateways for nucleocytoplasmic exchange. To analyze their structure in a close-to-life state, we studied transport-active, intact nuclei from Dictyostelium discoideum by means of cryoelectron tomography. Subvolumes of the tomograms containing individual NPCs were extracted in silico and subjected to three-dimensional classification and averaging, whereby distinct structural states were observed. The central plug/transporter (CP/T) was variable in volume and could occupy different positions, along the nucleocytoplasmic axis, which supports the notion that it essentially represents cargo in transit. Changes in the position of the CP/T were accompanied by structural rearrangements in the NPC scaffold.	Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Baumeister, W (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de; omedatia@biochem.mpg.de	Beck, Martin/B-5589-2011; Plitzko, Juergen M/H-9576-2014; Melchior, Frauke/E-2014-2014; Foerster, Friedrich/D-3710-2009	Beck, Martin/0000-0002-7397-1321; Plitzko, Juergen M/0000-0002-6402-8315; Melchior, Frauke/0000-0001-9546-8797; Foerster, Friedrich/0000-0002-6044-2746; Medalia, Ohad/0000-0003-0994-2937				AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Goldberg MW, 1996, J MOL BIOL, V257, P848, DOI 10.1006/jmbi.1996.0206; Grunewald K, 2003, BIOPHYS CHEM, V100, P577, DOI 10.1016/S0301-4622(02)00307-1; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Kiseleva E, 1998, J CELL SCI, V111, P223; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Siebrasse JP, 2002, EMBO REP, V3, P887, DOI 10.1093/embo-reports/kvf171; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	16	371	381	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1387	1390		10.1126/science.1104808	http://dx.doi.org/10.1126/science.1104808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15514115				2022-12-24	WOS:000225301600056
J	Brashares, JS; Arcese, P; Sam, MK; Coppolillo, PB; Sinclair, ARE; Balmford, A				Brashares, JS; Arcese, P; Sam, MK; Coppolillo, PB; Sinclair, ARE; Balmford, A			Bushmeat hunting, wildlife declines, and fish supply in West Africa	SCIENCE			English	Article							CONSERVATION; HARVEST	The multibillion-dollar trade in bushmeat is among the most immediate threats to the persistence of tropical vertebrates, but our understanding of its underlying drivers and effects on human welfare is limited by a lack of empirical data. We used 30 years of data from Ghana to link mammal declines to the bushmeat trade and to spatial and temporal changes in the availability of fish. We show that years of poor fish supply coincided with increased hunting in nature reserves and sharp declines in biomass of 41 wildlife species. Local market data provide evidence of a direct link between fish supply and subsequent bushmeat demand in villages and show bushmeat's role as a dietary staple in the region. Our results emphasize the urgent need to develop cheap protein alternatives to bushmeat and to improve fisheries management by foreign and domestic fleets to avert extinctions of tropical wildlife.	Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC V6T 1Z4, Canada; Ghana Wildlife Div, Accra, Ghana; Wildlife Conservat Soc, Bronx, NY 10460 USA; Univ British Columbia, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada; Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, ZA-7701 Cape Town, South Africa	University of Cambridge; University of California System; University of California Berkeley; University of British Columbia; Wildlife Conservation Society; University of British Columbia; University of Cape Town	Brashares, JS (corresponding author), Univ Cambridge, Dept Zool, Conservat Biol Grp, Downing St, Cambridge CB2 3EJ, England.	brashares@nature.berkeley.edu		Balmford, Andrew/0000-0002-0144-3589; Coppolillo, Peter/0000-0002-1502-8503				[Anonymous], 1996, SHAP 21 CENT CONTR D; Atta-Mills J, 2004, NAT RESOUR FORUM, V28, P13, DOI 10.1111/j.0165-0203.2004.00068.x; Barrett CB, 1998, LAND ECON, V74, P449, DOI 10.2307/3146878; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; CHRISTENSEN V, 2004, PECHERIES MARITIMES; DEI GJS, 1989, ECOL FOOD NUTR, V22, P225, DOI 10.1080/03670244.1989.9991071; *FAO, FISH DAT; FAO, STAT WORLD FISH AQ 2; Food and Agriculture Organization, COUNTR PROF; *IUCN, 2000, WORLD CONS UN; Kaczynski VM, 2002, MAR POLICY, V26, P75, DOI 10.1016/S0308-597X(01)00039-2; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Ntiamoa-Baidu Y., 1998, WILDLIFE DEV PLAN 19; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Robinson J., 2000, HUNTING SUSTAINABILI; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; *SAUP, WEB PROD MAR DAT; *UNEP, AFR ENV OUTL; Wilkie DS, 2000, SCIENCE, V287, P975; *WWF, 2001, W AFR PUTS EU SHAM	22	371	384	3	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1180	1183		10.1126/science.1102425	http://dx.doi.org/10.1126/science.1102425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539602				2022-12-24	WOS:000225193100048
J	Du, QS; Macara, IG				Du, QS; Macara, IG			Mammalian pins is a conformational switch that links NuMA to heterotrimeric G proteins	CELL			English	Article							ASYMMETRIC CELL-DIVISION; CAENORHABDITIS-ELEGANS EMBRYOS; DROSOPHILA NERVOUS-SYSTEM/; MITOTIC SPINDLE; G-ALPHA; BETA-GAMMA; POLARITY; MITOSIS; MICROTUBULES; POSITION	During asymmetric cell divisions, mitotic spindles align along the axis of polarization. In invertebrates, spindle positioning requires Pins or related proteins and a G protein a subunit. A mammalian Pins, called LGN, binds Galphai and also interacts through an N-terminal domain with the microtubule binding protein NuMA. During mitosis, LGN recruits NuMA to the cell cortex, while cortical association of LGN itself requires the C-terminal Galpha binding domain. Using a FRET biosensor, we find that LGN behaves as a conformational switch: in its closed state, the N and C termini interact, but NuMA or Galphai can disrupt this association, allowing LGN to interact simultaneously with both proteins, resulting in their cortical localization. Overexpression of Galphai or YFP-LGN causes a pronounced oscillation of metaphase spindles, and NuMA binding to LGN is required for these spindle movements. We propose that a related switch mechanism might operate in asymmetric cell divisions in the fly and nematode.	Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia	Macara, IG (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	igm9c@virginia.edu		Du, Quansheng/0000-0003-4079-8662	NCI NIH HHS [P01CA40042] Funding Source: Medline; NIGMS NIH HHS [GM070902] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RJ, 1996, J NEUROSCI, V16, P7610; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; COMPTON DA, 1995, J CELL SCI, V108, P621; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gordon MB, 2001, J CELL BIOL, V152, P425, DOI 10.1083/jcb.152.3.425; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Haren L, 2002, J CELL SCI, V115, P1815; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297	38	295	300	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					503	516		10.1016/j.cell.2004.10.028	http://dx.doi.org/10.1016/j.cell.2004.10.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537540	Bronze, Green Published			2022-12-24	WOS:000225183200009
J	Jia, ST; Yamada, T; Grewal, SIS				Jia, ST; Yamada, T; Grewal, SIS			Heterochromatin regulates cell type-specific long-range chromatin interactions essential for directed recombination	CELL			English	Article							MATING-TYPE INTERCONVERSION; BETA-GLOBIN LOCUS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; MEIOTIC RECOMBINATION; LYSINE-9 METHYLATION; V(D)J RECOMBINATION; EPIGENETIC CONTROL; DNA-REPLICATION; CHROMOSOME-III	Mating-type switching in Schizosaccharomyces pombe involves replacing genetic information at the expressed mat1 locus with sequences copied from one of two silent donor loci, mat2-P or mat3-M, located within a 20-kb heterochromatic domain. Donor selection is dictated by cell type: mat2 is the preferred donor in M cells, and mat3 is the preferred donor in P cells. Here we show that a recombination-promoting complex (RPC) containing Swi2 and Swi5 proteins exhibits cell type-specific localization pattern at the silent mating-type region and this differential localization modulates donor preference during mating-type switching. In P cells, RPC localization is restricted to a recombination enhancer located adjacent to mat3, but in M cells, RPC spreads in cis across the entire silent mating-type interval in a heterochromatin-dependent manner. Our analyses implicate heterochromatin in long-range regulatory interactions and suggest that heterochromatin imposes at the mating-type region structural organization that is important for the donor-choice mechanism.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Ayoub N, 1999, GENETICS, V152, P495; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BEACH DH, 1983, NATURE, V305, P682, DOI 10.1038/305682a0; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BRESCH C, 1968, MOL GEN GENET, V102, P301, DOI 10.1007/BF00433721; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Courey AJ, 2001, GENE DEV, V15, P2786; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; EGEL R, 1987, CURR GENET, V12, P429, DOI 10.1007/BF00434820; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; ENGELKE U, 1987, CURR GENET, V12, P535, DOI 10.1007/BF00419563; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Grishchuk AL, 2004, CURR GENET, V44, P317, DOI 10.1007/s00294-003-0439-7; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kaykov A, 2004, EMBO J, V23, P930, DOI 10.1038/sj.emboj.7600099; Klar A.J., 1989, MOBILE DNA, P671; KLAR AJS, 1991, GENETICS, V129, P1033; Lu BY, 2000, GENETICS, V155, P699; MIYATA H, 1981, J GEN APPL MICROBIOL, V27, P365, DOI 10.2323/jgam.27.365; Mizuno K, 1997, GENE DEV, V11, P876, DOI 10.1101/gad.11.7.876; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Park Y, 2001, SCIENCE, V293, P1083, DOI 10.1126/science.1063073; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Szeto L, 1997, GENE DEV, V11, P1899, DOI 10.1101/gad.11.15.1899; Thon G, 2000, GENETICS, V155, P551; THON G, 1993, GENETICS, V134, P1045; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tuzon CT, 2004, J CELL BIOL, V165, P759, DOI 10.1083/jcb.200312061; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Wu XH, 1996, CELL, V87, P277, DOI 10.1016/S0092-8674(00)81345-8	48	69	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					469	480		10.1016/j.cell.2004.10.020	http://dx.doi.org/10.1016/j.cell.2004.10.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537537	Bronze			2022-12-24	WOS:000225183200006
J	Pak, W; Hindges, R; Lim, YS; Pfaff, SL; O'Leary, DDM				Pak, W; Hindges, R; Lim, YS; Pfaff, SL; O'Leary, DDM			Magnitude of binocular vision controlled by islet-2 repression of a genetic program that specifies laterality of retinal axon pathfinding	CELL			English	Article							MAMMALIAN OPTIC CHIASM; VISUAL-SYSTEM; UNCROSSED AXONS; GANGLION-CELLS; IN-VITRO; MOUSE; PROJECTIONS; DIVERGENCE; RETINOGENICULATE; GUIDANCE	Pathfinding of retinal ganglion cell (RGC) axons at the midline optic chiasm determines whether RGCs project to ipsilateral or contralateral brain visual centers, critical for binocular vision. Using IsI2(tau-lac)Z knockin mice, we show that the LIM-homeodomain transcription factor IsI2 marks only contralaterally projecting RGCs. The transcription factor Zic2 and guidance receptor EphB1, required by RGCs to project ipsilaterally, colocalize in RGCs distinct from IsI2 RGCs in the ventral-temporal crescent (VTC), the source of ipsilateral projections. IsI2 knockout mice have an increased ipsilateral projection originating from significantly more RGCs limited to the VTC. IsI2 knockouts also have increased Zic2 and EphB1 expression and significantly more Zic2 RGCs in the VTC. We conclude that IsI2 specifies RGC laterality by repressing an ipsilateral pathfinding program unique to VTC RGCs and involving Zic2 and EphB1. This genetic hierarchy controls binocular vision by regulating the magnitude and source of ipsilateral projections and reveals unique retinal domains.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	doleary@salk.edu	Hindges, Robert/C-5344-2009	Hindges, Robert/0000-0003-0095-7913	NEI NIH HHS [R01 EY07025] Funding Source: Medline; NINDS NIH HHS [R01 NS37116] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brown LY, 2003, GENE EXPR PATTERNS, V3, P361, DOI 10.1016/S1567-133X(03)00043-7; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; FUKUDA Y, 1989, J NEUROSCI, V9, P2353; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Marcus RC, 2000, DEV BIOL, V221, P132, DOI 10.1006/dbio.2000.9660; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Mason CA, 1997, CURR OPIN NEUROBIOL, V7, P647, DOI 10.1016/S0959-4388(97)80084-0; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; OLEARY DDM, 1986, DEV BRAIN RES, V30, P96, DOI 10.1016/0165-3806(86)90136-7; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; REID RC, 2003, FUNDAMENTALS NEUROSC, P469; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868	29	122	123	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					567	578		10.1016/j.cell.2004.10.026	http://dx.doi.org/10.1016/j.cell.2004.10.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537545	Bronze			2022-12-24	WOS:000225183200014
J	Shen, J; Hirschtick, R				Shen, J; Hirschtick, R			Getting the lead out	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shen, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.								0	4	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2004	351	19					1996	1996		10.1056/NEJMicm030114	http://dx.doi.org/10.1056/NEJMicm030114			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867OG	15525725				2022-12-24	WOS:000224851300012
J	Connolly, MA; Gayer, M; Ryan, MJ; Salama, P; Spiegel, P; Heymann, DL				Connolly, MA; Gayer, M; Ryan, MJ; Salama, P; Spiegel, P; Heymann, DL			Communicable diseases in complex emergencies: impact and challenges	LANCET			English	Review							RESPIRATORY-TRACT INFECTIONS; SMEAR-POSITIVE TUBERCULOSIS; TREATED BED NETS; REFUGEE CAMP; DEVELOPING-COUNTRIES; PUBLIC-HEALTH; DOUBLE-BLIND; VITAMIN-A; MORTALITY; CHILDREN	Communicable diseases, alone or in combination with malnutrition, account for most deaths in complex emergencies. Factors promoting disease transmission interact synergistically leading to high incidence rates of diarrhoea, respiratory infection, malaria, and measles. This excess morbidity and mortality is avoidable as effective interventions are available. Adequate shelter, water, food, and sanitation linked to effective case management, immunisation, health education, and disease surveillance are crucial. However, delivery mechanisms are often compromised by loss of health staff, damage to infrastructure, insecurity, and poor co-ordination. Although progress has been made in the control of specific communicable diseases in camp settings, complex emergencies affecting large geographical areas or entire countries pose a greater challenge. Available interventions need to be implemented more systematically in complex emergencies with higher levels of coordination between governments, UN agencies, and non-governmental organisations. In addition, further research is needed to adapt and simplify interventions, and to explore novel diagnostics, vaccines, and therapies.	WHO, Complex Emergencies Programme, CH-1211 Geneva 27, Switzerland; UNICEF, Kabul, Afghanistan; UNHCR, Geneva, Switzerland	World Health Organization	Connolly, MA (corresponding author), WHO, Complex Emergencies Programme, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	connollyma@who.int	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				AABY P, 1988, REV INFECT DIS, V10, P478; Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; Ahmad K, 2000, LANCET, V355, P1439, DOI 10.1016/S0140-6736(05)74645-6; ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O; *AM PUBL HLTH ASS, 2000, CONTR COMM DIS MAN, P525; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P363; CHEN RT, 1994, INT J EPIDEMIOL, V23, P185, DOI 10.1093/ije/23.1.185; Colebunders R, 2002, BRIT MED J, V324, P802, DOI 10.1136/bmj.324.7341.802; Connolly MA, 2002, LANCET, V360, pS23, DOI 10.1016/S0140-6736(02)11807-1; DIAZ T, 1989, TROP DOCT, V19, P14, DOI 10.1177/004947558901900105; DUALEH MW, 1995, LANCET, V346, P1369, DOI 10.1016/S0140-6736(95)92386-1; Fawzi WW, 2000, J PEDIATR-US, V137, P660, DOI 10.1067/mpd.2000.110136; GESSNER BD, 1994, JAMA-J AM MED ASSOC, V272, P382, DOI 10.1001/jama.272.5.382; Graham K, 2002, MED VET ENTOMOL, V16, P404, DOI 10.1046/j.1365-2915.2002.00395.x; GRAVES PM, 1987, B WORLD HEALTH ORGAN, V65, P869; HARRELLBOND B, 1998, FORCED MIGRATION REV, V2, P22; HATCH DL, 1994, INT J EPIDEMIOL, V23, P1292, DOI 10.1093/ije/23.6.1292; Hazir T, 2002, LANCET, V360, P835; Holt BY, 2003, DISASTERS, V27, P1, DOI 10.1111/1467-7717.00216; Hopkins DR, 2002, LANCET, V360, pS21, DOI 10.1016/S0140-6736(02)11806-X; *IASC HIV AIDS EM, 2004, GUID HIV AIDS INT EM; *IASC HIV AIDS EM, 2002, MATR HIV AIDS INT EM, P12; Jamison D.T., 1993, DIS CONTROL PRIORITI; Julien MR, 1999, TROP MED INT HEALTH, V4, P794, DOI 10.1046/j.1365-3156.1999.00493.x; KAISER R, 2002, HIV SEROPREVALENCE B; Kessler C., TUBERCULOSIS CONTROL; Khaw AJ, 2000, DISASTERS, V24, P181, DOI 10.1111/1467-7717.00141; LEDUC JW, 1989, REV INFECT DIS, V11, pS730; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Macintyre K, 2003, INT J EPIDEMIOL, V32, P157, DOI 10.1093/ije/dyg019; MARFIN AA, 1994, JAMA-J AM MED ASSOC, V272, P377, DOI 10.1001/jama.272.5.377; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; Naficy A, 1998, JAMA-J AM MED ASSOC, V279, P521, DOI 10.1001/jama.279.7.521; Paquet C, 1998, B I PASTEUR, V96, P3, DOI 10.1016/S0020-2452(98)80024-9; Peterson EA, 1998, INT J EPIDEMIOL, V27, P520, DOI 10.1093/ije/27.3.520; Reintjes R, 2002, EMERG INFECT DIS, V8, P69, DOI 10.3201/eid0801.010131; Roberts L, 2001, B WORLD HEALTH ORGAN, V79, P280; Rodger AJ, 2002, B WORLD HEALTH ORGAN, V80, P451; Ronald C, 1999, BMJ, V318; Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3; Rowland M, 1999, T ROY SOC TROP MED H, V93, P133, DOI 10.1016/S0035-9203(99)90285-7; Rutta E, 2001, INT J TUBERC LUNG D, V5, P628; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Santaniello-Newton A, 2000, EPIDEMIOL INFECT, V124, P75, DOI 10.1017/S0950268899003398; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; SIDDIQUE AK, 1995, LANCET, V345, P359, DOI 10.1016/S0140-6736(95)90344-5; Soares J L, 1994, Med Trop (Mars), V54, P319; Sobsey MD, 2003, WATER SCI TECHNOL, V47, P221, DOI 10.2166/wst.2003.0199; Spiegel P, 2002, LANCET, V360, P1927, DOI 10.1016/S0140-6736(02)11915-5; Spiegel P, 2003, HIV AIDS REFUGEES RE; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Spiegel PB, 2001, LANCET, V357, P714, DOI 10.1016/S0140-6736(00)04143-X; Steering Committee for Humanitarian Response, 2004, SPHER PROJ HUM CHART; SUKRAKANCHANATRIKHAM P, 1992, TUBERCLE LUNG DIS, V73, P384, DOI 10.1016/0962-8479(92)90045-L; Talley L., 2001, J REFUG STUD, V14, P412; Tangermann RH, 2000, B WORLD HEALTH ORGAN, V78, P330; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; *UNHCR UNAIDS, 2003, HIV AIDS STI PREV CA; *UNHCR WHO UNAIDS, 1995, GUID HIV INT EM SETT; Van Nieuwenhove S, 2001, TROP MED INT HEALTH, V6, P335, DOI 10.1046/j.1365-3156.2001.00731.x; VANDAMME W, 1995, LANCET, V346, P360; *WHO, 1997, TUB CONTR REF SIT IN; [WHO UNICEF], 2001, WHOVB0113 UNICEF; WHO, 2002, 3 M TECHN SUPP NETW; WHO, ROLL BACK MAL; *WHO, 1995, M 13 14 FEBR 1995 GE; World Health Organization, 1999, WHOCDSCSRISR991; World Health Organization, 2002, COMM DIS PROF AFGH N; YIP R, 1993, JAMA-J AM MED ASSOC, V270, P587, DOI 10.1001/jama.270.5.587; 1996, REV EPIDEMIO SANTE P, V44, P358	76	263	271	2	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2004	364	9449					1974	1983		10.1016/S0140-6736(04)17481-3	http://dx.doi.org/10.1016/S0140-6736(04)17481-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874BX	15567014				2022-12-24	WOS:000225327000036
J	Wang, RC; Smogorzewska, A; de Lange, T				Wang, RC; Smogorzewska, A; de Lange, T			Homologous recombination generates T-loop-sized deletions at human telomeres	CELL			English	Article							SENESCENT HUMAN-CELLS; DNA-DAMAGE; DYSKERATOSIS-CONGENITA; MAMMALIAN TELOMERES; SACCHAROMYCES-CEREVISIAE; STOCHASTIC MECHANISM; HUMAN CANCER; LIFE-SPAN; TRF2; MAINTENANCE	The t-loop structure of mammalian telomeres is thought to repress nonhomologous end joining (NHEJ) at natural chromosome ends. Telomere NHEJ occurs upon loss of TRF2, a telomeric protein implicated in t-loop formation. Here we describe a mutant allele of TRF2, TRF2(DeltaB), that suppressed NHEJ but induced catastrophic deletions of telomeric DNA. The deletion events were stochastic and occurred rapidly, generating dramatically shortened telomeres that were accompanied by a DNA damage response and induction of senescence. TRF2(DeltaB)-induced deletions depended on XRCC3, a protein implicated in Holliday junction resolution, and created t-loop-sized telomeric circles. These telomeric circles were also detected in unperturbed cells and suggested that t-loop deletion by homologous recombination (HR) might contribute to telomere attrition. Human ALT cells had abundant-telomeric circles, pointing to frequent t-loop HR events that could promote rolling circle replication of telomeres in the absence of telomerase. These findings show that t-loop deletion by HR influences the integrity and dynamics of mammalian telomeres.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011; Wang, Richard/AAW-3066-2021; Smogorzewska, Agata/B-8891-2011	de Lange, Titia/0000-0002-9267-367X; Wang, Richard/0000-0003-4543-8295; Smogorzewska, Agata/0000-0001-6285-1562	NCI NIH HHS [K08 CA164047] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA164047] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey SM, 1996, MUTAGENESIS, V11, P139, DOI 10.1093/mutage/11.2.139; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Bechter OE, 2004, CELL CYCLE, V3, P547; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brenneman MA, 2002, MOL CELL, V10, P387, DOI 10.1016/S1097-2765(02)00595-6; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bucholc M, 2001, MOL CELL BIOL, V21, P6559, DOI 10.1128/MCB.21.19.6559-6573.2001; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Cohen S, 1996, MOL CELL BIOL, V16, P2002; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; De Lange T, 2000, COLD SPRING HARB SYM, V65, P265, DOI 10.1101/sqb.2000.65.265; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Jaco I, 2003, MOL CELL BIOL, V23, P5572, DOI 10.1128/MCB.23.16.5572-5580.2003; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Lee JH, 2003, MOL CANCER RES, V1, P674; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Marciniak RA, 2000, TRENDS GENET, V16, P193, DOI 10.1016/S0168-9525(00)01984-3; Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Natarajan S, 2002, MOL CELL BIOL, V22, P4512, DOI 10.1128/MCB.22.13.4512-4521.2002; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Regev A, 1998, ONCOGENE, V17, P3455, DOI 10.1038/sj.onc.1202250; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SMITH JR, 1980, SCIENCE, V207, P82; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Stansel RM, 2001, EMBO J, V20, P5532; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	72	414	433	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 29	2004	119	3					355	368		10.1016/j.cell.2004.10.011	http://dx.doi.org/10.1016/j.cell.2004.10.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507207	Bronze			2022-12-24	WOS:000224908300007
J	Wennberg, R; Zimmermann, C				Wennberg, R; Zimmermann, C			The PROGRESS trial three years later: time for a balanced report of effectiveness	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; STROKE		Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wennberg, R (corresponding author), Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON M5T 2S8, Canada.	Richard.Wennberg@uhn.on.ca		Zimmermann, Camilla/0000-0003-4889-0244				Britov A N, 2002, Klin Med (Mosk), V80, P53; Cates C, 2001, LANCET, V358, P1993, DOI 10.1016/S0140-6736(01)06978-1; Chalmers J, 2003, STROKE, V34, P2333, DOI 10.1161/01.STR.0000091397.81767.40; Chapman N, 2004, STROKE, V35, P116, DOI 10.1161/01.STR.0000106480.76217.6F; Chaturvedi V, 2003, EUR HEART J, V24, P475, DOI 10.1016/S0195-668X(02)00804-7; Jackson G, 2003, INT J CLIN PRACT, V57, P385; LIU LS, 1995, CHINESE MED J-PEKING, V108, P710; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Neal B, 2000, LANCET, V356, P1955; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Psaty BM, 2002, AM J HYPERTENS, V15, P472, DOI 10.1016/S0895-7061(02)02928-X; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Staessen JA, 2001, LANCET, V358, P1026, DOI 10.1016/S0140-6736(01)06226-2; Tirschwell David, 2002, ACP J Club, V136, P51; Tonkin AM, 2002, MED J AUSTRALIA, V176, P283, DOI 10.5694/j.1326-5377.2002.tb04410.x; Turnbull F, 2003, LANCET, V362, P1527; Tzourio C, 2003, ARCH INTERN MED, V163, P1069	17	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					968	970		10.1136/bmj.329.7472.968	http://dx.doi.org/10.1136/bmj.329.7472.968			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15499116	Green Published			2022-12-24	WOS:000224773200023
J	Lindsberg, PJ; Soinne, L; Tatlisumak, T; Roine, RO; Kallela, M; Happola, O; Kaste, M				Lindsberg, PJ; Soinne, L; Tatlisumak, T; Roine, RO; Kallela, M; Happola, O; Kaste, M			Long-term outcome after intravenous thrombolysis of basilar artery occlusion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE ISCHEMIC-STROKE; THERAPY; ASSOCIATION; QUALITY; LIFE; CARE	Context Basilar artery occlusion (BAO) is an infrequent disease with high morbidity and mortality. Intra-arterial thrombolysis is advocated for treatment but is limited to use at specialized centers. Objective To evaluate outcomes for patients with BAO treated with intravenous thrombolytic therapy. Design, Setting, and Participants During 1995 to 2003, 50 consecutive patients with angiographically proven BAO were treated according to an institutional therapy protocol based on intravenous thrombolysis with recombinant tissue plasminogen activator (alteplase). Patients were treated at an urban university teaching hospital receiving all patients with ischemic stroke who were considered for thrombolysis in a catchment area of 1.5 million inhabitants in Helsinki, Finland. Intervention Intravenous administration of alteplase (0.9 mg/kg) during a 1-hour infusion. Main Outcome Measures Basilar artery recanalization determined by magnetic resonance angiography and clinical outcomes at 3 months and at 1 year or longer determined by modified Rankin Scale and Barthel index scores. Results Recanalization was studied in 43 patients and verified in 26 (52%) of all patients. By 3 months, 20 patients (40%) had died while 11 had good outcomes (modified Rankin Scale score, 0-2); 12 (24%) reached independence in activities of daily living (Barthel Index score, 95-100), and 6 (16%) were severely disabled (Barthel Index score, 0-50). in the long term (median follow-up 2.8 years), 15 patients (30%) reached good outcomes (modified Rankin Scale score, 0-2) while 23 (46%) died. Conclusions Intravenous administration of alteplase for patients with BAO appears to be associated with rates of survival, recanalization, and independent functional outcome comparable with those reported with endovascular approaches. These data suggest that a randomized trial is needed to compare these approaches for treatment of BAO.	Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00029, Finland; Biomedicum Helsinki, Program Neurosci, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Lindsberg, PJ (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurol, POB 340, Helsinki 00029, Finland.	perttu.lindsberg@hus.fi	Soinne, Lauri/E-3703-2019; Lindsberg, Perttu J/F-1271-2010	Lindsberg, Perttu/0000-0001-7690-811X				Adams HP, 1996, STROKE, V27, P1711; Brandt T, 1996, STROKE, V27, P875, DOI 10.1161/01.STR.27.5.875; Cross DT, 1997, AM J NEURORADIOL, V18, P1221; Devuyst G, 2002, ARCH NEUROL-CHICAGO, V59, P567, DOI 10.1001/archneur.59.4.567; Eckert B, 2002, CEREBROVASC DIS, V14, P42, DOI 10.1159/000063722; HACKE W, 1988, STROKE, V19, P1216, DOI 10.1161/01.STR.19.10.1216; Hacke W, 2004, LANCET, V363, P768; Levy EI, 1999, NEUROSURGERY, V45, P539, DOI 10.1097/00006123-199909000-00025; Lindsberg P J, 1998, Duodecim, V114, P889; Lindsberg PJ, 2003, STROKE, V34, P1443, DOI 10.1161/01.STR.0000071111.98505.C7; Lindsberg PJ, 2003, CURR OPIN NEUROL, V16, P73, DOI 10.1097/00019052-200302000-00010; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Patrick DL, 2000, J CLIN EPIDEMIOL, V53, P779, DOI 10.1016/S0895-4356(00)00205-5; Richardson P G, 2001, Emerg Med (Fremantle), V13, P367, DOI 10.1046/j.1035-6851.2001.00242.x; Wijdicks EFM, 1997, MAYO CLIN PROC, V72, P1005, DOI 10.4065/72.11.1005	15	141	153	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2004	292	15					1862	1866		10.1001/jama.292.15.1862	http://dx.doi.org/10.1001/jama.292.15.1862			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IV	15494584	Bronze			2022-12-24	WOS:000224485100025
J	Belenkaya, TY; Han, C; Yan, D; Opoka, RJ; Khodoun, M; Liu, HZ; Lin, XH				Belenkaya, TY; Han, C; Yan, D; Opoka, RJ; Khodoun, M; Liu, HZ; Lin, XH			Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans	CELL			English	Article							GRADIENT FORMATION; TOUT-VELU; HEDGEHOG; GENE; PATTERN; PROTEIN; WINGLESS; DISTINCT; INTERNALIZATION; TRANSDUCTION	The Drosophila transforming growth factor beta(TGF-beta) homolog Decapentaplegic (Dpp) acts as a morphogen that forms a long-range concentration gradient to direct the anteroposterior patterning of the wing. Both planar transcytosis initiated by Dynamin-mediated endocytosis and extracellular diffusion have been proposed for Dpp movement across cells. In this work, we found that Dpp is mainly extracellular, and its extracellular gradient coincides with its activity gradient. We demonstrate that a blockage of endocytosis by the dynamin mutant shibire does not block Dpp movement but rather inhibits Dpp signal transduction, suggesting that endocytosis is not essential for Dpp movement but is involved in Dpp signaling. Furthermore, we show that Dpp fails to move across cells mutant for daily and daily-like (dly), two Drosophila glypican members of heparin sulfate proteoglycan (HSPG). Our results support a model in which Dpp moves along the cell surface by restricted extracellular diffusion involving the glypicans Daily and Dly.	Univ Cincinnati, Coll Med, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Childrens Hosp, Coll Med, Med Ctr,Grad Program Mol & Dev Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lin, XH (corresponding author), Univ Cincinnati, Coll Med, Div Dev Biol, Cincinnati, OH 45229 USA.	linyby@chmcc.org		Han, Chun/0000-0001-7319-8095	NHLBI NIH HHS [R01 HL-071898] Funding Source: Medline; NIGMS NIH HHS [R01 GM-63891] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063891] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baeg GH, 2001, DEVELOPMENT, V128, P87; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; POSAKONY LG, 1990, MECH DEVELOP, V33, P69, DOI 10.1016/0925-4773(90)90136-A; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; XU T, 1993, DEVELOPMENT, V117, P1223	58	239	246	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					231	244		10.1016/j.cell.2004.09.031	http://dx.doi.org/10.1016/j.cell.2004.09.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479640	Bronze			2022-12-24	WOS:000224577200011
J	Pang, PT; Teng, HK; Zaitsev, E; Woo, NT; Sakata, K; Zhen, SH; Teng, KK; Yung, WH; Hempstead, BL; Lu, B				Pang, PT; Teng, HK; Zaitsev, E; Woo, NT; Sakata, K; Zhen, SH; Teng, KK; Yung, WH; Hempstead, BL; Lu, B			Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity	SCIENCE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; LATE-PHASE; LASTING POTENTIATION; EXCITATORY SYNAPSES; BDNF; GROWTH; MEMORY; MICE	Long-term memory is thought to be mediated by protein synthesis-dependent, late-phase tong-term potentiation (L-LTP). Two secretory proteins, tissue plasminogen activator (tPA) and brain-derived neurotrophic factor (BDNF), have been implicated in this process, but their relationship is unclear. Here we report that tPA, by activating the extracellular protease plasmin, converts the precursor proBDNF to the mature BDNF (mBDNF), and that such conversion is critical for L-LTP expression in mouse hippocampus. Moreover, application of mBDNF is sufficient to rescue L-LTP when protein synthesis is inhibited, which suggests that mBDNF is a key protein synthesis product for L-LTP expression.	NICHD, Sect Neural Dev & Plast, Lab Cellular & Synapt Neurophysiol, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA; Chinese Univ Hong Kong, Fac Med, Dept Physiol, Shatin, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; Chinese University of Hong Kong	Lu, B (corresponding author), NICHD, Sect Neural Dev & Plast, Lab Cellular & Synapt Neurophysiol, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Sakata, Kazuko/I-2351-2017; Lu, Bai/A-4018-2012; Yung, Ho/R-6161-2018	Yung, Ho/0000-0002-5542-8173; Lu, Bai/0000-0001-5418-9759; Teng, Kenneth/0000-0002-9392-2172	NINDS NIH HHS [NS30658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Frey U, 1996, J NEUROSCI, V16, P2057; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hoffman KB, 1998, BRAIN RES, V811, P29, DOI 10.1016/S0006-8993(98)00906-8; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li TS, 2002, BIOPOLYMERS, V67, P10, DOI 10.1002/bip.10038; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Tsirka SE, 1997, J NEUROSCI, V17, P543; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295	31	852	895	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					487	491		10.1126/science.1100135	http://dx.doi.org/10.1126/science.1100135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486301				2022-12-24	WOS:000224626500054
J	Newell, ML; Coovadia, H; Cortina-Borja, M; Rollins, N; Gaillard, P; Dabis, F				Newell, ML; Coovadia, H; Cortina-Borja, M; Rollins, N; Gaillard, P; Dabis, F		IAS	Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis	LANCET			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; RANDOMIZED-TRIAL; NATURAL-HISTORY; ORAL ZIDOVUDINE; COTE-DIVOIRE; FOLLOW-UP; PREVENTION; REGIMEN	Background HIV contributes substantially to child mortality, but factors underlying these deaths are inadequately described. With individual data from seven randomised mother-to-child transmission (MTCT) intervention trials, we estimate mortality in African children born to HIV-infected mothers and analyse selected risk factors. Methods Early HIV infection was defined as a positive HIV-PCR test before 4 weeks of age; and late infection by a negative PCR test at or after 4 weeks of age, followed by a positive test. Mortality rate was expressed per 1000 child-years. We investigated the effect of maternal health, infant HIV infection, feeding practices, and age at acquisition of infection on mortality assessed with Cox proportional hazards models, and allowed for random effects for trials grouped geographically. Findings 378 (11%) of 3468 children died. By age 1 year, an estimated 35.2% infected and 4.9% unindected children will have died; by 2 years of age, 52.5% and 7.6% will have died, respectively. Mortality varied by geographical region, and was associated with maternal death (adjusted odds ratio 2.27, 95% CI 1.62-3.19), CD4+ cell counts <200 per mu L (1.91, 1.39-2.62), and infant HIV infection (8.16, 6.43-10.33). Mortality was not associated with either ever breastfeeding and never breastfeeding in either infected or uninfected children. In infected children, mortality was significantly lower for those with late infection than those with early infection (0.52, 0.39-0.70). This effect was also seen in analyses of survival from the age at infection (0.74, 0.55-0.99). Interpretation These findings highlight the necessity for timely antiretroviral care, for support for HIV-infected women and children in developing countries, and for assessment of prophylactic programmes to prevent MTCT, including child mortality and infection averted.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Ghent Int AIDS Soc, Working Grp HIV Infect Women & Children, Ghent, Belgium	University of London; University College London	Newell, ML (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	m.newell@ich.ucl.ac.uk	Gaillard, Philippe/E-7256-2019; Newell, Marie-Louise/AAE-8222-2019; Van de Perre, Philippe/B-9692-2008; Borja, Mario Cortina/A-3847-2009; Sharma, Sushma/AAA-4966-2022; DABIS, FRANCOIS/S-9298-2019	Newell, Marie-Louise/0000-0002-1074-7699; Van de Perre, Philippe/0000-0002-3912-0427; Borja, Mario Cortina/0000-0003-0627-2624; DABIS, FRANCOIS/0000-0002-1614-8857	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033345] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 2004, 2004 REP GLOB AIDS E; BECQUET R, 2003, ANTIRETROVIRAL TH S1, V8, pS200; Bertolli J, 2003, AIDS, V17, P2089, DOI 10.1097/00002030-200309260-00010; Brahmbhatt H, 2002, SOC SCI MED, V55, P585, DOI 10.1016/S0277-9536(01)00189-7; Coutsoudis A, 1999, AIDS, V13, P1517, DOI 10.1097/00002030-199908200-00012; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2003, ACTA PAEDIATR, V92, P890, DOI 10.1080/08035250310004261; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Gaillard P, 2001, AIDS, V15, P389, DOI 10.1097/00002030-200102160-00012; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Ioannidis JPA, 2004, AIDS, V18, P99, DOI 10.1097/00002030-200401020-00012; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Lepage P, 1998, PEDIATR INFECT DIS J, V17, P581, DOI 10.1097/00006454-199807000-00002; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; Mandelbrot L, 2002, SEX TRANSM INFECT, V78, P267, DOI 10.1136/sti.78.4.267; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Newell ML, 1998, AIDS, V12, P831, DOI 10.1097/00002030-199808000-00004; NEWELL ML, 2003, 2 IAS C HIV PATH TRE, P97; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Saba J, 2002, LANCET, V359, P1178; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Therneau T.M., 2000, MODELING SURVIVAL DA, V2, DOI 10.1007/978-1-4757-3294-8; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Zijenah LS, 2004, AIDS, V18, P273, DOI 10.1097/00002030-200401230-00017	32	848	867	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1236	1243		10.1016/S0140-6736(04)17140-7	http://dx.doi.org/10.1016/S0140-6736(04)17140-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464184				2022-12-24	WOS:000224254200030
J	Schaumberg, DA; Mendes, F; Balaram, M; Dana, MR; Sparrow, D; Hu, H				Schaumberg, DA; Mendes, F; Balaram, M; Dana, MR; Sparrow, D; Hu, H			Accumulated lead exposure and risk of age-related cataract in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; BLOOD-PRESSURE; BONE LEAD; COGNITIVE FUNCTION; VISUAL IMPAIRMENT; OXIDATIVE STRESS; HUMAN LENSES; CADMIUM; HEALTH; COPPER	Context Low-level lead exposure may increase the risk for a number of chronic age-related diseases. Several studies have documented the presence of lead in lenses with cataract. The intrusion of lead into the lens may alter lens redox status and cause protein conformational changes that decrease lens transparency. Objective To determine the relationship of cumulative lead exposure with the development of cataract. Design, Setting, and Participants Tibial (cortical) and patellar (trabecular) bone lead levels were measured by K x-ray fluorescence between 1991 and 1999 in a subset of participants in the Normative Aging Study (NAS), a Boston-based longitudinal study of aging in men. Among the first 795 NAS participants to have bone lead levels measured, we reviewed eye examination data (collected routinely every 3-5 years) for the period after the bone lead measurements were taken. We limited the population to men Aged 60 years and older who had sufficient eye examination information Available (n=642). Blood lead levels were also measured. Main Outcome Measures Cataract assessment was done while masked to the lead level results. A participant was considered to have cataract if there was documentation for either eye of cataract surgery or a cataract graded clinically as 3+ or higher on a 4-point scale. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated as estimates of the magnitude and significance of the relationship of lead exposure with cataract, in logistic regression models. Results The mean age of the study participants was 69 years and cataract was identified in 1-22 men. The age-adjusted OR (95% CI) for cataract for men in the highest vs lowest quintile of tibia lead level was 2.68 (1.31-5.50). Further adjustment for pack-years of cigarette smoking, diabetes, blood lead levels, and intake of vitamin C, vitamin E, and carotenoids resulted in an OR of 3.19 (95% CI, 1.48-6.90). For patella lead level, there was an increased risk of cataract in the highest vs lowest quintile (OR, 1.88; 95% CI, 0.88-4.02), but the trend was not significant (P=.16). Blood lead levels, more indicative of short-term exposure levels, were not significantly associated with,cataract (OR, 0.89; 95% CI, 0.46-1.72; P=73). Conclusions These epidemiological data suggest that accumulated lead exposure, such as that commonly experienced by adults in the United States, may be an important unrecognized risk factor for cataract. This research suggests that reduction of lead exposure could help decrease the global burden of cataract.	Harvard Univ, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Brigham & Womens Hosp,Div Prevent Med, E Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Brigham & Womens Hosp,Channing Lab, E Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Normat Aging Study, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Normat Aging Study, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Vet Affairs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Schaumberg, DA (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Brigham & Womens Hosp,Div Prevent Med, 900 Commonwealth Ave, E Boston, MA 02215 USA.	dschaumberg@dcs.bwh.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY000365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R44ES003918, P42ES005947, P30ES000002, R01ES005257] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR02635] Funding Source: Medline; NEI NIH HHS [K23 EY000365-04, K23 EY000365-05] Funding Source: Medline; NIEHS NIH HHS [ES 05257-06A1, P42-ES05947, 2 P30 ES00002, 2R44 ES03918-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Broman AT, 2002, INVEST OPHTH VIS SCI, V43, P3393; Burger D E, 1990, Basic Life Sci, V55, P287; Cekic O, 1998, BRIT J OPHTHALMOL, V82, P186, DOI 10.1136/bjo.82.2.186; Cekic O, 1998, OPHTHALMIC RES, V30, P49, DOI 10.1159/000055454; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; Cheng YW, 1998, AM J CARDIOL, V82, P594, DOI 10.1016/S0002-9149(98)00402-0; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Gavaghan H, 2002, B WORLD HEALTH ORGAN, V80, P82; Glenn BS, 2003, EPIDEMIOLOGY, V14, P30, DOI 10.1097/00001648-200301000-00011; GLYNN RJ, 1982, CIRCULATION, V66, P724, DOI 10.1161/01.CIR.66.4.724; GRUBB BR, 1986, EXP EYE RES, V43, P259, DOI 10.1016/S0014-4835(86)80094-X; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P961, DOI 10.2307/3434138; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Hu H, 1996, JAMA-J AM MED ASSOC, V275, P1171, DOI 10.1001/jama.275.15.1171; Ivers RQ, 2003, J AM GERIATR SOC, V51, P356, DOI 10.1046/j.1532-5415.2003.51109.x; KALCHER K, 1993, SCI TOTAL ENVIRON, V128, P21, DOI 10.1016/0048-9697(93)90177-8; Korrick SA, 1999, AM J PUBLIC HEALTH, V89, P330, DOI 10.2105/AJPH.89.3.330; Landrigan PJ, 2002, B WORLD HEALTH ORGAN, V80, P768; LEGGETT RW, 1993, ENVIRON HEALTH PERSP, V101, P598, DOI 10.2307/3431645; Mangas S, 2003, B WORLD HEALTH ORGAN, V81, P847; Mecocci P, 2004, NEUROL RES, V26, P598, DOI 10.1179/016164104225017659; Neal R, 1999, FREE RADICAL BIO MED, V26, P239, DOI 10.1016/S0891-5849(98)00214-7; Neal R, 1998, TOXICOLOGY, V130, P167, DOI 10.1016/S0300-483X(98)00104-8; Nucci C, 2004, GRAEF ARCH CLIN EXP, V242, P289, DOI 10.1007/s00417-003-0837-z; OFLAHERTY EJ, 1993, TOXICOL APPL PHARM, V118, P16, DOI 10.1006/taap.1993.1004; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Paterson CA, 1997, CURR EYE RES, V16, P333, DOI 10.1076/ceyr.16.4.333.10689; Payton M, 1998, NEUROTOXICOL TERATOL, V20, P19, DOI 10.1016/S0892-0362(97)00075-5; RACZ P, 1988, OPHTHALMIC RES, V20, P10, DOI 10.1159/000266248; RomeroAlvira D, 1996, MED HYPOTHESES, V46, P414, DOI 10.1016/S0306-9877(96)90196-6; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; Shukla N, 1996, SCI TOTAL ENVIRON, V181, P161, DOI 10.1016/0048-9697(95)05006-X; STEINBERG EP, 1993, ARCH OPHTHALMOL-CHIC, V111, P1041, DOI 10.1001/archopht.1993.01090080037016; Stewart WF, 1999, NEUROLOGY, V52, P1610, DOI 10.1212/WNL.52.8.1610; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; *US EPA, 1995, PUBL EPA; Vig EK, 2000, J AM GERIATR SOC, V48, P1501, DOI 10.1111/jgs.2000.48.11.1501; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268	41	65	66	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2750	2754		10.1001/jama.292.22.2750	http://dx.doi.org/10.1001/jama.292.22.2750			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585735	Bronze, Green Published			2022-12-24	WOS:000225546600024
J	Nishimune, H; Sanes, JR; Carlson, SS				Nishimune, H; Sanes, JR; Carlson, SS			A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals	NATURE			English	Article							EATON MYASTHENIC SYNDROME; NEUROTRANSMITTER RELEASE; MICE LACKING; NEUROMUSCULAR-JUNCTIONS; CA2+ CHANNEL; DIFFERENTIATION; TRANSMISSION; EXPRESSION; AUTOIMMUNE; SUBUNITS	Synapse formation requires the differentiation of a functional nerve terminal opposite a specialized postsynaptic membrane. Here, we show that laminin beta2, a component of the synaptic cleft at the neuromuscular junction, binds directly to calcium channels that are required for neurotransmitter release from motor nerve terminals. This interaction leads to clustering of channels, which in turn recruit other presynaptic components. Perturbation of this interaction in vivo results in disassembly of neurotransmitter release sites, resembling defects previously observed in an autoimmune neuromuscular disorder, Lambert-Eaton myasthenic syndrome. These results identify an extracellular ligand of the voltage-gated calcium channel as well as a new laminin receptor. They also suggest a model for the development of nerve terminals, and provide clues to the pathogenesis of a synaptic disease.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Washington University (WUSTL); Harvard University; University of Washington; University of Washington Seattle	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@mcb.harvard.edu	Nishimune, Hiroshi/B-7226-2013					Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; FUKUOKA T, 1987, ANN NEUROL, V22, P193, DOI 10.1002/ana.410220203; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P785; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; Maximov A, 2002, J NEUROSCI, V22, P6939; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; NAGEL A, 1988, ANN NEUROL, V24, P552, DOI 10.1002/ana.410240412; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Pagani R, 2004, NEUROSCIENCE, V123, P75, DOI 10.1016/j.neuroscience.2003.09.019; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Takamori M, 2000, NEUROSCI RES, V36, P183, DOI 10.1016/S0168-0102(99)00135-2; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Vincent A, 2000, EUR J BIOCHEM, V267, P6717, DOI 10.1046/j.1432-1327.2000.01785.x; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yin Y, 2003, GENESIS, V36, P114, DOI 10.1002/gene.10206	39	198	202	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					580	587		10.1038/nature03112	http://dx.doi.org/10.1038/nature03112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577901				2022-12-24	WOS:000225433200036
J	Barnard, DC; Ryan, K; Manley, JL; Richter, JD				Barnard, DC; Ryan, K; Manley, JL; Richter, JD			Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation	CELL			English	Article							MESSENGER-RNA POLYADENYLATION; POLY(A) POLYMERASE; SPECIFICITY FACTOR; OOCYTE MATURATION; 160-KD SUBUNIT; TRANSLATION; PHOSPHORYLATION; CLEAVAGE; PROTEIN; COMPLEX	Cytoplasmic polyadenylation-induced mRNA translation is a hallmark of early animal development. In Xenopus oocytes, where the molecular mechanism has been defined, the core factors that control this process include CPEB, an RNA binding protein whose association with the CPE specifies which mRNAs undergo polyadenylation; CPSF, a multifactor complex that interacts with the near-ubiquitous polyadenylation hexanucleotide AAUAAA; and maskin, a CPEB and eIF4E binding protein whose regulation of initiation is governed by poly(A) tail length. Here, we define two new factors that are essential for polyadenylation. The first is symplekin, a CPEB and CPSF binding protein that serves as a scaffold upon which regulatory factors are assembled. The second is xGLD-2, an unusual poly(A) polymerase that is anchored to CPEB and CPSF even before polyadenylation begins. The identification of these factors has broad implications for biological process that employ polyadenylation-regulated translation, such as gametogenesis, cell cycle progression, and synaptic plasticity.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of Massachusetts System; University of Massachusetts Worcester; Columbia University	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu	Ryan, Kevin/K-6527-2012	Ryan, Kevin/0000-0001-5304-2026; Manley, James/0000-0002-8341-1459	NICHD NIH HHS [HD37267] Funding Source: Medline; NIDDK NIH HHS [DK32520] Funding Source: Medline; NIGMS NIH HHS [GM28983, GM46779, F32-GM64872] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037267, R01HD037267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028983, F32GM064872, R01GM046779] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; BALLANTYNE S, 1995, RNA, V1, P64; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; GEBAUER F, 1995, MOL CELL BIOL, V15, P1422; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Helming S, 2001, MOL CELL BIOL, V21, P2026, DOI 10.1128/MCB.21.6.2026-2037.2001; Hofmann I, 2002, MOL BIOL CELL, V13, P1665, DOI 10.1091/mbc.01-12-0567; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003; Kim H, 2003, EMBO J, V22, P5208, DOI 10.1093/emboj/cdg486; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697; Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Xing HY, 2004, J BIOL CHEM, V279, P10551, DOI 10.1074/jbc.M311719200; Zhao J, 1999, MOL CELL BIOL, V19, P7733; Zhao WQ, 1996, MOL CELL BIOL, V16, P2378	42	250	259	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					641	651		10.1016/j.cell.2004.10.029	http://dx.doi.org/10.1016/j.cell.2004.10.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550246	Bronze			2022-12-24	WOS:000225389500010
J	Moya-Sola, S; Kohler, M; Alba, DM; Casanovas-Vilar, I; Galindo, J				Moya-Sola, S; Kohler, M; Alba, DM; Casanovas-Vilar, I; Galindo, J			Pierolapithecus catalaunicus, a new Middle Miocene great ape from Spain	SCIENCE			English	Article							HOMINOID GENUS; SKULL MATERIAL; LOCOMOTION; SKELETON; PRIMATES; ORIGINS	We describe a partial skeleton with facial cranium of Pierolapithecus catalaunicus gen. et sp. nov., a new Middle Miocene (12.5 to 13 million years ago) ape from Barranc de Can Vita 1 (Barcelona, Spain). It is the first known individual of this age that combines well-preserved cranial, dental, and postcranial material. The thorax, lumbar region, and wrist provide evidence of modern ape-like orthograde body design, and the facial morphology includes the basic derived great ape features. The new skeleton reveals that early great apes retained primitive monkeylike characters associated with a derived body structure that permits upright postures of the trunk. Pierolapithecus, hence, does not fit the theoretical model that predicts that all characters shared by extant great apes were present in their last common ancestor, but instead points to a large amount of homoplasy in ape evolution. The,overall pattern suggests that Pierolapithecus is probably close to the last common ancestor of great apes and humans.	Escola Ind 23, Inst Paleontol M Crusafont, Barcelona 08201, Spain; Palaeotheria, Barcelona 08019, Spain		Moya-Sola, S (corresponding author), Escola Ind 23, Inst Paleontol M Crusafont, Barcelona 08201, Spain.	moyass@diba.es	Alba, David/G-9716-2015; Galindo, Jordi/ABG-2299-2020; Casanovas-Vilar, Isaac/J-2517-2012	Alba, David/0000-0002-8886-5580; Galindo, Jordi/0000-0002-8796-3584; Casanovas-Vilar, Isaac/0000-0001-7092-9622; Kohler, Meike/0000-0002-6816-6651; Moya-Sola, Salvador/0000-0001-8506-1061; Kohler, Meike/0000-0001-9228-3164				Agusti J, 2001, EARTH-SCI REV, V52, P247, DOI 10.1016/S0012-8252(00)00025-8; Alpagut B, 1996, NATURE, V382, P349, DOI 10.1038/382349a0; ANDREWS P, 1992, NATURE, V360, P641, DOI 10.1038/360641a0; BEARD KC, 1986, FOLIA PRIMATOL, V47, P97; Begun David R., 1994, Yearbook of Physical Anthropology, V37, P11; Begun David R., 1997, P389; BEGUN DR, 1993, J HUM EVOL, V24, P373, DOI 10.1006/jhev.1993.1028; CRUSAFONT M, 1961, CR HEBD ACAD SCI, V252, P562; Daams R, 1999, EARTH PLANET SC LETT, V165, P287, DOI 10.1016/S0012-821X(98)00273-8; DEBONIS L, 1990, NATURE, V345, P712, DOI 10.1038/345712a0; FLEAGLE JG, 1976, FOLIA PRIMATOL, V26, P245, DOI 10.1159/000155756; Gebo DL, 1997, SCIENCE, V276, P401, DOI 10.1126/science.276.5311.401; GINGERICH PD, 1982, AM J PHYS ANTHROPOL, V58, P81, DOI 10.1002/ajpa.1330580110; HARRISON T, 1987, J HUM EVOL, V16, P41, DOI 10.1016/0047-2484(87)90060-1; HARRISON T, 1986, J HUM EVOL, V15, P541, DOI 10.1016/S0047-2484(86)80073-2; Ishida H, 2004, J HUM EVOL, V46, P69, DOI 10.1016/j.jhevol.2003.10.001; Kordos L, 2001, J HUM EVOL, V41, P689, DOI 10.1006/jhev.2001.0523; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kunimatsu Y, 2004, J HUM EVOL, V46, P365, DOI 10.1016/j.jhevol.2003.12.008; Le Gros Clark W.E., 1951, FOSSIL MAMMALS AFR, V1, P1; LEAKEY MG, 1991, FOLIA PRIMATOL, V28, P519; LEAKEY RE, 1986, NATURE, V324, P143, DOI 10.1038/324143a0; Lewis O.J., 1974, P143; MCCROSSIN ML, 1997, FUNCTION PHYLOGENY F, P225; Mones A., 1989, Journal of Vertebrate Paleontology, V9, P232; Moya-Sola S, 1999, P NATL ACAD SCI USA, V96, P313, DOI 10.1073/pnas.96.1.313; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Napier J. R., 1959, Fossil Mammals of Africa, V16, P1; Pickford M., 2002, Human Evolution, V17, P1, DOI 10.1007/BF02436425; Pilbeam D, 1996, MOL PHYLOGENET EVOL, V5, P155, DOI 10.1006/mpev.1996.0010; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; Pilbeam David, 1997, P13; SANDERS WJ, 1994, J HUM EVOL, V26, P203, DOI 10.1006/jhev.1994.1012; SARMIENTO EE, 1988, INT J PRIMATOL, V9, P281, DOI 10.1007/BF02737381; Schultz A. H., 1961, pUnpaginated; SCHULTZ AH, 1960, Z MORPHOL ANTHROPOL, V50, P136; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; SOLA SM, 2001, HOMINOID EVOLUTION C, V2, P192; Stauffer RL, 2001, J HERED, V92, P469, DOI 10.1093/jhered/92.6.469; van der Meulen Albert Jan, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P385; VILLALTA JF, 1944, NOTAS COM I GEOL MIN, V13, P1; VILLALTA JF, 1941, B I GEOL MIN ESP, V55, P129; WALKER A, 1968, NATURE, V217, P980, DOI 10.1038/217980a0; WARD CV, 1993, AM J PHYS ANTHROPOL, V92, P291, DOI 10.1002/ajpa.1330920306; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002	46	170	174	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1339	1344		10.1126/science.1103094	http://dx.doi.org/10.1126/science.1103094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550663	Green Submitted			2022-12-24	WOS:000225301600042
J	Leinders-Zufall, T; Brennan, P; Widmayer, P; Chandramani, P; Maul-Pavicic, A; Jager, M; Li, XH; Breer, H; Zufall, F; Boehm, T				Leinders-Zufall, T; Brennan, P; Widmayer, P; Chandramani, P; Maul-Pavicic, A; Jager, M; Li, XH; Breer, H; Zufall, F; Boehm, T			MHC class I peptides as chemosensory signals in the vomeronasal organ	SCIENCE			English	Article							ACCESSORY OLFACTORY SYSTEM; PHEROMONE RECEPTORS; SENSORY NEURONS; MUTANT MICE; MOUSE; GENES; COEXPRESSION; TRANSDUCTION; RECOGNITION; BEHAVIORS	The mammalian vomeronasal organ detects social information about gender, status, and individuality. The molecular cues carrying this information remain largely unknown. Here, we show that small peptides that serve as ligands for major histocompatibility complex (MHC) class I molecules function also as sensory stimuli for a subset of vomeronasal sensory neurons located in the basal Galphao- and V2R receptor-expressing zone of the vomeronasal epithelium. In behaving mice, the same peptides function as individuality signals underlying mate recognition in the context of pregnancy block. MHC peptides constitute a previously unknown family of chemosensory stimuli by which MHC genotypic diversity can influence social behavior.	Max Planck Inst Immunbiol, Dept Dev Immunol, D-79108 Freiburg, Germany; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; Univ Hohenheim, Inst Physiol, D-70593 Stuttgart, Germany	Max Planck Society; University System of Maryland; University of Maryland Baltimore; University of Cambridge; University Hohenheim	Zufall, F (corresponding author), Max Planck Inst Immunbiol, Dept Dev Immunol, D-79108 Freiburg, Germany.	fzufa001@umaryland.edu; boehm@immunbio.mpg.de	Leinders-Zufall, Trese/B-4103-2009; Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/S-3664-2019	Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X				Bargmann CI, 1997, CELL, V90, P585, DOI 10.1016/S0092-8674(00)80518-8; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; He XL, 2001, STRUCTURE, V9, P1213, DOI 10.1016/S0969-2126(01)00689-X; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Lau YE, 2000, NEUROREPORT, V11, P27, DOI 10.1097/00001756-200001170-00006; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; LLOYDTHOMAS A, 1982, NEUROSCIENCE, V7, P907, DOI 10.1016/0306-4522(82)90051-3; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; OCONNELL RJ, 1984, BEHAV NEUROSCI, V98, P1083, DOI 10.1037/0735-7044.98.6.1083; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Spehr M, 2002, J NEUROSCI, V22, P8429; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; Wysocki C.J., 1987, P125	31	422	438	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1033	1037		10.1126/science.1102818	http://dx.doi.org/10.1126/science.1102818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528444				2022-12-24	WOS:000225001100043
J	Shen, BZ; Goodman, HM				Shen, BZ; Goodman, HM			Uridine addition after microRNA-directed cleavage	SCIENCE			English	Article							MESSENGER-RNA; ARABIDOPSIS; TARGETS; MIRNA		Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Goodman, HM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 50 Blossom St, Boston, MA 02114 USA.	goodman@motbio.mgh.harvard.edu						FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; SHEN B, UNPUB; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	6	161	173	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					997	997		10.1126/science.1103521	http://dx.doi.org/10.1126/science.1103521			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528436				2022-12-24	WOS:000225001100032
J	Passegue, E; Wagner, EF; Weissman, IL				Passegue, E; Wagner, EF; Weissman, IL			JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; MICE LACKING JUNB; MYELOGENOUS LEUKEMIA; GENE-EXPRESSION; SELF-RENEWAL; PROGENITORS; GRANULOCYTE; APOPTOSIS; CANCER; BMI-1	The AP-1 transcription factor JunB is a transcriptional regulator of myelopoiesis. Inactivation of JunB in postnatal mice results in a myeloproliferative disorder (MPD) resembling early human chronic myelogenous leukemia (CML). Here, we show that JunB regulates the numbers of hematopoietic stem cells (HSC). JunB overexpression decreases the frequency of long-term HSC (LT-HSC), while JunB inactivation specifically expands the numbers of LT-HSC and granulocyte/macrophage progenitors (GMP) resulting in chronic MPD. Further, we demonstrate that junB inactivation must take place in LT-HSC, and not at later stages of myelopoiesis, to induce MPD and that only junB-deficient LT-HSC are capable of transplanting the MPD to recipient mice. These results demonstrate a stem cell-specific role for JunB in normal and leukemic hematopoiesis and provide experimental evidence that leukemic stem cells (LSC) can reside at the LT-HSC stage of development in a mouse model of MPD.	Stanford Univ, Sch Med, Inst Canc & Stem Cell Biol & Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Canc & Stem Cell Biol & Med, Dept Dev Biol, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Passegue, E (corresponding author), Stanford Univ, Sch Med, Inst Canc & Stem Cell Biol & Med, Dept Pathol, Stanford, CA 94305 USA.	passegue@stanford.edu		Passegue, Emmanuelle/0000-0002-3516-297X; Wagner, Erwin F/0000-0001-7872-0196	NCI NIH HHS [CA55209, CA86017] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086017] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allsopp RC, 2002, ONCOGENE, V21, P3270, DOI 10.1038/sj.onc.1205314; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Bruchova H, 2002, LEUKEMIA LYMPHOMA, V43, P1289, DOI 10.1080/10428190290026358; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Clarkson B, 2003, LEUKEMIA, V17, P1211, DOI 10.1038/sj.leu.2402912; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Domen J, 2000, IMMUNOL RES, V22, P83, DOI 10.1385/IR:22:2-3:83; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Dorsam ST, 2004, BLOOD, V103, P1676, DOI 10.1182/blood-2003-07-2202; Feldman E, 2003, EXP HEMATOL, V31, P702, DOI 10.1016/S0301-472X(03)00176-0; FIALKOW PJ, 1981, BLOOD, V58, P158, DOI 10.1182/blood.V58.1.158.158; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kantarjian HM, 2003, CANCER, V98, P522, DOI 10.1002/cncr.11543; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Matioli GT, 2002, MED HYPOTHESES, V59, P588, DOI 10.1016/S0306-9877(02)00220-7; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Yang MY, 2003, BLOOD, V101, P3205, DOI 10.1182/blood-2002-05-1598	46	292	313	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					431	443		10.1016/j.cell.2004.10.010	http://dx.doi.org/10.1016/j.cell.2004.10.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507213	Bronze			2022-12-24	WOS:000224908300013
J	Yedavalli, VSRK; Neuveut, C; Chi, YH; Kleiman, L; Jeang, KT				Yedavalli, VSRK; Neuveut, C; Chi, YH; Kleiman, L; Jeang, KT			Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function	CELL			English	Article							CONSTITUTIVE TRANSPORT ELEMENT; IMMUNODEFICIENCY-VIRUS REV; NUCLEAR-PORE COMPLEX; MESSENGER-RNA; D RETROVIRUS; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; CELLULAR-PROTEINS; CRM1; TYPE-1	A single transcript in its unspliced and spliced forms directs the synthesis of all HIV-1 proteins. Although nuclear export of intron-containing cellular transcripts is restricted in mammalian cells, HIV-1 has evolved the viral Rev protein to overcome this restriction for viral transcripts. Previously, CRM1 was identified as a cellular cofactor for Rev-dependent export of intron-containing HIV-1 RNA. Here, we present evidence that Rev/CRM1 activity utilizes the ATP-dependent DEAD box RNA helicase, DDX3. We show that DDX3 is a nucleo-cytoplasmic shuttling protein, which binds CRM1 and localizes to nuclear membrane pores. Knockdown of DDX3 using either antisense vector or dominant-negative mutants suppressed Rev-RRE-function in the export of incompletely spliced HIV-1 RNAs. Plausibly, DDX3 is the human RNA helicase which functions in the CRM1 RNA export pathway analogously to the postulated role for Dbp5p in yeast mRNA export.	NIAID, Mol Virol Sect, Mol Microbiol Lab, Bethesda, MD 20892 USA; McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Lady Davis Institute; McGill University	Jeang, KT (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Chi, Ya-Hui/ABE-8550-2020; Chi, Ya-Hui/B-1080-2010; Jeang, Kuan-Teh/A-2424-2008	Chi, Ya-Hui/0000-0002-9216-0938; Neuveut, Christine/0000-0001-6520-271X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547, ZIAAI000547] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Bear J, 1999, MOL CELL BIOL, V19, P6306; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Clouse KN, 2001, NAT CELL BIOL, V3, P97, DOI 10.1038/35050625; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; FULLERPACE FV, 1993, EMBO J, V12, P3619, DOI 10.1002/j.1460-2075.1993.tb06035.x; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gururajan R, 1997, BBA-GENE STRUCT EXPR, V1350, P169, DOI 10.1016/S0167-4781(96)00155-8; Harris ME, 2000, ESSAYS BIOCHEM, V36, P115, DOI 10.1042/bse0360115; Herold A, 2001, RNA, V7, P1768; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jeang KT, 2004, J BIOL CHEM, V279, P31991, DOI 10.1074/jbc.R400009200; JENSEN TH, 1995, GENE, V162, P235, DOI 10.1016/0378-1119(95)00328-4; Kadare G, 1997, J VIROL, V71, P2583; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Linder P, 2001, CURR BIOL, V11, pR961, DOI 10.1016/S0960-9822(01)00574-7; Linder P, 2003, BIOL CELL, V95, P157, DOI 10.1016/S0248-4900(03)00032-7; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Linder P, 2001, TRENDS BIOCHEM SCI, V26, P339, DOI 10.1016/S0968-0004(01)01870-9; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Park SH, 1998, CYTOGENET CELL GENET, V81, P178, DOI 10.1159/000015022; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; SODROSKI J, 1986, NATURE, V321, P410; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tang H, 1999, MOL CELL BIOL, V19, P3540; Tang HL, 2000, J BIOL CHEM, V275, P32694, DOI 10.1074/jbc.M003933200; Tang HL, 1997, VIROLOGY, V228, P333, DOI 10.1006/viro.1996.8407; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Van Baalen CA, 1998, J VIROL, V72, P6851, DOI 10.1128/JVI.72.8.6851-6857.1998; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zhang XF, 2003, J BIOCHEM, V134, P759, DOI 10.1093/jb/mvg197; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994	61	410	428	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					381	392		10.1016/j.cell.2004.09.029	http://dx.doi.org/10.1016/j.cell.2004.09.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507209	Bronze			2022-12-24	WOS:000224908300009
J	Howe, GR				Howe, GR			Studies of nuclear workers: the pros and cons	LANCET			English	Editorial Material							ATOMIC-ENERGY-AUTHORITY; MORTALITY; EMPLOYEES; CANCER		Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Howe, GR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	gh68@columbia.edu						Armitage P., 1987, STAT METHODS MED RES; Atkinson WD, 2004, OCCUP ENVIRON MED, V61, P577, DOI 10.1136/oem.2003.012443; BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; CARDIS E, 1994, LANCET, V344, P1039; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Muirhead C. R., 1999, Journal of Radiological Protection, V19, P3, DOI 10.1088/0952-4746/19/1/002; PERSTON DL, 2003, RADIAT RES, V160, P381; ROONEY C, 1993, BRIT MED J, V307, P1391, DOI 10.1136/bmj.307.6916.1391; *UNSCEAR, 2000, GEN ASS SCI ANN EFF, V2	9	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1199	1200		10.1016/S0140-6736(04)17157-2	http://dx.doi.org/10.1016/S0140-6736(04)17157-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464167				2022-12-24	WOS:000224254200007
J	Zhang, LX; Zhou, H; Su, Y; Sun, ZH; Zhang, HW; Zhang, L; Zhang, Y; Ning, YH; Chen, YG; Meng, AM				Zhang, LX; Zhou, H; Su, Y; Sun, ZH; Zhang, HW; Zhang, L; Zhang, Y; Ning, YH; Chen, YG; Meng, AM			Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors	SCIENCE			English	Article							TGF-BETA RECEPTOR; ONE-EYED-PINHEAD; WNT SIGNALS; GASTRULATION; INTERNALIZATION; ENDOCYTOSIS; ANTAGONIST; INTERACTS; ANTIVIN; SMAD2	Nodal proteins, members of the transforming growth factor-beta (TGFbeta) superfamily, have been identified as key endogenous mesoderm inducers in vertebrates. Precise control of Nodal signaling is essential for normal development of embryos. Here, we report that zebrafish dapper2 (dpr2) is expressed in mesoderm precursors during early embryogenesis and is positively regulated by Nodal signals. In vivo functional studies in zebrafish suggest that Dpr2 suppresses mesoderm induction activities of Nodal signaling. Dpr2 is localized in late endosomes, binds to the TGFbeta receptors ALK5 and ALK4, and accelerates lysosomal degradation of these receptors.	Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Dev Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Mol Cell Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, YG (corresponding author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Dev Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@mail.tsinghua.edu.cn; mengam@mail.tsinghua.edu.cn	Zhang, Yu/F-6583-2016; Su, Ying/M-5825-2013; Meng, Anming/A-4785-2012; Chen, Ye-Guang/L-6998-2019; Su, Ying/ABA-8545-2021; Zhang, Long/AAT-6571-2021	Su, Ying/0000-0002-8466-0043; Su, Ying/0000-0002-8466-0043; Zhang, Long/0000-0001-8139-0474; Meng, Anming/0000-0001-7228-3431; Zhang, Yu/0000-0001-5512-9272				Agathon A, 2001, GENESIS, V30, P178, DOI 10.1002/gene.1059; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Iratni R, 2002, SCIENCE, V298, P1996, DOI 10.1126/science.1073405; Katoh M, 2003, INT J ONCOL, V22, P907; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Osada SI, 2000, DEVELOPMENT, V127, P2503; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Thisse C, 1999, DEVELOPMENT, V126, P229; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang L., UNPUB; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	25	110	122	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					114	117		10.1126/science.1100569	http://dx.doi.org/10.1126/science.1100569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459392				2022-12-24	WOS:000224304000049
J	Fotin, A; Cheng, YF; Sliz, P; Grigorieff, N; Harrison, SC; Kirchhausen, T; Walz, T				Fotin, A; Cheng, YF; Sliz, P; Grigorieff, N; Harrison, SC; Kirchhausen, T; Walz, T			Molecular model for a complete clathrin lattice from electron cryomicroscopy	NATURE			English	Article							LIGHT-CHAINS; 3-DIMENSIONAL STRUCTURE; LOCATION; COATS; TRIMERIZATION; STABILIZATION; ORGANIZATION; RESOLUTION; SOFTWARE	Clathrin-coated vesicles are important vehicles of membrane traffic in cells. We report the structure of a clathrin lattice at subnanometre resolution, obtained from electron cryomicroscopy of coats assembled in vitro. We trace most of the 1,675-residue clathrin heavy chain by fitting known crystal structures of two segments, and homology models of the rest, into the electron microscopy density map. We also define the position of the central helical segment of the light chain. A helical tripod, the carboxyterminal parts of three heavy chains, projects inward from the vertex of each three-legged clathrin triskelion, linking that vertex to 'ankles' of triskelions centred two vertices away. Analysis of coats with distinct diameters shows an invariant pattern of contacts in the neighbourhood of each vertex, with more variable interactions along the extended parts of the triskelion 'legs'. These invariant local interactions appear to stabilize the lattice, allowing assembly and uncoating to be controlled by events at a few specific sites.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Biophys Grad Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Brandeis University; Brandeis University; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA.	Harrison@crystal.harvard.edu	Gimenez, Luis E Diaz/D-9291-2011	Cheng, Yifan/0000-0001-9535-0369; Walz, Thomas/0000-0003-2606-2835; Sliz, Piotr/0000-0002-6522-0835; Grigorieff, Nikolaus/0000-0002-1506-909X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chen CY, 2002, EMBO J, V21, P6072, DOI 10.1093/emboj/cdf594; CROWTHER RA, 1976, J MOL BIOL, V103, P785, DOI 10.1016/0022-2836(76)90209-6; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1992, YAAP ASAP SET AVERAG; KIRCHHAUSEN T, 1987, SCIENCE, V236, P320, DOI 10.1126/science.3563513; KIRCHHAUSEN T, 1986, J ULTRA MOL STRUCT R, V94, P199, DOI 10.1016/0889-1605(86)90067-4; KIRCHHAUSEN T, 1983, P NATL ACAD SCI-BIOL, V80, P2481, DOI 10.1073/pnas.80.9.2481; KIRCHHAUSEN T, 1993, J BIOL CHEM, V268, P10268; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCARMATO P, 1990, J BIOL CHEM, V265, P3661; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; THON F, 1966, Z NATURFORSCH PT A, VA 21, P476, DOI 10.1515/zna-1966-0417; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; UNGEWICKELL E, 1983, EMBO J, V2, P1401, DOI 10.1002/j.1460-2075.1983.tb01598.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x; VIGERS GPA, 1986, EMBO J, V5, P529, DOI 10.1002/j.1460-2075.1986.tb04242.x; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708	40	390	397	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					573	579		10.1038/nature03079	http://dx.doi.org/10.1038/nature03079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15502812				2022-12-24	WOS:000225433200035
J	Oberholzer-Gee, F; Inamdar, SN				Oberholzer-Gee, F; Inamdar, SN			Merck's recall of rofecoxib - A strategic perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Oberholzer-Gee, F (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							DANZON PM, W10536 NBER; Grabowski H, 2002, PHARMACOECONOMICS, V20, P11, DOI 10.2165/00019053-200220003-00002; PISANO GP, 97105 HARV BUS SCH	3	26	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2004	351	21					2147	2149		10.1056/NEJMp048284	http://dx.doi.org/10.1056/NEJMp048284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	871UU	15548771				2022-12-24	WOS:000225160600001
J	Baron, R; Janig, W				Baron, R; Janig, W			Complex regional pain syndromes - how do we escape the diagnostic trap?	LANCET			English	Editorial Material							REFLEX SYMPATHETIC DYSTROPHY; CRITERIA; CRPS		Univ Kiel, Neurol Klin, Dept Neurol Pain Res & Therapy, D-24105 Kiel, Germany; Univ Kiel, Dept Physiol, D-24105 Kiel, Germany	University of Kiel; University of Kiel	Baron, R (corresponding author), Univ Kiel, Neurol Klin, Dept Neurol Pain Res & Therapy, D-24105 Kiel, Germany.	r.baron@neurologie.uni-kiel.de	Baron, Ralf/E-4298-2010					Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Cocchiarella L., 2001, GUIDES EVALUATION PE; Graif M, 1998, SKELETAL RADIOL, V27, P262, DOI 10.1007/s002560050378; Harden R, 2001, COMPLEX REGIONAL PAI; Harden RN, 1999, PAIN, V83, P211, DOI 10.1016/S0304-3959(99)00104-9; HARDEN RN, IN PRESS CRPS CURREN; Huygen FJPM, 2002, MEDIAT INFLAMM, V11, P47, DOI 10.1080/09629350210307; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Schattschneider J, 2001, PROG PAIN RES MANAG, V22, P119; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; van de Beek WJT, 2003, PAIN, V103, P93, DOI 10.1016/S0304-3959(02)00444-X; van Hilten JJ, 2000, ANN NEUROL, V48, P113, DOI 10.1002/1531-8249(200007)48:1<113::AID-ANA18>3.0.CO;2-9; Wasner G, 2002, PAIN, V98, P19, DOI 10.1016/S0304-3959(01)00470-5; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Zyluk A, 1999, J HAND SURG-BRIT EUR, V24B, P16, DOI 10.1016/S0266-7681(99)90011-6	17	44	45	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 13	2004	364	9447					1739	1741		10.1016/S0140-6736(04)17416-3	http://dx.doi.org/10.1016/S0140-6736(04)17416-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PQ	15541435				2022-12-24	WOS:000225070600009
J	Vamvakas, EC				Vamvakas, EC			Platelet transfusion and adverse outcomes	LANCET			English	Editorial Material							ALLOGENEIC BLOOD-TRANSFUSION; RANDOMIZED CONTROLLED-TRIAL; POSTOPERATIVE INFECTION; CARDIAC-SURGERY		Univ Ottawa, Dept Pathol & Lab Med, Canadian Blood Serv, Ottawa, ON K1G 4J5, Canada	Canadian Blood Services; University of Ottawa	Vamvakas, EC (corresponding author), Univ Ottawa, Dept Pathol & Lab Med, Canadian Blood Serv, Ottawa, ON K1G 4J5, Canada.	stephen.vamvakas@bloodservices.ca						Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21; BORDIN JO, 1994, BLOOD, V84, P344; Bracey AW, 2002, TRANSFUSION, V42, p5S; Magee CC, 1997, CURR OPIN IMMUNOL, V9, P669, DOI 10.1016/S0952-7915(97)80047-7; MVAKAS EC, 2003, TRANSFUSION, V43, P963; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x; Vamvakas EC, 2002, TRANSFUS MED REV, V16, P304, DOI 10.1053/tmrv.2002.35209; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; van de Watering LMG, 1998, CIRCULATION, V97, P562; van Hilten JA, 2004, BMJ-BRIT MED J, V328, P1281, DOI 10.1136/bmj.38103.735266.55; Wallis JP, 2002, TRANSFUSION, V42, P1127, DOI 10.1046/j.1537-2995.2002.00181.x	13	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 13	2004	364	9447					1736	1738		10.1016/S0140-6736(04)17414-X	http://dx.doi.org/10.1016/S0140-6736(04)17414-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PQ	15541433				2022-12-24	WOS:000225070600007
J	Powell, K				Powell, K			Age is no barrier ...	NATURE			English	News Item							CRYOPRESERVED OVARIAN TISSUE; TRANSPLANTATION											Battaglia DE, 1996, HUM REPROD, V11, P2217; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Gruijters MJG, 2003, MOL CELL ENDOCRINOL, V211, P85, DOI 10.1016/j.mce.2003.09.024; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Oktay K, 2004, LANCET, V363, P837, DOI 10.1016/S0140-6736(04)15728-0; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Porcu E, 2004, EUR J OBSTET GYN R B, V113, pS14, DOI 10.1016/j.ejogrb.2003.11.004	9	6	6	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					40	42		10.1038/432040a	http://dx.doi.org/10.1038/432040a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525976	Bronze			2022-12-24	WOS:000224854900033
J	Kerr, T; Wodak, A; Elliott, R; Montaner, JS; Wood, E				Kerr, T; Wodak, A; Elliott, R; Montaner, JS; Wood, E			Opioid substitution and HIV/AIDS treatment and prevention	LANCET			English	Editorial Material							INJECTING DRUG-USERS; METHADONE-MAINTENANCE; BUPRENORPHINE; PROGRAMS; THERAPY; RISK; AIDS		St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Canadian HIV AIDS Legal Network, Montreal, PQ, Canada; St Vincents Hosp, Alcohol & Durg Serv, Sydney, NSW 2010, Australia; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; St Vincents Hospital Sydney; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	tkerr@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					[Anonymous], 2004, 2004 REP GLOB AIDS E; Antela A, 1997, AIDS, V11, P1405; Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170; BALL J, 1991, EFF METH MAINT TREAT; Bell J, 2000, DRUG SAFETY, V22, P179, DOI 10.2165/00002018-200022030-00002; Caplehorn JRM, 1996, SUBST USE MISUSE, V31, P177, DOI 10.3109/10826089609045806; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Judd LL, 1998, JAMA-J AM MED ASSOC, V280, P1936; Kerr T, 2004, LANCET, V364, P11, DOI 10.1016/S0140-6736(04)16610-5; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moreno A, 2001, AIDS, V15, P1068, DOI 10.1097/00002030-200105250-00021; *WHO, 2004, INV COMPR HLTH SECT; *WHO, 2004, ESS DRUG POL PROGR; *WHO, 2003, ESS MED WHO MOD LIST; *WHO UN OFF DRUG C, 2004, SUBST MAINT THER MAN; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; Wood E, 2003, AIDS, V17, P2419, DOI 10.1097/00002030-200311210-00003; World Health Organization, 2004, SCAL ANT THER RES LT	19	46	46	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV-DEC	2004	364	9449					1918	1919		10.1016/S0140-6736(04)17490-4	http://dx.doi.org/10.1016/S0140-6736(04)17490-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874BX	15566992				2022-12-24	WOS:000225327000006
J	Bonadonna, F; Nevitt, GA				Bonadonna, F; Nevitt, GA			Partner-specific odor recognition in an Antarctic seabird	SCIENCE			English	Article									CNRS, Ctr Ecol Fonct & Evolut, Behav Ecol Grp, F-34293 Montpellier 5, France; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of California System; University of California Davis	Bonadonna, F (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, Behav Ecol Grp, 1919 Route Mende, F-34293 Montpellier 5, France.	bonadonna@cefe.cnrs.fr	Bonadonna, Francesco/A-7456-2008	Bonadonna, Francesco/0000-0002-2702-5801				Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; De Leon A, 2003, BEHAVIOUR, V140, P925, DOI 10.1163/156853903770238382; Hagelin JC, 2003, P ROY SOC B-BIOL SCI, V270, P1323, DOI 10.1098/rspb.2003.2379; Mateo J, 2001, TRENDS ECOL EVOL, V16, P74, DOI 10.1016/S0169-5347(00)02042-5; Nevitt GA, 2000, BIOL BULL-US, V198, P245, DOI 10.2307/1542527; Warham J., 1996, BEHAV POPULATION BIO	6	193	196	28	1434	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					835	835		10.1126/science.1103001	http://dx.doi.org/10.1126/science.1103001			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514149				2022-12-24	WOS:000224969400036
J	Reznick, DN; Bryant, MJ; Roff, D; Ghalambor, CK; Ghalambor, DE				Reznick, DN; Bryant, MJ; Roff, D; Ghalambor, CK; Ghalambor, DE			Effect of extrinsic mortality on the evolution of senescence in guppies	NATURE			English	Article							LIFE-HISTORY EVOLUTION; POECILIA-RETICULATA; NATURAL-POPULATIONS; GENETIC-BASIS; REPRODUCTION; SPAN; PERFORMANCE; PREDATION; GROWTH	Classical theories(1,2) for the evolution of senescence predict that organisms that experience low mortality rates attributable to external factors, such as disease or predation, will evolve a later onset of senescence. Here we use patterns of senescence in guppies derived from natural populations that differ in mortality risk to evaluate the generality of these predictions. We have previously found that populations experiencing higher mortality rates evolve earlier maturity and invest more in reproduction, as predicted by evolutionary theory(3). We report here that these same populations do not have an earlier onset of senescence with respect to either mortality or reproduction but do with respect to swimming performance, which assesses neuromuscular function. This mosaic pattern of senescence challenges the generality of the association between decreased extrinsic mortality and delayed senescence and invites consideration of more derived theories for the evolution of senescence.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Calif Inst Arts, Sch Crit Studies, Valencia, CA 91355 USA; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University of California System; University of California Riverside; Colorado State University	Reznick, DN (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	david.reznick@ucr.edu	Ghalambor, Cameron/V-4486-2019; Ghalambor, Cameron/HGE-0411-2022	Ghalambor, Cameron/0000-0003-2515-4981; reznick, david/0000-0002-1144-0568				ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI [10.2307/2410191, 10.1111/j.1558-5646.1993.tb01241.x]; AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; CARVALHO GR, 1991, BIOL J LINN SOC, V42, P389, DOI 10.1111/j.1095-8312.1991.tb00571.x; Charlesworth B., 1980, EVOLUTION AGE STRUCT; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; Domenici P, 1997, J EXP BIOL, V200, P1165; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Hendry AP, 2004, P ROY SOC B-BIOL SCI, V271, P259, DOI 10.1098/rspb.2003.2600; HOLMES DJ, 1995, AM ZOOL, V35, P307; *INS CORP, 2001, S PLUS 6 WIND GUID S, V3; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; LUCKINBILL LS, 1985, HEREDITY, V55, P9, DOI 10.1038/hdy.1985.66; MCMILLAN I, 1970, GENETICS, V65, P349; MEDAWAR PB, 2002, UNSOLVED PROBLEM BIO; OPPENHEIMER L, 1981, BIOCHEM J, V197, P721, DOI 10.1042/bj1970721; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; Reznick D, 2002, MECH AGEING DEV, V123, P773, DOI 10.1016/S0047-6374(01)00423-7; Reznick D, 2001, EXP GERONTOL, V36, P791, DOI 10.1016/S0531-5565(00)00241-2; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Tatar M, 1997, OECOLOGIA, V111, P357, DOI 10.1007/s004420050246; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2003, EVOLUTION, V57, P1478	32	313	320	3	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1095	1099		10.1038/nature02936	http://dx.doi.org/10.1038/nature02936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510147				2022-12-24	WOS:000224730800040
J	Benner, SA				Benner, SA			Redesigning genetics	SCIENCE			English	Editorial Material							NUCLEIC-ACID; ENZYMATIC INCORPORATION; DIRECTED EVOLUTION; DNA-POLYMERASE; BASE-PAIR; RNA; STABILITY; THYMIDINE; SYSTEMS; ABILITY		Univ Florida, Dept Chem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Benner, SA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	benner@chem.ufl.edu						Ball P, 2004, NATURE, V431, P624, DOI 10.1038/431624a; Benner SA, 2002, BIOORG CHEM, V30, P62, DOI 10.1006/bioo.2001.1232; Collins ML, 1997, NUCLEIC ACIDS RES, V25, P2979, DOI 10.1093/nar/25.15.2979; Elbeik T, 2004, J CLIN MICROBIOL, V42, P563, DOI 10.1128/JCM.42.2.563-569.2004; Fa M, 2004, J AM CHEM SOC, V126, P1748, DOI 10.1021/ja038525p; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Geyer CR, 2003, STRUCTURE, V11, P1485, DOI 10.1016/j.str.2003.11.008; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Gibbs WW, 2004, SCI AM, V290, P74; Goodman MF, 1999, NAT BIOTECHNOL, V17, P640, DOI 10.1038/10852; Lai JS, 2004, J AM CHEM SOC, V126, P3040, DOI 10.1021/ja039571s; Liu HB, 2004, J AM CHEM SOC, V126, P1102, DOI 10.1021/ja038384r; Martinot TA, 2004, J ORG CHEM, V69, P3972, DOI 10.1021/jo0497959; MILLER PS, 1977, BIOCHEMISTRY-US, V16, P1988, DOI 10.1021/bi00628a036; Minakawa N, 2003, J AM CHEM SOC, V125, P9970, DOI 10.1021/ja0347686; Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506; Nielsen PE, 2004, MOL BIOTECHNOL, V26, P233, DOI 10.1385/MB:26:3:233; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; SWITZER C, 1989, J AM CHEM SOC, V111, P8322, DOI 10.1021/ja00203a067; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	21	33	33	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					625	626		10.1126/science.1101104	http://dx.doi.org/10.1126/science.1101104			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499002				2022-12-24	WOS:000224756700033
J	Della, M; Palmbos, PL; Tseng, HM; Tonkin, LM; Daley, JM; Topper, LM; Pitcher, RS; Tomkinson, AE; Wilson, TE; Doherty, AJ				Della, M; Palmbos, PL; Tseng, HM; Tonkin, LM; Daley, JM; Topper, LM; Pitcher, RS; Tomkinson, AE; Wilson, TE; Doherty, AJ			Mycobacterial Ku and ligase proteins constitute a two-component NHEJ repair machine	SCIENCE			English	Article							STRAND BREAK REPAIR; EUKARYOTIC DNA PRIMASE; SACCHAROMYCES-CEREVISIAE; POLYMERASE-LAMBDA; JOINING REPAIR; YEAST; COMPLEX; ENDS; IV; MU	In mammalian cells, repair of DNA double-strand. breaks (DSBs) by nonhomologous end-joining (NHEJ) is critical for genome stability. Although the end-bridging and ligation steps of NHEJ have been reconstituted in vitro, little is known about the end-processing reactions that occur before ligation. Recently, functionally homologous end-bridging and ligation activities have been identified in prokarya. Consistent with its homology to polymerases and nucleases, we demonstrate that DNA ligase D from Mycobacterium tuberculosis (Mt-Lig) possesses a unique variety of nucleotidyl transferase activities, including gap-filling polymerase, terminal transferase, and primase, and is also a 3' to 5' exonuclease. These enzyme activities allow the Mt-Ku and Mt-Lig proteins to join incompatible DSB ends in vitro, as well as to reconstitute NHEJ in vivo in yeast. These results demonstrate that prokaryotic Ku and ligase form a bona fide NHEJ system that encodes all the recognition, processing, and ligation activities required for DSB repair.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Mol Med Grad Program, San Antonio, TX USA; Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA	University of Sussex; University of Cambridge; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Doherty, AJ (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	AJD21@sussex.ac.uk		Doherty, Aidan/0000-0002-6370-1109	NATIONAL CANCER INSTITUTE [R01CA102563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102563, R01 CA102563-01A1] Funding Source: Medline; NIGMS NIH HHS [T32 GM007315] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Bebenek K, 2003, J BIOL CHEM, V278, P34685, DOI 10.1074/jbc.M305705200; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; CHENG SN, 2000, P INT WORKSH ANN COM, V1, P275; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Covo S, 2004, J BIOL CHEM, V279, P859, DOI 10.1074/jbc.M310447200; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; DELLA M, UNPUB; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Karathanasis E, 2002, GENETICS, V161, P1015; Koonin EV, 2000, J MOL MICROB BIOTECH, V2, P509; Krejci L, 2003, PROG NUCLEIC ACID RE, V74, P159, DOI 10.1016/S0079-6603(03)01013-4; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Ramsden DA, 1997, NATURE, V388, P488, DOI 10.1038/41351; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Weller GR, 2001, FEBS LETT, V505, P340, DOI 10.1016/S0014-5793(01)02831-9; Wilson TE, 2003, TRENDS BIOCHEM SCI, V28, P62, DOI 10.1016/S0968-0004(03)00005-7; Wilson TE, 2002, GENETICS, V162, P677; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599	29	166	174	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					683	685		10.1126/science.1099824	http://dx.doi.org/10.1126/science.1099824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499016				2022-12-24	WOS:000224756700050
J	Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ				Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ			A Silurian sea spider	NATURE			English	Article							HEREFORDSHIRE; ARTHROPOD; PYCNOGONIDA; PHYLOGENETICS	Pycnogonids (sea spiders) are marine arthropods numbering some 1,160 extant species. They are globally distributed in depths of up to 6,000 metres, and locally abundant(1,2); however, their typically delicate form and non-biomineralized cuticle has resulted in an extremely sparse fossil record that is not accepted universally(3). There are two opposing views of their phylogenetic position: either within Chelicerata as sister group to the euchelicerates(4-7), or as a sister taxon to all other euarthropods(8). The Silurian Herefordshire Konservat-Lagerstatte(9) in England (similar to425 million years (Myr) BP) yields exceptionally preserved three-dimensional fossils that provide unrivalled insights into the palaeobiology of a variety of invertebrates(10-14). The fossils are preserved as calcitic void in-fills in carbonate concretions within a volcaniclastic horizon(15), and are reconstructed digitally(12). Here we describe a new pycnogonid from this deposit, which is the oldest adult sea spider by similar to35 Myr and the most completely known fossil species. The large chelate first appendage is consistent with a chelicerate affinity for the pycnogonids. Cladistic analyses place the new species near the base of the pycnogonid crown group, implying that the latter had arisen by the Silurian period.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PS, England; Univ Museum Nat Hist, Geol Collect, Oxford OX1 3PW, England; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	University of Oxford; University of Oxford; Yale University; University of Leicester	Siveter, DJ (corresponding author), Univ Oxford, Dept Earth Sci, S Parks Rd, Oxford OX1 3PS, England.	derek.siveter@earth.ox.ac.uk	Sutton, Mark/A-4189-2010					[Anonymous], 1998, FOSSILS HUNSR CK SLA; Arango CP, 2003, MOL PHYLOGENET EVOL, V28, P588, DOI 10.1016/S1055-7903(03)00069-1; Arango CP, 2002, ORG DIVERS EVOL, V2, P107, DOI 10.1078/1439-6092-00035; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; BERGSTROM J, 1980, Palaeontologische Zeitschrift, V54, P7; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Briggs DEG, 2004, P ROY SOC B-BIOL SCI, V271, P131, DOI 10.1098/rspb.2003.2593; Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Child C. Allan, 1998, NIWA Biodiversity Memoir, V109, P1; DUNLOP JA, IN PRESS J ZOOL SYST; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; King P.E., 1973, PYCNOGONIDS; Miyazaki K, 2002, J MAR BIOL ASSOC UK, V82, P1037, DOI 10.1017/S0025315402006628; Orr PJ, 2000, J GEOL SOC LONDON, V157, P173, DOI 10.1144/jgs.157.1.173; Siveter DJ, 2003, SCIENCE, V302, P1749, DOI 10.1126/science.1091376; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; Sutton MD, 2001, P ROY SOC B-BIOL SCI, V268, P2355, DOI 10.1098/rspb.2001.1788; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; Vilpoux K, 2003, ARTHROPOD STRUCT DEV, V32, P349, DOI 10.1016/j.asd.2003.09.004; Waloszek D, 2002, PALAEONTOLOGY, V45, P421, DOI 10.1111/1475-4983.00244; Wilby PR, 1996, GEOLOGY, V24, P847, DOI 10.1130/0091-7613(1996)024<0847:MOSBII>2.3.CO;2	21	68	70	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					978	980		10.1038/nature02928	http://dx.doi.org/10.1038/nature02928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496921				2022-12-24	WOS:000224585600042
J	Kobasa, D; Takada, A; Shinya, K; Hatta, M; Halfmann, P; Theriault, S; Suzuki, H; Nishimura, H; Mitamura, K; Sugaya, N; Usui, T; Murata, T; Maeda, Y; Watanabe, S; Suresh, M; Suzuki, T; Suzuki, Y; Feldmann, H; Kawaoka, Y				Kobasa, D; Takada, A; Shinya, K; Hatta, M; Halfmann, P; Theriault, S; Suzuki, H; Nishimura, H; Mitamura, K; Sugaya, N; Usui, T; Murata, T; Maeda, Y; Watanabe, S; Suresh, M; Suzuki, T; Suzuki, Y; Feldmann, H; Kawaoka, Y			Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus	NATURE			English	Article							INFECTION; CYTOKINE; PATHOGENICITY; RESPONSES; PROTEIN; GENES	The 'Spanish' influenza pandemic of 1918-19 was the most devastating outbreak of infectious disease in recorded history. At least 20 million people(1) died from their illness, which was characterized by an unusually severe and rapid clinical course. The complete sequencing of several genes of the 1918 influenza virus has made it possible to study the functions of the proteins encoded by these genes in viruses generated by reverse genetics, a technique that permits the generation of infectious viruses entirely from cloned complementary DNA. Thus, to identify properties of the 1918 pandemic influenza A strain that might be related to its extraordinary virulence, viruses were produced containing the viral haemagglutinin(2) (HA) and neuraminidase(3) (NA) genes of the 1918 strain. The HA of this strain supports the pathogenicity of a mouse-adapted virus in this animal(4,5). Here we demonstrate that the HA of the 1918 virus confers enhanced pathogenicity in mice to recent human viruses that are otherwise non-pathogenic in this host. Moreover, these highly virulent recombinant viruses expressing the 1918 viral HA could infect the entire lung and induce high levels of macrophage-derived chemokines and cytokines, which resulted in infiltration of inflammatory cells and severe haemorrhage, hallmarks of the illness produced during the original pandemic(6).	Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; Hlth Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 3R2, Canada; Niigata Univ, Sch Med, Dept Publ Hlth, Niigata 9518510, Japan; Sendai Natl Hosp, Div Clin Res, Viral Res Ctr, Sendai, Miyagi 9838520, Japan; Nippon Kokan Ltd Co Hosp, Dept Pediat, Kawasaki, Kanagawa 2100852, Japan; Univ Shizuoka, Dept Appl Biol Chem, Shizuoka 4228529, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; COE Program 21st Century, Shizuoka 4228526, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Japan Science & Technology Agency (JST); Health Canada; University of Manitoba; Niigata University; University of Shizuoka; University of Shizuoka	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019; Takada, Ayato/A-6679-2012	Yasuo, Suzuki/0000-0003-3518-5642; Suresh, Marulasiddappa/0000-0003-1794-3358				Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; [Anonymous], FIELDS VIROLOGY; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; CONNOR JS, 1994, VIROLOGY, V15, P17; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Totani K, 2003, GLYCOBIOLOGY, V13, P315, DOI 10.1093/glycob/cwg032; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699	30	360	408	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					703	707		10.1038/nature02951	http://dx.doi.org/10.1038/nature02951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470432	Bronze			2022-12-24	WOS:000224299300044
J	Formisano, V; Atreya, S; Encrenaz, T; Ignatiev, N; Giuranna, M				Formisano, V; Atreya, S; Encrenaz, T; Ignatiev, N; Giuranna, M			Detection of methane in the atmosphere of Mars	SCIENCE			English	Article							SUBSURFACE LIFE; PHOTOCHEMISTRY; ECOSYSTEMS; STABILITY	We report a detection of methane in the martian atmosphere by the Planetary Fourier Spectrometer onboard the Mars Express spacecraft. The global average methane mixing ratio is found to be 10+/-5 parts per billion by volume (ppbv). However, the mixing ratio varies between 0 and 30 ppbv over the planet. The source of methane could be either biogenic or nonbiogenic, including past or present subsurface microorganisms, hydrothermal activity, or cometary impacts.	INAF IFSI, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Observ Paris, Lab Etud Spatiales & Instrumentat Astrophys, Observ Paris, F-92195 Meudon, France; Russian Acad Sci IKI, Space Res Inst, Moscow 117810, Russia	Istituto Nazionale Astrofisica (INAF); University of Michigan System; University of Michigan; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences	Formisano, V (corresponding author), INAF IFSI, Ist Fis Spazio Interplanetario, Via Fosso Cavaliere 100, I-00133 Rome, Italy.	formisan@nike.ifsi.rm.cnr.it	GIURANNA, Marco/S-9378-2017	GIURANNA, Marco/0000-0001-8967-9184; Ignatiev, Nikolay/0000-0002-6358-7094				[Anonymous], 1996, SOIL MICROBIOLOGY BI; ATREYA SK, 1995, ADV SPACE RES, V16, P57, DOI 10.1016/0273-1177(95)00250-I; ATREYA SK, 1994, J GEOPHYS RES-PLANET, V99, P13133, DOI 10.1029/94JE01085; BOSTON PJ, 1992, ICARUS, V95, P300, DOI 10.1016/0019-1035(92)90045-9; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Clancy R. T., 2003, Journal of Geophysical Research, V108, P2, DOI 10.1029/2003JE002058; Cronin J.R., 1988, METEORITES EARLY SOL, P819; Flynn GJ, 1996, EARTH MOON PLANETS, V72, P469, DOI 10.1007/BF00117551; FORMISANO V, UNPUB; Foustoukos DI, 2004, SCIENCE, V304, P1002, DOI 10.1126/science.1096033; Gibb EL, 2003, ICARUS, V165, P391, DOI 10.1016/S0019-1035(03)00201-X; GIURANNA M, UNPUB; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Krasnopolsky VA, 1998, SCIENCE, V280, P1576, DOI 10.1126/science.280.5369.1576; KRASNOPOLSKY VA, 2004, EUR GEOSC UN M NIC F; Kress ME, 2004, ICARUS, V168, P475, DOI 10.1016/j.icarus.2003.10.013; LELLOUCH E, 1991, PLANET SPACE SCI, V39, P219, DOI 10.1016/0032-0633(91)90145-Z; Levison HF, 2000, ICARUS, V143, P415, DOI 10.1006/icar.1999.6313; MAGUIRE WC, 1977, ICARUS, V32, P85, DOI 10.1016/0019-1035(77)90051-3; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; MUMMA MJ, 2003, AM ASS SCI DIV PLAN; NAIR H, 1994, ICARUS, V111, P124, DOI 10.1006/icar.1994.1137; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Summers ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015377; WALLENDAHL A, 1999, LUN PLAN SCI C, V30; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; Weiss BP, 2000, P NATL ACAD SCI USA, V97, P1395, DOI 10.1073/pnas.030538097; Wong AS, 2004, ADV SPACE RES, V33, P2236, DOI 10.1016/S0273-1177(03)00524-6; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003; Yung Y. L., 1999, PHOTOCHEMISTRY PLANE	31	527	548	4	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1758	1761		10.1126/science.1101732	http://dx.doi.org/10.1126/science.1101732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15514118				2022-12-24	WOS:000225630800047
J	Kargel, JS				Kargel, JS			Proof for water, hints of life?	SCIENCE			English	Editorial Material							MARS EXPLORATION ROVERS; MERIDIANI-PLANUM; OPPORTUNITY ROVER; SCIENCE; CHEMISTRY; SOILS		US Geol Survey, Flagstaff, AZ 86001 USA	United States Department of the Interior; United States Geological Survey	Kargel, JS (corresponding author), US Geol Survey, Flagstaff, AZ 86001 USA.	jkargel@usgs.gov						Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Benison KC, 2003, ASTROBIOLOGY, V3, P609, DOI 10.1089/153110703322610690; Burns R.G., 1988, LUNAR PLANET SCI, V18, P713; Catling DC, 2004, NATURE, V429, P707, DOI 10.1038/429707a; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dutrizac JE, 2000, REV MINERAL GEOCHEM, V40, P405, DOI 10.2138/rmg.2000.40.8; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020661; FERNANDEZREMOLA.DC, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE001918; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; JAMBOR JL, 2000, REV MINERAL GEOCHEM, P303; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; KARGEL JS, 2004, WARMER WETTER PLANET; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Marion GM, 2003, GEOCHIM COSMOCHIM AC, V67, P4251, DOI 10.1016/S0016-7037(03)00372-7; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; Pellenbarg RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001901; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	28	21	22	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1689	1691		10.1126/science.1105533	http://dx.doi.org/10.1126/science.1105533			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576596				2022-12-24	WOS:000225630800028
J	Hampton, T				Hampton, T			Shuffling mouse's genetic deck may illuminate causes of complex diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2004	292	21					2568	2568		10.1001/jama.292.21.2568	http://dx.doi.org/10.1001/jama.292.21.2568			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875GU	15572704				2022-12-24	WOS:000225409100005
J	Houghton, J; Stoicov, C; Nomura, S; Rogers, AB; Carlson, J; Li, HC; Cai, X; Fox, JG; Goldenring, JR; Wang, TC				Houghton, J; Stoicov, C; Nomura, S; Rogers, AB; Carlson, J; Li, HC; Cai, X; Fox, JG; Goldenring, JR; Wang, TC			Gastric cancer originating from bone marrow-derived cells	SCIENCE			English	Article							STEM-CELLS; PREMALIGNANT LESIONS; MICE; ADENOCARCINOMA	Epithelial cancers are believed to originate from transformation of tissue stem cells. However, bone marrow-derived cells (BMDCs), which are frequently recruited to sites of tissue injury and inflammation, might also represent a potential source of malignancy. We show that although acute injury, acute inflammation, or transient parietal cell loss within the stomach do not lead to BMDC recruitment, chronic infection of C57BL/6 mice with Helicobacter, a known carcinogen, induces repopulation of the stomach with BMDCs. Subsequently, these cells progress through metaplasia and dysplasia to intraepithelial cancer. These findings suggest that epithelial cancers can originate from marrow-derived sources and thus have broad implications for the multistep model of cancer progression.	Univ Massachusetts, Sch Med, Dept Med & Canc Biol, Worcester, MA 01605 USA; Vanderbilt Univ, Sch Med, Dept Surg, Epithelial Biol Program, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Bunkyo Ku, Tokyo 1138655, Japan; MIT, Div Comparat Med, Cambridge, MA 02139 USA; Vet Adm Med Ctr, Nashville, TN 37232 USA	University of Massachusetts System; University of Massachusetts Worcester; Vanderbilt University; Vanderbilt University; University of Tokyo; Massachusetts Institute of Technology (MIT); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Houghton, J (corresponding author), Univ Massachusetts, Sch Med, Dept Med & Canc Biol, Worcester, MA 01605 USA.	jeanmarie.houghton@umassmed.edu; tcw2l@columbia.edu		Wang, Timothy/0000-0001-5730-3019; Nomura, Sachiyo/0000-0003-4293-6205	NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NCI NIH HHS [CA95103, K22 CA90518, R01 CA87958] Funding Source: Medline; NIDDK NIH HHS [R01 DK58] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Clouston AD, 2001, PATHOLOGY, V33, P271; Couzin J, 2003, SCIENCE, V299, P1002, DOI 10.1126/science.299.5609.1002; Fox JG, 2003, CANCER RES, V63, P942; Fox JG, 2002, CANCER RES, V62, P696; Goldenring JR, 2000, GASTROENTEROLOGY, V118, P1080, DOI 10.1016/S0016-5085(00)70361-1; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; Normile D, 2002, SCIENCE, V298, P1869, DOI 10.1126/science.298.5600.1869; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Schmidt PH, 1999, LAB INVEST, V79, P639; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang TC, 1998, GASTROENTEROLOGY, V114, P675, DOI 10.1016/S0016-5085(98)70581-5	18	907	1031	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1568	1571		10.1126/science.1099513	http://dx.doi.org/10.1126/science.1099513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567866				2022-12-24	WOS:000225442700063
J	Kulathinal, RJ; Bettencourt, BR; Hartl, DL				Kulathinal, RJ; Bettencourt, BR; Hartl, DL			Compensated deleterious mutations in insect genomes	SCIENCE			English	Article							EVOLUTION	Relatively little is known about the importance of amino acid interactions in protein and phenotypic evolution. Here we examine whether mutations that are pathogenic in Drosophila melanogaster become fixed via epistasis in other Dipteran genomes. Overall divergence at pathogenic amino acid sites is reduced. However, similar to10% of the substitutions at these sites carry the exact same pathogenic amino acid found in D. melanogaster mutants. Hence compensatory mutation(s) must have evolved. Surprisingly, the fraction 10% is not affected by phylogenetic distance. These results support a selection-driven process that allows compensated amino acid substitutions to become rapidly fixed in taxa with large populations.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hartl, DL (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	dhartl@oeb.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG000739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068465] Funding Source: NIH RePORTER; NHGRI NIH HHS [P41-HG00739] Funding Source: Medline; NIGMS NIH HHS [GM068465] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dobzhansky Th., 1971, GENETICS EVOLUTIONAR; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kliman RM, 2000, GENETICS, V156, P1913; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; RICHARDS S, IN PRESS GENOME RES; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stephan W, 1996, GENETICS, V144, P419; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilke CO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-3; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	14	84	87	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1553	1554		10.1126/science.1100522	http://dx.doi.org/10.1126/science.1100522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15498973				2022-12-24	WOS:000225442700058
J	Peters, C; Baars, TL; Buhler, S; Mayer, A				Peters, C; Baars, TL; Buhler, S; Mayer, A			Mutual control of membrane fission and fusion proteins	CELL			English	Article							HOMOTYPIC VACUOLE FUSION; TRANS-COMPLEX FORMATION; SACCHAROMYCES-CEREVISIAE; YEAST VACUOLE; V-SNARES; ACTIN CYTOSKELETON; SECRETORY GRANULES; MAMMALIAN-CELLS; PLASMA-MEMBRANE; BINDING-PROTEIN	Membrane fusion and fission are antagonistic reactions controlled by different proteins. Dynamins promote membrane fission by GTP-driven changes of conformation and polymerization state, while SNAREs fuse membranes by forming complexes between t- and v-SNAREs from apposed vesicles. Here, we describe a role of the dynamin-like GTPase Vps1p in fusion of yeast vacuoles. Vps1p forms polymers that couple several t-SNAREs together. At the onset of fusion, the SNARE-activating ATPase Sec18p/NSF and the t-SNARE depolymerize Vps1p and release it from the membrane. This activity is independent of the SNARE coactivator Sec17p/alpha-SNAP and of the v-SNARE. Vps1p release liberates the t-SNAREs for initiating fusion and at the same time disrupts fission activity. We propose that reciprocal control between fusion and fission components exists, which may prevent futile cycles of fission and fusion.	Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland	University of Lausanne	Peters, C (corresponding author), Univ Lausanne, Dept Biochim, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	christopher.peters@unil.ch; andreas.mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X				BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CONRADT B, 1994, J CELL BIOL, V126, P99, DOI 10.1083/jcb.126.1.99; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; EKENA K, 1995, MOL CELL BIOL, V15, P1671; Galas MC, 2000, J NEUROCHEM, V75, P1511, DOI 10.1046/j.1471-4159.2000.0751511.x; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; LIU JP, 1994, J BIOL CHEM, V269, P21043; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Morsomme P, 2003, J CELL BIOL, V162, P403, DOI 10.1083/jcb.200212101; Muller JMM, 1999, NAT CELL BIOL, V1, P335, DOI 10.1038/14025; Muller JMM, 2002, J CELL BIOL, V157, P1161, DOI 10.1083/jcb.200202082; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Sanyal S, 2001, NEUROSCI LETT, V311, P21, DOI 10.1016/S0304-3940(01)02125-5; SCHMID SL, 1995, FASEB J, V9, P1445, DOI 10.1096/fasebj.9.14.7589986; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	61	103	106	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					667	678		10.1016/j.cell.2004.11.023	http://dx.doi.org/10.1016/j.cell.2004.11.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550248	Bronze			2022-12-24	WOS:000225389500012
J	van Roessel, P; Elliott, DA; Robinson, LM; Prokop, A; Brand, AH				van Roessel, P; Elliott, DA; Robinson, LM; Prokop, A; Brand, AH			Independent regulation of synaptic size and activity by the anaphase-promoting complex	CELL			English	Article							UBIQUITIN PROTEASOME SYSTEM; CELL-CYCLE; SUBSTRATE RECOGNITION; MITOTIC REGULATION; DROSOPHILA FIZZY; DNA-REPLICATION; PROTEIN-KINASE; KEN BOX; GENE; GROWTH	Neuronal plasticity relies on tightly regulated control of protein levels at synapses. One mechanism to control protein abundance is the ubiquitin-proteasome degradation system. Recent studies have implicated ubiquitin-mediated protein degradation in synaptic development, function, and plasticity, but little is known about the regulatory mechanisms controlling ubiquitylation in neurons. In contrast, ubiquitylation has long been studied as a central regulator of the eukaryotic cell cycle. A critical mediator of cell-cycle transitions, the anaphase-promoting complex/cyclosome (APC/C), is an E3 ubiquitin ligase. Although the APC/C has been detected in several differentiated cell types, a functional role for the complex in postmitotic cells has been elusive. We describe a novel postmitotic role for the APC/C at Drosophila neuromuscular synapses: independent regulation of synaptic growth and synaptic transmission. In neurons, the APC/C controls synaptic size via a downstream effector Liprin-alpha; in muscles, the APC/C regulates synaptic transmission, controlling the concentration of a postsynaptic glutamate receptor.	Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Anat, Cambridge CB2 1QR, England; Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Extracellular Matrix Res, Manchester M13 9PT, Lancs, England	Cancer Research UK; University of Cambridge; University of Cambridge; Case Western Reserve University; University of Manchester	Brand, AH (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	ahb@mole.bio.cam.ac.uk	Elliott, David/H-3334-2012; Brand, Andrea H/F-8220-2014	Elliott, David/0000-0003-1052-7407; Brand, Andrea H/0000-0002-2089-6954; Prokop, Andreas/0000-0001-8482-3298				BRAND AH, 1993, DEVELOPMENT, V118, P401; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; DAWSON IA, 1993, DEVELOPMENT, V117, P359; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fergestad T, 2001, J NEUROSCI, V21, P1218; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hedge Ashok N., 1997, Cell, V89, P115; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Huang JY, 2002, J CELL SCI, V115, P2847; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kashevsky H, 2002, P NATL ACAD SCI USA, V99, P11217, DOI 10.1073/pnas.172391099; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; LAHAVBARATZ S, 1995, P NATL ACAD SCI USA, V92, P9303, DOI 10.1073/pnas.92.20.9303; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Reed BH, 1997, DEVELOPMENT, V124, P3543; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stroschein SL, 2001, GENE DEV, V15, P2822; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; VANROESSEL P, 2002, THESIS U CAMBRIDGE C; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43889; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	78	182	185	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					707	718		10.1016/j.cell.2004.11.028	http://dx.doi.org/10.1016/j.cell.2004.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550251	Bronze			2022-12-24	WOS:000225389500015
J	Als, TD; Vila, R; Kandul, NP; Nash, DR; Yen, SH; Hsu, YF; Mignault, AA; Boomsma, JJ; Pierce, NE				Als, TD; Vila, R; Kandul, NP; Nash, DR; Yen, SH; Hsu, YF; Mignault, AA; Boomsma, JJ; Pierce, NE			The evolution of alternative parasitic life histories in large blue butterflies	NATURE			English	Article							MYRMICA HOST ANTS; MACULINEA-ALCON; SPECIFICITY; LEPIDOPTERA; FORMICIDAE; LYCAENIDAE; ADOPTION	Large blue (Maculinea) butterflies are highly endangered throughout the Palaearctic region, and have been the focus of intense conservation research(1-3). In addition, their extraordinary parasitic lifestyles make them ideal for studies of life history evolution. Early instars consume flower buds of specific host plants, but later instars live in ant nests where they either devour the brood (predators), or are fed mouth-to-mouth by the adult ants (cuckoos). Here we present the phylogeny for the group, which shows that it is a monophyletic clade nested within Phengaris, a rare Oriental genus whose species have similar life histories(4,5). Cuckoo species are likely to have evolved from predatory ancestors. As early as five million years ago, two Maculinea clades diverged, leading to the different parasitic strategies seen in the genus today. Contrary to current belief, the two recognized cuckoo species show little genetic divergence and are probably a single ecologically differentiated species(6-10). On the other hand, some of the predatory morphospecies exhibit considerable genetic divergence and may contain cryptic species. These findings have important implications for conservation and reintroduction efforts.	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Aarhus Univ, Dept Ecol & Genet, DK-8000 Aarhus C, Denmark; Univ Copenhagen, Inst Biol, Dept Populat Biol, DK-2100 Copenhagen, Denmark; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; Natl Taiwan Normal Univ, Dept Life Sci, Taipei 116, Taiwan	Harvard University; Aarhus University; University of Copenhagen; Imperial College London; National Sun Yat Sen University; National Taiwan Normal University	Pierce, NE (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	npierce@fas.harvard.edu	Boomsma, Jacobus J/M-2785-2014; Nash, David R./B-2916-2009; Vila, Roger/A-1817-2012	Boomsma, Jacobus J/0000-0002-3598-1609; Nash, David R./0000-0002-0462-6794; Vila, Roger/0000-0002-2447-4388; Kandul, Nikolay/0000-0001-7347-5558				Als TD, 2002, ECOL ENTOMOL, V27, P403, DOI 10.1046/j.1365-2311.2002.00427.x; Als TD, 2001, ANIM BEHAV, V62, P99, DOI 10.1006/anbe.2001.1716; Eastwood R, 2003, MOL PHYLOGENET EVOL, V27, P93, DOI 10.1016/S1055-7903(02)00370-6; Elfferich Nico W., 1998, Deinsea, V4, P97; ELIOT J N, 1973, Bulletin of the British Museum (Natural History) Entomology, V28, P371; ELMES GW, 1992, BIODIVERS CONSERV, V1, P155, DOI 10.1007/BF00695913; ELMES GW, 1991, J ZOOL, V223, P447, DOI 10.1111/j.1469-7998.1991.tb04775.x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Fiedler K., 1991, BONN ZOOL MONOGR, V31, P1; Fiedler K, 1998, J INSECT CONSERV, V2, P3, DOI 10.1023/A:1009618721239; Gadeberg RME, 1997, J INSECT CONSERV, V1, P99, DOI 10.1023/A:1018439211244; Geissler-Strobel Sabine, 1999, Neue Entomologische Nachrichten, V44, P1; IGARASHI S, 2000, LIFE HIST ASIAN BUTT, V2, P552; Jean J., 1996, ECOLOGICAL STUDIES 2; Munguira ML, 1999, ACTION PLAN MACULINE; Pierce Naomi E., 1995, Journal of the Lepidopterists' Society, V49, P412; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; RADCHENKO AG, 1994, ZOOL ZH, V73, P39; Sibatani Atuhiro, 1994, Tyo To Ga, V44, P157; Steiner FM, 2003, J INSECT CONSERV, V7, P1, DOI 10.1023/A:1024763305517; THOMAS JA, 1992, OECOLOGIA, V91, P101, DOI 10.1007/BF00317247; Thomas JA, 1998, ECOL ENTOMOL, V23, P457, DOI 10.1046/j.1365-2311.1998.00153.x; THOMAS JA, 1989, OECOLOGIA, V79, P452, DOI 10.1007/BF00378660; THOMAS JA, 1995, ECOLOGY AND CONSERVATION OF BUTTERFLIES, P180; TILDEN JW, 1947, PAN PACIFIC ENTOMOLO, V23, P42; Uchida H., 1995, BEAUTIFUL BUTTERFLY; VANSWAAY C, 1999, RED DATA BOOK EUROPE, P124; Wynhoff I, 1998, J INSECT CONSERV, V2, P15, DOI 10.1023/A:1009636605309; Yamaguchi S., 1988, LIFE HIST 5 MYRMECOP, P21	30	149	167	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					386	390		10.1038/nature03020	http://dx.doi.org/10.1038/nature03020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549104				2022-12-24	WOS:000225161400054
J	Sherwood, RI; Christensen, JL; Conboy, IM; Conboy, MJ; Rando, TA; Weissman, IL; Wagers, AJ				Sherwood, RI; Christensen, JL; Conboy, IM; Conboy, MJ; Rando, TA; Weissman, IL; Wagers, AJ			Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; SATELLITE CELLS; REGENERATION; EXPRESSION; MICE; TRANSPLANTATION; IDENTIFICATION; SPECIFICATION; POPULATION	Skeletal muscle regeneration in adults is thought to occur through the action of myogenic satellite cells located in close association with mature musclefibers; however, these precursor cells have not been prospectively isolated, and recent studies have suggested that additional muscle progenitors, including cells of bone marrow or hematopoietic origin, may exist. To clarify the origin(s) of adult myogenic cells, we used phenotypic, morphological, and functional criteria to identify and prospectively isolate a subset of myofiber-associated cells capable at the single cell level of generating myogenic colonies at high frequency. Importantly, although muscle-engrafted cells from marrow and/or circulation localized to the same anatomic compartment as myogenic satellite cells and expressed some though not all satellite cell markers, they displayed no intrinsic myogenicity. Together, these studies describe the clonal isolation of functional adult myogenic progenitors and demonstrate that these cells do not arise from hematopoietic or other bone marrow or circulating precursors.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Vet Affairs Palo alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; Vet Affairs Palo alto Hlth Care Syst, Serv Neurol, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wagers, AJ (corresponding author), Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu		Rando, Thomas/0000-0001-5843-8564	NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036409] Funding Source: NIH RePORTER; NCI NIH HHS [CA86065] Funding Source: Medline; NIA NIH HHS [AG05902] Funding Source: Medline; NINDS NIH HHS [R01-NS36409] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; BISCHOFF R, 1994, SATELLITE CELL MUSCL, P97; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj.gt.3301719; JOHNSON P, 1997, WEIRS HDB EXPT IMMUN, V2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; SHERWOOD RI, 2004, IN PRESS STEM CELLS; Shi DQ, 2004, BLOOD, V104, P290, DOI 10.1182/blood-2003-03-0688; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STAUBER WT, 1988, MED SCI SPORT EXER, V20, P345, DOI 10.1249/00005768-198808000-00004; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	35	360	377	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					543	554		10.1016/j.cell.2004.10.021	http://dx.doi.org/10.1016/j.cell.2004.10.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537543	Bronze			2022-12-24	WOS:000225183200012
J	Denli, AM; Tops, BBJ; Plasterk, RHA; Ketting, RF; Hannon, GJ				Denli, AM; Tops, BBJ; Plasterk, RHA; Ketting, RF; Hannon, GJ			Processing of primary microRNAs by the Microprocessor complex	NATURE			English	Article							RNAI EFFECTOR COMPLEXES; DSRNA-BINDING-PROTEIN; NUCLEAR EXPORT; C-ELEGANS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; INTERFERENCE; INITIATION; EXPRESSION; DICER	Mature microRNAs (miRNAs) are generated via a two-step processing pathway to yield similar to22-nucleotide small RNAs that regulate gene expression at the post-transcriptional level(1). Initial cleavage is catalysed by Drosha, a nuclease of the RNase III family, which acts on primary miRNA transcripts (pri-miRNAs) in the nucleus(2). Here we show that Drosha exists in a multiprotein complex, the Microprocessor, and begin the process of deconstructing that complex into its constituent components. Along with Drosha, the Microprocessor also contains Pasha (partner of Drosha), a double-stranded RNA binding protein. Suppression of Pasha expression in Drosophila cells or Caenorhabditis elegans interferes with pri-miRNA processing, leading to an accumulation of pri-miRNAs and a reduction in mature miRNAs. Finally, depletion or mutation of pash-1 in C. elegans causes de-repression of a let-7 reporter and the appearance of phenotypic defects overlapping those observed upon examination of worms with lesions in Dicer (dcr-1) or Drosha (drsh-1). Considered together, these results indicate a role for Pasha in miRNA maturation and miRNA-mediated gene regulation.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Hubrecht Lab Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Cold Spring Harbor Laboratory; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.org	Hannon, Gregory/AAB-3568-2019; Tops, Bastiaan/L-4697-2015	Tops, Bastiaan/0000-0002-1699-8210; Ketting, Rene/0000-0001-6161-5621				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; SIOLAS D, UNPUB NATURE BIOTECH; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	29	1836	1985	2	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					231	235		10.1038/nature03049	http://dx.doi.org/10.1038/nature03049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15531879				2022-12-24	WOS:000225020200049
J	Glotzer, SC				Glotzer, SC			Some assembly required	SCIENCE			English	Editorial Material							GOLD NANOPARTICLES; BUILDING-BLOCKS		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Glotzer, SC (corresponding author), Univ Michigan, Dept Chem Engn, 2300 Hayward St, Ann Arbor, MI 48109 USA.	sgtolzer@umich.edu						Blum AS, 2004, NANO LETT, V4, P867, DOI 10.1021/nl0497474; Cardoen G, 2004, MACROMOLECULES, V37, P5123, DOI 10.1021/ma049769c; Gracias DH, 2002, APPL PHYS LETT, V80, P2802, DOI 10.1063/1.1470222; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Laine RM, 1998, APPL ORGANOMET CHEM, V12, P715, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<715::AID-AOC778>3.0.CO;2-0; Malikova N, 2002, LANGMUIR, V18, P3694, DOI 10.1021/la025563y; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Nelson DR, 2002, NANO LETT, V2, P1125, DOI 10.1021/n10202096; Song T, 2003, POLYMER, V44, P2529, DOI [10.1016/S0032-3861(03)00107-1, 10.1016/s0032-3861(03)00107-1]; Wang SP, 2002, NANO LETT, V2, P817, DOI 10.1021/n10255193; Westenhoff S, 2002, J AM CHEM SOC, V124, P2448, DOI 10.1021/ja0173728; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zhang ZL, 2003, NANO LETT, V3, P1341, DOI 10.1021/nl034454g	16	328	339	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					419	420		10.1126/science.1099988	http://dx.doi.org/10.1126/science.1099988			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486279				2022-12-24	WOS:000224626500031
J	Mechelli, A; Crinion, JT; Noppeney, U; O'Doherty, J; Ashburner, J; Frackowiak, RS; Price, CJ				Mechelli, A; Crinion, JT; Noppeney, U; O'Doherty, J; Ashburner, J; Frackowiak, RS; Price, CJ			Structural plasticity in the bilingual brain - Proficiency in a second language and age at acquisition affect grey-matter density.	NATURE			English	Editorial Material							PET		Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Fdn Santa Lucia, I-00179 Rome, Italy	University of London; University College London; IRCCS Santa Lucia	Mechelli, A (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	a.mechelli@fil.ion.ucl.ac.uk	Ashburner, John/I-3757-2013; O'Doherty, John P/F-1204-2013; Mechelli, Andrea/B-1114-2011; Frackowiak, Richard S/I-1809-2013; Crinion, Jennifer/A-1992-2019; Frackowiak, Richard/H-4383-2011	Ashburner, John/0000-0001-7605-2518; Crinion, Jennifer/0000-0001-8080-6562; Frackowiak, Richard/0000-0002-3151-822X; Price, Catherine/0000-0001-7448-4835; Noppeney, Uta/0000-0002-7697-2290	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Poline JB, 1996, NEUROIMAGE, V4, P34, DOI 10.1006/nimg.1996.0027; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159	8	580	602	8	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					757	757		10.1038/431757a	http://dx.doi.org/10.1038/431757a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483594	Bronze			2022-12-24	WOS:000224435500027
J	Yernool, D; Boudker, O; Jin, Y; Gouaux, E				Yernool, D; Boudker, O; Jin, Y; Gouaux, E			Structure of a glutamate transporter homologue from Pyrococcus horikoshii	NATURE			English	Article							SCANNING MUTAGENESIS REVEALS; AMINO-ACID TRANSPORTERS; MEMBRANE TOPOLOGY; BACILLUS-STEAROTHERMOPHILUS; CONFORMATIONAL-CHANGES; ANOMALOUS DIFFRACTION; PERMEATION PATHWAY; ESCHERICHIA-COLI; REENTRANT LOOP; PROTON CURRENT	Glutamate transporters are integral membrane proteins that catalyse the concentrative uptake of glutamate from the synapse to intracellular spaces by harnessing pre-existing ion gradients. In the central nervous system glutamate transporters are essential for normal development and function, and are implicated in stroke, epilepsy and neurodegenerative diseases. Here we present the crystal structure of a eukaryotic glutamate transporter homologue from Pyrococcus horikoshii. The transporter is a bowl-shaped trimer with a solvent-filled extracellular basin extending halfway across the membrane bilayer. At the bottom of the basin are three independent binding sites, each cradled by two helical hairpins, reaching from opposite sides of the membrane. We propose that transport of glutamate is achieved by movements of the hairpins that allow alternating access to either side of the membrane.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JORDING D, 1993, MOL GEN GENET, V241, P106, DOI 10.1007/BF00280207; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kanner BI, 2002, BBA-BIOENERGETICS, V1555, P92, DOI 10.1016/S0005-2728(02)00260-8; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Slotboom DJ, 2001, TRENDS BIOCHEM SCI, V26, P534, DOI 10.1016/S0968-0004(01)01925-9; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLNER B, 1995, MOL MICROBIOL, V18, P123, DOI 10.1111/j.1365-2958.1995.mmi_18010123.x; Tzingounis AV, 1998, J BIOL CHEM, V273, P17315, DOI 10.1074/jbc.273.28.17315; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; Wheal H.V., 1995, EXCITATORY AMINO ACI; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	50	633	643	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					811	818		10.1038/nature03018	http://dx.doi.org/10.1038/nature03018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483603	Bronze			2022-12-24	WOS:000224435500038
J	Crown, J				Crown, J			Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancer	LANCET			English	Editorial Material									St Vincents Univ Hosp, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital	Crown, J (corresponding author), St Vincents Univ Hosp, Elm Pk, Dublin 4, Ireland.	John.crown@icorg.ie	Crown, John/AAL-3367-2020	Crown, John/0000-0002-3125-7613				CROWN J, 2003, P AN M AM SOC CLIN, V22, pA23; DAVIDSON NE, 1992, J CLIN ONCOL, V10, P517, DOI 10.1200/JCO.1992.10.4.517; FARQUHAR C, 2003, COCHRANE LIB; Hortobagyi GN, 2004, J CLIN ONCOL, V22, P2263, DOI 10.1200/JCO.2004.02.927; NITZ UA, 2003, P AN M AM SOC CLIN, V22, pA832; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P759, DOI 10.1093/jnci/djh133; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Weiss RB, 2001, J CLIN ONCOL, V19, P2771, DOI 10.1200/JCO.2001.19.11.2771; Zander AR, 2004, J CLIN ONCOL, V22, P2273, DOI 10.1200/JCO.2004.07.026	9	10	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1299	1300		10.1016/S0140-6736(04)17207-3	http://dx.doi.org/10.1016/S0140-6736(04)17207-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474123				2022-12-24	WOS:000224349700010
J	Villier, L; Korn, D				Villier, L; Korn, D			Morphological disparity of ammonoids and the mark of Permian mass extinctions	SCIENCE			English	Article							END	The taxonomic diversity of ammonoids, in terms of the number of taxa preserved, provides an incomplete picture of the extinction pattern during the Permian because of a strongly biased fossil record. The analysis of morphological disparity (the variety of shell shapes) is a powerful complementary tool for testing hypotheses about the selectivity of extinction and permits the recognition of three distinct patterns. First, a trend of decreasing disparity, ranging for about 30 million years, led to a minimum disparity immediately before the Permian-Triassic boundary. Second, the strongly selective Capitanian crisis fits a model of background extinction driven by standard environmental changes. Third, the end-Permian mass extinction operated as a random, nonselective sorting of morphologies, which is consistent with a catastrophic cause.	Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE 2761, CNRS, F-13331 Marseille 3, France; Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Villier, L (corresponding author), Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE 2761, CNRS, 3 Pl Victor Hugo, F-13331 Marseille 3, France.	lvillier@up.univ-mrs.fr	Korn, Dieter/B-2963-2009	Korn, Dieter/0000-0003-1104-6939				Aberhan M, 2003, GEOLOGY, V31, P1077, DOI 10.1130/G19938.1; Benton M. J., 2003, LIFE NEARLY DIED GRE; Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; Erwin DH, 2002, GEOL SOC AM SPEC PAP, V356, P363; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; GLENISTER BF, 1981, AMMONOIDEA, P49; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; KULLMANN J, 2002, GONIAT VERSION 3 1 P; LEONOVA TB, 2002, PALEONTOL J S1, V36; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Raup David M., 1996, P419; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Saunders WB, 2004, PALEOBIOLOGY, V30, P19, DOI 10.1666/0094-8373(2004)030<0019:TEHOSG>2.0.CO;2; Saunders WB, 1999, SCIENCE, V286, P760, DOI 10.1126/science.286.5440.760; Smith AB, 1998, NATURE, V392, P69, DOI 10.1038/32155; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; Wills M. A., 2001, FOSSILS PHYLOGENY FO, P55; ZHOU Z, 1996, PERMOPHILES, V29, P195	21	54	59	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					264	266		10.1126/science.1102127	http://dx.doi.org/10.1126/science.1102127			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472073				2022-12-24	WOS:000224419700036
J	Jeffery, WR; Strickler, AG; Yamamoto, Y				Jeffery, WR; Strickler, AG; Yamamoto, Y			Migratory neural crest-like cells form body pigmentation in a urochordate embryo	NATURE			English	Article							EVOLUTION; EXPRESSION; TUNICATE; PLACODES; PROTOCHORDATE; AMPHIOXUS; ORIGIN; PLATE; GENES	The neural crest, a source of many different cell types in vertebrate embryos, has not been identified in other chordates(1-3). Current opinion therefore holds that neural crest cells were a vertebrate innovation(4-7). Here we describe a migratory cell population resembling neural crest cells in the ascidian urochordate Ecteinascidia turbinata. Labelling of embryos and larvae with the vital lipophilic dye DiI enabled us to detect cells that emerge from the neural tube, migrate into the body wall and siphon primordia, and subsequently differentiate as pigment cells. These cells express HNK-1 antigen and Zic gene markers of vertebrate neural crest cells. The results suggest that migratory cells with some of the features of neural crest cells are present in the urochordates. Thus, we propose a hypothesis for neural crest evolution beginning with the release of migratory cells from the CNS to produce body pigmentation in the common ancestor of the urochordates and vertebrates. These cells may have gained additional functions or were joined by other cell types to generate the variety of derivatives typical of the vertebrate neural crest.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	jeffery@umd.edu		Yamamoto, Yoshiyuki/0000-0003-4830-5703				AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; ATOU Y, 2002, DEV GENES EVOL, V212, P87; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Berrill NJ, 1935, PHILOS T ROY SOC B, V225, P255, DOI 10.1098/rstb.1935.0013; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Burighel P, 1998, J COMP NEUROL, V394, P230, DOI 10.1002/(SICI)1096-9861(19980504)394:2<230::AID-CNE7>3.0.CO;2-3; Corbo JC, 1997, DEVELOPMENT, V124, P2335; Elms P, 2003, DEV BIOL, V264, P391, DOI 10.1016/j.ydbio.2003.09.005; ERICKSON CA, 1993, PIGM CELL RES, V6, P336, DOI 10.1111/j.1600-0749.1993.tb00611.x; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gostling NJ, 2003, EVOL DEV, V5, P136, DOI 10.1046/j.1525-142X.2003.03020.x; Hall BK, 1999, NEURAL CREST DEV EVO; Hirata M, 1997, ZOOL SCI, V14, P305, DOI 10.2108/zsj.14.305; Holland LZ, 2001, J ANAT, V199, P85, DOI 10.1046/j.1469-7580.199.parts1-2.8.x; JEFFERY WR, 1992, BIOESSAYS, V14, P219, DOI 10.1002/bies.950140404; JUNGALWALA FB, 1992, J NEUROCHEM, V58, P1045, DOI 10.1111/j.1471-4159.1992.tb09360.x; KATZ MJ, 1983, BIOL BULL-US, V164, P1, DOI 10.2307/1541186; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Le Douarin NM, 1999, NEURAL CREST, V2; LYERLA TA, 1975, BIOL BULL, V149, P178, DOI 10.2307/1540488; Manni L, 2001, EVOL DEV, V3, P297, DOI 10.1046/j.1525-142X.2001.01040.x; Manni L, 1999, J COMP NEUROL, V412, P527, DOI 10.1002/(SICI)1096-9861(19990927)412:3<527::AID-CNE11>3.0.CO;2-U; Nakata K, 1998, MECH DEVELOP, V75, P43, DOI 10.1016/S0925-4773(98)00073-2; Olsen CL, 1997, DEVELOPMENT, V124, P3609; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stone JR, 2004, EVOL DEV, V6, P123, DOI 10.1111/j.1525-142X.2004.04014.x; THIERY JP, 1982, DEV BIOL, V93, P324, DOI 10.1016/0012-1606(82)90121-X; THORNDYKE MC, 1979, CELL TISSUE RES, V203, P301; Wada H, 1998, DEVELOPMENT, V125, P1113; Wada H, 2001, DEV GROWTH DIFFER, V43, P509	30	188	196	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2004	431	7009					696	699		10.1038/nature02975	http://dx.doi.org/10.1038/nature02975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470430				2022-12-24	WOS:000224299300042
J	Tomita, J; Nakajima, M; Kondo, T; Iwasaki, H				Tomita, J; Nakajima, M; Kondo, T; Iwasaki, H			No transcription-translation feedback in circadian rhythm of KaiC phosphorylation	SCIENCE			English	Article							SYNECHOCOCCUS-ELONGATUS; CLOCK SYSTEM; CYANOBACTERIA; EXPRESSION	An autoregulatory transcription-translation feedback loop is thought to be essential in generating circadian rhythms in any model organism. In the cyanobacterium Synechococcus elongatus, the essential clock protein KaiC is proposed to form this type of transcriptional negative feedback. Nevertheless, we demonstrate here temperature-compensated, robust circadian cycling of KaiC phosphorylation even without kaiBC messenger RNA accumulation under continuous dark conditions. This rhythm persisted in the presence of a transcription or translation inhibitor. Moreover, kinetic profiles in the ratio of KaiC autophosphorylation-dephosphorylation were also temperature compensated in vitro. Thus, the cyanobacterial clock can keep time independent of de novo transcription. and translation processes.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Iwasaki, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	iwasaki@bio.nagoya-u.ac.jp	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Iwasaki, Hideo/0000-0002-3754-4955				Doolittle W F, 1979, Adv Microb Physiol, V20, P1; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Imai K, 2004, J BIOL CHEM, V279, P36534, DOI 10.1074/jbc.M405861200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mori T, 2001, SEMIN CELL DEV BIOL, V12, P271, DOI 10.1006/scdb.2001.0254; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; RODRIGUEZLOPEZ M, 1970, FEBS LETT, V9, P171, DOI 10.1016/0014-5793(70)80346-5; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	21	346	369	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					251	254		10.1126/science.1102540	http://dx.doi.org/10.1126/science.1102540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15550625				2022-12-24	WOS:000226361900042
J	Sharp, D				Sharp, D			Women are catching up, fast - perhaps	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							*HICK SPORTS, 2004, IND OL HIST; Holden C, 2004, SCIENCE, V305, P639, DOI 10.1126/science.305.5684.639; SLATER CA, 2002, FEMALE ATHLETE, P7; Tatem AJ, 2004, NATURE, V431, P525, DOI 10.1038/431525a; WOMEN OLYMPIC GAMES	5	0	0	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2006	2006		10.1016/S0140-6736(04)17530-2	http://dx.doi.org/10.1016/S0140-6736(04)17530-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582048				2022-12-24	WOS:000225495700010
J	Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Calvin, W; Farrand, WH; Goetz, W; Gotombek, M; Greeley, R; Grotzinger, J; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Morris, RV; Dobrea, EZN; Sullivan, RJ; Weitz, CM; Wolff, MJ				Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Calvin, W; Farrand, WH; Goetz, W; Gotombek, M; Greeley, R; Grotzinger, J; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Morris, RV; Dobrea, EZN; Sullivan, RJ; Weitz, CM; Wolff, MJ			Pancam multispectral imaging results from the Opportunity Rover at Meridiani Planum	SCIENCE			English	Article							MARS PATHFINDER; REFLECTANCE SPECTRA; HEMATITE; SOILS; PYROXENE; CRATER; ROCKS	Panoramic Camera (Pancam) images from Meridiani Planum reveal a low-albedo, generally flat, and relatively rock-free surface. Within and around impact craters and fractures, laminated outcrop rocks with higher albedo are observed. Fine-grained materials include dark sand, bright ferric iron-rich dust, angular rock clasts, and millimeter-size spheroidal granules that are eroding out of the laminated rocks. Spectra of sand, clasts, and one dark plains rock are consistent with mafic silicates such as pyroxene and olivine. Spectra of both the spherules and the laminated outcrop materials indicate the presence of crystalline ferric oxides or oxyhydroxides. Atmospheric observations show a steady decline in dust opacity during the mission. Astronomical observations captured solar transits by Phobos and Deimos and time-lapse observations of sunsets.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89501 USA; Space Sci Inst, Boulder, CO 80301 USA; Univ Copenhagen, DK-2100 Copenhagen O, Denmark; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Aarhus Univ, DK-8000 Aarhus C, Denmark; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Malin Space Sci Syst Inc, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Planetary Sci Inst, Tucson, AZ 85719 USA	Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Copenhagen; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Aarhus University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Bell, JF (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	jfb8@cornell.edu	Lemmon, Mark/X-2333-2019; Seelos, Frank/C-7875-2016; Johnson, Jeffrey R/F-3972-2015; Lemmon, Mark T/E-9983-2010; Hayes, Alexander G/P-2024-2014; Madsen, Morten Bo/D-2082-2011; Kinch, Kjartan Bergeron/C-5742-2015	Lemmon, Mark/0000-0002-4504-5136; Seelos, Frank/0000-0001-9721-941X; Johnson, Jeffrey R/0000-0002-5586-4901; Lemmon, Mark T/0000-0002-4504-5136; Hayes, Alexander G/0000-0001-6397-2630; Madsen, Morten Bo/0000-0001-8909-5111; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Soderblom, Jason/0000-0003-3715-6407; McLennan, Scott/0000-0003-4259-7178				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; ARVIDSON RE, 2003, J GEOPHYS RES, V108; BELL JA, UNPUB; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; BELL JF, 2003, J GEOPHYS RES, V108; Bishop JL, 1998, J GEOPHYS RES-PLANET, V103, P31457, DOI 10.1029/1998JE900008; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Cloutis EA, 2004, ICARUS, V172, P233, DOI 10.1016/j.icarus.2004.06.002; CLOUTIS EA, 1986, J GEOPHYS RES-SOLID, V91, P1641, DOI 10.1029/JB091iB11p11641; GOLOMBEK MP, 2003, J GEOPHYS RES, V108; Greeley R., 2003, J GEOPHYS RES, V108; GREELEY R, 2004, LUN PLAN SCI C, V35; Hapke B., 1993, THEORY REFLECTANCE E; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Johnson JR, 1999, J GEOPHYS RES-PLANET, V104, P8809, DOI 10.1029/98JE02247; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 1998, ICARUS, V134, P1, DOI 10.1006/icar.1998.5939; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1993, GEOCHIM COSMOCHIM AC, V57, P4597, DOI 10.1016/0016-7037(93)90185-Y; MORRIS RV, 1996, MINERAL SPECTROSCOPY, P327; Reid RJ, 1999, J GEOPHYS RES-PLANET, V104, P8907, DOI 10.1029/1998JE900011; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	29	104	109	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1703	1709		10.1126/science.1105245	http://dx.doi.org/10.1126/science.1105245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576603				2022-12-24	WOS:000225630800035
J	Soderblom, LA; Anderson, RC; Arvidson, RE; Bell, JF; Cabrol, NA; Calvin, W; Christensen, PR; Clark, BC; Economou, T; Ehlmann, BL; Farrand, WH; Fike, D; Gellert, R; Glotch, TD; Golombek, MP; Greeley, R; Grotzinger, JP; Herkenhoff, KE; Jerolmack, DJ; Johnson, JR; Jolliff, B; Klingelhofer, G; Knoll, AH; Learner, ZA; Li, R; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Morris, RV; Rice, JW; Richter, L; Rieder, R; Rodionov, D; Schroder, C; Seelos, FP; Soderblom, JM; Squyres, SW; Sullivan, R; Watters, WA; Weitz, CM; Wyatt, MB; Yen, A; Zipfel, J				Soderblom, LA; Anderson, RC; Arvidson, RE; Bell, JF; Cabrol, NA; Calvin, W; Christensen, PR; Clark, BC; Economou, T; Ehlmann, BL; Farrand, WH; Fike, D; Gellert, R; Glotch, TD; Golombek, MP; Greeley, R; Grotzinger, JP; Herkenhoff, KE; Jerolmack, DJ; Johnson, JR; Jolliff, B; Klingelhofer, G; Knoll, AH; Learner, ZA; Li, R; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Morris, RV; Rice, JW; Richter, L; Rieder, R; Rodionov, D; Schroder, C; Seelos, FP; Soderblom, JM; Squyres, SW; Sullivan, R; Watters, WA; Weitz, CM; Wyatt, MB; Yen, A; Zipfel, J			Soils of eagle crater and Meridiani Planum at the Opportunity Rover landing site	SCIENCE			English	Article							X-RAY SPECTROMETER; GUSEV CRATER; MOSSBAUER SPECTROMETER; CHEMICAL-COMPOSITION; PATHFINDER SITE; SPIRIT ROVER; MARS; ROCKS; CHEMISTRY; LOCALIZATION	The soils at the Opportunity site are fine-grained basaltic sands mixed with dust and sulfate-rich outcrop debris. Hematite is concentrated in spherules eroded from the strata. Ongoing saltation exhumes the spherules and their fragments, concentrating them at the surface. Spherules emerge from soils coated, perhaps from subsurface cementation, by salts. Two types of vesicular clasts may represent basaltic sand sources. Eolian ripples, armored by well-sorted hematite-rich grains, pervade Meridiani Planum. The thickness of the soil on the plain is estimated to be about a meter. The flatness and thin cover suggest that the plain may represent the original sedimentary surface.	US Geol Survey, Flagstaff, AZ 86001 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Reno, NV 89557 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; MIT, Cambridge, MA 02139 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR Inst Space Simulat, D-51147 Cologne, Germany; Planetary Sci Inst, Tucson, AZ 85719 USA	United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Washington University (WUSTL); Cornell University; National Aeronautics & Space Administration (NASA); Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; Lockheed Martin; University of Chicago; Massachusetts Institute of Technology (MIT); Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR)	Soderblom, LA (corresponding author), US Geol Survey, Flagstaff, AZ 86001 USA.	lsoderblom@usgs.gov	Johnson, Jeffrey R/F-3972-2015; Glotch, Timothy/B-6829-2008; Sullivan, Robert/AAR-8193-2020; Fike, David A/D-3634-2011; Schröder, Christian/B-3870-2009; Seelos, Frank/C-7875-2016	Johnson, Jeffrey R/0000-0002-5586-4901; Fike, David A/0000-0003-2848-0328; Schröder, Christian/0000-0002-7935-6039; Seelos, Frank/0000-0001-9721-941X; McLennan, Scott/0000-0003-4259-7178; Soderblom, Jason/0000-0003-3715-6407				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; CHRISTENSEN PR, 1988, J GEOPHYS RES-SOLID, V93, P7611, DOI 10.1029/JB093iB07p07611; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Golombek MP, 1999, J GEOPHYS RES-PLANET, V104, P8523, DOI 10.1029/98JE02554; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; GREELEY R, 1980, GEOPHYS RES LETT, V7, P121, DOI 10.1029/GL007i002p00121; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002110; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Moore H. J., 1977, Journal of Geophysical Research, V82, P4497, DOI 10.1029/JS082i028p04497; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	25	119	120	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1723	1726		10.1126/science.1105127	http://dx.doi.org/10.1126/science.1105127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576606	Green Published, Green Submitted			2022-12-24	WOS:000225630800038
J	Rape, M; Kirschner, MW				Rape, M; Kirschner, MW			Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry	NATURE			English	Article							CYCLIN-A; CELL-CYCLE; MITOTIC REGULATION; ACCUMULATION; DEGRADATION; PROTEOLYSIS; DROSOPHILA; COMPLEX/CYCLOSOME; PROMETAPHASE; PROGRESSION	Oscillations in cyclin-dependent kinase (CDK) activity drive the somatic cell cycle. After entry into mitosis, CDKs activate the anaphase-promoting complex (APC), which then promotes cyclin degradation and mitotic exit. The re-accumulation of cyclin A causes the inactivation of APC and entry into S phase, but how cyclin A can accumulate in the presence of active APC has remained unclear. Here we show that, during G1, APC autonomously switches to a state permissive for cyclin A accumulation. Crucial to this transition is the APC(Cdh1)-dependent autoubiquitination and proteasomal degradation of the ubiquitin-conjugating enzyme (E2) UbcH10. Because APC substrates inhibit the autoubiquitination of UbcH10, but not its E2 function, APC activity is maintained as long as G1 substrates are present. Thus, through UbcH10 degradation and cyclin A stabilization, APC autonomously downregulates its activity. This indicates that the core of the metazoan cell cycle could be described as a self-perpetuating but highly regulated oscillator composed of alternating CDK and APC activities.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 240 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu		Rape, Michael/0000-0003-4849-6343				Araki M, 2003, EMBO J, V22, P6115, DOI 10.1093/emboj/cdg573; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sprenger F, 1997, CURR BIOL, V7, P488, DOI 10.1016/S0960-9822(06)00220-X; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821	21	238	243	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					588	595		10.1038/nature03023	http://dx.doi.org/10.1038/nature03023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15558010				2022-12-24	WOS:000225433200037
J	Lee, I; Date, SV; Adai, AT; Marcotte, EM				Lee, I; Date, SV; Adai, AT; Marcotte, EM			A probabilistic functional network of yeast genes	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; DATABASE; ORGANIZATION; COMPLEXES; ALGORITHM; MODULES; GENOMES	A conceptual framework for integrating diverse functional genomics data was developed by reinterpreting experiments to provide numerical likelihoods that genes are functionally linked. This allows direct comparison and integration of different classes of data. The resulting probabilistic gene network estimates the functional coupling between genes. Within this framework, we reconstructed an extensive, high-quality functional gene network for Saccharomyces cerevisiae, consisting of 4681 (similar to81%) of the known yeast genes linked by similar to34,000 probabilistic linkages comparable in accuracy to small-scale interaction assays. The integrated linkages distinguish true from false-positive interactions in earlier data sets; new interactions emerge from genes' network contexts, as shown for genes in chromatin modification and ribosome biogenesis.	Univ Texas, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Lee, Insuk/F-7722-2010	Marcotte, Edward/0000-0001-8808-180X	NIGMS NIH HHS [GM067779-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067779] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stevens S, COMMUNICATION; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THOMPSON M, 2000, CURRENTS COMPUTATION; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	34	498	512	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1555	1558		10.1126/science.1099511	http://dx.doi.org/10.1126/science.1099511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567862				2022-12-24	WOS:000225442700059
J	Le Galliard, JF; Clobert, J; Ferriere, R				Le Galliard, JF; Clobert, J; Ferriere, R			Physical performance and darwinian fitness in lizards	NATURE			English	Article							LACERTA-VIVIPARA; NATURAL-SELECTION; BODY-SIZE; LOCOMOTOR CAPACITY; FOOD-CONSUMPTION; TRAITS; POPULATION; ADAPTATION; MORPHOLOGY; ENDURANCE	Strong evidence for a genetic basis of variation in physical performance has accumulated(1,2). Considering one of the basic tenets of evolutionary physiology-that physical performance and darwinian fitness are tightly linked(3)-one may expect phenotypes with exceptional physiological capacities to be promoted by natural selection. Why then does physical performance remain considerably variable in human and other animal populations(1,2,4)? Our analysis of locomotor performance in the common lizard (Lacerta vivipara) demonstrates that initial endurance (running time to exhaustion measured at birth) is indeed highly heritable, but natural selection in favour of this trait can be unexpectedly weak. A manipulation of dietary conditions unravels a proximate mechanism explaining this pattern. Fully fed individuals experience a marked reversal of performance within only one month after birth: juveniles with low endurance catch up, whereas individuals with high endurance lose their advantage. In contrast, dietary restriction allows highly endurant neonates to retain their locomotor superiority as they age. Thus, the expression of a genetic predisposition to high physical performance strongly depends on the environment experienced early in life.	Ecole Normale Super, CNRS, UMR 7625, Lab Fonctionnement & Evolut Syst Ecol, F-75230 Paris 05, France; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; University of Arizona	Le Galliard, JF (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, POB 1050,Blindern, N-0316 Oslo, Norway.	j.f.l.galliard@bio.uio.no	Ferriere, Regis/S-8050-2017; Le Galliard, Jean-François/E-8702-2011	Ferriere, Regis/0000-0002-5806-5566; Le Galliard, Jean-François/0000-0002-5965-9868				ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; AVERY RA, 1971, J ANIM ECOL, V40, P351, DOI 10.2307/3250; Bennett A.F., 1990, Oxford Surveys in Evolutionary Biology, V7, P251; BOUCHARD C, 1997, HUMAN KINETICS, P408; Clobert J, 2000, FUNCT ECOL, V14, P675, DOI 10.1046/j.1365-2435.2000.00477.x; CURETON KJ, 1980, MED SCI SPORT EXER, V12, P288; Falconer D. S., 1989, Introduction to quantitative genetics.; GARLAND T, 1984, AM J PHYSIOL, V247, pR806, DOI 10.1152/ajpregu.1984.247.5.R806; Garland Theodore Jr., 1994, P240; HUEY RB, 1984, ANIM BEHAV, V32, P41, DOI 10.1016/S0003-3472(84)80322-X; Irschick DJ, 2001, ANNU REV ECOL SYST, V32, P367, DOI 10.1146/annurev.ecolsys.32.081501.114048; Irschick DJ, 2002, INTEGR COMP BIOL, V42, P278, DOI 10.1093/icb/42.2.278; Janzen FJ, 1998, EVOLUTION, V52, P1564, DOI 10.1111/j.1558-5646.1998.tb02237.x; Janzen FJ, 2000, ECOLOGY, V81, P2290; JAYNE BC, 1990, EVOLUTION, V44, P1204, DOI 10.1111/j.1558-5646.1990.tb05226.x; KHODADOOST M, 1987, REV ECOL-TERRE VIE, V42, P193; Le Galliard JF, 2003, FUNCT ECOL, V17, P877, DOI 10.1046/j.0269-8463.2003.00800.x; Le Galliard JF, 2003, P ROY SOC B-BIOL SCI, V270, P1163, DOI 10.1098/rspb.2003.2360; Littell R. C, 1996, SAS SYSTEM MIXED MOD; Lorenzon P, 2001, EVOLUTION, V55, P392; MASSOT M, 1994, J ANIM ECOL, V63, P431, DOI 10.2307/5560; PRICE TD, 1984, EVOLUTION, V38, P483, DOI 10.1111/j.1558-5646.1984.tb00314.x; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; RISKA B, 1989, EVOLUTION, V43, P1172, DOI [10.2307/2409355, 10.1111/j.1558-5646.1989.tb02567.x]; Rupert JL, 2003, COMP BIOCHEM PHYS A, V136, P191, DOI 10.1016/S1095-6433(02)00349-5; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI 10.1111/j.1558-5646.1988.tb02507.x; Sorci G, 1999, EVOL ECOL RES, V1, P303; SORCI G, 1995, PHYSIOL ZOOL, V68, P698, DOI 10.1086/physzool.68.4.30166352; Swallow JG, 2001, J COMP PHYSIOL B, V171, P651, DOI 10.1007/s003600100216; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	30	174	175	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					502	505		10.1038/nature03057	http://dx.doi.org/10.1038/nature03057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565154				2022-12-24	WOS:000225322100046
J	Holmes, DR				Holmes, DR			Strokes and holes and headaches: are they a package deal?	LANCET			English	Editorial Material							PATENT FORAMEN OVALE; RECURRENT CEREBROVASCULAR EVENTS; ATRIAL SEPTAL ANEURYSM; TO-LEFT SHUNTS; TRANSCATHETER CLOSURE; PARADOXICAL EMBOLISM; MIGRAINE; PREVENTION		Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Holmes, DR (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.	Holmes.david@mayo.edu						Brandt RR, 2002, J AM SOC ECHOCARDIOG, V15, P1094, DOI 10.1067/mje.2002.121666; Bruch L, 2002, CIRCULATION, V105, P2845, DOI 10.1161/01.CIR.0000019069.32964.0E; Cohnheim J, 1877, THROMBOSE EMBOLIE VO, P134; Dearani JA, 1999, CIRCULATION, V100, P171; Del Sette M, 1998, CEREBROVASC DIS, V8, P327, DOI 10.1159/000015875; Fabricius Alex M, 2002, Asian Cardiovasc Thorac Ann, V10, P342; HOLMES DR, 1909, CURR PROB CARDIOLOGY, V29, P49; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; MAS JL, 1995, AM HEART J, V130, P1083, DOI 10.1016/0002-8703(95)90212-0; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Post MC, 2004, NEUROLOGY, V62, P1439, DOI 10.1212/01.WNL.0000120756.25236.37; Schwerzmann M, 2004, NEUROLOGY, V62, P1399, DOI 10.1212/01.WNL.0000120677.64217.A9; Sztajzel R, 2002, CEREBROVASC DIS, V13, P102, DOI 10.1159/000047758; Wilmshurst P, 2001, CLIN SCI, V100, P215, DOI 10.1042/CS20000231; Wilmshurst PT, 2000, LANCET, V356, P1648, DOI 10.1016/S0140-6736(00)03160-3; ZAHN FW, 1881, REV MED SUISSE ROMAN, V1, P227	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 20	2004	364	9448					1840	1842		10.1016/S0140-6736(04)17457-6	http://dx.doi.org/10.1016/S0140-6736(04)17457-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873HA	15555653				2022-12-24	WOS:000225269300009
J	Young, B; Krahn, A				Young, B; Krahn, A			Implications of defibrillation	LANCET			English	Editorial Material							HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS		Univ Western Ontario, London, ON N6A 5A5, Canada	Western University (University of Western Ontario)	Young, B (corresponding author), Univ Western Ontario, London, ON N6A 5A5, Canada.	bryan.young@lhsc.on.ca						Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Grubb NR, 1996, BMJ-BRIT MED J, V313, P143, DOI 10.1136/bmj.313.7050.143; Guglin ME, 2004, PACE, V27, P1072, DOI 10.1111/j.1540-8159.2004.00586.x; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kapp M B, 1989, Issues Law Med, V5, P337; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Virkkunen I, 2004, RESUSCITATION, V62, P299, DOI 10.1016/j.resuscitation.2004.04.003	9	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 20	2004	364	9448					1836	1837		10.1016/S0140-6736(04)17454-0	http://dx.doi.org/10.1016/S0140-6736(04)17454-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873HA	15555650				2022-12-24	WOS:000225269300006
J	Raoult, D; Audic, S; Robert, C; Abergel, C; Renesto, P; Ogata, H; La Scola, B; Suzan, M; Claverie, JM				Raoult, D; Audic, S; Robert, C; Abergel, C; Renesto, P; Ogata, H; La Scola, B; Suzan, M; Claverie, JM			The 1.2-megabase genome sequence of mimivirus	SCIENCE			English	Article							ORIGIN; EVOLUTION; PROTEIN; FAMILIES; DATABASE; VIRUSES	We recently reported the discovery and preliminary characterization of Mimivirus, the largest known virus, with a 400-nanometer particle size comparable to mycoplasma. Mimivirus is a double-stranded DNA virus growing in amoebae. We now present its 1,181,404-base pair genome sequence, consisting of 1262 putative open reading frames, 10% of which exhibit a similarity to proteins of known functions. In addition to exceptional genome size, Mimivirus exhibits many features that distinguish it from other nucleocytoplasmic large DNA viruses. The most unexpected is the presence of numerous genes encoding central protein-translation components, including four amino-acyl transfer RNA synthetases, peptide release factor 1, translation elongation factor EF-TU, and translation initiation factor 1. The genome also exhibits six tRNAs. Other notable features include the presence of both type I and type II topoisomerases, components of all DNA repair pathways, many polysaccharide synthesis enzymes, and one intein-containing gene. The size and complexity of the Mimivirus genome challenge the established frontier between viruses and parasitic cellular organisms. This new sequence data might help shed a new light on the origin of DNA viruses and their role in the early evolution of eukaryotes.	Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies, F-13385 Marseille 05, France; Inst Biol Struct & Microbiol, CNRS, UPR 2589, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Raoult, D (corresponding author), Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies, F-13385 Marseille 05, France.	Didier.Raoult@medecine.univ-mrs.fr; Jean-Michel.Claverie@igs.cnrs-mrs.fr	RAOULT, Didier/A-8434-2008; Claverie, Jean-Michel/AAG-4889-2019; Renesto, patricia/M-6105-2014; Claverie, Jean Michel/Z-2183-2019; LA SCOLA, Bernard/P-6477-2016; renesto, patricia/T-6446-2019	RAOULT, Didier/0000-0002-0633-5974; Claverie, Jean-Michel/0000-0003-1424-0315; LA SCOLA, Bernard/0000-0001-8006-7704; renesto, patricia/0000-0002-6749-7862; Abergel, Chantal/0000-0003-1875-4049; Audic, Stephane/0000-0001-6193-4374				ABERGEL C, UNPUB; Afonso CL, 1999, J VIROL, V73, P533, DOI 10.1128/JVI.73.1.533-552.1999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bell PJL, 2001, J MOL EVOL, V53, P251; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Forterre P, 2001, CR ACAD SCI III-VIE, V324, P1067, DOI 10.1016/S0764-4469(01)01403-2; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kawasaki T, 2002, VIROLOGY, V302, P123, DOI 10.1006/viro.2002.1572; La Scola B, 2003, SCIENCE, V299, P2033; Lazarevic V, 1998, P NATL ACAD SCI USA, V95, P1692, DOI 10.1073/pnas.95.4.1692; LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mindell DP, 2003, SCIENCE, V302, P1677; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; OGATA H, UNPUB; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pennisi E, 2004, SCIENCE, V305, P766, DOI 10.1126/science.305.5685.766; Pietrokovski S, 1998, CURR BIOL, V8, pR634, DOI 10.1016/S0960-9822(07)00409-5; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; Takemura M, 2001, J MOL EVOL, V52, P419, DOI 10.1007/s002390010171; TARNAS I, 2002, SCIENCE, V296, P2376; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; Villarreal LP, 2000, J VIROL, V74, P7079, DOI 10.1128/JVI.74.15.7079-7084.2000; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; YAMADA T, 1993, VIROLOGY, V197, P742, DOI 10.1006/viro.1993.1650; Zillig W, 1998, EXTREMOPHILES, V2, P131, DOI 10.1007/s007920050052	36	710	1656	4	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1344	1350		10.1126/science.1101485	http://dx.doi.org/10.1126/science.1101485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15486256				2022-12-24	WOS:000225301600043
J	Tomari, Y; Matranga, C; Haley, B; Martinez, N; Zamore, PD				Tomari, Y; Matranga, C; Haley, B; Martinez, N; Zamore, PD			A protein sensor for siRNA asymmetry	SCIENCE			English	Article							SEQUENCE-SPECIFIC INHIBITION; SMALL INTERFERING RNA; DISTINCT ROLES; ENZYME COMPLEX; DROSOPHILA; PATHWAYS; CELLS; ENDONUCLEASE; INITIATION; CLEAVAGE	To act as guides in the RNA interference (RNAi) pathway, small interfering RNAs (siRNAs) must be unwound into their component strands, then assembled with proteins to form the RNA-induced silencing complex (RISC), which catalyzes target messenger RNA cleavage. Thermodynamic differences in the base-pairing stabilities of the 5' ends of the two similar to21-nucleotide siRNA strands determine which siRNA strand is assembled into the RISC. We show that in Drosophila, the orientation of the Dicer-2/R2D2 protein heterodimer on the siRNA duplex determines which siRNA strand associates with the core RISC protein Argonaute 2. R2D2 binds the siRNA end with the greatest double-stranded character, thereby orienting the heterodimer on the siRNA duplex. Strong R2D2 binding requires a 5'-phosphate on the siRNA strand that is excluded from the RISC. Thus, R2D2 is both a protein sensor for siRNA thermodynamic asymmetry and a licensing factor for entry of authentic siRNAs into the RNAi pathway.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Tomari, Yukihide/A-8009-2009	Tomari, Yukihide/0000-0001-8442-0851; Zamore, Phillip/0000-0002-4505-9618; Matranga, Christian/0000-0002-9037-5468	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R01GM062862, R37GM062862] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM65236-01, GM62862-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	23	445	486	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2004	306	5700					1377	1380		10.1126/science.1102755	http://dx.doi.org/10.1126/science.1102755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550672				2022-12-24	WOS:000225301600053
J	Wei, L; MacDonald, TM; Walker, BR				Wei, L; MacDonald, TM; Walker, BR			Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TYPE-2 DIABETES-MELLITUS; RHEUMATOID-ARTHRITIS; BLOOD-PRESSURE; INSULIN-RESISTANCE; CUSHINGS-DISEASE; RISK-FACTORS; MORTALITY; POPULATION; COHORT	Background: Glucocorticoids have adverse systemic effects, including obesity, hypertension, and hyperglycemia, that may predispose to cardiovascular disease. The effect of glucocorticoid use on cardiovascular disease has not been quantified. Objective: To test the hypothesis that users of exogenous glucocorticoids have an increased risk for cardiovascular disease. Design: A cohort study using a record linkage database. Setting: Tayside, Scotland, United Kingdom. Patients: 68 781 glucocorticoid users and 82 202 nonusers without previous hospitalization for cardiovascular disease who were studied between 1993 and 1996. Measurements: The average daily dose of glucocorticoid exposure during follow-up was categorized as low (inhaled, nasal, and topical only), medium (oral, rectal, or parenteral <7.5 mg of prednisolone equivalent), or high (greater than or equal to7.5 mg of prednisolone equivalent). Poisson regression model, sensitivity analysis, and propensity score methods were used to investigate the association between glucocorticoid exposure and cardiovascular outcome. Results: 4383 cardiovascular events occurred in 257 487 person-years of follow-up for a rate of 17.0 (95% CI, 16.5 to 17.5) per 1000 person-years in the comparator group, and 5068 events occurred in 212 287 person-years for a rate of 23.9 (CI, 23.2 to 24.5) per 1000 person-years in the group exposed to glucocorticoids (22.1, 27.2, and 76.5 in low, medium, and high groups, respectively). The absolute risk difference was 6.9 (CI, 6.0 to 7.7) per 1000 person-years (5.1, 10.1, and 59.4, respectively). After adjustment for known covariates, the relative risk for a cardiovascular event in patients receiving high-dose glucocorticoids was 2.56 (CI, 2.18 to 2.99). Limitations: Because the data were observational, residual confounding cannot be excluded. Conclusion: Treatment with high-dose glucocorticoids seemed to be associated with increased risk for cardiovascular disease.	Univ Dundee, Ninewells Hosp & Med Sch, Med Monitoring Unit, Div Med & Therapeut, Dundee DD1 9SY, Scotland; Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Sch Mol & Clin Med, Edinburgh, Midlothian, Scotland	University of Dundee; University of Edinburgh; University of Edinburgh	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Monitoring Unit, Div Med & Therapeut, Dundee DD1 9SY, Scotland.	t.m.macdonald@dundee.ac.uk		MacDonald, Thomas/0000-0001-5189-6669				Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Au DH, 2000, AM J RESP CRIT CARE, V161, P827, DOI 10.1164/ajrccm.161.3.9904006; Bjorntorp P, 1999, DIABETIC MED, V16, P373, DOI 10.1046/j.1464-5491.1999.00067.x; *BRIT MED ASSM, 1998, BRIT NAT FORM; Colao A, 1999, J CLIN ENDOCR METAB, V84, P2664, DOI 10.1210/jc.84.8.2664; DeMaria AN, 2002, AM J CARDIOL, V89, p33D; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; EVANS JMM, 2000, PHARMACOEPIDEM DR S, P361; Fraser R, 1999, HYPERTENSION, V33, P1364, DOI 10.1161/01.HYP.33.6.1364; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P34; Hole DJ, 1996, BRIT MED J, V313, P711; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; MacDonald TM, 1997, BMJ-BRIT MED J, V315, P1333, DOI 10.1136/bmj.315.7119.1333; MAXWELL SRJ, 1994, POSTGRAD MED J, V70, P863, DOI 10.1136/pgmj.70.830.863; McEntegart A, 2001, RHEUMATOLOGY, V40, P640, DOI 10.1093/rheumatology/40.6.640; McMahon AD, 1998, PHARMACOEPIDEM DR S, V7, P275, DOI 10.1002/(SICI)1099-1557(199807/08)7:4<275::AID-PDS363>3.0.CO;2-N; MUTRU O, 1985, BMJ-BRIT MED J, V290, P1797, DOI 10.1136/bmj.290.6484.1797; NASHEL DJ, 1986, AM J MED, V80, P925, DOI 10.1016/0002-9343(86)90639-X; Page J, 2000, ARCH INTERN MED, V160, P777, DOI 10.1001/archinte.160.6.777; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; RAB ST, 1991, J AM COLL CARDIOL, V18, P1524, DOI 10.1016/0735-1097(91)90685-3; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Toren K, 1996, INT J EPIDEMIOL, V25, P617, DOI 10.1093/ije/25.3.617; TURNER R, 1997, SCOTLANDS HLTH SCOTT, V1, P140; Uddhammar A, 2002, J RHEUMATOL, V29, P737; Versaci F, 2002, J AM COLL CARDIOL, V40, P1935, DOI 10.1016/S0735-1097(02)02562-7; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Wang JX, 2001, PHARMACOEPIDEM DR S, V10, P105, DOI 10.1002/pds.572; Whitworth JA, 2000, HYPERTENSION, V36, P912, DOI 10.1161/01.HYP.36.5.912; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; 1998, SCOTTISH HLTH STAT	34	505	524	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 16	2004	141	10					764	770		10.7326/0003-4819-141-10-200411160-00007	http://dx.doi.org/10.7326/0003-4819-141-10-200411160-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872KU	15545676				2022-12-24	WOS:000225206900003
J	Fraser, HSF; Jazayeri, D; Nevil, P; Karacaoglu, Y; Farmer, PE; Lyon, E; Fawzi, MKCS; Leandre, F; Choi, SS; Mukherjee, JS				Fraser, HSF; Jazayeri, D; Nevil, P; Karacaoglu, Y; Farmer, PE; Lyon, E; Fawzi, MKCS; Leandre, F; Choi, SS; Mukherjee, JS			An information system and medical record to support HIV treatment in rural Haiti	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUB-SAHARAN AFRICA; TELEMEDICINE; TECHNOLOGY; GUIDELINES; COUNTRIES; INFECTION; INTERNET; ACCESS	Lack of infrastructure, including information and communication systems, is considered a barrier to successful HIV treatment programmes in resource poor areas. The authors describe how they set up a web based medical record system linking remote areas in rural Haiti and how it is used to track clinical outcomes, laboratory tests, and drug supplies and to create reports for funding agencies.	Brigham & Womens Hosp, Div Social Med & Healthcare Inequal, Boston, MA 02115 USA; Partners Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Infect Dis & Social Change, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard Medical School	Fraser, HSF (corresponding author), Brigham & Womens Hosp, Div Social Med & Healthcare Inequal, 75 Francis St, Boston, MA 02115 USA.	Hamish_fraser@hms.harvard.edu	Fraser, Hamish HS/E-3773-2013; Fraser, Hamish/AGP-6129-2022	Fraser, Hamish/0000-0003-4383-2854				Bates DW, 2001, J AM MED INFORM ASSN, V8, P299, DOI 10.1136/jamia.2001.0080299; Carnall D, 2000, BRIT MED J, V321, P976, DOI 10.1136/bmj.321.7267.976; Della Mea V, 1999, J TELEMED TELECARE, V5, P84, DOI 10.1258/1357633991933378; Dolin RH, 2001, J AM MED INFORM ASSN, V8, P552, DOI 10.1136/jamia.2001.0080552; DOUGLAS G, 2003, P AMIA S, P833; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; FRASER HS, 2001, MEDINFO 1, V10, P815; Fraser HSF, 2000, BRIT MED J, V321, P465, DOI 10.1136/bmj.321.7259.465; Fraser HSF, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P270; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Geissbuhler Antoine, 2003, AMIA Annu Symp Proc, P249; Halamka JD, 1997, J AM MED INFORM ASSN, V4, P458, DOI 10.1136/jamia.1997.0040458; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; Loewenson R, 2004, BMJ-BRIT MED J, V328, P241, DOI 10.1136/bmj.328.7434.241; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; MILBERG J, 2003, P HEL 2003 JOH JOH I, P44; *MIN HLTH BRAZ, NAT AIDS DRUG POL JU; Oberholzer Martin, 2003, Curr Probl Dermatol, V32, P102; OLSON C, 1997, MANAGING DRUG SUPPLY, P184; PakenhamWalsh N, 1997, BRIT MED J, V314, P90, DOI 10.1136/bmj.314.7074.90; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peleg M, 2004, J AM MED INFORM ASSN, V11, P1, DOI 10.1197/jamia.M1399; Richards T, 2001, BRIT MED J, V322, P1321, DOI 10.1136/bmj.322.7298.1321; Rind DM, 1997, ANN INTERN MED, V127, P138, DOI 10.7326/0003-4819-127-2-199707150-00008; Rotich JK, 2003, J AM MED INFORM ASSN, V10, P295, DOI 10.1197/jamia.M1301; SAFRAN C, 1995, LANCET, V346, P341, DOI 10.1016/S0140-6736(95)92226-1; TASSIE JM, 2002, INT C AIDS, V14; *WHO, 2003, EV BAS REC POL MAK H, P2; 2003, NY TIMES        0904, P22	30	68	69	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2004	329	7475					1142	1146		10.1136/bmj.329.7475.1142	http://dx.doi.org/10.1136/bmj.329.7475.1142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	871XJ	15539669	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225169600020
J	Samavat, A; Modell, B				Samavat, A; Modell, B			Iranian national thalassaemia screening programme	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRENATAL-DIAGNOSIS; BETA-THALASSEMIA		UCL, Ctr Hlth Informat & Multiprofess Educ, London N19 5LW, England; Minist Hlth & Med Educ, Dis Management Ctr, Genet Off, Tehran, Iran	University of London; University College London; Ministry of Health & Medical Education (MOHME)	Modell, B (corresponding author), UCL, Ctr Hlth Informat & Multiprofess Educ, London N19 5LW, England.	b.modell@pcps.ucl.ac.uk						Ahmed S, 2002, NEW ENGL J MED, V347, P1162, DOI 10.1056/NEJMsa013234; AKBARI M, 1997, AM J HUM GENET S, V61; Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978; Alwan A, 1997, EMRO TECHNICAL PUBLI; ANGASTINIOTIS M, 1986, World Health Forum, V7, P291; ANGASTINIOTIS MA, 1981, LANCET, V1, P369; Bain BJ, 1998, BRIT J HAEMATOL, V101, P783, DOI 10.1046/j.1365-2141.1998.00809.x; CAO A, 1993, BAILLIERE CLIN HAEM, V6, P263, DOI 10.1016/S0950-3536(05)80072-1; Farhud D. D., 1997, Iranian Journal of Public Health, V26, P1; Gohari LH, 2003, HEMOGLOBIN, V27, P129, DOI 10.1081/HEM-120021548; Loukopoulos D, 1996, SEMIN HEMATOL, V33, P76; MAGGIO A, 1992, LANCET, V339, P1361, DOI 10.1016/0140-6736(92)92012-5; Modell B, 2000, BMJ-BRIT MED J, V320, P337, DOI 10.1136/bmj.320.7231.337; Modell B, 2001, B WORLD HEALTH ORGAN, V79, P1006; MODELL B, 1980, BRIT MED J, V2, P737; Modell B., 2000, COMM GEN, V3, P144; Najmabadi H, 2001, HEMOGLOBIN, V25, P285, DOI 10.1081/HEM-100105221; Shadpour K., 1994, PHC EXPERIENCE IRAN; WHO M ETH ISS MED GE	19	185	191	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2004	329	7475					1134	1137		10.1136/bmj.329.7475.1134	http://dx.doi.org/10.1136/bmj.329.7475.1134			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	871XJ	15539666	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000225169600017
J	Carranza, J; Alarcos, S; Sanchez-Prieto, CB; Valencia, J; Mateos, C				Carranza, J; Alarcos, S; Sanchez-Prieto, CB; Valencia, J; Mateos, C			Disposable-soma senescence mediated by sexual selection in an ungulate	NATURE			English	Article							DEER CERVUS-ELAPHUS; RED DEER; TOOTH WEAR; EVOLUTION; DENSITY; AGE; SEGREGATION	Senescence may result from an optimal balance between current reproductive investment and bodily repair processes required for future reproduction(1), a theoretical prediction difficult to prove especially in large, long-lived animals. Here we propose that teeth that have fixed dimensions early in life, but that wear during chewing, can be taken as a measure of total lifetime 'repair', and their wear rate as a measure of current expenditure in performance. Our approach also considers the sexual selection process to investigate the advance of senescence in males compared with females, when selection favouring competition over mates reduces the reproductive lifespan of males(2). We studied carcasses of 2,141 male and 739 female red deer (Cervus elaphus) of different ages, finding that male molariform teeth emerged at a far smaller size than expected from body size dimorphism. This led to higher workload, steeper wear rate and earlier depletion of male teeth than in females, in concordance with sex-specific patterns of lifetime performance and reproduction. These findings provide the empirical support for the disposable-soma hypothesis of senescence(3), which predicts that investment in bodily repair will decrease when the return from this investment may not be realized as a result of other causes that limit survival or reproduction.	Univ Extremadura, Biol & Ethol Unit, F-10071 Caceres, Spain	Universidad de Extremadura	Carranza, J (corresponding author), Univ Extremadura, Biol & Ethol Unit, F-10071 Caceres, Spain.	carranza@unex.es	Carranza, Juan/E-4472-2010	Valencia, Juliana/0000-0002-8774-8315; Carranza, Juan/0000-0002-0368-7173				Bonenfant C, 2003, BEHAV ECOL, V14, P862, DOI 10.1093/beheco/arg077; Clutton-Brock T.H., 1988, P325; CLUTTONBROCK TH, 1987, J ZOOL, V211, P275, DOI 10.1111/j.1469-7998.1987.tb01534.x; EDNEY EB, 1968, NATURE, V220, P281, DOI 10.1038/220281a0; Ericsson G, 2001, ECOSCIENCE, V8, P157, DOI 10.1080/11956860.2001.11682641; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; GAILLARD JM, 1993, J ANIM ECOL, V62, P778; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Kirkwood T., 1985, HDB BIOL AGING, P2743; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Loe LE, 2003, OECOLOGIA, V135, P346, DOI 10.1007/s00442-003-1192-9; Medawar P. B., 1952, MODERN Q, V1, P30; MITCHELL B, 1967, J ANIM ECOL, V36, P279, DOI 10.2307/2912; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Mysterud Atle, 2001, Proceedings of the Royal Society Biological Sciences Series B, V268, P911; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; STAINES BW, 1978, J ZOOL, V185, P253; [No title captured]; [No title captured]	22	113	114	2	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					215	218		10.1038/nature03004	http://dx.doi.org/10.1038/nature03004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538368				2022-12-24	WOS:000225020200045
J	Singleton, MR; Dillingham, MS; Gaudier, M; Kowalczykowski, SC; Wigley, DB				Singleton, MR; Dillingham, MS; Gaudier, M; Kowalczykowski, SC; Wigley, DB			Crystal structure of RecBCD enzyme reveals a machine for processing DNA breaks	NATURE			English	Article							SINGLE-STRANDED-DNA; RECOMBINATION HOTSPOT-CHI; ESCHERICHIA-COLI; ATP HYDROLYSIS; HELICASE ACTIVITY; NUCLEASE ACTIVITY; RECD SUBUNIT; STEP-SIZE; TRANSLOCATION; SEQUENCE	RecBCD is a multi-functional enzyme complex that processes DNA ends resulting from a double-strand break. RecBCD is a bipolar helicase that splits the duplex into its component strands and digests them until encountering a recombinational hotspot (Chi site). The nuclease activity is then attenuated and RecBCD loads RecA onto the 3' tail of the DNA. Here we present the crystal structure of RecBCD bound to a DNA substrate. In this initiation complex, the DNA duplex has been split across the RecC subunit to create a fork with the separated strands each heading towards different helicase motor subunits. The strands pass along tunnels within the complex, both emerging adjacent to the nuclease domain of RecB. Passage of the 3' tail through one of these tunnels provides a mechanism for the recognition of a Chi sequence by RecC within the context of double-stranded DNA. Gating of this tunnel suggests how nuclease activity might be regulated.	London Res Inst, Canc Res UK Clare Hall Labs, Potters Bar EN6 3LD, Herts, England; Natl Inst Med Res, London NW7 1AA, England; Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Cancer Research UK; MRC National Institute for Medical Research; University of California System; University of California Davis; University of California System; University of California Davis	Wigley, DB (corresponding author), London Res Inst, Canc Res UK Clare Hall Labs, Potters Bar EN6 3LD, Herts, England.	dale.wigley@cancer.org.uk		Dillingham, Mark/0000-0002-4612-7141; Singleton, Martin/0000-0001-5716-7715				Amundsen SK, 2002, GENETICS, V161, P483; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Arnold DA, 2000, J MOL BIOL, V300, P469, DOI 10.1006/jmbi.2000.3861; Arnold DA, 1998, J BIOL CHEM, V273, P16476, DOI 10.1074/jbc.273.26.16476; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; BOEHMER PE, 1992, J BIOL CHEM, V267, P4981; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HW, 1997, J BIOL CHEM, V272, P10072; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; Farah JA, 1997, J MOL BIOL, V272, P699, DOI 10.1006/jmbi.1997.1259; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Handa N, 1997, GENES CELLS, V2, P525, DOI 10.1046/j.1365-2443.1997.1410339.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUHN B, 1979, J BIOL CHEM, V254, P1343; Kulkarni A, 2004, NUCLEIC ACIDS RES, V32, P3672, DOI 10.1093/nar/gkh675; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; PALAS KM, 1990, J BIOL CHEM, V265, P3447; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; ROSAMOND J, 1979, J BIOL CHEM, V254, P8646; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Weeks CM, 1999, ACTA CRYSTALLOGR D, V55, P492, DOI 10.1107/S0907444998012633; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	50	306	315	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					187	193		10.1038/nature02988	http://dx.doi.org/10.1038/nature02988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538360				2022-12-24	WOS:000225020200037
J	Heemsbergen, DA; Berg, MP; Loreau, M; van Haj, JR; Faber, JH; Verhoef, HA				Heemsbergen, DA; Berg, MP; Loreau, M; van Haj, JR; Faber, JH; Verhoef, HA			Biodiversity effects on soil processes explained by interspecific functional dissimilarity	SCIENCE			English	Article								The loss of biodiversity can have significant impacts on ecosystem functioning, but the mechanisms involved lack empirical confirmation. Using soil microcosms, we show experimentally that functional dissimilarity among detritivorous species, not species number, drives community compositional effects on leaf litter mass loss and soil respiration, two key soil ecosystem processes. These experiments confirm theoretical predictions that biodiversity effects on ecosystem functioning can be predicted by the degree of functional differences among species.	Vrije Univ Amsterdam, Inst Ecol Sci, Dept Anim Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Wageningen & Res Ctr, Alterra, NL-6700 AA Wageningen, Netherlands; Ecole Normale Super, Ecol Lab, F-75230 Paris, France	Vrije Universiteit Amsterdam; Wageningen University & Research; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Verhoef, HA (corresponding author), Vrije Univ Amsterdam, Inst Ecol Sci, Dept Anim Ecol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	herman.verhoef@ecology.fatw.vu.nl	Collison, Elizabeth/F-6146-2011	Berg, Matty P./0000-0001-8442-8503; van Hal, J.R./0000-0002-9466-8997				Andren O, 1999, APPL SOIL ECOL, V13, P105, DOI 10.1016/S0929-1393(99)00025-6; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; Coleman DC, 2018, FUNDAMENTALS SOIL EC, P77, DOI DOI 10.1016/B978-0-12-805251-8.00004; FABER JH, 1991, SOIL BIOL BIOCHEM, V23, P15, DOI 10.1016/0038-0717(91)90157-F; Laakso J, 1999, OIKOS, V87, P57, DOI 10.2307/3546996; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mikola J, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P169; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296	10	394	431	17	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1019	1020		10.1126/science.1101865	http://dx.doi.org/10.1126/science.1101865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528441				2022-12-24	WOS:000225001100039
J	Cantor, J; Baum, K				Cantor, J; Baum, K			The limits of conscientious objection - May pharmacists refuse to fill prescriptions for emergency contraception?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06510 USA; Wiggin & Dana, New Haven, CT USA	Yale University	Cantor, J (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.							*A GUTTM I, 2004, STAT POL BRIEF REF P; Alford S., 2001, TRANSITIONS, V12, P1; *AM PHARM ASS, COD ETH PHARM PREAMB; BRODY JE, 2004, NY TIMES        0921, pF7; Drazen JM, 2004, NEW ENGL J MED, V350, P1561, DOI 10.1056/NEJMe048057; ELLIOTT D, 2004, ALABAMA NURSES QUIT; FASSETT WE, 1996, ETHICAL ISSUES PHARM, P1; Foster DG, 2004, AM J OBSTET GYNECOL, V191, P150, DOI 10.1016/j.ajog.2004.01.004; Glasier A, 1997, NEW ENGL J MED, V337, P1058, DOI 10.1056/NEJM199710093371507; Hughes EC., 1972, OBSTET GYNECOLOGIC T; SAUER M, 1991, ST PETERSBURG T 1219, pB1; SEELEY RA, 1998, ADVICE CONSCIENTIOUS, P1; SIMON S, 2004, LOS ANGELES TIM 0320, pA18; Stanford JB, 2004, NEW ENGL J MED, V350, P2413; SWEENEY JF, 2004, PLAIN DEALER    0505, pE1; 2002, DAILY REPROD HLTH RE; 2004, CAPITAL TIMES   0513, pA16	17	78	79	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2004	351	19					2008	2012		10.1056/NEJMsb042263	http://dx.doi.org/10.1056/NEJMsb042263			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867OG	15525728				2022-12-24	WOS:000224851300016
J	Halperin, DT; Steiner, MJ; Cassell, MM; Green, EC; Hearst, N; Kirby, D; Gayle, HD; Cates, W				Halperin, DT; Steiner, MJ; Cassell, MM; Green, EC; Hearst, N; Kirby, D; Gayle, HD; Cates, W			The time has come for common ground on preventing sexual transmission of HIV	LANCET			English	Editorial Material							PARTNER REDUCTION; RISK; INFECTION; WOMEN; AGE		Univ Calif San Francisco, San Francisco, CA 94143 USA; Family Hlth Int, Res Triangle Pk, NC 27709 USA; Harvard Univ, Cambridge, MA 02138 USA; ETR Associates, Sacramento, CA USA; Int AIDS Soc, Seattle, WA USA	University of California System; University of California San Francisco; Harvard University	Halperin, DT (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	dhalp@worldwidedialup.net						CATES W, 2003, NETWORK, P22; Cohen J, 2004, SCIENCE, V304, P1932, DOI 10.1126/science.304.5679.1932; COHEN S, 2004, GUTTMACHER REPORT PU, P7; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; EPSTEIN H, 2004, NY TIMES MAGAZI 0613; Green Edward, 2003, RETHINKING AIDS PREV; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; *INT FED RED CROSS, REN OUR VOIC COD GOO; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; *US AG INT DEV BUR, 2003, ADD FAM PLANN PMTCT; WELLER S, 2002, COCHRANE LIB; Wilson D, 2004, BRIT MED J, V328, P848, DOI 10.1136/bmj.328.7444.848; 2003, MEASURE EVALUATION S	21	81	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2004	364	9449					1913	1915		10.1016/S0140-6736(04)17487-4	http://dx.doi.org/10.1016/S0140-6736(04)17487-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874BX	15566989				2022-12-24	WOS:000225327000003
J	Ansorge, MS; Zhou, MM; Lira, A; Hen, R; Gingrich, JA				Ansorge, MS; Zhou, MM; Lira, A; Hen, R; Gingrich, JA			Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice	SCIENCE			English	Article							DORSAL RAPHE NUCLEUS; SEROTONIN TRANSPORTER; ENDOGENOUS-DEPRESSION; ANTIDEPRESSANT DRUGS; MONOAMINE-OXIDASE; RECEPTOR-BINDING; MATERNAL-CARE; BRAIN-REGIONS; ANIMAL-MODEL; ANXIETY	Reduced serotonin transporter (5-HTT)-expression is associated with abnormal affective and anxiety-like symptoms in humans and rodents, but the mechanism of this effect is unknown. Transient inhibition of 5-HTT during early development with ftuoxetine, a commonly used serotonin selective reuptake inhibitor, produced abnormal emotional behaviors in adult mice. This effect mimicked the behavioral phenotype of mice genetically deficient in 5-HTT expression. These findings indicate a critical rote of serotonin in the maturation of brain systems that modulate emotional function in the adult and suggest a developmental mechanism to explain how low-expressing 5-HTT promoter alleles increase vulnerability to psychiatric disorders.	Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Sackler Inst Dev Psychobiol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Dev Psychobiol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Gingrich, JA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.	jag46@columbia.edu	ansorge, mark s/L-1360-2014					BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gingrich JA, 2003, CNS SPECTRUMS, V8, P572, DOI 10.1017/S1092852900018848; Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gutierrez B, 1998, HUM GENET, V103, P319, DOI 10.1007/s004390050823; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; HRDINA PD, 1990, J PHARMACOL EXP THER, V252, P410; Kent JM, 2000, LANCET, V355, P911, DOI 10.1016/S0140-6736(99)11381-3; Kinney GG, 1997, BRAIN RES, V756, P68, DOI 10.1016/S0006-8993(97)00119-4; Koch S, 2002, NEUROPSYCHOPHARMACOL, V27, P949, DOI 10.1016/S0893-133X(02)00377-9; LAUDER JM, 1978, DEV NEUROSCI-BASEL, V1, P15, DOI 10.1159/000112549; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2003, BEHAVIORAL GENETICS IN THE POSTGENOMIC ERA, P389, DOI 10.1037/10480-020; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; Nulman I, 1997, NEW ENGL J MED, V336, P258, DOI 10.1056/NEJM199701233360404; Nulman I, 2002, AM J PSYCHIAT, V159, P1889, DOI 10.1176/appi.ajp.159.11.1889; Rumajogee P, 2004, EUR J NEUROSCI, V19, P937, DOI 10.1111/j.0953-816X.2004.03194.x; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; SMYTHE JW, 1994, DEV BRAIN RES, V80, P183, DOI 10.1016/0165-3806(94)90103-1; Upton AL, 2002, NEUROSCIENCE, V111, P597, DOI 10.1016/S0306-4522(01)00602-9; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; VOGEL G, 1990, NEUROSCI BIOBEHAV R, V14, P85, DOI 10.1016/S0149-7634(05)80164-2; VORHEES CV, 1994, FUND APPL TOXICOL, V23, P194, DOI 10.1006/faat.1994.1098; Wisner KL, 1999, JAMA-J AM MED ASSOC, V282, P1264, DOI 10.1001/jama.282.13.1264; YAVARONE MS, 1993, TERATOLOGY, V47, P573, DOI 10.1002/tera.1420470609; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	37	625	635	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					879	881		10.1126/science.1101678	http://dx.doi.org/10.1126/science.1101678			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514160				2022-12-24	WOS:000224969400049
J	Romero, S; Le Clainche, C; Didry, D; Egile, C; Pantaloni, D; Carlier, MF				Romero, S; Le Clainche, C; Didry, D; Egile, C; Pantaloni, D; Carlier, MF			Formin is a processive motor that requires profilin to accelerate actin assembly and associated ATP hydrolysis	CELL			English	Article							DIAPHANOUS-RELATED FORMIN; BARBED-END; INDUCED NUCLEATION; MAMMALIAN HOMOLOG; MITOTIC SPINDLE; CAPPING PROTEIN; MOUSE FORMIN; POLYMERIZATION; MDIA1; ELONGATION	Motile and morphogenetic cellular processes are driven by site-directed assembly of actin filaments. Formins, proteins characterized by formin homology domains FH1 and FH2, are initiators of actin assembly. How formins simply bind to filament barbed ends in rapid equilibrium or find free energy to become a processive motor of filament assembly remains enigmatic. Here we demonstrate that the FH1-FH2 domain accelerates hydrolysis of ATP coupled to profilin-actin polymerization and uses the derived free energy for processive polymerization, increasing 15-fold the rate constant for profilin-actin association to barbed ends. Profilin is required for and takes part in the processive function. Single filaments grow at least 10 mum long from formin bound beads without detaching. Transitory formin-associated processes are generated by poisoning of the processive cycle by barbed-end capping proteins. We successfully reconstitute formin-induced motility in vitro, demonstrating that this mechanism accounts for the puzzlingly rapid formin-induced actin processes observed in vivo.	CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School	Carlier, MF (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ave de La Terrasse, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr	Le Clainche, Christophe/A-4782-2015; Romero, Stephane/GLR-3472-2022; Romero, Stephane/K-5998-2017	Le Clainche, Christophe/0000-0001-5659-677X; Romero, Stephane/0000-0002-7358-3871; Romero, Stephane/0000-0002-7358-3871				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arai R, 2002, J CELL SCI, V115, P887; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; BRUNE D, 1994, P NATL ACAD SCI USA, V91, P2930, DOI 10.1073/pnas.91.8.2930; CARLIER MF, 1986, J BIOL CHEM, V261, P785; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Frisch C, 2001, J MOL BIOL, V308, P69, DOI 10.1006/jmbi.2001.4577; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kato T, 2001, J CELL SCI, V114, P775; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; PANTALONI D, 1985, P NATL ACAD SCI USA, V82, P7207, DOI 10.1073/pnas.82.21.7207; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	54	416	428	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					419	429		10.1016/j.cell.2004.09.039	http://dx.doi.org/10.1016/j.cell.2004.09.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507212	Bronze			2022-12-24	WOS:000224908300012
J	Xu, P; Widmer, G; Wang, YP; Ozaki, LS; Alves, JM; Serrano, MG; Puiu, D; Manque, P; Akiyoshi, D; Mackey, AJ; Pearson, WR; Dear, PH; Bankier, AT; Peterson, DL; Abrahamsen, MS; Kapur, V; Tzipori, S; Buck, GA				Xu, P; Widmer, G; Wang, YP; Ozaki, LS; Alves, JM; Serrano, MG; Puiu, D; Manque, P; Akiyoshi, D; Mackey, AJ; Pearson, WR; Dear, PH; Bankier, AT; Peterson, DL; Abrahamsen, MS; Kapur, V; Tzipori, S; Buck, GA			The genome of Cryptosporidium hominis	NATURE			English	Article							TOXOPLASMA-GONDII; PARVUM; SEQUENCE; GENE; BIOSYNTHESIS; APICOMPLEXAN; ENCODE	Cryptosporidium species cause acute gastroenteritis and diarrhoea worldwide. They are members of the Apicomplexa - protozoan pathogens that invade host cells by using a specialized apical complex and are usually transmitted by an invertebrate vector or intermediate host. In contrast to other Apicomplexans, Cryptosporidium is transmitted by ingestion of oocysts and completes its life cycle in a single host. No therapy is available, and control focuses on eliminating oocysts in water supplies(1). Two species, C. hominis and C. parvum, which differ in host range, genotype and pathogenicity, are most relevant to humans(1-3). C. hominis is restricted to humans, whereas C. parvum also infects other mammals(2). Here we describe the eight-chromosome similar to9.2-million-base genome of C. hominis(2). The complement of C. hominis protein-coding genes shows a striking concordance with the requirements imposed by the environmental niches the parasite inhabits. Energy metabolism is largely from glycolysis. Both aerobic and anaerobic metabolisms are available, the former requiring an alternative electron transport system in a simplified mitochondrion. Biosynthesis capabilities are limited, explaining an extensive array of transporters. Evidence of an apicoplast is absent, but genes associated with apical complex organelles are present. C. hominis and C. parvum exhibit very similar gene complements, and phenotypic differences between these parasites must be due to subtle sequence divergence.	Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23298 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA; Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; Univ Minnesota, Biomed Genom Ctr, St Paul, MN 55108 USA; Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Tufts University; University of Virginia; University of Virginia; MRC Laboratory Molecular Biology; Virginia Commonwealth University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Buck, GA (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA.	saul.tzipori@tufts.edu; buck@mail2.vcu.edu	Dear, Paul H/A-1162-2012; Kapur, Vivek/F-7610-2013; Pearson, William/K-4908-2019; Alves, Joao M.P./G-8927-2011	Pearson, William/0000-0002-0727-3680; Alves, Joao M.P./0000-0001-5914-2087; manque, patricio/0000-0002-6606-0896; Kapur, Vivek/0000-0002-9648-0138				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Akiyoshi DE, 2002, INFECT IMMUN, V70, P5670, DOI 10.1128/IAI.70.10.5670-5675.2002; Atreya CE, 2004, J BIOL CHEM, V279, P18314, DOI 10.1074/jbc.M400009200; Bankier AT, 2003, GENOME RES, V13, P1787, DOI 10.1101/gr.1555203; Beyer TV, 2002, CELL BIOL INT, V26, P861, DOI 10.1006/cbir.2002.0943; Chaturvedi S, 1999, J BIOL CHEM, V274, P2424, DOI 10.1074/jbc.274.4.2424; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Jasso-Chavez R, 2003, EUR J BIOCHEM, V270, P4942, DOI 10.1046/j.1432-1033.2003.03896.x; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keithly JS, 1997, MOL BIOCHEM PARASIT, V88, P35, DOI 10.1016/S0166-6851(97)00063-7; LaGier MJ, 2003, MICROBIOL-SGM, V149, P3519, DOI 10.1099/mic.0.26365-0; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Muller M, 1998, SYST ASSOC SPEC VOL, V56, P109; Ngo HM, 2003, J BIOL CHEM, V278, P5343, DOI 10.1074/jbc.M208291200; Parsons M, 2000, PARASITOL TODAY, V16, P56, DOI 10.1016/S0169-4758(99)01590-2; Petry F, 1999, INT J PARASITOL, V29, P1249, DOI 10.1016/S0020-7519(99)00080-6; Priest JW, 2001, MOL BIOCHEM PARASIT, V113, P117, DOI 10.1016/S0166-6851(00)00386-8; Riordan CE, 2003, CURR GENET, V44, P138, DOI 10.1007/s00294-003-0432-1; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Simpson AGB, 2002, MOL BIOL EVOL, V19, P1782, DOI 10.1093/oxfordjournals.molbev.a004000; Stedman TT, 2003, J BIOL CHEM, V278, P5433, DOI 10.1074/jbc.M209390200; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; Tetley L, 1998, MICROBIOL-SGM, V144, P3249, DOI 10.1099/00221287-144-12-3249; Tzipori S, 2002, MICROBES INFECT, V4, P1047, DOI 10.1016/S1286-4579(02)01629-5; Zhu G, 2004, MOL BIOCHEM PARASIT, V134, P127, DOI 10.1016/j.molbiopara.2003.11.011; Zhu G, 2000, MICROBIOL-SGM, V146, P315, DOI 10.1099/00221287-146-2-315; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9; Zuther E, 1999, P NATL ACAD SCI USA, V96, P13387, DOI 10.1073/pnas.96.23.13387	30	392	433	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1107	1112		10.1038/nature02977	http://dx.doi.org/10.1038/nature02977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510150	hybrid			2022-12-24	WOS:000224730800043
J	Pritchard-Jones, K; Pritchard, J				Pritchard-Jones, K; Pritchard, J			Success of clinical trials in childhood Wilms' tumour around the world	LANCET			English	Editorial Material							INTERNATIONAL-SOCIETY; MALIGNANT NEOPLASMS; RENAL TUMORS; STAGE-I; DURATION; CHILDREN; OLDER		Royal Marsden Hosp, Inst Canc Res, Sutton SM2 5PT, Surrey, England; Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pritchard-Jones, K (corresponding author), Royal Marsden Hosp, Inst Canc Res, Downs Rd, Sutton SM2 5PT, Surrey, England.	kathy.pritchard-jones@icr.ac.uk	Pritchard-Jones, Kathy/F-4286-2014	Pritchard-Jones, Kathy/0000-0002-2384-9475				BERGERON C, 2003, MED PEDIATR ONCOL, V41, P289; BRESLOW NE, 1995, J CLIN ONCOL, V13, P1851, DOI 10.1200/JCO.1995.13.8.1851; Carli M, 1997, MED PEDIATR ONCOL, V29, P239, DOI 10.1002/(SICI)1096-911X(199710)29:4<239::AID-MPO1>3.3.CO;2-P; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; DECAMARGO B, 1994, CANCER-AM CANCER SOC, V73, P3081, DOI 10.1002/1097-0142(19940615)73:12<3081::AID-CNCR2820731229>3.0.CO;2-1; Green DM, 1998, J CLIN ONCOL, V16, P3744, DOI 10.1200/JCO.1998.16.12.3744; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; MITCHELL C, 2003, MED PEDIATR ONCOL, V41, P287; Pritchard-Jones K, 2003, J CLIN ONCOL, V21, P3269, DOI 10.1200/JCO.2003.01.062; STILLER CA, 1990, BRIT J CANCER, V62, P1026, DOI 10.1038/bjc.1990.432; Tournade MF, 2001, J CLIN ONCOL, V19, P488, DOI 10.1200/JCO.2001.19.2.488; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Weirich A, 2001, ANN ONCOL, V12, P311, DOI 10.1023/A:1011167924230	13	35	36	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 23	2004	364	9444					1468	1470		10.1016/S0140-6736(04)17289-9	http://dx.doi.org/10.1016/S0140-6736(04)17289-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864PN	15500874				2022-12-24	WOS:000224645500007
J	Kemner, KM; Kelly, SD; Lai, B; Maser, J; O'Loughlin, EJ; Sholto-Douglas, D; Cai, ZH; Schneegurt, MA; Kulpa, CF; Nealson, KH				Kemner, KM; Kelly, SD; Lai, B; Maser, J; O'Loughlin, EJ; Sholto-Douglas, D; Cai, ZH; Schneegurt, MA; Kulpa, CF; Nealson, KH			Elemental and redox analysis of single bacterial cells by X-ray microbeam analysis	SCIENCE			English	Article							PSEUDOMONAS-FLUORESCENS; ZONE PLATES; EXOPOLYSACCHARIDES; POLYSACCHARIDES; BIOFILMS; ALGINATE; CALCIUM; PUTIDA; IONS	High-energy x-ray fluorescence measurements were used to make elemental maps and qualitative chemical analyses of individual Pseudomonas fluorescens strain NCIMB 11764 cells. Marked differences between planktonic and adhered cells were seen in the morphology, elemental composition, and sensitivity to Cr(VI) of hydrated cells at spatial scales of 150 nm. This technology can be applied to natural geomicrobiological systems.	Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Wichita State University; University of Notre Dame; University of Southern California	Kemner, KM (corresponding author), Argonne Natl Lab, Div Environm Res, 9700 S Cass Ave, Argonne, IL 60439 USA.	kemner@anl.gov	O'Loughlin, Edward/C-9565-2013; Maser, Jörg/K-6817-2013	O'Loughlin, Edward/0000-0003-1607-9529; 				BEVERIDGE TJ, 1989, ANNU REV MICROBIOL, V43, P147, DOI 10.1146/annurev.mi.43.100189.001051; Braccini I, 1999, CARBOHYD RES, V317, P119, DOI 10.1016/S0008-6215(99)00062-2; Cai Z, 2000, AIP CONF PROC, V507, P472, DOI 10.1063/1.1291193; CONTI E, 1994, MICROBIOL-UK, V140, P1125, DOI 10.1099/13500872-140-5-1125; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; FETT WF, 1989, APPL ENVIRON MICROB, V55, P579, DOI 10.1128/AEM.55.3.579-583.1989; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Gregor JE, 1996, WATER RES, V30, P1319, DOI 10.1016/0043-1354(95)00194-8; Kemner KM, 1999, J SYNCHROTRON RADIAT, V6, P639, DOI 10.1107/S0909049598016586; Langley S, 1999, CAN J MICROBIOL, V45, P616, DOI 10.1139/cjm-45-7-616; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; READ RR, 1987, CAN J MICROBIOL, V33, P1080, DOI 10.1139/m87-189; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Winkelmann G., 1997, TRANSITION METALS MI; Yun W, 1999, REV SCI INSTRUM, V70, P2238, DOI 10.1063/1.1149744	18	134	140	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					686	687		10.1126/science.1103524	http://dx.doi.org/10.1126/science.1103524			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499017				2022-12-24	WOS:000224756700051
J	Nathan, C				Nathan, C			Antibiotics at the crossroads	NATURE			English	Editorial Material							DRUG DISCOVERY; MYCOBACTERIUM-TUBERCULOSIS; CHALLENGES		Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10021 USA.							[Anonymous], 2004, SCIENCE, V303, P1798, DOI 10.1126/science.303.5665.1796; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; *CDCP, 2000, PUBL HLTH ACT PLAN C; Chopra I, 1996, JAMA-J AM MED ASSOC, V275, P401, DOI 10.1001/jama.275.5.401; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; *GLOB ALL TUB DRUG, 2001, EC TB DRUG DEV; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Manetsch R, 2004, J AM CHEM SOC, V126, P12809, DOI 10.1021/ja046382g; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; *WHO, 2001, DRAFT GLOB STRAT CON; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E	23	301	315	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					899	902		10.1038/431899a	http://dx.doi.org/10.1038/431899a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496893				2022-12-24	WOS:000224585600016
J	Donnez, J; Dolmans, MM; Demylle, D; Jadoul, P; Pirard, C; Squifflet, J; Martinez-Madrid, B; Van Langendonckt, A				Donnez, J; Dolmans, MM; Demylle, D; Jadoul, P; Pirard, C; Squifflet, J; Martinez-Madrid, B; Van Langendonckt, A			Livebirth after orthotopic transplantation of cryopreserved ovarian tissue	LANCET			English	Article							CHILDHOOD-CANCER; CORTICAL STRIPS; FERTILITY; AUTOGRAFTS; FROZEN; SHEEP; LYMPHOMA; FRESH; RESTORATION; SURVIVORS	Background The lifesaving treatment endured by cancer patients leads, in many women, to early menopause and subsequent infertility. In clinical situations for which chemotherapy needs to be started, ovarian tissue cryopreservation looks to be a promising option to restore fertility. In 1997, biopsy samples of ovarian cortex were taken from a woman with stage IV Hodgkin's lymphoma and cryopreserved before chemotherapy was initiated. After her cancer treatment, the patient had premature ovarian failure. Methods In 2003, after freeze-thawing, orthotopic autotransplantation of ovarian cortical tissue was done by laparoscopy. Findings 5 months after reimplantation, basal body temperature, menstrual cycles, vaginal ultrasonography, and hormone concentrations indicated recovery of regular ovulatory cycles. Laparoscopy at 5 months confirmed the ultrasonographic data and showed the presence of a follicle at the site of reimplantation, clearly situated outside the ovaries, both of which appeared atrophic. From 5 to 9 months, the patient had menstrual bleeding and development of a follicle or corpus luteum with every cycle. 11 months after reimplantation, human chorionic gonadotrophin concentrations and vaginal echography confirmed a viable intrauterine pregnancy, which has resulted in a livebirth. Interpretation We have described a livebirth after orthotopic autotransplantation of cryopreserved ovarian tissue. Our findings suggest that cryopreservation of ovarian tissue should be offered to all young women diagnosed with cancer.	Univ Catholique Louvain, Clin Univ St Luc, Dept Gynaecol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Gynaecol Res Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Donnez, J (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Dept Gynaecol, Ave Hippocrate 10, B-1200 Brussels, Belgium.	donnez@gyne.ud.ac.be	Dolmans, Marie-Madeleine/AAI-7167-2020; Martinez-Madrid, Belen/K-7493-2017	Martinez-Madrid, Belen/0000-0001-6852-4597				Aubard Y, 1999, HUM REPROD, V14, P2149, DOI 10.1093/humrep/14.8.2149; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; Callejo J, 2001, J CLIN ENDOCR METAB, V86, P4489, DOI 10.1210/jc.86.9.4489; Campbell BK, 2000, MOL CELL ENDOCRINOL, V163, P131, DOI 10.1016/S0303-7207(00)00217-3; CANDY CJ, 1995, HUM REPROD, V10, P2334; Candy CJ, 2000, HUM REPROD, V15, P1300, DOI 10.1093/humrep/15.6.1300; Cortvrindt RG, 2001, FERTIL STERIL, V75, P588, DOI 10.1016/S0015-0282(00)01754-4; Donnez J, 1998, HUM REPROD UPDATE, V4, P248, DOI 10.1093/humupd/4.3.248; Donnez J, 2000, CURR OPIN OBSTET GYN, V12, P1, DOI 10.1097/00001703-200002000-00001; Galant C, 2004, AM J PATHOL, V165, P83, DOI 10.1016/S0002-9440(10)63277-4; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365; Kim SS, 2001, HUM REPROD, V16, P2056, DOI 10.1093/humrep/16.10.2056; Kim SS, 2003, HUM REPROD, V18, P1759, DOI 10.1093/humrep/deg381; Kim SS, 2001, FERTIL STERIL, V75, P1049, DOI 10.1016/S0015-0282(01)01790-3; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Lee DM, 2004, NATURE, V428, P137, DOI 10.1038/428137a; Meirow D, 1999, FERTIL STERIL, V71, P948, DOI 10.1016/S0015-0282(99)00067-9; Meirow D, 1998, FERTIL STERIL, V69, P996; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Oktay K, 2004, LANCET, V363, P837, DOI 10.1016/S0140-6736(04)15728-0; Oktay K, 2001, JAMA-J AM MED ASSOC, V286, P1490, DOI 10.1001/jama.286.12.1490; Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X; Rao GD, 2004, LANCET, V363, P1829, DOI 10.1016/S0140-6736(04)16320-4; Shaw JM, 1996, HUM REPROD, V11, P1668	27	1103	1195	3	65	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1405	1410		10.1016/S0140-6736(04)17222-X	http://dx.doi.org/10.1016/S0140-6736(04)17222-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488215				2022-12-24	WOS:000224485300026
J	Forde, SE; Thompson, JN; Bohannan, BJM				Forde, SE; Thompson, JN; Bohannan, BJM			Adaptation varies through space and time in a coevolving host-parasitoid interaction	NATURE			English	Article							LOCAL ADAPTATION; ANTAGONISTIC COEVOLUTION; RESOURCE ENRICHMENT; GENE FLOW; MODEL; COMMUNITY; BACTERIA; PRODUCTIVITY; POPULATIONS; SELECTION	One of the central challenges of evolutionary biology is to understand how coevolution organizes biodiversity over complex geographic landscapes. Most species are collections of genetically differentiated populations, and these populations have the potential to become adapted to their local environments in different ways. The geographic mosaic theory of coevolution incorporates this idea by proposing that spatial variation in natural selection and gene flow across a landscape can shape local coevolutionary dynamics(1-7). These effects may be particularly strong when populations differ across productivity gradients, where gene flow will often be asymmetric among populations(8). Conclusive empirical tests of this theory have been particularly difficult to perform because they require knowledge of patterns of gene flow, historical population relationships and local selection pressures(2). We have tested these predictions empirically using a model community of bacteria and bacteriophage ( viral parasitoids of bacteria). We show that gene flow across a spatially structured landscape alters coevolution of parasitoids and their hosts and that the resulting patterns of adaptation can fluctuate in both space and time.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University	Forde, SE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	forde@biology.ucsc.edu	Bohannan, Brendan J. M./R-1582-2017; Thompson, Jessica/GXW-0323-2022	Bohannan, Brendan J. M./0000-0003-2907-1016; 				Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brodie ED, 2002, EVOLUTION, V56, P2067; Buckling A, 2003, SCIENCE, V302, P2107, DOI 10.1126/science.1088848; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Futuyma DJ., 1998, EVOL BIOL; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Hochberg ME, 1998, AM NAT, V152, P620, DOI 10.1086/286194; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Nuismer SL, 1999, P ROY SOC B-BIOL SCI, V266, P605, DOI 10.1098/rspb.1999.0679; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SHRAG SJ, 1996, AM NAT, V148, P348; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	25	159	162	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					841	844		10.1038/nature02906	http://dx.doi.org/10.1038/nature02906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483611				2022-12-24	WOS:000224435500046
J	Molassiotis, A				Molassiotis, A			The prince and the professor - With respect, Professor Baum, you've got it wrong	BRITISH MEDICAL JOURNAL			English	Letter									Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England	University of Manchester	Molassiotis, A (corresponding author), Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England.	alex.molassiotis@man.ac.uk		Molassiotis, Alex/0000-0001-6351-9991				Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118; BRIGHTHOPE I, DO YOU TRUST ORTHODO	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					858	858		10.1136/bmj.329.7470.858-a	http://dx.doi.org/10.1136/bmj.329.7470.858-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472282	Green Published			2022-12-24	WOS:000224472800040
J	Kaplan, AE				Kaplan, AE			The long and the short of it...	NATURE			English	Editorial Material									Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Kaplan, AE (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.		Kaplan, Alexander E/A-8132-2009	Kaplan, Alexander E/0000-0002-8094-5332				Greene Brian, 2003, ELEGANT UNIVERSE; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Kaplan AE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.074801; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Zewail AH, 2001, NATURE, V412, P279, DOI 10.1038/35085661	5	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					633	633		10.1038/431633a	http://dx.doi.org/10.1038/431633a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470407	Bronze			2022-12-24	WOS:000224299300021
J	Daviglus, ML; Stamler, J; Pirzada, A; Yan, LJL; Garside, DB; Liu, K; Wang, RW; Dyer, AR; Lloyd-Jones, DM; Greenland, P				Daviglus, ML; Stamler, J; Pirzada, A; Yan, LJL; Garside, DB; Liu, K; Wang, RW; Dyer, AR; Lloyd-Jones, DM; Greenland, P			Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGE; OLDER AGE; PREVALENCE; OBESITY; TRENDS; LIFE; COHORTS	Content For women, impact of cardiovascular risk factors measured in young adulthood, particularly favorable (low-risk) profile, on mortality has been difficult to assess due to low short-term death rates. Objective To assess the relationship of baseline coronary risk factor status to mortality from coronary heart disease (CHD), cardiovascular diseases (CVDs), and all causes in young women. Design Prospective cohort study. Setting and Participants A total of 7302 women aged 18 to 39 years without prior CHID or major electrocardiographic abnormalities screened between 1967 and 1973 for the Chicago Heart Association Detection Project in Industry. Risk groups were defined using national guidelines for values of systolic and diastolic blood pressure, serum cholesterol level, body mass index, presence of diabetes, and smoking status. Participants were divided into 4 groups: low risk, 0 risk factors high but 1 or more unfavorable, 1 only risk factor high, and 2 or more risk factors high. Main Outcome Measures All-cause mortality, CHD mortality, and CVD mortality; hazard ratio of outcome measures comparing low-risk group with other groups. Results Only 20% met low-risk criteria; 59% had high levels of 1 or more risk factors. During an average follow-up of 31 years, there were 47 CHID deaths, 94 CVD deaths, and 469 deaths from all causes. The age-adjusted CVD death rate per 10000 person-years was lowest for low-risk women and increased with the number of risk factors, ie, 1.5, 1.7, 5.0, and 9.1 for low-risk; 0, 1, and 2 or more risk factors high, respectively. Multivariate-adjusted CVD mortality hazard ratio for low-risk women was 0.19 (95% confidence interval, 0.08-0.45) compared with women with 2 or more risk factors high. Similar patterns were observed for CHD and all-cause mortality and for both blacks and whites. Conclusion For women with favorable levels for all 5 major risk factors at younger ages, CHID and CVD are rare; long-term and all-cause mortality are much lower compared with others.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Daviglus, ML (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	daviglus@northwestern.edu	Pirzada, Amber/ABG-6028-2021; Greenland, Philip/ABD-5528-2021; Lloyd-Jones, Donald M/C-5899-2009	Pirzada, Amber/0000-0003-0526-3611; Lloyd-Jones, Donald/0000-0003-0847-6110	NHLBI NIH HHS [R01 HL21010] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Daviglus ML, 2003, ARCH INTERN MED, V163, P2460, DOI 10.1001/archinte.163.20.2460; Daviglus ML, 2004, AM J CARDIOL, V94, P367, DOI 10.1016/j.amjcard.2004.04.038; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Rosengren A, 2001, EUR HEART J, V22, P136, DOI 10.1053/euhj.2000.2179; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; *US DEP HHS, 1980, DHHS PUBL PHS, V1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 1992, INT STAT CLASS DIS R; World Health Organization, 1967, INT CLASS DIS 8 REV; Yan LJL, 2003, CIRCULATION, V107, pE7037	17	175	181	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1588	1592		10.1001/jama.292.13.1588	http://dx.doi.org/10.1001/jama.292.13.1588			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467061	Bronze			2022-12-24	WOS:000224254600026
J	Tsai, CJ; Leitzmann, MF; Willett, WC; Giovannucci, EL				Tsai, CJ; Leitzmann, MF; Willett, WC; Giovannucci, EL			The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men - A prospective cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-FAT; CHOLESTEROL CHOLELITHIASIS; GALLBLADDER-DISEASE; INSULIN-RESISTANCE; LIPIDS; ACIDS; PREVALENCE; HAMSTERS; QUESTIONNAIRE; POPULATION	Background: Monounsaturated and polyunsaturated fats act as inhibitors of cholesterol cholelithiasis in animal experiments. Objective: To examine the association between long-term intake of cis unsaturated fats and the incidence of gallstone disease in humans. Design: Prospective population-based cohort study. Setting: The Health Professional Follow-up Study. Participants: 45 756 men, age 40 to 75 years in 1986, who were free of gallstone disease. Measurements: Consumption of cis unsaturated fats was assessed starting in 1986 as part of the 131-item semi-quantitative food-frequency questionnaires. Questionnaires were mailed to participants every 2 years. The main outcome measure was self-reported newly diagnosed symptomatic gallstone disease. Results: During 14 years of follow-up, 2323 new cases of gallstone disease were documented. After adjustment for age and other potential risk factors, the relative risk for gallstone disease among men in the highest quintile of dietary intake of cis unsaturated fats compared with men in the lowest quintile was 0.82 (95% Cl, 0.69 to 0.96; P for trend = 0.006). The relative risk among men in the highest quintile of polyunsaturated fat consumption compared with men in the lowest quintile was 0.84 (Cl, 0.73 to 0.96; P for trend = 0.01), and the relative risk among men in the highest quintile of monounsaturated fat consumption compared with men in the lowest quintile was 0.83 (Cl, 0.70 to 1.00; P for trend = 0.01). Limitations: Outcomes were restricted to men with cholecystectomy or diagnostically confirmed but unremoved symptomatic gallstones. Conclusions: A high intake of polyunsaturated and monounsaturated fats in the context of an energy-balanced diet is associated with a reduced risk for gallstone disease in men.	Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Tsai, CJ (corresponding author), Univ Kentucky, Med Ctr, Div Digest Dis & Nutr, 800 Rose St,MN649, Lexington, KY 40536 USA.	hpcjt@channing.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NIDDK NIH HHS [DK46200] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayyad N, 1996, LIPIDS, V31, P721, DOI 10.1007/BF02522888; CHAIT A, 1979, J CLIN INVEST, V64, P1309, DOI 10.1172/JCI109587; CLANDININ MT, 1993, ANN NY ACAD SCI, V683, P151, DOI 10.1111/j.1749-6632.1993.tb35701.x; COHEN BI, 1992, LIPIDS, V27, P526, DOI 10.1007/BF02536135; Cox D. R., 1984, ANAL SURVIVAL DATA; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238; DIEHL AK, 1989, GASTROENTEROLOGY, V97, P1527, DOI 10.1016/0016-5085(89)90399-5; Dowling RH, 2000, ALIMENT PHARM THER, V14, P39, DOI 10.1046/j.1365-2036.2000.014s2039.x; Dubrac S, 2001, J HEPATOL, V35, P550, DOI 10.1016/S0168-8278(01)00180-5; Eritsland J, 2000, AM J CLIN NUTR, V71, p197S, DOI 10.1093/ajcn/71.1.197S; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Flanders W D, 1990, Epidemiology, V1, P239, DOI 10.1097/00001648-199005000-00010; GILAT T, 1985, AM J CLIN NUTR, V41, P336, DOI 10.1093/ajcn/41.2.336; HAY DW, 1990, HEPATOLOGY, V12, pS6; HAYES KC, 1992, ANNU REV NUTR, V12, P299, DOI 10.1146/annurev.nu.12.070192.001503; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2003, AM J CLIN NUTR, V78, p544S, DOI 10.1093/ajcn/78.3.544S; JONNALAGADDA SS, 1995, LIPIDS, V30, P415, DOI 10.1007/BF02536299; JORGENSEN T, 1989, SCAND J GASTROENTERO, V24, P821, DOI 10.3109/00365528909089221; JORGENSEN T, 1989, HEPATOLOGY, V9, P856, DOI 10.1002/hep.1840090611; LINOS AD, 1989, HPB SURG, V18, P221; Lovejoy J C, 1999, Curr Atheroscler Rep, V1, P215, DOI 10.1007/s11883-999-0035-5; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; MIETTINEN M, 1976, ANN CLIN RES, V8, P111; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Moerman Clara J., 1994, Annals of Epidemiology, V4, P248, DOI 10.1016/1047-2797(94)90104-X; *NAT HOSP DISCH SU, 2000, ADV DAT VIT HLTH STA; NEPOKROEFF CM, 1974, ARCH BIOCHEM BIOPHYS, V160, P387, DOI 10.1016/0003-9861(74)90412-3; Oliver MF, 1997, AM J CLIN NUTR, V66, P980; Ortega RM, 1997, J AM COLL NUTR, V16, P88, DOI 10.1080/07315724.1997.10718655; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rivellese AA, 2002, ANN NY ACAD SCI, V967, P329; Rose DP, 1997, AM J CLIN NUTR, V66, P998; Rothman K., 1998, MODERN EPIDEMIOLOGY; SCOBEY MW, 1991, HEPATOLOGY, V14, P679, DOI 10.1002/hep.1840140417; SHIFFMAN ML, 1993, GASTROENTEROLOGY, V105, P1200, DOI 10.1016/0016-5085(93)90968-I; *USDA, 1998, AGR HDB USDA, V8; Willett W, 2001, AM J EPIDEMIOL, V154, P1107, DOI 10.1093/aje/154.12.1107; Willett W., 2012, NUTR EPIDEMIOLOGY	41	47	49	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					514	522		10.7326/0003-4819-141-7-200410050-00007	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466768				2022-12-24	WOS:000224467800003
J	Henquet, C; Krabbendam, L; Spauwen, J; Kaplan, C; Lieb, R; Wittchen, HU; van Os, J				Henquet, C; Krabbendam, L; Spauwen, J; Kaplan, C; Lieb, R; Wittchen, HU; van Os, J			Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-USE; POPULATION; SCHIZOPHRENIA; VULNERABILITY	Objective To investigate the relation between cannabis use mid psychotic symptoms in individuals with above average predisposition for psychosis who first used cannabis during adolescence. Design Analysis of prospective data from a population based sample. Assessment of substance use, predisposition for psychosis, and psychotic symptoms was based on standardised personal interviews at baseline and at follow tip four years later. Participants 2437 young people (aged 14 to 24 years) with and without predisposition for psychosis. Main outcome measure Psychotic symptoms at follow up as a function of cannabis use mid predisposition for psychosis at baseline. Results After adjustment for age, sex, socioeconomic status, urbanicity childhood trauma, predisposition for psychosis at baseline, and use of other drugs, tobacco, and alcohol, cannabis use at baseline increased the cumulative incidence of psychotic symptoms at follow up four years later (adjusted odds ratio 1.67, 95% confidence interval 1.13 to 2.46). The effect of cannabis use was much stronger in those with any predisposition for psychosis at baseline (23.8% ad. Listed difference in risk, 95% confidence interval 7.9 to 39.7, P = 0.003) than in those without (5.6%, 0.4 to 10.8, P = 0.033). The risk difference in the "predisposition" group was significantly greater than the risk difference in the "no predisposition" group (test for interaction 18.2%, 1.6 to 34.8, P = 0.032). There was a close-response relation with increasing., frequency of cannabis use. Predisposition for psychosis at baseline did not significantly predict cannabis use four years later (adjusted odds ratio 1.42, 95% confidence interval 0.88 to 2.31). Conclusion Cannabis use moderately increases the risk of psychotic symptoms in young people but has a much stronger effect ill those with evidence of predisposition for psychosis.	Maastricht Univ, EURON, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands; Max Planck Inst Psychiat, Clin Psychol & Epidemiol Unit, D-80804 Munich, Germany; Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01187 Dresden, Germany	Maastricht University; Max Planck Society; Technische Universitat Dresden	van Os, J (corresponding author), Maastricht Univ, EURON, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Neuropsychol, POB 616, NL-6200 MD Maastricht, Netherlands.	j.vanos@spunimaas.nl	Wittchen, Hans-Ulrich/ABA-8901-2020; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; Wittchen, Hans-Ulrich/A-8507-2014; van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012; Krabbendam, Lydia/F-9163-2010	Wittchen, Hans-Ulrich/0000-0002-6311-7711; van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Krabbendam, Lydia/0000-0003-4074-5149	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016977] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA016977-01] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Breslow N. E., 1994, STAT METHODS CANC RE, VII; CHEN JP, 1990, EUR J PHARMACOL, V190, P259; Dean B, 2001, NEUROSCIENCE, V103, P9, DOI 10.1016/S0306-4522(00)00552-2; Degenhardt L, 2001, PSYCHOL MED, V31, P659, DOI 10.1017/S0033291701003865; Derogatis J, 1983, SCL 90 R ADM SCORING; DEROGATIS JR, 1983, SLC 90 R ADM STORING; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Kendler KS, 1996, SCHIZOPHRENIA BULL, V22, P511, DOI 10.1093/schbul/22.3.511; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Leweke FM, 1999, NEUROREPORT, V10, P1665, DOI 10.1097/00001756-199906030-00008; Lieb R, 2000, EUR ADDICT RES, V6, P170, DOI 10.1159/000052043; Macleod J, 2004, LANCET, V363, P1579, DOI 10.1016/S0140-6736(04)16200-4; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Read John, 2003, J Am Acad Psychoanal Dyn Psychiatry, V31, P247, DOI 10.1521/jaap.31.1.247.21938; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Sharpley M, 2001, BRIT J PSYCHIAT, V178, pS60, DOI 10.1192/bjp.178.40.s60; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477; Verdoux H, 2003, SCHIZOPHR RES, V59, P77, DOI 10.1016/S0920-9964(01)00401-7; Verdoux H, 2003, PSYCHOL MED, V33, P23, DOI 10.1017/S0033291702006384; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095	22	514	523	1	85	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 1	2005	330	7481					11	14		10.1136/bmj.38267.664086.63	http://dx.doi.org/10.1136/bmj.38267.664086.63			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15574485	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000226176700009
J	Chen, GYJ; Yao, SQ				Chen, GYJ; Yao, SQ			Lighting up cancer cells with "dots"	LANCET			English	Editorial Material							SEMICONDUCTOR QUANTUM DOTS; IN-VIVO		Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Yao, SQ (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.	chmyaosq@nus.edu.sg	Yao, Shao Q/B-8825-2008					Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Srinivasan R, 2004, COMB CHEM HIGH T SCR, V7, P597; Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764	10	12	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2004	364	9450					2001	2003		10.1016/S0140-6736(04)17527-2	http://dx.doi.org/10.1016/S0140-6736(04)17527-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582045				2022-12-24	WOS:000225495700007
J	Butler, D				Butler, D			The fertility riddle	NATURE			English	News Item							UNITED-STATES											Azziz R, 2004, REPROD BIOMED ONLINE, V8, P644, DOI 10.1016/S1472-6483(10)61644-6; Chandra A, 1998, FAM PLANN PERSPECT, V30, P34, DOI 10.2307/2991524; Joffe M, 2000, LANCET, V355, P1961, DOI 10.1016/S0140-6736(00)02328-X; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; *MPHPT, 2004, STAT HDB JAP 2004; Sharpe RM, 2002, NAT CELL BIOL, V4, pS33, DOI 10.1038/ncb-nm-fertilityS33; Tingen C, 2004, ENVIRON HEALTH PERSP, V112, P87, DOI 10.1289/ehp.6263; Tong S, 1998, HUM REPROD, V13, P95, DOI 10.1093/humrep/13.1.95; *UN DEP EC SOC AFF, 2004, WORLD FERT REP 2003	9	24	27	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					38	39		10.1038/432038a	http://dx.doi.org/10.1038/432038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525975				2022-12-24	WOS:000224854900032
J	Ango, F; di Cristo, G; Higashiyama, H; Bennett, V; Wu, P; Huang, ZJ				Ango, F; di Cristo, G; Higashiyama, H; Bennett, V; Wu, P; Huang, ZJ			Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at Purkinje axon initial segment	CELL			English	Article							ADHESION MOLECULES; TRANSGENIC MICE; INTERNEURONS; L1; SPECTRIN; HIPPOCAMPUS; INHIBITION; CORTEX; DIVERSITY; GUIDANCE	Distinct classes of GABAergic synapses are segregated into subcellular domains (i.e., dendrite, soma, and axon initial segment-AIS), thereby differentially regulating the input, integration, and output of principal neurons. In cerebellum, for example, basket interneurons make exquisitely precise "pinceau synapses" on AIS of Purkinje neurons, but the underlying mechanism is unknown. Using BAC transgenic reporter mice, we found that basket axons always contacted Purkinje soma before innervating AIS. This synapse targeting process followed the establishment of a subcellular gradient of neurofascin186 (NF186), an L1 family immunoglobulin cell adhesion molecule (L1 CAM), along the Purkinje AIS-soma axis. This gradient was dependent on ankyrinG, an AIS-restricted membrane adaptor protein that recruits NF186. In the absence of neurofascin gradient, basket axons lost directional growth along Purkinje neurons and precisely followed NF186 to ectopic locations. Disruption of NF186-ankyrinG interactions at AIS reduced pinceau synapse formation. These results implicate ankyrin-based localization of L1CAMs in subcellular organization of GABAergic synapses.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Cell Biol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Duke University; Howard Hughes Medical Institute	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X; Ango, Fabrice/0000-0002-5548-209X				BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; CAJAL SRY, 1911, MALOINE, P1909; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1984, J BIOL CHEM, V259, P1874; DICRISTO G, 2004, IN PRESS NAT NEUROSC; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Palay S.L., 1974, CEREBELLAR CORTEX; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Rosina A, 1999, NEUROREPORT, V10, P1613, DOI 10.1097/00001756-199905140-00041; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	49	271	277	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					257	272		10.1016/j.cell.2004.10.004	http://dx.doi.org/10.1016/j.cell.2004.10.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479642	Bronze			2022-12-24	WOS:000224577200013
J	Emoto, K; He, Y; Ye, B; Grueber, WB; Adler, PN; Jan, LY; Jan, YN				Emoto, K; He, Y; Ye, B; Grueber, WB; Adler, PN; Jan, LY; Jan, YN			Control of dendritic branching and tiling by the tricornered-kinase/furry signaling pathway in Drosophila sensory neurons	CELL			English	Article							RETINAL GANGLION-CELLS; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; PERIPHERAL NEURONS; SMALL GTPASES; RHO-GTPASES; MORPHOGENESIS; GENE; GROWTH	To cover the receptive field completely but without redundancy, neurons of certain functional groups exhibit tiling of their dendrites via dendritic repulsion. Here we show that two evolutionarily conserved proteins, the Tricornered (Trc) kinase and Furry (Fry), are essential for tiling and branching control of Drosophila sensory neuron dendrites. Dendrites of fry and trc mutants display excessive terminal branching and fail to avoid homologous dendritic branches, resulting in significant overlap of the dendritic fields. Trc control of dendritic branching involves regulation of RacGTPase, a pathway distinct from the action of Trc in tiling. Time-lapse analysis further reveals a specific loss of the ability of growing dendrites to turn away from nearby dendritic branches in fry mutants, suggestive of a defect in like-repels-like avoidance. Thus, the Trc/ Fry signaling pathway plays a key role in patterning dendritic fields by promoting avoidance between homologous dendrites as well as by limiting dendritic branching.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; Univ Virginia, Ctr Canc, Charlottesville, VA 22903 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Virginia; University of Virginia	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, 1550 4th St, San Francisco, CA 94143 USA.	ynjan@itsa.ucsf.edu	He, Ying/B-3952-2010; Ye, Bing/V-1306-2018; EMOTO, KAZUO/G-4992-2014	He, Ying/0000-0002-2052-8350; Ye, Bing/0000-0002-8828-4065; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; Grueber, Wesley/0000-0001-6751-256X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, F32NS046847] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053498] Funding Source: Medline; NINDS NIH HHS [F32 NS046847, R01NS40929, F32 NS046847-02, F32 NS046847-01, F32 NS046847-03] Funding Source: Medline; PHS HHS [R0153498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cong JL, 2001, DEVELOPMENT, V128, P2793; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Geng W, 2000, GENETICS, V156, P1817; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2001, J COMP NEUROL, V440, P271, DOI 10.1002/cne.1385; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hirata D, 2002, EMBO J, V21, P4863, DOI 10.1093/emboj/cdf495; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lohmann C, 2001, J NEUROBIOL, V48, P150, DOI 10.1002/neu.1048; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; PURPURA DP, 1975, ADV NEUROL, V12, P91; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Sugimura K, 2003, J NEUROSCI, V23, P3752; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	51	177	180	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					245	256		10.1016/j.cell.2004.09.036	http://dx.doi.org/10.1016/j.cell.2004.09.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479641	Bronze			2022-12-24	WOS:000224577200012
J	Rao, JVRP; Ganguly, NK; Mehendale, SM; Bollinger, RC				Rao, JVRP; Ganguly, NK; Mehendale, SM; Bollinger, RC			India's response to the HIV epidemic	LANCET			English	Editorial Material									Govt India, Minist Hlth & Family Welf, New Delhi 110011, India; Indian Council Med Res, New Delhi, India; Natl AIDS Res Inst, Pune, Maharashtra, India; Johns Hopkins Univ, Baltimore, MD USA	Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University	Rao, JVRP (corresponding author), Govt India, Minist Hlth & Family Welf, New Delhi 110011, India.	secyhlth@hub.nic.in		Bollinger, Robert/0000-0002-6798-6834				BECKER N E, 1986, Health and Social Work, V11, P26; Celentano D, 2004, 15 INT AIDS C BANGK; MAHAPATRA, 2004, SEATTLE POST IN 0916; *NAT AIDS CONTR OR, 2001, NAT BAS GEN POP BEH; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; *UNAIDS WHO, S AFR EP FACT SHEET; *UNAIDS WHO, IND EP FACT SHEET HI; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013	8	32	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1296	1297		10.1016/S0140-6736(04)17205-X	http://dx.doi.org/10.1016/S0140-6736(04)17205-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474121				2022-12-24	WOS:000224349700008
J	Gebelein, B; McKay, DJ; Mann, RS				Gebelein, B; McKay, DJ; Mann, RS			Direct integration of Hox and segmentation gene inputs during Drosophila development	NATURE			English	Article							BITHORAX COMPLEX; HOMEODOMAIN PROTEIN; LIMB DEVELOPMENT; ULTRABITHORAX PROTEINS; TARGET GENES; DISTAL-LESS; REPRESSION; EXPRESSION; EXTRADENTICLE; EMBRYO	During Drosophila embryogenesis, segments, each with an anterior and posterior compartment, are generated by the segmentation genes while the Hox genes provide each segment with a unique identity. These two processes have been thought to occur independently. Here we show that abdominal Hox proteins work directly with two different segmentation proteins, Sloppy paired and Engrailed, to repress the Hox target gene Distalless in anterior and posterior compartments, respectively. These results suggest that segmentation proteins can function as Hox cofactors and reveal a previously unanticipated use of compartments for gene regulation by Hox proteins. Our results suggest that these two classes of proteins may collaborate to directly control gene expression at many downstream target genes.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.	rsm10@columbia.edu	Nakafuku, Masato/J-3068-2013		NIGMS NIH HHS [R01 GM054510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286; Andrioli LPM, 2002, DEVELOPMENT, V129, P4931; Aspland SE, 1997, DEVELOPMENT, V124, P741; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; CADIGAN KM, 1994, GENE DEV, V8, P899, DOI 10.1101/gad.8.8.899; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; CASANOVA J, 1987, EMBO J, V6, P3103, DOI 10.1002/j.1460-2075.1987.tb02619.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Ferretti E, 2000, DEVELOPMENT, V127, P155; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Galant R, 2002, DEVELOPMENT, V129, P3115; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MANN RS, 1994, DEVELOPMENT, V120, P3205; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; Mann RS, 1996, NATURE, V383, P630, DOI 10.1038/383630a0; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nasiadka A., 2002, AD DEV BIOL, V12, P155; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C	47	117	117	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					653	659		10.1038/nature02946	http://dx.doi.org/10.1038/nature02946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470419				2022-12-24	WOS:000224299300031
J	Benamouzig, R; Chaussade, S				Benamouzig, R; Chaussade, S			Calcium supplementation for preventing colorectal cancer: where do we stand?	LANCET			English	Editorial Material							VITAMIN-D; ADENOMAS; RISK; RECURRENCE; TRIAL		Univ Paris 13, AP HP, Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France; Cochin Hosp, Dept Gastroenterol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Benamouzig, R (corresponding author), Univ Paris 13, AP HP, Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France.	apacc@club-internet.fr	Coriat, Romain/O-7902-2017; BENAMOUZIG, Robert/W-8067-2019	BENAMOUZIG, ROBERT/0000-0003-1952-6830				Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; BergsmaKadijk JA, 1996, EPIDEMIOLOGY, V7, P590, DOI 10.1097/00001648-199611000-00005; Boyapati SM, 2003, CANCER EPIDEM BIOMAR, V12, P631; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; WALLACE K, 2004, J NATL CANCER I, V96, P21; WEINGARTEN MA, 2004, COCHRANE LIB	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1197	1199		10.1016/S0140-6736(04)17156-0	http://dx.doi.org/10.1016/S0140-6736(04)17156-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464166				2022-12-24	WOS:000224254200006
J	Bonsall, MB; Jansen, VAA; Hassell, MP				Bonsall, MB; Jansen, VAA; Hassell, MP			Life history trade-offs assemble ecological guilds	SCIENCE			English	Article							LIMITING SIMILARITY; COMPETITION; DYNAMICS; HOST; COEXISTENCE	Ecological theory predicts that competition for a limiting resource will lead to the exclusion of species unless the within-species effects outweigh the between-species effects. Understanding how multiple competitors might coexist on a single resource has focused on the prescriptive formalism of a necessary niche width and limiting similarity. Here, we show how continuously varying life histories and trade-offs in these characteristics can allow multiple competitors to coexist, and we reveal how limiting similarity emerges and is shaped by the ecological and evolutionary characteristics of competitors. In this way, we illustrate how the interplay of ecological and evolutionary processes acts to shape ecological communities in a unique way. This leads us to argue that evolutionary processes (life-history trait trade-offs) are fundamental to the understanding of the structure of ecological communities.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England; Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	Imperial College London; University of London; Royal Holloway University London	Bonsall, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	m.bonsall@imperial.ac.uk	Jansen, Vincent A A/C-8353-2009	Bonsall, Michael/0000-0003-0250-0423; Jansen, Vincent A.A./0000-0002-6518-2090				ABRAMS P, 1975, THEOR POPUL BIOL, V8, P356, DOI 10.1016/0040-5809(75)90052-0; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bonsall MB, 2004, P ROY SOC B-BIOL SCI, V271, P1143, DOI 10.1098/rspb.2004.2722; Bonsall MB, 2002, ECOLOGY, V83, P925, DOI 10.1890/0012-9658(2002)083[0925:ETORPA]2.0.CO;2; BRIGGS CJ, 1993, AM NAT, V141, P372, DOI 10.1086/285479; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; HAIGH J, 1972, THEOR POPUL BIOL, V3, P290, DOI 10.1016/0040-5809(72)90005-6; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HASSELL MP, 2000, TEMPORAL SPATIAL DYN; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jansen VAA, 1999, ECOL LETT, V2, P379; Lack D., 1947, DARWINS FINCHES; LEVIN BR, 1971, EVOLUTION, V25, P249, DOI 10.1111/j.1558-5646.1971.tb01878.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; May R.M., 1974, STABILITY COMPLEXITY; MAY RM, 1981, AM NAT, V117, P234, DOI 10.1086/283704; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Morin P., 1999, COMMUNITY ECOL; NICHOLSON AJ, 1935, P ZOOL SOC LOND, V3, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Roff Derek A., 1992; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Stearns S.C., 1992, pi; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi	32	106	112	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					111	114		10.1126/science.1100680	http://dx.doi.org/10.1126/science.1100680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459391				2022-12-24	WOS:000224304000048
J	Wu, CW; Miloslavskaya, I; Demontis, S; Maestro, R; Galaktionov, K				Wu, CW; Miloslavskaya, I; Demontis, S; Maestro, R; Galaktionov, K			Regulation of cellular response to oncogenic and oxidative stress by Seladin-1	NATURE			English	Article							TRANSCRIPTIONAL ACTIVITY; ALZHEIMERS-DISEASE; INDUCED SENESCENCE; CELLS; MDM2; P53; FIBROBLASTS; RESISTANCE; ONCOPROTEIN; SUPPRESSOR	Expression of multiple oncogenes and inactivation of tumour suppressors is required to transform primary mammalian cells into cancer cells(1-3). Activated Ha-RasV12 (Ras) is usually associated with cancer, but it also produces paradoxical premature senescence(4) in primary cells by inducing reactive oxygen species(5) followed by accumulation of tumour suppressors p53 and p16(INK4a) (ref. 4). Here we identify, using a direct genetic screen, Seladin-1 (also known as Dhcr24) as a key mediator of Ras-induced senescence. Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53, thus resulting in p53 accumulation. Additionally, Seladin-1 associates with Mdm2 independently of p53, potentially affecting other Mdm2 targets. Ablation of Seladin-1 causes the bypass of Ras-induced senescence in rodent and human fibroblasts, and allows Ras to transform these cells. Wild-type Seladin-1, but not mutants that disrupt its association with either p53 or Mdm2, suppresses the transformed phenotype. The same mutants are also inactive in directing p53-dependent oxidative stress response. These results show an unanticipated role for Seladin-1, previously implicated in Alzheimer's disease(6) and cholesterol metabolism(7), in integrating cellular response to oncogenic and oxidative stress.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CRO IRCCS Aviano Natl Canc Inst, Dept Expt Oncol, MMNP Unit, I-33081 Aviano, PN, Italy	Baylor College of Medicine; IRCCS Aviano (CRO)	Galaktionov, K (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	kgalakt@bcm.tmc.edu	Maestro, Roberta/P-9748-2019; Maestro, Roberta/M-1846-2015	Maestro, Roberta/0000-0002-6642-5592; Maestro, Roberta/0000-0002-6642-5592				ANGULI G, 2003, MOL CANCER RES, V1, P1027; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Greeve I, 2000, J NEUROSCI, V20, P7345; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016	27	161	169	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					640	645		10.1038/nature03173	http://dx.doi.org/10.1038/nature03173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577914	Bronze			2022-12-24	WOS:000225433200050
J	Hippisley-Cox, J; O'Hanlon, S; Coupland, C				Hippisley-Cox, J; O'Hanlon, S; Coupland, C			Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53 000 patients in primary care	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine the effect of deprivation and ethnicity on the achievement of quality indicators for patients with diabetes and the extent of any inequalities between the sexes. Design Population based cross sectional survey using electronic general practice records. Setting 237 UK practices contributing to the QRESEARCH database. Participants 54 180 patients with diabetes, derived from a population of 1.8 million patients. Main outcome measures Adjusted odds ratios for 18 indicators for diabetes from the new general medical services contract for UK general practitioners and comparisons between patients from the most, deprived and most affluent fifths (areas of high and low ethnicity) and between men and women. Results The prevalence of diabetes was 3.0%, and there was a large variation between practices in achievement of indicators. Compared with patients from affluent areas, those from deprived areas were less likely to have body mass index and smoking status recorded. They were also less likely to have records for HbA(1c) concentration; an HbA(1c) value < 7.5% or < 10%; retinal screening; blood pressure; testing for neuropathy or microalbuminuria, or flu vaccination. Compared with patients from areas of low ethnicity those from areas of high ethnicity were less likely to have many measures recorded. Women were significantly less likely to have records for body mass index; pulses; blood pressure values below 145/85 mm Hg; testing for microalbuminuria; serum cholesterol concentration; serum cholesterol values < 5 mmol/l; and angiotensin converting enzyme inhibitors given in the presence of proteinuria or microalbuminuria. Conclusions Practices in areas of high deprivation and high ethnicity will have to work harder to achieve the quality indicators for diabetes, and it is possible that those practices that most need the resources are the ones least likely to get them.	Div Primary Care, Nottingham NG2 7RD, England; The Surgery, Guildford GU5 0PE, Surrey, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Tower Bldg,Univ Pk, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				[Anonymous], 2002, HLTH STAT Q; Department of Health, 2003, NAT SERV FRAM DIAB D; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Hippisley-Cox J, 2003, BRIT MED J, V326, P1439, DOI 10.1136/bmj.326.7404.1439	4	94	97	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 27	2004	329	7477					1267	1269		10.1136/bmj.38279.588125.7C	http://dx.doi.org/10.1136/bmj.38279.588125.7C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876FC	15548561	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225480900016
J	Mora, CV; Davison, M; Wild, JM; Walker, MM				Mora, CV; Davison, M; Wild, JM; Walker, MM			Magnetoreception and its trigeminal mediation in the homing pigeon	NATURE			English	Article							DISCRIMINATION; NAVIGATION	Two conflicting hypotheses compete to explain how a homing pigeon can return to its loft over great distances. One proposes the use of atmospheric odours(1) and the other the Earth's magnetic field(2-4) in the 'map' step of the map and compass' hypothesis of pigeon homing(5). Although magnetic effects on pigeon orientation(6,7) provide indirect evidence for a magnetic 'map', numerous conditioning experiments(8) have failed to demonstrate reproducible responses to magnetic fields by pigeons. This has led to suggestions that homing pigeons and other birds have no useful sensitivity to the Earth's magnetic field(9-11). Here we demonstrate that homing pigeons (Columba livia) can discriminate between the presence and absence of a magnetic anomaly in a conditioned choice experiment. This discrimination is impaired by attachment of a magnet to the cere, local anaesthesia of the upper beak area, and bilateral section of the ophthalmic branch of the trigeminal nerve, but not of the olfactory nerve. These results suggest that magnetoreception (probably magnetite-based) occurs in the upper beak area of the pigeon. Traditional methods of rendering pigeons anosmic might therefore cause simultaneous impairment of magnetoreception so that future orientation experiments will require independent evaluation of the pigeon's magnetic and olfactory systems.	Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Auckland, Sch Med, Dept Psychol, Auckland 1, New Zealand; Univ Auckland, Sch Med, Dept Anat, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Mora, CV (corresponding author), Univ N Carolina, Dept Biol, Coker Hall,CB 3280, Chapel Hill, NC 27599 USA.	cvmora@email.unc.edu	Davison, Michael/A-9717-2008	Davison, Michael/0000-0003-0452-2044; Walker, Michael/0000-0001-9631-9128				Beason RC, 1997, AUK, V114, P405, DOI 10.2307/4089242; Beason RC, 1996, J EXP BIOL, V199, P1241; Benhamou S, 2003, ANIM BEHAV, V65, P729, DOI 10.1006/anbe.2003.2092; Bonadonna F, 2002, J EXP BIOL, V205, P2519; CARMAN GJ, 1987, ANIM LEARN BEHAV, V15, P124, DOI 10.3758/BF03204957; DAVISON MC, 1978, J EXP ANAL BEHAV, V29, P331, DOI 10.1901/jeab.1978.29-331; Delius J.D., 1983, P327; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; GOULD JL, 1980, AM SCI, V68, P256; GRIFFIN DR, 1982, Q REV BIOL, V57, P293; KEETON WT, 1974, J COMP PHYSIOL, V95, P95, DOI 10.1007/BF00610108; Kramer G., 1953, Journal fuer Ornithologie, V94, P201, DOI 10.1007/BF01922508; MOORE BR, 1980, NATURE, V285, P69, DOI 10.1038/285069a0; Mouritsen H, 2003, J EXP BIOL, V206, P4155, DOI 10.1242/jeb.00650; PAPI F, 1972, Monitore Zoologico Italiano, V6, P85; Papi F, 2000, J EXP BIOL, V203, P3435; Papi F., 1992, ANIMAL HOMING, DOI [DOI 10.1007/978-94-011-1588-9_1, 10.1007/978-94-011-1588-9_1]; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Schmidt-Koenig K., 1983, P267; WALCOTT C, 1979, SCIENCE, V205, P1027, DOI 10.1126/science.472725; WALCOTT C, 1980, IEEE T MAGN, V16, P1008, DOI 10.1109/TMAG.1980.1060868; Walcott C., 1978, ANIMAL MIGRATION NAV, P143, DOI 10.1007/978-3-662-11147-5_13; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Walker MM, 1998, J THEOR BIOL, V192, P341, DOI 10.1006/jtbi.1998.0653; WALKER MM, 1985, J COMP PHYSIOL A, V157, P67, DOI 10.1007/BF00611096; WALLRAFF HG, 1989, J THEOR BIOL, V138, P511, DOI 10.1016/S0022-5193(89)80048-7; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; Wiltschko R., 1995, TIEROSYCHOL	30	208	230	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					508	511		10.1038/nature03077	http://dx.doi.org/10.1038/nature03077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565156				2022-12-24	WOS:000225322100048
J	Petersen, LR; Hayes, EB				Petersen, LR; Hayes, EB			Westward ho? The spread of West Nile virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Dis Control & Prevent, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Ft Collins, CO 80522 USA.								0	63	65	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2004	351	22					2257	2259		10.1056/NEJMp048261	http://dx.doi.org/10.1056/NEJMp048261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873RH	15564540				2022-12-24	WOS:000225298100002
J	Rocha, V; Labopin, M; Sanz, G; Arcese, W; Schwerdtfeger, R; Bosi, A; Jacobsen, N; Ruutu, T; de Lima, M; Finke, J; Frassoni, F; Gluckman, E				Rocha, V; Labopin, M; Sanz, G; Arcese, W; Schwerdtfeger, R; Bosi, A; Jacobsen, N; Ruutu, T; de Lima, M; Finke, J; Frassoni, F; Gluckman, E		Acute Leukemia Working Party Euro; Marrow Transplant Grp Eurocord Net	Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; PLACENTAL-BLOOD; CLASS-I; GRAFT; RECIPIENTS; CHILDREN; OUTCOMES; RECONSTITUTION; SECONDARY	BACKGROUND Promising results of cord-blood transplants from unrelated donors have been reported in adults. METHODS We compared outcomes in 682 adults with acute leukemia who received a hematopoietic stem-cell transplant from an unrelated donor: 98 received cord blood and 584 received bone marrow. The transplantations were performed from 1998 through 2002 and reported to Eurocord and the European Blood and Marrow Transplant Group. RESULTS Recipients of cord blood were younger than recipients of bone marrow ( median, 24.5 vs. 32 years of age; P< 0.001), weighed less ( median, 58 vs. 68 kg; P< 0.001), and had more advanced disease at the time of transplantation ( 52 percent vs. 33 percent, P< 0.001). All marrow transplants were HLA matched, whereas 94 percent of cord-blood grafts were HLA mismatched ( P< 0.001). The median number of nucleated cells that were infused was 0.23 x 10(8) per kilogram of the recipient's body weight for cord blood and 2.9 x 10(8) per kilogram for bone marrow ( P< 0.001). Multivariate analysis showed lower risks of grade II, III, or IV acute graft-versus-host disease (GVHD) after cord-blood transplantation ( relative risk, 0.57; 95 percent confidence interval, 0.37 to 0.87; P = 0.01), but neutrophil recovery was significantly delayed ( relative risk, 0.49; 95 percent confidence interval, 0.41 to 0.58; P< 0.001). The incidence of chronic GVHD, transplantation-related mortality, relapse rate, and leukemia-free survival were not significantly different in the two groups. CONCLUSIONS Cord blood from an unrelated donor is an alternative source of hematopoietic stem cells for adults with acute leukemia who lack an HLA-matched bone marrow donor.	Assistance Publ Hop Paris, Hop St Louis, Hematol Bone Marrow Transplant Dept, F-75475 Paris 10, France; Assistance Publ Hop Paris, Hop St Antoine, F-75475 Paris 10, France; Univ Paris, F-75252 Paris, France; Hosp Univ La Fe, Valencia, Spain; Univ Roma Tor Vergata, Rome, Italy; Deutsch Klin Diagnost, D-6200 Wiesbaden, Germany; Osped Careggi, Florence, Italy; Rigshosp, Univ Hosp Internal Med, DK-2100 Copenhagen, Denmark; Univ Helsinki, Cent Hosp, Helsinki, Finland; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Freiburg, Freiburg, Germany; Osped San Martino Genova, Genoa, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Hospital Universitari i Politecnic La Fe; University of Rome Tor Vergata; University of Florence; Azienda Ospedaliero Universitaria Careggi; Rigshospitalet; University of Copenhagen; University of Helsinki; Helsinki University Central Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Freiburg; University of Genoa; IRCCS AOU San Martino IST	Gluckman, E (corresponding author), Assistance Publ Hop Paris, Hop St Louis, Hematol Bone Marrow Transplant Dept, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	eliane.gluckman@sls.ap-hop-paris.fr	Rocha, Vanderson/AAO-1691-2020; Frassoni, Francesco/K-3971-2018	Frassoni, Francesco/0000-0003-1262-0648; SANZ, GUILLERMO/0000-0002-2767-8191; BOSI, ALBERTO/0000-0002-5486-4838				Barker JN, 2002, BIOL BLOOD MARROW TR, V8, P257, DOI 10.1053/bbmt.2002.v8.pm12064362; Barker JN, 2001, BLOOD, V97, P2957, DOI 10.1182/blood.V97.10.2957; Cairo MS, 1997, BLOOD, V90, P4665, DOI 10.1182/blood.V90.12.4665.4665_4665_4678; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frassoni F, 2003, BLOOD, V102, P1138, DOI 10.1182/blood-2003-03-0720; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Gluckman E, 2000, EXP HEMATOL, V28, P1197, DOI 10.1016/S0301-472X(00)00540-3; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Hansen JA, 1998, NEW ENGL J MED, V338, P962, DOI 10.1056/NEJM199804023381405; Klein AK, 2001, BIOL BLOOD MARROW TR, V7, P454, DOI 10.1016/S1083-8791(01)80013-6; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; Lewis ID, 2001, BLOOD, V97, P3441, DOI 10.1182/blood.V97.11.3441; Long GD, 2003, BIOL BLOOD MARROW TR, V9, P772, DOI 10.1016/j.bbmt.2003.08.007; Madrigal JA, 1997, HUM IMMUNOL, V56, P1, DOI 10.1016/S0198-8859(97)00125-0; Ooi J, 2004, BLOOD, V103, P489, DOI 10.1182/blood-2003-07-2420; Ooi J, 2001, BRIT J HAEMATOL, V114, P834, DOI 10.1046/j.1365-2141.2001.03049.x; Petersdorf EW, 1998, BLOOD, V92, P3515, DOI 10.1182/blood.V92.10.3515.422k49_3515_3520; RISDON G, 1994, CELL IMMUNOL, V154, P14, DOI 10.1006/cimm.1994.1053; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Rocha V, 2001, BLOOD, V97, P2962, DOI 10.1182/blood.V97.10.2962; Rubinstein P, 1998, NEW ENGL J MED, V339, P1565, DOI 10.1056/NEJM199811263392201; SANZ G, 2003, CURR OPIN ORGAN TRAN, V8, P109; Sanz GF, 2001, BLOOD, V98, P2332, DOI 10.1182/blood.V98.8.2332; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294	32	853	894	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2004	351	22					2276	2285		10.1056/NEJMoa041469	http://dx.doi.org/10.1056/NEJMoa041469			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873RH	15564544	Bronze			2022-12-24	WOS:000225298100006
J	Chuikov, S; Kurash, JK; Wilson, JR; Xiao, B; Justin, N; Ivanov, GS; McKinney, K; Tempst, P; Prives, C; Gamblin, SJ; Barlev, NA; Reinberg, D				Chuikov, S; Kurash, JK; Wilson, JR; Xiao, B; Justin, N; Ivanov, GS; McKinney, K; Tempst, P; Prives, C; Gamblin, SJ; Barlev, NA; Reinberg, D			Regulation of p53 activity through lysine methylation	NATURE			English	Article							HISTONE METHYLTRANSFERASE; DNA-BINDING; ACETYLATION; ACTIVATION; PROTEIN; PHOSPHORYLATION; UBIQUITINATION; TRANSCRIPTION; MDM2	p53 is a tumour suppressor that regulates the cellular response to genotoxic stresses. p53 is a short-lived protein and its activity is regulated mostly by stabilization via different post-translational modifications. Here we report a novel mechanism of p53 regulation through lysine methylation by Set9 methyltransferase. Set9 specifically methylates p53 at one residue within the carboxyl-terminus regulatory region. Methylated p53 is restricted to the nucleus and the modification positively affects its stability. Set9 regulates the expression of p53 target genes in a manner dependent on the p53-methylation site. The crystal structure of a ternary complex of Set9 with a p53 peptide and the cofactor product S-adenosyl-L-homocysteine (AdoHcy) provides the molecular basis for recognition of p53 by this lysine methyltransferase.	Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA; NEMC Tufts Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA; Natl Inst Med Res, MRC, Struct Biol Grp, London NW7 1AA, England; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts Medical Center; MRC National Institute for Medical Research; Columbia University; Memorial Sloan Kettering Cancer Center	Barlev, NA (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA.	nbarlev@tufts-nemc.org; reinbedf@UMDNJ.EDU	Ivanov, Gleb/AAD-6785-2022; Wilson, Jon R/B-7362-2019; Barlev, Nikolai A/K-5268-2017; Ivanov, Gleb/AAB-5447-2020; Justin, Neil/E-1774-2011	Wilson, Jon R/0000-0002-5157-5432; Barlev, Nikolai A/0000-0001-7111-2446; Gamblin, Steve/0000-0001-5331-639X; Reinberg, Danny/0000-0003-4288-2016; Tempst, Paul/0000-0002-6680-3987				Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; GRAND RJA, 1995, VIROLOGY, V210, P323, DOI 10.1006/viro.1995.1349; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gu Wei, 2004, Novartis Found Symp, V259, P197; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P552; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378	22	601	629	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					353	360		10.1038/nature03117	http://dx.doi.org/10.1038/nature03117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15525938				2022-12-24	WOS:000225161400046
J	Westover, KD; Bushnell, DA; Kornberg, RD				Westover, KD; Bushnell, DA; Kornberg, RD			Structural basis of transcription: Nucleotide selection by rotation in the RNA polymerase II active center	CELL			English	Article							3.3 ANGSTROM RESOLUTION; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; MECHANISM; DNA; CLEAVAGE; DISCRIMINATION; TRANSLOCATION; ARCHITECTURE; BINDING	Binding of a ribonucleoside triphosphate to an RNA polymerase II transcribing complex, with base pairing to the template DNA, was revealed by X-ray crystallography. Binding of a mismatched nucleoside triphosphate was also detected, but in an adjacent site, inverted with respect to the correctly paired nucleotide. The results are consistent with a two-step mechanism of nucleotide selection, with initial binding to an entry (E) site beneath the active center in an inverted orientation, followed by rotation into the nucleotide addition (A) site for pairing with the template DNA. This mechanism is unrelated to that of single subunit RNA polymerases and so defines a new paradigm for the large, multisubunit enzymes. Additional findings from these studies include a third nucleotide binding site that may define the length of backtracked RNA; DNA double helix unwinding in advance of the polymerase active center; and extension of the diffraction limit of RNA polymerase II crystals to 2.3 A.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Westover, Ken/AAZ-1795-2020	Westover, Ken/0000-0003-3653-5923	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21144] Funding Source: Medline; NIGMS NIH HHS [GM49985] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; BONNER G, 1994, J BIOL CHEM, V269, P25120; Brieba LG, 2000, BIOCHEMISTRY-US, V39, P919, DOI 10.1021/bi992324+; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; SHI YB, 1988, J MOL BIOL, V199, P277, DOI 10.1016/0022-2836(88)90314-2; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Temiakov D, 2003, ACTA CRYSTALLOGR D, V59, P185, DOI 10.1107/S0907444902019777; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	31	217	236	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					481	489		10.1016/j.cell.2004.10.016	http://dx.doi.org/10.1016/j.cell.2004.10.016			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537538	Bronze			2022-12-24	WOS:000225183200007
J	Gershon, D				Gershon, D			In the market-place	NATURE			English	Article																			0	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	2004	432	7014					243	245		10.1038/432243b	http://dx.doi.org/10.1038/432243b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538372	Bronze			2022-12-24	WOS:000225020200052
J	Hoffman, RJ; Dhaliwal, G; Gilden, DJ; Saint, S				Hoffman, RJ; Dhaliwal, G; Gilden, DJ; Saint, S			Special cure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IRON-DEFICIENCY ANEMIA; CELIAC-DISEASE; PREVALENCE; SPRUE; RISK		Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; Legacy Emanuel Hosp, Dept Med, Portland, OR USA; Legacy Good Samaritan Hosp, Dept Med, Portland, OR USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dhaliwal, G (corresponding author), Vet Affairs Med Ctr, Dept Med, 4150 Clement St 111, San Francisco, CA 94121 USA.	gurpreet.dhaliwal@med.va.gov	Saint, Sanjay/AAF-5126-2019		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER; AHRQ HHS [P20-HS11540] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		CORAZZA GR, 1995, SCAND J GASTROENTERO, V30, P153, DOI 10.3109/00365529509093254; COUNSELL CE, 1994, GUT, V35, P844, DOI 10.1136/gut.35.6.844; Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fine KD, 1996, NEW ENGL J MED, V334, P1163, DOI 10.1056/NEJM199605023341804; Fine KD, 2001, AM J GASTROENTEROL, V96, P138, DOI 10.1111/j.1572-0241.2001.03464.x; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; HIN H, 1999, BMJ-BRIT MED J, V318, P857; Karnam US, 2004, SOUTH MED J, V97, P30, DOI 10.1097/01.SMJ.0000051059.23259.56; KASSIRER JP, 1989, ANN INTERN MED, V110, P893, DOI 10.7326/0003-4819-110-11-893; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; MCINTYRE AS, 1993, GUT, V34, P1102, DOI 10.1136/gut.34.8.1102; McManus R, 2003, NEW ENGL J MED, V348, P2573, DOI 10.1056/NEJMcibr035033; Oxentenko AS, 2002, AM J GASTROENTEROL, V97, P933	15	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2004	351	19					1997	2002		10.1056/NEJMcps040877	http://dx.doi.org/10.1056/NEJMcps040877			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867OG	15525726				2022-12-24	WOS:000224851300014
J	Otto, GA; Puglisi, JD				Otto, GA; Puglisi, JD			The pathway of HCVIRES-mediated translation initiation	CELL			English	Article							HEPATITIS-C VIRUS; RIBOSOME ENTRY SITE; INTERNAL INITIATION; NONTRANSLATED REGIONS; MUTATIONAL ANALYSIS; DOMAIN-II; RNA; SUBUNITS; ELEMENT; BINDING	The HCV internal ribosome entry site (IRES) directly regulates the assembly of translation initiation complexes on viral mRNA by a sequential pathway that is distinct from canonical eukaryotic initiation. The HCV IRES can form a binary complex with an eIF-free 40S ribosomal subunit. Next, a 48S-like complex assembles at the AUG initiation codon upon association of eIF3 and ternary complex. 80S complex formation is rate limiting and follows the GTP-dependent association of the 60S subunit. Efficient assembly of the 48S-like and 80S complexes on the IRES mRNA is dependent upon maintenance of the highly conserved HCV IRES structure. This revised model of HCV IRES translation initiation provides a context to understand the function of different HCV IRES domains during translation initiation.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047365, R01AI047365] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47365] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; BROWN EA, 1992, NUCLEIC ACIDS RES, V20, P5041, DOI 10.1093/nar/20.19.5041; Buratti E, 1998, NUCLEIC ACIDS RES, V26, P3179, DOI 10.1093/nar/26.13.3179; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Fletcher SP, 2002, RNA, V8, P1558, DOI 10.1017/S1355838202023038; Fukushi S, 2001, J BIOL CHEM, V276, P20824, DOI 10.1074/jbc.C100206200; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; Hellen CUT, 1999, J VIRAL HEPATITIS, V6, P79, DOI 10.1046/j.1365-2893.1999.00150.x; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Honda M, 1999, J VIROL, V73, P1165, DOI 10.1128/JVI.73.2.1165-1174.1999; Honda M, 1996, RNA, V2, P955; Jubin R, 2000, J VIROL, V74, P10430, DOI 10.1128/JVI.74.22.10430-10437.2000; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kong LK, 2002, J VIROL, V76, P12457, DOI 10.1128/JVI.76.24.12457-12462.2002; Kruger M, 2000, P NATL ACAD SCI USA, V97, P8566, DOI 10.1073/pnas.97.15.8566; Lorsch JR, 1999, EMBO J, V18, P6705, DOI 10.1093/emboj/18.23.6705; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Lukavsky PJ, 2003, NAT STRUCT BIOL, V10, P1033, DOI 10.1038/nsb1004; Lytle JR, 2001, J VIROL, V75, P7629, DOI 10.1128/JVI.75.16.7629-7636.2001; Otto GA, 2002, RNA, V8, P913, DOI 10.1017/S1355838202022057; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Psaridi L, 1999, FEBS LETT, V453, P49, DOI 10.1016/S0014-5793(99)00662-6; Reynolds JE, 1996, RNA, V2, P867; Rijnbrand R, 2000, J VIROL, V74, P773, DOI 10.1128/JVI.74.2.773-783.2000; Safer B, 1979, Methods Enzymol, V60, P61; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; WANG CY, 1994, J VIROL, V68, P7301, DOI 10.1128/JVI.68.11.7301-7307.1994; WANG CY, 1995, RNA, V1, P526; WANG CY, 1993, J VIROL, V67, P3338, DOI 10.1128/JVI.67.6.3338-3344.1993; Wood J, 2001, J VIROL, V75, P1348, DOI 10.1128/JVI.75.3.1348-1358.2001; Zhao WD, 2001, J VIROL, V75, P3719, DOI 10.1128/JVI.75.8.3719-3730.2001	35	204	215	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					369	380		10.1016/j.cell.2004.09.038	http://dx.doi.org/10.1016/j.cell.2004.09.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507208	Green Submitted, Bronze			2022-12-24	WOS:000224908300008
J	Dyall, SD; Yan, WH; Delgadillo-Correa, MG; Lunceford, A; Loo, JA; Clarke, CF; Johnson, PJ				Dyall, SD; Yan, WH; Delgadillo-Correa, MG; Lunceford, A; Loo, JA; Clarke, CF; Johnson, PJ			Non-mitochondrial complex I proteins in a hydrogenosomal oxidoreductase complex	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; TRICHOMONAS-VAGINALIS; FERREDOXIN OXIDOREDUCTASE; PARACOCCUS-DENITRIFICANS; ANAEROBIC EUKARYOTES; NUCLEAR GENOMES; MITOCHONDRIA; EVOLUTION; ORIGIN; GENES	Trichomonas vaginalis is a unicellular microaerophilic eukaryote that lacks mitochondria yet contains an alternative organelle, the hydrogenosome, involved in pyruvate metabolism. Pathways between the two organelles differ substantially: in hydrogenosomes, pyruvate oxidation is catalysed by pyruvate: ferredoxin oxidoreductase (PFOR), with electrons donated to an [ Fe]hydrogenase which produces hydrogen. ATP is generated exclusively by substrate-level phosphorylation in hydrogenosomes, as opposed to oxidative phosphorylation in mitochondria(1). PFOR and hydrogenase are found in eubacteria and amitochondriate eukaryotes, but not in typical mitochondria(2-4). Analyses of mitochondrial genomes indicate that mitochondria have a single endosymbiotic origin from an alpha-proteobacterial-type progenitor(5). The absence of a genome in trichomonad hydrogenosomes(6) precludes such comparisons, leaving the endosymbiotic history of this organelle unclear(7). Although phylogenetic reconstructions of a few proteins indicate that trichomonad hydrogenosomes share a common origin with mitochondria(8-11), others do not(2-4,7). Here we describe a novel NADH dehydrogenase module of respiratory complex I that is coupled to the central hydrogenosomal fermentative pathway to form a hydrogenosomal oxidoreductase complex that seems to function independently of quinones. Phylogenetic analyses of hydrogenosomal complex I-like proteins Ndh51 and Ndh24 reveal that neither has a common origin with mitochondrial homologues. These studies argue against a vertical origin of trichomonad hydrogenosomes from the proto-mitochondrial endosymbiont.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; NASA, Astrobiol Inst, Ctr Astrobiol, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; National Aeronautics & Space Administration (NASA); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Johnson, PJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 1602 Mol Sci Bldg,609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	johnsonp@ucla.edu						Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bui ETN, 1996, P NATL ACAD SCI USA, V93, P9651, DOI 10.1073/pnas.93.18.9651; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Dolezal P, 2004, GENE, V329, P81, DOI 10.1016/j.gene.2003.12.022; Doolittle WE, 1998, TRENDS GENET, V14, P307; Doolittle WF, 2003, PHILOS T R SOC B, V358, P39, DOI 10.1098/rstb.2002.1185; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Horner DS, 2000, MOL BIOL EVOL, V17, P1695, DOI 10.1093/oxfordjournals.molbev.a026268; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Horner DS, 1996, P ROY SOC B-BIOL SCI, V263, P1053, DOI 10.1098/rspb.1996.0155; HRDY I, 1995, J MOL EVOL, V41, P388, DOI 10.1007/BF01215186; HRDY I, 1995, J EUKARYOT MICROBIOL, V42, P593, DOI 10.1111/j.1550-7408.1995.tb05913.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jonassen T, 2003, J BIOL CHEM, V278, P51735, DOI 10.1074/jbc.M308760200; Land KM, 2004, MOL MICROBIOL, V51, P115, DOI 10.1046/j.1365-2958.2003.03791.x; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Massanz C, 1998, J BACTERIOL, V180, P1023, DOI 10.1128/JB.180.5.1023-1029.1998; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Roger AJ, 1996, P NATL ACAD SCI USA, V93, P14618, DOI 10.1073/pnas.93.25.14618; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; YANO T, 1994, FEBS LETT, V354, P160, DOI 10.1016/0014-5793(94)01107-9	30	67	71	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1103	1107		10.1038/nature02990	http://dx.doi.org/10.1038/nature02990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510149				2022-12-24	WOS:000224730800042
J	Samatey, FA; Matsunami, H; Imada, K; Nagashima, S; Shaikh, TR; Thomas, DR; Chen, JZ; DeRosier, DJ; Kitao, A; Namba, K				Samatey, FA; Matsunami, H; Imada, K; Nagashima, S; Shaikh, TR; Thomas, DR; Chen, JZ; DeRosier, DJ; Kitao, A; Namba, K			Structure of the bacterial flagellar hook and implication for the molecular universal joint mechanism	NATURE			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; PROTEIN; FILAMENT; ROTATION; TRANSFORMATIONS; ORGANIZATION; CAULOBACTER; REFINEMENT; RESOLUTION	The bacterial flagellum is a motile organelle, and the flagellar hook is a short, highly curved tubular structure that connects the flagellar motor to the long filament acting as a helical propeller. The hook is made of about 120 copies of a single protein, FlgE, and its function as a nano-sized universal joint is essential for dynamic and efficient bacterial motility and taxis. It transmits the motor torque to the helical propeller over a wide range of its orientation for swimming and tumbling. Here we report a partial atomic model of the hook obtained by X-ray crystallography of FlgE31, a major proteolytic fragment of FlgE lacking unfolded terminal regions, and by electron cryomicroscopy and three-dimensional helical image reconstruction of the hook. The model reveals the intricate molecular interactions and a plausible switching mechanism for the hook to be flexible in bending but rigid against twisting for its universal joint function.	JST, ICORP, Dynam Nanomachine Project, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; JST, ERATO, Photon Nanomachine Project, Kyoto, Japan; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, WM Keck Inst Cellular Visualizat, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Univ Tokyo, Inst Mol & Cellular Biolsci, Bunkyo Ku, Tokyo 1130032, Japan	Japan Science & Technology Agency (JST); Osaka University; Japan Science & Technology Agency (JST); Brandeis University; Brandeis University; University of Tokyo	Namba, K (corresponding author), JST, ICORP, Dynam Nanomachine Project, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	keiichi@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016; Matsunami, Hideyuki/E-6632-2010; Kitao, Akio/B-8371-2008; Matsunami, Hideyuki/GOK-2037-2022; Samatey, Fadel/A-3204-2012	Matsunami, Hideyuki/0000-0001-5814-3766; Kitao, Akio/0000-0002-5221-0806; Matsunami, Hideyuki/0000-0001-5814-3766; Imada, Katsumi/0000-0003-1342-8885; Samatey, Fadel/0000-0002-0733-2863				AIZAWA S, 1980, J MOL BIOL, V137, P437, DOI 10.1016/0022-2836(80)90168-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; CASE DA, 2002, AMBER7; Chen JZ, 2003, J STRUCT BIOL, V144, P144, DOI 10.1016/j.jsb.2003.09.008; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P384, DOI 10.1128/JB.105.1.384-395.1971; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P376, DOI 10.1128/JB.105.1.376-383.1971; FAHRNER KA, 1994, J MOL BIOL, V238, P173, DOI 10.1006/jmbi.1994.1279; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Hasegawa K, 1998, BIOPHYS J, V74, P569, DOI 10.1016/S0006-3495(98)77815-4; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOMMA M, 1990, J MOL BIOL, V213, P819, DOI 10.1016/S0022-2836(05)80266-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAGAWA H, 1979, J MOL BIOL, V129, P333, DOI 10.1016/0022-2836(79)90286-9; KATO S, 1984, J MOL BIOL, V173, P463, DOI 10.1016/0022-2836(84)90391-7; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; KUTSUKAKE K, 1979, J BACTERIOL, V140, P267, DOI 10.1128/JB.140.1.267-275.1979; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; MORGAN DG, 1993, J MOL BIOL, V229, P79, DOI 10.1006/jmbi.1993.1009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Namba K, 1997, Q REV BIOPHYS, V30, P1, DOI 10.1017/S0033583596003319; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Samatey FA, 2000, J STRUCT BIOL, V132, P106, DOI 10.1006/jsbi.2000.4312; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; SAMATEY FA, IN PRESS ACTA CRYS D; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; VONDERVISZT F, 1992, J MOL BIOL, V226, P575, DOI 10.1016/0022-2836(92)90616-R; VONDERVISZT F, 1995, J MOL BIOL, V251, P520, DOI 10.1006/jmbi.1995.0453; WAGENKNECHT T, 1982, J MOL BIOL, V162, P69, DOI 10.1016/0022-2836(82)90162-0; WAGENKNECHT T, 1981, J MOL BIOL, V151, P439, DOI 10.1016/0022-2836(81)90005-X; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	46	149	151	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1062	1068		10.1038/nature02997	http://dx.doi.org/10.1038/nature02997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510139				2022-12-24	WOS:000224730800031
J	Tomkins, JL; Brown, GS				Tomkins, JL; Brown, GS			Population density drives the local evolution of a threshold dimorphism	NATURE			English	Article							MALE-MALE COMPETITION; SEXUAL SELECTION; EARWIG; SIZE; TACTICS	Evolution can favour more than one reproductive tactic among conspecifics of the same sex(1,2). Under the conditional evolutionarily stable strategy, individuals adopt the tactic that generates the highest fitness return for their status: large males guard females, whereas small males sneak copulations(3,4). Tactics change at the status at which fitness benefits switch from favouring one tactic to favouring the alternative(1,5). This 'switchpoint' is expressed in many species as a threshold between divergent morphologies(3). Environmental and demographic parameters that influence the relative fitness of male tactics are predicted to determine a population's switchpoint(1,5) and consequently whether the population is monomorphic or dimorphic. Here we show threshold evolution in the forceps dimorphism of the European earwig Forficula auricularia and document the transition from completely monomorphic to classical male-dimorphic populations over a distance of only 40 km. Because the superior fighting ability of the dominant morph(6) will be more frequently rewarded at high encounter rates, population density is likely to be a key determinant of the relative fitness of the alternative tactics, and consequently the threshold. We show that, as predicted, population density correlates strongly with the shift in threshold, and that this factor drives the local evolution of the male dimorphism in these island populations. Our data provide evidence for the origin of phenotypic diversity within populations(7-9), through the evolution of a switchpoint in a conditional strategy that has responded to local population density.	Univ St Andrews, Div Environm & Evolutionary Biol, St Andrews KY16 9TH, Fife, Scotland	University of St Andrews	Tomkins, JL (corresponding author), Univ St Andrews, Div Environm & Evolutionary Biol, Sir Harold Mitchell Bldg, St Andrews KY16 9TH, Fife, Scotland.	jlt1@st-andrews.ac.uk	Tomkins, Joseph L/A-8091-2011	Tomkins, Joseph L/0000-0003-1259-7898				Bateson W., 1892, Proceedings of the Zoological Society, P585; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.2307/2409478; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.1111/j.1558-5646.1996.tb02362.x, 10.2307/2410662]; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Forslund P, 2000, ANIM BEHAV, V59, P753, DOI 10.1006/anbe.1999.1359; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HAZEL WN, 1990, P ROY SOC B-BIOL SCI, V242, P181, DOI 10.1098/rspb.1990.0122; Hunt J, 2001, P ROY SOC B-BIOL SCI, V268, P2409, DOI 10.1098/rspb.2001.1758; Huxley JS, 1927, J GENET, V17, P309, DOI 10.1007/BF02983133; Kotiaho JS, 2001, BEHAV ECOL, V12, P553, DOI 10.1093/beheco/12.5.553; Maynard Smith J., 1982, pi; Moczek AP, 2003, BEHAV ECOL, V14, P841, DOI 10.1093/beheco/arg062; Moczek AP, 2002, EVOL ECOL RES, V4, P587; RADESATER T, 1993, ETHOLOGY, V95, P89, DOI 10.1111/j.1439-0310.1993.tb00460.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Roff DA, 1996, Q REV BIOL, V71, P3, DOI 10.1086/419266; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI 10.1111/j.1558-5646.1988.tb02507.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Snow D.W., 1998, BIRDS W PALEARCTIC; Tomkins JL, 1998, ANIM BEHAV, V56, P347, DOI 10.1006/anbe.1998.0838; Tomkins JL, 1999, BEHAV ECOL SOCIOBIOL, V47, P1, DOI 10.1007/s002650050643; TOMKINS JL, IN PRESS J EVOL BIOL; Unrug J, 2004, P ROY SOC B-BIOL SCI, V271, P1401, DOI 10.1098/rspb.2004.2729; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1986, P NATL ACAD SCI USA, V83, P1388, DOI 10.1073/pnas.83.5.1388; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Zar J.H., 2010, BIOSTAT ANAL	28	117	119	2	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1099	1103		10.1038/nature02918	http://dx.doi.org/10.1038/nature02918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510148				2022-12-24	WOS:000224730800041
J	Ito, K; Hirao, A; Arai, F; Matsuoka, S; Takubo, K; Hamaguchi, I; Nomiyama, K; Hosokawa, K; Sakurada, K; Nakagata, N; Ikeda, Y; Mak, TW; Suda, T				Ito, K; Hirao, A; Arai, F; Matsuoka, S; Takubo, K; Hamaguchi, I; Nomiyama, K; Hosokawa, K; Sakurada, K; Nakagata, N; Ikeda, Y; Mak, TW; Suda, T			Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells	NATURE			English	Article							ATAXIA-TELANGIECTASIA GENE; SERIAL TRANSPLANTATION; DEFICIENT MICE; DNA-DAMAGE; BMI-1; PROLIFERATION; TELOMERASE; QUIESCENCE; CAPACITY; PRODUCT	The 'ataxia telangiectasia mutated' (Atm) gene maintains genomic stability by activating a key cell-cycle checkpoint in response to DNA damage, telomeric instability or oxidative stress(1,2). Mutational inactivation of the gene causes an autosomal recessive disorder, ataxia-telangiectasia, characterized by immunodeficiency, progressive cerebellar ataxia, oculocutaneous telangiectasia, defective spermatogenesis, premature ageing and a high incidence of lymphoma(3,4). Here we show that ATM has an essential function in the reconstitutive capacity of haematopoietic stem cells (HSCs) but is not as important for the proliferation or differentiation of progenitors, in a telomere-independent manner. Atm(-/-) mice older than 24 weeks showed progressive bone marrow failure resulting from a defect in HSC function that was associated with elevated reactive oxygen species. Treatment with anti-oxidative agents restored the reconstitutive capacity of Atm(-/-) HSCs, resulting in the prevention of bone marrow failure. Activation of the p16(INK4a)-retinoblastoma (Rb) gene product pathway in response to elevated reactive oxygen species led to the failure of Atm(-/-) HSCs. These results show that the self-renewal capacity of HSCs depends on ATM-mediated inhibition of oxidative stress.	Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Internal Med, Div Hematol,Shinjuku Ku, Tokyo 1608582, Japan; Kyowa Hakko Kogyo Co Ltd, Biofrontier Labs, Machida, Tokyo 1948533, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Div Reprod Engn, Kumamoto 8600811, Japan; Univ Toronto, Adv Med Discovery Inst, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Adv Med Discovery Inst, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2C1, Canada	Keio University; Keio University; Kyowa Kirin Ltd; Kumamoto University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Suda, T (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	ahirao@sc.itc.keio.ac.jp; sudato@sc.itc.keio.ac.jp	Sakurada, Kazuhiro/AAH-2281-2021; Takubo, Keiyo/AAX-5546-2020; Arai, Fumio/J-5241-2013; Suda, Toshio/H-6761-2013	Sakurada, Kazuhiro/0000-0002-4858-2607; Takubo, Keiyo/0000-0002-1736-7592; Arai, Fumio/0000-0003-1936-4907; Suda, Toshio/0000-0001-7540-1771; Nakagata, Naomi/0000-0002-5737-9993				Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; MEYN MS, 1995, CANCER RES, V55, P5991; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yan MS, 2001, FASEB J, V15, P1132, DOI 10.1096/fj.00-0601com; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	30	906	945	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					997	1002		10.1038/nature02989	http://dx.doi.org/10.1038/nature02989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496926				2022-12-24	WOS:000224585600047
J	Oguma, T; Palmer, LJ; Birben, E; Sonna, LA; Asano, K; Lilly, CM				Oguma, T; Palmer, LJ; Birben, E; Sonna, LA; Asano, K; Lilly, CM			Role of prostanoid DP receptor variants in susceptibility to asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIONAL CLONING; GENE; LINKAGE; EOTAXIN; CELLS	BACKGROUND: Previous genetic studies have associated the region of the human genome (14q22.1) containing the gene for the prostanoid DP receptor (PTGDR) with asthma. A study of a mouse model suggests that the receptor is required for the expression of the asthma phenotype. Our associations of asthma with functional genetic variants of PTGDR link these observations. METHODS: We identified and evaluated combinations of genetic variants that influence PTGDR transcription for disease association in case-control studies of 518 white patients with asthma and 175 white controls and 80 black patients with asthma and 45 black controls. RESULTS: We identified four novel and two previously reported single-nucleotide polymorphisms (SNPs) in PTGDR and its vicinity. These define four common three-SNP haplotypes, which vary in their ability to support transcription of PTGDR and have distinct DNA-binding-protein affinity profiles. Individual PTGDR SNPs were significantly associated with asthma in both populations. Specific PTGDR haplotypes were significantly associated with a diagnosis of asthma in a large case-control study of whites (P=0.002); we confirmed these findings in a second population of blacks (P=0.01). Multivariate analysis of the haplotype combinations (diplotypes) demonstrated that both whites (odds ratio, 0.55; 95 percent confidence interval, 0.38 to 0.80; P=0.002) and blacks (odds ratio, 0.32; 95 percent confidence interval, 0.12 to 0.89; P=0.03) who had at least one copy of the haplotype with a low transcriptional efficiency had a lower risk of asthma than subjects with no copies of the haplotype. CONCLUSIONS: Our functional and genetic findings identify PTGDR as an asthma-susceptibility gene.	Brigham & Womens Hosp, Div Pulm & Crit Care, Combined Program Pulm & Crit Care Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Western Australian Inst Med Res, Perth, WA, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; USA, Inst Environm Med, Natick, MA 01760 USA; Keio Univ, Sch Med, Dept Med, Cardiopulm Div, Tokyo 160, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Western Australia; University of Western Australia; Keio University	Lilly, CM (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, Combined Program Pulm & Crit Care Med, 75 Francis St,Thorn 826C, Boston, MA 02115 USA.	clilly@partners.org	Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; BIRBEN, ESRA/0000-0003-1192-309X				Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hakonarson H, 2002, AM J HUM GENET, V71, P483, DOI 10.1086/342205; Hall IP, 1998, CLIN EXP ALLERGY, V28, P74; HALL IP, 1998, CLIN EXP ALLERGY S1, V28, P80; Jedrzkiewicz S, 2000, AM J PHYSIOL-LUNG C, V279, pL1058, DOI 10.1152/ajplung.2000.279.6.L1058; JOHNSTON SL, 1995, EUR RESPIR J, V8, P411, DOI 10.1183/09031936.95.08030411; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; Malerba G, 2001, J ALLERGY CLIN IMMUN, V107, P654, DOI 10.1067/mai.2001.113865; Mansur AH, 1999, AM J RESP CRIT CARE, V159, P1796, DOI 10.1164/ajrccm.159.6.9804036; Marsh DG, 1997, NAT GENET, V15, P389; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McCullagh P, 2019, GEN LINEAR MODELS, DOI [10.1201/9780203753736, DOI 10.1007/978-1-4899-3242-6, DOI 10.1201/9780203753736]; Mehta C R, 1994, Stat Methods Med Res, V3, P135, DOI 10.1177/096228029400300203; Nakamura H, 2001, J ALLERGY CLIN IMMUN, V108, P946, DOI 10.1067/mai.2001.120135; Oguma T, 2002, AM J RESP CRIT CARE, V165, P382, DOI 10.1164/ajrccm.165.3.2103093; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Shikanai T, 2002, J APPL PHYSIOL, V93, P37, DOI 10.1152/japplphysiol.00993.2001; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Sonna LA, 2001, CHEST, V119, P1676, DOI 10.1378/chest.119.6.1676; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166; 1997, GUIDELINES DIAGNOSIS, P1	33	113	126	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1752	1763		10.1056/NEJMoa031785	http://dx.doi.org/10.1056/NEJMoa031785			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15496624				2022-12-24	WOS:000224585200010
J	Arrasate, M; Mitra, S; Schweitzer, ES; Segal, MR; Finkbeiner, S				Arrasate, M; Mitra, S; Schweitzer, ES; Segal, MR; Finkbeiner, S			Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE EXPANSIONS; NEUROLOGICAL PHENOTYPE; IN-VITRO; AGGREGATION; DISEASE; NUCLEAR; REPEAT; FRAGMENTS	Huntington's disease is caused by an abnormal polyglutamine expansion within the protein huntingtin and is characterized by microscopic inclusion bodies of aggregated huntingtin and by the death of selected types of neuron. Whether inclusion bodies are pathogenic, incidental or a beneficial coping response is controversial. To resolve this issue we have developed an automated microscope that returns to precisely the same neuron after arbitrary intervals, even after cells have been removed from the microscope stage. Here we show, by survival analysis, that neurons die in a time-independent fashion but one that is dependent on mutant huntingtin dose and polyglutamine expansion; many neurons die without forming an inclusion body. Rather, the amount of diffuse intracellular huntingtin predicts whether and when inclusion body formation or death will occur. Surprisingly, inclusion body formation predicts improved survival and leads to decreased levels of mutant huntingtin elsewhere in a neuron. Thus, inclusion body formation can function as a coping response to toxic mutant huntingtin.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94141 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94141 USA; Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94141 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol & Physiol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.	sfinkbeiner@gladstone.ucsf.edu	Arrasate, Montserrat/ABB-4450-2020	Arrasate, Montserrat/0000-0002-8911-8990; Mitra, Siddhartha/0000-0003-3967-1496				Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; ARRASATE M, 2003, SOC NEUR ABSTR, V29; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Collett D., 1994, MODELING SURVIVAL DA; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hack NJ, 2000, J NEUROSCI METH, V95, P177, DOI 10.1016/S0165-0270(99)00178-8; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim M, 1999, J NEUROSCI, V19, P964; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kuemmerle S, 1999, ANN NEUROL, V46, P842; MACDONALD ME, 1998, TRINUCLEOTIDE DIS IN, P47; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Moulder KL, 1999, J NEUROSCI, V19, P705; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Preisinger E, 1999, PHILOS T ROY SOC B, V354, P1029, DOI 10.1098/rstb.1999.0455; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shimohata T, 2002, NEUROSCI LETT, V323, P215, DOI 10.1016/S0304-3940(02)00162-3; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Strebel A, 2001, CYTOMETRY, V43, P126, DOI 10.1002/1097-0320(20010201)43:2<126::AID-CYTO1027>3.0.CO;2-J; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Therneau T. M., 2000, STAT BIOL HEALTH; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X	50	1480	1510	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					805	810		10.1038/nature02998	http://dx.doi.org/10.1038/nature02998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483602	Bronze			2022-12-24	WOS:000224435500037
J	Yamamoto, Y; Stock, DW; Jeffery, WR				Yamamoto, Y; Stock, DW; Jeffery, WR			Hedgehog signalling controls eye degeneration in blind cavefish	NATURE			English	Article							SONIC HEDGEHOG; GENE; ASTYANAX; EXPRESSION; EVOLUTION; SYSTEM; RETINA; PAX2	Hedgehog (Hh) proteins are responsible for critical signalling events during development(1) but their evolutionary roles remain to be determined. Here we show that hh gene expression at the embryonic midline controls eye degeneration in blind cavefish. We use the teleost Astyanax mexicanus, a single species with an eyed surface-dwelling form ( surface fish) and many blind cave forms ( cavefish) 2, to study the evolution of eye degeneration. Small eye primordia are formed during cavefish embryogenesis, which later arrest in development, degenerate and sink into the orbits. Eye degeneration is caused by apoptosis of the embryonic lens, and transplanting a surface fish embryonic lens into a cavefish optic cup can restore a complete eye(3-5). Here we show that sonic hedgehog (shh) and tiggy-winkle hedgehog ( twhh) gene expression is expanded along the anterior embryonic midline in several different cavefish populations. The expansion of hh signalling results in hyperactivation of downstream genes, lens apoptosis and arrested eye growth and development. These features can be mimicked in surface fish by twhh and/or shh overexpression, supporting the role of hh signalling in the evolution of cavefish eye regression.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Boulder	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	jeffery@umd.edu	Zebrafish, UCL/A-3125-2009	Yamamoto, Yoshiyuki/0000-0003-4830-5703	NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014619] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Culver DC, 1982, CAVE LIFE EVOLUTION; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jeffery WR, 2003, INTEGR COMP BIOL, V43, P531, DOI 10.1093/icb/43.4.531; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jeffery WR, 1998, AM ZOOL, V38, P685; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; Li HS, 1997, DEVELOPMENT, V124, P603; MACDONALD JM, 1995, VET DERMATOL, V6, P121, DOI 10.1111/j.1365-3164.1995.tb00055.x; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mitchell RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Stenkamp DL, 2000, DEV BIOL, V220, P238, DOI 10.1006/dbio.2000.9629; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631	26	182	187	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					844	847		10.1038/nature02864	http://dx.doi.org/10.1038/nature02864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483612				2022-12-24	WOS:000224435500047
J	Buckner, M				Buckner, M			Sickle-cell disease: from sierra Leone to southeast London	LANCET			English	Editorial Material																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 9	2004	364	9442					1361	1361		10.1016/S0140-6736(04)17193-6	http://dx.doi.org/10.1016/S0140-6736(04)17193-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474139				2022-12-24	WOS:000224349700032
J	Kuma, A; Hatano, M; Matsui, M; Yamamoto, A; Nakaya, H; Yoshimori, T; Ohsumi, Y; Tokuhisa, T; Mizushima, N				Kuma, A; Hatano, M; Matsui, M; Yamamoto, A; Nakaya, H; Yoshimori, T; Ohsumi, Y; Tokuhisa, T; Mizushima, N			The role of autophagy during the early neonatal starvation period	NATURE			English	Article							PROTEIN CONJUGATION SYSTEM; KINASE CASCADE; GENE; CELLS; DISRUPTION; SENESCENCE; BECLIN-1; RECEPTOR; HOMOLOG; LC3	At birth the trans-placental nutrient supply is suddenly interrupted, and neonates face severe starvation until supply can be restored through milk nutrients(1). Here, we show that neonates adapt to this adverse circumstance by inducing autophagy. Autophagy is the primary means for the degradation of cytoplasmic constituents within lysosomes(2-4). The level of autophagy in mice remains low during embryogenesis; however, autophagy is immediately upregulated in various tissues after birth and is maintained at high levels for 3 - 12 h before returning to basal levels within 1 - 2 days. Mice deficient for Atg5, which is essential for autophagosome formation, appear almost normal at birth but die within 1 day of delivery. The survival time of starved Atg5-deficient neonates (similar to 12 h) is much shorter than that of wild-type mice (similar to21 h) but can be prolonged by forced milk feeding. Atg5-deficient neonates exhibit reduced amino acid concentrations in plasma and tissues, and display signs of energy depletion. These results suggest that the production of amino acids by autophagic degradation of 'self' proteins, which allows for the maintenance of energy homeostasis, is important for survival during neonatal starvation.	Japan Sci & Technol Agcy, PRESTO, Times Arrow & Biosignaling, Kawaguchi 3320012, Japan; Chiba Univ, Dept Dev Genet H2, Chiba 2608670, Japan; Chiba Univ, Grad Sch Med, Dept Pharmacol F2, Chiba 2608670, Japan; Chiba Univ, Biomed Res Ctr, Chiba 2608670, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 444, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan; Natl Inst Genet, Dept Cell Genet, Mishima, Shizuoka 4118540, Japan	Japan Science & Technology Agency (JST); Chiba University; Chiba University; Chiba University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokyo Metropolitan Institute of Medical Science; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Mizushima, N (corresponding author), Japan Sci & Technol Agcy, PRESTO, Times Arrow & Biosignaling, Kawaguchi 3320012, Japan.	nmizu@rinshoken.or.jp	Ohsumi, Yoshinori/C-6449-2009; Mizushima, Noboru/C-3635-2009	Ohsumi, Yoshinori/0000-0003-2384-2166; Mizushima, Noboru/0000-0002-6258-6444				Brun S, 1999, DIABETES, V48, P1217, DOI 10.2337/diabetes.48.6.1217; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MEDINA JM, 1992, PERINATAL BIOCH, P233; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; YAMAMOTO A, 1991, CELL STRUCT FUNCT, V16, P419, DOI 10.1247/csf.16.419; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	27	2306	2401	7	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1032	1036		10.1038/nature03029	http://dx.doi.org/10.1038/nature03029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15525940				2022-12-24	WOS:000225887000043
J	Logan, PA; Gladman, JRF; Avery, A; Walker, MF; Dyas, J; Groom, L				Logan, PA; Gladman, JRF; Avery, A; Walker, MF; Dyas, J; Groom, L			Randomised controlled trial of an occupational therapy intervention to increase outdoor mobility after stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUESTIONNAIRE	Objective To evaluate an occupational therapy intervention to improve outdoor mobility after stroke. Design Randomised controlled trial. Setting General practice registers, social services departments, a primary care rehabilitation service, and a geriatric day hospital. Participants 168 community dwelling people with a clinical diagnosis of stroke in previous 36 months: 86 were allocated to the intervention group and 82 to the control group. Interventions Leaflets describing local transport services for disabled people (control group) and leaflets with assessment and up to seven intervention sessions by an occupational therapist (intervention group). Main outcome measures Responses to postal questionnaires at four and 10 months: primary outcome measure was response to whether participant got out of the house as much as he or she would like, and secondary outcome measures were response to how many journeys outdoors had been made in the past month and scores on the Nottingham extended activities of daily living scale, Nottingham leisure questionnaire, and general health questionnaire. Results Participants in the treatment group were more likely to get out of the house as often as they wanted at both four months (relative risk 1.72, 95% confidence interval 1.25 to 2.37) and 10 months (1.74, 1.24 to 2.44). The treatment group reported more journeys outdoors in the month before assessment at both four months (median 37 in intervention group, 14 in control group: P < 0.0 1) and 10 months (median 42 in intervention group, 14 in control group: P < 0.01). At four months the mobility scores on the Nottingham extended activities of daily living scale were significantly higher in the intervention group, but there Were no significant differences in the other secondary outcomes. No significant differences were observed in these measures at 10 months. Conclusion A targeted occupational therapy intervention at home increases outdoor mobility in people after stroke.	Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England; Hucknall Hlth Ctr, Broxtowe & Hucknall Primary Care Trust, Off Res & Dev, Nottingham NG15 7JE, England	University of Nottingham	Gladman, JRF (corresponding author), Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England.	john.gladman@nottingham.ac.uk	; Gladman, John/M-7429-2015	Logan, Philippa/0000-0002-6657-2381; Gladman, John/0000-0002-8506-7786; Walker, Marion/0000-0002-3534-591X; Avery, Anthony/0000-0001-7591-4438				Collin C, 1988, Int Disabil Stud, V10, P61; Drummond A, 2001, CLIN REHABIL, V15, P647, DOI 10.1191/0269215501cr438oa; Goldberg D., 1992, GEN HLTH QUESTIONNAI; Legg L, 2004, LANCET, V363, P352; Logan PA, 2004, CLIN REHABIL, V18, P703, DOI 10.1191/0269215504cr742oa; Logan PA., 2001, BRIT J OCCUP THER, V64, P261; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Parker CJ, 2001, CLIN REHABIL, V15, P42, DOI 10.1191/026921501666968247; Parker CJ, 2000, INT J EPIDEMIOL, V29, P1065, DOI 10.1093/ije/29.6.1065; Pound P, 1998, CLIN REHABIL, V12, P338, DOI 10.1191/026921598677661555; Steultjens EMJ, 2003, STROKE, V34, P676, DOI 10.1161/01.STR.0000057576.77308.30; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5	12	77	80	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2004	329	7479					1372	1374A		10.1136/bmj.38264.679560.8F	http://dx.doi.org/10.1136/bmj.38264.679560.8F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15564229	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225785000017
J	Yang, LH				Yang, LH			Periodical cicadas as resource pulses in North American forests	SCIENCE			English	Article							TRANSIENT DYNAMICS; PREDATOR SATIATION; RIPARIAN FOREST; NITROGEN; MAGICICADA; HOMOPTERA; EMERGENCE; CICADIDAE; DENSITIES; RODENT	Resource pulses are occasional events of ephemeral resource superabundance that occur in many ecosystems. Aboveground consumers in diverse communities often respond strongly to resource pulses, but few studies have investigated the belowground consequences of resource pulses in natural ecosystems. This study shows that resource pulses of 17-year periodical cicadas (Magicicada spp.) directly increase microbial biomass and nitrogen availability in forest soils, with indirect effects on growth and reproduction in forest plants. These findings suggest that pulses of periodical cicadas create "bottom-up cascades," resulting in strong and reciprocal links between the aboveground and belowground components of a North American forest ecosystem.	Univ Calif Davis, Ctr Populat Biol, Sect Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Yang, LH (corresponding author), Univ Calif Davis, Ctr Populat Biol, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	lhyang@ucdavis.edu		Yang, Louie/0000-0002-9237-5357				Ben-David M, 1998, OIKOS, V83, P47, DOI 10.2307/3546545; Black C.A., 1968, SOIL PLANT RELATIONS, V2nd ed; BROWN JJ, 1973, J INSECT PHYSIOL, V19, P607, DOI 10.1016/0022-1910(73)90069-3; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; COLEMAN DC, 1996, FOOD WEBS INTEGRATIO, pCH3; DYBAS HS, 1962, ECOLOGY, V43, P432, DOI 10.2307/1933372; Elkinton JS, 1996, ECOLOGY, V77, P2332, DOI 10.2307/2265735; Galloway LF, 2001, ECOLOGY, V82, P2781, DOI 10.1890/0012-9658(2001)082[2781:PEEOLH]2.0.CO;2; Galloway LF, 2001, AM J BOT, V88, P832, DOI 10.2307/2657035; HAHUS SC, 1990, J MAMMAL, V71, P249, DOI 10.2307/1382177; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; KARBAN R, 1982, ECOLOGY, V63, P321, DOI 10.2307/1938949; Koenig WD, 2003, CAN J FOREST RES, V33, P1084, DOI 10.1139/X03-037; Lima M, 1999, ECOGRAPHY, V22, P213, DOI 10.1111/j.1600-0587.1999.tb00470.x; Lovett GM, 2002, BIOSCIENCE, V52, P335, DOI 10.1641/0006-3568(2002)052[0335:IDANCI]2.0.CO;2; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; RICHARDSON TE, 1992, EVOLUTION, V46, P1731, DOI [10.2307/2410027, 10.1111/j.1558-5646.1992.tb01165.x]; Rodenhouse NL, 1997, AM MIDL NAT, V137, P124, DOI 10.2307/2426761; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Stapp P, 2003, OIKOS, V102, P111, DOI 10.1034/j.1600-0706.2003.12445.x; SWEENEY BW, 1982, EVOLUTION, V36, P810, DOI 10.1111/j.1558-5646.1982.tb05447.x; Wardle DA., 2002, COMMUNITIES ECOSYSTE, P7; WHEELER GL, 1992, FOREST ECOL MANAG, V51, P339, DOI 10.1016/0378-1127(92)90333-5; Whiles MR, 2001, AM MIDL NAT, V145, P176, DOI 10.1674/0003-0031(2001)145[0176:EOPCMC]2.0.CO;2; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; WILLIAMS KS, 1993, ECOLOGY, V74, P1143, DOI 10.2307/1940484; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.1890/0012-9658(1999)080[1632:TENOSO]2.0.CO;2; Zackrisson O, 1999, OIKOS, V84, P17, DOI 10.2307/3546862	34	145	153	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1565	1567		10.1126/science.1103114	http://dx.doi.org/10.1126/science.1103114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567865				2022-12-24	WOS:000225442700062
J	Collins, FS; Lander, ES; Rogers, J; Waterston, RH				Collins, FS; Lander, ES; Rogers, J; Waterston, RH		Int Human Genome Sequencing Conso	Finishing the euchromatic sequence of the human genome	NATURE			English	Article							RECENT SEGMENTAL DUPLICATIONS; COMPREHENSIVE GENETIC-MAP; DNA-SEQUENCE; PHYSICAL MAP; MOUSE GENOME; SACCHAROMYCES GENOMES; LINKAGE MAP; CHROMOSOME; HUMAN-CHROMOSOME-13; SELECTION	The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers similar to99% of the euchromatic genome and is accurate to an error rate of similar to1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human genome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead.				fc23a@nih.gov; lander@broad.mit.edu; jrh@sanger.ac.uk; waterston@gs.washington.edu	Schmutz, Jeremy/N-3173-2013; Ponting, Chris/AAV-2621-2021; Eyras, Eduardo/ABG-7144-2020; Taylor, Todd/A-7121-2009; Fernandez, Xose/ABA-7117-2020; Couronne, Olivier Couronne/G-1244-2012; Xiong, Yuqing/D-5404-2009; Cuomo, Christina/L-2222-2019; Seaman, Steven/A-2755-2013; Vastrik, Imre/C-2690-2009; Chothia, Tom/HDM-3159-2022; Hubbard, Tim J.P./AAT-4571-2020; Li, Wei/A-8544-2009; 郑, 征/C-8514-2011; Glöckner, Gernot/A-7800-2010; Lewis, Ernest K/B-3821-2012; Severin, Jessica/AAQ-2723-2020; Deloukas, Panos/B-2922-2013; Wilson, Richard K./AAF-4139-2019; Itoh, Takehiko/E-8873-2014; Hubbard, Tim J/C-2567-2008; Smith, Andy/A-7512-2011; Andrews, Dan/ABG-4815-2020; Santoyo-Lopez, Javier/C-9714-2012; Rodriguez, Joseph/I-9277-2014; dobson, richard/C-9269-2011; Redon, Richard/F-3303-2014	Schmutz, Jeremy/0000-0001-8062-9172; Eyras, Eduardo/0000-0003-0793-6218; Taylor, Todd/0000-0003-4247-6253; Fernandez, Xose/0000-0001-7139-6215; Xiong, Yuqing/0000-0001-5826-3696; Cuomo, Christina/0000-0002-5778-960X; Seaman, Steven/0000-0003-3349-3334; Hubbard, Tim J.P./0000-0002-1767-9318; Glöckner, Gernot/0000-0002-9061-1061; Lewis, Ernest K/0000-0003-3905-8691; Severin, Jessica/0000-0003-1274-208X; Deloukas, Panos/0000-0001-9251-070X; Wilson, Richard K./0000-0002-1992-1358; Itoh, Takehiko/0000-0002-6113-557X; Hubbard, Tim J/0000-0002-1767-9318; Smith, Andy/0000-0001-8580-278X; Santoyo-Lopez, Javier/0000-0003-1988-5059; Rodriguez, Joseph/0000-0002-6017-1376; Malfatti, Stephanie/0000-0003-4225-9857; Whittaker, Charles/0000-0002-2400-0094; Hughes, Jaime/0000-0001-6045-4053; Schuster, Michael/0000-0003-2975-8969; Lindsay, Sarah/0000-0002-0965-3070; Keenan, Stephen/0000-0002-9141-7690; dobson, richard/0000-0003-4224-9245; MCLELLAN, MICHAEL/0000-0002-2703-8784; Leongamornlert, Daniel/0000-0002-3486-3168; Hinrichs, Angie/0000-0002-1697-1130; Webber, Caleb/0000-0001-8063-7674; Pruitt, Kim/0000-0001-7950-1374; Wollard, Jessica/0000-0002-9329-2609; Rigby, Rachel Elizabeth/0000-0001-5201-9422; Steward, Charles/0000-0001-8829-5349; Andrews, Dan/0000-0003-3922-6376; Maslen, Gareth/0000-0001-7318-3678; Nicol, Robert/0000-0003-1932-1392; Bonfield, James/0000-0002-6447-4112; Pitesky, Maurice/0000-0003-0084-6404; Palaniappan, Krishnaveni/0000-0003-4484-7505; Petit, Jean-Louis/0000-0002-8566-0571; de Berardinis, Veronique/0000-0002-3273-4135; Siepel, Adam/0000-0002-3557-7219; Benkahla, Alia/0000-0001-9988-3250; Dunham, Ian/0000-0003-2525-5598; Redon, Richard/0000-0001-7751-2280; Gammon, Stuart/0000-0002-8651-6897; Kay, Mike/0000-0002-3282-0834; Clarke, Laura/0000-0002-5989-6898; Flanagan, Judith/0000-0002-4053-3288; Ito, Fumiaki/0000-0002-4129-4899; Mott, Richard/0000-0002-1022-9330	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Felsenfeld A, 1999, GENOME RES, V9, P1; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FUREY TS, IN PRESS GENOME RES; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lai ZW, 1999, NAT GENET, V23, P309, DOI 10.1038/15484; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; MADAN K, 1974, ANN GENET-PARIS, V17, P81; Maston GA, 2002, MOL BIOL EVOL, V19, P320, DOI 10.1093/oxfordjournals.molbev.a004085; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nilsson M, 1997, NAT GENET, V16, P252, DOI 10.1038/ng0797-252; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; RUDD MK, IN PRESS TRENDS GENE; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Szymanski M, 2003, NUCLEIC ACIDS RES, V31, P429, DOI 10.1093/nar/gkg124; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	71	3337	3743	6	324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					931	945		10.1038/nature03001	http://dx.doi.org/10.1038/nature03001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496913	Green Published, Bronze			2022-12-24	WOS:000224585600034
J	Bulte, E; Damania, R; Gillson, L; Lindsay, K				Bulte, E; Damania, R; Gillson, L; Lindsay, K			Space - The final frontier for economists and elephants	SCIENCE			English	Editorial Material							BIODIVERSITY; SERENGETI		Tilburg Univ, Dept Econ, NL-5000 LE Tilburg, Netherlands; Univ Adelaide, Sch Econ, Adelaide, SA 5005, Australia; Univ Oxford, Dept Zool, Environm Change Inst, Biodivers Res Grp, Oxford OX1 3PS, England; Amboseli Trust Elephants, Amboseli Elephant Res Project, Nairobi 00519, Kenya	Tilburg University; University of Adelaide; University of Oxford	Bulte, E (corresponding author), Tilburg Univ, Dept Econ, POB 90153, NL-5000 LE Tilburg, Netherlands.		Gillson, Lindsey/AAR-6531-2020	Gillson, Lindsey/0000-0001-9607-6760; Bulte, Erwin/0000-0001-9491-5268				Barbier E.B., 1990, ELEPHANTS EC IVORY; BARNES J, 1990, FUTURE BOTSWANAS ELE, P60; Barrett CB, 1998, LAND ECON, V74, P449, DOI 10.2307/3146878; BRANDER J, 1997, CAN J ECON, V50, P526; Bulte EH, 1999, AM J AGR ECON, V81, P453, DOI 10.2307/1244594; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Finnoff D, 2003, J ENVIRON ECON MANAG, V45, P589, DOI 10.1016/S0095-0696(02)00025-6; Fischer C, 2004, J ENVIRON ECON MANAG, V48, P926, DOI 10.1016/j.jeem.2003.12.003; Rogers KH., 2003, KRUGER EXPERIENCE EC, P41; Ross M. L., 2001, TIMBER BOOMS I BREAK; Sanchirico JN, 1999, J ENVIRON ECON MANAG, V37, P129, DOI 10.1006/jeem.1998.1060; Saphores JD, 2003, J ECON DYN CONTROL, V28, P509, DOI 10.1016/S0165-1889(03)00033-2; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; SWANSON TM, 1994, OXFORD ECON PAP, V46, P800, DOI 10.1093/oep/46.Supplement_1.800; 2004, CONT INT TRAD END SP	15	12	13	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					420	421		10.1126/science.1105392	http://dx.doi.org/10.1126/science.1105392			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	864IF	15486280				2022-12-24	WOS:000224626500032
J	Kah, LC; Lyons, TW; Frank, TD				Kah, LC; Lyons, TW; Frank, TD			Low marine sulphate and protracted oxygenation of the proterozoic biosphere	NATURE			English	Article							SULFUR ISOTOPIC COMPOSITION; OCEAN CHEMISTRY; SEAWATER; BASIN; GEOCHEMISTRY; RISE	Progressive oxygenation of the Earth's early biosphere is thought to have resulted in increased sulphide oxidation during continental weathering, leading to a corresponding increase in marine sulphate concentration(1). Accurate reconstruction of marine sulphate reservoir size is therefore important for interpreting the oxygenation history of early Earth environments. Few data, however, specifically constrain how sulphate concentrations may have changed during the Proterozoic era (2.5 - 0.54 Gyr ago). Prior to 2.2 Gyr ago, when oxygen began to accumulate in the Earth's atmosphere(2,3), sulphate concentrations are inferred to have been <1 mM and possibly < 200 muM, on the basis of limited isotopic variability preserved in sedimentary sulphides(4) and experimental data showing suppressed isotopic fractionation at extremely low sulphate concentrations(1,5). By 0.8 Gyr ago, oxygen and thus sulphate levels may have risen significantly(6,7). Here we report large stratigraphic variations in the sulphur isotope composition of marine carbonate-associated sulphate, and use a rate-dependent model for sulphur isotope change that allows us to track changes in marine sulphate concentrations throughout the Proterozoic. Our calculations indicate sulphate levels between 1.5 and 4.5 mM, or 5 - 15 per cent of modern values, for more than 1 Gyr after initial oxygenation of the Earth's biosphere. Persistence of low oceanic sulphate demonstrates the protracted nature of Earth's oxygenation. It links biospheric evolution to temporal patterns in the depositional behaviour of marine iron- and sulphur-bearing minerals(4), biological cycling of redox-sensitive elements(6) and availability of trace metals essential to eukaryotic development(8).	Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA	University of Tennessee System; University of Tennessee Knoxville; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln	Kah, LC (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	lckah@utk.edu	Kah, Linda C/J-3754-2019	Kah, Linda C/0000-0001-7172-2033; Frank, Tracy/0000-0002-8422-7389				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Azmy K, 2001, PRECAMBRIAN RES, V112, P303, DOI 10.1016/S0301-9268(01)00194-2; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; BOSSCHER H, 1993, J GEOL, V101, P345, DOI 10.1086/648228; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; BURDETT JW, 1989, EARTH PLANET SC LETT, V94, P189, DOI 10.1016/0012-821X(89)90138-6; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Frank TD, 2003, GEOL MAG, V140, P397, DOI 10.1017/S0016756803007830; GELLATLY AM, IN PRESS GEOCHIM COS; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Habicht KS, 2001, GEOLOGY, V29, P555, DOI 10.1130/0091-7613(2001)029<0555:IFBSRN>2.0.CO;2; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Kampschulte A, 2001, CHEM GEOL, V175, P149, DOI 10.1016/S0009-2541(00)00367-3; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Luepke JJ, 2001, PRECAMBRIAN RES, V111, P79, DOI 10.1016/S0301-9268(01)00157-7; Lyons TW, 2000, GEOCHIM COSMOCHIM AC, V64, P427, DOI 10.1016/S0016-7037(99)00323-3; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; Staudt WJ, 1995, ACS SYM SER, V612, P332; Strauss H, 1997, PALAEOGEOGR PALAEOCL, V132, P97, DOI 10.1016/S0031-0182(97)00067-9; WHELAN JF, 1990, AM J SCI, V290, P396, DOI 10.2475/ajs.290.4.396	30	345	364	4	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					834	838		10.1038/nature02974	http://dx.doi.org/10.1038/nature02974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483609	Green Published			2022-12-24	WOS:000224435500044
J	Chen, AE; Ginty, DD; Fan, CM				Chen, AE; Ginty, DD; Fan, CM			Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins	NATURE			English	Article							SKELETAL-MUSCLE; SONIC HEDGEHOG; BETA-CATENIN; EXPRESSION; MYOD; TRANSCRIPTION; PATHWAY; FAMILY; GENES; MYF-5	Select members of the Wnt family of secreted glycoproteins have been implicated in inducing the myogenic determinant genes Pax3, MyoD and Myf5 during mammalian embryogenesis(1,2), but the mechanism of induction has not been defined. We describe an unexpected role for protein kinase A (PKA) signalling via CREB in this induction. Using a combination of in vitro explant assays, mutant analysis and gene delivery into mouse embryos cultured ex vivo, we demonstrate that adenylyl cyclase signalling via PKA and its target transcription factor CREB are required for Wnt-directed myogenic gene expression. Wnt proteins can also stimulate CREB-mediated transcription, providing evidence for a Wnt signalling pathway involving PKA and CREB. Our findings raise the possibility that PKA/CREB signalling may also contribute to other Wnt-regulated processes in embryonic patterning, stem cell renewal and cancer(3).	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Fan, CM (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	fan@ciwemb.edu						Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Barnes MR, 1998, TRENDS PHARMACOL SCI, V19, P399, DOI 10.1016/S0165-6147(98)01246-2; BOBER E, 1994, DEVELOPMENT, V120, P603; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Buttitta L, 2003, DEV BIOL, V258, P91, DOI 10.1016/S0012-1606(03)00116-7; Capdevila J, 1998, DEV BIOL, V193, P182, DOI 10.1006/dbio.1997.8806; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Fan CM, 1997, DEV BIOL, V191, P160, DOI 10.1006/dbio.1997.8713; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Ikeya M, 1998, DEVELOPMENT, V125, P4969; IYENGAR R, 1994, METHODS ENZYMOLOGY H, V237, P26; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Manning D.R., 1999, G PROTEINS TECHNIQUE; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Ordahl C., 2000, SOMITOGENESIS 2, P129; OTT MO, 1991, DEVELOPMENT, V111, P1097; PARR BA, 1993, DEVELOPMENT, V119, P247; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Wang HY, 2004, CELL MOL LIFE SCI, V61, P69, DOI 10.1007/s00018-003-3165-x; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434	28	247	256	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					317	322		10.1038/nature03126	http://dx.doi.org/10.1038/nature03126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15568017				2022-12-24	WOS:000226381300056
J	Jennerjahn, TC; Ittekkot, V; Arz, HW; Behling, H; Patzold, J; Wefer, G				Jennerjahn, TC; Ittekkot, V; Arz, HW; Behling, H; Patzold, J; Wefer, G			Asynchronous terrestrial and marine signals of climate change during Heinrich events	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; NORTHEASTERN BRAZIL; TROPICAL ATLANTIC; ORGANIC-MATTER; NORTH-ATLANTIC; SEA-LEVEL; OCEAN; PALEOCLIMATE; DEGLACIATION; CIRCULATION	Tropical regions have been reported to play a key role in climate dynamics. To date, however, there are uncertainties in the timing and the amplitude of the response of tropical ecosystems to millennial-scale climate change. We present evidence of an asynchrony between terrestrial and marine signals of climate change during Heinrich events preserved in marine sediment cores from the Brazilian continental margin. The inferred time tag of about 1000 to 2000 years is much larger than the ecological response to recent climate change and appears to be related to the nature of hydrological changes.	Zentrum Marine Trop Okol, D-28359 Bremen, Germany; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Deutsch Forschungsgemeinsch, Forschungszentrum Ozeanrander RCOM, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; German Research Foundation (DFG)	Jennerjahn, TC (corresponding author), Zentrum Marine Trop Okol, Fahrenheitstr 6, D-28359 Bremen, Germany.	tim.jennerjahn@zmt-bremen.de	Arz, Helge/A-6659-2013; Ittekkot, Venugopalan/AAC-3437-2022; Gerold, Wefer/S-2291-2016; Jennerjahn, Tim/AAE-9146-2020; Patzold, Jurgen/D-5111-2017	Gerold, Wefer/0000-0002-6803-2020; Jennerjahn, Tim/0000-0003-1022-5126; Ittekkot, Venugopalan/0000-0003-2667-5068; Patzold, Jurgen/0000-0001-8074-4103; Arz, Helge Wolfgang/0000-0002-1997-1718				ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Arz HW, 1999, EARTH PLANET SC LETT, V167, P105, DOI 10.1016/S0012-821X(99)00025-4; Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; BARRETTO HT, 1975, J SEDIMENT PETROL, V45, P822; Behling H, 2000, QUATERNARY SCI REV, V19, P981, DOI 10.1016/S0277-3791(99)00046-3; BRADLEY RS, 1991, PALEOCLIMATOLOGY; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Broecker WS, 2001, SCIENCE, V294, P2308, DOI 10.1126/science.1068389; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P271, DOI 10.1029/1999PA900003; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Farrera I, 1999, CLIM DYNAM, V15, P823, DOI 10.1007/s003820050317; FISCHER G, 1991, MAR CHEM, V35, P581, DOI 10.1016/S0304-4203(09)90044-5; Galimov E.M, 1985, BIOL FRACTIONATION I; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Jansen JHF, 1998, MAR GEOL, V151, P143, DOI 10.1016/S0025-3227(98)00074-7; Jennerjahn TC, 1999, MAR GEOL, V161, P129, DOI 10.1016/S0025-3227(99)00045-6; JENNERJAHN TC, UNPUB; Kerr RA, 2001, SCIENCE, V292, P660, DOI 10.1126/science.292.5517.660; Ledru MP, 2002, GEOLOGY, V30, P275, DOI 10.1130/0091-7613(2002)030<0275:TCITGO>2.0.CO;2; MCMANUS JF, 1994, NATURE, V371, P326, DOI 10.1038/371326a0; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Sarnthein M., 2000, EOS T AM GEOPHYS UN, V81, P625; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Vidal L, 1997, EARTH PLANET SC LETT, V146, P13, DOI 10.1016/S0012-821X(96)00192-6; WADA E, 1991, NITROGEN SEA FORMS A; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	117	122	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2236	2239		10.1126/science.1102490	http://dx.doi.org/10.1126/science.1102490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15576572	Green Submitted			2022-12-24	WOS:000225950000040
J	Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Christensen, PR; Chu, P; Davis, K; Ehlmann, BL; Golombek, MP; Gorevan, S; Guinness, EA; Haldemann, AFC; Herkenhoff, KE; Landis, G; Li, R; Lindemann, R; Ming, DW; Myrick, T; Parker, T; Richter, L; Seelos, FP; Soderblom, LA; Squyres, SW; Sullivan, RJ; Wilson, J				Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Christensen, PR; Chu, P; Davis, K; Ehlmann, BL; Golombek, MP; Gorevan, S; Guinness, EA; Haldemann, AFC; Herkenhoff, KE; Landis, G; Li, R; Lindemann, R; Ming, DW; Myrick, T; Parker, T; Richter, L; Seelos, FP; Soderblom, LA; Squyres, SW; Sullivan, RJ; Wilson, J			Localization and physical property experiments conducted by opportunity at Meridiani Planum	SCIENCE			English	Article							MARS; ROVER; SPECTROMETER; HEMATITE	The location of the Opportunity landing site was determined to better than 10-m absolute accuracy from analyses of radio tracking data. We determined Rover locations during traverses with an error as small as several centimeters using engineering telemetry and overlapping images. Topographic profiles generated from rover data show that the plains are very smooth from meter- to centimeter-length scales, consistent with analyses of orbital observations. Solar cell output decreased because of the deposition of airborne dust on the panels. The lack of dust-covered surfaces on Meridiani Planum indicates that high velocity winds must remove this material on a continuing basis. The low mechanical strength of the evaporitic rocks as determined from grinding experiments, and the abundance of coarse-grained surface particles argue for differential erosion of Meridiani Planum.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Zentrun Luft & Raumfahrt, Inst Raumsimulat, D-51170 Cologne, Germany	Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University System of Ohio; Ohio State University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR)	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	arvidson@wunder.wustl.edu	Haldemann, Albert F C/I-9224-2012; Seelos, Frank/C-7875-2016	Haldemann, Albert F C/0000-0003-3741-8841; Seelos, Frank/0000-0001-9721-941X				Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002041; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; ARVIDSON RE, 2004, SCIENCE, V305, P5685; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Li RX, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001443; MYNCK TM, 2004, AIAA SPAC 2004 C EXH; Neumann GA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017048; RICHTER L, 1999, 13 C INT SOC TERR VE; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	16	97	105	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1730	1733		10.1126/science.1104211	http://dx.doi.org/10.1126/science.1104211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576608				2022-12-24	WOS:000225630800040
J	Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, JC; Garcia, L; Danos, O				Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, JC; Garcia, L; Danos, O			Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping	SCIENCE			English	Article							PRE-MESSENGER-RNA; DUCHENNE MUSCULAR-DYSTROPHY; MDX MOUSE MUSCLE; SKELETAL-MUSCLE; GENE-TRANSFER; HEMOPHILIA-B; DELIVERY; EXPRESSION; MUTATION; VECTOR	Most mutations in the, dystrophin gene create a frameshift or a stop in the mRNA and are associated with severe Duchenne muscular dystrophy. Exon skipping that naturally occurs at low frequency sometimes eliminates the mutation and leads to the production of a rescued protein. We have achieved persistent exon skipping that removes the mutated exon on the dystrophin messenger mRNA of the mdx mouse, by a single administration of an AAV vector expressing antisense sequences linked to a modified U7 small nuclear RNA. We report the sustained production of functional dystrophin at physiological levels in entire groups of muscles and the correction of the muscular dystrophy.	Genethon, Evry, France; CNRS, UMR 8115, Evry, France; Hop & Int Cochin, Lab Biochim & Genet Mol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP	Danos, O (corresponding author), Genethon, 1 Rue Int, Evry, France.	danos@genethon.fr	Goyenvalle, Aurelie/G-3402-2016	Goyenvalle, Aurelie/0000-0003-3938-1165				Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; Brun C, 2003, CELL MOL LIFE SCI, V60, P557, DOI 10.1007/s000180300047; Chao HJ, 2000, MOL THER, V2, P619, DOI 10.1006/mthe.2000.0219; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; De Angelis FG, 2002, P NATL ACAD SCI USA, V99, P9456, DOI 10.1073/pnas.142302299; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; Gebski BL, 2003, HUM MOL GENET, V12, P1801, DOI 10.1093/hmg/ddg196; Gorman L, 1998, P NATL ACAD SCI USA, V95, P4929, DOI 10.1073/pnas.95.9.4929; GOYENVALLE A, UNPUB; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Herzog RW, 1999, NAT MED, V5, P56, DOI 10.1038/4743; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mann CJ, 2002, J GENE MED, V4, P644, DOI 10.1002/jgm.295; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; NICHOLSON LVB, 1993, NEUROMUSCULAR DISORD, V3, P525, DOI 10.1016/0960-8966(93)90109-W; Parrish EP, 1996, GENE THER, V3, P13; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Suter D, 1999, HUM MOL GENET, V8, P2415, DOI 10.1093/hmg/8.13.2415; Vacek MM, 2003, BLOOD, V101, P104, DOI 10.1182/blood-2002-06-1869; Vincent-Lacaze N, 1999, J VIROL, V73, P1949, DOI 10.1128/JVI.73.3.1949-1955.1999; Wells KE, 2003, FEBS LETT, V552, P145, DOI 10.1016/S0014-5793(03)00904-9; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	29	366	429	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1796	1799		10.1126/science.1104297	http://dx.doi.org/10.1126/science.1104297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15528407				2022-12-24	WOS:000225630800059
J	Pernet, B				Pernet, B			The cryptic filtering house of an invertebrate larva	SCIENCE			English	Article							ZOOPLANKTON; FLOW		Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Pernet, B (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	bpernet@csulb.edu		Pernet, Bruno/0000-0002-6200-5654				Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; AKESSON BERTIL, 1961, ACTA ZOOL, V42, P177; Brainerd EL, 2001, NATURE, V412, P387, DOI 10.1038/35086666; EMLET RB, 1985, SCIENCE, V228, P1016, DOI 10.1126/science.228.4702.1016; Flood Per R., 1998, P105; HAMNER WM, 1975, LIMNOL OCEANOGR, V20, P907, DOI 10.4319/lo.1975.20.6.0907; Strathmann R.R., 1987, P465; TRANTER PRG, 1982, J MAR BIOL ASSOC UK, V62, P845, DOI 10.1017/S0025315400070387	8	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1757	1757		10.1126/science.1104279	http://dx.doi.org/10.1126/science.1104279			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576614				2022-12-24	WOS:000225630800046
J	Fotin, A; Cheng, YF; Grigorieff, N; Walz, T; Harrison, SC; Kirchhausen, T				Fotin, A; Cheng, YF; Grigorieff, N; Walz, T; Harrison, SC; Kirchhausen, T			Structure of an auxilin-bound clathrin coat and its implications for the mechanism of uncoating	NATURE			English	Article							IN-VIVO; DISSOCIATION; VESICLES; HSC70; IDENTIFICATION; COMPLEX; ATPASE	Clathrin-coated pits invaginate from specific membrane compartments and pinch off as coated vesicles. These vesicles then uncoat rapidly once released. The Hsc70 molecular chaperone effects the uncoating reaction, and is guided to appropriate locations on clathrin lattices by the J-domain-containing co-chaperone molecule auxilin(1-4). This raises the question of how a local event such as ATP hydrolysis by Hsc70 can catalyse a global disassembly. Here, we have used electron cryomicroscopy to determine 12-Angstrom-resolution structures of in-vitro-assembled clathrin coats in association with a carboxy-terminal fragment of auxilin that contains both the clathrin-binding region and the J domain. We have located the auxilin fragment by computing differences between these structures and those lacking auxilin (described in an accompanying paper(5)). Auxilin binds within the clathrin lattice near contacts between an inward-projecting C-terminal helical tripod and the crossing of two 'ankle' segments; it also contacts the terminal domain of yet another clathrin 'leg'. It therefore recruits Hsc70 to the neighbourhood of a set of critical interactions. Auxilin binding produces a local change in heavy-chain contacts, creating a detectable global distortion of the clathrin coat. We propose a mechanism by which local destabilization of the lattice promotes general uncoating.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Biophys Grad Program, Boston, MA 02115 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Howard Hughes Med Inst, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02454 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Brandeis University; Howard Hughes Medical Institute; Brandeis University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA.	Kirchhausen@crystal.harvard.edu	Gimenez, Luis E Diaz/D-9291-2011	Walz, Thomas/0000-0003-2606-2835; Grigorieff, Nikolaus/0000-0002-1506-909X; Cheng, Yifan/0000-0001-9535-0369				Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; FOTIN A, NATURE; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Gruschus JM, 2004, BIOCHEMISTRY-US, V43, P3111, DOI 10.1021/bi0354740; Holstein SEH, 1996, J CELL BIOL, V135, P925, DOI 10.1083/jcb.135.4.925; Jiang JW, 2003, BIOCHEMISTRY-US, V42, P5748, DOI 10.1021/bi034270g; Ma YC, 2002, J BIOL CHEM, V277, P49267, DOI 10.1074/jbc.M203695200; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; Scheele U, 2001, J BIOL CHEM, V276, P36131, DOI 10.1074/jbc.M106511200; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1985, J BIOL CHEM, V260, P57; SCHRODER S, 1995, EUR J BIOCHEM, V228, P297, DOI 10.1111/j.1432-1033.1995.tb20263.x; Smith CJ, 2004, J MOL BIOL, V336, P461, DOI 10.1016/j.jmb.2003.12.006; TAKENAKA IM, 1995, J BIOL CHEM, V270, P19839, DOI 10.1074/jbc.270.34.19839; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0	18	120	124	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					649	653		10.1038/nature03078	http://dx.doi.org/10.1038/nature03078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15502813				2022-12-24	WOS:000225433200052
J	Hsu, LF; Jais, P; Sanders, P; Garrigue, S; Hocini, M; Sacher, F; Takahashi, Y; Rotter, M; Pasquie, J; Scavee, C; Bordachar, P; Clementy, J; Haissaguerre, M				Hsu, LF; Jais, P; Sanders, P; Garrigue, S; Hocini, M; Sacher, F; Takahashi, Y; Rotter, M; Pasquie, J; Scavee, C; Bordachar, P; Clementy, J; Haissaguerre, M			Catheter ablation for atrial fibrillation in congestive heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY VEIN ISOLATION; LEFT-VENTRICULAR FUNCTION; LONG-TERM SURVIVAL; PACEMAKER IMPLANTATION; ATRIOVENTRICULAR NODE; PERMANENT PACEMAKER; SINUS RHYTHM; MORTALITY; CARDIOMYOPATHY; DOFETILIDE	BACKGROUND: Congestive heart failure and atrial fibrillation often coexist, and each adversely affects the other with respect to management and prognosis. We prospectively evaluated the effect of catheter ablation for atrial fibrillation on left ventricular function in patients with heart failure. METHODS: We studied 58 consecutive patients with congestive heart failure and a left ventricular ejection fraction of less than 45 percent who were undergoing catheter ablation for atrial fibrillation. We selected as controls 58 patients without congestive heart failure who were undergoing ablation for atrial fibrillation, matched according to age, sex, and classification of atrial fibrillation. We evaluated the patients' left ventricular function and dimensions, symptom score, exercise capacity, and quality of life at baseline and at months 1, 3, 6, and 12. RESULTS: After a mean (+/-SD) of 12+/-7 months, 78 percent of the patients with congestive heart failure and 84 percent of the controls remained in sinus rhythm (P=0.34) (69 percent and 71 percent, respectively, were in sinus rhythm without the administration of antiarrhythmic drugs). The patients with congestive heart failure had significant improvement in left ventricular function (increases in the ejection fraction and fractional shortening of 21+/-13 percent and 11+/-7 percent, respectively; P<0.001 for both comparisons), left ventricular dimensions (decreases in the diastolic and systolic diameters of 6+/-6 mm and 8+/-7 mm, respectively; P=0.03 and P<0.001, respectively), exercise capacity, symptoms, and quality of life. The ejection fraction improved significantly not only in patients without concurrent structural heart disease (24+/-10 percent, P<0.001) and those with inadequate rate control before ablation (23+/-10 percent, P<0.001), but also in those with coexisting heart disease (16+/-14 percent, P<0.001) and adequate rate control before ablation (17+/-15 percent, P<0.001). CONCLUSIONS: Restoration and maintenance of sinus rhythm by catheter ablation without the use of drugs in patients with congestive heart failure and atrial fibrillation significantly improve cardiac function, symptoms, exercise capacity, and quality of life.	Hop Cardiol Haut Leveque, F-33604 Bordeaux, France; Univ Bordeaux 2, F-33076 Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Jais, P (corresponding author), Hop Cardiol Haut Leveque, Ave Magellan, F-33604 Bordeaux, France.	pierre.jais@chu-bordeaux.fr	Sanders, Prashanthan/D-7641-2013; Pasquié, Jean Luc/O-2216-2018	Sanders, Prashanthan/0000-0003-3803-8429; Pasquié, Jean Luc/0000-0003-3773-5804				[Anonymous], 2001, CIRCULATION, V104, P2118; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Brignole M, 1998, CIRCULATION, V98, P953, DOI 10.1161/01.CIR.98.10.953; Bubien RS, 1996, CIRCULATION, V94, P1585, DOI 10.1161/01.CIR.94.7.1585; Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056; Clark DM, 1997, J AM COLL CARDIOL, V30, P1039, DOI 10.1016/S0735-1097(97)00254-4; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; DOSHI R, 2004, AM COLL CARD ANN SCI; Ehrlich JR, 2002, J CARDIOVASC ELECTR, V13, P399, DOI 10.1046/j.1540-8167.2002.00399.x; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; Greene HL, 2003, J AM COLL CARDIOL, V42, P20, DOI 10.1016/S0735-1097(03)00559-X; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; Kanagaratnam L, 2001, PACE, V24, P1774, DOI 10.1046/j.1460-9592.2001.01774.x; Kay GN, 1998, J INTERV CARD ELECTR, V2, P121, DOI 10.1023/A:1009795330454; Leon AR, 2002, J AM COLL CARDIOL, V39, P1258, DOI 10.1016/S0735-1097(02)01779-5; MIDDLEKAUFF HR, 1991, CIRCULATION, V84, P40, DOI 10.1161/01.CIR.84.1.40; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Ozcan C, 2003, AM J CARDIOL, V92, P33, DOI 10.1016/S0002-9149(03)00460-0; Ozcan C, 2001, NEW ENGL J MED, V344, P1043, DOI 10.1056/NEJM200104053441403; Pappone C, 2001, CIRCULATION, V104, P2539, DOI 10.1161/hc4601.098517; Pedersen OD, 2001, CIRCULATION, V104, P292, DOI 10.1161/01.CIR.104.3.292; Pozzoli M, 1998, J AM COLL CARDIOL, V32, P197, DOI 10.1016/S0735-1097(98)00221-6; Redfield MM, 2000, MAYO CLIN PROC, V75, P790, DOI 10.4065/75.8.790; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Stevenson WG, 1999, NEW ENGL J MED, V341, P910, DOI 10.1056/NEJM199909163411209; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Ware J, 1994, SF 36 PHYS MENTAL SU; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	37	603	631	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2373	2383		10.1056/NEJMoa041018	http://dx.doi.org/10.1056/NEJMoa041018			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575053				2022-12-24	WOS:000225429000006
J	Vivier, E; Nunes, JA; Vely, F				Vivier, E; Nunes, JA; Vely, F			Natural killer cell signaling pathways	SCIENCE			English	Article							INHIBITORY RECEPTORS; MEDIATED CYTOTOXICITY; NK CELLS; PROTEINS; NKG2D	Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in the early defenses against foreign cells, as well as autologous cells undergoing various forms of stress, such as microbial infection or tumor transformation. NK cell activation is controlled by a dynamic balance between complementary and antagonistic pathways that are initiated upon interaction with potential target cells. NK cells express an array of activating cell surface receptors that can trigger cytolytic programs, as well as cytokine or chemokine secretion. Some of these activating cell surface receptors initiate protein tyrosine kinase (PTK)-dependent pathways through noncovalent associations with transmembrane signaling adaptors that harbor intracytoplasmic ITAMs (immunoreceptor tyrosine-based activation motifs). Additional cell surface receptors that are not directly coupled to ITAMs also participate in NK cell activation. These include NKG2D, which is noncovalently associated to the DAP10 transmembrane signaling adaptor, as well as integrins and cytokine receptors. NK cells also express cell surface inhibitory receptors that antagonize activating pathways through protein tyrosine phosphatases (PTPs). These inhibitory cell surface receptors are characterized by intracytoplasmic ITIMs (immunoreceptor tyrosine-based inhibition motifs). The tyrosine-phosphorylation status of several signaling components that are substrates for both PTKs and PTPs is thus key to the propagation of the NK cell effector pathways. Understanding the integration of these multiple signals is central to the understanding and manipulation of NK cell effector signaling pathways.	Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, F-13288 Marseille 09, France; Inst Cancerol Marseille, INSERM, UMR 599, F-13009 Marseille, France; Univ Mediterranee, Fac Pharm, INSERM, U608, F-13005 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Vivier, E (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, Campus Luminy,Case 906, F-13288 Marseille 09, France.	vivier@ciml.univ-mrs.fr	NUNES, Jacques A/F-4952-2013; Vély, Frédéric/HHM-3894-2022; Vivier, Eric/F-8939-2010	NUNES, Jacques A/0000-0003-4865-0400; Vivier, Eric/0000-0001-7022-8287; Vely, Frederic/0000-0002-1682-0949				Augugliaro R, 2003, EUR J IMMUNOL, V33, P1235, DOI 10.1002/eji.200323896; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Blery M, 1997, J BIOL CHEM, V272, P8989; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Gismondi A, 2004, BLOOD, V104, P436, DOI 10.1182/blood-2003-07-2621; Jevremovic D, 1999, J IMMUNOL, V162, P2453; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y; Perez OD, 2004, BLOOD, V104, P1083, DOI 10.1182/blood-2003-08-2652; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; VELY F, 1963, J IMMUNOL, V2075, P97; WANGE RL, 2000, SCI STKE, pRE1; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	17	479	500	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2004	306	5701					1517	1519		10.1126/science.1103478	http://dx.doi.org/10.1126/science.1103478			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567854				2022-12-24	WOS:000225442700048
J	Bowen, GJ; Beerling, DJ; Koch, PL; Zachos, JC; Quattlebaum, T				Bowen, GJ; Beerling, DJ; Koch, PL; Zachos, JC; Quattlebaum, T			A humid climate state during the Palaeocene/Eocene thermal maximum	NATURE			English	Article							CARBON-ISOTOPE COMPOSITION; MASSIVE DISSOCIATION; SEA-LEVEL; EOCENE; TEMPERATURE; MODEL; ASSIMILATION; METHANE; LEAVES; FOSSIL	An abrupt climate warming of 5 to 10 degreesC during the Palaeocene/Eocene boundary thermal maximum (PETM) 55 Myr ago is linked to the catastrophic release of similar to1,050-2,100 Gt of carbon from sea-floor methane hydrate reservoirs(1). Although atmospheric methane, and the carbon dioxide derived from its oxidation, probably contributed to PETM warming, neither the magnitude nor the timing of the climate change is consistent with direct greenhouse forcing by the carbon derived from methane hydrate. Here we demonstrate significant differences between marine(2,3) and terrestrial(4-6) carbon isotope records spanning the PETM. We use models of key carbon cycle processes(7-9) to identify the cause of these differences. Our results provide evidence for a previously unrecognized discrete shift in the state of the climate system during the PETM, characterized by large increases in mid-latitude tropospheric humidity and enhanced cycling of carbon through terrestrial ecosystems. A more humid atmosphere helps to explain PETM temperatures, but the ultimate mechanisms underlying the shift remain unknown.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of California System; University of California Santa Cruz; University of Sheffield	Bowen, GJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	gbowen@biology.utah.edu	Beerling, David J/C-2840-2009; Zachos, James C/A-7674-2008; Bowen, Gabriel J/C-1708-2008	Beerling, David J/0000-0003-1869-4314; Zachos, James C/0000-0001-8439-1886; 				BEERLING DJ, 1995, GLOB CHANGE BIOL, V1, P289, DOI 10.1111/j.1365-2486.1995.tb00027.x; Bolle MP, 2001, CLAY MINER, V36, P249, DOI 10.1180/000985501750177979; Bowen GJ, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002117; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bowen GJ., 2001, PALEOCENE EOCENE STR, P73; CERLING TE, 1984, EARTH PLANET SC LETT, V71, P229, DOI 10.1016/0012-821X(84)90089-X; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; Friedman I., 1977, DATA GEOCHEMISTRY; Granier A, 1996, GLOBAL CHANGE BIOL, V2, P265, DOI 10.1111/j.1365-2486.1996.tb00078.x; Grocke DR, 1999, GEOLOGY, V27, P155, DOI 10.1130/0091-7613(1999)027<0155:CICOLC>2.3.CO;2; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1995, PALAEOGEOGR PALAEOCL, V115, P61, DOI 10.1016/0031-0182(94)00107-J; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; MACDONALD NW, 1995, SOIL SCI SOC AM J, V59, P233, DOI 10.2136/sssaj1995.03615995005900010036x; Magioncalda R, 2004, GEOLOGY, V32, P553, DOI 10.1130/G20476.1; Renssen H, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000968; Schafer KVR, 2003, GLOBAL CHANGE BIOL, V9, P1378, DOI 10.1046/j.1365-2486.2003.00662.x; Schmidt GA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000757; Schmitz B, 2003, GEOLOGY, V31, P689, DOI 10.1130/G19527.1; Sewall JO, 2000, GLOBAL PLANET CHANGE, V26, P445, DOI 10.1016/S0921-8181(00)00056-4; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Tu TTN, 2004, PALAEOGEOGR PALAEOCL, V212, P199, DOI 10.1016/j.palaeo.2004.05.023; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	30	232	243	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					495	499		10.1038/nature03115	http://dx.doi.org/10.1038/nature03115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565152				2022-12-24	WOS:000225322100044
J	Gershon, D				Gershon, D			Probing real-time protein interactions	NATURE			English	Article																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	2004	432	7014					249	249		10.1038/432249a	http://dx.doi.org/10.1038/432249a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538375	Bronze			2022-12-24	WOS:000225020200054
J	Atkinson, A; Siegel, V; Pakhomov, E; Rothery, P				Atkinson, A; Siegel, V; Pakhomov, E; Rothery, P			Long-term decline in krill stock and increase in salps within the Southern Ocean	NATURE			English	Article							SEA-ICE EXTENT; ANTARCTIC KRILL; EUPHAUSIA-SUPERBA; ABUNDANCE; ECOSYSTEM; CARBON	Antarctic krill ( Euphausia superba) and salps ( mainly Salpa thompsoni) are major grazers in the Southern Ocean(1-4), and krill support commercial fisheries(5). Their density distributions(1,3,4,6) have been described in the period 1926 - 51, while recent localized studies(7-10) suggest short-term changes. To examine spatial and temporal changes over larger scales, we have combined all available scientific net sampling data from 1926 to 2003. This database shows that the productive southwest Atlantic sector contains > 50% of Southern Ocean krill stocks, but here their density has declined since the 1970s. Spatially, within their habitat, summer krill density correlates positively with chlorophyll concentrations. Temporally, within the southwest Atlantic, summer krill densities correlate positively with sea-ice extent the previous winter. Summer food and the extent of winter sea ice are thus key factors in the high krill densities observed in the southwest Atlantic Ocean. Krill need the summer phytoplankton blooms of this sector, where winters of extensive sea ice mean plentiful winter food from ice algae, promoting larval recruitment(7-11) and replenishing the stock. Salps, by contrast, occupy the extensive lower-productivity regions of the Southern Ocean and tolerate warmer water than krill(2-4,12). As krill densities decreased last century, salps appear to have increased in the southern part of their range. These changes have had profound effects within the Southern Ocean food web(10,13).	British Antarctic Survey, NERC, Cambridge CB3 OET, England; Sea Fisheries Res Inst, D-22767 Hamburg, Germany; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Univ Ft Hare, Fac Sci & Technol, Dept Zool, ZA-5700 Alice, South Africa; NERC, Ctr Ecol & Hydrol, Huntingdon PE28 2LS, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of British Columbia; University of Fort Hare; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Atkinson, A (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 OET, England.	aat@bas.ac.uk						Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Baker A. de C., 1954, Discovery Reports, V27, P201; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Constable AJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001270; Curran MAJ, 2003, SCIENCE, V302, P1203, DOI 10.1126/science.1087888; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Everson E., 2000, KRILL BIOL ECOLOGY F; Foxton P., 1966, Discovery Reports, V34, P1; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Hofmann EE, 1998, ANTARCT SCI, V10, P406, DOI 10.1017/S0954102098000492; Hofmann EE, 2003, DEEP-SEA RES PT II, V50, P3121, DOI 10.1016/j.dsr2.2003.07.012; LAWS RM, 1985, AM SCI, V73, P26; Le Fevre J, 1998, J MARINE SYST, V17, P325, DOI 10.1016/S0924-7963(98)00047-5; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marr J., 1962, DISCOVERY REP, V32, P33; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; MURPHY EJ, 1995, J ANIM ECOL, V64, P333, DOI 10.2307/5895; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Nicol S, 2000, CCAMLR SCI, V7, P87; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pakhomov EA, 2002, DEEP-SEA RES PT II, V49, P1881, DOI 10.1016/S0967-0645(02)00017-6; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; Quetin Langdon B., 1996, Antarctic Research Series, V70, P357; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Siegel V, 2000, CAN J FISH AQUAT SCI, V57, P151, DOI 10.1139/cjfas-57-S3-151; Smetacek V., 1990, P103; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675	30	800	866	15	413	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					100	103		10.1038/nature02996	http://dx.doi.org/10.1038/nature02996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525989				2022-12-24	WOS:000224854900048
J	Bhatt, DL; Roe, MT; Peterson, ED; Li, Y; Chen, AY; Harrington, RA; Greenbaum, AB; Berger, PB; Cannon, CP; Cohen, DJ; Gibson, CM; Saucedo, JF; Kleiman, NS; Hochman, JS; Boden, WE; Brindis, RG; Peacock, WF; Smith, SC; Pollack, CV; Gibler, WB; Ohman, EM				Bhatt, DL; Roe, MT; Peterson, ED; Li, Y; Chen, AY; Harrington, RA; Greenbaum, AB; Berger, PB; Cannon, CP; Cohen, DJ; Gibson, CM; Saucedo, JF; Kleiman, NS; Hochman, JS; Boden, WE; Brindis, RG; Peacock, WF; Smith, SC; Pollack, CV; Gibler, WB; Ohman, EM		CRUSADE Investigators	Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes - Results from the CRUSADE quality improvement initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLATELET GLYCOPROTEIN IIB/IIIA; ACUTE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; ARTERY-DISEASE; ACC/AHA GUIDELINES; HEART-ASSOCIATION; ELDERLY-PATIENTS; TRIAL; CARE; ANGIOGRAPHY	Context The American College of Cardiology/American Heart Association (ACC/ AHA) guidelines for the management of non-ST-segment elevation acute coronary syndromes (NSTE ACS) recommend early invasive management for high-risk patients, given the benefits with this approach demonstrated in randomized clinical trials. Objectives To determine the use and predictors of early invasive management strategies (cardiac catheterization <48 hours following presentation) in high-risk patients with NSTE ACS and to examine the association of early invasive management with mortality. Design, Setting, and Patients The CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Quality Improvement Initiative evaluated care patterns and outcomes for 17926 high-risk NSTE ACS patients (positive cardiac markers and/or ischemic electrocardiographic changes) based on ACC/AHA guidelines recommendations at 248 US hospitals with catheterization and revascularization facilities between March 2000 and September 2002. Main Outcome Measures Use of early invasive management within 48 hours of presentation, predictors of early invasive management, and in-hospital mortality. Results Of the 17926 patients analyzed, 8037 (44.8%) underwent early cardiac catheterization less than 48 hours following presentation. Predictors of early invasive management included cardiology care, younger age, lack of prior or current congestive heart failure, lack of renal insufficiency, ischemic electrocardiographic changes, positive cardiac markers, white race, and male sex. Patients treated with early invasive management were more likely to be treated with medications and interventions recommended by the ACC/AHA guidelines and had a lower risk of in-hospital mortality after adjusting for differences in clinical characteristics and after comparing propensity-matched pairs (2.5% vs 3.7%, P<.001). Conclusions An early invasive management strategy is not utilized in the majority of high-risk patients with NSTE ACS. This strategy appears to be reserved for patients without significant comorbidities and those cared for by cardiologists and is associated with a lower risk of in-hospital mortality.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Duke Clin Res Inst, Durham, NC USA; Henry Ford Heart & Vasc Inst, Detroit, MI USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, TIMI Study Grp, Boston, MA USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Baylor Coll Med, Houston, TX 77030 USA; NYU, Sch Med, New York, NY USA; Univ Connecticut, Hartford, CT 06112 USA; Kaiser Permanente Hlth Syst, San Francisco, CA USA; Univ N Carolina, Chapel Hill, NC USA; Penn Hosp, Philadelphia, PA 19107 USA; Univ Cincinnati, Cincinnati, OH USA	Cleveland Clinic Foundation; Duke University; Henry Ford Health System; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oklahoma System; University of Oklahoma Health Sciences Center; Baylor College of Medicine; New York University; University of Connecticut; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; University of Cincinnati	Bhatt, DL (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	bhattd@ccf.org	Peterson, Eric David/ABF-5033-2021; Gibson, C. Michael/AAE-8212-2019	Hochman, Judith/0000-0002-5889-5981				Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Bassand JP, 2000, EUR HEART J, V21, P1289, DOI 10.1053/euhj.2000.2256; Bavry AA, 2004, AM J CARDIOL, V93, P830, DOI 10.1016/j.amjcard.2003.12.019; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Cho L, 2003, AM J MED, V114, P106, DOI 10.1016/S0002-9343(02)01446-8; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Denton TA, 2003, ANN THORAC SURG, V75, P758, DOI 10.1016/S0003-4975(02)04885-3; Garg PP, 2002, MED CARE, V40, P614, DOI 10.1097/00005650-200207000-00008; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Januzzi JL, 2002, AM J CARDIOL, V90, P1246, DOI 10.1016/S0002-9149(02)02844-8; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Keeley EC, 2003, AM J CARDIOL, V92, P509, DOI 10.1016/S0002-9149(03)00716-1; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Parsons, 2001, P 26 ANN SAS US GROU; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Pollack CV, 2003, ANN EMERG MED, V41, P355, DOI 10.1067/mem.2003.88; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sabatine MS, 2004, CIRCULATION, V109, P874, DOI 10.1161/01.CIR.0000112604.74713.35; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sharis PJ, 2002, AM J CARDIOL, V90, P1154, DOI 10.1016/S0002-9149(02)02788-1; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 2003, CIRCULATION, V107, P1463, DOI 10.1161/01.CIR.0000063680.45780.A0; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Yusuf S, 2001, NEW ENGL J MED, V345, P494	36	447	469	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2004	292	17					2096	2104		10.1001/jama.292.17.2096	http://dx.doi.org/10.1001/jama.292.17.2096			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868OC	15523070	Bronze			2022-12-24	WOS:000224921900022
J	Zimetbaum, P; Josephson, ME				Zimetbaum, P; Josephson, ME			Is there a role for maintaining sinus rhythm in patients with atrial fibrillation?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TORSADE-DE-POINTES; QUALITY-OF-LIFE; RANDOMIZED-TRIAL; DUAL-CHAMBER; FOLLOW-UP; CATHETER ABLATION; ELDERLY-PATIENTS; MANAGEMENT; THERAPY; AMIODARONE	Recent studies have indicated that outcomes in patients with atrial fibrillation who are managed with rate control and anticoagulation are similar to those in patients who have maintenance of sinus rhythm. These studies did not include important groups of patients with atrial fibrillation in whom antiarrhythmic therapy may be appropriate. This perspective argues for the maintenance of sinus rhythm and for the use of antiarrhythmic therapy that includes medications, invasive procedures, and a combination of both in appropriate patients.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Zimetbaum, P (corresponding author), Beth Israel Deaconess Med Ctr, 185 Pilgram Rd, Boston, MA 02215 USA.							Andersen HR, 1997, LANCET, V350, P1210, DOI 10.1016/S0140-6736(97)03425-9; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; CRIJNS HJ, 1988, AM J CARDIOL, V62, P1303, DOI 10.1016/0002-9149(88)90282-2; Essebag V, 2003, J AM COLL CARDIOL, V41, P249, DOI 10.1016/S0735-1097(02)02709-2; Franz MR, 1997, J AM COLL CARDIOL, V30, P1785, DOI 10.1016/S0735-1097(97)00385-9; Friedman PL, 1998, AM J CARDIOL, V82, p50N, DOI 10.1016/S0002-9149(98)00586-4; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldschlager N, 2000, ARCH INTERN MED, V160, P1741, DOI 10.1001/archinte.160.12.1741; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hauser TH, 2003, AM J CARDIOL, V91, P1437, DOI 10.1016/S0002-9149(03)00395-3; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; HOHNLOSER SH, 1994, ANN INTERN MED, V121, P529, DOI 10.7326/0003-4819-121-7-199410010-00009; Huang DT, 1998, J CARDIOVASC ELECTR, V9, P462, DOI 10.1111/j.1540-8167.1998.tb01837.x; KERR CR, 2002, PACE, V25, P553; Kochiadakis GE, 1999, J AM COLL CARDIOL, V33, P966, DOI 10.1016/S0735-1097(98)00678-0; Kochiadakis GE, 1999, AM J CARDIOL, V83, P58, DOI 10.1016/S0002-9149(98)00783-8; Kondo N, 2003, ANN THORAC SURG, V75, P1490, DOI 10.1016/S0003-4975(02)04900-7; Kowey PR, 2003, AM J CARDIOL, V91, p33D, DOI 10.1016/S0002-9149(02)03377-5; Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040; Lamas GA, 1998, NEW ENGL J MED, V338, P1097, DOI 10.1056/NEJM199804163381602; Lee MA, 2003, J AM COLL CARDIOL, V41, P1926, DOI 10.1016/S0735-1097(03)00426-1; McNamara RL, 2003, ANN INTERN MED, V139, P1018, DOI 10.7326/0003-4819-139-12-200312160-00012; Natale A, 2000, J AM COLL CARDIOL, V35, P1898, DOI 10.1016/S0735-1097(00)00635-5; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Pappone C, 2004, CIRCULATION, V109, P2724, DOI 10.1161/01.CIR.0000131866.44650.46; Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Saad EB, 2003, ANN INTERN MED, V138, P634, DOI 10.7326/0003-4819-138-8-200304150-00010; SALATA JJ, 1995, CIRC RES, V76, P110, DOI 10.1161/01.RES.76.1.110; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Stabile G, 2001, J AM COLL CARDIOL, V37, P1639, DOI 10.1016/S0735-1097(01)01214-1; Steinberg JS, 2004, CIRCULATION, V109, P1973, DOI 10.1161/01.CIR.0000118472.77237.FA; STEVENSON WG, 1985, PACE, V8, P528, DOI 10.1111/j.1540-8159.1985.tb05854.x; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Tieleman RG, 1997, AM J CARDIOL, V79, P53, DOI 10.1016/S0002-9149(96)00675-3; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; VanGelder IC, 1996, ARCH INTERN MED, V156, P2585, DOI 10.1001/archinte.156.22.2585; Weerasooriya R, 2003, J AM COLL CARDIOL, V41, P1697, DOI 10.1016/S0735-1097(03)00338-3; Wijffels MCEF, 2003, J CARDIOVASC ELECTR, V14, pS40, DOI 10.1046/j.1540-8167.14.s9.20.x; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Yang T, 1996, CIRCULATION, V93, P407, DOI 10.1161/01.CIR.93.3.407; Zimetbaum P, 2001, Heart Dis, V3, P148, DOI 10.1097/00132580-200105000-00004; Zimetbaum P, 2003, AM J CARDIOL, V91, P81, DOI 10.1016/S0002-9149(02)03004-7; 2001, CIRCULATION, V104, P2990; 2003, J AM COLL CARDIOL, V42, P20, DOI DOI 10.1016/S0735-1097(03)00559-X	56	11	12	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2004	141	9					720	726		10.7326/0003-4819-141-9-200411020-00015	http://dx.doi.org/10.7326/0003-4819-141-9-200411020-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867JT	15520430				2022-12-24	WOS:000224839600010
J	Peeling, RW; Mabey, D; Fitzgerald, DW; Watson-Jones, D				Peeling, RW; Mabey, D; Fitzgerald, DW; Watson-Jones, D			Avoiding HIV and dying of syphilis	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; CONGENITAL-SYPHILIS; ANTENATAL SYPHILIS; COST-EFFECTIVENESS; PREGNANCY; HAITI; TRANSMISSION; EXPERIENCE; NEVIRAPINE; TANZANIA		WHO, WHO Special Programme Res & Training Trop Dis, UNICEF UNDP World Bank, Diagnost Res & Dev, CH-1211 Geneva 27, Switzerland; London Sch Hyg & Trop Med, London WC1, England; Grp Haitien Etud Sarcome Kaposi & Infect Opportun, Port Au Prince, Haiti	The World Bank; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Peeling, RW (corresponding author), WHO, WHO Special Programme Res & Training Trop Dis, UNICEF UNDP World Bank, Diagnost Res & Dev, CH-1211 Geneva 27, Switzerland.	peelingr@who.int		Mabey, David/0000-0002-0031-8276				Fitzgerald D W, 1998, Int J Infect Dis, V2, P127, DOI 10.1016/S1201-9712(98)90113-8; Fitzgerald DW, 2003, AM J PUBLIC HEALTH, V93, P444, DOI 10.2105/AJPH.93.3.444; *GLOB FOR HLTH RES, 2004, 10 90 REP HLTH RES 2, P23; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; HIRA SK, 1990, GENITOURIN MED, V66, P159; Hook EW, 2002, SEX TRANSM DIS, V29, P486, DOI 10.1097/00007435-200208000-00010; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Oliff M, 2003, REPROD HEALTH MATTER, V11, P37, DOI 10.1016/S096-88080(03)02174-8; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; Peeling RW, 2004, B WORLD HEALTH ORGAN, V82, P439; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; SCHULZ KF, 1987, GENITOURIN MED, V63, P320; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Temmerman M, 1999, INT J STD AIDS, V10, P405, DOI 10.1258/0956462991914339; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNICEF, 2002, MOTH TO CHILD TRANSM; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; *WHO UNICEF, 2004, FAR MOR PREGN WOM GE; World Bank, 1993, WORLD DEV REP 1993 I; World Health Organisation (WHO), SEX TRANSM DIS DIAGN	22	49	51	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 30	2004	364	9445					1561	1563		10.1016/S0140-6736(04)17327-3	http://dx.doi.org/10.1016/S0140-6736(04)17327-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	866IQ	15519615				2022-12-24	WOS:000224767600006
J	Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; Kuehn, N; Gray, A; Giddings, J; Peskett, E; Fox, R; Bruce, I; Walker, C; Sawyer, C; Okkenhaug, K; Finan, P; Vanhaesebroeck, B				Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; Kuehn, N; Gray, A; Giddings, J; Peskett, E; Fox, R; Bruce, I; Walker, C; Sawyer, C; Okkenhaug, K; Finan, P; Vanhaesebroeck, B			Essential role for the p110 delta phosphoinositide 3-kinase in the allergic response	NATURE			English	Article							FC-EPSILON-RI; INCREASED INSULIN SENSITIVITY; MAST-CELL ACTIVATION; MICE LACKING; P85-ALPHA SUBUNIT; P110 DELTA; KIT; DIFFERENTIATION; HYPOGLYCEMIA; SURVIVAL	Inflammatory substances released by mast cells induce and maintain the allergic response(1,2). Mast cell differentiation and activation are regulated, respectively, by stem cell factor (SCF; also known as Kit ligand) and by allergen in complex with allergen-specific immunoglobulin E (IgE)(2,3). Activated SCF receptors and high-affinity receptors for IgE (FcepsilonRI) engage phosphoinositide 3-kinases (PI(3)Ks) to generate intracellular lipid second messenger signals(2-5). Here, we report that genetic or pharmacological inactivation of the p110delta isoform of PI(3) K in mast cells leads to defective SCF-mediated in vitro proliferation, adhesion and migration, and to impaired allergen-IgE-induced degranulation and cytokine release. Inactivation of p110delta protects mice against anaphylactic allergic responses. These results identify p110delta as a new target for therapeutic intervention in allergy and mast-cell-related pathologies.	Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; Frimorfo, CH-1705 Fribourg, Switzerland; Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland	Ludwig Institute for Cancer Research; University of London; University College London; Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Dundee	Vanhaesebroeck, B (corresponding author), Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.	bartvanh@ludwig.ucl.ac.uk	Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Pearce, Wayne/0000-0001-5407-4767; Thomas, Matthew/0000-0003-3472-3904; Peskett, Emma/0000-0002-0978-5401; Box, Carol/0000-0002-8919-8724; Gray, Alexander/0000-0001-9227-0363; BILANCIO, Antonio/0000-0002-5118-3359	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000850] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Besmer P, 1991, CURR OPIN CELL BIOL, V3, P939, DOI 10.1016/0955-0674(91)90111-B; Campbell E, 1999, AM J PATHOL, V154, P1259, DOI 10.1016/S0002-9440(10)65377-1; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Chen D, 2004, MOL CELL BIOL, V24, P320, DOI 10.1128/MCB.24.1.320-329.2004; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Fukao T, 2003, J MOL MED, V81, P524, DOI 10.1007/s00109-003-0475-2; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hinton HJ, 1999, J IMMUNOL, V162, P7002; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Okayama Y, 2003, EUR J IMMUNOL, V33, P1450, DOI 10.1002/eji.200323563; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Rivera J, 2002, MOL IMMUNOL, V38, P1253, DOI 10.1016/S0161-5890(02)00072-X; Sadhu C, 2003, BIOCHEM BIOPH RES CO, V308, P764, DOI 10.1016/S0006-291X(03)01480-3; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Tan BL, 2003, BLOOD, V101, P4725, DOI 10.1182/blood-2002-08-2521; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Tilley SL, 2000, J CLIN INVEST, V105, P361, DOI 10.1172/JCI8253; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9	30	336	413	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					1007	1011		10.1038/nature02991	http://dx.doi.org/10.1038/nature02991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496927	Bronze			2022-12-24	WOS:000224585600049
J	FitzGerald, GA				FitzGerald, GA			Coxibs and cardiovascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPEUTIC ARTHRITIS RESEARCH; RANDOMIZED CONTROLLED-TRIAL; LUMIRACOXIB; IBUPROFEN; NAPROXEN; TARGET; COX-2		Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.		FitzGerald, Garret A/A-4222-2010					Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1	5	676	719	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1709	1711		10.1056/NEJMp048288	http://dx.doi.org/10.1056/NEJMp048288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15470192				2022-12-24	WOS:000224585200002
J	Yamamoto, KR				Yamamoto, KR			Bankrolling stem-cell research with California dollars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1711	1713		10.1056/NEJMp048224	http://dx.doi.org/10.1056/NEJMp048224			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863TH	15496617				2022-12-24	WOS:000224585200003
J	Martin, MD				Martin, MD			Shower time	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Martin, MD (corresponding author), 2901 Montopolis Dr, Austin, TX 78741 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2004	141	8					647	647		10.7326/0003-4819-141-8-200410190-00017	http://dx.doi.org/10.7326/0003-4819-141-8-200410190-00017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864SD	15492347				2022-12-24	WOS:000224652300011
J	Grima, B; Chelot, E; Xia, RH; Rouyer, F				Grima, B; Chelot, E; Xia, RH; Rouyer, F			Morning and evening peaks of activity rely on different clock neurons of the Drosophila brain	NATURE			English	Article							CIRCADIAN PACEMAKER CELLS; BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; PERIOD; GENE; MELANOGASTER; OSCILLATIONS; NEUROPEPTIDE; PROJECTIONS; MUTATION	In Drosophila, a 'clock' situated in the brain controls circadian rhythms of locomotor activity. This clock relies on several groups of neurons that express the Period ( PER) protein, including the ventral lateral neurons (LN(v)s), which express the Pigment-dispersing factor (PDF) neuropeptide, and the PDF-negative dorsal lateral neurons (LN(d)s)(1). In normal cycles of day and night, adult flies exhibit morning and evening peaks of activity(1,2); however, the contribution of the different clock neurons to the rest activity pattern remains unknown. Here, we have used targeted expression of PER to restore the clock function of specific subsets of lateral neurons in arrhythmic per 0 mutant flies. We show that PER expression restricted to the LNvs only restores the morning activity, whereas expression of PER in both the LNvs and LNds also restores the evening activity. This provides the first neuronal bases for 'morning' and 'evening' oscillators in the Drosophila brain. Furthermore, we show that the LNvs alone can generate 24 h activity rhythms in constant darkness, indicating that the morning oscillator is sufficient to drive the circadian system.	CNRS, UPR 2216, NGI, Inst Neurobiol Alfred Fessard, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rouyer, F (corresponding author), CNRS, UPR 2216, NGI, Inst Neurobiol Alfred Fessard, Av Terrasse, F-91198 Gif Sur Yvette, France.	rouyer@iaf.cnrs-gif.fr	Rouyer, François/L-9043-2018	Rouyer, François/0000-0001-5641-397X				Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Cheng YZ, 1998, J NEUROSCI, V18, P741; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; HALLIBURTON IW, 1980, J GEN VIROL, V48, P1, DOI 10.1099/0022-1317-48-1-1; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Klarsfeld A, 2003, BEHAV PROCESS, V64, P161, DOI 10.1016/S0376-6357(03)00133-5; Malpel S, 2002, DEVELOPMENT, V129, P1443; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011	21	484	495	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					869	873		10.1038/nature02935	http://dx.doi.org/10.1038/nature02935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483616				2022-12-24	WOS:000224435500052
J	Heekeren, HR; Marrett, S; Bandettini, PA; Ungerleider, LG				Heekeren, HR; Marrett, S; Bandettini, PA; Ungerleider, LG			A general mechanism for perceptual decision-making in the human brain	NATURE			English	Article							HUMAN EXTRASTRIATE CORTEX; PREFRONTAL CORTEX; NEURAL BASIS; REPRESENTATION; ATTENTION; OBJECTS; MICROSTIMULATION; MEMORY; FACES; AREA	Findings from single-cell recording studies suggest that a comparison of the outputs of different pools of selectively tuned lower-level sensory neurons may be a general mechanism by which higher-level brain regions compute perceptual decisions. For example, when monkeys must decide whether a noisy field of dots is moving upward or downward, a decision can be formed by computing the difference in responses between lower-level neurons sensitive to upward motion and those sensitive to downward motion(1-4). Here we use functional magnetic resonance imaging and a categorization task in which subjects decide whether an image presented is a face or a house to test whether a similar mechanism is also at work for more complex decisions in the human brain and, if so, where in the brain this computation might be performed. Activity within the left dorsolateral prefrontal cortex is greater during easy decisions than during difficult decisions, covaries with the difference signal between face- and house-selective regions in the ventral temporal cortex, and predicts behavioural performance in the categorization task. These findings show that even for complex object categories, the comparison of the outputs of different pools of selectively tuned neurons could be a general mechanism by which the human brain computes perceptual decisions.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; NIMH, Funct MRI Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Heekeren, HR (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	hauke@nih.gov	Bandettini, Peter A./F-5871-2012; Heekeren, Hauke/B-7739-2008	Heekeren, Hauke/0000-0001-7912-6826; Marrett, Sean/0000-0001-8179-6511	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002783, ZIAMH002035, Z01MH002035, Z01MH002783] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEEKEREN HR, 2002, SOC NEUR ABSTR; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Pessoa L, 2003, J NEUROSCI, V23, P3990; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Sharma J, 2003, SCIENCE, V300, P1758, DOI 10.1126/science.1081721; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	31	506	512	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					859	862		10.1038/nature02966	http://dx.doi.org/10.1038/nature02966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483614				2022-12-24	WOS:000224435500050
J	Gershengorn, MC; Hardikar, AA; Wei, CJ; Geras-Raaka, E; Marcus-Samuels, B; Raaka, BM				Gershengorn, MC; Hardikar, AA; Wei, CJ; Geras-Raaka, E; Marcus-Samuels, B; Raaka, BM			Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells	SCIENCE			English	Article							INSULIN-PRODUCING CELLS; PANCREATIC BETA-CELLS; ADULT-MOUSE PANCREAS; IN-VITRO; STEM-CELLS; DIABETES-MELLITUS; PROGENITOR CELLS; DIFFERENTIATION; GENE; LINEAGES	Insulin-expressing beta cells, found in pancreatic islets, are capable of generating more beta cells even in the adult. We show that fibroblast-like cells derived from adult human islets donated postmortem proliferate readily in vitro. These mesenchymal-type cells, which exhibit no hormone expression, can then be induced to differentiate into hormone-expressing islet-like cell aggregates, which reestablishes the epithelial character typical of islet cells. Immunohistochemistry, in situ hybridization, and messenger RNA measurements in single cells and cell populations establish the transition of epithelial. cells within islets to mesenchymal cells in culture and then to insulin-expressing epithelial, cells.	NIDDKD, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gershengorn, MC (corresponding author), NIDDKD, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA.	marving@intra.niddk.nih.gov	Hardikar, Anandwardhan/ACF-7730-2022	Wei, Chiju/0000-0003-1551-5931	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK011007, ZIADK011007] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham EJ, 2002, ENDOCRINOLOGY, V143, P3152, DOI 10.1210/en.143.8.3152; Beattie GM, 1999, DIABETES, V48, P1013, DOI 10.2337/diabetes.48.5.1013; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bonner-Weir S, 2002, J PATHOL, V197, P519, DOI 10.1002/path.1158; Bouckenooghe T, 2003, CELL TRANSPLANT, V12, P799, DOI 10.3727/000000003108747271; Cornelius JG, 1997, HORM METAB RES, V29, P271, DOI 10.1055/s-2007-979036; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; GERSHENGORN MC, UNPUB; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Hay ED, 1995, ACTA ANAT, V154, P8; Herrera PL, 2002, INT J DEV BIOL, V46, P97; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Lechner A, 2003, AM J PHYSIOL-ENDOC M, V284, pE259, DOI 10.1152/ajpendo.00393.2002; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Rajagopal J, 2003, SCIENCE, V299, P363; Ramiya VK, 2000, NAT MED, V6, P278; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Soria B, 2001, DIFFERENTIATION, V68, P205, DOI 10.1046/j.1432-0436.2001.680408.x; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsukita S, 2000, ANN NY ACAD SCI, V915, P129, DOI 10.1111/j.1749-6632.2000.tb05235.x; WELSH M, 1985, J BIOL CHEM, V260, P3590; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521; Zwillich T, 2000, SCIENCE, V289, P531, DOI 10.1126/science.289.5479.531	27	347	406	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2261	2264		10.1126/science.1101968	http://dx.doi.org/10.1126/science.1101968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15564314	Green Published			2022-12-24	WOS:000225950000048
J	McMichael, AJ; Butler, CD				McMichael, AJ; Butler, CD			Climate change, health, and development goals	LANCET			English	Editorial Material									Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Butler, Colin D./H-2267-2019	Butler, Colin D./0000-0002-2942-5294				Birdsall N., 2001, POPULATION MATTERS; *INT PAN CLIM CHAN, 2001, 3 INT PAN CLIM CHANG, V1; Loh J., 2004, LIVING PLANET REPORT; Schellnhuber HJ, 2002, GLOB CHANGE IGBP SER, P151; SIMMS A, 2004, WORKING GROUP CLIMAT; WALTER J, 2002, END DEV GLOBAL WARMI; *WSSD, 2002, MILL DEV GOALS	7	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2004	2006		10.1016/S0140-6736(04)17529-6	http://dx.doi.org/10.1016/S0140-6736(04)17529-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582047				2022-12-24	WOS:000225495700009
J	Haferkamp, I; Schmitz-Esser, S; Linka, N; Urbany, C; Collingro, A; Wagner, M; Horn, M; Neuhaus, HE				Haferkamp, I; Schmitz-Esser, S; Linka, N; Urbany, C; Collingro, A; Wagner, M; Horn, M; Neuhaus, HE			A candidate NAD(+) transporter in an intracellular bacterial symbiont related to Chlamydiae	NATURE			English	Article							PLASTIDIC ATP/ADP TRANSPORTER; RICKETTSIA-PROWAZEKII; ADENINE-NUCLEOTIDE; ENDOSYMBIONTS; PERMEABILITY; ARABIDOPSIS; EXPRESSION; PROTEINS	Bacteria living within eukaryotic cells can be essential for the survival or reproduction of the host(1,2) but in other cases are among the most successful pathogens(3,4). Environmental Chlamydiae, including strain UWE25, thrive as obligate intracellular symbionts within protozoa; are recently discovered relatives of major bacterial pathogens of humans; and also infect human cells(4-7). Genome analysis of UWE25 predicted that this symbiont is unable to synthesize the universal electron carrier nicotinamide adenine dinucleotide (NAD(+))(7). Compensation of limited biosynthetic capacity in intracellular bacteria is usually achieved by import of primary metabolites(8-11). Here, we report the identification of a candidate transporter protein from UWE25 that is highly specific for import of NAD(+) when synthesized heterologously in Escherichia coli. The discovery of this candidate NAD(+)/ADP exchanger demonstrates that intact NAD(+) molecules can be transported through cytoplasmic membranes. This protein acts together with a newly discovered nucleotide transporter and an ATP/ADP translocase(12), and allows UWE25 to exploit its host cell by means of a sophisticated metabolic parasitism.	Univ Kaiserslautern, D-67653 Kaiserslautern, Germany; Univ Vienna, Inst Okol & Nat Schutz, Abt Mikrobielle Okol, A-1090 Vienna, Austria	University of Kaiserslautern; University of Vienna	Neuhaus, HE (corresponding author), Univ Kaiserslautern, D-67653 Kaiserslautern, Germany.	neuhaus@rhrk.uni-kl.de	Collingro, Astrid/ABA-2082-2021; Schmitz-Esser, Stephan/AAA-7287-2019; Wagner, Michael/A-7801-2011; Horn, Matthias/G-1136-2011	Collingro, Astrid/0000-0002-4100-832X; Schmitz-Esser, Stephan/0000-0002-1907-0709; Wagner, Michael/0000-0002-9778-7684; Horn, Matthias/0000-0002-8309-5855; Linka, Nicole/0000-0002-1400-717X				ATKINSON WH, 1989, J BACTERIOL, V171, P761, DOI 10.1128/jb.171.2.761-766.1989; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Fritsche TR, 2000, APPL ENVIRON MICROB, V66, P2613, DOI 10.1128/AEM.66.6.2613-2619.2000; GAUTOM RK, 1995, J EUKARYOT MICROBIOL, V42, P452, DOI 10.1111/j.1550-7408.1995.tb05890.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; Hofmann K., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; KRAUSE DC, 1985, P NATL ACAD SCI USA, V82, P3015, DOI 10.1073/pnas.82.9.3015; Linka N, 2003, GENE, V306, P27, DOI 10.1016/S0378-1119(03)00429-3; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAHONY JB, 2003, MANUAL CLIN MICROBIO, P991; MANGOLD HK, 1967, DUNNSCHICHT CHROMATO, P749; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Moulder J. W., 1962, BIOCH INTRACELLULAR; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; WINKLER HH, 1976, J BIOL CHEM, V251, P389; Zhang QH, 2002, SCIENCE, V295, P1895	27	84	86	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					622	625		10.1038/nature03131	http://dx.doi.org/10.1038/nature03131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577910				2022-12-24	WOS:000225433200046
J	Feng, L; Gell, DA; Zhou, SP; Gu, LC; Kong, Y; Li, JQ; Hu, M; Yan, N; Lee, C; Rich, AM; Armstrong, RS; Lay, PA; Gow, AJ; Weiss, MJ; Mackay, JP; Shi, YG				Feng, L; Gell, DA; Zhou, SP; Gu, LC; Kong, Y; Li, JQ; Hu, M; Yan, N; Lee, C; Rich, AM; Armstrong, RS; Lay, PA; Gow, AJ; Weiss, MJ; Mackay, JP; Shi, YG			Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin	CELL			English	Article							CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; NMR STRUCTURE; PROTEIN; CYTOGLOBIN; GLOBIN; OXIDATION; INSIGHTS; PROGRAM; BLOOD	Hemoglobin A (HbA), the oxygen delivery system in humans, comprises two a and two beta subunits. Free alpha-hemoglobin (alphaHb) is unstable, and its precipitation contributes to the pathophysiology of beta thalassemia. In erythrocytes, the alpha-hemoglobin stabilizing protein (AHSP) binds aft and inhibits its precipitation. The crystal structure of AHSP bound to Fe(II)-alphaHb reveals that AHSP specifically recognizes the G and H helices of alphaHb through a hydrophobic interface that largely recapitulates the alpha(1)-beta(1) interface of hemoglobin. The AHSP-alphaHb interactions are extensive but suboptimal, explaining why beta-hemoglobin can competitively displace AHSP to form HbA. Remarkably, the Fe(II)-heme group in AHSP bound aft is coordinated by the distal but not the proximal histidine. Importantly, binding to AHSP facilitates the conversion of oxy-alphaHb to a deoxygenated, oxidized [Fe(III)], nonreactive form in which all six coordinate positions are occupied. These observations reveal the molecular mechanisms by which AHSP stabilizes free alphaHb.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Sydney, Sch Chem, Ctr Heavy Met Res, Sydney, NSW 2006, Australia; Univ Sydney, Sch Chem, Ctr Struct Biol & Struct Chem, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Sydney; Princeton University; University of Sydney; University of Sydney	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	weissmi@email.chop.edu; j.mackay@mmb.usyd.edu.au; yshi@molbio.princeton.edu	Weiss, Mitchell J/A-1245-2013; Lay, Peter A/B-4698-2014; Gow, Andrew/N-8566-2013; Weiss, Mitchell J/W-9814-2018; Gow, Andrew/AAR-2309-2020; Mackay, Joel/D-6834-2011	Lay, Peter A/0000-0002-3232-2720; Gow, Andrew/0000-0003-0876-5158; Weiss, Mitchell J/0000-0003-2460-3036; Gow, Andrew/0000-0003-0876-5158; Mackay, Joel/0000-0001-7508-8033; Gell, David/0000-0003-0382-1181; Shi, Yigong/0000-0003-2030-168X	NIDDK NIH HHS [R01 DK061692] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; BAGLIONI C, 1967, EUR J BIOCHEM, V2, P480, DOI 10.1111/j.1432-1033.1967.tb00162.x; BAGLIONI C, 1966, BIBL HAEMATOL, V29, P1056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNN HF, 1987, BLOOD, V69, P1; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Deane H., 1902, RECORDS GEOLOGICAL S, V1, P15; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; FERMI G, 1981, ATLAS MOL STRUCTURE; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; GODDARD TD, 2004, SPARKY 3 11 COMPUTER; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Naito NR, 2001, BIOCHEMISTRY-US, V40, P2060, DOI 10.1021/bi0021028; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Rachmilewitz EA, 2001, DISORDERS HEMOGLOBIN, P233; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; SPIRO TG, 1976, J AM CHEM SOC, V98, P5482, DOI 10.1021/ja00434a013; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Vitagliano L, 2004, EUR J BIOCHEM, V271, P1651, DOI 10.1111/j.1432-1033.2004.04054.x; VULSTER GW, 1993, J AM CHEM SOC, V115, P7772	38	124	131	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					629	640		10.1016/j.cell.2004.11.025	http://dx.doi.org/10.1016/j.cell.2004.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550245	Bronze			2022-12-24	WOS:000225389500009
J	Saito, H; Kubota, M; Roberts, RW; Chi, QY; Matsunami, H				Saito, H; Kubota, M; Roberts, RW; Chi, QY; Matsunami, H			RTP family members induce functional expression of mammalian odorant receptors	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; HUMAN OLFACTORY RECEPTOR; TASTE RECEPTORS; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; MULTIGENE FAMILY; BINDING PROTEIN; CELL-TYPE; MOUSE; IDENTIFICATION	Transport of G protein-coupled receptors (GPCRs) to the cell surface membrane is critical in order for the receptors to recognize their ligands. However, mammalian GPCR odorant receptors (ORs), when heterologously expressed in cells, are poorly expressed on the cell surface. Here we show that the transmembrane proteins RTP1 and RTP2 promote functional cell surface expression of ORs expressed in HEK293T cells. Genes encoding these proteins are expressed specifically in olfactory neurons. These proteins are associated with OR proteins and enhance the OR responses to odorants. Similar although weaker effects were seen with a third protein, REEP1. These findings suggest that RTP1 and RTP2 in particular play significant roles in the translocation of ORs to the plasma membrane as well as in the functioning of ORs. We have used this approach to identify active odorant ligands for ORs, providing a platform for screening the chemical selectivity of the large OR family.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Matsunami, H (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Res Dr, Durham, NC 27710 USA.	hiroaki.matsunami@duke.edu			NIDCD NIH HHS [DC05782] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005782] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen CN, 2002, PLANT MOL BIOL, V49, P633, DOI 10.1023/A:1015593715144; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gaillard I, 2002, EUR J NEUROSCI, V15, P409, DOI 10.1046/j.0953-816x.2001.01871.x; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hatt H, 1999, CELL MOL BIOL, V45, P285; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hurt CM, 2000, J BIOL CHEM, V275, P35424, DOI 10.1074/jbc.M006241200; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Katada S, 2004, J NEUROCHEM, V90, P1453, DOI 10.1111/j.1471-4159.2004.02619.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; McClintock TS, 2003, NEUROREPORT, V14, P1547, DOI 10.1097/00001756-200308260-00001; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Murrell JR, 1999, J NEUROSCI, V19, P8260; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zozulya S, 2001, GENOME BIOL, V2	65	428	476	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					679	691		10.1016/j.cell.2004.11.021	http://dx.doi.org/10.1016/j.cell.2004.11.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550249	Bronze			2022-12-24	WOS:000225389500013
J	Bornebroek, M; Kumar-Singh, S				Bornebroek, M; Kumar-Singh, S			A novel drug target in Alzheimer's disease	LANCET			English	Editorial Material							BETA-SECRETASE ACTIVITY; THERAPEUTICS; BACE		Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Univ Antwerp VIB, Dept Mol Genet, Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Flanders Institute for Biotechnology (VIB); University of Antwerp	Bornebroek, M (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands.	m.bornebroek@erasmusmc.nl	Kumar-Singh, Samir/G-6280-2012	Kumar-Singh, Samir/0000-0001-9466-6732				Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Cruts M, 2001, NEUROSCI LETT, V313, P105, DOI 10.1016/S0304-3940(01)02234-0; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Kumar-Singh S, 2002, AM J PATHOL, V161, P507, DOI 10.1016/S0002-9440(10)64207-1; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lobo A, 2000, NEUROLOGY, V54, pS4; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5	12	5	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2004	364	9447					1738	1739		10.1016/S0140-6736(04)17415-1	http://dx.doi.org/10.1016/S0140-6736(04)17415-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PQ	15541434				2022-12-24	WOS:000225070600008
J	Hoffman, HM; Rosengren, S; Boyle, DL; Cho, JY; Nayar, J; Mueller, JL; Anderson, JP; Wanderer, AA; Firestein, GS				Hoffman, HM; Rosengren, S; Boyle, DL; Cho, JY; Nayar, J; Mueller, JL; Anderson, JP; Wanderer, AA; Firestein, GS			Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist	LANCET			English	Article							NF-KAPPA-B; PYRIN; GENE; MUTATIONS; CIAS1; FEVER; ACTIVATION; PHENOTYPE; URTICARIA; DEAFNESS	Background Familial cold autoinflammatory syndrome (FCAS) is an autosomal dominant disorder characterised by recurrent episodes of rash, arthralgia, and fever after cold exposure. The genetic basis of this disease has been elucidated. Cryopyrin, the protein that is altered in FCAS, is one of the adaptor proteins that activate caspase 1, resulting in release of interleukin 1. Methods An experimental cold challenge protocol was developed to study the acute inflammatory mechanisms occurring after a general cold exposure in FCAS patients and to investigate the effects of pretreatment with an antagonist of interleukin 1 receptor (IL-1Ra). ELISA, real-time PCR, and immunohistochemistry were used to measure cytokine responses. Findings After cold challenge, untreated patients with FCAS developed rash, fever, and arthralgias within 1-4 h. Significant increases in serum concentrations of interleukin 6 and white-blood-cell counts were seen 4-8 h after cold challenge. Serum concentrations of interleukin 1 and cytokine mRNA in peripheral-blood leucocytes were not raised, but amounts of interleukin 1 protein and mRNA were high in affected skin. IL-1Ra administered before cold challenge blocked symptoms and increases in white-blood-cell counts and serum interleukin 6. Interpretation The ability of IL-1Ra to prevent the clinical features and haematological and biochemical changes in patients with FCAS indicates a central role for interleukin 1beta in this disorder. Involvement of cryopyrin in activation of caspase 1 and NF-kappaB signalling suggests that it might have a role in many chronic inflammatory diseases. Relevance to practice These findings support a new therapy for a disorder with no previously known acceptable treatment. They also offer insights into the role of interleukin 1beta in more common inflammatory diseases.	Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Sch Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, UCSD Clin Invest Inst, La Jolla, CA 92093 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat & Allergy, Denver, CO USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hoffman, HM (corresponding author), Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	hahoffman@ucsd.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047360] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00827, M01 RR000827] Funding Source: Medline; NIAID NIH HHS [R01 AI52430, R01 AI052430] Funding Source: Medline; NIAMS NIH HHS [P30 AR047360, 5 P30 AR47360] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; HAWKINS PN, 2000, ARTHRITIS RHEUM, V50, P607; Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Johnstone RF, 2003, ANN ALLERG ASTHMA IM, V90, P233, DOI 10.1016/S1081-1206(10)62147-3; Luheshi GN, 1998, ANN NY ACAD SCI, V856, P83, DOI 10.1111/j.1749-6632.1998.tb08316.x; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; MUCKLE TJ, 1962, Q J MED, V31, P235; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; OGOSTINI L, 2004, IMMUNITY, V20, P319; RICHARDS N, 2001, J BIOL CHEM, V9, P9; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Taylor PC, 2003, CURR PHARM DESIGN, V9, P1095, DOI 10.2174/1381612033454991	26	408	434	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2004	364	9447					1779	1785		10.1016/S0140-6736(04)17401-1	http://dx.doi.org/10.1016/S0140-6736(04)17401-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PQ	15541451	Green Accepted			2022-12-24	WOS:000225070600031
J	Treanor, J				Treanor, J			Weathering the influenza vaccine crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Rochester, Med Ctr, Infect Dis Unit, Rochester, NY 14642 USA	University of Rochester	Treanor, J (corresponding author), Univ Rochester, Med Ctr, Infect Dis Unit, Rochester, NY 14642 USA.							*CDCP, 2004, INT EST POP TARG INF; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor J, 2002, VACCINE, V20, P1099, DOI 10.1016/S0264-410X(01)00440-6; WOOD JM, 1998, TXB INFLUENZA, P333	5	34	35	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2004	351	20					2037	2040		10.1056/NEJMp048290	http://dx.doi.org/10.1056/NEJMp048290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	869TM	15492296	Bronze			2022-12-24	WOS:000225007200002
J	Abrescia, NGA; Cockburn, JJB; Grimes, JM; Sutton, GC; Diprose, JM; Butcher, SJ; Fuller, SD; Martin, CS; Burnett, RM; Stuart, DI; Bamford, DH; Bamford, JKH				Abrescia, NGA; Cockburn, JJB; Grimes, JM; Sutton, GC; Diprose, JM; Butcher, SJ; Fuller, SD; Martin, CS; Burnett, RM; Stuart, DI; Bamford, DH; Bamford, JKH			Insights into assembly from structural analysis of bacteriophage PRD1	NATURE			English	Article							CRYSTAL-STRUCTURE; CAPSID PROTEIN; COAT PROTEIN; VIRUS PRD1; WILD-TYPE; MEMBRANE; ADENOVIRUS; EVOLUTION; VERTEX; RESOLUTION	The structure of the membrane-containing bacteriophage PRD1 has been determined by X-ray crystallography at about 4 Angstrom resolution. Here we describe the structure and location of proteins P3, P16, P30 and P31. Different structural proteins seem to have specialist roles in controlling virus assembly. The linearly extended P30 appears to nucleate the formation of the icosahedral facets ( composed of trimers of the major capsid protein, P3) and acts as a molecular tape-measure, defining the size of the virus and cementing the facets together. Pentamers of P31 form the vertex base, interlocking with subunits of P3 and interacting with the membrane protein P16. The architectural similarities with adenovirus and one of the largest known virus particles PBCV-1 support the notion that the mechanism of assembly of PRD1 is scaleable and applies across the major viral lineage formed by these viruses.	Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, Cent Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QT, England; Univ Helsinki, Inst Biotechnol, Viikinkaari 5 00014, Finland; Univ Helsinki, Fac Biosci, Viikki Bioctr, Viikinkaari 5 00014, Finland; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Helsinki; University of Helsinki; The Wistar Institute	Stuart, DI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk	Abrescia, Nicola Gerardo/AAY-2323-2020; Butcher, Sarah J/H-5579-2012; San Martín, Carmen/A-4074-2010; Abrescia, Nicola GA/F-5898-2011	Abrescia, Nicola Gerardo/0000-0001-5559-1918; San Martín, Carmen/0000-0001-9799-175X; Stuart, David/0000-0002-3426-4210; Cockburn, Joseph/0000-0003-4730-1436; Butcher, Sarah/0000-0001-7060-5871; Bamford, Dennis/0000-0002-6438-8118; Grimes, Jonathan Mark/0000-0001-9698-0389				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAMFORD D, 1982, J VIROL, V44, P1031, DOI 10.1128/JVI.44.3.1031-1038.1982; BAMFORD DH, 1995, ADV VIRUS RES, V45, P281, DOI 10.1016/S0065-3527(08)60064-0; Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; BAMFORD JKH, 1991, VIROLOGY, V183, P658, DOI 10.1016/0042-6822(91)90995-N; Bamford JKH, 2002, J STRUCT BIOL, V139, P103, DOI 10.1016/S1047-8477(02)00562-2; Belnap DM, 2000, TRENDS MICROBIOL, V8, P91, DOI 10.1016/S0966-842X(00)01704-2; Benson SD, 2002, ACTA CRYSTALLOGR D, V58, P39, DOI 10.1107/S0907444901017279; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BURNETT RM, 1985, J MOL BIOL, V185, P125, DOI 10.1016/0022-2836(85)90187-1; Butcher SJ, 1995, EMBO J, V14, P6078, DOI 10.1002/j.1460-2075.1995.tb00298.x; Caldentey J, 2000, BIOCHEMISTRY-US, V39, P10566, DOI 10.1021/bi000711+; CHIU W, 1997, STRUCTURAL BIOL VIRU, P209; Cockburn JJB, 2003, ACTA CRYSTALLOGR D, V59, P538, DOI 10.1107/S0907444902023491; DELANO WL, 1995, ACTA CRYSTALLOGR D, V51, P740, DOI 10.1107/S0907444995001284; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Esnouf RM, 1997, ACTA CRYSTALLOGR D, V53, P665, DOI 10.1107/S0907444997005829; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Gowen B, 2003, J VIROL, V77, P7863, DOI 10.1128/JVI.77.14.7863-7871.2003; Grahn AM, 2002, MOL MICROBIOL, V46, P1199, DOI 10.1046/j.1365-2958.2002.03250.x; Grahn AM, 2002, J VIROL, V76, P4866, DOI 10.1128/JVI.76.10.4866-4872.2002; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Jaatinen ST, 2004, J VIROL, V78, P9790, DOI 10.1128/JVI.78.18.9790-9797.2004; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LUO C, 1993, VIROLOGY, V194, P564, DOI 10.1006/viro.1993.1295; MINDICH L, 1982, J VIROL, V44, P1021, DOI 10.1128/JVI.44.3.1021-1030.1982; Morais MC, 2003, NAT STRUCT BIOL, V10, P572, DOI 10.1038/nsb939; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rydman PS, 2002, J BACTERIOL, V184, P104, DOI 10.1128/JB.184.1.104-110.2002; Rydman PS, 1999, J MOL BIOL, V291, P575, DOI 10.1006/jmbi.1999.2978; Rydman PS, 2001, J MOL BIOL, V313, P785, DOI 10.1006/jmbi.2001.5068; Rydman PS, 2000, MOL MICROBIOL, V37, P356, DOI 10.1046/j.1365-2958.2000.01996.x; Sambrook J., 2001, MOL CLONING LAB MANU; San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837; San Martin C, 2001, STRUCTURE, V9, P917, DOI 10.1016/S0969-2126(01)00642-6; Sokolova A, 2001, J BIOL CHEM, V276, P46187, DOI 10.1074/jbc.M106848200; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; Stromsten NJ, 2003, J VIROL, V77, P6314, DOI 10.1128/JVI.77.11.6314-6321.2003; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Thuman-Commike PA, 1999, BIOPHYS J, V76, P3267, DOI 10.1016/S0006-3495(99)77479-5; Xu L, 2003, STRUCTURE, V11, P309, DOI 10.1016/S0969-2126(03)00023-6; Yan XD, 2000, NAT STRUCT BIOL, V7, P101, DOI 10.1038/72360	48	204	210	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					68	74		10.1038/nature03056	http://dx.doi.org/10.1038/nature03056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525981				2022-12-24	WOS:000224854900039
J	Gestwicki, JE; Crabtree, GR; Graef, IA				Gestwicki, JE; Crabtree, GR; Graef, IA			Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation	SCIENCE			English	Article							ALZHEIMERS-DISEASE THERAPIES; LIGANDS; TOXICITY; TARGETS; BINDING; DRUGS; FKBP	Protein aggregation is involved in the pathogenesis of neurodegenerative diseases and hence is considered an attractive target for therapeutic intervention. However, protein-protein interactions are exceedingly difficult to inhibit. Small molecules tack sufficient steric bulk to prevent interactions between large peptide surfaces. To yield potent inhibitors of beta-amyloid (Abeta) aggregation, we synthesized small molecules that increase their steric bulk by binding to chaperones but also have a moiety available for interaction with Abeta. This strategy yields potent inhibitors of Abeta aggregation and could lead to therapeutics for Alzheimer's disease and other forms of neurodegeneration.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Graef, IA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94305 USA.	graef@cmgm.stanford.edu			NINDS NIH HHS [NS046789] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Braun PD, 2003, J AM CHEM SOC, V125, P7575, DOI 10.1021/ja035176q; Briesewitz R, 1999, P NATL ACAD SCI USA, V96, P1953, DOI 10.1073/pnas.96.5.1953; Citron M, 2002, NEUROBIOL AGING, V23, P1017, DOI 10.1016/S0197-4580(02)00122-7; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Janus C, 2000, BBA-MOL BASIS DIS, V1502, P63, DOI 10.1016/S0925-4439(00)00033-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lee VMY, 2002, NEUROBIOL AGING, V23, P1039, DOI 10.1016/S0197-4580(02)00121-5; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Michaelis ML, 2003, J PHARMACOL EXP THER, V304, P897, DOI 10.1124/jpet.102.035840; Pollock R, 2002, NAT BIOTECHNOL, V20, P729, DOI 10.1038/nbt0702-729; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; STANDAERT RF, 1990, NATURE, V346, P671, DOI 10.1038/346671a0; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Veselovsky AV, 2002, J MOL RECOGNIT, V15, P405, DOI 10.1002/jmr.597; Wong SS, 1998, J AM CHEM SOC, V120, P603, DOI 10.1021/ja9737735	26	160	171	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					865	869		10.1126/science.1101262	http://dx.doi.org/10.1126/science.1101262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	869FS	15514157				2022-12-24	WOS:000224969400045
J	Korenjak, M; Taylor-Harding, B; Binne, UK; Satterlee, JS; Stevaux, O; Aasland, R; White-Cooper, H; Dyson, N; Brehm, A				Korenjak, M; Taylor-Harding, B; Binne, UK; Satterlee, JS; Stevaux, O; Aasland, R; White-Cooper, H; Dyson, N; Brehm, A			Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes	CELL			English	Article							DNA-REPLICATION; CELL-CYCLE; RETINOBLASTOMA PROTEIN; NEGATIVE REGULATOR; RB; CHROMATIN; RAS; LOCALIZATION; MECHANISMS; TRANSITION	The retinoblastoma tumor suppressor protein (pRb) regulates gene transcription by binding E2F transcription factors. pRb can recruit several repressor complexes to E2F bound promoters; however, native pRb repressor complexes have not been isolated. We have purified E2F/RBF repressor complexes from Drosophila embryo extracts and characterized their roles in E2F regulation. These complexes contain RBF, E2F and Myb-interacting proteins that have previously been shown to control developmentally regulated patterns of DNA replication in follicle cells. The complexes localize to transcriptionally silent sites on polytene chromosomes and mediate stable repression of a specific set of E2F targets that have sex- and differentiation-specific expression patterns. Strikingly, seven of eight complex subunits are structurally and functionally related to C. elegans synMuv class B genes, which cooperate to control vulval differentiation in the worm. These results reveal an extensive evolutionary conservation of specific pRb repressor complexes that physically combine subunits with established roles in the regulation of transcription, DNA replication, and chromatin structure.	Univ Munich, Adolf Butenandt Inst, Lehrstuhl Mol Biol, Munich, Germany; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Univ Bergen, Dept Mol Biol, Bergen, Norway; Univ Bergen, Computat Biol Unit, Bergen, Norway; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Munich; Harvard University; Massachusetts General Hospital; University of Bergen; University of Bergen; University of Oxford	Brehm, A (corresponding author), Univ Munich, Adolf Butenandt Inst, Lehrstuhl Mol Biol, Munich, Germany.	abrehm@lmu.de	White-Cooper, Helen/A-4633-2010	White-Cooper, Helen/0000-0002-3373-8023; Nolan-Stevaux, Olivier/0000-0002-5934-4786	NCI NIH HHS [CA64402, P01 CA95281, CA95281] Funding Source: Medline; NIGMS NIH HHS [GM53203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095281, R01CA064402] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Angus SP, 2004, MOL CELL BIOL, V24, P5404, DOI 10.1128/MCB.24.12.5404-5420.2004; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; BEALL EL, 2004, GENES DEV; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cayirlioglu P, 2001, DEVELOPMENT, V128, P5085; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Frolov MV, 2003, GENE DEV, V17, P723, DOI 10.1101/gad.1031803; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Joaquin M, 2002, ONCOGENE, V21, P7923, DOI 10.1038/sj.onc.1206001; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Owen AB, 2003, GENOME RES, V13, P1828, DOI 10.1101/gr.1125403; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shen WH, 2002, TRENDS PLANT SCI, V7, P505, DOI 10.1016/S1360-1385(02)02351-8; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stevaux O, 2002, EMBO J, V21, P4927, DOI 10.1093/emboj/cdf501; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Taylor-Harding B, 2004, MOL CELL BIOL, V24, P9124, DOI 10.1128/MCB.24.20.9124-9136.2004; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338	46	231	240	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					181	193		10.1016/j.cell.2004.09.034	http://dx.doi.org/10.1016/j.cell.2004.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479636	Bronze			2022-12-24	WOS:000224577200007
J	Partridge, EA; Le Roy, C; Di Guglielmo, GM; Pawling, J; Cheung, P; Granovsky, M; Nabi, IR; Wrana, JL; Dennis, JW				Partridge, EA; Le Roy, C; Di Guglielmo, GM; Pawling, J; Cheung, P; Granovsky, M; Nabi, IR; Wrana, JL; Dennis, JW			Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis	SCIENCE			English	Article							GROWTH; COMPLEX; METASTASIS; EXPRESSION; PATHWAYS; MOUSE; CELLS	The Golgi enzyme beta1,6 N-acetylglucosaminyltransferase V (Mgat5) is upregulated in carcinomas and promotes the substitution of N-glycan with poly N-acetyllactosamine, the preferred ligand for galectin-3 (Gal-3). Here, we report that expression of Mgat5 sensitized mouse cells to multiple cytokines. Gal-3 cross-linked Mgat5-modified N-glycans on epidermal growth factor and transforming growth factor-beta receptors at the cell surface and delayed their removal by constitutive endocytosis. Mgat5 expression in mammary carcinoma was rate limiting for cytokine signaling and consequently for epithelial-mesenchymal transition, cell motility, and tumor metastasis. Mgat5 also promoted cytokine-mediated leukocyte signaling, phagocytosis, and extravasation in vivo. Thus, conditional regulation of N-glycan processing drives synchronous modification of cytokine receptors, which balances their surface retention against loss via endocytosis.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ British Columbia, Dept Lab Med & Pathol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Anat Cell Biol & Physiol, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of British Columbia; University of British Columbia	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	Dennis@mshri.on.ca	Wrana, Jeffrey/F-8857-2013; Nabi, Ivan/GWZ-5144-2022; Le Roy, Christine/N-3718-2017; Dennis, James/E-7268-2013; Nabi, Ivan R/C-5493-2009	Nabi, Ivan/0000-0002-0670-0513; Le Roy, Christine/0000-0003-3538-6487; 				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Gong HC, 1999, CANCER RES, V59, P6239; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; MIYOSHI E, 1995, J BIOL CHEM, V270, P6216, DOI 10.1074/jbc.270.11.6216; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Park SC, 2002, MECH AGEING DEV, V123, P917, DOI 10.1016/S0047-6374(02)00029-5; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stroop CJM, 2000, GLYCOBIOLOGY, V10, P901, DOI 10.1093/glycob/10.9.901; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	27	564	595	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					120	124		10.1126/science.1102109	http://dx.doi.org/10.1126/science.1102109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459394				2022-12-24	WOS:000224304000051
J	Pearcy, M; Aron, S; Doums, C; Keller, L				Pearcy, M; Aron, S; Doums, C; Keller, L			Conditional use of sex and parthenogenesis for worker and queen production in ants	SCIENCE			English	Article							HYMENOPTERA; FEMALES; CASTE; CYCLE	The near-ubiquity of sexual reproduction in animal species has long been considered a paradox because sexually reproducing individuals transmit only half of their genome to their progeny. Here, we show that the ant Cataglyphis cursor circumvents this cost by using alternative modes of reproduction for the production of reproductive and nonreproductive offspring. New queens are almost exclusively produced by parthenogenesis, whereas workers are produced by normal sexual reproduction. By selectively using sex for somatic growth and parthenogenesis for germline production, C. cursor has taken advantage of the ant caste system to benefit from the advantages of both sexual and asexual reproduction.	Free Univ Brussels, B-1050 Brussels, Belgium; Univ Paris 06, F-75252 Paris 05, France; Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	Universite Libre de Bruxelles; Vrije Universiteit Brussel; UDICE-French Research Universities; Sorbonne Universite	Aron, S (corresponding author), Free Univ Brussels, CP 160-12,Av FD Roosevelt 50, B-1050 Brussels, Belgium.	saron@ulb.ac.be	keller, laurent/AAI-7175-2020; Doums, Claudie/S-4054-2019	Doums, Claudie/0000-0001-6284-2412; keller, laurent/0000-0002-5046-9953				BAUDRY E, IN PRESS GENETICS; Bell G, 1982, MASTERPIECE NATURE E; Bourke A, 1995, SOCIAL EVOLUTION ANT, DOI DOI 10.1186/s12862-015-0383-4; CAGNIANT H, 1979, INSECT SOC, V26, P51, DOI 10.1007/BF02283912; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Crozier R.H., 1996, EVOLUTION SOCIAL INS; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; Hartmann A, 2003, P NATL ACAD SCI USA, V100, P12836, DOI 10.1073/pnas.2132993100; HEINZE J, 1995, NATURWISSENSCHAFTEN, V82, P40, DOI 10.1007/s001140050139; ITOW T, 1984, INSECT SOC, V31, P87, DOI 10.1007/BF02223694; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; KELLER L, 1991, ETHOL ECOL EVOL, V3, P307, DOI 10.1080/08927014.1991.9525359; LENOIR A, 1988, Psyche (Cambridge), V95, P21, DOI 10.1155/1988/54685; Maynard Smith J., 1978, EVOLUTION SEX; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Suomalainen E., 1987, CYTOLOGY EVOLUTION P; TSUJI K, 1995, INSECT SOC, V42, P333, DOI 10.1007/BF01240430; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Wilson EO., 1971, INSECT SOC	28	140	144	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1780	1783		10.1126/science.1105453	http://dx.doi.org/10.1126/science.1105453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576621	Green Published			2022-12-24	WOS:000225630800054
J	Rieder, R; Gellert, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhoffer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J				Rieder, R; Gellert, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhoffer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J			Chemistry of rocks and soils at Meridiani Planum from the alpha particle X-ray spectrometer	SCIENCE			English	Article							CHEMICAL-COMPOSITION; GUSEV CRATER; MARS; HEMATITE; ROVERS	The Alpha Particle X-ray Spectrometer on the Opportunity rover determined major and minor elements of soils and rocks in Meridiani Planum. Chemical compositions differentiate between basaltic rocks, evaporite-rich rocks, basaltic soils, and hematite-rich soils. Although soils are compositionally similar to those at previous landing sites, differences in iron and some minor element concentrations signify the addition of local components. Rocky outcrops are rich in sulfur and variably enriched in bromine relative to chlorine. The interaction with water in the past is indicated by the chemical features in rocks and soils at this site.	Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Enrico Fermi Inst, Lab Astrophys & Space Res, Chicago, IL 60637 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Max Planck Society; Johannes Gutenberg University of Mainz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Cornell University	Rieder, R (corresponding author), Max Planck Inst Chem, JJ Becher Weg 27, D-55128 Mainz, Germany.	rieder@mpch-mainz.mpg.de						BANIN A., 2000, MARS, P594; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; DREIBUS G, COMMUNICATION; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020181; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GOREVAN SP, 2003, J GEOPHYS RES-PLANET, V108; KARGEL JS, 1965, LUNAR PLANET SCI, V35; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Zeh H. D, 1981, LANDOLTBORNSTEIN A, V2, P257; Zipfel J, 2004, METEORIT PLANET SCI, V39, pA118	16	305	315	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1746	1749		10.1126/science.1104358	http://dx.doi.org/10.1126/science.1104358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576611				2022-12-24	WOS:000225630800043
J	Truckses, DM; Garrenton, LS; Thorner, J				Truckses, DM; Garrenton, LS; Thorner, J			Jekyll and Hyde in the microbial world	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; FILAMENTOUS GROWTH; YEAST; KINASE; GPR1; ACT	Fungi are nonmotile organisms that obtain carbon from compounds in their immediate surroundings. Confronted with nutrient limitation, the yeast Saccharomyces cerevisiae undergoes a dimorphic transition, switching from spherical cells to filaments of adherent, elongated cells that can invade the substratum. A complex web of sensing mechanisms and cooperation among signaling networks (including a mitogen-activated protein kinase cascade, cyclic adenosine monophosphate-dependent protein kinase, and 5'-adenosine monophosphate-activated protein kinase) elicits the appropriate changes in physiology, cell cycle progression, cell polarity, and gene expression to achieve this differentiation. Highly related signaling processes control filamentation and virulence of many human fungal pathogens.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA.	jeremy@socrates.berketey.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021841, R01GM021841] Funding Source: NIH RePORTER; NCI NIH HHS [CA-09041] Funding Source: Medline; NIGMS NIH HHS [GM-21841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1111/j.1574-6976.2001.tb00573.x; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Kuchin S, 2003, BIOCHEM SOC T, V31, P175, DOI 10.1042/bst0310175; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; Mosch H U, 2000, Contrib Microbiol, V5, P185; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Rohde JR, 2003, CURR TOP MICROBIOL, V279, P53; Sanchez-Martinez C, 2001, CURR OPIN MICROBIOL, V4, P214, DOI 10.1016/S1369-5274(00)00191-0; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; TRUCKSES DM, 2004, SCI STKE         NOV; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Zarrinpar A, 2004, MOL CELL, V14, P825, DOI 10.1016/j.molcel.2004.06.011	22	20	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1509	1511		10.1126/science.1104677	http://dx.doi.org/10.1126/science.1104677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567850				2022-12-24	WOS:000225442700044
J	Weibezahn, J; Tessarz, P; Schlieker, C; Zahn, R; Maglica, Z; Lee, S; Zentgraf, H; Weber-Ban, EU; Dougan, DA; Tsai, FTF; Mogk, A; Bukau, B				Weibezahn, J; Tessarz, P; Schlieker, C; Zahn, R; Maglica, Z; Lee, S; Zentgraf, H; Weber-Ban, EU; Dougan, DA; Tsai, FTF; Mogk, A; Bukau, B			Thermotolerance requires refolding of aggregated proteins by substrate translocation through the central pore of ClpB	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; HSP100 CHAPERONE; DNAK CHAPERONE; DISAGGREGATION; BINDING; DEGRADATION; PROTEASE; ATPASE; IDENTIFICATION; COMMUNICATION	Cell survival under severe thermal stress requires the activity of the CIpB (Hsp104) AAA+ chaperone that solubilizes and reactivates aggregated proteins in concert with the DnaK (Hsp70) chaperone system. How protein disaggregation is achieved and whether survival is solely dependent on CIpB-mediated elimination of aggregates or also on reactivation of aggregated proteins has been unclear. We engineered a CIpB variant, BAP, which associates with the CIpP peptidase and thereby is converted into a degrading disaggregase. BAP translocates substrates through its central pore directly into CIpP for degradation. CIpB-dependent translocation is demonstrated to be an integral part of the disaggregation mechanism. Protein disaggregation by the BAP/CIpP complex remains dependent on DnaK, defining a role for DnaK at early stages of the disaggregation reaction. The activity switch of BAP to a degrading disaggregase does not support thermotolerance development, demonstrating that cell survival during severe thermal stress requires reactivation of aggregated proteins.	Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Baylor College of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); La Trobe University	Mogk, A (corresponding author), Heidelberg Univ, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	a.mogk@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	dougan, david/B-3359-2010; Tessarz, Peter/ABB-6551-2021; Maglica, Željka/S-7423-2018; Tessarz, Peter/I-9035-2014	dougan, david/0000-0001-9313-1904; Tessarz, Peter/0000-0002-6953-9835; Maglica, Željka/0000-0002-6438-861X; Tessarz, Peter/0000-0002-6953-9835; Bukau, Bernd/0000-0003-0521-7199; Weber-Ban, Eilika/0000-0002-5773-9274	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067672] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM67672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Friant S, 2003, EMBO J, V22, P3783, DOI 10.1093/emboj/cdg375; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Konieczny I, 2002, J BIOL CHEM, V277, P18483, DOI 10.1074/jbc.M107580200; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Maurizi MR, 2004, STRUCTURE, V12, P175, DOI 10.1016/j.str.2004.01.021; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlee S, 2004, J MOL BIOL, V336, P275, DOI 10.1016/j.jmb.2003.12.013; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; ZEHNBAUER BA, 1981, P NATL ACAD SCI-BIOL, V78, P2043, DOI 10.1073/pnas.78.4.2043	41	370	374	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					653	665		10.1016/j.cell.2004.11.027	http://dx.doi.org/10.1016/j.cell.2004.11.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550247	hybrid			2022-12-24	WOS:000225389500011
J	Elphick, GF; Querbes, W; Jordan, JA; Gee, GV; Eash, S; Manley, K; Dugan, A; Stanifer, M; Bhatnagar, A; Kroeze, WK; Roth, BL; Atwood, WJ				Elphick, GF; Querbes, W; Jordan, JA; Gee, GV; Eash, S; Manley, K; Dugan, A; Stanifer, M; Bhatnagar, A; Kroeze, WK; Roth, BL; Atwood, WJ			The human polyomavirus, JCV, uses serotonin receptors to infect cells	SCIENCE			English	Article							TONSILLAR STROMAL CELLS; FETAL GLIAL-CELLS; CAVEOLAR ENDOCYTOSIS; B-LYMPHOCYTES; HUMAN BRAIN; VIRUS; SIMIAN-VIRUS-40; REVEALS; 5-HT2A; PHARMACOLOGY	The human polyomavirus, JCV, causes the fatal demyelinating disease progressive multifocal leukoencephalopathy in immunocompromised patients. We found that the serotonergic receptor SHT2AR could act as the cellular receptor for JCV on human glial cells. The SHT2A receptor antagonists inhibited JCV infection, and monoclonal antibodies directed at 5HT(2A) receptors blocked infection of glial cells by JCV, but not by SV40. Transfection of 5HT(2A) receptor-negative HeLa cells with a 5HT(2A) receptor rescued virus infection, and this infection was blocked by antibody to the 5HT(2A) receptor. A tagged SHT2A receptor colocalized with labeled JCV in an endosomal compartment following internalization. Serotonin receptor antagonists may thus be useful in the treatment of progressive multifocal leukoencephalopathy.	Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; Brown Univ, Grad Program Mol Biol Cellular Biol & Biochem, Providence, RI 02912 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Brown University; Brown University; Brown University; Case Western Reserve University	Atwood, WJ (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Walter_Atwood@Brown.edu	Roth, Bryan L/F-3928-2010; Stanifer, Megan/ABB-4254-2020; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Gee, Gretchen/0000-0003-0403-3240; Stanifer, Megan/0000-0002-5606-1297	NCI NIH HHS [R01 CA71878] Funding Source: Medline; NIMH NIH HHS [R01MH61887, R01MH57635] Funding Source: Medline; NINDS NIH HHS [R01 NS43097] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057635, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043097] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baum S, 2003, J NEUROVIROL, V9, P32, DOI 10.1080/13550280390195342; Belachew S, 1998, NEUROREPORT, V9, P973, DOI 10.1097/00001756-199804200-00004; Berger JR, 1999, SEMIN NEUROL, V19, P193, DOI 10.1055/s-2008-1040837; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; BOESS FG, 1994, NEUROPHARMACOLOGY, V33, P275, DOI 10.1016/0028-3908(94)90059-0; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Chang M, 2000, J BIOL CHEM, V275, P7021, DOI 10.1074/jbc.275.10.7021; Chen BJ, 2002, VIROLOGY, V300, P282, DOI 10.1006/viro.2002.1522; CHOUDHARY MS, 1992, MOL PHARMACOL, V42, P627; Cohen Z, 1999, J CEREBR BLOOD F MET, V19, P908, DOI 10.1097/00004647-199908000-00010; DUDLEY M, 1990, Society for Neuroscience Abstracts, V16, P1037; Eash S, 2004, AM J PATHOL, V164, P419, DOI 10.1016/S0002-9440(10)63132-X; Fonseca MI, 2001, MOL BRAIN RES, V89, P11; Gillman PK, 1999, J PSYCHOPHARMACOL, V13, P100, DOI 10.1177/026988119901300111; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; HERNDON JL, 1992, J MED CHEM, V35, P4903, DOI 10.1021/jm00104a017; Herrick-Davis K, 2000, J PHARMACOL EXP THER, V295, P226; Holman RC, 1998, NEUROEPIDEMIOLOGY, V17, P303, DOI 10.1159/000026184; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; HOYER D, 1994, PHARMACOL REV, V46, P157; Kristiansen K, 1996, EUR J PHARMACOL, V306, P195, DOI 10.1016/0014-2999(96)00180-X; Liu CK, 1998, J VIROL, V72, P4643, DOI 10.1128/JVI.72.6.4643-4649.1998; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; MANDL C, 1987, J VIROL, V61, P755, DOI 10.1128/JVI.61.3.755-763.1987; Merzak A, 1996, MOL BRAIN RES, V41, P1, DOI 10.1016/0169-328X(96)00058-7; Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P815, DOI 10.1124/jpet.102.039883; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Norkin LC, 1999, IMMUNOL REV, V168, P13, DOI 10.1111/j.1600-065X.1999.tb01279.x; PADGETT BL, 1971, LANCET, V1, P1257; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000; Querbes W, 2004, J VIROL, V78, P250, DOI 10.1128/JVI.78.1.250-256.2004; Velasco M, 1998, Am J Ther, V5, P37, DOI 10.1097/00045391-199801000-00007; WALKER DL, 1986, PAPOVAVIRIDAE, V1, P327; Wei G, 2000, J NEUROVIROL, V6, P127, DOI 10.3109/13550280009013156	39	331	368	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1380	1383		10.1126/science.1103492	http://dx.doi.org/10.1126/science.1103492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550673	Green Submitted			2022-12-24	WOS:000225301600054
J	Bhutta, ZA; Khan, I; Salat, S; Raza, F; Khan, I; Ara, H				Bhutta, ZA; Khan, I; Salat, S; Raza, F; Khan, I; Ara, H			Reducing length of stay in hospital for very low birthweight infants by involving mothers in a stepdown unit: an experience from Karachi (Pakistan)	BRITISH MEDICAL JOURNAL			English	Article							NEONATAL-MORTALITY; OUTCOMES; BABIES; CARE; NETWORK; RISK; AGE	Problem Clinical care of infants with a very low birth weight (less than 1500 g) in developing Countries can be labour intensive and is often associated with a prolonged stay in hospital. The Aga Khan University Medical Center in Karachi, Pakistan, established a neonatal intensive care unit in 1987. By 1993-4, very low birthweight infants remained in hospital for 18-21 days. Strategies for change A stepdown unit was established in September 1994, with mothers providing all basic nursing care for their infants before being discharged under supervision. Key measures for improvement We analysed neonatal outcomes for the time periods before and after the stepdown unit was created (1987-94 and 1995-2001). We compared these two time periods for survival after birth until discharge, morbidity patterns during hospitalisation, length of stay in hospital, and readmission rates to hospital in the four weeks after discharge. Effects of change of 509 consecutive, very low birthweight infants, 494 (97%) preterm and 140 (28%) weighing < 1000 g at birth), 391 (76%) survived to discharge from the hospital. The length of hospitalisation fell significantly from 1987-90, when it was 34 (SD 18) days, to 16 (SD 14) days in 1999-2001 (P < 0.001). Readmission rates to hospital did not rise, nor did adverse outcomes at 12 months of age. Lessons learnt Our results indicate that it is possible to involve mothers in the active care of their very low birthweight infants before discharge. This may translate into earlier discharge from hospital to home settings without any increase in short term complications and readmissions.	Aga Khan Univ, Neonatal Intens Care Unit, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Neonatal Intens Care Unit, Karachi 74800, Pakistan.	zulfiqar.b.hutta@aku.edu						ALI MM, 1988, BANGLADESH J CHILD H, V12, P90; Arce Casas A, 2003, An Pediatr (Barc), V59, P454; Arif MA, 1999, J TROP PEDIATRICS, V45, P278, DOI 10.1093/tropej/45.5.278; Atasay B, 2003, TURKISH J PEDIATR, V45, P283; BALCOM RJ, 1993, PEDIATRICS, V91, P540; Bhutta ZA, 1999, PEDIATR PULM, V27, P305, DOI 10.1002/(SICI)1099-0496(199905)27:5<305::AID-PPUL2>3.0.CO;2-Q; BOO N Y, 1992, SMJ Singapore Medical Journal, V33, P33; Boo NY, 1996, J PAEDIATR CHILD H, V32, P439, DOI 10.1111/j.1440-1754.1996.tb00946.x; Callaghan LA, 2003, ARCH DIS CHILD-FETAL, V88, pF94, DOI 10.1136/fn.88.2.F94; COCKBURN F, 1993, LANCET, V342, P193; Cooper PA, 1997, PEDIATRICS, V99, P537, DOI 10.1542/peds.99.4.537; Darlow BA, 2003, ARCH DIS CHILD-FETAL, V88, pF23, DOI 10.1136/fn.88.1.F23; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; GRAY RH, 1991, INT J EPIDEMIOL, V20, P467, DOI 10.1093/ije/20.2.467; *GRUP COL NEOC, 2002, J PERINATOL, V22, P2; Ho JJ, 1999, J PAEDIATR CHILD H, V35, P175, DOI 10.1046/j.1440-1754.1999.t01-1-00340.x; Kaiser Jeffrey R, 2004, J Perinatol, V24, P343, DOI 10.1038/sj.jp.7211113; Kambarami R. A., 1999, Central African Journal of Medicine, V45, P56; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; Lincetto O, 1998, ACTA PAEDIATR, V87, P433; Mbweza E, 1996, Int Nurs Rev, V43, P53; Merritt T Allen, 2003, Semin Neonatol, V8, P95, DOI 10.1016/S1084-2756(02)00219-1; Ravikumara M., 1996, Indian Journal of Pediatrics, V63, P785, DOI 10.1007/BF02730930; Rogowski J, 2003, PEDIATRICS, V111; Tafari N, 1974, J Trop Pediatr Environ Child Health, V20, P73; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608	26	59	60	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 13	2004	329	7475					1151	1155		10.1136/bmj.329.7475.1151	http://dx.doi.org/10.1136/bmj.329.7475.1151			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	871XJ	15539671	Green Published			2022-12-24	WOS:000225169600022
J	Poy, MN; Eliasson, L; Krutzfeldt, J; Kuwajima, S; Ma, XS; MacDonald, PE; Pfeffer, S; Tuschl, T; Rajewsky, N; Rorsman, P; Stoffel, M				Poy, MN; Eliasson, L; Krutzfeldt, J; Kuwajima, S; Ma, XS; MacDonald, PE; Pfeffer, S; Tuschl, T; Rajewsky, N; Rorsman, P; Stoffel, M			A pancreatic islet-specific microRNA regulates insulin secretion	NATURE			English	Article							PROTEIN; IDENTIFICATION; EXOCYTOSIS; EXPRESSION; LIN-14; RNAS; V-1	MicroRNAs (miRNAs) constitute a growing class of non-coding RNAs that are thought to regulate gene expression by translational repression(1). Several miRNAs in animals exhibit tissue-specific or developmental-stage-specific expression, indicating that they could play important roles in many biological processes(2-4). To study the role of miRNAs in pancreatic endocrine cells we cloned and identified a novel, evolutionarily conserved and islet-specific miRNA (miR-375). Here we show that overexpression of miR-375 suppressed glucose-induced insulin secretion, and conversely, inhibition of endogenous miR-375 function enhanced insulin secretion. The mechanism by which secretion is modified by miR-375 is independent of changes in glucose metabolism or intracellular Ca2+-signalling but correlated with a direct effect on insulin exocytosis. Myotrophin (Mtpn) was predicted to be and validated as a target of miR-375. Inhibition of Mtpn by small interfering (si) RNA mimicked the effects of miR-375 on glucose-stimulated insulin secretion and exocytosis. Thus, miR-375 is a regulator of insulin secretion and may thereby constitute a novel pharmacological target for the treatment of diabetes.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Lund Univ, Dept Physiol Sci, SE-22184 Lund, Sweden; NYU, Dept Biol Biol & Math, New York, NY 10003 USA; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford OX3 7LJ, England	Rockefeller University; Rockefeller University; Lund University; New York University; University of Oxford	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@rockefeller.edu	Tuluc, Petronel/C-2527-2011; Poy, Matthew/F-6914-2017; Rorsman, Patrik/A-4331-2016; Eliasson, Lena/E-9294-2012; Pfeffer, Sebastien/A-6512-2010; Pfeffer, Sébastien/H-3212-2019; MacDonald, Patrick/A-4154-2008	Poy, Matthew/0000-0002-4904-2426; Rorsman, Patrik/0000-0001-7578-0767; Eliasson, Lena/0000-0002-6467-5029; Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer, Sébastien/0000-0002-8458-348X; Rajewsky, Nikolaus/0000-0002-4785-4332; Stoffel, Markus/0000-0003-1304-5817; MacDonald, Patrick/0000-0002-5439-6288				Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larsen CM, 1998, J BIOL CHEM, V273, P15294, DOI 10.1074/jbc.273.24.15294; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Shih DQ, 2002, P NATL ACAD SCI USA, V99, P3818, DOI 10.1073/pnas.062605899; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yamakuni T, 2002, FEBS LETT, V530, P94, DOI 10.1016/S0014-5793(02)03431-2; Zhao C, 2001, DIABETES, V50, P361, DOI 10.2337/diabetes.50.2.361; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	1641	1947	2	175	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					226	230		10.1038/nature03076	http://dx.doi.org/10.1038/nature03076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538371				2022-12-24	WOS:000225020200048
J	Hurwitz, CA; Duncan, J; Wolfe, J				Hurwitz, CA; Duncan, J; Wolfe, J			Caring for the child with cancer at the close of life - "There are people who make it, and I'm hoping I'm one of them"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEDIATRIC PALLIATIVE CARE; MALIGNANT-DISEASE; TERMINAL CANCER; ILL PATIENTS; SYMPTOMS; END; PAIN; METHYLPHENIDATE; HYDRATION; DYSPNEA	Approximately 25% of children with cancer die of their disease. Early in the course of a patient's illness, it is often impossible to determine whether the disease will be cured with cancer-directed treatment. When potentially curative therapy is no longer an option, the patient, family, and oncology team face enormous medical, psychological, and spiritual challenges. Optimal palliative care requires willingness on the part of the physician and caregiver team to engage the patient and family in discussions of their hopes and fears and to provide solace and support for emotional and physical pain. Using the comments of a child in the terminal phase of acute leukemia, his mother, and his physician, we describe opportunities and important lessons often revealed only when families and their caregivers face the end of a child's life. A broad-minded assessment of the patient's and family's physical, emotional, and spiritual needs and clarification of realistic goals and hopes not only improves the clinical care that the patient receives but also contributes to the sense of satisfaction and meaning that the physician can gain from the experience of caring for children at the end of life.	Dana Farber Canc Inst, Dept Pediat Oncol, Pediat Adv Care Team, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Maine Med Ctr, Maine Childrens Canc Program, Portland, ME USA; Maine Med Ctr, Barbara Bush Childrens Hosp, Portland, ME USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Maine Medical Center; Maine Medical Center	Wolfe, J (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Pediat Adv Care Team, 44 Binney St, Boston, MA 02115 USA.	joanne_wolfe@dfci.harvard.edu						Abrahm J, 2000, PHYS GUIDE PAIN SYMP; ADAMS VD, 1986, J WATER POLLUT CON F, V58, P449; ADAMS-GREENLY M, 1991, Pediatrician, V18, P3; Allard P, 1999, J PAIN SYMPTOM MANAG, V17, P256, DOI 10.1016/S0885-3924(98)00157-2; ANGELL M, 1982, NEW ENGL J MED, V306, P98, DOI 10.1056/NEJM198201143060210; Back Anthony L, 2003, Ann Intern Med, V138, P439; Berger AM, 2002, PRINCIPLES PRACTICE; Block SD, 2001, JAMA-J AM MED ASSOC, V285, P2898, DOI 10.1001/jama.285.22.2898; BLUEBLONDLANGNE.M, 1978, PRIVATE WORLDS DYING; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P365, DOI 10.1016/0885-3924(92)90091-U; BRUERA E, 1987, CANCER TREAT REP, V71, P67; Bruera E, 1996, SUPPORT CARE CANCER, V4, P147, DOI 10.1007/BF01845764; BRUERA E, 1993, ANN INTERN MED, V119, P906, DOI 10.7326/0003-4819-119-9-199311010-00007; Bruera Eduardo, 2002, J Palliat Med, V5, P127, DOI 10.1089/10966210252785097; BUCHAN ML, 1995, J CLIN ETHIC, V6, P53; Burns J P, 1997, New Horiz, V5, P72; Carrese JA, 2000, J GEN INTERN MED, V15, P92, DOI 10.1046/j.1525-1497.2000.03399.x; CHRIST G, 1984, CHILDHOOD CANCER IMP, P109; Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269; Christ GH, 2000, CANCER PRACT, V8, P72, DOI 10.1046/j.1523-5394.2000.82005.x; Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; Davis B, 2001, TXB PALLIATIVE NURSI, P363; Davis CL, 1997, BRIT MED J, V315, P931; Drake R, 2003, J PAIN SYMPTOM MANAG, V26, P594, DOI 10.1016/S0885-3924(03)00202-1; Escalante CP, 1996, CANCER, V78, P1314, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2; Feudtner C, 2002, PEDIATRICS, V109, P887, DOI 10.1542/peds.109.5.887; Field M. J., 2003, CHILDREN DIE IMPROVI; HAIN RDW, 1995, PALLIATIVE MED, V9, P201, DOI 10.1177/026921639500900305; Hilden JM, 2001, IMPROVING PALLIATIVE, P161; Himelstein BP, 2004, NEW ENGL J MED, V350, P1752, DOI 10.1056/NEJMra030334; Hinds PS, 2001, CANCER NURS, V24, P122, DOI 10.1097/00002820-200104000-00007; Hongo T, 2003, PEDIATR INT, V45, P60, DOI 10.1046/j.1442-200X.2003.01668.x; Ingham J M, 1998, Hosp J, V13, P89; Jecker Nancy S, 1995, Rep Inst Philos Public Policy, V15, P10; KANE JR, 2002, PRINCIPLES PRACTICE, P1044; KOREN G, 1989, PEDIATR CLIN N AM, V36, P1141; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Mack JW, 2004, J CLIN ONCOL, V22, P563, DOI 10.1200/JCO.2004.04.078; MACK JW, 2004, 40 ANN M AM SOC CLIN; Mancini I, 1998, SUPPORT CARE CANCER, V6, P356, DOI 10.1007/s005200050177; MCCANN RM, 1994, JAMA-J AM MED ASSOC, V272, P1263, DOI 10.1001/jama.272.16.1263; Meares C J, 1994, Am J Hosp Palliat Care, V11, P10, DOI 10.1177/104990919401100304; Miaskowski C, 1998, PRINC PR SUPPORT ONC, V1, P1; Mock V, 1997, Oncol Nurs Forum, V24, P991; MOUNT BM, 1986, J CLIN ONCOL, V4, P1127, DOI 10.1200/JCO.1986.4.7.1127; Nelson RM, 2000, PEDIATRICS, V106, P351; Ng K, 1998, J PAIN SYMPTOM MANAG, V16, P307, DOI 10.1016/S0885-3924(98)00097-9; Nitschke R, 2001, J CLIN ONCOL, V19, P595, DOI 10.1200/JCO.2001.19.2.595; Portenoy R K, 1991, J Palliat Care, V7, P13; Rabow MW, 2004, JAMA-J AM MED ASSOC, V291, P483, DOI 10.1001/jama.291.4.483; Rozans M, 2002, J CLIN ONCOL, V20, P335, DOI 10.1200/JCO.20.1.335; Rusy LM, 2000, PEDIATR CLIN N AM, V47, P589, DOI 10.1016/S0031-3955(05)70227-3; SHAPIRO DL, 1984, JAMA-J AM MED ASSOC, V252, P2031, DOI 10.1001/jama.252.15.2031; Sirkia K, 1998, J PAIN SYMPTOM MANAG, V15, P220, DOI 10.1016/S0885-3924(98)00366-2; SOURKES B M, 1991, Journal of Psychosocial Oncology, V9, P81, DOI 10.1300/J077v09n02_06; Sourkes BM, 1996, J PALLIATIVE CARE, V12, P56, DOI 10.1177/082585979601200312; Steiner N, 1998, J PALLIAT CARE, V14, P6, DOI 10.1177/082585979801400202; Stevens M.M., 1998, OXFORD TXB PALLIATIV, P1045; TAKETOMO CK, 2003, PEDIAT DOSAGE HDB; Tobias JD, 2000, PEDIATR CLIN N AM, V47, P527, DOI 10.1016/S0031-3955(05)70224-8; Vullo-Navich K, 1998, Am J Hosp Palliat Care, V15, P77, DOI 10.1177/104990919801500205; Waller A, 1994, Am J Hosp Palliat Care, V11, P22; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; WILWERDING MB, 1995, SUPPORT CARE CANCER, V3, P135, DOI 10.1007/BF00365854; Wolfe J, 2002, PEDIATR CLIN N AM, V49, P1043, DOI 10.1016/S0031-3955(02)00034-2; Wolfe J, 2000, NEW ENGL J MED, V342, P326, DOI 10.1056/NEJM200002033420506; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469; Wolfe J, 2000, J CLIN ETHIC, V11, P157; Worden JW., 1996, CHILDREN GRIEF PAREN; 2000, EVIDENCE BASED SYMPT	72	70	70	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2004	292	17					2141	2149		10.1001/jama.292.17.2141	http://dx.doi.org/10.1001/jama.292.17.2141			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868OC	15523075				2022-12-24	WOS:000224921900027
J	Frank, RAW; Titman, CM; Pratap, JV; Luisi, BF; Perham, RN				Frank, RAW; Titman, CM; Pratap, JV; Luisi, BF; Perham, RN			A molecular switch and proton wire synchronize the active sites in thiamine enzymes	SCIENCE			English	Article							DEHYDROGENASE MULTIENZYME COMPLEX; YEAST PYRUVATE-DECARBOXYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BACILLUS-STEAROTHERMOPHILUS; 3-DIMENSIONAL STRUCTURE; REGULATORY PROPERTIES; ANGSTROM RESOLUTION; STRUCTURAL BASIS; E1 COMPONENT	Thiamine diphosphate (ThDP) is used as a cofactor in many key metabolic enzymes. We present evidence that the ThDPs in the two active sites of the E1 (EC 1.2.4.1) component of the pyruvate dehydrogenase complex communicate over a distance of 20 angstroms by reversibly shuttling a proton through an acidic tunnel in the protein. This "proton wire" permits the cofactors to serve reciprocally as general acid/base in catalysis and to switch the conformation of crucial active-site peptide loops. This synchronizes the progression of chemical events and can account for the oligomeric organization, conformational asymmetry, and "ping-pong" kinetic properties of E1 and other thiamine-dependent enzymes.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	ben@cryst.bioc.cam.ac.uk; r.n.perham@bioc.cam.ac.uk	Titman, Christopher M/M-2223-2013	Titman, Christopher M/0000-0001-8698-8352; Frank, Rene/0000-0001-9724-9547				AEvarsson A, 2000, STRUCTURE, V8, P277, DOI 10.1016/S0969-2126(00)00105-2; AEvarsson A, 1999, NAT STRUCT BIOL, V6, P785; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; BISSWANGER H, 1971, EUR J BIOCHEM, V24, P376, DOI 10.1111/j.1432-1033.1971.tb19696.x; BRESLOW R, 1957, J AM CHEM SOC, V79, P1762, DOI 10.1021/ja01564a064; Caines MEC, 2004, J BIOL CHEM, V279, P5685, DOI 10.1074/jbc.M310803200; Chauhan HJ, 2000, EUR J BIOCHEM, V267, P7158, DOI 10.1046/j.1432-1327.2000.01820.x; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; FRANK R, UNPUB; Fries M, 2003, BIOCHEMISTRY-US, V42, P6996, DOI 10.1021/bi027397z; Hawksley D, 2001, J CHEM SOC PERK T 1, P144, DOI 10.1039/b006962k; HORN F, 1983, J BIOL CHEM, V258, P6912; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jones DD, 2001, J MOL BIOL, V305, P49, DOI 10.1006/jmbi.2000.4257; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Latimer WM, 1920, J AM CHEM SOC, V42, P1419, DOI 10.1021/ja01452a015; Lessard IAD, 1996, BIOCHEMISTRY-US, V35, P16863, DOI 10.1021/bi961683r; Levitzki A, 1976, Curr Top Cell Regul, V10, P1; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; Nagradova NK, 2001, FEBS LETT, V487, P327, DOI 10.1016/S0014-5793(00)02338-3; Nakai T, 2004, J MOL BIOL, V337, P1011, DOI 10.1016/j.jmb.2004.02.011; Nemeria N, 2002, BIOCHEMISTRY-US, V41, P15459, DOI 10.1021/bi0205909; NIKKOLA M, 1994, J MOL BIOL, V238, P387, DOI 10.1006/jmbi.1994.1299; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Schellenberger A, 1998, BBA-PROTEIN STRUCT M, V1385, P177, DOI 10.1016/S0167-4838(98)00067-3; Schellenberger A, 1997, METHOD ENZYMOL, V279, P131; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; SUGDEN PH, 1978, BIOCHEM J, V173, P659, DOI 10.1042/bj1730659; SUNDSTROM M, 1992, FEBS LETT, V313, P229, DOI 10.1016/0014-5793(92)81197-T; Szoke A, 2003, FEBS LETT, V553, P18, DOI 10.1016/S0014-5793(03)01008-1	33	144	146	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					872	876		10.1126/science.1101030	http://dx.doi.org/10.1126/science.1101030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514159				2022-12-24	WOS:000224969400047
J	Madara, J				Madara, J			Building an intestine - Architectural contributions of commensal bacteria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Madara, J (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002	4	30	36	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1685	1686		10.1056/NEJMcibr042621	http://dx.doi.org/10.1056/NEJMcibr042621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483290				2022-12-24	WOS:000224427300019
J	Noskov, SY; Berneche, S; Roux, B				Noskov, SY; Berneche, S; Roux, B			Control of ion selectivity in potassium channels by electrostatic and dynamic properties of carbonyl ligands	NATURE			English	Article							K+ CHANNEL; CONDUCTION; PERMEATION; ENERGY; FILTER; NA+; SIMULATIONS; MUTATIONS; OCCUPANCY; PROTEINS	Potassium channels are essential for maintaining a normal ionic balance across cell membranes. Central to this function is the ability of such channels to support transmembrane ion conduction at nearly diffusion-limited rates while discriminating for K+ over Na+ by more than a thousand-fold. This selectivity arises because the transfer of the K+ ion into the channel pore is energetically favoured, a feature commonly attributed to a structurally precise fit between the K+ ion and carbonyl groups lining the rigid and narrow pore(1). But proteins are relatively flexible structures(2,3) that undergo rapid thermal atomic fluctuations larger than the small difference in ionic radius between K+ and Na+. Here we present molecular dynamics simulations for the potassium channel KcsA, which show that the carbonyl groups coordinating the ion in the narrow pore are indeed very dynamic ('liquid-like') and that their intrinsic electrostatic properties control ion selectivity. This finding highlights the importance of the classical concept of field strength(4). Selectivity for K+ is seen to emerge as a robust feature of a flexible fluctuating pore lined by carbonyl groups.	Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, New York, NY 10021 USA; Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland	Cornell University; University of Basel	Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, 1300 York Ave, New York, NY 10021 USA.	benoit.roux@med.cornell.edu	Noskov, Sergei/B-3654-2010; Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094; Noskov, Sergei/0000-0001-7769-335X				Allen TW, 2000, J CHEM PHYS, V112, P8191, DOI 10.1063/1.481420; ALLEN TW, IN PRESS J GEN PHYSL; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; AQVIST J, 1992, J PHYS CHEM-US, V96, P10019, DOI 10.1021/j100203a079; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; EISENMAN G, 1962, Biophys J, V2, P259; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Luzhkov VB, 2001, BBA-PROTEIN STRUCT M, V1548, P194, DOI 10.1016/S0167-4838(01)00213-8; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARRONE TJ, 1995, J AM CHEM SOC, V117, P779, DOI 10.1021/ja00107a022; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614; Pauling L, 1960, NATURE CHEM BOND, VThird, P644; Shrivastava IH, 2002, BIOPHYS J, V83, P633, DOI 10.1016/S0006-3495(02)75197-7; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	32	426	436	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					830	834		10.1038/nature02943	http://dx.doi.org/10.1038/nature02943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483608				2022-12-24	WOS:000224435500043
J	Xu, X; Norell, MA				Xu, X; Norell, MA			A new troodontid dinosaur from China with avian-like sleeping posture	NATURE			English	Article							EVOLUTION; THEROPODA; SKULL	Discovering evidence of behaviour in fossilized vertebrates is rare. Even rarer is evidence of behaviour in non-avialan dinosaurs that directly relates to stereotypical behaviour seen in extant birds (avians) and not previously predicted in non-avialan dinosaurs(1,2). Here we report the discovery of a new troodontid taxon from the Early Cretaceous Yixian Formation of western Liaoning, China. Numerous other three-dimensionally preserved vertebrate fossils have been recovered recently at this locality, including some specimens preserving behavioural information(3). The new troodontid preserves several features that have been implicated in avialan origins. Notably, the specimen is preserved in the stereotypical sleeping or resting posture found in extant Aves(4). Evidence of this behaviour outside of the crown group Aves further demonstrates that many bird features occurred early in dinosaurian evolution(5,6).	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xu@amnh.org; xingxu@vip.sina.com						Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chang M., 2003, JEHOL BIOTA; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Clark James M., 1999, American Museum Novitates, V3265, P1; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; Elzanowski Andrzej, 2002, P129; Guo ZF, 2003, SCI CHINA SER D, V46, P1261, DOI 10.1360/03yd0071; HILL RW, 1980, PHYSIOL ZOOL, V53, P305, DOI 10.1086/physzool.53.3.30155793; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Loope DB, 1998, GEOLOGY, V26, P27, DOI 10.1130/0091-7613(1998)026<0027:LADIAL>2.3.CO;2; Makovicky PJ, 2003, AM MUS NOVIT, P1; Marsh R.L., 1989, Advances in Comparative and Environmental Physiology, V4, P205; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1997, American Museum Novitates, V3215, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Schweitzer MH, 2001, J EXP ZOOL, V291, P317, DOI 10.1002/jez.1132; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; WING LW, 1956, NATURAL HIST BIRDS; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD	30	163	180	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					838	841		10.1038/nature02898	http://dx.doi.org/10.1038/nature02898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483610				2022-12-24	WOS:000224435500045
J	Xu, X; Norell, MA; Kuang, XW; Wang, XL; Zhao, Q; Jia, CK				Xu, X; Norell, MA; Kuang, XW; Wang, XL; Zhao, Q; Jia, CK			Basal tyrannosauroids from China and evidence for protofeathers in tyrannosauroids	NATURE			English	Article							NORTH-AMERICA; DINOSAURIA; EVOLUTION; THEROPOD; INFORMATION; ANATOMY	Tyrannosauroids are one of the last and the most successful large-bodied predatory dinosaur groups(1-5), but their early history remains poorly understood. Here we report a new basal tyrannosauroid from the Early Cretaceous Yixian Formation of western Liaoning, China, which is small and gracile and has relatively long arms with three-fingered hands. The new taxon is the earliest known unquestionable tyrannosauroid found so far(6-9). It shows a mosaic of characters, including a derived cranial structure resembling that of derived tyrannosauroids(1-5) and a primitive postcranial skeleton similar to basal coelurosaurians. One of the specimens also preserves a filamentous integumentary covering similar to that of other coelurosaurian theropods from western Liaoning. This provides the first direct fossil evidence that tyrannosauroids had protofeathers.	Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Tianjin Museum Nat Hist, Tianjin 300074, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	xu@amnh.org; norell@amnh.org						Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Buffetaut E, 1996, NATURE, V381, P689, DOI 10.1038/381689a0; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P227; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Currie PJ, 2001, CAN J EARTH SCI, V38, P1729, DOI 10.1139/e01-042; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Gauthier JA., 1986, ORIGIN BIRDS EVOLUTI, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz Thomas R. Jr, 2001, P64; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Manabe M, 1999, J PALEONTOL, V73, P1176, DOI 10.1017/S002233600003105X; Martin LD, 2000, AM ZOOL, V40, P687, DOI 10.1668/0003-1569(2000)040[0687:TFROFE]2.0.CO;2; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Spinage C.A., 1994, ELEPHANTS; Swisher C.C., 2001, CHINESE SCI BULL, V46, P2009; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X., 2002, THESIS CHINESE ACAD	30	177	200	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					680	684		10.1038/nature02855	http://dx.doi.org/10.1038/nature02855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470426	Green Published			2022-12-24	WOS:000224299300038
J	Hrdy, I; Hirt, RP; Dolezal, P; Bardonova, L; Foster, PG; Tachezy, J; Embley, TM				Hrdy, I; Hirt, RP; Dolezal, P; Bardonova, L; Foster, PG; Tachezy, J; Embley, TM			Trichomonas hydrogenosomes contain the NADH dehydrogenase module of mitochondrial complex I	NATURE			English	Article							PYRUVATE METABOLISM; VAGINALIS; EVOLUTION; EUKARYOTE; CHLOROPLASTS; DNA	Hydrogenosomes are double-membraned ATP-producing and hydrogen-producing organelles of diverse anaerobic eukaryotes(1). In some versions of endosymbiotic theory they are suggested to be homologues of mitochondria(2-4), but alternative views suggest they arose from an anaerobic bacterium that was distinct from the mitochondrial endosymbiont(5,6). Here we show that the 51-kDa and 24-kDa subunits of the NADH dehydrogenase module in complex I, the first step in the mitochondrial respiratory chain(7), are active in hydrogenosomes of Trichomonas vaginalis. Like mitochondrial NADH dehydrogenase, the purified Trichomonas enzyme can reduce a variety of electron carriers including ubiquinone, but unlike the mitochondrial enzyme it can also reduce ferredoxin, the electron carrier used(1) for hydrogen production. The presence of NADH dehydrogenase solves the long-standing conundrum of how hydrogenosomes regenerate NAD(+) after malate oxidation. Phylogenetic analyses show that the Trichomonas 51-kDa homologue shares common ancestry with the mitochondrial enzyme. Recruitment of complex I subunits into a H-2-producing pathway provides evidence that mitochondria and hydrogenosomes are aerobic and anaerobic homologues of the same endosymbiotically derived organelle.	Charles Univ Prague, Dept Parasitol, CR-12844 Prague 2, Czech Republic; Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England	Charles University Prague; Newcastle University - UK; Natural History Museum London	Tachezy, J (corresponding author), Charles Univ Prague, Dept Parasitol, Vinicna 7, CR-12844 Prague 2, Czech Republic.	tachezy@natur.cuni.cz; martin.embley@ncl.ac.uk	Dolezal, Pavel/V-1907-2017; Hirt, Robert/R-5429-2017; Hrdý, Ivan/K-8931-2017; Tachezy, Jan/R-4945-2017	Dolezal, Pavel/0000-0003-1285-9026; Hirt, Robert/0000-0002-3760-9958; Hrdý, Ivan/0000-0002-5595-9177; Tachezy, Jan/0000-0001-6976-8446; Foster, Peter/0000-0003-0194-9237; Embley, Thomas Martin/0000-0002-1484-340X				Benchimol M, 1996, BIOL CELL, V87, P197, DOI 10.1016/S0248-4900(97)89276-3; Biagini GA, 1997, FEMS MICROBIOL LETT, V155, P133, DOI 10.1016/S0378-1097(97)00333-9; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; Delsuc F, 2003, SCIENCE, V301, P1482; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; EMBLEY TM, 1995, P ROY SOC B-BIOL SCI, V262, P87, DOI 10.1098/rspb.1995.0180; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Gaziova I, 2003, J BIOL CHEM, V278, P10900, DOI 10.1074/jbc.M202347200; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; OWEN R, 1843, LECT COMP PHYSL INVE; PILKINGTON SJ, 1991, BIOCHEMISTRY-US, V30, P2166, DOI 10.1021/bi00222a021; Plumper E, 1998, PROTIST, V149, P303, DOI 10.1016/S1434-4610(98)70037-9; Rasoloson D, 2002, MICROBIOL-SGM, V148, P2467, DOI 10.1099/00221287-148-8-2467; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotte C, 2001, MOL BIOL EVOL, V18, P710, DOI 10.1093/oxfordjournals.molbev.a003853; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; WHATLEY JM, 1979, PROC R SOC SER B-BIO, V204, P165, DOI 10.1098/rspb.1979.0020; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yano T, 2002, MOL ASPECTS MED, V23, P345, DOI 10.1016/S0098-2997(02)00011-0	30	201	206	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					618	622		10.1038/nature03149	http://dx.doi.org/10.1038/nature03149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577909				2022-12-24	WOS:000225433200045
J	Wang, YQ; Dohlman, HG				Wang, YQ; Dohlman, HG			Pheromone signaling mechanisms in yeast: A prototypical sex machine	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE REQUIRES; G-PROTEIN; GLOBAL ANALYSIS; FACTOR RECEPTOR; GAMMA-SUBUNITS; UBIQUITINATION; TRANSDUCTION; KINASES; GENOME	The actions of many extracellular stimuli are elicited by complexes of cell surface receptors, heterotrimeric guanine nucleotide-binding proteins (G proteins), and mitogen-activated protein (MAP) kinase complexes. Analysis of haploid yeast cells and their response to peptide mating pheromones has produced important advances in our understanding of G,protein and MAP kinase signaling mechanisms. Many of the components, their interrelationships, and-their regulators were first identified in yeast. Current analysis of the pheromone response pathway (see the Connections Maps at Science's Signal Transduction Knowledge Environment) will benefit from new and powerful genomic, proteomic, and computational approaches that will likely reveal additional general principles that are applicable to more complex organisms.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729				CHOI KY, 1994, CELL, V78, P499; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; DOHLMAN HG, 2004, SCI STKE         NOV; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Truckses DM, 2004, SCIENCE, V306, P1509, DOI 10.1126/science.1104677; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; ZHAO ZS, 1995, MOL CELL BIOL, V15, P5246; ZHOU ZQ, 1993, MOL CELL BIOL, V13, P2069, DOI 10.1128/MCB.13.4.2069	19	73	76	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1508	1509		10.1126/science.1104568	http://dx.doi.org/10.1126/science.1104568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567849				2022-12-24	WOS:000225442700043
J	Pham, CG; Bubici, C; Zazzeroni, F; Papa, S; Jones, J; Alvarez, K; Jayawardena, S; De Smaele, E; Cong, R; Beaumont, C; Torti, FM; Torti, SV; Franzoso, G				Pham, CG; Bubici, C; Zazzeroni, F; Papa, S; Jones, J; Alvarez, K; Jayawardena, S; De Smaele, E; Cong, R; Beaumont, C; Torti, FM; Torti, SV; Franzoso, G			Ferritin heavy chain upregulation by NF-kappa B inhibits TNF alpha-induced apoptosis by suppressing reactive oxygen species	CELL			English	Article							OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; CELL-DEATH; JNK; ACTIVATION; IRON; TARGET; ROS; GADD45-BETA; INDUCTION	During inflammation, NF-kappaB transcription factors antagonize apoptosis induced by tumor necrosis factor (TNF)alpha. This antiapoptotic activity of NF-kappaB involves suppressing the accumulation of reactive oxygen species (ROS) and controlling the activation of the c-Jun N-terminal kinase (JNK) cascade. However, the mechanism(s) by which NF-kappaB inhibits ROS accumulation is unclear. We identify ferritin heavy chain (FHC)-the primary iron storage factor-as an essential mediator of the antioxidant and protective activities of NF-kappaB. FHC is induced downstream of NF-kappaB and is required to prevent sustained JNK activation and, thereby, apoptosis triggered by TNFalpha. FHC-mediated inhibition of JNK signaling depends on suppressing ROS accumulation and is achieved through iron sequestration. These findings establish a basis for the NF-kappaB-mediated control of ROS induction and identify a mechanism by which NF-kappaB suppresses proapoptotic JNK signaling. Our results suggest modulation of FHC or, more broadly, of iron metabolism as a potential approach for anti-inflammatory therapy.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; CHU Bichat, Serv Hematol & Immunol Biol, INSERM, U409, Paris, France; Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	University of Chicago; University of Chicago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Wake Forest University; Wake Forest University	Franzoso, G (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.	gfranzos@midway.uchicago.edu	De Smaele, Enrico/C-1124-2013; Papa, Salvatore/J-9413-2012; Franzoso, Guido/GRR-8628-2022	De Smaele, Enrico/0000-0003-4524-4423; Papa, Salvatore/0000-0002-8369-6538; Zazzeroni, Francesca/0000-0002-4474-3274; Bubici, Concetta/0000-0002-8074-4661; Franzoso, Guido/0000-0002-0778-988X	NATIONAL CANCER INSTITUTE [R01CA084040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042412, R37DK042412] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA84040] Funding Source: Medline; NHLBI NIH HHS [HL07237] Funding Source: Medline; NIDDK NIH HHS [DK42412] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Bernard D, 2001, CANCER RES, V61, P2656; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cozzi A, 2003, FEBS LETT, V537, P187, DOI 10.1016/S0014-5793(03)00114-5; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Gerondakis S, 2003, SEMIN IMMUNOL, V15, P159, DOI 10.1016/S1044-5323(03)00036-8; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Smirnov IM, 1999, AM J PHYSIOL-LUNG C, V277, pL257, DOI 10.1152/ajplung.1999.277.2.L257; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Vulcano M, 2000, INT J IMMUNOPHARMACO, V22, P635, DOI 10.1016/S0192-0561(00)00026-6; Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193; Yang DC, 2002, ANTICANCER RES, V22, P1513; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	39	501	521	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					529	542		10.1016/j.cell.2004.10.017	http://dx.doi.org/10.1016/j.cell.2004.10.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537542	Bronze			2022-12-24	WOS:000225183200011
J	Gregory, RI; Yan, KP; Amuthan, G; Chendrimada, T; Doratotaj, B; Cooch, N; Shiekhattar, R				Gregory, RI; Yan, KP; Amuthan, G; Chendrimada, T; Doratotaj, B; Cooch, N; Shiekhattar, R			The Microprocessor complex mediates the genesis of microRNAs	NATURE			English	Article							RNASE-III; EXPRESSION; BRCA1	MicroRNAs (miRNAs) are a growing family of small non-protein-coding regulatory genes that regulate the expression of homologous target-gene transcripts. They have been implicated in the control of cell death and proliferation in flies(1,2), haematopoietic lineage differentiation in mammals(3), neuronal patterning in nematodes(4) and leaf and flower development in plants(5-8). miRNAs are processed by the RNA-mediated interference machinery. Drosha is an RNase III enzyme that was recently implicated in miRNA processing. Here we show that human Drosha is a component of two multi-protein complexes. The larger complex contains multiple classes of RNA-associated proteins including RNA helicases, proteins that bind double-stranded RNA, novel heterogeneous nuclear ribonucleoproteins and the Ewing's sarcoma family of proteins. The smaller complex is composed of Drosha and the double-stranded-RNA-binding protein, DGCR8, the product of a gene deleted in DiGeorge syndrome. In vivo knock-down and in vitro reconstitution studies revealed that both components of this smaller complex, termed Microprocessor, are necessary and sufficient in mediating the genesis of miRNAs from the primary miRNA transcript.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.upenn.edu						Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yamagishi H, 2003, TRENDS MOL MED, V9, P383, DOI 10.1016/S1471-4914(03)00141-2; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	23	1971	2110	3	188	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					235	240		10.1038/nature03120	http://dx.doi.org/10.1038/nature03120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15531877				2022-12-24	WOS:000225020200050
J	Groopman, J				Groopman, J			Doctors and patients: A great case	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Groopman, J (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2004	351	20					2043	2045		10.1056/NEJMp048032	http://dx.doi.org/10.1056/NEJMp048032			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	869TM	15537903				2022-12-24	WOS:000225007200004
J	Gahrton, G				Gahrton, G			New therapeutic targets in multiple myeloma	LANCET			English	Editorial Material							STEM-CELL TRANSPLANTATION; MARROW TRANSPLANTATION; BONE-MARROW; LEUKEMIA; CHEMOTHERAPY		Karolinska Inst, Huddinge Hosp, Dept Med, S-14186 Huddinge, Sweden	Karolinska Institutet	Gahrton, G (corresponding author), Karolinska Inst, Huddinge Hosp, Dept Med, S-14186 Huddinge, Sweden.	Gosta.Gahrton@medhs.ki.se						Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Corradini P, 2003, BLOOD, V102, P1927, DOI 10.1182/blood-2003-01-0189; Gahrton G, 2001, BRIT J HAEMATOL, V113, P209, DOI 10.1046/j.1365-2141.2001.02726.x; Goldman JM, 2004, EXP HEMATOL, V32, P2, DOI 10.1016/j.exphem.2003.10.001; Guven H, 2003, LEUKEMIA, V17, P1973, DOI 10.1038/sj.leu.2403083; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Sirohi B, 2004, LANCET, V363, P875, DOI 10.1016/S0140-6736(04)15736-X; ABOUT MMRC	12	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 6	2004	364	9446					1648	1649		10.1016/S0140-6736(04)17371-6	http://dx.doi.org/10.1016/S0140-6736(04)17371-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868NZ	15530610				2022-12-24	WOS:000224921600008
J	Marlovits, TC; Kubori, T; Sukhan, A; Thomas, DR; Galan, JE; Unger, VM				Marlovits, TC; Kubori, T; Sukhan, A; Thomas, DR; Galan, JE; Unger, VM			Structural insights into the assembly of the type III secretion needle complex	SCIENCE			English	Article							PROTEINS	Type III secretion systems (TTSSs) mediate translocation of virulence factors into host cells. We report the 17-angstrom resolution structures of a central component of Salmonella typhimurium TTSS, the needle complex, and its assembly precursor, the bacterial envelope-anchored base. Both the base and the fully assembled needle complex adopted multiple oligomeric states in vivo, and needle assembly was accompanied by recruitment of the protein PrgJ as a structural component of the base. Moreover, conformational changes during needle assembly created scaffolds for anchoring both PrgJ and the needle substructure and may provide the basis for substrate-specificity switching during type III secretion.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Microbial Pathogenet, New Haven, CT 06536 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA	Yale University; Yale University; Brandeis University	Unger, VM (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	vinzenz.unger@yale.edu	Kubori, Tomoko/AAH-3609-2019; Marlovits, Thomas/A-3568-2019	Kubori, Tomoko/0000-0003-1098-6021; Marlovits, Thomas/0000-0001-8106-4038	NCRR NIH HHS [P42 RR-01081] Funding Source: Medline; NIAID NIH HHS [AI30492] Funding Source: Medline; NIGMS NIH HHS [GM35433, R01 GM066145, GM66145] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030492, R37AI030492, R01AI030492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035433, R01GM066145, R37GM035433] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; MARLOVITS TC, UNPUB; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8	14	300	306	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1040	1042		10.1126/science.1102610	http://dx.doi.org/10.1126/science.1102610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528446	Green Accepted			2022-12-24	WOS:000225001100045
J	Arendt, D; Tessmar-Raible, K; Snyman, H; Dorresteijn, AW; Wittbrodt, J				Arendt, D; Tessmar-Raible, K; Snyman, H; Dorresteijn, AW; Wittbrodt, J			Ciliary photoreceptors with a vertebrate-type opsin in an invertebrate brain	SCIENCE			English	Article							CIRCADIAN-RHYTHMS; HOMEOBOX GENE; PINEAL-GLAND; EYE; TRANSDUCIN; EXPRESSION; ZEBRAFISH; RHODOPSIN; EVOLUTION; LOOP	For vision, insect and vertebrate eyes use rhabdomeric and ciliary photoreceptor cells, respectively. These cells show distinct architecture and transduce the light signal by different phototransductory cascades. In the marine rag-worm Platynereis, we find both cell types: rhabdomeric photoreceptor cells in the eyes and ciliary photoreceptor cells in the brain. The latter use a photopigment closely related to vertebrate rod and cone opsins. Comparative analysis indicates that both types of photoreceptors, with distinct opsins, coexisted in Urbilateria, the last common ancestor of insects and vertebrates, and sheds new light on vertebrate eye evolution.	European Mol Biol Lab, Dept Dev Biol, D-69012 Heidelberg, Germany; Univ Marburg, Inst Spezielle Zool, D-35032 Marburg, Germany; Univ Giessen, Inst Allgemeine & Spezielle Zool, D-35390 Giessen, Germany	European Molecular Biology Laboratory (EMBL); Philipps University Marburg; Justus Liebig University Giessen	Arendt, D (corresponding author), European Mol Biol Lab, Dept Dev Biol, Meyerhofstr 1, D-69012 Heidelberg, Germany.	detlev.arendt@embl.de; jochen.wittbrodt@embl.de	Wittbrodt, Joachim/D-4735-2014; Tessmar-Raible, Kristin/F-9642-2011	Wittbrodt, Joachim/0000-0001-8550-7377; Tessmar-Raible, Kristin/0000-0002-8038-1741; Dorresteijn, Adriaan/0000-0003-2314-1634				Arendt D, 2003, INT J DEV BIOL, V47, P563; Arendt D, 2002, DEVELOPMENT, V129, P1143; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Chen CMA, 2002, DEVELOPMENT, V129, P5363, DOI 10.1242/dev.00114; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Deschet K, 1999, MECH DEVELOP, V83, P179, DOI 10.1016/S0925-4773(99)00037-4; DHAINAUT.N, 1965, CR HEBD ACAD SCI, V261, P1085; EDWARDS PR, COMMUNICATION; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Fukada Y, 2002, MOL NEUROBIOL, V25, P19, DOI 10.1385/MN:25:1:019; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Raible F, 2004, CURR BIOL, V14, pR106, DOI 10.1016/j.cub.2004.01.015; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; VERNET G, 1974, Annales des Sciences Naturelles Zoologie et Biologie Animale, V16, P27; Vigh B, 2002, HISTOL HISTOPATHOL, V17, P555, DOI 10.14670/HH-17.555; von Salvini-Plawen L, 1977, EVOLUTIONARY BIOL, P207; WHITTLE AC, 1974, CELL TISSUE RES, V154, P379; WILSON SW, 1991, DEVELOPMENT, V112, P723	24	277	285	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					869	871		10.1126/science.1099955	http://dx.doi.org/10.1126/science.1099955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514158				2022-12-24	WOS:000224969400046
J	Gil, L; Fuentes-Utrilla, P; Soto, A; Cervera, MT; Collada, C				Gil, L; Fuentes-Utrilla, P; Soto, A; Cervera, MT; Collada, C			English elm is a 2,000-year-old Roman clone	NATURE			English	Editorial Material									UPM, Escuela Tecn Super Ingenieros Montes, Dept Silvopascicultura, Madrid 28040, Spain; UPM, Escuela Tecn Super Ingenieros Montes, Dept Biotecnol, Madrid 28040, Spain; Inst Nacl Invest Agr, Madrid 28040, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Gil, L (corresponding author), UPM, Escuela Tecn Super Ingenieros Montes, Dept Silvopascicultura, Ciudad Univ S-N, Madrid 28040, Spain.	lgil@montes.upm.es	Cervera, M. Teresa/G-9181-2012; Gil, Luis/E-3216-2014; Collada, Carmen/H-1529-2015; Soto, Alvaro/E-3737-2012	Cervera, M. Teresa/0000-0001-6797-2347; Gil, Luis/0000-0002-5252-2607; Collada, Carmen/0000-0003-0236-1312; Soto, Alvaro/0000-0002-0144-1399				ASH HB, 1941, LJ MODERATUS COLUMEL; BRASIER CM, 1996, FOREST COMM REP FORE, P20; Brown AG, 2001, ANTIQUITY, V75, P745, DOI 10.1017/S0003598X00089250; COLLADA C, IN PRESS MOL ECOL NO; DumolinLapegue S, 1997, GENETICS, V146, P1475; FORSTER ES, 1954, LJ MODERATUS COLUMEL, V2; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HEYBROEK HM, 2000, FORESTRY COMPENDIUM; Lopez-Almansa JC, 2003, AM J BOT, V90, P603, DOI 10.3732/ajb.90.4.603; MARTIN R, 1971, RECH ARONOMES LATINS; Richens RH., 1983, ELM; Tovar A, 1975, HOMENAJE NACL LJ MOD, P93	12	69	75	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2004	431	7012					1053	1053		10.1038/4311053a	http://dx.doi.org/10.1038/4311053a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510138				2022-12-24	WOS:000224730800029
J	Solanki, SK; Usoskin, IG; Kromer, B; Schussler, M; Beer, J				Solanki, SK; Usoskin, IG; Kromer, B; Schussler, M; Beer, J			Unusual activity of the Sun during recent decades compared to the previous 11,000 years	NATURE			English	Article							SOLAR MODULATION; BE-10; C-14; FIELD	Direct observations of sunspot numbers are available for the past four centuries(1,2), but longer time series are required, for example, for the identification of a possible solar influence on climate and for testing models of the solar dynamo. Here we report a reconstruction of the sunspot number covering the past 11,400 years, based on dendrochronologically dated radiocarbon concentrations. We combine physics-based models for each of the processes connecting the radiocarbon concentration with sunspot number. According to our reconstruction, the level of solar activity during the past 70 years is exceptional, and the previous period of equally high activity occurred more than 8,000 years ago. We find that during the past 11,400 years the Sun spent only of the order of 10% of the time at a similarly high level of magnetic activity and almost all of the earlier high-activity periods were shorter than the present episode. Although the rarity of the current episode of high average sunspot numbers may indicate that the Sun has contributed to the unusual climate change during the twentieth century, we point out that solar variability is unlikely to have been the dominant cause of the strong warming during the past three decades(3).	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Oulu, Oulu Unit, Sodankyla Geophys Observ, Oulu, Finland; Heidelberger Akad Wissensch, Inst Umweltphys, D-69120 Heidelberg, Germany; EAWAG, Dept Surface Waters, CH-8600 Dubendorf, Switzerland	Max Planck Society; University of Oulu; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Solanki, SK (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany.	solanki@mps.mpg.de	Usoskin, Ilya G./E-5089-2014; Solanki, Sami K/E-2487-2013	Usoskin, Ilya G./0000-0001-8227-9081; Solanki, Sami K/0000-0002-3418-8449				Bard E, 1997, EARTH PLANET SC LETT, V150, P453, DOI 10.1016/S0012-821X(97)00082-4; Beer J, 2000, SPACE SCI REV, V94, P53, DOI 10.1023/A:1026778013901; BEER J, 1990, NATURE, V347, P164, DOI 10.1038/347164a0; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; BROECKER WS, 1994, NATURE, V367, P414, DOI 10.1038/367414a0; CASTAGNOLI G, 1980, RADIOCARBON, V22, P133, DOI 10.1017/S0033822200009413; Damon P.E., 1991, SUN TIME, P360; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; ELSASSER W, 1956, NATURE, V178, P1226, DOI 10.1038/1781226a0; Hongre L, 1998, PHYS EARTH PLANET IN, V106, P311, DOI 10.1016/S0031-9201(97)00115-5; Hoyt DV, 1998, SOL PHYS, V179, P189, DOI 10.1023/A:1005007527816; MUSCHELER R, 2003, ESA, P305; Solanki SK, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009753; Solanki SK, 2002, ASTRON ASTROPHYS, V383, P706, DOI 10.1051/0004-6361:20011790; Solanki SK, 2000, NATURE, V408, P445, DOI 10.1038/35044027; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; STUIVER M, 1989, NATURE, V338, P405, DOI [10.1038/338405a0, 10.1038/286868a0]; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Stuiver M., 1993, HOLOCENE, V3, P289, DOI DOI 10.1177/095968369300300401; SUESS HE, 1955, SCIENCE, V122, P415, DOI 10.1126/science.122.3166.415-a; Usoskin IG, 2004, ASTRON ASTROPHYS, V413, P745, DOI 10.1051/0004-6361:20031533; Usoskin IG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.211101; Usoskin IG, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009343; Usoskin IG, 2002, SOL PHYS, V207, P389, DOI 10.1023/A:1016266801300; USOSKIN IG, IN PRESS RADIOCARBON; Yang S, 2000, GEOPHYS J INT, V140, P158, DOI 10.1046/j.1365-246x.2000.00011.x	26	643	681	9	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1084	1087		10.1038/nature02995	http://dx.doi.org/10.1038/nature02995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510145				2022-12-24	WOS:000224730800037
J	Jaillon, O; Aury, JM; Brunet, F; Petit, JL; Stange-Thomann, N; Mauceli, E; Bouneau, L; Fischer, C; Ozouf-Costaz, C; Bernot, A; Nicaud, S; Jaffe, D; Fisher, S; Lutfalla, G; Dossat, C; Segurens, B; Dasilva, C; Salanoubat, M; Levy, M; Boudet, N; Castellano, S; Anthouard, R; Jubin, C; Castelli, V; Katinka, M; Vacherie, B; Biemont, C; Skalli, Z; Cattolico, L; Poulain, J; de Berardinis, V; Cruaud, C; Duprat, S; Brottier, P; Coutanceau, JP; Gouzy, J; Parra, G; Lardier, G; Chapple, C; McKernan, KJ; McEwan, P; Bosak, S; Kellis, M; Volff, JN; Guigo, R; Zody, MC; Mesirov, J; Lindblad-Toh, K; Birren, B; Nusbaum, C; Kahn, D; Robinson-Rechavi, M; Laudet, V; Schachter, V; Quetier, F; Saurin, W; Scarpelli, C; Wincker, P; Lander, ES; Weissenbach, J; Roest Crollius, H				Jaillon, O; Aury, JM; Brunet, F; Petit, JL; Stange-Thomann, N; Mauceli, E; Bouneau, L; Fischer, C; Ozouf-Costaz, C; Bernot, A; Nicaud, S; Jaffe, D; Fisher, S; Lutfalla, G; Dossat, C; Segurens, B; Dasilva, C; Salanoubat, M; Levy, M; Boudet, N; Castellano, S; Anthouard, R; Jubin, C; Castelli, V; Katinka, M; Vacherie, B; Biemont, C; Skalli, Z; Cattolico, L; Poulain, J; de Berardinis, V; Cruaud, C; Duprat, S; Brottier, P; Coutanceau, JP; Gouzy, J; Parra, G; Lardier, G; Chapple, C; McKernan, KJ; McEwan, P; Bosak, S; Kellis, M; Volff, JN; Guigo, R; Zody, MC; Mesirov, J; Lindblad-Toh, K; Birren, B; Nusbaum, C; Kahn, D; Robinson-Rechavi, M; Laudet, V; Schachter, V; Quetier, F; Saurin, W; Scarpelli, C; Wincker, P; Lander, ES; Weissenbach, J; Roest Crollius, H			Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype	NATURE			English	Article							RAY-FINNED FISHES; DNA-SEQUENCE; GENE DUPLICATION; SACCHAROMYCES-CEREVISIAE; COMPACT GENOME; ANIMAL GENOMES; EVOLUTION; CHROMOSOME; NUCLEOTIDE; ORIGIN	Tetraodon nigroviridis is a freshwater puffer fish with the smallest known vertebrate genome. Here, we report a draft genome sequence with long-range linkage and substantial anchoring to the 21 Tetraodon chromosomes. Genome analysis provides a greatly improved fish gene catalogue, including identifying key genes previously thought to be absent in fish. Comparison with other vertebrates and a urochordate indicates that fish proteins have diverged markedly faster than their mammalian homologues. Comparison with the human genome suggests similar to900 previously unannotated human genes. Analysis of the Tetraodon and human genomes shows that whole-genome duplication occurred in the teleost fish lineage, subsequent to its divergence from mammals. The analysis also makes it possible to infer the basic structure of the ancestral bony vertebrate genome, which was composed of 12 chromosomes, and to reconstruct much of the evolutionary history of ancient and recent chromosome rearrangements leading to the modern human karyotype.	CNRS, UMR Genoscope 8030, F-91057 Evry, France; Univ Evry, F-91057 Evry, France; Ecole Normale Super Lyon, Mol & Cellular Biol Lab, CNRS, UMR 5161,INRA,UMR 1237, F-69364 Lyon 07, France; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard, Cambridge, MA 02141 USA; Museum Natl Hist Nat, Dept Systemat & Evolut, Serv Systemat Mol, CNRS,IFR 101, F-75231 Paris, France; CNRS, UMR 5124, F-34293 Montpellier 5, France; UPF, IMIM, Grp Recerca Informat Biomed, Barcelona, Catalonia, Spain; Programa Bioinformat & Genom, Barcelona, Catalonia, Spain; Univ Lyon 1, CNRS, UMR Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France; INRA, CNRS, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; Agencourt Biosci Corp, Beverly, MA 01915 USA; Univ Wurzburg, Biozentrum, Biofuture Res Grp, D-97074 Wurzburg, Germany; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of Wurzburg; Massachusetts Institute of Technology (MIT); Whitehead Institute	Weissenbach, J (corresponding author), CNRS, UMR Genoscope 8030, 2 Rue Gaston Cremieux, F-91057 Evry, France.	jsbach@genoscope.cns.fr	Jaillon, Olivier/GRY-6287-2022; Kahn, Daniel/B-9393-2013; Gasull, Martina/J-4076-2019; Mesirov, Jill/AGF-7626-2022; Lutfalla, Georges/AAW-9386-2021; Aury, Jean-Marc/N-1621-2019; Robinson-Rechavi, Marc/E-9727-2011; Guigo, Roderic/D-1303-2010; Kellis, Manolis/ABE-7385-2020; Gouzy, Jerome/AAH-4977-2020; Castellano, Sergi/A-7437-2016	Kahn, Daniel/0000-0001-8093-0854; Aury, Jean-Marc/0000-0003-1718-3010; Robinson-Rechavi, Marc/0000-0002-3437-3329; Guigo, Roderic/0000-0002-5738-4477; Kellis, Manolis/0000-0001-7113-9630; Gouzy, Jerome/0000-0001-5695-4557; Cruaud, Corinne/0000-0002-4752-7278; Brunet, Frederic/0000-0001-5145-8925; Poulain, Julie/0000-0002-8744-3116; Parra, Genis/0000-0002-0575-2936; Castellano, Sergi/0000-0002-5819-4210; Petit, Jean-Louis/0000-0002-8566-0571; de Berardinis, Veronique/0000-0002-3273-4135; LUTFALLA, Georges/0000-0002-6591-7894; McKernan, Kevin/0000-0002-3908-1122; Jaillon, Olivier/0000-0002-7237-9596; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; Vacherie, Benoit/0000-0002-1564-0575				Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Artiguenave F, 2000, FEBS LETT, V487, P13, DOI 10.1016/S0014-5793(00)02273-0; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Bouneau L, 2003, GENOME RES, V13, P1686, DOI 10.1101/gr.726003; Chiu CH, 2004, GENOME RES, V14, P11, DOI 10.1101/gr.1712904; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Fischer C, 2000, CYTOGENET CELL GENET, V88, P50, DOI 10.1159/000015484; Friedman R, 2001, GENOME RES, V11, P1842, DOI 10.1101/gr.200601; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Graves JAM, 2002, CYTOGENET GENOME RES, V99, P141, DOI 10.1159/000071585; Grutzner F, 1999, CHROMOSOME RES, V7, P655, DOI 10.1023/A:1009292220760; Gu X, 1996, P NATL ACAD SCI USA, V93, P4671, DOI 10.1073/pnas.93.10.4671; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hatfield D. L., 2001, SELENIUM ITS MOL BIO; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Holland PWH, 1999, SEMIN CELL DEV BIOL, V10, P515, DOI 10.1006/scdb.1999.0331; HOLLAND PWH, 1994, DEVELOPMENT, P125; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Hughes AL, 2001, GENOME RES, V11, P771, DOI 10.1101/gr.GR-1600R; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1985, MOL BIOL EVOL, V2, P150; Martin A, 2001, MOL BIOL EVOL, V18, P89, DOI 10.1093/oxfordjournals.molbev.a003723; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ojima Y., 1983, P111; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Prohaska SJ, 2004, THEOR BIOSCI, V123, P89, DOI 10.1016/j.thbio.2004.03.004; Richard F, 2003, CHROMOSOME RES, V11, P605, DOI 10.1023/A:1024957002755; Robinson-Rechavi M, 2001, CURR BIOL, V11, pR458, DOI 10.1016/S0960-9822(01)00280-9; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Tavare S, 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	57	1476	1578	3	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					946	957		10.1038/nature03025	http://dx.doi.org/10.1038/nature03025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496914	Bronze			2022-12-24	WOS:000224585600035
J	Zhang, FC; Zhou, ZH				Zhang, FC; Zhou, ZH			Leg feathers in an Early Cretaceous bird	NATURE			English	Editorial Material							DINOSAURS		Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhang, FC (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	fuchengzhang@yeah.net						Chang M., 2003, JEHOL BIOTA; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Christiansen P, 2004, CR PALEVOL, V3, P99, DOI 10.1016/j.crpv.2003.12.001; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Gatesy SM, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P333; Norberg R.A., 1985, P303; Norberg U., 1990, VERTEBRATE FLIGHT ME; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; PENNYCUICK CJ, 1972, ANIMAL FLIGHT; Prum RO, 2003, NATURE, V421, P323, DOI 10.1038/421323a; Witmer Lawrence M., 2002, P3; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	13	35	39	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					925	925		10.1038/431925a	http://dx.doi.org/10.1038/431925a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496911	Green Published, Bronze			2022-12-24	WOS:000224585600032
J	Reber, M; Burrola, P; Lemke, G				Reber, M; Burrola, P; Lemke, G			A relative signalling model for the formation of a topographic neural map	NATURE			English	Article							RETINAL AXON GUIDANCE; GANGLION-CELL AXONS; VISUAL-SYSTEM; EPH RECEPTORS; IN-VITRO; PROJECTION; KINASE; ELF-1; CONNECTIONS; MODULATION	The highly ordered wiring of retinal ganglion cell (RGC) neurons in the eye to their synaptic targets in the superior colliculus of the midbrain has long served as the dominant experimental system for the analysis of topographic neural maps(1-3). Here we describe a quantitative model for the development of one arm of this map the wiring of the nasal - temporal axis of the retina to the caudal rostral axis of the superior colliculus. The model is based on RGC - RGC competition that is governed by comparisons of EphA receptor signalling intensity, which are made using ratios of, rather than absolute differences in, EphA signalling between RGCs(4). Molecular genetic experiments, exploiting a combinatorial series of EphA receptor knock-in and knockout mice, confirm the salient predictions of the model, and show that it both describes and predicts topographic mapping.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	lemke@salk.edu	Reber, Michael/D-6250-2012	Reber, Michael/0000-0001-8842-7276				Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FRASER SE, 1980, ANNU REV NEUROSCI, V3, P319, DOI 10.1146/annurev.ne.03.030180.001535; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; SIMON DK, 1992, J NEUROSCI, V12, P1212; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; WALTER J, 1987, DEVELOPMENT, V101, P685; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	30	95	97	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					847	853		10.1038/nature02957	http://dx.doi.org/10.1038/nature02957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483613				2022-12-24	WOS:000224435500048
J	Tu, DC; Batten, ML; Palczewski, K; Van Gelder, RN				Tu, DC; Batten, ML; Palczewski, K; Van Gelder, RN			Nonvisual photoreception in the chick iris	SCIENCE			English	Article							BLUE-LIGHT PHOTORECEPTORS; PROTEIN-KINASES; SMOOTH-MUSCLE; MICE; CRYPTOCHROMES; PHOTOSENSITIVITY; STAUROSPORINE; CONTRACTION; MELANOPSIN; RESPONSES	The embryonic chicken iris constricts to light ex vivo, but with characteristics atypical of visual phototransduction. The chick iris was most sensitive to short-wavelength light, demonstrating an action spectrum consistent with cryptochrome rather than with opsin pigments. Pupillary responses did not attenuate after saturating light exposure, but showed paradoxical potentiation. Iris photosensitivity was not affected by retinoid depletion or inhibitors of visual phototransduction. Knockdown of cryptochrome expression, but not of melanopsin expression, decreased iris photosensitivity. These data characterize a non-opsin photoreception mechanism in a vertebrate eye and suggest a conserved photoreceptive role for cryptochromes in vertebrates.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	Vangelder@vision.wustl.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659				Abdel-Latif AA, 2001, EXP BIOL MED, V226, P153, DOI 10.1177/153537020122600302; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown-Sequard E., 1847, CR HEBD ACAD SCI, V25, P482; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; DEGUCHI T, 1981, NATURE, V290, P706, DOI 10.1038/290706a0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Kureishi Y, 1999, EUR J PHARMACOL, V376, P315, DOI 10.1016/S0014-2999(99)00367-2; McBee JK, 2001, J BIOL CHEM, V276, P48483, DOI 10.1074/jbc.M105840200; Moriya T, 1996, J EXP ZOOL, V276, P11, DOI 10.1002/(SICI)1097-010X(19960901)276:1<11::AID-JEZ2>3.3.CO;2-N; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pasqualetti M, 2003, EUR J NEUROSCI, V18, P364, DOI 10.1046/j.1460-9568.2003.02770.x; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; TU DC, UNPUB; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200	23	48	49	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					129	131		10.1126/science.1101484	http://dx.doi.org/10.1126/science.1101484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459395				2022-12-24	WOS:000224304000053
J	Mueller, AK; Labaied, M; Kappe, SHI; Matuschewski, K				Mueller, AK; Labaied, M; Kappe, SHI; Matuschewski, K			Genetically modified Plasmodium parasites as a protective experimental malaria vaccine	NATURE			English	Article							SPOROZOITE STAGE; GENOME SEQUENCE; BERGHEI; FALCIPARUM; LIVER	Malaria is a mosquito-borne disease that is transmitted by inoculation of the Plasmodium parasite sporozoite stage. Sporozoites invade hepatocytes(1), transform into liver stages, and subsequent liver-stage development ultimately results in release of pathogenic merozoites(2). Liver stages of the parasite are a prime target for malaria vaccines because they can be completely eliminated by sterilizing immune responses, thereby preventing malarial infection(3). Using expression profiling, we previously identified genes that are only expressed in the pre-erythrocytic stages of the parasite(4,5). Here, we show by reverse genetics that one identified gene, UIS3 (upregulated in infective sporozoites gene 3), is essential for early liver-stage development. uis3-deficient sporozoites infect hepatocytes but are unable to establish blood-stage infections in vivo, and thus do not lead to disease. Immunization with uis3-deficient sporozoites confers complete protection against infectious sporozoite challenge in a rodent malaria model. This protection is sustained and stage specific. Our findings demonstrate that a safe and effective, genetically attenuated whole-organism malaria vaccine is possible.	Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Heidelberg, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA	Center for Infectious Disease Research; Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle	Kappe, SHI (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	Stefan.Kappe@sbri.org; Kai_Matuschewski@med.uni-heidelberg.de		Matuschewski, Kai/0000-0001-6147-8591				Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hoffman S, 2004, NATURE, V430, P940, DOI 10.1038/430940a; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kappe SHI, 2003, TRENDS PARASITOL, V19, P135, DOI 10.1016/S1471-4922(03)00007-2; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; MEIS JFGM, 1983, NATURE, V302, P424, DOI 10.1038/302424a0; MEIS JFGM, 1985, CELL TISSUE RES, V241, P353, DOI 10.1007/BF00217180; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SHORTT HE, 1948, NATURE, V161, P126, DOI 10.1038/161126a0; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Thathy Vandana, 2002, Methods Mol Med, V72, P317, DOI 10.1385/1-59259-271-6:317; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618	18	375	406	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					164	167		10.1038/nature03188	http://dx.doi.org/10.1038/nature03188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15580261				2022-12-24	WOS:000226252200039
J	Bach, PB; Schrag, D; Begg, CB				Bach, PB; Schrag, D; Begg, CB			Resurrecting treatment histories of dead patients - A study design that should be laid to rest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERMINAL CANCER-PATIENTS; LAST YEAR; MEDICAL EXPENDITURES; MANAGED CARE; UNITED-STATES; OLDER-ADULTS; HOSPICE USE; LIFE; END; COSTS	In this article we address whether studies of care rendered to patients prior to their death ("studies of decedents") produce an accurate portrait of care provided to patients who are dying. Studies of decedents typically analyze the care provided to patients over a defined interval antecedent to death. Studies of dying patients analyze care provided to patients subsequent to the time that their terminal status is perceived. We address whether 2 fundamental differences between studies of decedents and studies of the dying-the Ways that subjects are identified and the time periods that are examined-lead to differences in interpretation of study results. Using examples from population-based cohorts of individuals with cancer, we show that both the differences in subject selection and time period introduce very substantial biases into studies of decedents. We conclude that studying care received prior to death can lead to invalid conclusions about the quality or type of care provided to dying patients.	Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, Dept Epidemiol & Biostat, 1275 York Ave,Box 221, New York, NY 10021 USA.	bachp@mskcc.org		Schrag, Deborah/0000-0002-4334-5717	NCI NIH HHS [K23CA86968, R01CA090226] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090226, K23CA086968] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 1998, AM J RESP CRIT CARE, V158, P1410, DOI 10.1164/ajrccm.158.5.9804042; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Christakis N A, 1998, Hosp J, V13, P71; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Collett D, 1994, MODELLING SURVIVAL D; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2002, J CLIN ONCOL, V20, P1786, DOI 10.1200/JCO.2002.07.142; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Emanuel EJ, 2002, ARCH INTERN MED, V162, P1722, DOI 10.1001/archinte.162.15.1722; Greiner KA, 2003, J AM GERIATR SOC, V51, P970, DOI 10.1046/j.1365-2389.2003.51310.x; Hefflin BJ, 1998, J AM GERIATR SOC, V46, P1396, DOI 10.1111/j.1532-5415.1998.tb06006.x; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Levinsky NG, 1999, J AM GERIATR SOC, V47, P553, DOI 10.1111/j.1532-5415.1999.tb02569.x; Levinsky NG, 2001, JAMA-J AM MED ASSOC, V286, P1349, DOI 10.1001/jama.286.11.1349; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Lipton H L, 1987, Compr Gerontol B, V1, P89; LONG SH, 1984, INQUIRY-J HEALTH CAR, V21, P315; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 1997, New Horiz, V5, P56; MCCALL N, 1984, MED CARE, V22, P329, DOI 10.1097/00005650-198404000-00004; McCarthy EP, 2003, JAMA-J AM MED ASSOC, V289, P2238, DOI 10.1001/jama.289.17.2238; Mukamel DB, 2002, MED CARE, V40, P1136, DOI 10.1097/00005650-200212000-00002; *NAT CANC POL BOAR, 2003, DESCR DEATH AM WHAT; Ngo-Metzger Q, 2003, AM J MED, V115, P47, DOI 10.1016/S0002-9343(03)00258-4; RILEY G, 1987, INQUIRY-J HEALTH CAR, V24, P233; SCITOVSKY AA, 1988, MILBANK Q, V66, P640, DOI 10.2307/3349934; SPECTOR WD, 1984, INQUIRY-J HEALTH CAR, V21, P328; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Warren JL, 2002, MED CARE, V40, P3; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607	35	198	198	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2765	2770		10.1001/jama.292.22.2765	http://dx.doi.org/10.1001/jama.292.22.2765			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585737				2022-12-24	WOS:000225546600026
J	Stradner, A; Sedgwick, H; Cardinaux, F; Poon, WCK; Egelhaaf, SU; Schurtenberger, P				Stradner, A; Sedgwick, H; Cardinaux, F; Poon, WCK; Egelhaaf, SU; Schurtenberger, P			Equilibrium cluster formation in concentrated protein solutions and colloids	NATURE			English	Article							PHASE-TRANSITIONS; MODEL; SEPARATION; GELATION; LIQUID; STATES	Controlling interparticle interactions, aggregation and cluster formation is of central importance in a number of areas, ranging from cluster formation in various disease processes to protein crystallography and the production of photonic crystals. Recent developments in the description of the interaction of colloidal particles with short-range attractive potentials have led to interesting findings including metastable liquid-liquid phase separation and the formation of dynamically arrested states (such as the existence of attractive and repulsive glasses, and transient gels)(1-7). The emerging glass paradigm has been successfully applied to complex soft-matter systems, such as colloid polymer systems(8) and concentrated protein solutions(9). However, intriguing problems like the frequent occurrence of cluster phases remain(10-13). Here we report small-angle scattering and confocal microscopy investigations of two model systems: protein solutions and colloid-polymer mixtures. We demonstrate that in both systems, a combination of short-range attraction and long-range repulsion results in the formation of small equilibrium clusters. We discuss the relevance of this finding for nucleation processes during protein crystallization, protein or DNA self-assembly and the previously observed formation of cluster and gel phases in colloidal suspensions(12-17).	Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ Edinburgh, COSMIC, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Fribourg; University of Edinburgh; University of Edinburgh; University of Edinburgh	Schurtenberger, P (corresponding author), Univ Fribourg, Dept Phys, Chemin Musee 3, CH-1700 Fribourg, Switzerland.	peter.schurtenberger@unifr.ch	Poon, Wilson C K/B-5960-2013; Stradner, Anna/B-5195-2015; Poon, Wilson/V-3495-2019; Schurtenberger, Peter/K-1777-2013	Poon, Wilson C K/0000-0003-0760-7940; Stradner, Anna/0000-0003-3310-3412; Poon, Wilson/0000-0003-0760-7940; Schurtenberger, Peter/0000-0002-2790-8831; Egelhaaf, Stefan U./0000-0002-2574-3498	Engineering and Physical Sciences Research Council [GR/S10377/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bergenholtz J, 2003, LANGMUIR, V19, P4493, DOI 10.1021/la0340089; Broide ML, 1996, PHYS REV E, V53, P6325, DOI 10.1103/PhysRevE.53.6325; Dawson KA, 2002, CURR OPIN COLLOID IN, V7, P218, DOI 10.1016/S1359-0294(02)00052-3; Eckert T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.125701; Foffi G, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031407; Groenewold J, 2001, J PHYS CHEM B, V105, P11702, DOI 10.1021/jp011646w; Guillot S, 2003, LANGMUIR, V19, P230, DOI 10.1021/la0206561; Kulkarni AM, 2003, FARADAY DISCUSS, V123, P37, DOI 10.1039/b204453f; Malfois M, 1996, J CHEM PHYS, V105, P3290, DOI 10.1063/1.471843; Muschol M, 1997, J CHEM PHYS, V107, P1953, DOI 10.1063/1.474547; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Pham KN, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011503; Pham KN, 2002, SCIENCE, V296, P104, DOI 10.1126/science.1068238; Piazza R, 2000, CURR OPIN COLLOID IN, V5, P38, DOI 10.1016/S1359-0294(00)00034-0; Poon WCK, 2002, J PHYS-CONDENS MAT, V14, pR859, DOI 10.1088/0953-8984/14/33/201; Puertas AM, 2004, J CHEM PHYS, V121, P2813, DOI 10.1063/1.1768936; Rojas LF, 2002, EUROPHYS LETT, V60, P802, DOI 10.1209/epl/i2002-00380-5; SCHURTENBERGER P, 1989, PHYS REV LETT, V63, P2064, DOI 10.1103/PhysRevLett.63.2064; Sciortino F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.055701; Sciortino F, 2002, NAT MATER, V1, P145, DOI 10.1038/nmat752; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; TANFORD C, 1972, BIOCHEMISTRY-US, V11, P2192, DOI 10.1021/bi00761a029; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Yethiraj A, 2003, NATURE, V421, P513, DOI 10.1038/nature01328	25	879	883	8	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					492	495		10.1038/nature03109	http://dx.doi.org/10.1038/nature03109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565151	Green Submitted			2022-12-24	WOS:000225322100043
J	Ando, R; Mizuno, H; Miyawaki, A				Ando, R; Mizuno, H; Miyawaki, A			Regulated fast nucleocytoplasmic shuttling observed by reversible protein highlighting	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; CELLS; KINASE	The observation of the regulation of fast protein dynamics in a cellular context requires the development of reliable technologies. Here, a signal regulation cascade reliant on the stimulus-dependent acceleration of the bidirectional flow of mitogen-activated protein kinase (extracellular signal-regulated kinase) across the nuclear envelope was visualized by reversible protein highlighting. Light-induced conversion between the bright and dark states of a monomeric fluorescent protein engineered from a novel coral protein was employed. Because of its photochromic properties, the protein could be highlighted, erased, and highlighted again in a nondestructive manner, allowing direct observation of regulated fast nucleocytoplasmic shuttling of key signaling molecules.	RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Adv Technol Dev Grp, Wako, Saitama 3510198, Japan	RIKEN	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Adv Technol Dev Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	Mizuno, Hideaki/AAH-5737-2021; Miyawaki, Atsushi/K-3569-2014	Mizuno, Hideaki/0000-0002-6983-5255; Miyawaki, Atsushi/0000-0002-2329-3235				Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; FELDHERR CM, 1993, EXP CELL RES, V205, P179, DOI 10.1006/excr.1993.1073; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liang YC, 2003, P NATL ACAD SCI USA, V100, P8109, DOI 10.1073/pnas.0832270100; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Volmat V, 2001, J CELL SCI, V114, P3433; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	20	625	648	7	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1370	1373		10.1126/science.1102506	http://dx.doi.org/10.1126/science.1102506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550670				2022-12-24	WOS:000225301600051
J	Mower, JP; Stefanovic, S; Young, GJ; Palmer, JD				Mower, JP; Stefanovic, S; Young, GJ; Palmer, JD			Plant genetics - Gene transfer from parasitic to host plants	NATURE			English	Editorial Material							FLOWERING PLANTS; TRANSMISSION		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Mower, JP (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jpalmer@bio.indiana.edu	Mower, Jeff/B-7875-2008; Palmer, Jeffrey/P-6747-2014; Mower, Jeff/P-5893-2019	Mower, Jeff/0000-0002-1501-5809; Palmer, Jeffrey/0000-0002-4626-2220; Mower, Jeff/0000-0002-1501-5809				Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; HOSFORD RM, 1967, BOT REV, V33, P387, DOI 10.1007/BF02858742; Luteyn JL, 1999, PARAMOS CHECKLIST PL; Marcone C, 1999, J PHYTOPATHOL, V147, P187, DOI 10.1111/j.1439-0434.1999.tb03827.x; Molau U., 1990, OPERA BOT, V102, P1; Nickrent Daniel L., 1998, P211; Ronsted N, 2002, BOT J LINN SOC, V139, P323, DOI 10.1046/j.1095-8339.2002.00070.x; TESSENE MF, 1969, MICH BOT, V8, P72; Won H, 2003, P NATL ACAD SCI USA, V100, P10824, DOI 10.1073/pnas.1833775100; YUNCKER TG, 1932, MEM TORREY BOT CLUB, V18, P111	12	158	167	6	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					165	166		10.1038/432165b	http://dx.doi.org/10.1038/432165b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538356				2022-12-24	WOS:000225020200031
J	Villareal, DT; Holloszy, JO				Villareal, DT; Holloszy, JO			Effect of DHEA on abdominal fat and insulin action in elderly women and men - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVATED RECEPTOR-ALPHA; DEHYDROEPIANDROSTERONE-SULFATE CONCENTRATIONS; REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; BODY-COMPOSITION; GENE-EXPRESSION; VISCERAL FAT; OBESITY; RESISTANCE; RATS	Context Dehydroepiandrosterone (DHEA) administration has been shown to reduce accumulation of abdominal visceral fat and protect against insulin resistance in laboratory animals, but it is not known whether DHEA decreases abdominal obesity in humans. DHEA is widely available as a dietary supplement without a prescription. Objective To determine whether DHEA replacement therapy decreases abdominal fat and improves insulin action in elderly persons. Design and Setting Randomized, double-blind, placebo-controlled trial conducted in a US university-based research center from June 2001 to February 2004. Participants Fifty-six elderly persons (28 women and 28 men aged 71 [range, 65-78] years) with age-related decrease in DHEA level. Intervention Participants were randomly assigned to receive 50 mg/d of DHEA or matching placebo for 6 months. Main Outcome Measures The primary outcome measures were 6-month change in visceral and subcutaneous abdominal fat measured by magnetic resonance imaging and glucose and insulin responses to an oral glucose tolerance test (OGTT). Results Of the 56 men and women enrolled, 52 underwent follow-up evaluations. Compliance with the intervention was 97% in the DHEA group and 95% in the placebo group. Based on intention-to-treat analyses, DHEA therapy compared with placebo induced significant decreases in visceral fat area (-13 cm(2) vs +3 cm(2), respectively; P=.001) and subcutaneous fat (-13 cm(2) vs +2 cm(2), P=.003). The insulin area under the curve (AUC) during the OGTT was significantly reduced after 6 months of DHEA therapy compared with placebo (-1119 muU/mL per 2 hours vs +818 muU/mL per 2 hours, P=.007). Despite the lower insulin levels, the glucose AUC was unchanged, resulting in a significant increase in an insulin sensitivity index in response to DHEA compared with placebo (+1.4 vs -0.7, P=.005). Conclusion DHEA replacement could play a role in prevention and treatment of the metabolic syndrome associated with abdominal obesity.	Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Holloszy, JO (corresponding author), Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, Campus Box 8113,4566 Scott Ave, St Louis, MO 63110 USA.	jho1losz@im.wustl.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020076, P60AG013629] Funding Source: NIH RePORTER; NCRR NIH HHS [K23RR16191, RR00036] Funding Source: Medline; NIA NIH HHS [AG20076, AG13629] Funding Source: Medline; NIDDK NIH HHS [DK56341, DK20579] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AER CTR, 1997, MED SCI SPORT EXER S, V6, P10; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Arlt W, 2001, J CLIN ENDOCR METAB, V86, P4686, DOI 10.1210/jc.86.10.4686; Arlt W, 1999, J CLIN ENDOCR METAB, V84, P2170, DOI 10.1210/jc.84.6.2170; BarrettConnor E, 1996, J CLIN ENDOCR METAB, V81, P59, DOI 10.1210/jc.81.1.59; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; CLEARY MP, 1986, INT J OBESITY, V10, P193; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; DAUGHADAY WH, 1980, J CLIN ENDOCR METAB, V51, P781, DOI 10.1210/jcem-51-4-781; Diamond P, 1996, J ENDOCRINOL, V150, pS43; Ferrannini E, 1997, HYPERTENSION, V30, P1144, DOI 10.1161/01.HYP.30.5.1144; Flynn MA, 1999, J CLIN ENDOCR METAB, V84, P1527, DOI 10.1210/jc.84.5.1527; Friedman L.M., 1980, FUNDAMENTALS CLIN TR; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; HAFFNER SM, 1994, METABOLISM, V43, P599, DOI 10.1016/0026-0495(94)90202-X; HAFFNER SM, 1993, INT J OBESITY, V17, P643; Han DH, 1998, J GERONTOL A-BIOL, V53, pB19, DOI 10.1093/gerona/53A.1.B19; Hansen PA, 1997, AM J PHYSIOL-REG I, V273, pR1704, DOI 10.1152/ajpregu.1997.273.5.R1704; Jedrzejuk D, 2003, Aging Male, V6, P151, DOI 10.1080/713604785; Kawano H, 2003, J CLIN ENDOCR METAB, V88, P3190, DOI 10.1210/jc.2002-021603; KHORRAM O, 1997, J GERONTOL A-BIOL, V52, P1; Kim H, 2003, DIABETES, V52, P1770, DOI 10.2337/diabetes.52.7.1770; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MOHAN PF, 1990, J NUTR, V120, P1103, DOI 10.1093/jn/120.9.1103; Morales AJ, 1998, CLIN ENDOCRINOL, V49, P421, DOI 10.1046/j.1365-2265.1998.00507.x; MORALES AJ, 1995, J CLIN ENDOCR METAB, V80, P2799; MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Munzer T, 2001, J CLIN ENDOCR METAB, V86, P3604, DOI 10.1210/jc.86.8.3604; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; Peters JM, 1996, MOL PHARMACOL, V50, P67; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Schoonjans K, 1996, J LIPID RES, V37, P907; SHIMOKATA H, 1989, J GERONTOL, V44, P66; Tenenbaum A, 2004, CIRCULATION, V109, P2197, DOI 10.1161/01.CIR.0000126824.12785.B6; Villareal D, 2000, J AM GERIATR SOC, V48, pS24; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x; YEN TT, 1977, LIPIDS, V12, P409, DOI 10.1007/BF02533624	44	181	199	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2004	292	18					2243	2248		10.1001/jama.292.18.2243	http://dx.doi.org/10.1001/jama.292.18.2243			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PK	15536111	Bronze			2022-12-24	WOS:000225070000025
J	Birnbaum, SG; Yuan, PX; Wang, M; Vijayraghavan, S; Bloom, AK; Davis, DJ; Gobeske, KT; Sweatt, JD; Manji, HK; Arnsten, AFT				Birnbaum, SG; Yuan, PX; Wang, M; Vijayraghavan, S; Bloom, AK; Davis, DJ; Gobeske, KT; Sweatt, JD; Manji, HK; Arnsten, AFT			Protein kinase C overactivity impairs prefrontal cortical regulation of working memory	SCIENCE			English	Article							BIPOLAR DISORDER; ALPHA-1-ADRENERGIC AGONIST; AUDITORY HALLUCINATIONS; CORTEX; SCHIZOPHRENIA; PERFORMANCE; MONKEYS	The prefrontal cortex is a higher brain region that regulates thought, behavior, and emotion using representational knowledge, operations often referred to as working memory. We tested the influence of protein kinase C (PKC) intracellular signaling on prefrontal cortical cognitive function and showed that high levels of PKC activity in prefrontal cortex, as seen for example during stress exposure, markedly impair behavioral and electrophysiological measures of working memory. These data suggest that excessive PKC activation can disrupt prefrontal cortical regulation of behavior and thought, possibly contributing to signs of prefrontal cortical dysfunction such as distractibility, impaired judgment, impulsivity, and thought disorder.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; NIMH, Mol Pathophysiol Lab, Bethesda, MD 20892 USA	Yale University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06520 USA.	amy.arnsten@yale.edu		Sweatt, J. David/0000-0003-3567-485X	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006036, R37AG006036] Funding Source: NIH RePORTER; NIA NIH HHS [AG06036] Funding Source: Medline; NIMH NIH HHS [P50 MH068789] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Arnsten AFT, 1997, PHARMACOL BIOCHEM BE, V58, P55, DOI 10.1016/S0091-3057(96)00477-7; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; Coyle JT, 2002, NAT MED, V8, P557, DOI 10.1038/nm0602-557; ELLICOTT A, 1990, AM J PSYCHIAT, V147, P1194; Frith C, 1996, PHILOS T R SOC B, V351, P1505, DOI 10.1098/rstb.1996.0136; GOLDMANRAKIC PS, 1991, AM PSYCHOP, P1; Koh PO, 2003, ARCH GEN PSYCHIAT, V60, P311, DOI 10.1001/archpsyc.60.3.311; KROWCHUK HV, 1995, ANN REV NURSING, V13, P87; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; MARKOVAC J, 1988, NATURE, V334, P71, DOI 10.1038/334071a0; Mazure C.M, 1995, DOES STRESS CAUSE PS, V46; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607	18	228	238	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					882	884		10.1126/science.1100021	http://dx.doi.org/10.1126/science.1100021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514161				2022-12-24	WOS:000224969400050
J	Nelson, DE; Ihekwaba, AEC; Elliott, M; Johnson, JR; Gibney, CA; Foreman, BE; Nelson, G; See, V; Horton, CA; Spiller, DG; Edwards, SW; McDowell, HP; Unitt, JF; Sullivan, E; Grimley, R; Benson, N; Broomhead, D; Kell, DB; White, MRH				Nelson, DE; Ihekwaba, AEC; Elliott, M; Johnson, JR; Gibney, CA; Foreman, BE; Nelson, G; See, V; Horton, CA; Spiller, DG; Edwards, SW; McDowell, HP; Unitt, JF; Sullivan, E; Grimley, R; Benson, N; Broomhead, D; Kell, DB; White, MRH			Oscillations in NF-kappa B signaling control the dynamics of gene expression	SCIENCE			English	Article							P65 SUBUNIT; TRANSCRIPTION; ALPHA; CELLS; PHOSPHORYLATION; ACTIVATION; TIME; ACETYLATION; MECHANISMS; SERINE-536	Signaling by the transcription factor nuclear factor kappa B (NF-kappaB) involves its release from inhibitor kappa B (IkappaB) in the cytosol, followed by translocation into the nucleus. NF-kappaB regulation Of IkappaBalpha transcription represents a delayed negative feedback loop that drives oscillations in NF-kappaB translocation. Single-cell time-lapse imaging band computational modeling of NF-kappaB (RelA) localization showed asynchronous oscillations following cell stimulation that decreased in frequency with increased IkappaBalpha transcription. Transcription of target genes depended on oscillation persistence, involving cycles of RelA phosphorytation and dephosphorylation. The functional consequences of NF-kappaB signaling may thus depend on number, period, and amplitude of oscillations.	Ctr Cell Imaging, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Manchester, Inst Sci & Technol, Dept Chem, Manchester M60 1QD, Lancs, England; Univ Manchester, Inst Sci & Technol, Dept Math, Manchester M60 1QD, Lancs, England; Alder Hey Childrens Hosp, Royal Liverpool Childrens Natl Hlth Serv Trust, Liverpool L12 2AP, Merseyside, England; AstraZeneca Res & Dev Charnwood, Dept Biol Mol, Loughborough LE11 5RH, Leics, England; Pfizer Ltd, Cent Res, Sandwich CT13 9NJ, Kent, England; AstraZeneca Res & Dev Charnwood, Adv Sci & Technol Lab, Loughborough LE11 5RH, Leics, England	University of Liverpool; University of Manchester; University of Manchester; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; AstraZeneca; Pfizer; AstraZeneca	White, MRH (corresponding author), Ctr Cell Imaging, Sch Biol Sci, Biosci Res Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	mwhite@liv.ac.uk	Johnson, James R/A-8174-2012; nelson, glyn/A-6346-2009; Broomhead, David S/C-6836-2009; Spiller, David G/I-3645-2012; Johnson, James R/D-9721-2014; Kell, Douglas/E-8318-2011	nelson, glyn/0000-0002-1895-4772; Johnson, James R/0000-0002-8849-0993; Kell, Douglas/0000-0001-5838-7963; Nelson, David/0000-0002-5034-0885; White, Michael/0000-0002-3617-3232; Edwards, Steven/0000-0002-7074-0552; Spiller, David Geoffrey/0000-0003-2502-6787; Ihekwaba, Adaoha/0000-0003-2787-7286				ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; McFerran DW, 2001, ENDOCRINOLOGY, V142, P3255, DOI 10.1210/en.142.7.3255; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Nelson G, 2002, J CELL SCI, V115, P1137; Nelson G, 2003, J CELL SCI, V116, P2495, DOI 10.1242/jcs.00461; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Ting AY, 2002, SCIENCE, V298, P1189, DOI 10.1126/science.1079331; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	27	907	925	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					704	708		10.1126/science.1099962	http://dx.doi.org/10.1126/science.1099962			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499023				2022-12-24	WOS:000224756700057
J	Majeed, A; Williams, S; Jarman, B; Aylin, P				Majeed, A; Williams, S; Jarman, B; Aylin, P			Prescribing of antibiotics and admissions for respiratory tract infections in England	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Majeed, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Majeed, Azeem/0000-0002-2357-9858; Aylin, Paul/0000-0003-4589-1743					0	22	23	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 16	2004	329	7471					879	879		10.1136/bmj.329.7471.879	http://dx.doi.org/10.1136/bmj.329.7471.879			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863MU	15485964	Green Published			2022-12-24	WOS:000224566800013
J	Chen, HT; Hahn, S				Chen, HT; Hahn, S			Mapping the location of TFIIB within the RNA polymerase II transcription preinitiation complex: A model for the structure of PIC	CELL			English	Article							N-TERMINAL DOMAIN; TATA-BOX; ZINC RIBBON; PROMOTER DNA; START SITE; INITIATION; BINDING; PROTEIN; IDENTIFICATION; HOLOENZYME	Biochemical probes positioned on the surface of the general transcription factor TFIIB were used to probe the architecture of the RNA polymerase II (Pol II) transcription preinitiation complex (PIC). In PICs, the TFIIB linker and core domains are positioned over the central cleft and wall of Pol II. This positioning is not observed in the smaller Pol II-TFIIB complex. These results lead to a new model for the structure of the PIC, which agrees with most previously documented protein-DNA interactions within Pol II and archaea PICs. Specific interaction of the TFIIB core domain with Pol II positions and orients the promoter DNA over the Pol II central cleft, and TBP-DNA bending leads to bending of the promoter around the surface of Pol II. The TFIIF subunit Tfg1 was found in close proximity to the TFIIB B finger, linker, and core domains, suggesting that these two factors closely cooperate during initiation.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	shahn@fhcrc.org	Chen, Hung-Ta/ABC-8094-2021	Chen, Hung-Ta/0000-0003-1192-0382; Hahn, Steven/0000-0001-7240-2533	NIGMS NIH HHS [R01 GM053451-07, R01 GM053451-08, R01 GM053451-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053451] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bell SD, 1998, COLD SPRING HARB SYM, V63, P41, DOI 10.1101/sqb.1998.63.41; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen HT, 2000, PROTEIN SCI, V9, P1743, DOI 10.1110/ps.9.9.1743; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; CHEN Y, 1994, SCIENCE, V265, P90, DOI 10.1126/science.8016656; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Craighead JL, 2002, STRUCTURE, V10, P1117, DOI 10.1016/S0969-2126(02)00813-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Datwyler SA, 2000, TRENDS BIOCHEM SCI, V25, P408, DOI 10.1016/S0968-0004(00)01652-2; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Douziech M, 2000, MOL CELL BIOL, V20, P8168, DOI 10.1128/MCB.20.21.8168-8177.2000; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hahn S, 2000, GENE DEV, V14, P719; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; MARTINEZ E, 1995, P NATL ACAD SCI USA, V92, P11864, DOI 10.1073/pnas.92.25.11864; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	49	105	110	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					169	180		10.1016/j.cell.2004.09.028	http://dx.doi.org/10.1016/j.cell.2004.09.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479635	Bronze			2022-12-24	WOS:000224577200006
J	Hayashi, T; Carthew, RW				Hayashi, T; Carthew, RW			Surface mechanics mediate pattern formation in the developing retina	NATURE			English	Article							CELL-ADHESION; DROSOPHILA; CADHERIN; EYE; GENE; SPECIFICATION; EXPRESSION; ARMADILLO; TENSIONS; TISSUES	Pattern formation of biological structures involves organizing different types of cells into a spatial configuration. In this study, we investigate the physical basis of biological patterning of the Drosophila retina in vivo. We demonstrate that E- and N-cadherins mediate apical adhesion between retina epithelial cells. Differential expression of N-cadherin within a sub-group of retinal cells (cone cells) causes them to form an overall shape that minimizes their surface contact with surrounding cells. The cells within this group, in both normal and experimentally manipulated conditions, pack together in the same way as soap bubbles do. The shaping of the cone cell group and packing of its components precisely imitate the physical tendency for surfaces to be minimized. Thus, simple patterned expression of N-cadherin results in a complex spatial pattern of cells owing to cellular surface mechanics.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	Northwestern University; University of Tokyo	Hayashi, T (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	t-hayashi@northwestern.edu; r-carthew@northwestern.edu	Hayashi, Takashi/D-5466-2016					BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLOCHLINGER K, 1993, DEVELOPMENT, V117, P441; Bloor JW, 2002, DEVELOPMENT, V129, P3173; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chanut F, 2002, GENETICS, V160, P623; CHICHILNISKY EJ, 1986, J THEOR BIOL, V123, P81, DOI 10.1016/S0022-5193(86)80237-5; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foty RA, 1996, DEVELOPMENT, V122, P1611; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hayashi T, 1998, DEV BIOL, V200, P131, DOI 10.1006/dbio.1998.8959; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito K, 1997, DEVELOPMENT, V124, P761; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Morgan T.H., 1927, EXPT EMBRYOLOGY; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pignoni F, 1997, DEVELOPMENT, V124, P271; Plateau J., 1873, STATIQUE EXPT THEORI; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; TAYLOR JE, 1976, ANN MATH, V103, P489, DOI 10.2307/1970949; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thompson D., 1917, GROWTH FORM; VINCENT JP, 1994, CELL, V77, P909, DOI 10.1016/0092-8674(94)90139-2; Wolff Tanya, 1993, P1277; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	40	243	248	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					647	652		10.1038/nature02952	http://dx.doi.org/10.1038/nature02952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470418				2022-12-24	WOS:000224299300030
J	Rao, SV; Jollis, JG; Harrington, RA; Granger, CB; Newby, LK; Armstrong, PW; Moliterno, DJ; Lindblad, L; Pieper, K; Topol, EJ; Stamler, JS; Califf, RM				Rao, SV; Jollis, JG; Harrington, RA; Granger, CB; Newby, LK; Armstrong, PW; Moliterno, DJ; Lindblad, L; Pieper, K; Topol, EJ; Stamler, JS; Califf, RM			Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELL TRANSFUSION; TRIAL; STRATEGIES; SURVIVAL; IMPACT	Context It is unclear if blood transfusion in anemic patients with acute coronary syndromes is associated with improved survival. Objective To determine the association between blood transfusion and mortality among patients with acute coronary syndromes who develop bleeding, anemia, or both during their hospital course. Design, Setting, and Patients We analyzed 24112 enrollees in 3 large international trials of patients with acute coronary syndromes (the GUSTO IIb, PURSUIT, and PARAGON B trials). Patients were grouped according to whether they received a blood transfusion during the hospitalization. The association between transfusion and outcome was assessed using Cox proportional hazards modeling that incorporated transfusion as a time-dependent covariate and the propensity to receive blood, and a landmark analysis. Main Outcome Measure Thirty-day mortality. Results Of the patients included, 2401 (10.0%) underwent at least 1 blood transfusion during their hospitalization. Patients who underwent transfusion were older and had more comorbid illness at presentation and also had a significantly higher unadjusted rate of 30-day death (8.00% vs 3.08%; P<.001), myocardial infarction (MI) (25.16% vs 8.16%; P<.001), and death/Ml (29.24% vs 10.02%; P<.001) compared with patients who did not undergo transfusion. Using Cox proportional hazards modeling that incorporated transfusion as a time-dependent covariate, transfusion was associated with an increased hazard for 30-day death (adjusted hazard ratio [HR], 3.94; 95% confidence interval [CI], 3.26-4.75) and 30-day death/Ml (HR, 2.92; 95% Cl, 2.55-3.35). In the landmark analysis that included procedures and bleeding events, transfusion was associated with a trend toward increased mortality. The predicted probability of 30-day death was higher with transfusion at nadir hematocrit values above 25%. Conclusions Blood transfusion in the setting of acute coronary syndromes is associated with higher mortality, and this relationship persists after adjustment for other predictive factors and timing of events. Given the limitations of post hoc analysis of clinical trials data, a randomized trial of transfusion strategies is warranted to resolve the disparity in results between our study and other observational studies. We suggest caution regarding the routine use of blood transfusion to maintain arbitrary hematocrit levels in stable patients with ischemic heart disease.	Duke Clin Res Inst, Durham, NC 27715 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Univ Alberta, Dept Cardiol, Edmonton, AB, Canada; Univ Kentucky, Div Cardiol, Lexington, KY USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; University of Alberta; University of Kentucky; Cleveland Clinic Foundation	Rao, SV (corresponding author), Duke Clin Res Inst, POB 17969,2400 Pratt St, Durham, NC 27715 USA.	sunil.rao@duke.edu	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291; Topol, Eric/0000-0002-1478-4729; Armstrong, Paul/0000-0002-0460-3445; Stamler, Jonathan/0000-0002-6866-1572				ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; ANDERSON JR, 1985, CANCER TREAT REP, V69, P1139; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Casutt M, 1999, CRIT CARE MED, V27, P2194, DOI 10.1097/00003246-199910000-00021; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; DIETRICH KA, 1990, CRIT CARE MED, V18, P940, DOI 10.1097/00003246-199009000-00007; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; Fransen E, 1999, CHEST, V116, P1233, DOI 10.1378/chest.116.5.1233; GOODNOUGH LT, 1993, AM J MED, V94, P509, DOI 10.1016/0002-9343(93)90086-5; Greenburg AG, 1995, AM J SURG, V170, pS44, DOI 10.1016/S0002-9610(99)80058-0; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HEBERT PC, 2001, CMAJ S11, V156, pS27; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; PARAGON B, 2002, CIRCULATION, V105, P316; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1996, NEW ENGL J MED, V335, P775; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615	23	788	818	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1555	1562		10.1001/jama.292.13.1555	http://dx.doi.org/10.1001/jama.292.13.1555			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467057	Bronze			2022-12-24	WOS:000224254600022
J	Wang, TJ; Parise, H; Levy, D; Dagostino, RB; Wolf, PA; Vasan, RS; Benjamin, EJ				Wang, TJ; Parise, H; Levy, D; Dagostino, RB; Wolf, PA; Vasan, RS; Benjamin, EJ			Obesity and the risk of new-onset atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CORONARY-HEART-DISEASE; NATURAL-HISTORY; FRAMINGHAM; HYPERTENSION; SIZE; PREVALENCE; POPULATION; ECHOCARDIOGRAPHY; PREDICTORS	Context Obesity is associated with atrial enlargement and ventricular diastolic dysfunction, both known predictors of atrial fibrillation (AF). However, it is unclear whether obesity is a risk factor for AF. Objective. To examine the association between body mass index (BMI) and the risk of developing AF. Design, Setting, and Participants Prospective, community-based observational cohort in Framingham, Mass. We studied 5282 participants (mean age, 57 [SD, 13] years; 2898 women [55%]) without baseline AF (electrocardiographic AF or arterial flutter). Body mass index (calculated as weight in kilograms divided by square of height in meters) was evaluated as both a continuous and a categorical variable (normal defined as <25.0; overweight, 25.0 to <30.0; and obese, greater than or equal to30.0). In addition to adjusting for clinical confounders by multivariable techniques, we also examined models including echocardiographic left atrial diameter to examine whether the influence of obesity was mediated by changes in left atrial dimensions. Main Outcome Measure Association between BMI or BMI category and risk of developing new-onset AF. Results During a mean follow-up of 13.7 years, 526 participants (234 women) developed AF. Age-adjusted incidence rates for AF increased across the 3 BMI categories in men (9.7,10.7, and 14.3 per 1000 person-years) and women (5.1, 8.6, and 9.9 per 1000 person-years). In multivariable models adjusted for cardiovascular risk factors and interim myocardial infarction or heart failure, a 4% increase in AF risk per 1-unit increase in BMI was observed in men (95% confidence interval [Cl], 1 %-7%; P=.02) and in women (95% Cl, 1%-7%; P=.009). Adjusted hazard ratios for AF associated with obesity were 1.52 (95% Cl, 1.09-2.13; P=.02) and 1.46 (95% Cl, 1.03-2.07; P=.03) for men and women, respectively, compared with individuals with normal BMI. After adjustment for echocardiographic left atrial diameter in addition to clinical risk factors, BMI was no longer associated with AF risk (adjusted hazard ratios per 1-unit increase in BMI, 1.00 [95% Cl, 0.97-1.04], P=.84 in men; 0.99 [95% Cl, 0.96-1.02], P=.56 in women). Conclusions Obesity is an important, potentially modifiable risk factor for AF. The excess risk of AF associated with obesity appears to be mediated by left atrial dilatation. These prospective data raise the possibility that interventions to promote normal weight may reduce the population. burden of AF.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Boston Med Ctr, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Prevent Med Sect, Boston, MA 02118 USA	Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University	Benjamin, EJ (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	emelia@bu.edu	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Wolf, Philip/0000-0002-3628-301X; Benjamin, Emelia/0000-0003-4076-2336; Parise, Helen/0000-0001-7761-4973	NHLBI NIH HHS [K23-HL074077-01, N01-HC-25195, K24-HL-04334] Funding Source: Medline; NINDS NIH HHS [6R01-NS-17950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL074077, K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALAUDDIN A, 1990, SURGERY, V108, P809; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Engeli S, 2001, J MOL MED, V79, P21, DOI 10.1007/s001090000144; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Halligan SC, 2004, ANN INTERN MED, V140, P265, DOI 10.7326/0003-4819-140-4-200402170-00008; Iacobellis G, 2002, OBES RES, V10, P767, DOI 10.1038/oby.2002.104; Kanagala R, 2003, CIRCULATION, V107, P2589, DOI 10.1161/01.CIR.0000068337.25994.21; Kannel W., 1987, SOME RISK FACTORS RE; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; KANNER AD, 1981, J BEHAV MED, V1, P1; Kistler PM, 2004, J AM COLL CARDIOL, V44, P109, DOI 10.1016/j.jacc.2004.03.044; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; MESSERLI FH, 1982, CIRCULATION, V66, P55, DOI 10.1161/01.CIR.66.1.55; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Pelat M, 1999, HYPERTENSION, V34, P1066, DOI 10.1161/01.HYP.34.5.1066; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAVAGE DD, 1987, HYPERTENSION, V9, P40; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; VAZIRI SM, 1995, HYPERTENSION, V25, P1155, DOI 10.1161/01.HYP.25.6.1155; Vincent HK, 1999, INT J OBESITY, V23, P67, DOI 10.1038/sj.ijo.0800761; Wilhelmsen L, 2001, J INTERN MED, V250, P382, DOI 10.1046/j.1365-2796.2001.00902.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	35	918	956	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2004	292	20					2471	2477		10.1001/jama.292.20.2471	http://dx.doi.org/10.1001/jama.292.20.2471			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873TD	15562125	Bronze			2022-12-24	WOS:000225303000021
J	MacLennan, C; Solomon, T				MacLennan, C; Solomon, T			Potential neurovirulence of common cold virus	LANCET			English	Editorial Material							INTERCELLULAR-ADHESION MOLECULE-1; COMPLEMENT REGULATORS; ENTEROVIRUS-71; POLIOMYELITIS		Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre 3, Malawi; Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; Univ Liverpool, Dept Neurol Sci, Liverpool L69 3BX, Merseyside, England; Univ Liverpool, Dept Med Microbiol, Liverpool L69 3BX, Merseyside, England	University of Malawi; University of Birmingham; University of Liverpool; University of Liverpool	MacLennan, C (corresponding author), Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, POB 30096, Blantyre 3, Malawi.	cmaclennan@mlw.medcol.mw	MacLennan, Calman A/L-9343-2014	MacLennan, Calman A/0000-0001-9694-0846; Solomon, Tom/0000-0001-7266-6547				Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; DELATORRE JC, 1992, P NATL ACAD SCI USA, V89, P2531, DOI 10.1073/pnas.89.7.2531; Dufresne AT, 2004, P NATL ACAD SCI USA, V101, P13636, DOI 10.1073/pnas.0403998101; ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85; Gromeier M, 1998, J VIROL, V72, P5056, DOI 10.1128/JVI.72.6.5056-5060.1998; Kaminski HJ, 2004, EXP NEUROL, V189, P333, DOI 10.1016/j.expneurol.2004.06.005; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; PULLI T, 1995, VIROLOGY, V212, P30, DOI 10.1006/viro.1995.1450; Rieder E, 2001, Dev Biol (Basel), V105, P111; Shafren DR, 1997, J VIROL, V71, P4736, DOI 10.1128/JVI.71.6.4736-4743.1997; Singhrao SK, 1999, LAB INVEST, V79, P1247; Solomon T, 2003, CURR OPIN INFECT DIS, V16, P375, DOI 10.1097/00001432-200310000-00002; Wen YY, 2003, J MED VIROL, V70, P109, DOI 10.1002/jmv.10366	13	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 20	2004	364	9448					1839	1840		10.1016/S0140-6736(04)17456-4	http://dx.doi.org/10.1016/S0140-6736(04)17456-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873HA	15555652	Green Submitted			2022-12-24	WOS:000225269300008
J	Goldenberg, SJ; Cascio, TC; Shumway, SD; Garbutt, KC; Liu, JD; Xiong, Y; Zheng, N				Goldenberg, SJ; Cascio, TC; Shumway, SD; Garbutt, KC; Liu, JD; Xiong, Y; Zheng, N			Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases	CELL			English	Article							I-KAPPA-B; F-BOX PROTEINS; CYCLIN-E; NEDD8 MODIFICATION; COP9 SIGNALOSOME; MEDIATED DEGRADATION; CONJUGATION PATHWAY; SCF; MOTIF; CUL1	The SCF ubiquitin ligase complex regulates diverse cellular functions by ubiquitinating numerous protein substrates. Cand1, a 120 kDa HEAT repeat protein, forms a tight complex with the Cul1-Roc1 SCF catalytic core, inhibiting the assembly of the multisubunit E3 complex. The crystal structure of the Cand1-Cul1-Roc1 complex shows that Cand1 adopts a highly sinuous superhelical structure, clamping around the elongated SCF scaffold protein Cull. At one end, a Cand1 beta hairpin protrusion partially occupies the adaptor binding site on Cul1, inhibiting its interactions with the Skp1 adaptor and the substrate-recruiting F box protein subunits. At the other end, two Cand1 HEAT repeats pack against a conserved Cul1 surface cleft and bury a Cul1 lysine residue, whose modification by the ubiquitin-like protein, Nedd8, is able to block Cand1-Cul1 association. Together with biochemical evidence, these structural results elucidate the mechanisms by which Cand1 and Nedd8 regulate the assembly-disassembly cycles of SCIF and other cullin-dependent E3 complexes.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu			NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NCI NIH HHS [CA107134] Funding Source: Medline; NIGMS NIH HHS [2 T32 GM07270-29] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; DeLano WL, 2002, PYMOL USERS MANUAL; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Fan MY, 2003, MOL ENDOCRINOL, V17, P356, DOI 10.1210/me.2002-0323; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Hwang JW, 2003, FEBS LETT, V541, P102, DOI 10.1016/S0014-5793(03)00321-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar A, 1998, P NATL ACAD SCI USA, V95, P2417, DOI 10.1073/pnas.95.5.2417; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mathias N, 1999, MOL CELL BIOL, V19, P1759; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang XP, 2003, PLANT CELL, V15, P1071, DOI 10.1105/tpc.009936; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yogosawa S, 1996, BIOCHEM BIOPH RES CO, V229, P612, DOI 10.1006/bbrc.1996.1852; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	85	208	215	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					517	528		10.1016/j.cell.2004.10.019	http://dx.doi.org/10.1016/j.cell.2004.10.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537541	Bronze, Green Published			2022-12-24	WOS:000225183200010
J	Matheus, P; Burns, J; Weinstock, J; Hofreiter, M				Matheus, P; Burns, J; Weinstock, J; Hofreiter, M			Pleistocene brown bears in the mid-continent of North America	SCIENCE			English	Article							LAURENTIDE		Univ Alaska Fairbanks, Alaska Quaternary Ctr, Fairbanks, AK 99775 USA; Prov Museum Alberta, Edmonton, AB, Canada; Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Oxford, England; Max Planck Evolutionary Anthropol, Leipzig, Germany	University of Alaska System; University of Alaska Fairbanks; University of Oxford; Max Planck Society	Matheus, P (corresponding author), Univ Alaska Fairbanks, Alaska Quaternary Ctr, Fairbanks, AK 99775 USA.	ffpem1@uaf.edu	Hofreiter, Michael/A-3996-2017	Hofreiter, Michael/0000-0003-0441-4705				Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Burns JA, 1996, QUATERN INT, V32, P107, DOI 10.1016/1040-6182(95)00057-7; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Kurten B., 1980, PLEISTOCENE MAMMALS; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; YOUNG RR, 1994, GEOLOGY, V22, P683, DOI 10.1130/0091-7613(1994)022<0683:ASLWLG>2.3.CO;2	6	18	19	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1150	1150		10.1126/science.1101495	http://dx.doi.org/10.1126/science.1101495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539594	Green Submitted			2022-12-24	WOS:000225193100037
J	Nakagawa, I; Amano, A; Mizushima, N; Yamamoto, A; Yamaguchi, H; Kamimoto, T; Nara, J; Funao, J; Nakata, M; Tsuda, K; Hamada, S; Yoshimori, T				Nakagawa, I; Amano, A; Mizushima, N; Yamamoto, A; Yamaguchi, H; Kamimoto, T; Nara, J; Funao, J; Nakata, M; Tsuda, K; Hamada, S; Yoshimori, T			Autophagy defends cells against invading group a Streptococcus	SCIENCE			English	Article							PYOGENES; VIRULENCE; INVASION	We found that the autophagic machinery could effectively eliminate pathogenic group A Streptococcus (GAS) within nonphagocytic cells. After escaping from endosomes into the cytoplasm, GAS became enveloped by autophagosome-like compartments and were killed upon fusion of these compartments with lysosomes. In autophagy-deficient Atg5(-/-) cells, GAS survived, multiplied, and were released from the cells. Thus, the autophagic machinery can act as an innate defense system against invading pathogens.	Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Bunkyo Ku, Tokyo 1138613, Japan; Nagahama Inst Biosci & Technol, Fac Biosci, Dept Cell Biol, Nagahama, Shiga 5260829, Japan; Natl Inst Genet, SOKENDAI, Dept Cell Genet, Mishima, Shizuoka 4118540, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nakagawa, I (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ichiro@dent.osaka-u.ac.jp; tamyoshi@lab.nig.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Nara, Atsuki/0000-0002-4115-3017; Nakata, Masanobu/0000-0003-1686-5415				Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; TWETEN RK, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P207; Walker DH, 1997, LAB INVEST, V76, P129; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	20	898	930	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1037	1040		10.1126/science.1103966	http://dx.doi.org/10.1126/science.1103966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528445				2022-12-24	WOS:000225001100044
J	Hankins, C				Hankins, C			From a vicious circle to a virtuous circle: reinforcing strategies of risk, vulnerability, and impact reduction for HIV prevention	LANCET			English	Editorial Material									UNAIDS Joint UN Programme HIV AIDS, Social Mobilisat & Strateg Informat Dept, CH-1211 Geneva 27, Switzerland	UNAIDS	Hankins, C (corresponding author), UNAIDS Joint UN Programme HIV AIDS, Social Mobilisat & Strateg Informat Dept, CH-1211 Geneva 27, Switzerland.	hankinsc@unaids.org		Hankins, Catherine/0000-0002-1642-8592				Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; *UNAIDS, 2001, GLOB STRAT FRAM HIV; UNAIDS, 2004, 4 UNAIDS; *UNAIDS, 2004, GLOB COAL WOM AIDS; UNAIDS/WHO, 2004, AIDS EP UPD	5	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV-DEC	2004	364	9449					1915	1916		10.1016/S0140-6736(04)17488-6	http://dx.doi.org/10.1016/S0140-6736(04)17488-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874BX	15566990				2022-12-24	WOS:000225327000004
J	Ponsky, TA; Huang, ZHJ; Kittle, K; Eichelberger, MR; Gilbert, JC; Brody, F; Newman, KD				Ponsky, TA; Huang, ZHJ; Kittle, K; Eichelberger, MR; Gilbert, JC; Brody, F; Newman, KD			Hospital- and patient-level characteristics and the risk of appendiceal rupture and negative appendectomy in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED-TOMOGRAPHY; QUALITY; IMPACT; CT; EPIDEMIOLOGY; CARE	Context The rates of appendiceal rupture and negative appendectomy in children remain high despite efforts to reduce them. Both outcomes are used as measures of hospital quality. Little is known about the factors that influence these rates. Objective To investigate the association between hospital- and patient-level characteristics and the rates of appendiceal rupture and negative appendectomy in children. Design, Setting, and Patients Retrospective review using the Pediatric Health Information System database containing information on 24 411 appendectomies performed on children aged 5 to 17 years at 36 pediatric hospitals in the United States between 1997 and 2002. Main Outcome Measures Rates of negative appendectomy and appendiceal rupture; the odds ratio (OR) of negative appendectomy and appendiceal rupture by hospital patient age, race, and health insurance status, and hospital fiscal year and appendectomy volume. Negative appendectomy rate was defined as the number of patients with appendectomy but without appendicitis divided by the total number of appendectomies. Results The median negative appendectomy rate was 3.06% (range, 1%-12%) and the median appendiceal rupture rate was 35.08% (range, 22%-62%). The adjusted OR for appendiceal rupture was higher in Asian children (1.66; 95% confidence interval [CI], 1.24-2.23) and black children (1.13; 95 % CI, 1.01-1.30) compared with white children. Children without health insurance and children with public insurance had increased odds of appendiceal rupture compared with children who had private health insurance (adjusted OR, 1.36; 95% Cl, 1.22-1.53 for self-insured; adjusted OR, 1, 48; 95% CI, 1.34-1.64 for public insurance). No correlation existed between negative appendectomy rate and race, health insurance status, or hospital appendiceal rupture rate. The negative appendectomy rate improved as the hospital appendectomy volume increased. Conclusion The rate of appendiceal rupture in school-aged children was associated with race and health insurance status and not with negative appendectomy rate and therefore is more likely to be associated with prehospitalization factors such as access to care, quality of care, and patient or physician education.	Childrens Natl Med Ctr, Dept Surg, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Biostat, Washington, DC 20010 USA; George Washington Univ, Med Ctr, Washington, DC 20037 USA; Child Hlth Corp Amer, Overland Pk, KS USA	Children's National Health System; Children's National Health System; George Washington University	Newman, KD (corresponding author), Childrens Natl Med Ctr, Dept Surg, 111 Michigan Ave,West Wing,4th Floor,Suite 200, Washington, DC 20010 USA.	knewman@cnmc.org	Ponsky, Todd/J-1214-2014	Ponsky, Todd/0000-0001-7195-1493				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; [Anonymous], US CENSUS BUREAU PRO; Applegate KE, 2001, RADIOLOGY, V220, P103, DOI 10.1148/radiology.220.1.r01jl17103; Balthazar EJ, 1998, AM J GASTROENTEROL, V93, P768; Bratton SL, 2000, PEDIATRICS, V106, P75, DOI 10.1542/peds.106.1.75; BRAVEMAN P, 1994, NEW ENGL J MED, V331, P444, DOI 10.1056/NEJM199408183310706; BRENDER JD, 1985, PEDIATRICS, V76, P301; DEZIEL DJ, 2002, CONTEMP SURG, V58, P286; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; Fuchs JR, 2002, J SURG RES, V106, P131, DOI 10.1006/jsre.2002.6441; Guagliardo MF, 2003, ACAD EMERG MED, V10, P1218, DOI 10.1197/S1069-6563(03)00492-5; Hale DA, 1997, ARCH SURG-CHICAGO, V132, P153; HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004; Kaiser S, 2002, RADIOLOGY, V223, P633, DOI 10.1148/radiol.2233011076; LUCKMANN R, 1991, EPIDEMIOLOGY, V2, P323, DOI 10.1097/00001648-199109000-00003; McDonald GP, 2001, AM SURGEON, V67, P1017; Norton VC, 1997, ANN EMERG MED, V29, P467, DOI 10.1016/S0196-0644(97)70218-X; Pena BMG, 2002, PEDIATRICS, V110, P1088, DOI 10.1542/peds.110.6.1088; Pittman-Waller VA, 2000, AM SURGEON, V66, P548; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; ROTHROCK SG, 1991, ANN EMERG MED, V20, P45, DOI 10.1016/S0196-0644(05)81117-5; SCHER KS, 1980, SOUTHERN MED J, V73, P1561, DOI 10.1097/00007611-198012000-00005; VELANOVICH V, 1992, AM SURGEON, V58, P264; WONG ML, 1994, J PEDIATR SURG, V29, P1356, DOI 10.1016/0022-3468(94)90115-5; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	185	185	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2004	292	16					1977	1982		10.1001/jama.292.16.1977	http://dx.doi.org/10.1001/jama.292.16.1977			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865DO	15507583	Bronze			2022-12-24	WOS:000224682900022
J	Venn, A; Bruinsma, F; Werther, G; Pyett, P; Baird, D; Jones, P; Rayner, P; Lumley, J				Venn, A; Bruinsma, F; Werther, G; Pyett, P; Baird, D; Jones, P; Rayner, P; Lumley, J			Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility	LANCET			English	Article							SEX STEROID TREATMENT; MANAGEMENT; STATURE	Background Treatment with oestrogen to reduce the adult height of tall girls has been available since the 1950s. We undertook a retrospective cohort study to assess the long-term effects of this treatment on fertility. Methods Eligible participants were identified from the records of Australian paediatric endocrinologists who assessed tall girls from 1959 to 1993, and from self-referrals. Individuals included girls who had received oestrogen treatment (diethylstilboestrol or ethinyl oestradiol) (treated group) and those who were assessed but not treated (untreated group). Information about reproductive history was sought by telephone interview. Findings 1432 eligible individuals were identified, of whom 1243 (87%) could be traced. Of these, 780 (63%) completed interviews: 651 were identified from endocrinologists' records, 129 were self-referred. Treated (n=371) and untreated (n=409) women were similar in socioeconomic and other characteristics. After adjustment for age, treated women were more likely to have ever tried for 12 months or more to become pregnant without success (relative risk [RR] 1.80, 95% CI 1.40-2-30); more likely to have seen a doctor because they were having difficulty becoming pregnant (RR 1.80, 1.39-2.32); and more likely to have ever taken fertility drugs (RR 2.05, 1.39-3.04). Time to first pregnancy analysis showed that the treated group was 40% less likely to conceive in any given menstrual cycle of unprotected intercourse (age-adjusted fecundability ratio 0.59, 95% CI 0.46-0.76). These associations persisted when self-referred women were excluded. Interpretation High-dose oestrogen treatment in adolescence seems to reduce female fertility in later life. This finding has implications for current treatment practices and for our understanding of reproductive biology.	Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia; La Trobe Univ, Bundoora, Vic, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Hormone Res, Melbourne, Vic, Australia; NIEHS, Res Triangle Pk, NC 27709 USA	University of Tasmania; Menzies Institute for Medical Research; La Trobe University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Venn, A (corresponding author), Univ Tasmania, Menzies Res Inst, Private Bag 23, Hobart, Tas 7001, Australia.	Alison.Venn@utas.edu.au	Rayner, Jo-Anne/B-4934-2016; Venn, Alison J/J-2803-2013; Baird, Donna D/D-5214-2017; Werther, George/B-3784-2012	Rayner, Jo-Anne/0000-0001-8622-9997; Baird, Donna D/0000-0002-5544-2653; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049003, Z01ES049003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barnard Neal D, 2002, J Pediatr Adolesc Gynecol, V15, P23, DOI 10.1016/S1083-3188(01)00135-8; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; CONTE FA, 1978, PEDIATRICS, V62, P1091; CRAWFORD JD, 1978, PEDIATRICS, V62, P1189; DEWAAL WJ, 1995, ARCH DIS CHILD, V73, P311, DOI 10.1136/adc.73.4.311; Drop SLS, 1998, ENDOCR REV, V19, P540, DOI 10.1210/er.19.5.540; GOLDZIEHER MA, 1956, J CLIN ENDOCR METAB, V16, P249, DOI 10.1210/jcem-16-2-249; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; NORMANN EK, 1991, ARCH DIS CHILD, V66, P1275, DOI 10.1136/adc.66.11.1275; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P204, DOI 10.1111/j.1467-842X.2003.tb00809.x; TRYGSTAD O, 1986, ACTA ENDOCRINOL-COP, V113, P170; WEINBERG CR, 1993, STAT MED, V12, P867, DOI 10.1002/sim.4780120906; WETTENHALL HNB, 1975, J PEDIATR-US, V86, P602; WETTENHALL HNB, 1981, CLIN PAEDIAT ENDOCRI, P134	14	65	65	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2004	364	9444					1513	1518		10.1016/S0140-6736(04)17274-7	http://dx.doi.org/10.1016/S0140-6736(04)17274-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864PN	15500896				2022-12-24	WOS:000224645500029
J	Rakhilin, SV; Olson, PA; Nishi, A; Starkova, NN; Fienberg, AA; Nairn, AC; Surmeier, DJ; Greengard, P				Rakhilin, SV; Olson, PA; Nishi, A; Starkova, NN; Fienberg, AA; Nairn, AC; Surmeier, DJ; Greengard, P			A network of control mediated by regulator of calcium/calmodulin-dependent signaling	SCIENCE			English	Article							INNERVATED BRAIN-REGIONS; RAT STRIATAL NEURONS; MEDIUM SPINY NEURONS; CYCLIC-AMP; DOPAMINE-RECEPTORS; CA2+ CURRENTS; INTACT-CELLS; PHOSPHORYLATION; CALMODULIN; ARPP-21	Calmodulin (CaM) is A major effector for the intracellular actions of Ca2+ in nearly all cell types. We identified a CaM-binding protein, designated regulator of calmodulin signaling (RCS). G protein-coupled receptor (GPCR)-dependent activation of protein kinase A (PKA) led to phosphorylation of RCS at Ser(55) and increased its binding to CaM. Phospho RCS acted as a competitive inhibitor of CaM-dependent enzymes, including protein phosphatase 2B (PP2B, also called calcineurin). Increasing RCS phosphorylation blocked GPCR- and PP2B-mediated suppression of L-type Ca2+ currents in striatal neurons. Conversely, genetic deletion of RCS significantly increased this modulation. Through a molecular mechanism that amplifies GPCR- and PKA-mediated signaling and attenuates GPCR- and PP2B-mediated signaling, RCS synergistically increases the phosphorylation of key proteins whose phosphorylation is regulated by PKA and PP2B.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Kurume Univ, Sch Med, Dept Pharmacol, Fukuoka 8300011, Japan; Intra Cellular Therapies Inc, New York, NY 10032 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; Northwestern University; Feinberg School of Medicine; Kurume University; Yale University	Nairn, AC (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.	angus.nairn@yale.edu; j-surmeier@northwestern.edu; greengard@rockefeller.edu		Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012958, P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10044, DA12958, P01 DA010044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; NINDS NIH HHS [NS34696] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; BERNARD V, 1992, J NEUROSCI, V12, P3591; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; BRENE S, 1994, J NEUROSCI, V14, P985, DOI 10.1523/JNEUROSCI.14-03-00985.1994; Caporaso GL, 2000, NEUROPHARMACOLOGY, V39, P1637, DOI 10.1016/S0028-3908(99)00230-0; DUVOISIN RC, 1967, ARCH NEUROL-CHICAGO, V17, P124, DOI 10.1001/archneur.1967.00470260014002; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; GIRAULT JA, 1990, NEUROSCIENCE, V37, P317; HEMMINGS HC, 1989, J BIOL CHEM, V264, P7726; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HERSCH SM, 1994, J NEUROSCI, V14, P3351; Hornykiewicz O, 1987, Adv Neurol, V45, P19; HOWE AR, 1995, J NEUROSCI, V15, P458; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kisielow J, 2001, EUR J IMMUNOL, V31, P1141, DOI 10.1002/1521-4141(200104)31:4<1141::AID-IMMU1141>3.0.CO;2-R; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Nishi A, 1997, J NEUROSCI, V17, P8147; OUIMET CC, 1989, J NEUROSCI, V9, P865; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RAKHILIN SV, UNPUB; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Zainelli GM, 2004, J NEUROSCI, V24, P1954, DOI 10.1523/JNEUROSCI.4424-03.2004	25	79	85	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					698	701		10.1126/science.1099961	http://dx.doi.org/10.1126/science.1099961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499021				2022-12-24	WOS:000224756700055
J	Kolaczkowski, B; Thornton, JW				Kolaczkowski, B; Thornton, JW			Performance of maximum parsimony and likelihood phylogenetics when evolution is heterogeneous	NATURE			English	Article							MITOCHONDRIAL-DNA; COVARIOTIDE MODEL; INFERENCE; SEQUENCES; ACCURACY; BIAS	All inferences in comparative biology depend on accurate estimates of evolutionary relationships. Recent phylogenetic analyses have turned away from maximum parsimony towards the probabilistic techniques of maximum likelihood and bayesian Markov chain Monte Carlo (BMCMC). These probabilistic techniques represent a parametric approach to statistical phylogenetics, because their criterion for evaluating a topology-the probability of the data, given the tree-is calculated with reference to an explicit evolutionary model from which the data are assumed to be identically distributed. Maximum parsimony can be considered nonparametric, because trees are evaluated on the basis of a general metric-the minimum number of character state changes required to generate the data on a given tree-without assuming a specific distribution(1). The shift to parametric methods was spurred, in large part, by studies showing that although both approaches perform well most of the time(2), maximum parsimony is strongly biased towards recovering an incorrect tree under certain combinations of branch lengths, whereas maximum likelihood is not(3-6). All these evaluations simulated sequences by a largely homogeneous evolutionary process in which data are identically distributed. There is ample evidence, however, that real-world gene sequences evolve heterogeneously and are not identically distributed(7-16). Here we show that maximum likelihood and BMCMC can become strongly biased and statistically inconsistent when the rates at which sequence sites evolve change non-identically over time. Maximum parsimony performs substantially better than current parametric methods over a wide range of conditions tested, including moderate heterogeneity and phylogenetic problems not normally considered difficult.	Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Thornton, JW (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022					Chang JT, 1996, MATH BIOSCI, V134, P189, DOI 10.1016/0025-5564(95)00172-7; Delarbre C, 2002, MOL PHYLOGENET EVOL, V22, P184, DOI 10.1006/mpev.2001.1045; DONALDSON TS, 1968, J AM STAT ASSOC, V63, P660, DOI 10.2307/2284037; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FITCH WM, 1976, J MOL EVOL, V8, P13, DOI 10.1007/BF01738880; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huelsenbeck JP, 2002, MOL BIOL EVOL, V19, P698, DOI 10.1093/oxfordjournals.molbev.a004128; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inagaki Y, 2004, MOL BIOL EVOL, V21, P1340, DOI 10.1093/molbev/msh130; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lockhart PJ, 1998, MOL BIOL EVOL, V15, P1183, DOI 10.1093/oxfordjournals.molbev.a026025; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Misof B, 2002, J MOL EVOL, V55, P460, DOI 10.1007/s00239-002-2341-1; MIYAMOTO MM, 1995, MOL BIOL EVOL, V12, P503; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; Philippe H, 2001, TRENDS BIOCHEM SCI, V26, P414, DOI 10.1016/S0968-0004(01)01877-1; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pupko T, 2002, P ROY SOC B-BIOL SCI, V269, P1313, DOI 10.1098/rspb.2002.2025; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Sanderson MJ, 2000, SYST BIOL, V49, P817, DOI 10.1080/106351500750049860; Sullivan J, 2001, SYST BIOL, V50, P723, DOI 10.1080/106351501753328848; SWOFFORD D.L., 2003, PAUP PHYLOGENETIC AN; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Tuffley C, 1997, B MATH BIOL, V59, P581, DOI 10.1016/S0092-8240(97)00001-3; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	30	410	422	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					980	984		10.1038/nature02917	http://dx.doi.org/10.1038/nature02917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496922				2022-12-24	WOS:000224585600043
J	Nobrega, MA; Zhu, YW; Plajzer-Frick, I; Afzal, V; Rubin, EM				Nobrega, MA; Zhu, YW; Plajzer-Frick, I; Afzal, V; Rubin, EM			Megabase deletions of gene deserts result in viable mice	NATURE			English	Article							DNA-SEQUENCE; EXPRESSION; SKELETAL; INTERVAL; ENHANCER; NUMBER	The functional importance of the roughly 98% of mammalian genomes not corresponding to protein coding sequences remains largely undetermined(1). Here we show that some large-scale deletions of the non-coding DNA referred to as gene deserts(2-4) can be well tolerated by an organism. We deleted two large non-coding intervals, 1,511 kilobases and 845 kilobases in length, from the mouse genome. Viable mice homozygous for the deletions were generated and were indistinguishable from wildtype littermates with regard to morphology, reproductive fitness, growth, longevity and a variety of parameters assaying general homeostasis. Further detailed analysis of the expression of multiple genes bracketing the deletions revealed only minor expression differences in homozygous deletion and wild-type mice. Together, the two deleted segments harbour 1,243 non-coding sequences conserved between humans and rodents (more than 100 base pairs, 70% identity). Some of the deleted sequences might encode for functions unidentified in our screen; nonetheless, these studies further support the existence of potentially 'disposable DNA' in the genomes of mammals.	DOE Joint Genome Inst Walnut Creek, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Rubin, EM (corresponding author), DOE Joint Genome Inst Walnut Creek, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov						Anderson JP, 2004, MOL CELL BIOL, V24, P3757, DOI 10.1128/MCB.24.9.3757-3768.2004; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bentley DR, 2004, NATURE, V429, P440, DOI 10.1038/nature02622; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Frazer KA, 2004, GENOME RES, V14, P367, DOI 10.1101/gr.1961204; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hogan B, 1994, MANIPULATING MOUSE E; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jasny BR, 2001, SCIENCE, V291, P1153, DOI 10.1126/science.291.5506.1153; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; OVCHARENKO I, IN PRESS GENOMICS; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SAUER B, 1990, New Biologist, V2, P441; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhu YW, 2000, P NATL ACAD SCI USA, V97, P1137, DOI 10.1073/pnas.97.3.1137	28	127	141	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					988	993		10.1038/nature03022	http://dx.doi.org/10.1038/nature03022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496924	Green Submitted			2022-12-24	WOS:000224585600045
J	Sampath, P; Mazumder, B; Seshadri, V; Gerber, CA; Chavatte, L; Kinter, M; Ting, SM; Dignam, JD; Kim, S; Driscoll, DM; Fox, PL				Sampath, P; Mazumder, B; Seshadri, V; Gerber, CA; Chavatte, L; Kinter, M; Ting, SM; Dignam, JD; Kim, S; Driscoll, DM; Fox, PL			Noncanonical function of glutamyl-prolyi-tRNA synthetase: Gene-specific silencing of translation	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; MESSENGER-RNA; GAMMA-INTERFERON; MACROMOLECULAR ASSEMBLAGE; MONOCYTIC CELLS; IFN-GAMMA; KINASE-C; COMPLEX; CERULOPLASMIN; IDENTIFICATION	Aminoacyl tRNA synthetases (ARS) catalyze the ligation of amino acids to cognate tRNAs. Chordate ARSs have evolved distinctive features absent from ancestral forms, including compartmentalization in a multisynthetase complex (MSC), noncatalytic peptide appendages, and ancillary functions unrelated to aminoacylation. Here, we show that glutamyl-prolyl-tRNA synthetase (GluProRS), a bifunctional ARS of the MSC, has a regulated, noncanonical activity that blocks synthesis of a specific protein. GluProRS was identified as a component of the interferon (IFN)gamma-activated inhibitor of translation (GAIT) complex by RNA affinity chromatography using the ceruloplasmin (Cp) GAIT element as ligand. In response to IFN-gamma, GluProRS is phosphorylated and released from the MSC, binds the Cp 3'-untranslated region in an mRNP containing three additional proteins, and silences Cp mRNA translation. Thus, GluProRS has divergent functions in protein synthesis: in the MSC, its aminoacylation activity supports global translation, but translocation of GluProRS to an inflammation-responsive mRNP causes gene-specific translational silencing.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol, Cleveland, OH 44115 USA; Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43614 USA; Seoul Natl Univ, Coll Pharm, Ctr ARS Network, Seoul 151742, South Korea	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Seoul National University (SNU)	Fox, PL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Kim, Sunghoon/AAE-8314-2020	Kinter, Michael/0000-0001-7409-8918; Mazumder, Barsanjit/0000-0003-3069-7833; Chavatte, Laurent/0000-0001-7696-2431	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067725, P01HL029582, P01HL076491] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL29582, HL76491, HL67725] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; BERG BH, 1990, BIOCHIM BIOPHYS ACTA, V1038, P391, DOI 10.1016/0167-4838(90)90254-D; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CLEMENS MJ, 1990, TRENDS BIOCHEM SCI, V15, P172, DOI 10.1016/0968-0004(90)90153-3; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; ELGLAYAR S, 2003, J IMMUNOL, V171, P4561; FETT R, 1991, J BIOL CHEM, V266, P1448; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Garcia GE, 2003, KIDNEY INT, V64, P160, DOI 10.1046/j.1523-1755.2003.00077.x; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Harris CE, 1999, J VIROL, V73, P72, DOI 10.1128/JVI.73.1.72-80.1999; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; KLEBANOFF SJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P302, DOI 10.1016/0003-9861(92)90522-X; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Mazumder B, 1997, J IMMUNOL, V159, P1938; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; MAZUMDER B, 2003, CELL, V28, P91; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Mukhopadhyay CK, 1997, P NATL ACAD SCI USA, V94, P11546, DOI 10.1073/pnas.94.21.11546; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; PENDERGAST AM, 1987, J BIOL CHEM, V262, P5939; PENDERGAST AM, 1985, J BIOL CHEM, V260, P1769; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; SCHRAY B, 1991, NUCLEIC ACIDS RES, V19, P5307, DOI 10.1093/nar/19.19.5307; Shiba K, 2002, J MOL EVOL, V55, P727, DOI 10.1007/s00239-002-2368-3; STANDART N, 1994, BIOCHIMIE, V76, P867, DOI 10.1016/0300-9084(94)90189-9; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; TING SM, 1992, J BIOL CHEM, V267, P17701; VENEMA RC, 1991, J BIOL CHEM, V266, P5298; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wu H, 1995, BIOCHEMISTRY-US, V34, P16327, DOI 10.1021/bi00050a013; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	56	199	215	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					195	208		10.1016/j.cell.2004.09.030	http://dx.doi.org/10.1016/j.cell.2004.09.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479637	Bronze			2022-12-24	WOS:000224577200008
J	Madden, MEE; Bodnar, RJ; Rimstidt, JD				Madden, MEE; Bodnar, RJ; Rimstidt, JD			Jarosite as an indicator of water-limited chemical weathering on Mars	NATURE			English	Article							MARTIAN REGOLITH; METEORITES; CLIMATE; SOIL; CHEMISTRY; SULFUR; BASALT; SALTS; ROCKS	The Mars Exploration Rover Opportunity identified the ferric sulphate mineral jarosite and possible relicts of gypsum at the Meridiani Planum landing site(1). On Earth, jarosite has been found to form in acid mine drainage environments, during the oxidation of sulphide minerals(2), and during alteration of volcanic rocks by acidic, sulphur-rich fluids near volcanic vents(3). Jarosite formation is thus thought to require a wet, oxidizing and acidic environment. But jarosite on Earth only persists over geologically relevant time periods in arid environments because it rapidly decomposes to produce ferric oxyhydroxides in more humid climates(4). Here we present equilibrium thermodynamic reaction-path simulations that constrain the range of possible conditions under which such aqueous alteration phases are likely to have formed on Mars. These calculations simulate the chemical weathering of basalt at relevant martian conditions. We conclude that the presence of jarosite combined with residual basalt at Meridiani Planum indicates that the alteration process did not proceed to completion, and that following jarosite formation, arid conditions must have prevailed.	Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Madden, MEE (corresponding author), Virginia Tech, Dept Geosci, 4044 Derring Hall, Blacksburg, VA 24061 USA.	melwood@vt.edu	Bodnar, Robert J/A-1916-2009; Rimstidt, James/N-8910-2013; Elwood Madden, Megan/C-3381-2009	Elwood Madden, Megan/0000-0002-6735-4554				Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bethke C.M., 1996, GEOCHEMICAL BIOGEOCH; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Fieldes M., 1975, Soil components. Volume 2. Inorganic components (Gieseking, J.E., Ed)., P351; Fulignati P, 2002, J VOLCANOL GEOTH RES, V115, P397, DOI 10.1016/S0377-0273(02)00209-3; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; GOODING JL, 1992, ICARUS, V99, P28, DOI 10.1016/0019-1035(92)90168-7; HEMLEY JJ, 1986, GEOLOGY, V14, P377, DOI 10.1130/0091-7613(1986)14<377:EOPOOM>2.0.CO;2; Herbert RB, 1997, CLAY CLAY MINER, V45, P261, DOI 10.1346/CCMN.1997.0450214; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Langmuir D., 1996, AQUEOUS ENV GEOCHEMI; Levine J.S., 1985, PHOTOCHEMISTRY ATMOS, P337; Linke W.F., 1958, SOLUBILITIES INORGAN, VI; Marion GM, 2003, GEOCHIM COSMOCHIM AC, V67, P4251, DOI 10.1016/S0016-7037(03)00372-7; McSween HY, 2000, GEOCHIM COSMOCHIM AC, V64, P2155, DOI 10.1016/S0016-7037(99)00401-9; MORRIS R, 2004, LUN PLAN SCI C, V35; Owen T., 1992, COMPOSITION EARLY HI, P818; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; ROSENBAUER RJ, 1983, ECON GEOL, V78, P1701, DOI 10.2113/gsecongeo.78.8.1701; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Sharp T. G., 2003, GEOPHYS RES LETT, V30; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Ziegler K, 2003, CHEM GEOL, V202, P461, DOI 10.1016/j.chemgeo.2002.06.001	30	214	219	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					821	823		10.1038/nature02971	http://dx.doi.org/10.1038/nature02971			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483605				2022-12-24	WOS:000224435500040
J	Weng, AP; Ferrando, AA; Lee, W; Morris, JP; Silverman, LB; Sanchez-Irizarry, C; Blacklow, SC; Look, AT; Aster, JC				Weng, AP; Ferrando, AA; Lee, W; Morris, JP; Silverman, LB; Sanchez-Irizarry, C; Blacklow, SC; Look, AT; Aster, JC			Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia	SCIENCE			English	Article							GAMMA-SECRETASE; TRANSCRIPTIONAL ACTIVATION; TRANSGENIC MICE; PROTEIN; COMPLEX; INACTIVATION; PRESENILIN; INDUCTION; RECEPTORS; DOMAINS	Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a gene encoding a transmembrane receptor that regulates normal T cell development. Here, we report that more than 50% of human T-ALLs, including tumors from all major molecular oncogenic subtypes, have activating mutations that involve the extracellular heterodimerization domain and/or the C-terminal PEST domain of NOTCH1. These findings greatly expand the role of activated NOTCH1 in the molecular pathogenesis of human T-ALL and provide a strong rationale for targeted therapies that interfere with NOTCH signaling.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Aster, JC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu	Weng, Andrew P/I-5015-2014; Ferrando, Adolfo A/Q-7026-2016	Weng, Andrew/0000-0001-7394-5425	NATIONAL CANCER INSTITUTE [R01CA094233, P01CA068484, K08CA098093, R56CA094233, P01CA109901, P30CA021765, R01CA082308] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA109901, CA82308, CA68484, CA98093, CA109901, CA21765, CA94233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; ASTER J, UNPUB; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Berry LW, 1997, DEVELOPMENT, V124, P925; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feldman BJ, 2000, BLOOD, V96, P1906, DOI 10.1182/blood.V96.5.1906.h8001906_1906_1913; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KRAMER H, 2000, SCI STKE, pPE1; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; SANCHEZIRIZARRY C, IN PRESS MOL CELL BI; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	25	2080	2228	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					269	271		10.1126/science.1102160	http://dx.doi.org/10.1126/science.1102160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472075				2022-12-24	WOS:000224419700038
J	Steliarova-Foucher, E; Stiller, C; Kaatsch, P; Berrino, F; Coebergh, JW; Lacour, B; Parkin, M				Steliarova-Foucher, E; Stiller, C; Kaatsch, P; Berrino, F; Coebergh, JW; Lacour, B; Parkin, M			Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; INCREASING INCIDENCE; CHILDHOOD-CANCER; LEUKEMIA; BRITAIN; DISEASE	Background Cancer is rare before age 20 years. We aimed to use the European database of childhood and adolescent cancer cases, within the Automated Childhood Cancer Information System project, to estimate patterns and trends of incidence and survival within Europe. Methods Comparable, high-quality data from 63 European population-based cancer registries consisted of 113000 tumours in children and 18 243 in adolescents diagnosed in 1970-99. Incidence rates and survival were compared by region (east vs west), period, and malignant disease. Findings In the 1990s, age-standardised incidence rates were 140 per million for children (0-14 years) and 157 per million for ages 0-19 years. Over the three decades, overall incidence increased by 1.0% per year (p<0.0001) in children (increases for most tumour types), and by 1.5% (p<0.0001) in adolescents (15-19 years; notable increases were recorded for carcinomas, lymphomas, and germ-cell tumours). Overall 5-year survival for children in the 1990s was 64% in the east and 75% in the west, with differences between regions for virtually all tumour groups; 5-year survival was much the same in adolescents. Survival has improved dramatically since the 1970s in children and adolescents, more so in the west than in the east. Interpretation our results are clear evidence of an increase of cancer incidence in childhood and adolescence during the past decades, and of an acceleration of this trend. Geographical and temporal patterns suggest areas for further study into causes of these neoplasms, as well as providing an indicator of progress of public-health policy in Europe.	Int Agcy Res Canc, F-69372 Lyon, France; Univ Oxford, Childhood Canc Res Grp, Oxford, England; Johannes Gutenberg Univ Mainz, German Childhood Canc Registry, D-6500 Mainz, Germany; Natl Canc Inst, I-20133 Milan, Italy; Dutch Childhood Oncol Grp, The Hague, Netherlands; Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands; Fac Med, French Natl Registry Childhood Solid Tumours, Vandoeuvre Les Nancy, France	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; Johannes Gutenberg University of Mainz; Fondazione IRCCS Istituto Nazionale Tumori Milan; Dutch Childhood Oncology Group; Erasmus University Rotterdam; Universite de Lorraine	Steliarova-Foucher, E (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	steliarova@iarc.fr	Steliarova-Foucher, Eva/L-6508-2019; Berrino, Franco/AAC-2364-2020	Steliarova-Foucher, Eva/0000-0001-5777-9199; Berrino, Franco/0000-0002-4858-1866; Coebergh, Jan Willem/0000-0002-2419-3930; Stiller, Charles/0000-0002-3006-7869				ALEXANDER FE, 1995, EUR J CANCER, V31A, P863, DOI 10.1016/0959-8049(95)00023-2; [Anonymous], 2003, EUR J CANCER, V39, P2247, DOI 10.1016/j.ejca.2003.09.015; BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270; CARTWRIGHT R, 1994, LEUKEMIA LYMPHOMA, V14, P387, DOI 10.3109/10428199409049694; Coebergh JWW, 2001, EUR J CANCER, V37, P671, DOI 10.1016/S0959-8049(01)00005-3; CORREA P, 1971, INT J CANCER, V8, P192, DOI 10.1002/ijc.2910080203; COURTBROWN W, 1961, BMJ-BRIT MED J, V1, P981; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Ferlay J, 2001, IARC CANCERBASE; FERLAY J, IARCTOOLS; Ferraris AM, 1997, ANN HEMATOL, V74, P131, DOI 10.1007/s002770050270; Gatta G, 2003, ANN ONCOL, V14, pV119, DOI 10.1093/annonc/mdg755; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Honjo S, 2003, INT J CANCER, V103, P538, DOI 10.1002/ijc.10859; Hrusak O, 2002, LEUKEMIA, V16, P720, DOI 10.1038/sj/leu/2402422; JENSEN OM, 1991, IARC SCI PUBL, V95, P159; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Kirkwood B., 1988, BR K ESSENTIALS MED; Kramarova E, 1996, INT J CANCER, V68, P759; KRAMAROVA E, 1996, 29 IARC; Magnani C, 2003, INT J CANCER, V105, P552, DOI 10.1002/ijc.11112; McNally RJQ, 2001, CANCER-AM CANCER SOC, V92, P1967, DOI 10.1002/1097-0142(20011001)92:7<1967::AID-CNCR1716>3.0.CO;2-#; Parkin D. M, 1988, IARC SCI PUBLICATION, V87; PARKIN DM, 2003, IARC TECHNICAL PUBLI, V40, P69; Parkin DM, 1994, 19 IARC; Parkin DM, 1998, IARC SCI PUBLICATION, V144; Percy C, 1992, INT CLASSIFICATION D; Shibata Y, 2001, LANCET, V358, P1965, DOI 10.1016/S0140-6736(01)06971-9; SMITH MA, 1999, NIH PUB; Stiller C A, 1990, Paediatr Perinat Epidemiol, V4, P303, DOI 10.1111/j.1365-3016.1990.tb00654.x; STILLER CA, 1991, BRIT J CANCER, V64, P543, DOI 10.1038/bjc.1991.347; Weidmann C, 1999, EUR J CANCER, V35, P1235, DOI 10.1016/S0959-8049(99)00108-2	34	397	410	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2097	2105		10.1016/S0140-6736(04)17550-8	http://dx.doi.org/10.1016/S0140-6736(04)17550-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589307	Green Submitted			2022-12-24	WOS:000225742300022
J	Klingelhofer, G; Morris, RV; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Zubkov, B; Foh, J; Bonnes, U; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE				Klingelhofer, G; Morris, RV; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Zubkov, B; Foh, J; Bonnes, U; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE			Jarosite and hematite at Meridiani Planum from Opportunity's Mossbauer spectrometer	SCIENCE			English	Article							1ST SHERGOTTITE; BOUNCE ROCK; X-RAY; MARS; MINERALOGY; SOILS; CRATER; METEORITE; SULFATES; WATER	Mossbauer spectra measured by the Opportunity rover revealed four mineralogical components in Meridiani Planum at Eagle crater: jarosite- and hematite-rich outcrop, hematite-rich soil, olivine-bearing basaltic soil, and a pyroxene-bearing basaltic rock (Bounce rock). Spherutes, interpreted to be concretions, are hematite-rich and dispersed throughout the outcrop. Hematitic soils both within and outside Eagle crater are dominated by spherules and their fragments. Olivine-bearing basaltic soil is present throughout the region. Bounce rock is probably an impact erratic. Because jarosite is a hydroxide sulfate mineral, its presence at Meridiani Planum is mineralogical evidence for aqueous processes on Mars, probably under acid-sulfate conditions.	Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; IKI, Space Res Inst, Moscow 117997, Russia; Copanhia Vale Rio Doce Grp, Vitoria, Spain; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Tech Univ Darmstadt, D-64289 Darmstadt, Germany; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Cornell Univ, Ithaca, NY 14853 USA; Washington Univ, St Louis, MO 63130 USA	Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Technical University of Darmstadt; University of Alabama System; University of Alabama Birmingham; Cornell University; Washington University (WUSTL)	Klingelhofer, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, Staudinger Weg 9, D-55128 Mainz, Germany.	klingel@mail.uni-mainz.de	de Souza, Paulo A/B-8961-2008; de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; Schröder, Christian/B-3870-2009	de Souza, Paulo A/0000-0002-0091-8925; de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Renz, Franz/0000-0003-1494-1242				Bishop J.L., 1996, SPEC PUBL GEOCHEM SO, V5, P337; Bishop JL, 1998, J GEOPHYS RES-PLANET, V103, P31457, DOI 10.1029/1998JE900008; Burns R.G., 1988, LUNAR PLANET SCI, V18, P713; BURNS RG, 1989, ACS SYM SER, V415, P262; BURNS RG, 1993, GEOCHIM COSMOCHIM AC, V57, P4555, DOI 10.1016/0016-7037(93)90182-V; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; BURNS RG, 1986, NATURE, V320, P55, DOI 10.1038/320055a0; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14415, DOI 10.1029/JB095iB09p14415; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dang MZ, 1998, HYPERFINE INTERACT, V117, P271, DOI 10.1023/A:1012655729417; de Souza PA, 1999, LAB ROBOTICS AUTOMAT, V11, P3, DOI 10.1002/(SICI)1098-2728(1999)11:1<3::AID-LRA2>3.0.CO;2-F; DEGRAVE E, 1990, PHYS CHEM MINER, V17, P344, DOI 10.1007/BF00200130; DEGRAVE E, 1991, PHYS CHEM MINER, V18, P337, DOI 10.1007/BF00200191; Dyar MD, 2003, METEORIT PLANET SCI, V38, P1733, DOI 10.1111/j.1945-5100.2003.tb00012.x; GOLOMBEK, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE002074; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; HRYNKIEWICZ AZ, 1965, J INORG NUCL CHEM, V27, P2513, DOI 10.1016/0022-1902(65)80150-6; JOHNSTON JH, 1977, GEOCHIM COSMOCHIM AC, V41, P539, DOI 10.1016/0016-7037(77)90291-5; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; MCCAMMON C, 1995, AGU REFERENCE SHELF, V2, P332; MENZIES ON, 2001, LUNAR PLANET SCI, V32; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MORRIS RV, 1996, SPEC PUBL GEOCHEM SO, V5, P327; MURAD E, 1994, CLAY MINER, V29, P1, DOI 10.1180/claymin.1994.029.1.01; Murad E., 1987, MOSSBAUER SPECTRA AP, P507, DOI 10.1007/978-1-4899-0462-1.; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rodionov D, 2004, METEORIT PLANET SCI, V39, pA91; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; SHERMAN DM, 1988, AM MINERAL, V73, P1346; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; STEVENS JG, 1998, MOSSBAUER MINERL HDB; VISTISEN L, 1992, PHYS SCRIPTA, V46, P94, DOI 10.1088/0031-8949/46/1/018; Zipfel J, 2004, METEORIT PLANET SCI, V39, pA118	40	606	618	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1740	1745		10.1126/science.1104653	http://dx.doi.org/10.1126/science.1104653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576610				2022-12-24	WOS:000225630800042
J	Losos, JB; Schoener, TW; Spiller, DA				Losos, JB; Schoener, TW; Spiller, DA			Predator-induced behaviour shifts and natural selection in field-experimental lizard populations	NATURE			English	Article							ANOLIS LIZARDS; DRIVE	The role of behaviour in evolutionary change has long been debated. On the one hand, behavioural changes may expose individuals to new selective pressures by altering the way that organisms interact with the environment, thus driving evolutionary divergence(1-3). Alternatively, behaviour can act to retard evolutionary change(4-6): by altering behavioural patterns in the face of new environmental conditions, organisms can minimize exposure to new selective pressures. This constraining influence of behaviour has been put forward as an explanation for evolutionary stasis within lineages(4,7-9) and niche conservatism within clades(10,11). Nonetheless, the hypothesis that behavioural change prevents natural selection from operating in new environments has never been experimentally tested. We conducted a controlled and replicated experimental study of selection in entirely natural populations; we demonstrate that lizards alter their habitat use in the presence of an introduced predator, but that these behavioural shifts do not prevent patterns of natural selection from changing in experimental populations.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Davis	Losos, JB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	losos@biology.wustl.edu						Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Brandon R.N., 1988, P51; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Coope G. R., 1995, P55; DeWitt TJ, 2003, J SEA RES, V49, P143, DOI 10.1016/S1385-1101(02)00220-4; Eldredge N., 1989, MACROEVOLUTIONARY DY; Garland Theodore Jr., 1994, P240; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Irschick DJ, 1999, AM NAT, V154, P293, DOI 10.1086/303239; Janzen FJ, 1998, EVOLUTION, V52, P1564, DOI 10.1111/j.1558-5646.1998.tb02237.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LEVITON JS, 2001, PALEONTOLOGY MACROEV; LITTELL RC, 1999, SAS SYSTEM LINEAR MO; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Losos JB, 1999, ECOLOGY, V80, P252, DOI 10.2307/176994; PACALA SW, 1985, ECOLOGY, V66, P129, DOI 10.2307/1941313; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; Schoener TW, 2002, ECOL MONOGR, V72, P383, DOI 10.1890/0012-9615(2002)072[0383:POACAL]2.0.CO;2; SCHOENER TW, 1982, OECOLOGIA, V53, P160, DOI 10.1007/BF00545659; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; SCHOENER TW, 1982, OIKOS, V39, P1, DOI 10.2307/3544525; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; WCISLO WT, 1989, ANNU REV ECOL SYST, V20, P137, DOI 10.1146/annurev.es.20.110189.001033; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18; WYLES JS, 1983, P NATL ACAD SCI-BIOL, V80, P4394, DOI 10.1073/pnas.80.14.4394	30	190	193	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					505	508		10.1038/nature03039	http://dx.doi.org/10.1038/nature03039			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565155				2022-12-24	WOS:000225322100047
J	Pandolfi, PP				Pandolfi, PP			Breast cancer - Loss of PTEN predicts resistance to treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERBB2		Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.							Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972	5	127	144	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2004	351	22					2337	2338		10.1056/NEJMcibr043143	http://dx.doi.org/10.1056/NEJMcibr043143			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873RH	15564551				2022-12-24	WOS:000225298100017
J	Teixeira, A; Tahiri-Alaoui, A; West, S; Thomas, B; Ramadass, A; Martianov, I; Dye, M; James, W; Proudfoot, NJ; Akoulitchev, A				Teixeira, A; Tahiri-Alaoui, A; West, S; Thomas, B; Ramadass, A; Martianov, I; Dye, M; James, W; Proudfoot, NJ; Akoulitchev, A			Autocatalytic RNA cleavage in the human beta-globin pre-mRNA promotes transcription termination	NATURE			English	Article							SELF-SPLICING RNA; IN-VIVO; CATALYSIS; TETRAHYMENA; EXPRESSION; INTRON	New evidence indicates that termination of transcription is an important regulatory step, closely related to transcriptional interference(1) and even transcriptional initiation(2). However, how this occurs is poorly understood. Recently, in vivo analysis of transcriptional termination for the human beta-globin gene revealed a new phenomenon-co-transcriptional cleavage (CoTC)(3). This primary cleavage event within beta-globin pre-messenger RNA, downstream of the poly(A) site, is critical for efficient transcriptional termination by RNA polymerase II3. Here we show that the CoTC process in the human beta-globin gene involves an RNA self-cleaving activity. We characterize the autocatalytic core of the CoTC ribozyme and show its functional role in efficient termination in vivo. The identified core CoTC is highly conserved in the 3' flanking regions of other primate beta-globin genes. Functionally, it resembles the 3' processive, self-cleaving ribozymes described for the protein-encoding genes from the myxomycetes Didymium iridis and Physarum polycephalum, indicating evolutionary conservation of this molecular process. We predict that regulated autocatalytic cleavage elements within pre-mRNAs may be a general phenomenon and that functionally it may provide the entry point for exonucleases involved in mRNA maturation, turnover and, in particular, transcriptional termination.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; Wellcome Trust Sanger Institute	Akoulitchev, A (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	alexandre.akoulitchev@path.ox.ac.uk	Teixeira, Alexandre/N-9654-2013; james, william/H-4289-2013; West, Steven/AAG-4009-2019	Teixeira, Alexandre/0000-0001-8899-9514; james, william/0000-0002-2506-1198; West, Steven/0000-0002-7622-9050; Martiyanov, Igor/0000-0001-6108-2036; Proudfoot, Nicholas/0000-0001-8646-3222				ADAMS SE, 1988, NUCLEIC ACIDS RES, V16, P4287, DOI 10.1093/nar/16.10.4287; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BASS BL, 1984, NATURE, V308, P820, DOI 10.1038/308820a0; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Lee JM, 1997, J BIOL CHEM, V272, P10990; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Lilley DMJ, 2003, TRENDS BIOCHEM SCI, V28, P495, DOI 10.1016/S0968-0004(03)00191-9; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; ROCHELEAU GA, 1994, NUCLEIC ACIDS RES, V22, P4315, DOI 10.1093/nar/22.20.4315; Samarsky DA, 1999, P NATL ACAD SCI USA, V96, P6609, DOI 10.1073/pnas.96.12.6609; Stage-Zimmermann TK, 1998, RNA, V4, P875, DOI 10.1017/S1355838298980876; TAHIRIALAOUI A, 2002, NUCLEIC ACIDS RES, V30, P1; Vader A, 1999, EMBO J, V18, P1003, DOI 10.1093/emboj/18.4.1003; van Hoof A, 2002, CURR BIOL, V12, pR285, DOI 10.1016/S0960-9822(02)00802-3; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yonaha M, 2000, EMBO J, V19, P3770, DOI 10.1093/emboj/19.14.3770; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	81	88	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					526	530		10.1038/nature03032	http://dx.doi.org/10.1038/nature03032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565159				2022-12-24	WOS:000225322100052
J	Haber, P; DeStefano, F; Angulo, FJ; Iskander, J; Shadomy, SV; Weintraub, E; Chen, RT				Haber, P; DeStefano, F; Angulo, FJ; Iskander, J; Shadomy, SV; Weintraub, E; Chen, RT			Guillain-Barre syndrome following influenza vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EVENT-REPORTING-SYSTEM; CAMPYLOBACTER-JEJUNI; UNITED-STATES; ASSOCIATION; INFECTION; VACCINES; SAFETY; VAERS	Context An unexplained increase in the risk of Guillain-Barre syndrome (GBS) occurred among recipients of the swine influenza vaccine in 1976-1977. Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990. Objective to evaluate trends of reports to VAERS of GBS following influenza vaccination in adults. Design, Setting, and Participants VAERS is the US national spontaneous reporting system for adverse events following vaccination. Reports of GBS in persons 18 years or older following influenza vaccination were evaluated for each influenza season from July 1, 1990, through June 30, 2003. The number of people vaccinated was estimated from the National Health Interview Survey and US census data. Beginning in 1994, active follow-up was conducted to verify GBS diagnosis and obtain other clinical details. Main Outcome Measure Reporting rates of GBS following influenza vaccination over time. Results From July 1990 through June 2003, VAERS received 501 reports of GBS following influenza vaccination in adults. The median onset interval (13 days) was longer than that of non-GBS reports of adverse events after influenza vaccine (1 day) (P<.001). The annual reporting rate decreased 4-fold from a high of 0.17 per 100 000 vaccinees in 1993-1994 to 0.04 in 2002-2003 (P<.001). A GBS diagnosis was confirmed in 82% of reports. Preceding illness within 4 weeks of vaccination was identified in 24% of reported cases. Conclusions From 1990 to 2003, VAERS reporting rates of GBS after influenza vaccination decreased. The long onset interval and low prevalence of other preexisting illnesses are consistent with a possible causal association between GBS and influenza vaccine. These findings require additional research, which can lead to a fuller understanding of the causes of GBS and its possible relationship with influenza vaccine.	Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control, Natl Ctr Infect Dis, Div Bacterial & Mycot Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Haber, P (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,Mail Stop E-61, Atlanta, GA 30333 USA.	PHaber@cdc.gov	Chen, Robert T/AIA-8164-2022; Shadomy, Sean/ABA-1234-2020	Chen, Robert T/0000-0002-3094-8367; 				BREMAN JG, 1984, AM J EPIDEMIOL, V119, P880, DOI 10.1093/oxfordjournals.aje.a113810; *CDCP, 1976, MMWR-MORBID MORTAL W, V25, P401; Chen R, 1992, POST MARKETING SURVE, V6, P5; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Ellenberg SS, 1997, PUBLIC HEALTH REP, V112, P10; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Institute of Medicine, 2003, IMM SAF REV INFL VAC; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; MARKS JS, 1980, JAMA-J AM MED ASSOC, V243, P2490, DOI 10.1001/jama.243.24.2490; MASSEY J, 1989, VITAL HLTH STAT 2, V110; MISHU B, 1993, CLIN INFECT DIS, V17, P104, DOI 10.1093/clinids/17.1.104; O'Mara D, 2003, INFECT MED, V20, P548; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Teutsch S.M., 2000, PRINCIPLES PRACTICE; *US GOV, 2002, US GOV CENS REP; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Vugia D., 2004, Morbidity and Mortality Weekly Report, V53, P340; ZHOU W, 2003, MMWR-MORBID MORTAL W, P1	27	179	193	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2004	292	20					2478	2481		10.1001/jama.292.20.2478	http://dx.doi.org/10.1001/jama.292.20.2478			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873TD	15562126				2022-12-24	WOS:000225303000022
J	Nolan, MF; Malleret, G; Dudman, JT; Buhl, DL; Santoro, B; Gibbs, E; Vronskaya, S; Buzsaki, G; Siegelbaum, SA; Kandel, ER; Morozov, A				Nolan, MF; Malleret, G; Dudman, JT; Buhl, DL; Santoro, B; Gibbs, E; Vronskaya, S; Buzsaki, G; Siegelbaum, SA; Kandel, ER; Morozov, A			A behavioral role for dendritic integration: HCN1 channels constrain spatial inputs to distal dendrites memory and plasticity at of CA1 pyramidal neurons	CELL			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL GAMMA OSCILLATIONS; CURRENT I-H; SYNAPTIC MODIFICATIONS; PACEMAKER CHANNELS; THETA OSCILLATIONS; CATION CURRENTS; MICE LACKING; CELLS; MOUSE	The importance of long-term synaptic plasticity as a cellular substrate for learning and memory is well established. By contrast, little is known about how learning and memory are regulated by voltage-gated ion channels that integrate synaptic information. We investigated this question using mice with general or forebrain-restricted knockout of the HCN1 gene, which we find encodes a major component of the hyperpolarization-activated inward current (I-h) and is an important determinant of dendritic integration in hippocampal CA1 pyramidal cells. Deletion of HCN1 from forebrain neurons enhances hippocampal-dependent learning and memory, augments the power of theta oscillations, and enhances long-term potentiation (LTP) at the direct perforant path input to the distal dendrites of CA1 pyramidal neurons, but has little effect on LTP at the more proximal Schaffer collateral inputs. We suggest that HCN1 channels constrain learning and memory by regulating dendritic integration of distal synaptic inputs to pyramidal cells.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Dept Physiol, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Biophys, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; NIMH, Hlth Behav Genet, Bethesda, MD 20892 USA	Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Kandel, ER (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	erk5@columbia.edu	Nolan, Matthew/A-1356-2009; Buhl, Derek/AAV-3911-2021	Nolan, Matthew/0000-0003-1062-6501; Santoro, Bina/0000-0002-4277-1992; Buzsaki, Gyorgy/0000-0002-3100-4800; Buhl, Derek/0000-0003-4433-7150	NIMH NIH HHS [MH045923, MH54671] Funding Source: Medline; NINDS NIH HHS [NS36658, NS34994] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045923, R37MH045923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS036658] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bliss TVP, 2003, PHILOS T ROY SOC B, V358, P607, DOI 10.1098/rstb.2003.1282; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buhl DL, 2003, J NEUROSCI, V23, P1013; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kubota M, 2001, BIOCHEM BIOPH RES CO, V282, P242, DOI 10.1006/bbrc.2001.4572; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meiri N, 1997, P NATL ACAD SCI USA, V94, P4430, DOI 10.1073/pnas.94.9.4430; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; STROHMANN B, 1994, J NEUROPHYSIOL, V71, P1361, DOI 10.1152/jn.1994.71.4.1361; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, J NEUROSCI, V23, P7358; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Xu CQ, 2004, EUR J NEUROSCI, V19, P2299, DOI 10.1111/j.0953-816X.2004.03316.x	52	363	373	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					719	732		10.1016/S0092-8674(04)01055-4	http://dx.doi.org/10.1016/S0092-8674(04)01055-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550252	Bronze			2022-12-24	WOS:000225389500016
J	Amexo, M; Tolhurst, R; Barnish, G; Bates, I				Amexo, M; Tolhurst, R; Barnish, G; Bates, I			Malaria misdiagnosis: effects on the poor and vulnerable	LANCET			English	Review							PNEUMONIA; OVERLAP; BURDEN; CARE; COST; PAY	Context Effective and affordable treatment is recommended for all cases of malaria within 24 h of the onset of illness. Most cases of "malaria" (ie, fever) are self-diagnosed and most treatments, and deaths, occur at home. The most ethical and cost-effective policy is to ensure that newer drug combinations are only used for true cases of malaria. Although it is cost effective to improve the accuracy of malaria diagnosis, simple, accurate, and inexpensive methods are not widely available, particularly in poor communities where they are most needed. Starting point In a recent study in Uganda, Karin Kallander and colleagues emphasise the difficulty in making a presumptive diagnosis of malaria, and highlight the urgent need for improved diagnostic tools that can be used at community and primary-care level, especially in poorer populations (Acta Trap 2004; 90: 211-14). Where next? Health systems need strengthening at referral and community level, so that rapid accurate diagnosis and effective treatment is available for those who are least able to withstand the consequences of illness. Indirect evidence strongly suggests that misdiagnosis of malaria contributes to a vicious cycle of increasing ill-health and deepening poverty. Much better direct evidence is needed about why and how misdiagnosis affects the poor and vulnerable.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	ibates@liv.ac.uk		bates, imelda/0000-0002-0862-8199; Tolhurst, Rachel/0000-0002-3005-6641				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; ASENSOOKYERE WK, 1994, WORLD HEALTH FORUM, V15, P265; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Duffy PE, 2004, LANCET, V363, P3, DOI 10.1016/S0140-6736(03)15230-0; El-Nageh M M, 1996, World Health Forum, V17, P200; FOSU GB, 1981, SOC SCI MED-MED ANTH, V15, P471, DOI 10.1016/0160-7987(81)90021-1; Goodman CA, 2001, HEALTH ECON, V10, P731, DOI 10.1002/hec.621; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Narayan D., 2000, VOICES POOR CRYING O; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Pagnoni F, 1997, T ROY SOC TROP MED H, V91, P512, DOI 10.1016/S0035-9203(97)90006-7; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Waddington C., 1990, International Journal of Health Planning and Management, V5, P287, DOI 10.1002/hpm.4740050405; *WHO, 2003, EC COST MAL, P10; YODER RA, 1989, SOC SCI MED, V29, P35, DOI 10.1016/0277-9536(89)90125-1	22	337	340	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2004	364	9448					1896	1898		10.1016/S0140-6736(04)17446-1	http://dx.doi.org/10.1016/S0140-6736(04)17446-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873HA	15555670				2022-12-24	WOS:000225269300031
J	Wickens, M; Gonzalez, TN				Wickens, M; Gonzalez, TN			Knives, accomplices, and RNA	SCIENCE			English	Editorial Material							POLYADENYLATION; CLEAVAGE; COMPLEX; PROTEINS; TRANSCRIPTION; ENDONUCLEASE; COMPONENT; MECHANISM; ENZYMES; SNORNA		Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	wickens@biochem.wisc.edu						Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Aravind L, 1999, In Silico Biol, V1, P69; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; MAIZELS N, 1999, RNA WORLD, P79; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; MOORE CL, 1986, EMBO J, V5, P1929, DOI 10.1002/j.1460-2075.1986.tb04446.x; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; OCONNOR JP, 1992, MOL CELL BIOL, V12, P3843, DOI 10.1128/MCB.12.9.3843; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; SHEETS MD, 1987, MOL CELL BIOL, V7, P1518, DOI 10.1128/MCB.7.4.1518; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733	24	17	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1299	1300		10.1126/science.1100137	http://dx.doi.org/10.1126/science.1100137			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550648				2022-12-24	WOS:000225301600027
J	Huyen, Y; Zgheib, O; DiTullio, RA; Gorgoulis, VG; Zacharatos, P; Petty, TJ; Sheston, EA; Mellert, HS; Stavridi, ES; Halazonetis, TD				Huyen, Y; Zgheib, O; DiTullio, RA; Gorgoulis, VG; Zacharatos, P; Petty, TJ; Sheston, EA; Mellert, HS; Stavridi, ES; Halazonetis, TD			Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks	NATURE			English	Article							SMN TUDOR DOMAIN; DAMAGE; PROTEIN; CHECKPOINT; PHOSPHORYLATION; GENE; RECOGNITION; BINDING; MOTIF; ATM	The mechanisms by which eukaryotic cells sense DNA double-strand breaks (DSBs) in order to initiate checkpoint responses are poorly understood. 53BP1 is a conserved checkpoint protein with properties of a DNA DSB sensor(1-5). Here, we solved the structure of the domain of 53BP1 that recruits it to sites of DSBs. This domain consists of two tandem tudor folds with a deep pocket at their interface formed by residues conserved in the budding yeast Rad9 and fission yeast Rhp9/Crb2 orthologues. In vitro, the 53BP1 tandem tudor domain bound histone H3 methylated on Lys 79 using residues that form the walls of the pocket; these residues were also required for recruitment of 53BP1 to DSBs. Suppression of DOT1L, the enzyme that methylates Lys 79 of histone H3, also inhibited recruitment of 53BP1 to DSBs. Because methylation of histone H3 Lys 79 was unaltered in response to DNA damage, we propose that 53BP1 senses DSBs indirectly through changes in higher-order chromatin structure that expose the 53BP1 binding site.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Biomed Grad Studies Program, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Athens, Sch Med, Dept Histol & Embryol, Athens 11527, Greece	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; Athens Medical School; National & Kapodistrian University of Athens	Halazonetis, TD (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	halazonetis@wistar.upenn.edu	Halazonetis, Thanos/D-7923-2011; Petty, Tom/A-6758-2011; Gorgoulis, Vassilis/AAD-3630-2019; ZACHARATOS, PANAGIOTIS V/G-9954-2014	Petty, Tom/0000-0002-4007-6515; Gorgoulis, Vassilis/0000-0001-9001-4112; ZACHARATOS, PANAGIOTIS V/0000-0001-8324-5481				Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; GAME JC, 2004, GENETICS        0915, DOI DOI 10.1534/GENETICS.104.028613; Huyen Y, 2004, STRUCTURE, V12, P1237, DOI 10.1016/j.str.2004.05.007; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mochan TA, 2003, CANCER RES, V63, P8586; Mozziconacci J, 2003, J STRUCT BIOL, V143, P72, DOI 10.1016/S1047-8477(03)00102-3; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Willson J, 1997, NUCLEIC ACIDS RES, V25, P2138, DOI 10.1093/nar/25.11.2138; Xia ZF, 2001, J BIOL CHEM, V276, P2708, DOI 10.1074/jbc.M007665200	30	671	709	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					406	411		10.1038/nature03114	http://dx.doi.org/10.1038/nature03114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15525939				2022-12-24	WOS:000225161400059
J	Wilson, FH; Hariri, A; Farhi, A; Zhao, HY; Petersen, KF; Toka, HR; Nelson-Williams, C; Raja, KM; Kashgarian, CM; Shulman, GI; Scheinman, SJ; Lifton, RP				Wilson, FH; Hariri, A; Farhi, A; Zhao, HY; Petersen, KF; Toka, HR; Nelson-Williams, C; Raja, KM; Kashgarian, CM; Shulman, GI; Scheinman, SJ; Lifton, RP			A cluster of metabolic defects caused by mutation in a mitochondrial tRNA	SCIENCE			English	Article							INSULIN-RESISTANCE; DIETARY MAGNESIUM; HYPERTENSION; RISK; CHOLESTEROL; DISEASE; SERUM; OBESITY	Hypertension and dyslipidemia are risk factors for atherosclerosis and occur together more often than expected by chance. Although this clustering suggests shared causation, unifying factors remain unknown. We describe a large kindred with a syndrome including hypertension, hypercholesterolemia, and hypomagnesemia. Each phenotype is transmitted on the maternal lineage with a pattern indicating mitochondrial inheritance. Analysis of the mitochondrial genome of the maternal lineage identified a homoplasmic mutation substituting cytidine for uridine immediately S' to the mitochondrial transfer RNA(Ite) anticodon. Uridine at this position is nearly invariate among transfer RNAs because of its role in stabilizing the anticodon loop. Given the known loss of mitochondrial function with aging, these findings may have implications for the common clustering of these metabolic disorders.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Biostat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell & Mol Physiol, New Haven, CT 06510 USA; SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Toka, Hakan/AAQ-2162-2021; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Wilson, Frederick/0000-0002-5019-0186	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000125, MO1 RR-00125] Funding Source: Medline; NHLBI NIH HHS [P50 HL055007, P50 HL-55007] Funding Source: Medline; NIA NIH HHS [R01 AG023686-02, R01 AG023686-03, R01 AG023686, R01 AG023686-04, R01 AG023686-01A1] Funding Source: Medline; NIDDK NIH HHS [R01 DK-49230, R01 DK049230] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Atlante A, 1998, INT J MOL MED, V1, P709; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; CRIQUI MH, 1986, CIRCULATION S1, V73, P140; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mizushima S, 1998, J HUM HYPERTENS, V12, P447, DOI 10.1038/sj.jhh.1000641; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Peacock JM, 1999, ANN EPIDEMIOL, V9, P159, DOI 10.1016/S1047-2797(98)00040-4; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; QUIGLEY GJ, 1976, SCIENCE, V194, P796, DOI 10.1126/science.790568; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WILLIAMS RR, 1988, JAMA-J AM MED ASSOC, V259, P3579, DOI 10.1001/jama.259.24.3579; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P19, DOI 10.1093/oxfordjournals.aje.a113510; Zager RA, 2003, AM J PHYSIOL-RENAL, V285, pF1092, DOI 10.1152/ajprenal.00187.2003	31	253	272	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1190	1194		10.1126/science.1102521	http://dx.doi.org/10.1126/science.1102521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15498972	Green Accepted			2022-12-24	WOS:000225193100052
J	Cumberland, P; Rahi, JS; Peckham, CS				Cumberland, P; Rahi, JS; Peckham, CS			Impact of congenital colour vision deficiency on education and unintentional injuries: findings from the 1958 British birth cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Rahi, JS (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	j.rahi@ich.ucl.ac.uk	peckham, catherine s/I-6300-2013	Rahi, Jugnoo/0000-0002-5718-9209				ESSEN J, 1978, ED RES, V20, P300; *HLTH SAF EX, 1987, COL VIS, P1; Holroyd E, 1997, CHILD CARE HLTH DEV, V23, P391, DOI 10.1111/j.1365-2214.1997.tb00906.x; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; LAMPE JM, 1973, J SCHOOL HEALTH, V43, P309, DOI 10.1111/j.1746-1561.1973.tb03718.x	5	20	23	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2004	329	7474					1074	1075		10.1136/bmj.38176.685208.F7	http://dx.doi.org/10.1136/bmj.38176.685208.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PN	15465847	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000225070300020
J	Andersson, N; Ho-Foster, A; Matthis, J; Marokoane, N; Mashiane, V; Mhatre, S; Mitchell, S; Mokoena, T; Monasta, L; Ngxowa, N; Salcedo, MP; Sonnekus, H				Andersson, N; Ho-Foster, A; Matthis, J; Marokoane, N; Mashiane, V; Mhatre, S; Mitchell, S; Mokoena, T; Monasta, L; Ngxowa, N; Salcedo, MP; Sonnekus, H			National cross sectional study of views on sexual violence and risk of HIV infection and AIDS among South African school pupils	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENDER; WOMEN; PREVENTION; PREVALENCE; EDUCATION; BEHAVIOR; HEALTH; RAPE	Objective To investigate the views of school pupils on sexual violence and on the risk of HIV infection and AIDS and their experiences of sexual violence. Design National cross sectional study. Setting 5162 classes in 1418 South African schools. Participants 269 705 pupils aged 10-19 years in grades 6-11. Main outcome measure Answers to questions about sexual violence and about the risk of HIV infection and AIDS. Results Misconceptions about: sexual violence were common among both sexes, but more females held views that would put them at high risk of HIV infection. One third of the respondents thought they might be HIV positive. This was associated with misconceptions about sexual violence and about the risk of HIV infection and AIDS. Around 11% of males and 4% of females claimed to have forced someone else to have sex; 66% of these males and 71% of these females had themselves been forced to have sex. A history of forced sex was a powerful determinant of views on sexual violence and risk of HIV infection. Conclusions The views of South African youth on sexual violence and on the risk of HIV infection and AIDS were compatible with acceptance of sexual coercion and "adaptive" attitudes to survival in a violent society. Views differed little between the sexes.	Univ Autonoma Guerrero, CIET, Acapulco, Mexico; CIETafrica, ZA-2041 Houghton, South Africa		Andersson, N (corresponding author), Univ Autonoma Guerrero, CIET, Apdo Postal 182, Acapulco, Mexico.	neil@ciet.org	Ho-Foster, Ari/AAM-9225-2021; Andersson, Neil/G-2248-2011; Monasta, Lorenzo/B-1388-2012	Ho-Foster, Ari/0000-0001-9817-8090; Monasta, Lorenzo/0000-0001-7774-548X				Andersson N, 2002, CIETMAP FREE GIS EPI; ARMSTRONG S, 1993, WORLD AIDS, P27; Blumenthal S, 1999, CHILD ABUSE NEGLECT, V23, P129, DOI 10.1016/S0145-2134(98)00117-3; Bowley DM, 2002, SAMJ S AFR MED J, V92, P744; Buzi RS, 2003, J SCHOOL HEALTH, V73, P191, DOI 10.1111/j.1746-1561.2003.tb03602.x; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Eaton L, 2003, SOC SCI MED, V56, P149, DOI 10.1016/S0277-9536(02)00017-5; Garcia-Moreno C, 2000, AIDS, V14, pS253; Hartung TK, 2002, INT J STD AIDS, V13, P829, DOI 10.1258/095646202321020107; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Kim J, 2002, SOC SCI MED, V54, P1243, DOI 10.1016/S0277-9536(01)00093-4; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mitchell C, 2003, CULT HEALTH SEX, V5, P513, DOI 10.1080/13691050110149909; Peltzer K, 2000, PSYCHOL REP, V87, P593; Taylor M, 2003, J SCHOOL HEALTH, V73, P97, DOI 10.1111/j.1746-1561.2003.tb03580.x; Varga CA, 2003, STUD FAMILY PLANN, V34, P160, DOI 10.1111/j.1728-4465.2003.00160.x; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4	20	43	44	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					952	954A		10.1136/bmj.38226.617454.7C	http://dx.doi.org/10.1136/bmj.38226.617454.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	866KU	15485935	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000224773200018
J	Lenton, TM; Schellnhuber, HJ; Szathmary, E				Lenton, TM; Schellnhuber, HJ; Szathmary, E			Climbing the co-evolution ladder	NATURE			English	Editorial Material									Tyndall Ctr, Southampton, Hants, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Collegium Budapest, H-1014 Budapest, Hungary	University of Southampton; University of East Anglia	Lenton, TM (corresponding author), Tyndall Ctr, Southampton, Hants, England.		Szathmáry, Eörs/A-5007-2011; Lenton, Tim M/X-1893-2018; Schellnhuber, Hans Joachim/B-2607-2012; Schellnhuber, Hans Joachim/O-3873-2019; Szathmary, Eors/AAS-1202-2021	Lenton, Tim M/0000-0002-6725-7498; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Szathmary, Eors/0000-0001-5227-2997				Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Lenton TM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018802; Lovelock J, 1988, AGES GAIA BIOGRAPHY; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; SCHELLNHUBER HJ, 2004, DAHLEM WORKSHOP REPO, V91; Smith J. M., 1995, MAJOR TRANSITIONS EV	6	29	33	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2004	431	7011					913	913		10.1038/431913a	http://dx.doi.org/10.1038/431913a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496901	Bronze			2022-12-24	WOS:000224585600024
J	O'Dowd, CD; Facchini, MC; Cavalli, F; Ceburnis, D; Mircea, M; Decesari, S; Fuzzi, S; Yoon, YJ; Putaud, JP				O'Dowd, CD; Facchini, MC; Cavalli, F; Ceburnis, D; Mircea, M; Decesari, S; Fuzzi, S; Yoon, YJ; Putaud, JP			Biogenically driven organic contribution to marine aerosol	NATURE			English	Article							SUBMICRON AEROSOL; CLOUD ALBEDO; SULFUR; FRACTIONATION; TRANSPORT; MATTER; MASS	Marine aerosol contributes significantly to the global aerosol load and consequently has an important impact on both the Earth's albedo and climate. So far, much of the focus on marine aerosol has centred on the production of aerosol from sea-salt(1) and non-sea-salt sulphates(2,3). Recent field experiments, however, have shown that known aerosol production processes for inorganic species cannot account for the entire aerosol mass that occurs in submicrometre sizes(4-6). Several experimental studies have pointed to the presence of significant concentrations of organic matter in marine aerosol(7-11). There is some information available about the composition of organic matter(12-14), but the contribution of organic matter to marine aerosol, as a function of aerosol size, as well as its characterization as hydrophilic or hydrophobic, has been lacking. Here we measure the physical and chemical characteristics of submicrometre marine aerosol over the North Atlantic Ocean during plankton blooms progressing from spring through to autumn. We find that during bloom periods, the organic fraction dominates and contributes 63% to the submicrometre aerosol mass (about 45% is water-insoluble and about 18% water-soluble). In winter, when biological activity is at its lowest, the organic fraction decreases to 15%. Our model simulations indicate that organic matter can enhance the cloud droplet concentration by 15% to more than 100% and is therefore an important component of the aerosol-cloud-climate feedback system involving marine biota.	CNR, Ist Sci Atmosfera & Clima, I-40129 Bologna, Italy; Natl Univ Ireland, Dept Expt Phys, Galway, Ireland; Natl Univ Ireland, Environm Change Inst, Galway, Ireland; Inst Phys, Environm Phys & Chem Div, LT-2053 Vilnius, Lithuania; Commiss European Communities, Inst Environm & Sustainabil, Joint Res Ctr, I-21021 Ispra, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; European Commission Joint Research Centre; EC JRC ISPRA Site	Facchini, MC (corresponding author), CNR, Ist Sci Atmosfera & Clima, I-40129 Bologna, Italy.	mc.facchini@isac.cnr.it	Facchini, Maria Cristina/AAA-1592-2019; Facchini, Maria Cristina/B-3369-2014; FACCHINI, MARIA CRISTINA/O-1230-2015; Decesari, Stefano/B-9588-2015; O'Dowd, Colin D/K-8904-2012; Ceburnis, Darius/C-1293-2012; Fuzzi, Sandro/F-2675-2010	Facchini, Maria Cristina/0000-0003-4833-9305; Facchini, Maria Cristina/0000-0003-4833-9305; FACCHINI, MARIA CRISTINA/0000-0003-4833-9305; Decesari, Stefano/0000-0001-6486-3786; O'Dowd, Colin D/0000-0002-3068-2212; Ceburnis, Darius/0000-0003-0231-5324; Fuzzi, Sandro/0000-0002-5275-2381				Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; BLANCHARD DC, 1976, ADV CHEM SER, V145, P360; Cavalli F, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005137; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Facchini MC, 1999, NATURE, V401, P257, DOI 10.1038/45758; GAGOSIAN RB, 1981, NATURE, V291, P312, DOI 10.1038/291312a0; GEEVER M, 2003, J AER SCI, V1, pS637; GERSHEY RM, 1983, LIMNOL OCEANOGR, V28, P309, DOI 10.4319/lo.1983.28.2.0309; Gogou AI, 1998, J CHROMATOGR A, V799, P215, DOI 10.1016/S0021-9673(97)01106-0; HOFFMAN EJ, 1974, J GEOPHYS RES, V79, P4474, DOI 10.1029/JC079i030p04474; Huebert BJ, 1998, J GEOPHYS RES-ATMOS, V103, P16493, DOI 10.1029/98JD00770; KAWAMURA K, 1990, J ATMOS CHEM, V11, P107, DOI 10.1007/BF00053670; Kleefeld S, 2002, ATMOS ENVIRON, V36, P4479, DOI 10.1016/S1352-2310(02)00346-1; Martensson EM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002263; McInnes LM, 1996, ATMOS ENVIRON, V30, P869, DOI 10.1016/1352-2310(95)00354-1; Middlebrook AM, 1998, J GEOPHYS RES-ATMOS, V103, P16475, DOI 10.1029/97JD03719; Mochida M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001278; Nenes A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015295; Novakov T, 1997, J GEOPHYS RES-ATMOS, V102, P21307, DOI 10.1029/97JD01487; ODowd CD, 1997, ATMOS ENVIRON, V31, P73, DOI 10.1016/S1352-2310(96)00106-9; Oppo C, 1999, MAR CHEM, V63, P235, DOI 10.1016/S0304-4203(98)00065-6; Putaud JP, 2000, TELLUS B, V52, P141, DOI 10.1034/j.1600-0889.2000.00056.x; Quinn PK, 2000, J GEOPHYS RES-ATMOS, V105, P6785, DOI 10.1029/1999JD901034; SHAW GE, 1983, CLIMATIC CHANGE, V5, P297, DOI 10.1007/BF02423524	24	682	692	13	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					676	680		10.1038/nature02959	http://dx.doi.org/10.1038/nature02959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470425				2022-12-24	WOS:000224299300037
J	Carvalho, AB; Clark, AG				Carvalho, AB; Clark, AG			Y chromosome of D-pseudoobscura is not homologous to the ancestral Drosophila Y	SCIENCE			English	Article							OBSCURA GROUP; EVOLUTION; MELANOGASTER; FERTILITY; SEQUENCES; PATTERNS; GENOME; GENES	We report a genome-wide search of Y-linked genes in Drosophila pseudoobscura. All six identifiable orthologs of the D. melanogaster, Y-linked genes have autosomal inheritance in D. pseudoobscura. Four-orthologs were investigated in detail and proved to be Y-linked in D. guanche and D. bifasciata, which shows that less than 18 million years ago the ancestral Drosophila Y chromosome was translocated to an autosome in the D. pseudoobscura lineage. We found 15 genes and pseudogenes in the current Y of D. pseudoobscura, and none are shared with the D. melanogaster Y. Hence, the Y chromosome in the D. pseudoobscura lineage appears to have arisen de novo and is not homologous to the D. melanogaster Y.	Univ Fed Rio de Janeiro, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidade Federal do Rio de Janeiro; Cornell University	Carvalho, AB (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Caixa Postal 68011, BR-21944970 Rio De Janeiro, Brazil.	bernardo@biologia.ufrj.br	Carvalho, Antonio/D-5402-2013	Carvalho, Antonio/0000-0001-8959-6469; Clark, Andrew/0000-0001-7159-8511	FOGARTY INTERNATIONAL CENTER [R03TW005673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064590] Funding Source: NIH RePORTER; FIC NIH HHS [TW005673] Funding Source: Medline; NIGMS NIH HHS [GM64590] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachtrog D, 2003, NAT GENET, V34, P215, DOI 10.1038/ng1164; Baffi MA, 2002, BIOCHEM GENET, V40, P411, DOI 10.1023/A:1020729612672; Bull J. J., 1983, EVOLUTION SEX DETERM; BUNEMANN H, COMMUNICATION; Carvalho AB, 2003, GENETICA, V117, P227, DOI 10.1023/A:1022900313650; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; COOPER KW, 1946, GENETICS, V31, P181; GATTI M, 1983, CHROMOSOMA, V88, P349, DOI 10.1007/BF00285858; GODDARD K, 1990, EVOLUTION, V44, P1656, DOI 10.1111/j.1558-5646.1990.tb03854.x; Hackstein JHP, 1996, BIOESSAYS, V18, P317, DOI 10.1002/bies.950180410; Kalmykova AI, 1997, P NATL ACAD SCI USA, V94, P6297, DOI 10.1073/pnas.94.12.6297; Kurek R, 2000, GENETICA, V109, P113, DOI 10.1023/A:1026552604229; O'Grady PM, 1999, MOL PHYLOGENET EVOL, V12, P124, DOI 10.1006/mpev.1998.0598; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; RICHARDS S, IN PRESS GENOME RES; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; STEINEMANN M, 1984, CHROMOSOMA, V91, P46, DOI 10.1007/BF00286484; STEINEMANN M, 1993, P NATL ACAD SCI USA, V90, P5737, DOI 10.1073/pnas.90.12.5737; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; VOELKER RA, 1971, EVOLUTION, V25, P119, DOI 10.1111/j.1558-5646.1971.tb01865.x; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Yu YC, 1999, HEREDITY, V83, P39, DOI 10.1038/sj.hdy.6885470	24	118	119	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					108	110		10.1126/science.1101675	http://dx.doi.org/10.1126/science.1101675			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15528405				2022-12-24	WOS:000226214300048
J	Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Ehlmann, BL; Farrand, W; Gaddis, L; Greeley, R; Grotzinger, J; Hayes, AG; Hviid, SF; Johnson, JR; Jolliff, B; Kinch, KM; Knoll, AH; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Ming, DW; Rice, JW; Richter, L; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Thompson, S; Wdowiak, T; Weitz, C; Whelley, P				Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Ehlmann, BL; Farrand, W; Gaddis, L; Greeley, R; Grotzinger, J; Hayes, AG; Hviid, SF; Johnson, JR; Jolliff, B; Kinch, KM; Knoll, AH; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Ming, DW; Rice, JW; Richter, L; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Thompson, S; Wdowiak, T; Weitz, C; Whelley, P			Evidence from Opportunity's microscopic imager for water on Meridiani Planum	SCIENCE			English	Article							SOILS; ROVER; MARS; CRATER; ROCKS	The Microscopic Imager on the Opportunity rover analyzed textures of soils and rocks at Meridiani Planum at a scale of 31 micrometers per pixel. The uppermost millimeter of some soils is weakly cemented, whereas other soils show little evidence of cohesion. Rock outcrops are laminated on a millimeter scale; image mosaics of cross-stratification suggest that some sediments were deposited by flowing water. Vugs in some outcrop faces are probably molds formed by dissolution of relatively soluble minerals during diagenesis. Microscopic images support the hypothesis that hematite-rich spherules observed in outcrops and soils also formed diagenetically as concretions.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Copenhagen, Ctr Planetary Sci, Danish Space Res Inst, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-1168 Copenhagen, Denmark; Space Sci Inst, Boulder, CO 80301 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Max Planck Inst Aeron, D-37191 Katlenburg, Germany; Aarhus Univ, Inst Phys & Astron, Aarhus, Denmark; Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Off, Houston, TX 77058 USA; DLR Inst Raumsimulat, Cologne, Germany; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Planetary Sci Inst, Tucson, AZ 85719 USA	United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); Max Planck Society; Aarhus University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Kinch, Kjartan Bergeron/C-5742-2015; Whelley, Patrick/B-9560-2012; Johnson, Jeffrey R/F-3972-2015; Hayes, Alexander G/P-2024-2014; Madsen, Morten Bo/D-2082-2011; Sullivan, Robert/AAR-8193-2020	Kinch, Kjartan Bergeron/0000-0002-4629-8880; Whelley, Patrick/0000-0003-3266-9772; Johnson, Jeffrey R/0000-0002-5586-4901; Hayes, Alexander G/0000-0001-6397-2630; Madsen, Morten Bo/0000-0001-8909-5111; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dickinson WW, 2003, GEOLOGY, V31, P199, DOI 10.1130/0091-7613(2003)031<0199:APAAFW>2.0.CO;2; Dietz R.S., 1968, SHOCK METAMORPHISM N, P267; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; IVERSEN JD, 1982, SEDIMENTOLOGY, V29, P111, DOI 10.1111/j.1365-3091.1982.tb01713.x; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; MARION GM, 1995, 9512 US ARM CORPS EN; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; SellesMartinez J, 1996, EARTH-SCI REV, V41, P177, DOI 10.1016/S0012-8252(96)00022-0; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	20	123	124	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1727	1730		10.1126/science.1105286	http://dx.doi.org/10.1126/science.1105286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576607	Green Published			2022-12-24	WOS:000225630800039
J	Squyres, SW; Grotzinger, JP; Arvidson, RE; Bell, JF; Calvin, W; Christensen, PR; Clark, BC; Crisp, JA; Farrand, WH; Herkenhoff, KE; Johnson, JR; Klingelhofer, G; Knoll, AH; McLennan, SM; McSween, HY; Morris, RV; Rice, JW; Rieder, R; Soderblom, LA				Squyres, SW; Grotzinger, JP; Arvidson, RE; Bell, JF; Calvin, W; Christensen, PR; Clark, BC; Crisp, JA; Farrand, WH; Herkenhoff, KE; Johnson, JR; Klingelhofer, G; Knoll, AH; McLennan, SM; McSween, HY; Morris, RV; Rice, JW; Rieder, R; Soderblom, LA			In situ evidence for an ancient aqueous environment at Meridiani Planum, Mars	SCIENCE			English	Article							OPPORTUNITY ROVER; NEAR-SURFACE; SOILS; CLASSIFICATION; CHEMISTRY; HEMATITE; CRATER; ROCKS	Sedimentary rocks at Eagle crater in Meridiani Planum are composed of fine-grained siliciclastic materials derived from weathering of basaltic rocks, sulfate minerals (including magnesium sulfate and jarosite) that constitute several tens of percent of the rock by weight, and hematite. Cross-stratification observed in rock outcrops indicates eolian and aqueous transport. Diagenetic features include hematite-rich concretions and crystal-mold vugs. We interpret the rocks to be a mixture of chemical and siliciciastic sediments with a complex diagenetic history. The environmental conditions that they record include episodic inundation by shallow surface water, evaporation, and desiccation. The geologic record at Meridiani Planum suggests that conditions were suitable for biological activity for a period of time in martian history.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; MIT, Dept Earth Atrmospher & Planetary Sci, Cambridge, MA 02139 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Space Sci Inst, Boulder, CO 80301 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Max Planck Inst Chem, D-55128 Mainz, Germany	Cornell University; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; Lockheed Martin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Max Planck Society	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astrosun.tn.cornell.edu	Johnson, Jeffrey R/F-3972-2015; Crisp, Joy/H-8287-2016	Johnson, Jeffrey R/0000-0002-5586-4901; Crisp, Joy/0000-0002-3202-4416; McLennan, Scott/0000-0003-4259-7178				[Anonymous], 1982, STRUCTURES SEQUENCES; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002041; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Billi D, 2002, RES MICROBIOL, V153, P7, DOI 10.1016/S0923-2508(01)01279-7; Bonny S, 2003, CAN J EARTH SCI, V40, P1483, DOI 10.1139/E03-060; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Fernandez-Remolar DC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001918; FERNANDEZREMOLA.D, 2002, P 33 LUN PLAN SCI C; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Hardie L.A., 1983, 6 INT S SALT I ALEX, V1, P11; HARDIE LA, 1991, ANNU REV EARTH PL SC, V19, P131, DOI 10.1146/annurev.earth.19.1.131; HARDIE LA, 1984, AM J SCI, V284, P193, DOI 10.2475/ajs.284.3.193; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Hunter R.E., 1983, EOLIAN SEDIMENTS PRO, V38, P429; Kinsman D.J., 1969, AAPG BULL, V53, P830, DOI DOI 10.1306/5D25C363-16C1-11D7-8645000102C1865D; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; LANE MD, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GLO17183; Middleton G.V., 1984, SEPM SHORT COURSE 3, P401; Mountney NP, 2002, SEDIMENTOLOGY, V49, P805, DOI 10.1046/j.1365-3091.2002.00472.x; RENAULT RW, 1994, SEDIMENTOLOGY GEOCHE; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; RUBIN DM, 1982, SEDIMENTOLOGY, V29, P121, DOI 10.1111/j.1365-3091.1982.tb01714.x; Seilacher A, 2001, SEDIMENT GEOL, V143, P41, DOI 10.1016/S0037-0738(01)00092-6; SellesMartinez J, 1996, EARTH-SCI REV, V41, P177, DOI 10.1016/S0012-8252(96)00022-0; Smoot J.P., 1991, DEV SEDIMENTOL, V50, P189, DOI DOI 10.1016/S0070-4571(08)70261-9; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P680, DOI 10.2110/jsr.60.680; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; WIBERG PL, 1987, WATER RESOUR RES, V23, P1471, DOI 10.1029/90WR02770; Zettler LAA, 2002, NATURE, V417, P137	35	734	752	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1709	1714		10.1126/science.1104559	http://dx.doi.org/10.1126/science.1104559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576604	Green Submitted			2022-12-24	WOS:000225630800036
J	Panchanathan, K; Boyd, R				Panchanathan, K; Boyd, R			Indirect reciprocity can stabilize cooperation without the second-order free rider problem	NATURE			English	Article							GROUP SELECTION; EVOLUTION; NORMS; PUNISHMENT; DEFECTORS	Models of large-scale human cooperation take two forms. 'Indirect reciprocity'(1) occurs when individuals help others in order to uphold a reputation and so be included in future cooperation. In 'collective action'(2), individuals engage in costly behaviour that benefits the group as a whole. Although the evolution of indirect reciprocity is theoretically plausible(3-6), there is no consensus about how collective action evolves. Evidence suggests that punishing free riders can maintain cooperation(7-9), but why individuals should engage in costly punishment is unclear. Solutions to this 'second-order free rider problem' include meta-punishment(10), mutation(11), conformism(12), signalling(13-15) and group-selection(16-18). The threat of exclusion from indirect reciprocity can sustain collective action in the laboratory(19). Here, we show that such exclusion is evolutionarily stable, providing an incentive to engage in costly cooperation, while avoiding the second-order free rider problem because punishers can withhold help from free riders without damaging their reputations. However, we also show that such a strategy cannot invade a population in which indirect reciprocity is not linked to collective action arises.	Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Panchanathan, K (corresponding author), Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA 90095 USA.	buddha@ucla.edu						Alexander R., 2008, ESSAYS PEDAGOGY; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bowles S, 2004, ROUNDTABLE SER BEHAV, P1; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; ELLISON G, 1993, ECONOMETRICA, V61, P1047, DOI 10.2307/2951493; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; LEIMAR O, 2001, P ROY SOC LOND B BIO, V268, P2495; Maynard Smith J., 1982, pi; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; OLSON M., 1971, LOGIC COLLECTIVE ACT; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Samuelson L., 1997, EVOLUTIONARY GAMES E; Sethi R, 1996, AM ECON REV, V86, P766; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; Sober E., 1999, OTHERS EVOLUTION PSY; SOLTIS J, 1995, CURR ANTHROPOL, V36, P473, DOI 10.1086/204381; Sugden R, 1986, EC RIGHTS COOPERATIO; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778	30	528	541	4	112	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					499	502		10.1038/nature02978	http://dx.doi.org/10.1038/nature02978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565153				2022-12-24	WOS:000225322100045
J	Niessing, D; Huttelmaier, S; Zenklusen, D; Singer, RH; Burley, SK				Niessing, D; Huttelmaier, S; Zenklusen, D; Singer, RH; Burley, SK			She2p is a novel RNA binding protein with a basic helical hairpin motif	CELL			English	Article							ASH1 MESSENGER-RNA; BUDDING YEAST DEPENDS; STRUCTURAL ELEMENTS; MYOSIN MYO4P; LOCALIZATION; FUMARASE; MOTOR; ASSOCIATION; TRANSLATION; DETERMINANT	Selective transport of mRNAs in ribonucleoprotein particles (mRNP) ensures asymmetric distribution of information within and among eukaryotic cells. Actin-dependent transport of ASH1 mRNA in yeast represents one of the best-characterized examples of mRNP translocation. Formation of the ASH1 mRNP requires recognition of zip code elements by the RNA binding protein She2p. We determined the X-ray structure of She2p at 1.95 A resolution. She2p is a member of a previously unknown class of nucleic acid binding proteins, composed of a single globular domain with a five alpha helix bundle that forms asymmetric homodimer. After demonstrating potent, dimer-dependent RNA binding in vitro, we mapped the RNA binding surface of She2p to a basic helical hairpin in vitro and in vivo and present a mechanism for mRNA-dependent initiation of ASH1 mRNP complex assembly.	Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Burley, SK (corresponding author), Struct Genomix Inc, 10505 Roselle St, San Diego, CA 92121 USA.	sburley@stromix.com	Niessing, Dierk/M-4619-2014; Hüttelmaier, Stefan/AAQ-1203-2021; Zenklusen, Daniel/C-4503-2008; Niessing, Dierk/AAE-4936-2022	Niessing, Dierk/0000-0002-5589-369X; Zenklusen, Daniel/0000-0002-0067-0093; Niessing, Dierk/0000-0002-5589-369X; Burley, Stephen K./0000-0002-2487-9713	NIGMS NIH HHS [GM61262, GM57071] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061262, R01GM057071] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Chartrand P, 2001, ANNU REV CELL DEV BI, V17, P297, DOI 10.1146/annurev.cellbio.17.1.297; Cohen SL, 2001, ANNU REV BIOPH BIOM, V30, P67, DOI 10.1146/annurev.biophys.30.1.67; Darzacq X, 2003, CURR OPIN MICROBIOL, V6, P614, DOI 10.1016/j.mib.2003.10.005; Dasgupta S, 1997, PROTEINS, V28, P494, DOI 10.1002/(SICI)1097-0134(199708)28:4<494::AID-PROT4>3.0.CO;2-A; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Ding B, 2003, CURR OPIN PLANT BIOL, V6, P596, DOI 10.1016/j.pbi.2003.09.010; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Estevez M, 2002, PROTEIN SCI, V11, P1552, DOI 10.1110/ps.0201502; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; FerreDAmare AR, 1997, METHOD ENZYMOL, V276, P157, DOI 10.1016/S0076-6879(97)76056-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonsalvez GB, 2003, RNA, V9, P1383, DOI 10.1261/rna.5120803; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Ke HM, 1997, METHOD ENZYMOL, V276, P448, DOI 10.1016/S0076-6879(97)76071-3; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Kruse C, 2002, J CELL BIOL, V159, P971, DOI 10.1083/jcb.200207101; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Mohr E, 2001, INT J BIOCHEM CELL B, V33, P669, DOI 10.1016/S1357-2725(01)00047-4; Munchow S, 1999, J CELL SCI, V112, P1511; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Steward O, 2001, Results Probl Cell Differ, V34, P1; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WEAVER TM, 1995, NAT STRUCT BIOL, V2, P654, DOI 10.1038/nsb0895-654; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; WOODS SA, 1986, BIOCHEM J, V237, P547, DOI 10.1042/bj2370547; ZUCKER M, 1989, SCIENCE, V244, P48	59	60	62	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					491	502		10.1016/j.cell.2004.10.018	http://dx.doi.org/10.1016/j.cell.2004.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537539	Bronze			2022-12-24	WOS:000225183200008
J	Vega, RB; Matsuda, K; Oh, J; Barbosa, AC; Yang, XL; Meadows, E; McAnally, J; Pomajzl, C; Shelton, JM; Richardson, JA; Karsenty, G; Olson, EN				Vega, RB; Matsuda, K; Oh, J; Barbosa, AC; Yang, XL; Meadows, E; McAnally, J; Pomajzl, C; Shelton, JM; Richardson, JA; Karsenty, G; Olson, EN			Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis	CELL			English	Article							INDIAN HEDGEHOG; BONE-FORMATION; DIFFERENTIATION; EXPRESSION; CARTILAGE; CBFA1; TRANSCRIPTION; COLLAGEN; ENHANCER; PATHWAY	Histone deacetylases (HDACs) modulate cell growth and differentiation by governing chromatin structure and repressing the activity of specific transcription factors. We showed previously that HDAC9 acts as a negative regulator of cardiomyocyte hypertrophy and skeletal muscle differentiation. Here we report that HDAC4, which is expressed in prehypertrophic chondrocytes, regulates chondrocyte hypertrophy and endochondral bone formation by interacting with and inhibiting the activity of Runx2, a transcription factor necessary for chondrocyte hypertrophy. HDAC4-null mice display premature ossification of developing bones due to ectopic and early onset chondrocyte hypertrophy, mimicking the phenotype that results from constitutive Runx2 expression in chondrocytes. Conversely, overexpression of HDAC4 in proliferating chondrocytes in vivo inhibits chondrocyte hypertrophy and differentiation, mimicking a Runx2 loss-of-function phenotype. These results establish HDAC4 as a central regulator of chondrocyte hypertrophy an skeletogenesis and suggest general roles for class II HDACs in the control of cellular hypertrophy.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Baylor Coll Med, Dept Mol & Human Genet, Bone Dis Program Texas, Houston, TX 77030 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Matsuda, Koichi/D-4597-2011	Matsuda, Koichi/0000-0001-7292-2686				Akiyama H, 1999, BIOCHEM BIOPH RES CO, V257, P814, DOI 10.1006/bbrc.1999.0494; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Shelton JM, 2000, J LIPID RES, V41, P532; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stott NS, 1997, J CELL SCI, V110, P2691; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	35	610	650	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					555	566		10.1016/j.cell.2004.10.024	http://dx.doi.org/10.1016/j.cell.2004.10.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537544	Bronze			2022-12-24	WOS:000225183200013
J	Kangas, AT; Evans, AR; Thesleff, I; Jernvall, J				Kangas, AT; Evans, AR; Thesleff, I; Jernvall, J			Nonindependence of mammalian dental characters	NATURE			English	Article							MORPHOLOGICAL EVIDENCE; MOLECULAR-DATA; ECTODYSPLASIN; GENE; PHENOTYPE; EVOLUTION; RECEPTOR; TEETH; MOUSE; EDAR	Studies of mammalian evolution frequently use data derived from the dentition(1-4). Dental characters are particularly central for inferring phylogenetic relationships of fossil taxa(1-4), of which teeth are often the only recovered part. The use of different aspects of dental morphology as phylogenetic signals implies the independence of dental characters from each other. Here we report, however, that, at least developmentally, most dental characters may be nonindependent. We investigated how three different levels of the cell signalling protein ectodysplasin (Eda)(5) changed dental characters in mouse. We found that with increasing expression levels of this one gene, the number of cusps increases, cusp shapes and positions change, longitudinal crests form, and number of teeth increases. The consistent modification of characters related to lateral placement of cusps can be traced to a small difference in the formation of an early signalling centre at the onset of tooth crown formation. Our results suggest that most aspects of tooth shape have the developmental potential for correlated changes during evolution which may, if not taken into account, obscure phylogenetic history.	Univ Helsinki, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland	University of Helsinki	Jernvall, J (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, POB 56, FIN-00014 Helsinki, Finland.	jernvall@fastmail.fm	Evans, Alistair R/D-4239-2011; Self, Casey J/B-6871-2011	Evans, Alistair R/0000-0002-4078-4693; 				Archibald JD, 2003, MOL PHYLOGENET EVOL, V28, P350, DOI 10.1016/S1055-7903(03)00034-4; Bateson W., 1894, MAT STUDY VARIATION, DOI 10.5962/bhl.title.88017; Beard KC, 1996, SCIENCE, V272, P82, DOI 10.1126/science.272.5258.82; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Dawson Mary R., 1998, Bulletin of Carnegie Museum of Natural History, V34, P278; Evans AR, 2001, J MICROSC-OXFORD, V204, P108, DOI 10.1046/j.1365-2818.2001.00939.x; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Flynn L.J., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V92, P589; Geisler JH, 2003, J VERTEBR PALEONTOL, V23, P991, DOI 10.1671/32; Goodwin HT, 1998, J MAMMAL, V79, P1161, DOI 10.2307/1383007; Hlusko LJ, 2004, P NATL ACAD SCI USA, V101, P2653, DOI 10.1073/pnas.0307678101; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; JERNVALL J, 1999, PALAEONTOL ELECT, V2; Laurikkala J, 2001, DEV BIOL, V229, P443, DOI 10.1006/dbio.2000.9955; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Meng J, 2003, B AM MUS NAT HIST, P1; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nowak RM, 1991, WALKERS MAMMALS WORL; O'Leary MA, 2003, SYST BIOL, V52, P853, DOI 10.1080/10635150390252279; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; VANVALEN L, 1970, DEV BIOL, V23, P456, DOI 10.1016/0012-1606(70)90110-7; Viriot L, 2002, CONNECT TISSUE RES, V43, P129, DOI 10.1080/03008200290001168; Weiss KM, 1998, CRIT REV ORAL BIOL M, V9, P369, DOI 10.1177/10454411980090040101; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	30	226	235	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					211	214		10.1038/nature02927	http://dx.doi.org/10.1038/nature02927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538367				2022-12-24	WOS:000225020200044
J	Strauss, JF; Kafrissen, M				Strauss, JF; Kafrissen, M			Waiting for the second coming	NATURE			English	Editorial Material									Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Ortho McNeil Pharmaceut, Clin Affairs, Raritan, NJ 08869 USA	University of Pennsylvania; Pennsylvania Medicine; Johnson & Johnson; Johnson & Johnson USA	Strauss, JF (corresponding author), Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA.							HARRISON PF, 1996, CONTRACEPTIVE RES DE; Mastroianni Jr Luigi, 1990, DEV NEW CONTRACEPTIV; NASS S, 2004, NEW FRONTIERS CONTRA	3	16	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					43	45		10.1038/432043a	http://dx.doi.org/10.1038/432043a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525977				2022-12-24	WOS:000224854900034
J	Mimura, S; Seki, T; Tanaka, S; Diffley, JFX				Mimura, S; Seki, T; Tanaka, S; Diffley, JFX			Phosphorylation-dependent binding of mitotic cyclins to Cdc6 contributes to DNA replication control	NATURE			English	Article							S-PHASE; MOLECULAR-BASIS; PROTEIN; PROTEOLYSIS; DOMAIN; SPECIFICITY; COMPONENT; KINASES; TARGETS	Cyclin-dependent kinases (CDKs) limit the activation of DNA replication origins to once per cell cycle by preventing the assembly of pre-replicative complexes (pre-RCs) during S, G2 and M phases of the cell cycle in the budding yeast Saccharomyces cerevisiae(1,2). CDKs inhibit each pre-RC component (ORC, Cdc6, Cdt1/Mcm2-7) by different mechanisms. We show here that the mitotic CDK, Clb2/Cdc28, binds tightly to an amino-terminal domain (NTD) of Cdc6, and that Cdc6 in this complex is unable to assemble pre-RCs. We present evidence indicating that this Clb2-dependent mechanism contributes to preventing rereplication in vivo. CDK interaction with the NTD of Cdc6 is mediated by the cyclin subunit Clb2, and could be reconstituted with recombinant Clb2 protein and synthetic NTD peptides. Tight Clb2 binding occurred only when the NTD was phosphorylated on CDK consensus sites. Human CDKs containing cyclins A, B and E also bound specifically to phospho-NTD peptides. We propose that direct binding of cyclins to phosphopeptide motifs may be a widespread phenomenon contributing to the targeting of CDKs to substrates.	Canc Res UK London Res Inst, Clare Hall Labs, Potters Bar EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	john.diffley@cancer.org.uk	Tanaka, Seiji/Q-8601-2019	Tanaka, Seiji/0000-0003-3882-3494; Diffley, John/0000-0001-5184-7680				Adams PD, 1999, MOL CELL BIOL, V19, P1068; Archambault V, 2003, MOL BIOL CELL, V14, P4592, DOI 10.1091/mbc.E03-06-0384; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; HALFORD KA, 2003, BIOCH ANAL YEAST PRE; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	23	90	90	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1118	1123		10.1038/nature03024	http://dx.doi.org/10.1038/nature03024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15496876				2022-12-24	WOS:000224730800045
J	Kosak, ST; Groudine, M				Kosak, ST; Groudine, M			Gene order and dynamic domains	SCIENCE			English	Editorial Material							SPATIAL-ORGANIZATION; CHROMOSOMAL DOMAINS; COEXPRESSED GENES; EXPRESSED GENES; GENOME; CHROMATIN; TRANSCRIPTION; HETEROCHROMATIN; DIFFERENTIATION; ACTIVATION	When considering the daunting complexity of eukaryotic genomes, some comfort can be found in the fact that the human genome may contain only 30,000 to 40,000 genes. Moreover, growing evidence suggests that genomes may be organized in such a way as to take advantage of space. A gene's location in the linear DNA sequence and its position in the three-dimensional nucleus can both be important in its regulation. Contrary to prevailing notions in this postgenomic era, the bacteriophage lambda, a paragon of simplicity, may stilt have a few things to teach us with respect to these facets of nonrandom genomes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Groudine, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	markg@fhcrc.org		Kosak, Steven/0000-0002-3329-9032				Belmont A, 2003, CURR OPIN CELL BIOL, V15, P304, DOI 10.1016/S0955-0674(03)00045-0; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; BRAND M, UNPUB; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chowdhury D, 2004, IMMUNOL REV, V200, P182, DOI 10.1111/j.0105-2896.2004.00177.x; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Leung AKL, 2003, CRIT REV EUKAR GENE, V13, P39, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.40; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; PTASHNE M, 2004, GENETIC SWITCH; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Volpi EV, 2000, J CELL SCI, V113, P1565; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	35	106	108	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					644	647		10.1126/science.1103864	http://dx.doi.org/10.1126/science.1103864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499009				2022-12-24	WOS:000224756700039
J	Stolc, V; Gauhar, Z; Mason, C; Halasz, G; van Batenburg, MF; Rifkin, SA; Hua, SJ; Herreman, T; Tongprasit, W; Barbano, PE; Bussemaker, HJ; White, KP				Stolc, V; Gauhar, Z; Mason, C; Halasz, G; van Batenburg, MF; Rifkin, SA; Hua, SJ; Herreman, T; Tongprasit, W; Barbano, PE; Bussemaker, HJ; White, KP			A gene expression map for the euchromatic genome of Drosophila melanogaster	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVITY; SEQUENCE; DOMAINS	We used a maskless photolithography method to produce DNA oligonucleotide microarrays with unique probe sequences tiled throughout the genome of Drosophila melanogaster and across predicted splice junctions. RNA expression of protein coding and nonprotein coding sequences was determined for each major stage of the life cycle, including adult mates and females. We detected transcriptional activity for 93% of annotated genes and RNA expression for 41% of the probes in intronic and intergenic sequences. Comparison to genome-wide RNA interference data and to gene annotations revealed distinguishable levels of expression for different classes of genes and higher levels of expression for genes with essential cellular functions. Differential splicing was observed in about 40% of predicted genes, and 5440 previously unknown splice forms were detected. Genes within, conserved regions of synteny with D. pseudoobscura had highly correlated expression; these regions ranged in length from 10 to 900 kilobase pairs. The expressed intergenic and intronic sequences are more likely to be evolutionarily conserved than nonexpressed ones, and about 15% of them appear to be developmentally regulated. Our results provide a draft expression map for the entire nonrepetitive genome, which reveals a much more extensive and diverse set of expressed sequences than was previously predicted.	Yale Univ, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Dept Math, New Haven, CT 06520 USA; NASA, Ames Res Ctr, Genome Res Facil, Moffett Field, CA 94035 USA; Eloret Corp, Sunnyvale, CA 94087 USA; Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1100 DE Amsterdam, Netherlands; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Yale University; Yale University; Yale University; Yale University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Columbia University; University of Amsterdam; Academic Medical Center Amsterdam; Columbia University	White, KP (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06520 USA.	kevin.white@yale.edu		Rifkin, Scott/0000-0001-8476-3256	NIGMS NIH HHS [T32GM008224-17] Funding Source: Medline; NLM NIH HHS [P20LM007276-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [P20LM007276] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashburner M, 1999, GENETICS, V153, P179; BENDER W, 1985, COLD SPRING HARB SYM, V50, P173, DOI 10.1101/SQB.1985.050.01.023; Bender W, 2002, DEVELOPMENT, V129, P4923; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Vos J, 2002, ONCOGENE, V21, P6848, DOI 10.1038/sj.onc.1205868; Fisher RH, 1950, STAT METHODS RES WOR, P99; HALASZ G, UNPUB; Hild M, 2004, GENOME BIOL, V5; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Reinke V, 2002, ANNU REV GENOM HUM G, V3, P153, DOI 10.1146/annurev.genom.3.031302.100922; RICHARDS S, UNPUB; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	32	239	254	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					655	660		10.1126/science.1101312	http://dx.doi.org/10.1126/science.1101312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499012	Green Submitted			2022-12-24	WOS:000224756700042
J	Currie, MP; Karwatowski, SP; Perera, J; Langford, EJ				Currie, MP; Karwatowski, SP; Perera, J; Langford, EJ			Introduction of nurse led DC cardioversion service in day surgery unit: prospective audit	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE PATIENTS; ATRIAL-FIBRILLATION; SUICIDAL IDEATION; AMERICAN-COLLEGE; TASK-FORCE; OLDER; DEPRESSION; BEHAVIOR; SOCIETY; PEOPLE	Problem Atrial fibrillation is the most common persistent arrhythmia in adults and carries an increased risk of thromboembolism and stroke. Electrical (DC) cardioversion is an effective treatment, but logistical difficulties in many institutions lead to problems providing a prompt service. This reduces the rate of long term success, delays relief of symptoms, and increases the burden on anticoagulation clinics. Design Prospective audit of introduction of a collaborative, nurse led DC cardioversion service in a day surgery unit. Setting Day surgery unit 5 km from an acute hospital in southeast London. Key measures for improvement Waiting times, success of procedures, and complication rates. Strategies for change Collaborative working across traditional specialty boundaries; empowerment of patients within the process; using a nurse consultant as a single point of reference to coordinate the service. Effects of change Sinus rhythm was restored in 131 (92%) of the first 143 patients treated. Three patients needed hospital admission; all were discharged uneventfully within 24 hours. No important complications occurred. Waiting times were reduced from 27 weeks to eight weeks for patients eligible for the service. Lessons learnt Elective DC cardioversion under general anaesthesia can be safely done by an appropriately trained nurse in a day surgery unit remote from an acute general hospital. This model of care is effective and can reduce waiting times and relieve pressure on acute beds and junior doctors.	Princess Royal Univ Hosp, Bromley Hosp NHS Trust, Dept Cardiol, Orpington BR6 8ND, Kent, England; Bromley Hosp NHS Trust, Dept Anaesthet, Day Surg Unit, Bromley, England		Currie, MP (corresponding author), Princess Royal Univ Hosp, Bromley Hosp NHS Trust, Dept Cardiol, Orpington BR6 8ND, Kent, England.	mary.currie@bromleyhospitals.nhs.uk						Alexopoulos GS, 1999, ARCH GEN PSYCHIAT, V56, P1048, DOI 10.1001/archpsyc.56.11.1048; Bartels SJ, 2002, AM J GERIAT PSYCHIAT, V10, P417, DOI 10.1176/appi.ajgp.10.4.417; Beautrais AL, 2002, SUICIDE LIFE-THREAT, V32, P1, DOI 10.1521/suli.32.1.1.22184; Callahan CM, 1996, J AM GERIATR SOC, V44, P1205, DOI 10.1111/j.1532-5415.1996.tb01370.x; CONWELL Y, 1990, J AM GERIATR SOC, V38, P640, DOI 10.1111/j.1532-5415.1990.tb01422.x; Cook JM, 2002, AM J GERIAT PSYCHIAT, V10, P437, DOI 10.1176/appi.ajgp.10.4.437; De Leo D, 2002, BRIT J PSYCHIAT, V181, P226, DOI 10.1192/bjp.181.3.226; De Leo D, 1990, DEPRESSION SUICIDE L; DEBEAUVOIR S, 1972, COMING AGE, P522; Department of Health, 2001, REF GUID CONS EX TRE; Duberstein PR, 2004, PSYCHOL MED, V34, P137, DOI 10.1017/S0033291703008584; Erlangsen A, 2003, J GERONTOL B-PSYCHOL, V58, pS314, DOI 10.1093/geronb/58.5.S314; FOSTER JR, 1984, HDB STUDIES PSYCHIAT, P265; Fuster V, 2001, EUR HEART J, V22, P1852, DOI 10.1053/euhj.2001.2983; Gallo JJ, 1994, J GERONTOL, V49, P251; HARRIS EC, 1994, MEDICINE, V73, P281, DOI 10.1097/00005792-199411000-00001; Harwood D, 2001, INT J GERIATR PSYCH, V16, P155, DOI 10.1002/1099-1166(200102)16:2<155::AID-GPS289>3.0.CO;2-0; Jackson A, 2002, NURS TIMES, V98, P34; JONES JS, 1990, AM J PSYCHIAT, V147, P1225; JORM AF, 1995, AGE AGEING, V24, P389, DOI 10.1093/ageing/24.5.389; Lykouras L, 2002, J AFFECT DISORDERS, V69, P225, DOI 10.1016/S0165-0327(00)00322-0; NAKRA B, 1990, VERWOERDTS CLIN GERO, P107; Quinn T, 1998, Nurs Crit Care, V3, P59; RAO R, 1998, BRIT MED J, V317, pB1016; Rubio A, 2001, BIOL PSYCHIAT, V49, P137, DOI 10.1016/S0006-3223(00)00952-5; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; Skoog I, 1996, AM J PSYCHIAT, V153, P1015; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Tracy CM, 2000, J AM COLL CARDIOL, V36, P1725, DOI 10.1016/S0735-1097(00)01085-8; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	30	15	15	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 16	2004	329	7471					892	895B		10.1136/bmj.329.7471.892	http://dx.doi.org/10.1136/bmj.329.7471.892			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863MU	15485966	Green Published			2022-12-24	WOS:000224566800018
J	Afshar, K; Willard, FS; Colombo, K; Johnston, CA; McCudden, CR; Siderovski, DP; Gonczy, P				Afshar, K; Willard, FS; Colombo, K; Johnston, CA; McCudden, CR; Siderovski, DP; Gonczy, P			RIC-8 is required for GPR-1/2-Dependent G alpha function during asymmetric division of C-elegans embryos	CELL			English	Article							CELL-DIVISION; GOLOCO MOTIF; G-PROTEINS; DROSOPHILA NEUROBLAST; GUANINE-NUCLEOTIDES; SPINDLE POSITION; DISTINCT ROLES; BETA-GAMMA; COMPLEX; ORIENTATION	Heterotrimeric G proteins are crucial for asymmetric cell division, but the mechanisms of signal activation remain poorly understood. Here, we establish that the evolutionarily conserved protein RIC-8 is required for proper asymmetric division of one-cell stage C. elegans embryos. Spindle severing experiments demonstrate that RIC-8 is required for generation of substantial pulling forces on astral microtubules. RIC-8 physically interacts with GOA-1 and GPA-16, two Galpha subunits that act in a partially redundant manner in one-cell stage embryos. RIC-8 preferentially binds to GDP bound GOA-1 and is a guanine nucleotide exchange factor (GEF) for GOA-1. Our analysis suggests that RIC-8 acts before the GoLoco protein GPR-1/2 in the sequence of events leading to Galpha activation. Furthermore, coimmunoprecipitation and in vivo epistasis demonstrate that inactivation of the Gbeta subunit GPB-1 alleviates the need for RIC-8 in one-cell stage embryos. Our findings suggest a mechanism in which RIC-8 favors generation of Galpha free from Gbetagamma and enables GPR-1/2 to mediate asymmetric cell division.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	Swiss Institute Experimental Cancer Research; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	pierre.gonczy@isrec.unil.ch	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; McCudden, Christopher/0000-0002-4172-4641; Gonczy, Pierre/0000-0002-6305-6883	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533, R01GM062338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62338, GM065533] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Oxford GS, 2004, METHOD ENZYMOL, V390, P437; Pichler S, 2000, DEVELOPMENT, V127, P2063; Praitis V, 2001, GENETICS, V157, P1217; Robatzek M, 2000, GENETICS, V156, P1069; Ross EM, 1999, CRC METH SIG TRANS, P123; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	38	148	155	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					219	230		10.1016/j.cell.2004.09.026	http://dx.doi.org/10.1016/j.cell.2004.09.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479639	Bronze, Green Published			2022-12-24	WOS:000224577200010
J	Fraidenraich, D; Stillwell, E; Romero, E; Wilkes, D; Manova, K; Basson, CT; Benezra, R				Fraidenraich, D; Stillwell, E; Romero, E; Wilkes, D; Manova, K; Basson, CT; Benezra, R			Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells	SCIENCE			English	Article							GROWTH-FACTOR-I; TRANSGENIC MICE; GENE; EXPRESSION; PROLIFERATION; MORPHOGENESIS; DIFFERENTIATION; OVEREXPRESSION; NEUROGENESIS; INDUCTION	We report that Id knockout mouse embryos display multiple cardiac defects, but mid-gestation lethality is rescued by the injection of 15 wild-type embryonic stem (ES) cells into mutant blastocysts. Myocardial markers altered in Id mutant cells are restored to normal throughout the chimeric myocardium. Intraperitoneal injection of ES cells into female mice before conception also partially rescues the cardiac phenotype with no incorporation of ES cells. Insulin-like growth factor 1, a long-range secreted factor, in combination with WNT5a, a locally secreted factor, likely account for complete reversion of the cardiac phenotype. Thus, ES cells have the potential to reverse congenital defects through Id-dependent local and long-range effects in a mammalian embryo.	Cornell Univ, Canc Biol & Genet Program, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Mol Cytol Core Facil, Weill Med Coll, Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cornell Univ, Mol Cardiol Lab, Weill Med Coll, Greenberg Cardiol Div,Dept Med, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Benezra, R (corresponding author), Cornell Univ, Canc Biol & Genet Program, Weill Med Coll, New York, NY 10021 USA.	r-benezra@ski.mskcc.org			NATIONAL CANCER INSTITUTE [R01CA107429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL076568] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107429, R01CA107429] Funding Source: Medline; NHLBI NIH HHS [KO1HL076568, K01 HL076568] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMO M, 1989, ENDOCRINOLOGY, V124, P2737, DOI 10.1210/endo-124-6-2737; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen J, 1998, DEVELOPMENT, V125, P1943; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Clouthier DE, 2003, DEV BIOL, V261, P506, DOI 10.1016/S0012-1606(03)00128-3; Hatcher CJ, 2001, DEV BIOL, V230, P177, DOI 10.1006/dbio.2000.0134; Jen Y, 1996, DEV DYNAM, V207, P235; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kelly RG, 1997, DEV BIOL, V187, P183, DOI 10.1006/dbio.1997.8577; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Tran CM, 1998, DEVELOPMENT, V125, P1951; Wu H, 1999, DEVELOPMENT, V126, P3597; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	21	153	172	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					247	252		10.1126/science.1102612	http://dx.doi.org/10.1126/science.1102612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472070	Green Accepted			2022-12-24	WOS:000224419700031
J	Foster, KR; Shaulsky, G; Strassmann, JE; Queller, DC; Thompson, CRL				Foster, KR; Shaulsky, G; Strassmann, JE; Queller, DC; Thompson, CRL			Pleiotropy as a mechanism to stabilize cooperation	NATURE			English	Article							AMEBA DICTYOSTELIUM-DISCOIDEUM; SOCIAL AMEBA; EVOLUTION; EXPRESSION; DIF-1	Most genes affect many traits(1-4). This phenomenon, known as pleiotropy, is a major constraint on evolution because adaptive change in one trait may be prevented because it would compromise other traits affected by the same genes(2,4). Here we show that pleiotropy can have an unexpected effect and benefit one of the most enigmatic of adaptations-cooperation. A spectacular act of cooperation occurs in the social amoeba Dictyostelium discoideum, in which some cells die to form a stalk that holds the other cells aloft as reproductive spores(5,6). We have identified a gene, dimA(7), in D. discoideum that has two contrasting effects. It is required to receive the signalling molecule DIF-1 that causes differentiation into prestalk cells. Ignoring DIF-1 and not becoming prestalk should allow cells to cheat by avoiding the stalk. However, we find that in aggregations containing the wildtype cells, lack of the dimA gene results in exclusion from spores. This pleiotropic linkage of stalk and spore formation limits the potential for cheating in D. discoideum because defecting on prestalk cell production results in an even greater reduction in spores. We propose that the evolution of pleiotropic links between cheating and personal costs can stabilize cooperative adaptations.	Rice Univ, Houston, TX 77005 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	Rice University; Baylor College of Medicine; University of Manchester	Foster, KR (corresponding author), Rice Univ, Houston, TX 77005 USA.	krfoster@rice.edu; christopher.thompson@man.ac.uk		Strassmann, Joan/0000-0003-0638-8440; Foster, Kevin/0000-0003-4687-6633; Shaulsky, Gad/0000-0002-0532-0551				Atzmony D, 1997, CURR SCI INDIA, V72, P142; BARTON NH, 1990, GENETICS, V124, P773; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Frank SA, 2003, EVOLUTION, V57, P693; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; JERMYN KA, 1991, DEVELOPMENT, V111, P779; Kay RR, 2001, DEVELOPMENT, V128, P4959; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Keller L, 1999, LEVELS SELECTION EVO; Kessin RH., 2001, DICTYOSTELIUM EVOLUT, V38; LEACH CK, 1973, J EMBRYOL EXP MORPH, V29, P647; Nunney L, 1999, MG BEH ECOL, P238; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Smith J. M., 1995, MAJOR TRANSITIONS EV; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Thompson CRL, 2000, DEV BIOL, V227, P56, DOI 10.1006/dbio.2000.9877; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Travisano M, 2004, TRENDS MICROBIOL, V12, P72, DOI 10.1016/j.tim.2003.12.009; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Vulic M, 2001, GENETICS, V158, P519; Wright S., 1968, EVOLUTION GENETICS P, P373	30	193	198	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					693	696		10.1038/nature02894	http://dx.doi.org/10.1038/nature02894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470429				2022-12-24	WOS:000224299300041
J	Gunnarsson, TG; Gill, JA; Sigurbjornsson, T; Sutherland, WJ				Gunnarsson, TG; Gill, JA; Sigurbjornsson, T; Sutherland, WJ			Pair bonds - Arrival synchrony in migratory birds	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; Langhus, IS-570 Fljot, Iceland	University of East Anglia; University of East Anglia	Gunnarsson, TG (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	t.gunnarsson@uea.ac.uk	Gunnarsson, Tomas G/L-9783-2015; Sutherland, William/B-1291-2013; Gill, Jennifer A/A-7759-2008	Gunnarsson, Tomas Gretar/0000-0001-7692-0637; Sutherland, William/0000-0002-6498-0437				COULSON JC, 1980, P INT ORN C, V17, P823; Ens B.J., 1996, PARTNERSHIPS BIRDS S, P344; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; GUNNARSSON TG, IN PRESS BIRD STUDY; Handel CM, 2000, ANIM BEHAV, V60, P471, DOI 10.1006/anbe.2000.1505; Reynolds JD, 1997, BEHAV ECOL, V8, P126, DOI 10.1093/beheco/8.2.126	6	71	75	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2004	431	7009					646	646		10.1038/431646a	http://dx.doi.org/10.1038/431646a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470417				2022-12-24	WOS:000224299300029
J	Frosh, A; Smith, LC; Jackson, CJ; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J				Frosh, A; Smith, LC; Jackson, CJ; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J			Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; ACCUMULATION; APPENDIX; SAMPLES	Variant Creutzfeldt-Jakob disease (CJD) is thought to be caused by dietary or other exposure to bovine spongiform encephalopathy (BSE) prions. The prevalence of preclinical or subclinical prion infection in the UK is currently unknown. Since clinical variant CJD is uniformly associated with tonsillar prion infection, we screened 2000 anonymous surgical tonsillectomy specimens for disease-associated prion protein. Analysis by both high sensitivity immunoblotting and immunohistochemistry detected no positive cases. However, this negative result cannot provide reassurance that relevant community infection is unlikely because of the fairly small sample size, demographic and age-related factors, and unknown test sensitivity during the prolonged incubation period. Nevertheless, our findings establish a protocol for prevalence screening on a national scale.	Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, MRC Prion Unit, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Collinge, J (corresponding author), Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Wadsworth, Jonathan/0000-0002-4797-2259	Medical Research Council [MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; FRASER H, 1992, PRION DIS HUMANS ANI; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	10	48	52	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1260	1262		10.1016/S0140-6736(04)17143-2	http://dx.doi.org/10.1016/S0140-6736(04)17143-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464187				2022-12-24	WOS:000224254200033
J	Eckart, RE; Scoville, SL; Campbell, CL; Shry, EA; Stajduhar, KC; Potter, RN; Pearse, LA; Virmani, R				Eckart, RE; Scoville, SL; Campbell, CL; Shry, EA; Stajduhar, KC; Potter, RN; Pearse, LA; Virmani, R			Sudden death in young adults: A 25-year review of autopsies in military recruits	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY ANOMALIES; SICKLE-CELL TRAIT; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC DEATH; CARDIOVASCULAR-DISEASE; WATER-INTOXICATION; POPULATION; ECHOCARDIOGRAPHY; ATHLETE; CLASSIFICATION	Background: Sudden death among military recruits is a rare but devastating occurrence. Because extensive medical data are available on this cross-sectional and diverse population, identification of the underlying causes of sudden death may promote health care policy to reduce the incidence of sudden death. Objective: To determine the causes of nontraumatic sudden death among a cohort of military recruits. Design: Retrospective cohort study using demographic and autopsy data from the Department of Defense Recruit Mortality Registry. Setting: Basic military training. Patients: All nontraumatic sudden deaths from a monitored 6.3 million men and women age 18 to 35 years. Measurements: Descriptive analysis, crude mortality rates of causes of sudden death, and frequency of events as a function of cause of death. Results: Of 126 nontraumatic sudden deaths (rate, 13.0/100 000 recruit-years), 108 (86%) were related to exercise. The most common cause of sudden death was an identifiable cardiac abnormality (64 of 126 recruits [51%]); however, a substantial number of deaths remained unexplained (44 of 126 recruits [35%]). The predominant structural cardiac abnormalities were coronary artery abnormalities (39 of 64 recruits [61%]), myocarditis (13 of 64 recruits [20%]), and hypertrophic cardiomyopathy (8 of 64 recruits [13%]). An anomalous coronary artery accounted for one third (21 of 64 recruits) of the cases in this cohort, and, in each, the left coronary artery arose from the right (anterior) sinus of Valsalva, coursing between the pulmonary artery and aorta. Limitations: This cohort underwent a preenlistment screening program that included history and physical examination; this may have altered outcomes. Conclusions: cardiac abnormalities are the leading identifiable cause of sudden death among military recruits; however, more than one third of sudden deaths remain unexplained after detailed medical investigation.	Brooke Army Med Ctr, San Antonio, TX USA; Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; Wilford Hall USAF Med Ctr, Lackland AFB, TX 78236 USA; Armed Forces Inst Pathol, Washington, DC 20306 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; United States Department of Defense; United States Air Force; United States Department of Defense	Eckart, RE (corresponding author), Brigham & Womens Hosp, USA, Cardiac Arrhythmia Serv, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	Robert.Eckart@us.army.mil						ANDERSON TM, 1983, PEDIATRICIAN, V13, P165; ANGELINI P, 1989, AM HEART J, V117, P418, DOI 10.1016/0002-8703(89)90789-8; Angelini P, 2002, TEX HEART I J, V29, P271; Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; Basso C, 2001, Cardiol Rev, V9, P312, DOI 10.1097/00045415-200111000-00005; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Cupp MJ, 1999, AM FAM PHYSICIAN, V59, P1239; Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0; Dodge-Khatami A, 2000, Ann Thorac Surg, V69, pS270; EPSTEIN SE, 1986, J AM COLL CARDIOL, V7, P220, DOI 10.1016/S0735-1097(86)80285-6; Felmeden D, 2000, INT J CLIN PRACT, V54, P390; Franklin BA, 1997, SPORTS MED, V24, P97, DOI 10.2165/00007256-199724020-00003; Gardner JW, 2002, MIL MED, V167, P964; Gardner JW, 2002, MIL MED, V167, P432; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; Kollef M H, 1990, Mil Med, V155, pA7; LEWIS JF, 1989, AM J CARDIOL, V64, P1029, DOI 10.1016/0002-9149(89)90802-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1998, ANN INTERN MED, V129, P379, DOI 10.7326/0003-4819-129-5-199809010-00006; Maron BJ, 2003, AM J CARDIOL, V91, P1195, DOI 10.1016/S0002-9149(03)00266-2; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Maron BJ, 1998, CURR PROB CARDIOLOGY, V23, P482, DOI 10.1016/S0146-2806(98)80008-X; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; McNeill KM, 2000, EMERG INFECT DIS, V6, P415, DOI 10.3201/eid0604.000419; Murray MJ, 1996, MIL MED, V161, P303, DOI 10.1093/milmed/161.5.303; MURRY PM, 1995, AM J CARDIOL, V76, P849, DOI 10.1016/S0002-9149(99)80244-6; Neuhauser KM, 1999, MIL MED, V164, P841, DOI 10.1093/milmed/164.12.841; Phelps SE, 2000, MIL MED, V165, P157, DOI 10.1093/milmed/165.2.157; PHILLIPS M, 1986, JAMA-J AM MED ASSOC, V256, P2696, DOI 10.1001/jama.256.19.2696; ROTHMAN KJ, 1975, INT J BIOMED COMPUT, V6, P33, DOI 10.1016/0020-7101(75)90022-7; Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12; SCOVILLE S, 2002, THESIS U HLTH SCI; Scoville SL, 2004, AM J PREV MED, V26, P205, DOI 10.1016/j.amepre.2003.12.003; Scoville SL, 2004, AM J PREV MED, V26, P194, DOI 10.1016/j.amepre.2003.11.001; Shry EA, 2001, AM J CARDIOL, V87, P1428, DOI 10.1016/S0002-9149(01)01572-7; TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640, DOI 10.1016/0735-1097(92)90019-J; Villa RB, 2001, REV ESP CARDIOL, V54, P269; Virmani Renu, 1997, Cardiology Clinics, V15, P439, DOI 10.1016/S0733-8651(05)70351-9; Waller B F, 1985, Cardiovasc Clin, V15, P9; WEIDENBENER EJ, 1995, CLIN J SPORT MED, V5, P86, DOI 10.1097/00042752-199504000-00003	45	585	615	2	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					829	834		10.7326/0003-4819-141-11-200412070-00005	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583223				2022-12-24	WOS:000225530700001
J	Phan, RT; Dalla-Favera, R				Phan, RT; Dalla-Favera, R			The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; TRANSCRIPTIONAL REPRESSOR; TUMOR SUPPRESSION; LYMPHOMA; INFLAMMATION; MUTATIONS; DIFFERENTIATION	The human proto-oncogene BCL6 encodes a BTB/POZ-zinc-finger transcriptional repressor that is necessary for germinal-centre formation and is implicated in the pathogenesis of B-cell lymphoma(1-3). The precise function of BCL6 in germinal-centre development and lymphomagenesis is unclear because very few direct BCL6 target genes have been identified(4-7). Here we report that BCL6 suppresses the expression of the p53 ( also known as TP53) tumour suppressor gene and modulates DNA damage-induced apoptotic responses in germinal-centre B cells. BCL6 represses p53 transcription by binding two specific DNA sites within the p53 promoter region and, accordingly, p53 expression is absent in germinal-centre B cells where BCL6 is highly expressed. Suppression of BCL6 expression via specific short interfering RNA leads to increased levels of p53 messenger RNA and protein both under basal conditions and in response to DNA damage. Most notably, constitutive expression of BCL6 protects B cell lines from apoptosis induced by DNA damage. These results suggest that an important function of BCL6 is to allow germinal-centre B cells to tolerate the physiological DNA breaks required for immunoglobulin class switch recombination and somatic hypermutation without inducing a p53-dependent apoptotic response. These findings also imply that deregulated BCL6 expression contributes to lymphomagenesis in part by functional inactivation of p53.	Columbia Univ, Inst Canc Res, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Res, New York, NY 10032 USA.	rd10@columbia.edu						Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; LO CF, 1994, BLOOD, V83, P1757; LOCOCO F, 1993, BLOOD, V82, P2289; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Offit K, 1995, LEUKEMIA LYMPHOMA, V20, P85, DOI 10.3109/10428199509054757; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	29	482	506	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					635	639		10.1038/nature03147	http://dx.doi.org/10.1038/nature03147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577913				2022-12-24	WOS:000225433200049
J	Calonge, N; Randhawa, G				Calonge, N; Randhawa, G			The meaning of the US Preventive Services Task Force grade I recommendation: Screening for hepatitis C virus infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The U.S. Preventive Services Task Force (USPSTF) formulates evidence-based recommendations for clinical preventive services. These recommendations are communicated by letter grades that reflect the quality of evidence and the magnitude of net health benefit expected from delivering the preventive service. When the USPSTF finds insufficient evidence to determine the balance of health benefits or harms of delivering a preventive service, because of a lack of studies, poor-quality studies, or good-quality studies with conflicting results, the USPSTF assigns the service an I letter grade. The USPSTF found insufficient evidence to recommend for or against screening for hepatitis C virus infection in high-risk individuals (I letter grade). This recommendation reflects the need for further research that would provide adequate evidence to assess the net health benefit for persons screened for hepatitis C virus infection.										Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Chou R, 2004, ANN INTERN MED, V140, P465, DOI 10.7326/0003-4819-140-6-200403160-00014	2	18	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2004	141	9					718	719		10.7326/0003-4819-141-9-200411020-00014	http://dx.doi.org/10.7326/0003-4819-141-9-200411020-00014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867JT	15520429				2022-12-24	WOS:000224839600009
J	Leung, GM; Hedley, AJ; Ho, LM; Chau, P; Wong, IOL; Thach, TQ; Ghani, AC; Donnelly, CA; Fraser, C; Riley, S; Ferguson, NM; Anderson, RM; Tsang, T; Leung, PY; Wong, V; Chan, JCK; Tsui, E; Lo, SV; Lam, TH				Leung, GM; Hedley, AJ; Ho, LM; Chau, P; Wong, IOL; Thach, TQ; Ghani, AC; Donnelly, CA; Fraser, C; Riley, S; Ferguson, NM; Anderson, RM; Tsang, T; Leung, PY; Wong, V; Chan, JCK; Tsui, E; Lo, SV; Lam, TH			The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients	ANNALS OF INTERNAL MEDICINE			English	Article							TRANSMISSION DYNAMICS; CORONAVIRUS INFECTION; SARS CORONAVIRUS; LABORATORY TESTS; OUTBREAK; TORONTO; CHILDREN; IMPACT; AGENT; CHINA	Background: As yet, no one has written a comprehensive epidemiologic account of a severe acute respiratory syndrome (SARS) outbreak from an affected country. Objective: To provide a comprehensive epidemiologic account of a SARS outbreak from an affected territory. Design: Epidemiologic analysis. Setting: The 2003 Hong Kong SARS outbreak. Participants: All 1755 cases and 302 deaths. Measurements: Sociodemographic characteristics; infection clusters by time, occupation, setting, and workplace; and geospatial relationships were determined. The mean and variance in the time from infection to onset (incubation period) were estimated in a small group of patients with known exposure. The mean and variance in time from onset to admission, from admission to discharge, or from admission to death were calculated. Logistic regression was used to identify important predictors of case fatality. Results: 49.3% of patients were infected in clinics, hospitals, or elderly or nursing homes, and the Amoy Gardens cluster accounted for 18.8% of cases. The ratio of women to men among infected individuals was 5:4. Health care workers accounted for 23.1% of all reported cases. The estimated mean incubation period was 4.6 days (95% CI, 3.8 to 5.8 days). Mean time from symptom onset to hospitalization varied between 2 and 8 days, decreasing over the course of the epidemic. Mean time from onset to death was 23.7 days (CI, 22.0 to 25.3 days), and mean time from onset to discharge was 26.5 days (CI, 25.8 to 27.2 days). Increasing age, male sex, atypical presenting symptoms, presence of comorbid conditions, and high lactate dehydrogenase level on admission were associated with a greater risk for death. Limitations: Estimates of the incubation period relied on statistical assumptions because few patients had known exposure times. Temporal changes in case management as the epidemic progressed, unavailable treatment information, and several potentially important factors that could not be thoroughly analyzed because of the limited sample size complicate interpretation of factors related to case fatality. Conclusions: This analysis of the complete data on the 2003 SARS epidemic in Hong Kong has revealed key epidemiologic features of the epidemic as it evolved.	Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Dept Community Med, 21 Sassoon Rd,Fac Med Bldg,Pokfulam, Hong Kong, Hong Kong, Peoples R China.	commed@hkucc.hku.hk	Hedley, Anthony J/A-9113-2013; Ghani, Azra/B-8560-2009; Fraser, Christophe/A-8109-2008; Thach, Thuan-Quoc/C-4416-2009; Leung, Gabriel Matthew/C-4336-2009; Riley, Steven/C-4384-2009; Hedley, Anthony/C-4305-2009; Ferguson, Neil/B-8578-2008; Lam, Tai Hing/C-4317-2009	Fraser, Christophe/0000-0003-2399-9657; Thach, Thuan-Quoc/0000-0003-3404-3888; Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; Ghani, Azra/0000-0002-0007-4910; Anderson, Roy/0000-0002-9528-3175; ho, lm/0000-0002-2709-927X; Leung, Gabriel/0000-0002-2503-6283; Riley, Steven/0000-0001-7904-4804; Lam, Tai Hing/0000-0002-2033-9971				[Anonymous], 2013, WHOCDSCSRGAR2003; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Center for Disease Control and Prevention, 2004, PUBL HLTH GUID COMM; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Fouchier RAM, 2004, CAN MED ASSOC J, V170, P63; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Gomez G, 2004, STAT PAP, V45, P139, DOI 10.1007/BF02777221; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8; HONAKER J, 2004, AMELIA PROGRAM MISSI; Hong Kong SAR Government, 2020, VACC PASS Q A; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; LAI PC, 2004, IN PRESS ENV HLTH PE; Lam TH, 2003, INT J EPIDEMIOL, V32, P178, DOI 10.1093/ije/dyg067; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Leung GM, 2004, EMERG INFECT DIS, V10, P1653, DOI 10.3201/eid1009.040155; Leung GM, 2004, ANN INTERN MED, V141, P333, DOI 10.7326/0003-4819-141-5-200409070-00106; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Naylor CD, 2004, JAMA-J AM MED ASSOC, V291, P2483, DOI 10.1001/jama.291.20.2483; Ng PC, 2004, PEDIATRICS, V113, pE7, DOI 10.1542/peds.113.1.e7; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poon LLM, 2003, J CLIN VIROL, V28, P233, DOI 10.1016/j.jcv.2003.08.004; Rainer TH, 2004, ANN INTERN MED, V140, P614, DOI 10.7326/0003-4819-140-8-200404200-00008; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rubin DB, 2004, MULTIPLE IMPUTATION; Stuart A, 1994, KENDALLS ADV THEORY; Tai D Y, 2003, Ann Acad Med Singap, V32, pS34; Tang P, 2004, CAN MED ASSOC J, V170, P47; Wand M. P., 1995, KERNEL SMOOTHING; WHO, 2002, SUMM PROB SARS CAS O; WHO, 2003, US LAB METH SARS DIA; Wong Wing-Wai, 2003, J Chin Med Assoc, V66, P323; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	36	223	233	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2004	141	9					662	673		10.7326/0003-4819-141-9-200411020-00006	http://dx.doi.org/10.7326/0003-4819-141-9-200411020-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867JT	15520422				2022-12-24	WOS:000224839600002
J	Gerrienne, P; Meyer-Berthaud, B; Fairon-Demaret, M; Streel, M; Steemans, P				Gerrienne, P; Meyer-Berthaud, B; Fairon-Demaret, M; Streel, M; Steemans, P			Runcaria, a middle Devonian seed plant precursor	SCIENCE			English	Article							GYMNOSPERM EVOLUTION; ORIGIN; HETEROSPORY; HABIT; NOV; GEN	The emergence of the seed habit in the Middle Pateozoic was a decisive evolutionary breakthrough. Today, seed plants are the most successful plant lineage, with more than 250,000 living species. We have identified a middle Givetian (385 million years ago) seed precursor from Belgium predating the earliest seeds by about 20 million years. Runcaria is a small, radially symmetrical, integumented megasporangium surrounded by a cupule. The megasporangium bears an unopened distal extension protruding above the multilobed integument. This extension is assumed to be involved in anemophilous pollination. Runcaria sheds new light on the sequence of character acquisition leading to the seed.	Univ Liege, Dept Geol, Liege 1, Belgium; Ctr Cooperat Int Rech Agron Dev, F-34398 Montpellier 5, France	University of Liege; CIRAD	Gerrienne, P (corresponding author), Univ Liege, Dept Geol, B18, Liege 1, Belgium.	p.gerrienne@ulg.ac.be	Gerrienne, Philippe/C-8362-2009	Steemans, Philippe/0000-0003-1183-6324				Arkhangelskaya AD, 2003, REV PALAEOBOT PALYNO, V127, P45, DOI 10.1016/S0034-6667(03)00093-9; BATEMAN RM, 1994, BIOL REV, V69, P345, DOI 10.1111/j.1469-185X.1994.tb01276.x; Beck C.B., 1988, ORIGIN EVOLUTION GYM, P1; CHALONER WG, 1977, NATURE, V265, P233, DOI 10.1038/265233a0; DIMICHELE WA, 1989, TAXON, V38, P1, DOI 10.2307/1220881; Fairon-Demaret M, 1987, B I R SCI NAT BELG, V57, P183; FaironDemaret M, 1996, REV PALAEOBOT PALYNO, V93, P217, DOI 10.1016/0034-6667(95)00127-1; GALTIER J, 1989, NATURE, V340, P225, DOI 10.1038/340225a0; HAIG D, 1989, BIOL J LINN SOC, V38, P215, DOI 10.1111/j.1095-8312.1989.tb01576.x; Hemsley Alan R., 1993, Palaeontographica Abteilung B Palaeophytologie, V229, P135; Hilton J, 1996, REV PALAEOBOT PALYNO, V93, P235, DOI 10.1016/0034-6667(95)00128-X; Hilton J, 1998, ACTA BOT SIN, V40, P981; Kaufmann B, 2004, J GEOL, V112, P495, DOI 10.1086/421077; Li CS, 1997, BOT J LINN SOC, V123, P133; Marshall JEA, 2003, PALAEONTOLOGY, V46, P647, DOI 10.1111/1475-4983.00314; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Rothwell G. W, 1988, ORIGIN EVOLUTION GYM, P85; ROTHWELL GW, 1994, SYST BOT, V19, P443, DOI 10.2307/2419767; ROTHWELL GW, 1987, AM J BOT, V74, P970, DOI 10.2307/2443879; ROTHWELL GW, 1989, BOT GAZ, V150, P170, DOI 10.1086/337763; Rowe NP, 1997, PALAEONTOLOGY, V40, P575; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Stockmans F, 1968, I ROYAL SCI NATURELL, V159, P1; STREEL M, 1987, REV PALAEOBOT PALYNO, V50, P211, DOI 10.1016/0034-6667(87)90001-7; Tucker RD, 1998, EARTH PLANET SC LETT, V158, P175, DOI 10.1016/S0012-821X(98)00050-8	25	69	82	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2004	306	5697					856	858		10.1126/science.1102491	http://dx.doi.org/10.1126/science.1102491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514154				2022-12-24	WOS:000224969400042
J	Clark, M; Price, PE				Clark, M; Price, PE			Is wound healing a true science or a clinical art?	LANCET			English	Editorial Material							GENE-TRANSFER		Cardiff Univ, Cardiff Medictr, Wound Healing Res Unit, Cardiff CF14 4UJ, S Glam, Wales	Cardiff University	Clark, M (corresponding author), Cardiff Univ, Cardiff Medictr, Wound Healing Res Unit, Heath Pk, Cardiff CF14 4UJ, S Glam, Wales.	clarkm@whru.co.uk						Andreadis ST, 2004, EXPERT OPIN BIOL TH, V4, P783, DOI 10.1517/14712598.4.6.783; Appleton I, 2003, IDRUGS, V6, P1067; Cullum N, 2004, COCHRANE LIB; Eming SA, 2004, EXPERT OPIN BIOL TH, V4, P1373, DOI 10.1517/14712598.4.9.1373; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Mustoe T, 2004, AM J SURG, V187, p65S, DOI 10.1016/S0002-9610(03)00306-4; Severens Johan L, 2002, Adv Skin Wound Care, V15, P72, DOI 10.1097/00129334-200203000-00008; Tomic-Canic M, 2004, AM J SURG, V188, p67S, DOI 10.1016/S0002-9610(03)00293-9	8	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1388	1389		10.1016/S0140-6736(04)17240-1	http://dx.doi.org/10.1016/S0140-6736(04)17240-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488204				2022-12-24	WOS:000224485300009
J	Malasarn, D; Saltikov, W; Campbell, KM; Santini, JM; Hering, JG; Newman, DK				Malasarn, D; Saltikov, W; Campbell, KM; Santini, JM; Hering, JG; Newman, DK			arrA is a reliable marker for As(V) respiration	SCIENCE			English	Article									CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; La Trobe Univ, Dept Microbiol, Bundoora, Vic 3086, Australia	California Institute of Technology; California Institute of Technology; California Institute of Technology; La Trobe University	Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu		Campbell, Kate/0000-0002-8715-5544				Akai J, 2004, APPL GEOCHEM, V19, P215, DOI 10.1016/j.apgeochem.2003.09.008; Harvey CF, 2002, SCIENCE, V298, P1602, DOI 10.1126/science.1076978; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Kneebone PE, 2002, ENVIRON SCI TECHNOL, V36, P381, DOI 10.1021/es010922h; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093	7	190	198	8	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					455	455		10.1126/science.1102374	http://dx.doi.org/10.1126/science.1102374			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486292				2022-12-24	WOS:000224626500043
J	Mandal, M; Lee, M; Barrick, JE; Weinberg, Z; Emilsson, GM; Ruzzo, WL; Breaker, RR				Mandal, M; Lee, M; Barrick, JE; Weinberg, Z; Emilsson, GM; Ruzzo, WL; Breaker, RR			A glycine-dependent riboswitch that uses cooperative binding to control gene expression	SCIENCE			English	Article							MESSENGER-RNA STRUCTURE; MECHANISM; TRANSCRIPTION	We identified a previously unknown riboswitch class in bacteria that is selectively triggered by glycine. A representative of these glycine-sensing RNAs from Bacillus subtilis operates as a rare genetic on switch for the gcvT operon, which codes for proteins that form the glycine cleavage system. Most glycine riboswitches integrate two ligand-binding domains that function cooperatively to more closely approximate a two-state genetic switch. This advanced form of riboswitch may have evolved to ensure that excess glycine is efficiently used to provide carbon flux through the citric acid cycle and maintain adequate amounts of the amino acid for protein synthesis. Thus, riboswitches perform key regulatory roles and exhibit complex performance characteristics that previously had been observed only with protein factors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Yale University; Yale University; University of Washington; University of Washington Seattle	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Lee, Mark/0000-0002-9576-9589; Weinberg, Zasha/0000-0002-6681-3624; Ruzzo, Walter L./0000-0002-6260-2926; Breaker, Ronald/0000-0002-2165-536X				ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Hill AV., 1910, J PHYSIOL-LONDON, V40, P4, DOI [DOI 10.1371/JOURNAL.PONE.0041098, DOI 10.1113/JPHYSIOL.1910.SP001386]; Jose AM, 2001, NUCLEIC ACIDS RES, V29, P1631, DOI 10.1093/nar/29.7.1631; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KURGANOV BI, 1978, ALLOSTERIC ENZYMES; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M., UNPUB; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Ptashne M., 2002, GENES SIGNALS; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; SUDARSAN N, 1932, GENE DEV, V17, P2688; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; WEISSBLUTH M, 1974, MOL BIOL BIOCH BIOPH, V15, P27; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	28	391	432	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					275	279		10.1126/science.1100829	http://dx.doi.org/10.1126/science.1100829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472076				2022-12-24	WOS:000224419700040
J	Sharp, D				Sharp, D			Labelling salt in food: if yes, how?	LANCET			English	Editorial Material							DASH-SODIUM TRIAL; INFORMATION PROGRAM; BLOOD-PRESSURE; RESTRICTION; REDUCTION; IMPACT		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Beard TC, 2003, LANCET, V362, P403, DOI 10.1016/S0140-6736(03)14032-9; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; *CONS ACT SALT HLT, SALT SOD LAB FOOD; *FED BAK, BAK IND SALT; Food and Nutrition Board Institute of Medicine, 2004, DIET REF INT DRIS RE; *FOOD STAND AG, 2004, AG LAUCH SALT CAMP; *FOOD STAND AG, 2004, UPD IND SALT RED ACT; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; Girgis S, 2003, EUR J CLIN NUTR, V57, P616, DOI 10.1038/sj.ejcn.1601583; HANNEMAN RL, 2004, COMMUNICATION   0406; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; HM Government/Department of Health, 2004, CM6374; Hooper L, 2002, BMJ-BRIT MED J, V325, P628, DOI 10.1136/bmj.325.7365.628; Hooper L., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003656.PUB2; *I FOOD SCI TECHN, 2003, CURR HOT TOP SALT JU; JURGENS G, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004022.PUB2; McCarron DA, 2003, AM J HYPERTENS, V16, P92, DOI 10.1016/S0895-7061(02)03200-4; Neily JB, 2002, AM HEART J, V143, P29, DOI 10.1067/mhj.2002.119380; O'Shaughnessy KM, 2004, J CLIN INVEST, V113, P1075, DOI 10.1172/JCI200421560; *SALT MAN ASS, 2002, RESP SALT MAN ASS SA; Williams P, 2003, HEALTH PROMOT INT, V18, P51, DOI 10.1093/heapro/18.1.51; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	23	18	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2079	2081		10.1016/S0140-6736(04)17564-8	http://dx.doi.org/10.1016/S0140-6736(04)17564-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589296				2022-12-24	WOS:000225742300007
J	Gallavotti, A; Zhao, Q; Kyozuka, J; Meeley, RB; Ritter, M; Doebley, JF; Pe, ME; Schmidt, RJ				Gallavotti, A; Zhao, Q; Kyozuka, J; Meeley, RB; Ritter, M; Doebley, JF; Pe, ME; Schmidt, RJ			The role of barren stalk1 in the architecture of maize	NATURE			English	Article							AXILLARY MERISTEM DEVELOPMENT; ZEA-MAYS; EVOLUTION; GENE; DOMESTICATION; DIVERSITY; TRANSCRIPTION; POLYMORPHISM; ARABIDOPSIS; REGULATORS	The architecture of higher plants is established through the activity of lateral meristems-small groups of stem cells formed during vegetative and reproductive development. Lateral meristems generate branches and inflorescence structures, which define the overall form of a plant(1-3), and are largely responsible for the evolution of different plant architectures(3). Here, we report the isolation of the barren stalk1 gene, which encodes a non-canonical basic helix-loop-helix protein required for the initiation of all aerial lateral meristems in maize. barren stalk1 represents one of the earliest genes involved in the patterning of maize inflorescences, and, together with the teosinte branched1 gene(4), it regulates vegetative lateral meristem development. The architecture of maize has been a major target of selection for early agriculturalists and modern farmers, because it influences harvesting, breeding strategies and mechanization. By sampling nucleotide diversity in the barren stalk1 region, we show that two haplotypes entered the maize gene pool from its wild progenitor, teosinte, and that only one was incorporated throughout modern inbreds, suggesting that barren stalk1 was selected for agronomic purposes.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Pioneer HiBred Int Inc, Crop Genet Res, Johnston, IA 50131 USA	University of California System; University of California San Diego; University of Milan; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; DuPont	Schmidt, RJ (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	rschmidt@ucsd.edu	Kyozuka, Junko/E-7844-2012					Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; HOFMEYER JDJ, 1931, THESIS CORNELL U ITH; Hubbard L, 2002, GENETICS, V162, P1927; HUDSON RR, 1987, GENETICS, V116, P153; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McSteen P, 2001, DEVELOPMENT, V128, P2881; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Ritter MK, 2002, AM J BOT, V89, P203, DOI 10.3732/ajb.89.2.203; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sussex IM, 2001, CURR OPIN PLANT BIOL, V4, P33, DOI 10.1016/S1369-5266(00)00132-1; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999	30	226	255	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					630	635		10.1038/nature03148	http://dx.doi.org/10.1038/nature03148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577912				2022-12-24	WOS:000225433200048
J	Bonhoeffer, S; Chappey, C; Parkin, NT; Whitcomb, JM; Petropoulos, CJ				Bonhoeffer, S; Chappey, C; Parkin, NT; Whitcomb, JM; Petropoulos, CJ			Evidence for positive epistasis in HIV-1	SCIENCE			English	Article							DELETERIOUS MUTATIONS; RNA VIRUS; RECOMBINATION; EVOLUTION; FITNESS; SEX; HYPOTHESES; CELLS	Reproductive strategies such as sexual reproduction and recombination that involve the shuffling of parental genomes for the production of offspring are ubiquitous in nature. However, their evolutionary benefit remains unclear. Many theories have identified potential benefits, but progress is hampered by the scarcity of relevant data. One class of theories is based on the assumption that mutations affecting fitness exhibit negative epistasis. Retroviruses recombine frequently and thus provide a unique opportunity to test these theories. Using amino acid sequence data and fitness values from 9466 human immunodeficiency virus 1 (HIV-1) isolates, we find in contrast to these theories strong statistical evidence for a predominance of positive epistasis in HIV-1.	ETH Zentrum NW, ETH Zurich, CH-8092 Zurich, Switzerland; ViroLogic, San Francisco, CA 94080 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bonhoeffer, S (corresponding author), ETH Zentrum NW, ETH Zurich, CH-8092 Zurich, Switzerland.	seb@env.ethz.ch	Bonhoeffer, Sebastian/A-2735-2008; Parkin, Neil/P-2724-2019	Bonhoeffer, Sebastian/0000-0001-8052-3925; 	NIAID NIH HHS [R43 AI057068, R43 AI050321] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI050321, R43AI057068] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bretscher MT, 2004, BIOESSAYS, V26, P180, DOI 10.1002/bies.10386; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; de la Pena M, 2000, EVOLUTION, V54, P686; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1999, J MOL EVOL, V49, P703, DOI 10.1007/PL00000082; FELDMAN MW, 1980, P NATL ACAD SCI-BIOL, V77, P4838, DOI 10.1073/pnas.77.8.4838; Iles MM, 2003, GENETICS, V165, P2249; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Maynard Smith J, 1976, EVOLUTION SEX; Michod R. E., 1988, THE EVOLUTION OF SEX; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Peters AD, 2000, GENETICS, V156, P1635; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Rivero A, 2003, EVOLUTION, V57, P1698, DOI 10.1111/j.0014-3820.2003.tb00375.x; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; SZATHMARY E, 1993, GENETICS, V133, P127; TEMIN HM, 1991, TRENDS GENET, V7, P71, DOI 10.1016/0168-9525(91)90048-U; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Wloch DM, 2001, GENETICS, V159, P441	27	185	187	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1547	1550		10.1126/science.1101786	http://dx.doi.org/10.1126/science.1101786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567861				2022-12-24	WOS:000225442700056
J	Sanders, SL; Portoso, M; Mata, J; Bahler, J; Allshire, RC; Kouzarides, T				Sanders, SL; Portoso, M; Mata, J; Bahler, J; Allshire, RC; Kouzarides, T			Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage	CELL			English	Article							NUCLEOSOME CORE PARTICLE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; REPLICATION CHECKPOINT; PURIFICATION; GENE; METHYLTRANSFERASE; CHROMATIN; PROTEIN; PHOSPHORYLATION	Histone lysine methylation is a key regulator of gene expression and heterochromatin function, but little is known as to how this modification impinges on other chromatin activities. Here we demonstrate that a previously uncharacterized SET domain protein, Set9, is responsible for H4-K20 methylation in the fission yeast Schizosaccharomyces pombe. Surprisingly, H4-K20 methylation does not have any apparent role in the regulation of gene expression or heterochromatin function. Rather, we find the modification has a role in DNA damage response. Loss of Set9 activity or mutation of H4-K20 markedly impairs cell survival after genotoxic challenge and compromises the ability of cells to maintain checkpoint mediated cell cycle arrest. Genetic experiments link Set9 to Crb2, a homolog of the mammalian checkpoint protein 53BP1, and the enzyme is required for Crb2 localization to sites of DNA damage. These results argue that H4-K20 methylation functions as a "histone mark" required for the recruitment of the checkpoint protein Crb2.	Wellcome Trust Canc Res UK, Gurdon Inst, Cambridge CB2 1QN, England; Wellcome Trust Canc Res UK, Dept Pathol, Cambridge CB2 1QN, England; Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Cancer Research UK; Cancer Research UK; University of Edinburgh; Wellcome Trust Sanger Institute	Kouzarides, T (corresponding author), Wellcome Trust Canc Res UK, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	tk106@mole.bio.cam.ac.uk	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Allshire, Robin/0000-0002-8005-3625; Mata, Juan/0000-0002-5514-3653; Kouzarides, Tony/0000-0002-8918-4162	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Allshire R, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P149; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Carr AM, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P41; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Edwards RJ, 1997, METHOD ENZYMOL, V283, P471; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2004, P NATL ACAD SCI USA, V101, P1427, DOI 10.1073/pnas.0307342101; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Logie C, 1999, METHOD ENZYMOL, V304, P726; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Watson A, 2004, MOL BIOL CELL, V15, P851, DOI 10.1091/mbc.E03-08-0569; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Willson J, 1997, NUCLEIC ACIDS RES, V25, P2138, DOI 10.1093/nar/25.11.2138; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378	42	430	450	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					603	614		10.1016/j.cell.2004.11.009	http://dx.doi.org/10.1016/j.cell.2004.11.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550243	Bronze			2022-12-24	WOS:000225389500007
J	De Yoreo, JJ; Dove, PM				De Yoreo, JJ; Dove, PM			Shaping crystals with biorriolecules	SCIENCE			English	Editorial Material							ATOMIC-FORCE MICROSCOPY; ABALONE SHELL PROTEINS; CALCITE; GROWTH; MORPHOLOGY; CRYSTALLIZATION; IONS; CITRATE; STEPS		Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94551 USA; Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Virginia Polytechnic Institute & State University	De Yoreo, JJ (corresponding author), Lawrence Livermore Natl Lab, Chem & Mat Sci Directorate, Livermore, CA 94551 USA.	deyoreo1@llnl.gov; dove@vt.edu	Dove, Patricia M/A-7911-2010					ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Becker U, 2001, PHYS CHEM MINER, V28, P545, DOI 10.1007/s002690100188; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Davis KJ, 2004, AM MINERAL, V89, P714; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; FU G, UNPUB; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; Han YJ, 2003, J AM CHEM SOC, V125, P4032, DOI 10.1021/ja034094z; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Rohl AL, 2003, CURR OPIN SOLID ST M, V7, P21, DOI 10.1016/S1359-0286(03)00019-6; SHIRANE Y, 1993, J UROLOGY, V150, P1980, DOI 10.1016/S0022-5347(17)35950-5; Thomas TN, 2004, LANGMUIR, V20, P7643, DOI 10.1021/la049546f; Thompson JB, 2000, BIOPHYS J, V79, P3307, DOI 10.1016/S0006-3495(00)76562-3; Touryan LA, 2004, NAT MATER, V3, P239, DOI 10.1038/nmat1096; Walters DA, 1997, BIOPHYS J, V72, P1425, DOI 10.1016/S0006-3495(97)78789-7; WILLIAMS ED, 1991, SCIENCE, V251, P393, DOI 10.1126/science.251.4992.393	21	147	152	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2004	306	5700					1301	1302		10.1126/science.1100889	http://dx.doi.org/10.1126/science.1100889			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550649				2022-12-24	WOS:000225301600028
J	Fischer, MA; Schneeweiss, S; Avorn, J; Solomon, DH				Fischer, MA; Schneeweiss, S; Avorn, J; Solomon, DH			Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; REGIONAL-VARIATIONS; ROFECOXIB; TRIAL; EFFICACY; OUTCOMES	Background: Over the past five years, selective cyclooxygenase-2 inhibitors (coxibs) have accounted for a growing proportion of prescriptions for nonsteroidal antiinflammatory drugs (NSAIDs). To control these expenses, many state Medicaid programs have implemented prior-authorization requirements before coxibs can be prescribed. We evaluated the effect of such programs on the use of coxibs by Medicaid beneficiaries. Methods: We surveyed state Medicaid agencies to determine whether prescription of coxibs required prior authorization and, if so, the criteria for authorization. For each program, we compared these criteria with evidence-based recommendations for prescribing of coxibs. Using data for all filled prescriptions in 50 state Medicaid programs from 1999 through the end of 2003, we calculated the proportion of defined daily doses of NSAIDs accounted for by coxibs. Time-series analyses were used to measure the changes in prescription patterns after the implementation of each prior-authorization program. Results: By 2001, coxibs accounted for half of all NSAID doses covered by Medicaid. This proportion varied widely according to the state in 2003, from a low of 11 percent to a high of 70 percent of all NSAID doses. Twenty-two states implemented prior-authorization programs for coxibs during the study period. Overall, the implementation of such programs reduced the proportion of NSAID doses made up by coxibs by 15.0 percent (95 percent confidence interval, 10.9 to 19.2 percent), corresponding to a decrease of $10.28 (95 percent confidence interval, $7.56 to $13.00) in spending per NSAID prescription. The effect of such programs was not influenced by the degree to which a prior-authorization program incorporated evidence-based prescribing recommendations. Conclusions: The use of coxibs and spending on NSAIDs varies widely by state and declined substantially after the implementation of prior-authorization programs. Determining whether these reductions are clinically appropriate will have important implications for the development of rational drug-reimbursement policies.	Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fischer, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	mfischer@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR048616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015507] Funding Source: NIH RePORTER; AHRQ HHS [HS-010881] Funding Source: Medline; NIAMS NIH HHS [AR-48616] Funding Source: Medline; NIDA NIH HHS [DA-15507] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; [Anonymous], 2004, PHARM BEN STAT MED A; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Avorn J, 2004, POWERFUL MED BENEFIT; Bensen WG, 1999, MAYO CLIN PROC, V74, P1095, DOI 10.4065/74.11.1095; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; *CTR MED MED SERV, 2003, MED ENR BEN SEL FISC; *CTR MED MED SERV, 2004, MSIS STAT REP FED FI; Day R, 2000, ARCH INTERN MED, V160, P1781, DOI 10.1001/archinte.160.12.1781; Dubois RW, 2004, ALIMENT PHARM THER, V19, P197, DOI 10.1111/j.0269-2813.2004.01834.x; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; *HLTH CAR FIN ADM, 2000, STAT DRUG UT DAT; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; *IMS HLTH IMS NAT, 2004, LEAD 20 THER CLASS U; JENKINS CL, 2004, WASHINGTON POST 0303, pB1; KAYE N, 2002, AFFORDING PRESCRIPTI; Lanza FL, 1998, AM J GASTROENTEROL, V93, P2037; LaPensee Kenneth T, 2003, J Manag Care Pharm, V9, P36; Mello MM, 2004, NEW ENGL J MED, V350, P608, DOI 10.1056/NEJMlim035683; Momani AA, 2002, ANN PHARMACOTHER, V36, P1686; Motheral B, 2001, MED CARE, V39, P1293, DOI 10.1097/00005650-200112000-00005; *NAT I CLIN EXC, 2001, GUID US CYCL COX 2 S; PEAR R, 2004, NY TIMES        0130, pA1; Saag K, 2000, ARCH FAM MED, V9, P1124, DOI 10.1001/archfami.9.10.1124; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Smalley W, 2002, ARTHRITIS RHEUM, V46, P2195, DOI 10.1002/art.10425; SMALLEY WE, 1995, NEW ENGL J MED, V332, P1612, DOI 10.1056/NEJM199506153322406; Solomon DH, 2003, AM J MED, V115, P715, DOI 10.1016/j.amjmed.2003.08.025; SOMERS S, 2003, MODEL PRESCRIPTION D; STACY J, 2004, J MANAGE CARE PHARM, V10, P87; Stacy Jane, 2003, J Manag Care Pharm, V9, P327; Statacorp, 2001, STAT STAT SOFTW REL; STEIN C, 2004, BOSTON GLOBE    0217, pC1; STEIN C, 2004, BOSTON GLOBE    0217, pC4; *THOMS PDR, 2004, DRUG TOP RED BOOK; TILLY J, 2003, PRIOR AUTHORIZATION; Veney JE, 1991, EVALUATION DECISION; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; *WHO COLL CTR DRUG, 2004, ATC DDD IND 2004	41	104	105	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2004	351	21					2187	2194		10.1056/NEJMsa042770	http://dx.doi.org/10.1056/NEJMsa042770			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	871UU	15548779				2022-12-24	WOS:000225160600009
J	Finch, L				Finch, L			Fighting for food aid - the struggle to assist groups affected by HIV/AIDS	LANCET			English	Editorial Material									Ndi Moyo, Salima, Malawi		Finch, L (corresponding author), Ndi Moyo, POB 84, Salima, Malawi.	tfinch@mw.celtelplus.com						Food and Nutrition Technical Assistance (FANTA), 2001, HIV AIDS GUID NUTR C, P24; *UNICEF, 2003, REV LINK HIV AIDS NU; Uys L., 2003, HOME BASED HIV AIDS	3	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 6	2004	364	9446					1650	1651		10.1016/S0140-6736(04)17372-8	http://dx.doi.org/10.1016/S0140-6736(04)17372-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868NZ	15530611				2022-12-24	WOS:000224921600009
J	Gazzani, S; Lawrenson, T; Woodward, C; Headon, D; Sablowski, R				Gazzani, S; Lawrenson, T; Woodward, C; Headon, D; Sablowski, R			A link between rnRNA turnover and RNA interference in Arabidopsis	SCIENCE			English	Article							MESSENGER-RNA; C-ELEGANS; GERM-LINE; GENE; POLYMERASE; TRANSGENE; PROTEIN; REQUIRES; WUSCHEL; TARGETS	In RNA interference (RNAi), double-stranded RNA (dsRNA) triggers degradation of homologous messenger RNA. In many organisms, RNA-dependent RNA polymerase (RdRp) is required to initiate or amplify RNAi, but the substrate for dsRNA synthesis in vivo is not known. Here, we show that RdRp-dependent transgene silencing in Arabidopsis was caused by mutation of XRN4, which is a ribonuclease (RNase) implicated in mRNA turnover by means of decapping and 5'-3' exonucteotysis. When both XRN4 and the RdRp were mutated, the plants accumulated decapped transgene mRNA. We propose that mRNAs lacking a cap structure become exposed to RdRp to initiate or maintain RNAi.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Washington; University of Washington Seattle; University of Manchester	Sablowski, R (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	robert.sablowski@bbsrc.ac.uk		Sablowski, Robert/0000-0002-1732-2909	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000594] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dernburg AF, 2000, GENE DEV, V14, P1578; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Gallois JL, 2002, DEVELOPMENT, V129, P3207; GAZZI S, UNPUB; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ito T, 2004, NATURE, V430, P356, DOI 10.1038/nature02733; Kastenmayer JP, 2000, P NATL ACAD SCI USA, V97, P13985, DOI 10.1073/pnas.97.25.13985; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Klahre U, 2002, P NATL ACAD SCI USA, V99, P11981, DOI 10.1073/pnas.182204199; LAWRENSON T, UNPUB; Lechtenberg B, 2003, PLANT J, V34, P507, DOI 10.1046/j.1365-313X.2003.01746.x; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Lynn K, 1999, DEVELOPMENT, V126, P469; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Newbury S, 2004, RNA, V10, P59, DOI 10.1261/rna.2195504; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3	29	251	263	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1046	1048		10.1126/science.1101092	http://dx.doi.org/10.1126/science.1101092			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528448				2022-12-24	WOS:000225001100047
J	Aitken, RJ; Koopman, P; Lewis, SEM				Aitken, RJ; Koopman, P; Lewis, SEM			Seeds of concern	NATURE			English	Article							PARENTAL OCCUPATIONAL-EXPOSURE; TESTICULAR DYSGENESIS SYNDROME; SEMEN QUALITY; SPERM; RISK; ABNORMALITIES; FREQUENCY; ESTROGENS; CANCER; TIME		Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Queens Univ Belfast, Belfast BT12 6BJ, Antrim, North Ireland	University of Newcastle; University of Queensland; Queens University Belfast	Aitken, RJ (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia.	jaitken@mail.newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; Lewis, Sheena E M/ABI-8338-2020; Koopman, Peter A/C-9416-2009	Aitken, Robert John/0000-0002-9152-156X; Koopman, Peter A/0000-0001-6939-0914				AITKEN RJ, IN PRESS INT J ANDRO; AITKEN RJ, IN PESS REPROD FERTI; Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366; Anderson D, 2003, MUTAT RES-REV MUTAT, V544, P173, DOI 10.1016/j.mrrev.2003.06.016; Anderson D, 2002, ADV EXP MED BIOL, V518, P11; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chitra K. C., 2004, Indian Journal of Experimental Biology, V42, P220; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; Handelsman DJ, 2001, REPROD FERT DEVELOP, V13, P317, DOI 10.1071/RD00103; Hill KA, 2004, ENVIRON MOL MUTAGEN, V43, P110, DOI 10.1002/em.20004; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Jobling S, 2004, AQUAT TOXICOL, V66, P205, DOI 10.1016/j.aquatox.2004.01.001; Klaassen C.D., 2001, CASARETT DOULLS TOXI; Knight JA, 1997, J OCCUP ENVIRON MED, V39, P333, DOI 10.1097/00043764-199704000-00011; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; Kuhnert B, 2004, HUM REPROD UPDATE, V10, P327, DOI 10.1093/humupd/dmh030; Oliva A, 2001, HUM REPROD, V16, P1768, DOI 10.1093/humrep/16.8.1768; Pettersson A, 2004, INT J CANCER, V109, P941, DOI 10.1002/ijc.20088; ROBAIRE B, 2003, ADV MALE MED DEV TOX; SAFE SH, 1995, ENVIRON HEALTH PERSP, V103, P346, DOI 10.2307/3432287; Schuppe HC, 2000, ANDROLOGIA, V32, P255, DOI 10.1046/j.1439-0272.2000.00393.x; Semenza JC, 1997, ENVIRON HEALTH PERSP, V105, P1030, DOI 10.2307/3433835; Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x; Shu XO, 1999, CANCER EPIDEM BIOMAR, V8, P783; Singh NP, 2003, FERTIL STERIL, V80, P1420, DOI 10.1016/j.fertnstert.2003.04.002; Skakkebaek NE, 2004, INT J ANDROL, V27, P189, DOI 10.1111/j.1365-2605.2004.00488.x; Slama R, 2002, HUM REPROD, V17, P503, DOI 10.1093/humrep/17.2.503; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; TRACEY E, 2004, CANC NEW S WALES INC; WHORTON D, 1979, J OCCUP ENVIRON MED, V21, P161	31	247	250	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					48	52		10.1038/432048a	http://dx.doi.org/10.1038/432048a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525979	Bronze			2022-12-24	WOS:000224854900036
J	Zhou, ZH; Zhang, FC				Zhou, ZH; Zhang, FC			A precocial avian embryo from the Lower Cretaceous of China	SCIENCE			English	Article									Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhou, ZH (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhonghe@yeah.net						Horner JR, 1996, NATURE, V383, P103, DOI 10.1038/383103b0; Norell Mark A., 2001, American Museum Novitates, V3315, P1, DOI 10.1206/0003-0082(2001)315<0001:AEODTF>2.0.CO;2; RICKLEFS RE, 1998, AVIAN GROWTH DEV EVO, P31; Schweitzer MH, 2002, J VERTEBR PALEONTOL, V22, P191, DOI 10.1671/0272-4634(2002)022[0191:LCAEWE]2.0.CO;2; Sibley CG., 1990, PHYLOGENY CLASSIFICA; Starck J.M., 1993, Current Ornithology, V10, P275; [No title captured]	7	62	74	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					653	653		10.1126/science.1100000	http://dx.doi.org/10.1126/science.1100000			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499011				2022-12-24	WOS:000224756700041
J	Wood, C; Clauss, M				Wood, C; Clauss, M			Panda phlebotomies? The need for comparative screening for haemochromatosis	LANCET			English	Editorial Material							IRON; LEMURS; STORES		Inst Anim Physiol, D-5764 Oberschleissheim, Germany; Zhejiang Univ, Coll Life Sci, Hangzhou 310027, Zhejiang, Peoples R China; Zhejiang Univ, Minist Educ, Key Lab Conservat Genet & Reprod Biol Endangered, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Clauss, M (corresponding author), Inst Anim Physiol, D-5764 Oberschleissheim, Germany.	clauss@tiph.vetmed.uni-muenchen.de	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/A-4710-2008; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Wood, Christopher/0000-0002-5517-9496				BENIRSCHKE K, 1985, ADV VET SCI COMP MED, V30, P167; Clauss M., 2002, P EUROPEAN ASS ZOO W, V4, P123; Dutton CJ, 2003, J ZOO WILDLIFE MED, V34, P16, DOI 10.1638/1042-7260(2003)34[0016:BEOFRL]2.0.CO;2; GONZALES J, 1984, ZOO BIOL, V3, P255, DOI 10.1002/zoo.1430030308; Lowenstine Linda J., 1999, P260; Mazzaro LM, 2004, ZOO BIOL, V23, P205, DOI 10.1002/zoo.10126; O'Toole D, 2001, VET PATHOL, V38, P372, DOI 10.1354/vp.38-4-372; Paglia DE, 1999, P AM ASS ZOO VET ANN, P163; Paglia DE, 2000, P AM ASS ZOO VET, P124; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; WEEKS BR, 1989, AM J VET RES, V50, P198; Wood C, 2003, AM J PRIMATOL, V61, P101, DOI 10.1002/ajp.10113; ZHANG H, 1993, INT S PROT GIANT PAN, P351	13	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1384	1385		10.1016/S0140-6736(04)17237-1	http://dx.doi.org/10.1016/S0140-6736(04)17237-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488201				2022-12-24	WOS:000224485300006
J	Cuello, LG; Cortes, DM; Perozo, E				Cuello, LG; Cortes, DM; Perozo, E			Molecular architecture of the KvAP voltage-dependent K+ channel in a lipid bilayer	SCIENCE			English	Article							GATED SODIUM-CHANNELS; POTASSIUM CHANNEL; TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE; CHARGE MOVEMENT; SHAKER; S4; CONDUCTION; MECHANISM; SENSOR	We have analyzed the local structure and dynamics of the prokaryotic voltage-dependent K+ channel (KvAP) at 0 millivolts, using site-directed spin labeling and electron paramagnetic resonance spectroscopy. We show that the S4 segment is located at the protein/lipid interface, with most of its charges protected from the lipid environment. Structurally, S4 is highly dynamic and is separated into two short helices by a flexible linker. Accessibility and dynamics data indicate that the S1 segment is surrounded by other parts of the protein. We propose that S1 is at the contact interface between the voltage-sensing and pore domains. These results establish the general principles of voltage-dependent channel structure in a biological membrane.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA	University of Virginia	Perozo, E (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA.	eperozo@virginia.edu						Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Goldstein SAN, 1996, NEURON, V16, P717, DOI 10.1016/S0896-6273(00)80092-6; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Huang C C, 2000, Pac Symp Biocomput, P230; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; MCHAOURAB HS, 2000, DISTANCE MEASUREMENT; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Steinhoff HJ, 2003, METHODS, V29, P188, DOI 10.1016/S1046-2023(02)00309-2; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	33	190	195	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					491	495		10.1126/science.1101373	http://dx.doi.org/10.1126/science.1101373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486302				2022-12-24	WOS:000224626500055
J	Ogawa, M; Yoshimori, T; Suzuki, T; Sagara, H; Mizushima, N; Sasakawa, C				Ogawa, M; Yoshimori, T; Suzuki, T; Sagara, H; Mizushima, N; Sasakawa, C			Escape of intracellular Shigella from autophagy	SCIENCE			English	Article							BACTERIAL; INVASION; PROTEIN; SPREAD; ICSA	The degradation of undesirable cellular components or organelles, including invading microbes, by autophagy is crucial for cell survival. Here, Shigella, an invasive bacteria, was found to be able to escape autophagy by secreting IcsB by means of the type III secretion system. Mutant bacteria lacking IcsB were trapped by autophagy during multiplication within the host cells. IcsB did not directly inhibit autophagy. Rather, Shigella VirG, a protein required for intracellular actin-based motility, induced autophagy by binding to the autophagy protein, Atg5. In nonmutant Shigella, this binding is competitively inhibited by IcsB binding to VirG.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Minato Ku, Tokyo 1088639, Japan; Natl Inst Genet, Dept Cell Genet, Shizuoka 4118540, Japan; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan	University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444				BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Suzuki T, 1996, J BIOL CHEM, V271, P21878, DOI 10.1074/jbc.271.36.21878; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	17	685	707	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					727	731		10.1126/science.1106036	http://dx.doi.org/10.1126/science.1106036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15576571				2022-12-24	WOS:000226814900044
J	Judd, A; Hickman, M; Jones, S; McDonald, T; Parry, JV; Stimson, GV; Hall, AJ				Judd, A; Hickman, M; Jones, S; McDonald, T; Parry, JV; Stimson, GV; Hall, AJ			Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSAY		Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Ctr Res Drugs & Hlth Behav, London W6 8RP, England; Hlth Protect Agcy London, Sexually Transmitted & Blood Borne Virus Lab, London, England; London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England	Imperial College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	Judd, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Ctr Res Drugs & Hlth Behav, London W6 8RP, England.	a.judd@imperial.ac.uk	Hickman, Matthew/Y-2400-2019; Judd, Ali/B-5132-2009	Hickman, Matthew/0000-0001-9864-459X; Judd, Ali/0000-0003-3176-5295				CONNELL JA, 1993, J MED VIROL, V41, P159, DOI 10.1002/jmv.1890410212; Hickman M, 2004, J EPIDEMIOL COMMUN H, V58, P766, DOI 10.1136/jech.2003.015164; *HLTH PROT AG SCOT, 2003, SHOOT INF INJ DRUG U; Judd A, 2003, J MED VIROL, V71, P49, DOI 10.1002/jmv.10463; Murphy G, 2004, AIDS, V18, P265, DOI 10.1097/00002030-200401230-00016	5	127	129	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 1	2005	330	7481					24	25		10.1136/bmj.38286.841227.7C	http://dx.doi.org/10.1136/bmj.38286.841227.7C			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15533854	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000226176700015
J	Arici, A; Bukulmez, O				Arici, A; Bukulmez, O			Phyto-oestrogens and the endometrium	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; SOY PHYTOESTROGENS; BREAST-CANCER; HOT FLASHES; LONG-TERM; TRIAL; HYPERPLASIA; ISOFLAVONES		Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Div Reprod Endocrinol & Infertil, New Haven, CT 06510 USA; Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Dallas, TX 75235 USA	Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Arici, A (corresponding author), Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Div Reprod Endocrinol & Infertil, 333 Cedar St, New Haven, CT 06510 USA.	aydin.arici@yale.edu						BAIRD DD, 1995, J CLIN ENDOCR METAB, V80, P1685, DOI 10.1210/jc.80.5.1685; Clark TJ, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-18; Han KK, 2002, OBSTET GYNECOL, V99, P389, DOI 10.1016/S0029-7844(01)01744-6; Johnson EB, 2001, OBSTET GYNECOL, V98, P947, DOI 10.1016/S0029-7844(01)01542-3; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; Kayisli UA, 2002, J CLIN ENDOCR METAB, V87, P5539, DOI 10.1210/jc.2002-020716; Knight D C, 1999, Climacteric, V2, P79, DOI 10.3109/13697139909025570; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; Lethaby A., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000402, DOI 10.1002/14651858.CD000402, 10.1002/14651858.CD000402.pub2]; Montgomery BE, 2004, OBSTET GYNECOL SURV, V59, P368, DOI 10.1097/00006254-200405000-00025; Murray MJ, 2003, MENOPAUSE, V10, P456, DOI 10.1097/01.GME.0000063567.84134.D1; Penotti M, 2003, FERTIL STERIL, V79, P1112, DOI 10.1016/S0015-0282(03)00158-4; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Somekawa Y, 2001, J CLIN ENDOCR METAB, V86, P3202, DOI 10.1210/jc.86.7.3202; St Clair RW, 1998, CURR OPIN LIPIDOL, V9, P457, DOI 10.1097/00041433-199810000-00010; Terakawa N, 1997, J Obstet Gynaecol Res, V23, P223; Unfer V, 2004, J SOC GYNECOL INVEST, V11, P323, DOI 10.1016/j.jsgi.2003.12.007; Unfer V, 2004, FERTIL STERIL, V82, P145, DOI 10.1016/j.fertnstert.2003.11.041; Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449	19	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2081	2082		10.1016/S0140-6736(04)17565-X	http://dx.doi.org/10.1016/S0140-6736(04)17565-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589297				2022-12-24	WOS:000225742300008
J	Lennon, VA; Wingerchuk, DM; Kryzer, TJ; Pittock, SJ; Lucchinetti, CF; Fujihara, K; Nakashima, I; Weinshenker, BG				Lennon, VA; Wingerchuk, DM; Kryzer, TJ; Pittock, SJ; Lucchinetti, CF; Fujihara, K; Nakashima, I; Weinshenker, BG			A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis	LANCET			English	Article							DISEASE; GUIDELINES	Background Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multiple sclerosis. Neither disease has a distinguishing biomarker, but optimum treatments differ. The relation of neuromyelitis optica to optic-spinal multiple sclerosis in Asia is uncertain. We assessed the capacity of a putative marker for neuromyelitis optica (NMO-IgG) to distinguish neuromyelitis optica and related disorders from multiple sclerosis. Methods Indirect immunofluorescence with a composite substrate of mouse tissues identified a distinctive NMO-IgG staining pattern, which we characterised further by dual immunostaining. We tested masked serum samples from 102 North American patients with neuromyelitis optica or with syndromes that suggest high risk of the disorder, and 12 Japanese patients. with optic-spinal multiple sclerosis. Control patients had multiple sclerosis, other myelopathies, optic neuropathies, and miscellaneous disorders. We also established clinical diagnoses for 14 patients incidentally shown to have NMO-IgG among 85 000 tested for suspected paraneoplastic autoimmunity. Findings NMO-IgG outlines CNS microvessels, pia, subpia, and Virchow-Robin space. It partly colocalises with laminin. Sensitivity and specificity were 73% (95% CI 60-86) and 91% (79-100) for neuromyelitis optica and 58% (30-86) and 100% (66-100) for optic-spinal multiple sclerosis. NMO-IgG was detected in half of patients with high-risk syndromes. Of 14 seropositive cases identified incidentally, 12 had neuromyelitis optica or a high-risk syndrome for the disease. Interpretation NMO-IgG is a specific marker autoantibody of neuromyelitis optica and binds at or near the blood-brain barrier. it distinguishes neuromyelitis optica from multiple sclerosis. Asian optic-spinal multiple sclerosis seems to be the same as neuromyelitis optica.	Mayo Clin & Mayo Fdn, Neuroimmunol Lab, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin Scottsdale, Dept Neurol, Scottsdale, AZ USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Tohoku University	Lennon, VA (corresponding author), Mayo Clin & Mayo Fdn, Neuroimmunol Lab, Dept Neurol, Guggenheim Bldg,Room 828, Rochester, MN 55905 USA.	lennon.vanda@mayo.edu	Weinshenker, Brian G/ABH-6146-2020; Nakashima, Ichiro/AAC-3073-2019	Weinshenker, Brian G/0000-0001-5806-6203; Nakashima, Ichiro/0000-0002-2612-8948				Cree BAC, 2002, SEMIN NEUROL, V22, P105, DOI 10.1055/s-2002-36534; de Seze J, 2003, MULT SCLER J, V9, P521, DOI 10.1191/1352458503ms947oa; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; LEE KH, 1991, NEUROLOGY, V41, P657, DOI 10.1212/WNL.41.5.657; Lennon VA, 2003, J CLIN INVEST, V111, P907, DOI 10.1172/JCI200317429; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mandler RN, 1998, NEUROLOGY, V51, P1219, DOI 10.1212/WNL.51.4.1219; MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211; Misu T, 2002, BRAIN, V125, P2460, DOI 10.1093/brain/awf260; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Weinshenker BG, 2003, LANCET, V361, P889, DOI 10.1016/S0140-6736(03)12784-5; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yu ZY, 2001, ANN NEUROL, V49, P146	18	2186	2411	5	112	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2106	2112		10.1016/S0140-6736(04)17551-X	http://dx.doi.org/10.1016/S0140-6736(04)17551-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589308				2022-12-24	WOS:000225742300023
J	Steer, PJ; Little, MP; Kold-Jensen, T; Chapple, J; Elliott, P				Steer, PJ; Little, MP; Kold-Jensen, T; Chapple, J; Elliott, P			Maternal blood pressure in pregnancy, birth weight, and perinatal. mortality in first births: prospective study	BRITISH MEDICAL JOURNAL			English	Article							CHRONIC-FATIGUE-SYNDROME; MEAN ARTERIAL-PRESSURE; HYPERTENSIVE DISORDERS; HYPOTENSION; FETAL; PREECLAMPSIA; DEFINITION; CLASSIFICATION; POPULATION	Objective To investigate the relation of diastolic blood pressure in pregnancy with birth weight and perinatal mortality. Design Prospective study. Setting 15 maternity units in one London health region, 1988-2000. Participants 210 814 first singleton births of babies weighing more than 200 g among mothers with no hypertension before 20 weeks' gestation and without proteinuria, delivering between 24 and 43 weeks' gestation. Main outcome measures' Birth weight and perinatal mortality. Results The mean (SD) birth weight of babies born to mothers with no hypertension before 20 weeks' gestation or proteinuria was 3282 g (545 g) and there were 1335 perinatal deaths, compared with 94 perinatal deaths among women with proteinuria or a history of hypertension. Diastolic blood pressure at booking for antenatal checks was progressively higher from weeks 34 to 40 of gestation. The birth weight of babies being delivered after 34 weeks was highest for highest recorded maternal diastolic blood pressures of between 70 and 80 turn Hg and lower for blood pressures outside this range. Both low and high diastolic blood pressures were associated with statistically significantly higher perinatal mortality. Using a linear quadratic model, 94 of 825 (11.4%) perinatal deaths could be attributed to mothers having blood pressure differing from the optimal blood pressure (82.7 turn Hg) predicted by the fitted model. Most of these excess deaths occurred with blood pressures below the optimal value. Conclusion Both low and high diastolic blood pressures in women during pregnancy are associated with small babies and high perinatal mortality.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London SW10 9NH, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Imperial College London; Imperial College London	Steer, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London SW10 9NH, England.	p.steer@imperial.ac.uk		Little, Mark/0000-0003-0980-7567; Jensen, Tina Kold/0000-0003-2311-5778				American College of Obstetricians and Gynecologists, 1996, HYP PREGN; Biswas A, 1997, ACTA OBSTET GYN SCAN, V76, P829, DOI 10.3109/00016349709024360; Brown MA, 1998, AM J OBSTET GYNECOL, V178, P836, DOI 10.1016/S0002-9378(98)70501-0; Carstairs V., 1991, DEPRIVATION HLTH SCO; *CESDI, 1998, CONF ENQ STILLB DEAT; CLAPP JF, 1988, AM J OBSTET GYNECOL, V159, P1456, DOI 10.1016/0002-9378(88)90574-1; CLEARY R, 1994, BRIT J OBSTET GYNAEC, V101, P1042, DOI 10.1111/j.1471-0528.1994.tb13579.x; COGSWELL ME, 1995, SEMIN PERINATOL, V19, P222, DOI 10.1016/S0146-0005(05)80028-X; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; Davison A. C., 1997, BOOTSTRAP METHODS TH; DESWIET M, 1991, BRIT J OBSTET GYNAEC, V98, P239; deSwiet M, 1996, BRIT J OBSTET GYNAEC, V103, P862; Easterling TR, 1999, OBSTET GYNECOL, V93, P725, DOI 10.1016/S0029-7844(98)00522-5; FRIEDMAN EA, 1978, JAMA-J AM MED ASSOC, V239, P2249; GRUNBERGER W, 1979, GYNECOL OBSTET INVES, V10, P32; HALLIGAN A, 1993, J HYPERTENS, V11, P869, DOI 10.1097/00004872-199308000-00014; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; JOHENNING AR, 1992, AM J OBSTET GYNECOL, V167, P577, DOI 10.1016/S0002-9378(11)91552-X; Lenfant C, 2001, J Clin Hypertens (Greenwich), V3, P75; MACGILLIVRAY I, 1969, CLIN SCI, V37, P395; MARGULIES M, 1987, AM J OBSTET GYNECOL, V156, P1105, DOI 10.1016/0002-9378(87)90119-0; Mathias CJ, 2001, LANCET, V357, P348, DOI 10.1016/S0140-6736(00)03642-4; MCCULLAGH P., 1991, GEN LINEAR MODELS; MOUTQUIN JM, 1985, AM J OBSTET GYNECOL, V151, P191, DOI 10.1016/0002-9378(85)90010-9; NG PH, 1992, AUST NZ J OBSTET GYN, V32, P14, DOI 10.1111/j.1479-828X.1992.tb01888.x; Owens PE, 2000, J HUM HYPERTENS, V14, P243, DOI 10.1038/sj.jhh.1000973; PAGE EW, 1976, AM J OBSTET GYNECOL, V125, P740, DOI 10.1016/0002-9378(76)90839-5; PERRY IJ, 1991, BRIT J OBSTET GYNAEC, V98, P241, DOI 10.1111/j.1471-0528.1991.tb13386.x; PILGRIM JA, 1992, BRIT MED J, V304, P75, DOI 10.1136/bmj.304.6819.75; *PROSP STUD COLL, 2004, LANCET, V360, P1903; REDMAN CWG, 1988, LANCET, V1, P809; REISS RE, 1987, AM J OBSTET GYNECOL, V156, P894, DOI 10.1016/0002-9378(87)90347-4; Rowe PC, 2002, J PEDIATR-US, V140, P387, DOI 10.1067/mpd.2002.124318; Shennan A, 1996, LANCET, V347, P139, DOI 10.1016/S0140-6736(96)90338-4; Steer PJ, 1999, BRIT J OBSTET GYNAEC, V106, P753, DOI 10.1111/j.1471-0528.1999.tb08394.x; Streeten DHP, 2000, AM J MED SCI, V320, P1, DOI 10.1097/00000441-200007000-00001; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; 1998, REPORT CONFIDENTIAL	38	99	101	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1312	1314B		10.1136/bmj.38258.566262.7C	http://dx.doi.org/10.1136/bmj.38258.566262.7C			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15561733	Green Submitted, Green Published			2022-12-24	WOS:000225657800016
J	Schultz, T; Samoylova, E; Radloff, W; Hertel, IV; Sobolewski, AL; Domcke, W				Schultz, T; Samoylova, E; Radloff, W; Hertel, IV; Sobolewski, AL; Domcke, W			Efficient deactivation of a model base pair via excited-state hydrogen transfer	SCIENCE			English	Article							AB-INITIO; ELECTRONIC-SPECTRA; CYTOSINE; GUANINE; 2-AMINOPYRIDINE; DYNAMICS; DECAY	We present experimental and theoretical evidence for an excited-state deactivation mechanism specific to hydrogen-bonded aromatic dimers, which may account, in part, for the photostability of the Watson-Crick base pairs in DNA. Femtosecond time-resolved mass spectroscopy of 2-aminopyridine clusters reveals an excited-state lifetime of 65+/-10 picoseconds for the near-planar hydrogen-bonded dimer, which is significantly shorter than the lifetime of either the monomer or the 3- and 4-membered nonplanar clusters. Ab initio calculations of reaction pathways and potential-energy profiles identify the mechanism of the enhanced excited-state decay of the dimer: Conical intersections connect the locally excited (1)pipi* state and the electronic ground state with a (1)pipi* charge-transfer state that is strongly stabilized by the transfer of a proton.	Max Born Inst, D-10247 Berlin, Germany; Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Technical University of Munich	Schultz, T (corresponding author), Max Born Inst, Max Born Str 2A, D-10247 Berlin, Germany.	schultz@mbi-berlin.de	Samoylova, Elena/A-3016-2011; Schultz, Thomas/C-2749-2009; Domcke, Wolfgang/C-1179-2010; Sobolewski, Andrzej L/K-8868-2016	Schultz, Thomas/0000-0001-6901-1814; Sobolewski, Andrzej L./0000-0001-5718-489X				Borst DR, 2002, J PHYS CHEM A, V106, P4022, DOI 10.1021/jp0140769; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; de Vries M., COMMUNICATION; Domcke W., 2004, CONICAL INTERSECTION; DOUHAL A, 1995, NATURE, V378, P260, DOI 10.1038/378260a0; HAGER JW, 1987, J PHYS CHEM-US, V91, P1375, DOI 10.1021/j100290a021; Ismail N, 2002, J AM CHEM SOC, V124, P6818, DOI 10.1021/ja0258273; Jurecka P, 2003, J AM CHEM SOC, V125, P15608, DOI 10.1021/ja036611j; Merchan M, 2003, J AM CHEM SOC, V125, P8108, DOI 10.1021/ja0351600; Nir E, 2002, PHYS CHEM CHEM PHYS, V4, P732, DOI 10.1039/b107429f; Sobolewski AL, 2004, PHYS CHEM CHEM PHYS, V6, P2763, DOI 10.1039/b314419d; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P1093, DOI 10.1039/b110941n; Sobolewski AL, 2003, CHEM PHYS, V294, P73, DOI 10.1016/S0301-0104(03)00388-4	13	288	290	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1765	1768		10.1126/science.1104038	http://dx.doi.org/10.1126/science.1104038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576616				2022-12-24	WOS:000225630800049
J	[Anonymous]				[Anonymous]			Opportunity at Meridiani Planum: Plates	SCIENCE			English	Article																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1715	1722						8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576605				2022-12-24	WOS:000225630800037
J	Lee, TH				Lee, TH			Rationing influenza vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*COMM MA, 2004, REV ORD EST RUL PRIO; SINGER DE, 1983, NEW ENGL J MED, V309, P1155, DOI 10.1056/NEJM198311103091905	2	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2365	2366		10.1056/NEJMp048328	http://dx.doi.org/10.1056/NEJMp048328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575049				2022-12-24	WOS:000225429000002
J	Davis, S; Kopecky, KJ; Hamilton, TE; Onstad, L				Davis, S; Kopecky, KJ; Hamilton, TE; Onstad, L		Hanford Thyroid Dis Study Team	Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford Nuclear Site	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FINE-NEEDLE-ASPIRATION; ATOMIC-BOMB SURVIVORS; POPULATION-BASED COHORT; FOLLOW-UP; CHILDHOOD IRRADIATION; RETROSPECTIVE COHORT; FOLLICULAR NEOPLASIA; RISK-FACTORS; CANCER RISK; SERUM TSH	Context Approximately 740000 Ci (2.73 X 10(16) Bq) of iodine 131 (I-131) were released to the atmosphere from the Hanford Nuclear Site in Washington State from 1944 through 1957. The risk of thyroid disease resulting from prolonged environmental I-131 exposure is poorly understood. Objective The Hanford Thyroid Disease Study (HTDS) was conducted to determine if thyroid disease is increased among persons exposed as children to atmospheric releases of I-131 from Hanford. Design Retrospective cohort study. Exposure could have occurred from December 1944 through 1957. Follow-up occurred until the time of the HTDS examination (December 1992-September 1997). Participants' thyroid radiation doses from Hanford's 1111 releases were estimated from interview data regarding residence and dietary histories. Setting The cohort included a sample of all births from 1940 through 1946 to mothers with usual residence in 1 of 7 counties in eastern Washington State. Participants Of 5199 individuals identified, 4350 were located alive and 3440 were evaluable; ie, had sufficient data for dose estimation and received an HTDS evaluation for thyroid disease, including a thyroid ultrasound, physical examination, and fine needle biopsy if required to evaluate thyroid nodularity. Main Outcome Measures Thyroid cancer, benign thyroid nodules, total neoplasia, any thyroid nodules, autoimmune thyroiditis, and hypothyroidism. Results There was no evidence of a relationship between Hanford radiation dose and the cumulative incidence of any of the outcomes. These results remained unchanged after taking into account several factors that might confound the relationship between radiation do, se and the outcomes of interest. Conclusion These results do not support the hypothesis that exposure during infancy and childhood to 131 1 at the dose levels (median, 97 mGy; mean, 174 mGy) and exposure circumstances experienced by our study participants increases the risk of the forms of thyroid disease evaluated in this study.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Canc Prevent, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Div Endocrinol & Metab, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Davis, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, 1100 Fairview Ave N,M4-B874,POB 19024, Seattle, WA 98109 USA.	sdavis@fhcrc.org	Hamilton, Thomas Edward/GQB-4837-2022					AKIYAMA M, 1995, INT J RADIAT BIOL, V68, P497, DOI 10.1080/09553009514551491; amashita S., 1997, P 5 CHERN SAS MED CO; Astakhova LN, 1998, RADIAT RES, V150, P349, DOI 10.2307/3579983; BEACH SA, 1962, PHYS MED BIOL, V6, P538; BOOK SA, 1980, RADIAT RES, V81, P254, DOI 10.2307/3575401; CHRISTOV K, 1978, RADIAT RES, V73, P330, DOI 10.2307/3574824; CLARK DE, 1955, JAMA-J AM MED ASSOC, V159, P1007, DOI 10.1001/jama.1955.02960270027007; CONARD RA, 1980, US DEP ENERGY PUBLIC, P51; DAVIS S, 2004, RADIAT RES, V62, P241; Davis S., 2002, HANFORD THYROID DIS; DEGROOT LJ, 1983, AM J MED, V74, P852, DOI 10.1016/0002-9343(83)91077-X; Dickman PW, 2003, INT J CANCER, V106, P580, DOI 10.1002/ijc.11258; DOBYNS BM, 1974, J CLIN ENDOCR METAB, V38, P976, DOI 10.1210/jcem-38-6-976; DUFFY BJ, 1950, J CLIN ENDOCRINOL, V10, P1296, DOI 10.1210/jcem-10-10-1296; Eheman CR, 2003, THYROID, V13, P453, DOI 10.1089/105072503322021115; Farris WT, 1996, HEALTH PHYS, V71, P588, DOI 10.1097/00004032-199610000-00016; Franklyn JA, 1999, LANCET, V353, P2111, DOI 10.1016/S0140-6736(98)12295-X; GEUL KW, 1993, CLIN ENDOCRINOL, V39, P275, DOI 10.1111/j.1365-2265.1993.tb02366.x; Hahn K, 2001, RADIAT RES, V156, P61, DOI 10.1667/0033-7587(2001)156[0061:TCADAO]2.0.CO;2; Hall P, 1996, RADIAT RES, V145, P86, DOI 10.2307/3579200; HAMILTON TE, 1987, JAMA-J AM MED ASSOC, V258, P629, DOI 10.1001/jama.258.5.629; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; *HANF ENV DOS REC, 1990, PNL7412 HEDR BATT PA; Heeb CM, 1996, HEALTH PHYS, V71, P545, DOI 10.1097/00004032-199610000-00012; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HOLM LE, 1980, J NATL CANCER I, V65, P1221; HOLM LE, 1980, J NATL CANCER I, V64, P1055; HOLM LE, 1980, NEW ENGL J MED, V303, P188, DOI 10.1056/NEJM198007243030404; HOLM LE, 1984, RAD CARCINOGENESIS E, P263; JAMES RA, 1964, US DEP ENERGY PUBLIC; KAPLAN MM, 1988, J CLIN ENDOCR METAB, V66, P376, DOI 10.1210/jcem-66-2-376; KAPLAN MM, 1983, AM J MED, V74, P272, DOI 10.1016/0002-9343(83)90626-5; KERBER RA, 1993, JAMA-J AM MED ASSOC, V270, P2076; Kopecky KJ, 2004, HEALTH PHYS, V87, P15, DOI 10.1097/00004032-200407000-00003; LARSEN PR, 1982, JAMA-J AM MED ASSOC, V247, P1571, DOI 10.1001/jama.247.11.1571; LESSARD E, 1985, US DEP ENERGY PUBLIC; Moysich KB, 2002, LANCET ONCOL, V3, P269, DOI 10.1016/S1470-2045(02)00727-1; NAGATAKI S, 1994, JAMA-J AM MED ASSOC, V272, P364, DOI 10.1001/jama.272.5.364; Napier BA, 2002, HEALTH PHYS, V83, P204, DOI 10.1097/00004032-200208000-00006; *NAT COUNC RAD PRO, 1985, 80 NAT COUNC RAD PRO; *NCI, 1997, EST EXP THYR REC AM; Pacini F, 1998, LANCET, V352, P763, DOI 10.1016/S0140-6736(97)11397-6; POTTERN LM, 1990, J CLIN EPIDEMIOL, V43, P449, DOI 10.1016/0895-4356(90)90133-A; Prentice R L, 1982, Natl Cancer Inst Monogr, V62, P207; Raber W, 2000, THYROID, V10, P709, DOI 10.1089/10507250050137806; RALLISON ML, 1974, AM J MED, V56, P457, DOI 10.1016/0002-9343(74)90476-8; RALLISON ML, 1975, JAMA-J AM MED ASSOC, V233, P1069, DOI 10.1001/jama.233.10.1069; RON E, 1989, RADIAT RES, V120, P516, DOI 10.2307/3577801; Ron E, 1998, JAMA-J AM MED ASSOC, V280, P347, DOI 10.1001/jama.280.4.347; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Ron E., 1984, RAD CARCINOGENESIS E, P139; SAFA AM, 1975, NEW ENGL J MED, V292, P167, DOI 10.1056/NEJM197501232920401; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; SCHNEIDER AB, 1986, ANN INTERN MED, V105, P405, DOI 10.7326/0003-4819-105-3-405; SCHNEIDER AB, 1993, J CLIN ENDOCR METAB, V77, P362, DOI 10.1210/jc.77.2.362; SCHNEIDER AB, 1985, MEDICINE, V64, P1; SEVENS W, 1992, NN01CO23917 NCI; Shipler DB, 1996, HEALTH PHYS, V71, P532, DOI 10.1097/00004032-199610000-00011; SHORE RE, 1976, ARCH ENVIRON HEALTH, V31, P21, DOI 10.1080/00039896.1976.10667184; SHORE RE, 1993, RADIAT RES, V134, P217, DOI 10.2307/3578462; SHORE RE, 1984, RAD CARCINOGENESIS E, P131; SIKOV MR, 1969, RADIAT RES, V38, P449, DOI 10.2307/3572786; SIMPSON CL, 1955, RADIOLOGY, V64, P840, DOI 10.1148/64.6.840; THOMPSON DE, 1994, RAD RES S, V137, P17; Tomer Y, 1997, CLIN IMMUNOL IMMUNOP, V82, P3, DOI 10.1006/clin.1996.4243; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377; *UN SCI COMM EFF A, 2000, SOURC EFF IONZ RAD, V2; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vermiglio F, 1999, THYROID, V9, P781, DOI 10.1089/thy.1999.9.781; World Health Organization, 1977, INT CLASS DIS; YOSHIMOTO Y, 1995, RADIAT RES, V141, P278, DOI 10.2307/3579004	71	89	93	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2004	292	21					2600	2613		10.1001/jama.292.21.2600	http://dx.doi.org/10.1001/jama.292.21.2600			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875GU	15572718	Bronze			2022-12-24	WOS:000225409100023
J	Gfeller, A; Farmer, EE				Gfeller, A; Farmer, EE			Keeping the leaves green above us	SCIENCE			English	Article							TRANSCRIPTION FACTOR; PLANT DEFENSE; JASMONATE; ARABIDOPSIS; RESPONSES; CORONATINE-INSENSITIVE1; SIGNALS; ENCODES; TOMATO	The-plant immune system relies to a great extent on the highly regulated expression of hundreds of defense genes encoding antimicrobial proteins, such as defensins, and antiherbivore proteins, such as lectins. The expression of many of these genes is controlled by a family of mediators known as jasmonates;these cyclic oxygenated fatty acid derivatives are reminiscent of prostaglandins. The roles of jasmonates also extend to the control of reproductive development. How are these complex events regulated? Nearly 20 members of the jasmonate family have been characterized. Some, like jasmonic acid, exist in unmodified forms, whereas others are conjugated to other lipids or to hydrophobic amino acids. Why do so many chemically different forms of these mediators exist, and do individual jasmonates have unique signaling properties or are they made to facilitate transport within and between cells? Key features of the jasmonate signal pathway have been identified and include the specific activation of E3-type ubiquitin ligases thought to target as-yet-undescribed transcriptional repressors for modification or destruction. Several classes of transcription factor are known to function in the jasmonate pathway, and, in some cases, these proteins provide nodes that integrate this network with other important defensive and developmental pathways. Progress in jasmonate research is now rapid, but large gaps in our knowledge exist. Aimed to keep pace with progress, the ensemble of jasmonate Connections Maps at the Signal Transduction Knowledge Environment describe (i) the canonical signaling pathway, (ii) the Arabidopsis signaling pathway, and (iii) the biogenesis and structures of the jasmonates themselves.	Univ Lausanne, Gene Express Lab, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Gene Express Lab, Biol Bldg, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011					Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Evans NH, 2003, PLANT PHYSIOL, V131, P8, DOI 10.1104/pp.014266; Hara-Nishimura I, 2003, CURR OPIN PLANT BIOL, V6, P583, DOI 10.1016/j.pbi.2003.09.015; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; LIECHTI R, 2004, SCI STKE         NOV; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370	16	20	26	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1515	1516		10.1126/science.1104352	http://dx.doi.org/10.1126/science.1104352			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567853				2022-12-24	WOS:000225442700047
J	Hernandez, JV; Kay, ER; Leigh, DA				Hernandez, JV; Kay, ER; Leigh, DA			A reversible synthetic rotary molecular motor	SCIENCE			English	Article							BROWNIAN MOTORS; UNIDIRECTIONAL ROTATION; MOTION; RATCHETS; TRANSPORT; ACCELERATION; SPEED; ROTOR	The circumrotation of a submolecular fragment in either direction in a synthetic molecular structure is described. The movement of a small ring around a larger one occurs through positional displacements arising from biased Brownian motion that are kinetically captured and then directionally released. The sense of rotation is governed solely by the order in which a series of orthogonal chemical transformations is performed. The minimalist nature of the [2]catenane flashing ratchet design permits certain mechanistic comparisons with the Smoluchowski-Feynman ratchet and pawl. Even when no work has to be done against an opposing force and no net energy is used to power the motion, a finite conversion of energy is intrinsically required for the molecular motor to undergo directional rotation. Nondirectional rotation has no such, requirement.	Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Edinburgh	Leigh, DA (corresponding author), Univ Edinburgh, Sch Chem, Kings Bldg,W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	David.Leigh@ed.ac.uk	Kay, Euan R/G-4473-2011; Leigh, David/K-5965-2015	Kay, Euan R/0000-0001-8177-6393; Leigh, David/0000-0002-1202-4507				Altieri A, 2003, ANGEW CHEM INT EDIT, V42, P2296, DOI 10.1002/anie.200250745; Astumian RD, 1998, EUR BIOPHYS J BIOPHY, V27, P474, DOI 10.1007/s002490050158; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Astumian RD, 2002, PHYS TODAY, V55, P33, DOI 10.1063/1.1535005; Bader JS, 1999, P NATL ACAD SCI USA, V96, P13165, DOI 10.1073/pnas.96.23.13165; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Boyer PD, 1998, ANGEW CHEM INT EDIT, V37, P2297, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2296::AID-ANIE2296>3.0.CO;2-W; Davis AP, 1998, ANGEW CHEM INT EDIT, V37, P909, DOI 10.1002/(SICI)1521-3773(19980420)37:7<909::AID-ANIE909>3.0.CO;2-X; FAUCHEUX LP, 1995, PHYS REV LETT, V74, P1504, DOI 10.1103/PhysRevLett.74.1504; Feynman R.P., 1963, FEYNMAN LECT PHYS; Gatti FG, 2003, P NATL ACAD SCI USA, V100, P10, DOI 10.1073/pnas.0134757100; Hawthorne MF, 2004, SCIENCE, V303, P1849, DOI 10.1126/science.1093846; Kelly TR, 2000, J AM CHEM SOC, V122, P6935, DOI 10.1021/ja001048f; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Kelly TR, 1997, ANGEW CHEM INT EDIT, V36, P1866, DOI 10.1002/anie.199718661; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Koumura N, 2002, J AM CHEM SOC, V124, P5037, DOI 10.1021/ja012499i; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Linke H, 2002, APPL PHYS A-MATER, V75, P167, DOI 10.1007/s003390201401; Magnasco MO, 1998, J STAT PHYS, V93, P615, DOI 10.1023/B:JOSS.0000033245.43421.14; Mandl CP, 2004, ANGEW CHEM INT EDIT, V43, P1622, DOI 10.1002/anie.200301697; Matthias S, 2003, NATURE, V424, P53, DOI 10.1038/nature01736; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7; Parrondo JMR, 2004, CONTEMP PHYS, V45, P147, DOI 10.1080/00107510310001644836; Parrondo JMR, 1996, AM J PHYS, V64, P1125, DOI 10.1119/1.18393; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; ROUSSELET J, 1994, NATURE, V370, P446, DOI 10.1038/370446a0; SCHLIWA M, 2003, MOL MOTORS; ter Wiel MKJ, 2003, J AM CHEM SOC, V125, P15076, DOI 10.1021/ja036782o; van Delden RA, 2004, ORG BIOMOL CHEM, V2, P1531, DOI 10.1039/b402222j; von Smoluchowski M, 1912, PHYS Z, V13, P1069	33	471	471	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1532	1537		10.1126/science.1103949	http://dx.doi.org/10.1126/science.1103949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	875ST	15567858	Green Submitted			2022-12-24	WOS:000225442700052
J	Gillespie, KM; Bain, SC; Barnett, AH; Bingley, PJ; Christie, MR; Gill, GV; Gale, EAM				Gillespie, KM; Bain, SC; Barnett, AH; Bingley, PJ; Christie, MR; Gill, GV; Gale, EAM			The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes	LANCET			English	Article								The incidence of childhood type 1 diabetes has risen over the past 50 years. We compared the frequency of HLA class II haplotypes in 194 patients diagnosed more than 50 years ago and 582 age-matched and sex-matched individuals diagnosed between 1985 and 2002. The proportion of high-risk susceptibility genotypes was increased in the earlier cohort (p=0.003), especially in those diagnosed at age 5 years or younger, which is consistent with the hypothesis that the rise of type 1 diabetes is due to a major environmental effect.	Univ Bristol, Diabet & Metab Div Med, Bristol, Avon, England; Univ Birmingham, Birmingham, W Midlands, England; Birmingham Heartlands & Solihull NHS Trust, Birmingham, W Midlands, England; Univ Liverpool, Univ Hosp Aintree, Dept Med, Liverpool L69 3BX, Merseyside, England; Guys Kings & St Thomas Sch Med, Dept Med, London, England	University of Bristol; University of Birmingham; University of Liverpool; University of London; King's College London	Gale, EAM (corresponding author), Southmead Gen Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk		Christie, Michael/0000-0001-5192-3196				Bain SC, 2003, DIABETIC MED, V20, P808, DOI 10.1046/j.1464-5491.2003.01029.x; Chowdhury TA, 1999, DIABETOLOGIA, V42, P1017, DOI 10.1007/s001250051262; FALCONER DS, 1964, INTRO QUANTITATIVE G, P301; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gillespie KM, 2000, TISSUE ANTIGENS, V56, P530, DOI 10.1034/j.1399-0039.2000.560607.x; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4	7	212	216	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 6	2004	364	9446					1699	1700		10.1016/S0140-6736(04)17357-1	http://dx.doi.org/10.1016/S0140-6736(04)17357-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868NZ	15530631				2022-12-24	WOS:000224921600033
J	Cockburn, JJB; Abrescia, NGA; Grimes, JM; Sutton, GC; Diprose, JM; Benevides, JM; Thomas, GJ; Bamford, JKH; Bamford, DH; Stuart, DI				Cockburn, JJB; Abrescia, NGA; Grimes, JM; Sutton, GC; Diprose, JM; Benevides, JM; Thomas, GJ; Bamford, JKH; Bamford, DH; Stuart, DI			Membrane structure and interactions with protein and DNA in bacteriophage PRD1	NATURE			English	Article							VIRAL MEMBRANE; INTERNAL MEMBRANE; CRYOELECTRON MICROSCOPY; BACTERIAL-VIRUS; UNIQUE VERTEX; PRD1; ORGANIZATION; MODEL	Membranes are essential for selectively controlling the passage of molecules in and out of cells and mediating the response of cells to their environment. Biological membranes and their associated proteins present considerable difficulties for structural analysis. Although enveloped viruses have been imaged at about 9 Angstrom resolution by cryo-electron microscopy and image reconstruction(1,2), no detailed crystallographic structure of a membrane system has been described. The structure of the bacteriophage PRD1 particle, determined by X-ray crystallography at about 4 Angstrom resolution, allows the first detailed analysis of a membrane-containing virus(3). The architecture of the viral capsid and its implications for virus assembly are presented in the accompanying paper(3). Here we show that the electron density also reveals the icosahedral lipid bilayer, beneath the protein capsid, enveloping the viral DNA. The viral membrane contains about 26,000 lipid molecules asymmetrically distributed between the membrane leaflets. The inner leaflet is composed predominantly of zwitterionic phosphatidylethanolamine molecules, facilitating a very close interaction with the viral DNA, which we estimate to be packaged to a pressure of about 45 atm, factors that are likely to be important during membrane-mediated DNA translocation into the host cell. In contrast, the outer leaflet is enriched in phosphatidylglycerol and cardiolipin, which show a marked lateral segregation within the icosahedral asymmetric unit. In addition, the lipid headgroups show a surprising degree of order.	Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, Cent Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QT, England; Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Helsinki, Fac Biosci, Viikki Bioctr, FIN-00014 Helsinki, Finland	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Missouri System; University of Missouri Kansas City; University of Helsinki; University of Helsinki	Stuart, DI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk	Abrescia, Nicola Gerardo/AAY-2323-2020; Abrescia, Nicola GA/F-5898-2011	Abrescia, Nicola Gerardo/0000-0001-5559-1918; Cockburn, Joseph/0000-0003-4730-1436; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389				BAMFORD D, 1982, J VIROL, V44, P1031, DOI 10.1128/JVI.44.3.1031-1038.1982; BAMFORD DH, 1995, ADV VIRUS RES, V45, P281, DOI 10.1016/S0065-3527(08)60064-0; Bamford JKH, 2002, J STRUCT BIOL, V139, P103, DOI 10.1016/S1047-8477(02)00562-2; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Butcher SJ, 1995, EMBO J, V14, P6078, DOI 10.1002/j.1460-2075.1995.tb00298.x; CASPAR DLD, 1971, NATURE-NEW BIOL, V231, P46, DOI 10.1038/newbio231046a0; Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2; DAVIS TN, 1982, VIROLOGY, V120, P287, DOI 10.1016/0042-6822(82)90031-9; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Gowen B, 2003, J VIROL, V77, P7863, DOI 10.1128/JVI.77.14.7863-7871.2003; Grahn AM, 1999, J BACTERIOL, V181, P6689, DOI 10.1128/JB.181.21.6689-6696.1999; Grahn AM, 2002, MOL MICROBIOL, V46, P1199, DOI 10.1046/j.1365-2958.2002.03250.x; Laurinavicius S, 2004, VIROLOGY, V322, P328, DOI 10.1016/j.virol.2004.02.009; Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Rydman PS, 2002, J BACTERIOL, V184, P104, DOI 10.1128/JB.184.1.104-110.2002; Rydman PS, 1999, J MOL BIOL, V291, P575, DOI 10.1006/jmbi.1999.2978; Rydman PS, 2001, J MOL BIOL, V313, P785, DOI 10.1006/jmbi.2001.5068; Rydman PS, 2000, MOL MICROBIOL, V37, P356, DOI 10.1046/j.1365-2958.2000.01996.x; San Martin C, 2001, STRUCTURE, V9, P917, DOI 10.1016/S0969-2126(01)00642-6; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Stromsten NJ, 2003, J VIROL, V77, P6314, DOI 10.1128/JVI.77.11.6314-6321.2003; STRUTH B, 2002, PHYS REV LETT, V88, P55023; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Tuma R, 1996, J MOL BIOL, V257, P102, DOI 10.1006/jmbi.1996.0150; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990	28	111	114	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					122	125		10.1038/nature03053	http://dx.doi.org/10.1038/nature03053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525993				2022-12-24	WOS:000224854900053
J	Voordouw, ACG; Sturkenboom, MCJM; Dieleman, JP; Stijnen, T; Smith, DJ; van der Lei, J; Stricker, BHC				Voordouw, ACG; Sturkenboom, MCJM; Dieleman, JP; Stijnen, T; Smith, DJ; van der Lei, J; Stricker, BHC			Annual revaccination against influenza and mortality risk in community-dwelling elderly parsons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINE USE; EFFICACY; DISEASE; EPIDEMIC; REDUCTION; IMPACT	Context Although large-scale observational studies have demonstrated the effectiveness of influenza vaccination, no large studies have systematically addressed the clinical benefit of annual revaccinations. Objective To investigate the effect of annual influenza revaccination on mortality in community-dwelling elderly persons. Design, Setting, and Participants A population-based cohort study using the computerized Integrated Primary Care Information (IPCI) database in the Netherlands including community-dwelling individuals aged 65 years or older from 1996 through 2002. For each year, we computed the individual cumulative exposure to influenza vaccination since study start. Main Outcome Measure Association between the number of consecutive influenza vaccinations and all-cause mortality vs no vaccination after adjusting forage, sex, chronic respiratory and cardiovascular disease, hypertension, diabetes mellitus, renal failure, and cancer. Results The study population included 26071 individuals, of whom 3485 died during follow-up. Overall, a first vaccination was associated with a nonsignificant annual reduction of mortality risk of 10% (hazard ratio [HR], 0.90; 95% confidence interval [CI], 0.78-1.03) while revaccination was associated with a reduced mortality risk of 24% (HR, 0.76; 95% Cl, 0.70-0.83). Compared with a first vaccination, revaccination was associated with a reduced annual mortality risk of 15% (HR, 0.85; 95% Cl, 0.75-0.96). During the epidemic periods this reduction was 28% (HR, 0.72; 95% Cl, 0.53-0.96). Similar estimates were obtained for persons with and without chronic comorbidity and those aged 70 years or older at baseline. overall, influenza vaccination is estimated to prevent 1 death for every 302 vaccinees at a vaccination coverage that varied between 64% and 74%. Conclusion Annual influenza vaccination is associated with a reduction in all-cause mortality risk in a population of community-dwelling elderly persons, particularly in older individuals.	Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Internal Med, Pharmacoepidemiol Unit, Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Virol, Rotterdam, Netherlands; Inspectorate Hlth Care, Med Evaluat Board, The Hague, Netherlands; Inspectorate Hlth Care, Drug Safety Unit, The Hague, Netherlands; Univ Cambridge, Dept Zool, Cambridge, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Stricker, BHC (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Smith, Derek/Z-3075-2019	Smith, Derek/0000-0002-2393-1890				AHMED AEH, 1995, LANCET, V346, P591, DOI 10.1016/S0140-6736(95)91434-X; ARDEN N, 1995, AM J PUBLIC HEALTH, V85, P399, DOI 10.2105/AJPH.85.3.399; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; CARRAT F, 1995, J EPIDEMIOL COMMUN H, V49, P419, DOI 10.1136/jech.49.4.419; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; deBruijn IA, 1997, VACCINE, V15, P1323, DOI 10.1016/S0264-410X(97)00019-4; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hak E, 2002, CLIN INFECT DIS, V35, P370, DOI 10.1086/341403; HOSKINS TW, 1979, LANCET, V1, P33; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; KEITEL WA, 1988, AM J EPIDEMIOL, V127, P353, DOI 10.1093/oxfordjournals.aje.a114809; Lamberts H, 2002, FAM PRACT, V19, P433, DOI 10.1093/fampra/19.5.433; MCELHANEY JE, 1992, J GERONTOL, V47, pM3, DOI 10.1093/geronj/47.1.M3; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; SAAH AJ, 1986, ARCH INTERN MED, V146, P2353, DOI 10.1001/archinte.146.12.2353; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; SPRENGER MJW, 1993, INT J EPIDEMIOL, V22, P334, DOI 10.1093/ije/22.2.334; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; vanEssen GA, 1997, AGE AGEING, V26, P275; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Voordouw BCG, 2003, ARCH INTERN MED, V163, P1089, DOI 10.1001/archinte.163.9.1089	27	118	121	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2004	292	17					2089	2095		10.1001/jama.292.17.2089	http://dx.doi.org/10.1001/jama.292.17.2089			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868OC	15523069	Bronze			2022-12-24	WOS:000224921900021
J	Ira, G; Pellicioli, A; Balijja, A; Wang, X; Fiorani, S; Carotenuto, W; Liberi, G; Bressan, D; Wan, LH; Hollingsworth, NM; Haber, JE; Foiani, M				Ira, G; Pellicioli, A; Balijja, A; Wang, X; Fiorani, S; Carotenuto, W; Liberi, G; Bressan, D; Wan, LH; Hollingsworth, NM; Haber, JE; Foiani, M			DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1	NATURE			English	Article							DOUBLE-STRAND BREAKS; CELL-CYCLE; DEPENDENT PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; G2/M ARREST; REPAIR; KINASE; ADAPTATION; PROTEIN	A single double-strand break (DSB) induced by HO endonuclease triggers both repair by homologous recombination and activation of the Mec1-dependent DNA damage checkpoint in budding yeast(1-6). Here we report that DNA damage checkpoint activation by a DSB requires the cyclin-dependent kinase CDK1 (Cdc28) in budding yeast. CDK1 is also required for DSB-induced homologous recombination at any cell cycle stage. Inhibition of homologous recombination by using an analogue-sensitive CDK1 protein(7,8) results in a compensatory increase in non-homologous end joining. CDK1 is required for efficient 5' to 3' resection of DSB ends and for the recruitment of both the single-stranded DNA-binding complex, RPA, and the Rad51 recombination protein. In contrast, Mre11 protein, part of the MRX complex, accumulates at unresected DSB ends. CDK1 is not required when the DNA damage checkpoint is initiated by lesions that are processed by nucleotide excision repair. Maintenance of the DSB-induced checkpoint requires continuing CDK1 activity that ensures continuing end resection. CDK1 is also important for a later step in homologous recombination, after strand invasion and before the initiation of new DNA synthesis.	FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20122 Milan, Italy; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	IFOM - FIRC Institute of Molecular Oncology; Brandeis University; Brandeis University; University of Milan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Haber, JE (corresponding author), FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	haber@brandeis.edu; marco.foiani@ifom-ieo-campus.it	LIBERI, GIORDANO/AAY-7273-2020; Foiani, Marco/M-8234-2014; Ira, Grzegorz/B-7912-2010; Pellicioli, Achille/B-8765-2017	LIBERI, GIORDANO/0000-0003-3160-2242; Foiani, Marco/0000-0003-4795-834X; Pellicioli, Achille/0000-0002-1528-9009; Haber, James/0000-0002-1878-0610	NIAID NIH HHS [R01 AI044009, AI44009] Funding Source: Medline; NIGMS NIH HHS [R01 GM080600, R01 GM050717] Funding Source: Medline; Telethon [GGP030412] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600, R01GM050717] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Karathanasis E, 2002, GENETICS, V161, P1015; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Liberles DA, 2001, GENOME BIOL, V2; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Naiki T, 2004, MOL CELL BIOL, V24, P3277, DOI 10.1128/MCB.24.8.3277-3285.2004; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Toh GWL, 2003, BIOCHEM SOC T, V31, P242, DOI 10.1042/bst0310242; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	559	572	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2004	431	7011					1011	1017		10.1038/nature02964	http://dx.doi.org/10.1038/nature02964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496928	Green Accepted			2022-12-24	WOS:000224585600050
J	Spagnoli, LG; Mauriello, A; Sangiorgi, G; Fratoni, S; Bonanno, E; Schwartz, RS; Piepgras, DG; Pistolese, R; Ippoliti, A; Holmes, DR				Spagnoli, LG; Mauriello, A; Sangiorgi, G; Fratoni, S; Bonanno, E; Schwartz, RS; Piepgras, DG; Pistolese, R; Ippoliti, A; Holmes, DR			Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATHEROSCLEROTIC PLAQUES; INFLAMMATION; ENDARTERECTOMY; PATHOGENESIS; ULCERATION; THROMBOSIS; MORPHOLOGY; DISEASE; PROTEIN; LESIONS	Context Recent studies suggest that factors other than the degree of carotid stenosis are involved in ischemic stroke pathogenesis, especially modifications of plaque composition and related complications. Objective To examine the role of carotid plaque rupture and thrombosis in ischemic stroke pathogenesis in patients undergoing carotid endarterectomy, excluding those with possible cardiac embolization or with severe stenosis of the circle of Willis. Design, Setting, and Patients A total of 269 carotid plaques selected from an interinstitutional Carotid Tissue Bank were studied by histology after surgical endarterectomy between January 1995 and December 2002. A total of 96 plaques were from patients with ipsilateral major stroke, 91 plaques from patients with transient ischemic attack (TIA), and 82 plaques from patients without symptoms. Main Outcome Measures Differences in the frequency of thrombosis, cap rupture, cap erosion, inflammatory infiltrate, and major cardiovascular risk factors between study groups. Results A thrombotically active carotid plaque associated with high inflammatory infiltrate was observed in 71 (74.0%) of 96 patients with ipsilateral major stroke (and in all 32 plaques from patients operated within 2 months of symptom onset) compared with 32 (35.2%) of 91 patients with TIA (P<.001) or 12 (14.6%) of 82 patients who were without symptoms (P<.001). In addition, a fresh thrombus was observed in 53.8% of patients with stroke operated 13 to 24 months after the cerebrovascular event, An acute thrombus was associated with cap rupture in 64 (90.1%) of 71 thrombosed plaques from patients with stroke and with cap erosion in the remaining 7 cases (9.9%). Ruptured plaques of patients affected by stroke were characterized by the presence of a more severe inflammatory infiltrate, constituted by monocytes, macrophages, and T lymphocyte cells compared with that observed in the TIA and asymptomatic groups (P=.001). There was no significant difference between groups in major cardiovascular risk factors. Conclusion These results demonstrate a major role of carotid thrombosis and inflammation in ischemic stroke in patients affected by carotid atherosclerotic disease.	Univ Roma Tor Vergata, Dept Cardiovasc Dis, Div Vasc Surg, I-00133 Rome, Italy; Minneapolis Cardiovasc Res Inst, Minneapolis, MN USA; Mayo Clin & Mayo Fdn, Dept Neurol Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Cardiovasc Dis, Rochester, MN 55905 USA	University of Rome Tor Vergata; Mayo Clinic; Mayo Clinic; Mayo Clinic	Spagnoli, LG (corresponding author), Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Cattedra Anat & Istol Patol, Via Montpellier 1, I-00133 Rome, Italy.	spagnoli@uniroma2.it	MAURIELLO, ALESSANDRO/K-4705-2016; Sangiorgi, Giuseppe M/H-5141-2019	MAURIELLO, ALESSANDRO/0000-0002-7351-5676; Sangiorgi, Giuseppe M/0000-0001-5862-1967; IPPOLITI, ARNALDO/0000-0001-5311-8203; bonanno, elena/0000-0002-0222-0141; Spagnoli, Luigi Giusto/0000-0002-0684-5501; ippoliti, arnaldo/0000-0002-2804-0157				Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1978, NEUROLOGY, V28, P769; Bassiouny HS, 1997, J VASC SURG, V26, P585, DOI 10.1016/S0741-5214(97)70056-9; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Carr S, 1996, J VASC SURG, V23, P755, DOI 10.1016/S0741-5214(96)70237-9; Chamorro A, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000075297; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; ELIASZIW M, 1994, STROKE, V25, P304, DOI 10.1161/01.STR.25.2.304; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Fujii K, 2003, CIRCULATION, V108, P2473, DOI 10.1161/01.CIR.0000097121.95451.39; Goldstein LB, 2003, STROKE, V34, P2767, DOI 10.1161/01.STR.0000097803.90702.31; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; GOMEZ CR, 1990, STROKE, V21, P148, DOI 10.1161/01.STR.21.1.148; Gorelick PB, 2002, STROKE, V33, P862, DOI 10.1161/hs0302.103657; Hatsukami TS, 1997, STROKE, V28, P95, DOI 10.1161/01.STR.28.1.95; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Mauriello A, 2000, CIRCULATION, V101, P744, DOI 10.1161/01.CIR.101.7.744; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; SITZER M, 1995, STROKE, V26, P1231, DOI 10.1161/01.STR.26.7.1231; SPAGNOLI LG, 1994, ATHEROSCLEROSIS, V108, P39, DOI 10.1016/0021-9150(94)90036-1; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tilton RG, 2002, DRUG NEWS PERSPECT, V15, P351, DOI 10.1358/dnp.2002.15.6.701654; VANDAMME H, 1993, INT ANGIOL, V12, P299; Verheye S, 2002, CIRCULATION, V105, P1596, DOI 10.1161/01.CIR.0000012527.94843.BF; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; ZHENG Z, 2003, CURR MOL MED, V361, P372	38	335	364	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2004	292	15					1845	1852		10.1001/jama.292.15.1845	http://dx.doi.org/10.1001/jama.292.15.1845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IV	15494582	Bronze			2022-12-24	WOS:000224485100023
J	Bianco, PR				Bianco, PR			Hepatitis CNS3 helicase unwinds RNA in leaps and bounds	LANCET			English	Editorial Material							C VIRUS; MACROMOLECULAR MACHINES; STEP-SIZE; MECHANISMS		SUNY Buffalo, Dept Microbiol & Immunol, Ctr Single Mol Biophys, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bianco, PR (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Ctr Single Mol Biophys, Buffalo, NY 14214 USA.	pbianco@buffalo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066831] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66831-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Borowski P, 2003, EUR J BIOCHEM, V270, P1645, DOI 10.1046/j.1432-1033.2003.03540.x; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dev Anouk, 2004, Curr Gastroenterol Rep, V6, P77, DOI 10.1007/s11894-004-0030-5; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88	14	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1385	1387		10.1016/S0140-6736(04)17238-3	http://dx.doi.org/10.1016/S0140-6736(04)17238-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488202				2022-12-24	WOS:000224485300007
J	Bossuyt, F; Meegaskumbura, M; Beenaerts, N; Gower, DJ; Pethiyagoda, R; Roelants, K; Mannaert, A; Wilkinson, M; Bahir, MM; Manamendra-Arachchi, K; Ng, PKL; Schneider, CJ; Oommen, OV; Milinkovitch, MC				Bossuyt, F; Meegaskumbura, M; Beenaerts, N; Gower, DJ; Pethiyagoda, R; Roelants, K; Mannaert, A; Wilkinson, M; Bahir, MM; Manamendra-Arachchi, K; Ng, PKL; Schneider, CJ; Oommen, OV; Milinkovitch, MC			Local endemism within the western Ghats-Sri Lanka biodiversity hotspot	SCIENCE			English	Article							EVOLUTION	The apparent biotic affinities between the mainland and the island in the Western Ghats-Sri Lanka biodiversity hotspot have been interpreted as the result of frequent migrations during recent periods of low sea level. We show, using molecular phylogenies of two invertebrate and four vertebrate groups, that biotic interchange between these areas has been much more limited than hitherto assumed. Despite several extended periods of land connection during the past 500,000 years, Sri Lanka has maintained a fauna that is largely distinct from that of the Indian mainland. Future conservation programs for the subcontinent should take into account such patterns of local endemism at the finest scale at which they may occur.	Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, B-1050 Brussels, Belgium; Free Univ Brussels, Inst Mol Biol & Med, Lab Evolutionary Genet, B-6041 Gosselies, Belgium; Boston Univ, Dept Biol, Boston, MA 02215 USA; Wildlife Heritage Trust, Colombo 8, Sri Lanka; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Univ Kerala, Dept Zool, Thiruvananthapuram 695581, Kerala, India	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Boston University; Natural History Museum London; National University of Singapore; University of Kerala	Bossuyt, F (corresponding author), Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, Pleinlaan 2, B-1050 Brussels, Belgium.	fbossuyt@vub.ac.be	Meegaskumbura, Madhava/F-8782-2013; Beenaerts, Natalie/AAC-5579-2021; Ng, Peter/J-7393-2012; Wilkinson, Mark/J-2026-2014; Pethiyagoda, Rohan/C-2307-2009	Meegaskumbura, Madhava/0000-0002-4599-6724; Wilkinson, Mark/0000-0002-9459-8976; Pethiyagoda, Rohan/0000-0001-7215-9617; Milinkovitch, Michel/0000-0002-2553-0724; Roelants, Kim/0000-0001-5367-5958; Bossuyt, Franky/0000-0001-6804-9271; Beenaerts, Natalie/0000-0001-5655-5943				BOTT R, 1970, ARK ZOOL, V22, P627; BOTT R, 1970, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V526, P1; CADLE JE, 1990, BIOL J LINN SOC, V40, P293, DOI 10.1111/j.1095-8312.1990.tb00541.x; Daniels RJR, 2001, CURR SCI INDIA, V81, P240; Darlington PJ., 1957, ZOOGEOGRAPHY GEOGRAP; Erdelen W., 1990, VEGETATION EROSION, P491; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; INGER R F, 1984, Journal of the Bombay Natural History Society, V81, P551; KIRTISINGHE P, 1957, AMPHIBIAN FAUNA CEYL; MacArthur R. H., 1967, THEORY ISLAND BIOGEO; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Moritz Craig, 1997, P442; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ng Peter K.L., 1995, Journal of South Asian Natural History, V1, P129; Ng Peter K. L., 2001, Zeylanica, V6, P113; Pan GB, 1997, CLIMATES S ASIA; Pethiyagoda R, 1991, FRESHWATER FISHES SR; Pethiyagoda R, 1998, OCC PAP WILDL HERITA, V2, P1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; SENANAYAKE FR, 1977, NATURE, V265, P351, DOI 10.1038/265351a0; SMITH MA, 1943, SERPENTES FAUNA BRIT, V3; Vaz GG, 2000, CURR SCI INDIA, V79, P228; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB; [No title captured]	27	247	273	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					479	481		10.1126/science.1100167	http://dx.doi.org/10.1126/science.1100167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486298				2022-12-24	WOS:000224626500051
J	Jetz, W; Carbone, C; Fulford, J; Brown, JH				Jetz, W; Carbone, C; Fulford, J; Brown, JH			The scaling of animal space use	SCIENCE			English	Article							HOME-RANGE SIZE; POPULATION ENERGY-USE; BODY-SIZE; MAMMALS; DENSITY; MASS; AREA; ABUNDANCE; ECOLOGY; BIRDS	Space used by animals increases with increasing body size. Energy requirements alone can explain how population density decreases, but not the steep rate at which home range area increases. We present a general mechanistic model that predicts the frequency of interaction, spatial overlap, and loss of resources to neighbors. Extensive empirical evidence supports the model, demonstrating that spatial constraints on defense cause exclusivity of home range use to decrease with increasing body size. In large mammals, over 90% of available resources may be lost to neighbors. Our model offers a general framework to understand animal space use and sociality.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Zool Soc London, Inst Zool, London NW1 4RY, England	Princeton University; University of New Mexico; Zoological Society of London	Jetz, W (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wjetz@princeton.edu	Jetz, Walter/ABF-1517-2020	Jetz, Walter/0000-0002-1971-7277				Barrett L, 1998, FUNCT ECOL, V12, P857, DOI 10.1046/j.1365-2435.1998.00261.x; Blackburn TM, 1997, J ANIM ECOL, V66, P233, DOI 10.2307/6025; Blackburn TM, 1996, OIKOS, V75, P303, DOI 10.2307/3546254; Calder WA., 1984, SIZE FUNCTION LIFE H; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CARBONE C, IN PRESS AM NAT; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Johnson CN, 1999, OIKOS, V85, P565, DOI 10.2307/3546706; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kirschfeld K., 1976, P354; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; Marquet PA, 2002, SCIENCE, V295, P2229, DOI 10.1126/science.1070587; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Okubo A., 1980, DIFFUSION ECOLOGICAL; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Silva M, 2001, GLOBAL ECOL BIOGEOGR, V10, P469, DOI 10.1046/j.1466-822x.2001.00261.x; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231	31	380	390	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					266	268		10.1126/science.1102138	http://dx.doi.org/10.1126/science.1102138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472074				2022-12-24	WOS:000224419700037
J	Stuart, AJ; Kosintsev, PA; Higham, TFG; Lister, AM				Stuart, AJ; Kosintsev, PA; Higham, TFG; Lister, AM			Pleistocene to Holocene extinction dynamics in giant deer and woolly mammoth	NATURE			English	Article							MEGALOCEROS-GIGANTEUS BLUMENBACH; IRISH ELK; EUROPE; ISLAND	The extinction of the many well-known large mammals (megafauna) of the Late Pleistocene epoch has usually been attributed to 'overkill' by human hunters, climatic/vegetational changes or to a combination of both(1,2). An accurate knowledge of the geography and chronology of these extinctions is crucial for testing these hypotheses. Previous assumptions that the megafauna of northern Eurasia had disappeared by the Pleistocene/Holocene transition(2) were first challenged a decade ago by the discovery that the latest woolly mammoths on Wrangel Island, northeastern Siberia, were contemporaneous with ancient Egyptian civilization(3,4). Here we show that another spectacular megafaunal species, the giant deer or 'Irish elk', survived to around 6,900 radiocarbon yr BP (about 7,700 yr ago) in western Siberia-more than three millennia later than its previously accepted terminal date(2,5)-and therefore, that the reasons for its ultimate demise are to be sought in Holocene not Pleistocene events. Before their extinction, both giant deer and woolly mammoth underwent dramatic shifts in distribution, driven largely by climatic/vegetational changes. Their differing responses reflect major differences in ecology.	UCL, Dept Biol, London WC1E 6BT, England; Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; Univ Oxford, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3JQ, England	University of London; University College London; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Oxford	Stuart, AJ (corresponding author), UCL, Dept Biol, Mortimer St, London WC1E 6BT, England.	Tony@megafauna.freeserve.co.uk	Higham, Tom/Y-2707-2019	Higham, Tom/0000-0002-5949-598X; Lister, Adrian/0000-0002-7985-138X				Aaris-Sorensen K, 2004, BOREAS, V33, P61, DOI 10.1080/03009480310006970; BARNOSKY AD, 1986, QUATERNARY RES, V25, P128, DOI 10.1016/0033-5894(86)90049-9; BARNOSKY AD, 1985, SCIENCE, V228, P340, DOI 10.1126/science.228.4697.340; FORONOVA IV, 2001, UNITED I GEOLOGY T, V848, P243; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gonzalez S, 2000, NATURE, V405, P753, DOI 10.1038/35015668; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Guenther E., 1960, SCHRIFT NATURWISS VE, V30, P79; Guthrie RD, 2004, NATURE, V429, P746, DOI 10.1038/nature02612; Hoekstra R, 2001, PSYCHIAT RES, V103, P115, DOI 10.1016/S0165-1781(01)00282-7; Kahlke Ralf-Dietrich, 1994, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V546, P1; Kaiser K., 1999, EISZEITALTER GEGENWA, V49, P102; LISTER AM, 1994, ZOOL J LINN SOC-LOND, V112, P65, DOI 10.1111/j.1096-3642.1994.tb00312.x; Litt T, 2003, QUATERNARY SCI REV, V22, P7, DOI 10.1016/S0277-3791(02)00180-4; Markova Anastasia K., 1997, Paleontologia i Evolucio, V28-29, P5; Martin P. S., 1984, QUATERNARY EXTINCTIO, P364; MITCHELL G. F., 1949, PROC ROY IRISH ACAD SECT B, V52, P291; Moen RA, 1999, EVOL ECOL RES, V1, P235; Panova N, 1996, FOREST DEV PROCESS U, P26; PAVLOW M, 1906, MEM ACAD SCI ST PETE, V20, P1; SERIKOV YB, 2000, PALEOLITHIC MESOLITH, P351; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Stuart AJ, 2002, QUATERNARY SCI REV, V21, P1559, DOI 10.1016/S0277-3791(02)00026-4; STUART AJ, IN PRESS QUAT INT; Tzedakis PC, 1995, QUATERNARY SCI REV, V14, P967, DOI 10.1016/0277-3791(95)00042-9; VARTANYAN SL, 1993, NATURE, V362, P337, DOI 10.1038/362337a0; Vereshchagin N.K., 1984, P483; Woodman P, 1997, QUATERNARY SCI REV, V16, P129, DOI 10.1016/S0277-3791(96)00037-6; Woodman P. C, 1985, QUATERNARY HIST IREL, P251	29	222	245	1	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					684	689		10.1038/nature02890	http://dx.doi.org/10.1038/nature02890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470427				2022-12-24	WOS:000224299300039
J	Christensen, PR; Wyatt, MB; Glotch, TD; Rogers, AD; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Faracaro, A; Fergason, RL; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, AG; Johnson, JR; Knudson, AT; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Smith, MD; Squyres, SW; Ruff, SW; Wolff, MJ				Christensen, PR; Wyatt, MB; Glotch, TD; Rogers, AD; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Faracaro, A; Fergason, RL; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, AG; Johnson, JR; Knudson, AT; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Smith, MD; Squyres, SW; Ruff, SW; Wolff, MJ			Mineralogy at Meridiani Planum from the Mini-TES experiment on the Opportunity Rover	SCIENCE			English	Article							THERMAL EMISSION-SPECTROSCOPY; MARTIAN SURFACE; CRYSTALLINE HEMATITE; TERRA-MERIDIANI; SPIRIT ROVER; GUSEV CRATER; MGS-TES; MARS; ROCKS; SPECTROMETER	The Miniature Thermal Emission Spectrometer (Mini-TES) on Opportunity investigated the mineral abundances and compositions of outcrops, rocks, and soils at Meridiani Planum. Coarse crystalline hematite and olivine-rich basaltic sands were observed as predicted from orbital TES spectroscopy. Outcrops of aqueous origin are composed of 15 to 35% by volume magnesium and calcium sulfates [a high-silica component modeled as a combination of glass, feldspar, and sheet silicates (similar to20 to 30%)], and hematite; only minor jarosite is identified in Mini-TES spectra. Mini-TES spectra show only a hematite signature in the millimeter-sized spherules. Basaltic materials have more plagioclase than pyroxene, contain olivine, and are similar in inferred mineral composition to basalt mapped from orbit. Bounce rock is dominated by clinopyroxene and is close in inferred mineral composition to the basaltic martian meteorites. Bright wind streak material matches global dust. Waterlain rocks covered by unaltered basaltic sands suggest a change from an aqueous environment to one dominated by physical weathering.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Dept Geol Sci, Reno, NV 89557 USA; Univ Hawaii, Inst Geophys & Planetol, Honolulu, HI 96822 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Martinez, GA 30907 USA	Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; Cornell University; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Smith, Michael/C-8875-2012; Rogers, Deanne/I-9737-2016; Glotch, Timothy/B-6829-2008; Hayes, Alexander G/P-2024-2014; Moersch, Jeffrey E/F-7189-2010; Johnson, Jeffrey R/F-3972-2015; Rogers, A. Deanne/ABE-8469-2021	Rogers, Deanne/0000-0002-4671-2551; Hayes, Alexander G/0000-0001-6397-2630; Moersch, Jeffrey E/0000-0003-3433-9419; Johnson, Jeffrey R/0000-0002-5586-4901; Rogers, A. Deanne/0000-0002-4671-2551; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; BISHOP JL, 2001, 64 ANN MET SOC M, V36, P21; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002233; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CHRISTENSEN PR, 1993, J GEOPHYS RES-SOL EA, V98, P19819, DOI 10.1029/93JB00135; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Feely KC, 1999, J GEOPHYS RES-PLANET, V104, P24195, DOI 10.1029/1999JE001034; Glotch TD, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002224; Graff T.G., 2003, THESIS ARIZONA STATE; GREELEY R, 2001, LUNAR PLANET SCI, V32; Hamilton VE, 2000, J GEOPHYS RES-PLANET, V105, P9717, DOI 10.1029/1999JE001113; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hamilton VE, 1997, J GEOPHYS RES-PLANET, V102, P25593, DOI 10.1029/97JE01874; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Johnson JR, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001405; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001832; Lane MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017183; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MCSWEEN HY, 1983, GEOCHIM COSMOCHIM AC, V47, P1501, DOI 10.1016/0016-7037(83)90309-5; ONDRUSEK J, 1993, J GEOPHYS RES-SOL EA, V98, P15903, DOI 10.1029/93JB01559; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rogers D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001913; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VEVERKA J, 1981, ICARUS, V45, P154, DOI 10.1016/0019-1035(81)90011-7; Wyatt MB, 2004, GEOLOGY, V32, P645, DOI 10.1130/G20527.1; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	47	305	312	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1733	1739		10.1126/science.1104909	http://dx.doi.org/10.1126/science.1104909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576609				2022-12-24	WOS:000225630800041
J	Minelli, A				Minelli, A			Bits and pieces	SCIENCE			English	Editorial Material							SEGMENTATION; EXPRESSION		Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Minelli, A (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	alessandro.minelli@unipd.it		Minelli, Alessandro/0000-0003-3387-1489				Ansenne A., 1990, P125; Braun V, 2003, BIOINFORMATICS, V19, P851, DOI 10.1093/bioinformatics/btg087; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Chertenko L.P., 2003, THESIS, P190, DOI [10.13140/RG.2.2.14771.37925, DOI 10.13140/RG.2.2.14771.37925]; Holland P.W.H., 1990, Seminars in Developmental Biology, V1, P135; Jacobs DK, 2000, EVOL DEV, V2, P340, DOI 10.1046/j.1525-142x.2000.00077.x; Janssen R, 2004, DEV BIOL, V268, P89, DOI 10.1016/j.ydbio.2003.12.021; LAWRENCE PA, 1993, MAKING FLY; Minelli A, 2004, TRENDS ECOL EVOL, V19, P423, DOI 10.1016/j.tree.2004.06.007; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x	12	6	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1693	1694		10.1126/science.1098138	http://dx.doi.org/10.1126/science.1098138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576599				2022-12-24	WOS:000225630800031
J	DeFelice, LJ				DeFelice, LJ			Going against the flow	NATURE			English	Editorial Material									Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	DeFelice, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.			De Felice, Louis/0000-0002-4594-3171				DeFelice LJ, 2004, TRENDS NEUROSCI, V27, P352, DOI 10.1016/j.tins.2004.04.007; Hodgkin A. L., 1992, CHANCE DESIGN; Lauger P., 1991, ELECTROGENIC ION PUM; Stein W., 1990, CHANNELS CARRIERS PU	4	5	5	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2004	432	7015					279	279		10.1038/432279a	http://dx.doi.org/10.1038/432279a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549077	Bronze			2022-12-24	WOS:000225161400024
J	Bell, ML; McDermott, A; Zeger, SL; Samet, JM; Dominici, F				Bell, ML; McDermott, A; Zeger, SL; Samet, JM; Dominici, F			Ozone and short-term mortality in 95 US urban communities, 1987-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARTICULATE AIR-POLLUTION; TIME-SERIES; EXPOSURE; CITIES; HEALTH; MATTER; ASSOCIATIONS; METAANALYSIS; POLLUTANTS; PARTICLES	Context Ozone has been associated with various adverse health effects, including increased rates of hospital admissions and exacerbation of respiratory illnesses. Although numerous time-series studies have estimated associations between day-today variation in ozone levels and mortality counts, results have been inconclusive. Objective To investigate whether short-term (daily and weekly) exposure to ambient ozone is associated with mortality in the United States. Design and Setting Using analytical methods and databases developed for the National Morbidity, Mortality, and Air Pollution Study, we estimated a national average relative rate of mortality associated with short-term exposure to ambient ozone for 95 large US urban communities from 1987-2000. We used distributed-lag models for estimating community-specific relative rates of mortality adjusted for time-varying confounders (particulate matter, weather, seasonality, and long-term trends) and hierarchical models for combining relative rates across communities to estimate a national average relative rate, taking into account spatial heterogeneity. Main Outcome Measure Daily counts of total non-injury-related mortality and cardiovascular and respiratory mortality in 95 large US communities during a 14-year period. Results A 10-ppb increase in the previous week's ozone was associated with a 0.52% increase in daily mortality (95% posterior interval [PI], 0.27%-0.77%) and a 0.64% increase in cardiovascular and respiratory mortality (95% PI, 0.31%-0.98%). Effect estimates for aggregate ozone during the previous week were larger than for models considering only a single day's exposure. Results were robust to adjustment for particulate matter, weather, seasonality, and long-term trends. Conclusions These results indicate a statistically significant association between short-term changes in ozone and mortality on average for 95 large US urban communities, which include about 40% of the total US population. The findings indicate that this widespread pollutant adversely affects public health.	Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bell, ML (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 205 Prospect St, New Haven, CT 06511 USA.	michelle.bell@yale.edu	Bell, Michelle/Y-4608-2018	Bell, Michelle/0000-0002-3965-1359; Zeger, Scott/0000-0001-8907-1603	NIEHS NIH HHS [ES012054-01, R01 ES012054, P30 ES003819, P30 ES 03819] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, R01ES012054] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anderson H.R., 2004, METAANALYSIS TIME SE; Anderson HR, 2001, OCCUP ENVIRON MED, V58, P504, DOI 10.1136/oem.58.8.504; Bascom R, 1996, AM J RESP CRIT CARE, V153, P477, DOI 10.1164/ajrccm.153.2.8564086; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; BorjaAburto VH, 1997, AM J EPIDEMIOL, V145, P258, DOI 10.1093/oxfordjournals.aje.a009099; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Braga ALF, 2001, J OCCUP ENVIRON MED, V43, P927; Carlin B. P., 2000, C&H TEXT STAT SCI; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Dominici F, 2000, J ROY STAT SOC A STA, V163, P263, DOI 10.1111/1467-985X.00170; Dominici F, 2003, ENVIRON HEALTH PERSP, V111, P39, DOI 10.1289/ehp.5181; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Dominici F, 2002, J AM STAT ASSOC, V97, P100, DOI 10.1198/016214502753479266; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P293, DOI 10.2307/2288631; EVERSON P, 2000, 2 LEVEL NORMAL INDEP; FOLINSBEE LJ, 1994, AM J RESP CRIT CARE, V149, P98, DOI 10.1164/ajrccm.149.1.8111607; Frank R, 2001, AM J RESP CRIT CARE, V164, P1253, DOI 10.1164/ajrccm.164.7.2010043; Gelman A., 2003, BAYESIAN DATA ANAL; Goldberg MS, 2001, AM J EPIDEMIOL, V154, P817, DOI 10.1093/aje/154.9.817; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; HAAGENSMIT AJ, 1952, IND ENG CHEM, V44, P1342, DOI 10.1021/ie50510a045; HEI (Health Effects Institute), 2003, REV AN TIM SER STUD; Hoek G, 1997, ARCH ENVIRON HEALTH, V52, P455, DOI 10.1080/00039899709602224; Hong YC, 1999, ENVIRON HEALTH PERSP, V107, P873, DOI 10.2307/3454474; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Ito K, 1996, J EXPO ANAL ENV EPID, V6, P79; Kelsall JE, 1997, AM J EPIDEMIOL, V146, P750; Le Tertre A, 2002, ARCH ENVIRON HEALTH, V57, P311, DOI 10.1080/00039890209601414; Lee JT, 2000, ENVIRON RES, V84, P247, DOI 10.1006/enrs.2000.4096; Levy JI, 2001, ENVIRON HEALTH PERSP, V109, P1215, DOI 10.2307/3454743; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; LIPPMANN M, 1993, J EXPO ANAL ENV EPID, V3, P103; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; MCCULLAGH P., 1991, GEN LINEAR MODELS; *NAT CLIM DAT CTR, NCDC SURF AIRW; Prescott GJ, 1998, OCCUP ENVIRON MED, V55, P697, DOI 10.1136/oem.55.10.697; Saez M, 2002, ENVIRON HEALTH PERSP, V110, P221, DOI 10.1289/ehp.02110221; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Samet JM, 2000, NATL MORBIDITY MORTA; SAMET JM, 2000, NATL MORBIDITY MOR 1; Schwartz J., 2003, MORBIDITY MORTALITY, V20, P25; Schwarz N, 2002, PSYCHOL INQ, V13, P87; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794; Stieb DM, 2003, J AIR WASTE MANAGE, V53, P258, DOI 10.1080/10473289.2003.10466149; Thurston G.D., 1999, AIR POLLUT HLTH, P485, DOI DOI 10.1016/B978-012352335-8/50097-1; Thurston GD, 2001, J EXPO ANAL ENV EPID, V11, P286, DOI 10.1038/sj.jea.7500169; Touloumi G, 1997, AM J EPIDEMIOL, V146, P177, DOI 10.1093/oxfordjournals.aje.a009249; U.S. EPA, GREEN BOOK NON AR CR; *US EPA, 2003, 454K03001 EPA US EPA; Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279; 1997, FED REG, V62, P38855	53	826	852	11	199	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2004	292	19					2372	2378		10.1001/jama.292.19.2372	http://dx.doi.org/10.1001/jama.292.19.2372			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PL	15547165	Green Accepted, Bronze			2022-12-24	WOS:000225070100026
J	Pal, U; Li, X; Wang, T; Montgomery, RR; Ramamoorthi, N; deSilva, AM; Bao, FK; Yang, XF; Pypaert, M; Pradhan, D; Kantor, FS; Telford, S; Anderson, JF; Fikrig, E				Pal, U; Li, X; Wang, T; Montgomery, RR; Ramamoorthi, N; deSilva, AM; Bao, FK; Yang, XF; Pypaert, M; Pradhan, D; Kantor, FS; Telford, S; Anderson, JF; Fikrig, E			TROSPA, an Ixodues scapularis receptor for Borrelia burgdorferi	CELL			English	Article							LYME-DISEASE SPIROCHETE; SURFACE PROTEIN-A; TICKS; INFECTION; PATHOGENS	The Lyme disease agent Borrelia burgdorferi naturally persists in a cycle that primarily involves ticks and mammals. We have now identified a tick receptor (TROSPA) that is required for spirochetal colonization of Ixodes scapularis. B. burgdorferi outer surface protein A, which is abundantly expressed on spirochetes within the arthropod and essential for pathogen adherence to the vector, specifically bound to TROSPA. TROSPA mRNA levels in ticks increased following spirochete infestation and decreased in response to engorgement, events that are temporally linked to B. burgdorferi entry into and egress from the vector. The blockade of TROSPA by TROSPA antisera or by the repression of TROSPA expression via RNA interference reduced B. burgdorferi adherence to the L scapularis gut in vivo, thereby preventing efficient colonization of the vector and subsequently reducing pathogen transmission to the mammalian host. Identification of an I. scapularis receptor for B. burgdorferi is the first step toward elucidating arthropod ligands that are required for survival of spirochetes in nature.	Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Immunol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Harvard Univ, Sch Publ Hlth, Dept Trop Publ Hlth, Boston, MA 02115 USA; Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard T.H. Chan School of Public Health; Connecticut Agricultural Experiment Station	Fikrig, E (corresponding author), Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	Pradhan, Debabrata/W-5476-2019; Yang, X. Frank/F-3266-2010; desilva, Aravinda/ABE-6260-2020; Pal, Utpal/I-5265-2015; Li, Xin/E-3505-2011	Pradhan, Debabrata/0000-0003-4995-6882; desilva, Aravinda/0000-0003-3317-5950; Li, Xin/0000-0002-7270-3480; Montgomery, Ruth/0000-0002-8661-4454				Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MALAWISTA SE, 2000, ARTHRITIS ALLIED CON, P2321; MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U, 2001, J IMMUNOL, V166, P7398, DOI 10.4049/jimmunol.166.12.7398; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Sauer J.R.a.H., 1986, MORPHOLOGY PHYSL BIO, V1; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Sonenshine D.E, 1993, BIOL TICKS, V1; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI21681, 10.1172/JCI200421681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960	23	302	317	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					457	468		10.1016/j.cell.2004.10.027	http://dx.doi.org/10.1016/j.cell.2004.10.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537536	Bronze			2022-12-24	WOS:000225183200005
J	Tibbetts, EA; Dale, J				Tibbetts, EA; Dale, J			A socially enforced signal of quality in a paper wasp	NATURE			English	Article							INDIVIDUAL IDENTITY; PLUMAGE VARIABILITY; SPARROWS; SIZE; BADGES; COST	Organisms use signals of quality to communicate information about aspects of their relative phenotypic and genetic constitution(1-4). Badges of status(5-7) are a subset of signals of quality that reveal information about an individual's size and dominance. In general, signals of quality require high and differential costs to remain honest(1,2) (that is, prevent low-quality cheaters from exploiting any fitness benefits associated with communicating high quality). The theoretically required costs for badges of status remain controversial because the development (or 'production') of such signals often seems to be relatively cost-free(5,6,8). One important hypothesis is that such signals impose social (or 'maintenance') costs incurred through repeated agonistic interactions with other individuals(9-12). However, convincing empirical evidence for social costs remains elusive(6,7). Here we report social costs in a previously undescribed badge of status: the highly variable black facial patterns of female paper wasps, Polistes dominulus. Facial patterns strongly predict body size and social dominance. Moreover, in staged contests between pairs of unfamiliar wasps, subordinate wasps with experimentally altered facial features ('cheaters') received considerably more aggression from the dominant than did sham controls, indicating that facial patterns are signals and that dishonest signalling imposes social costs.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; Univ Arizona, Div Neurobiol, Tucson, AZ 85721 USA; Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Cornell University; University of Arizona; University of Arizona; Simon Fraser University	Tibbetts, EA (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	eat11@email.arizona.edu	Dale, James/E-7203-2011	Dale, James/0000-0001-5950-5829; Tibbetts, Elizabeth/0000-0002-5625-892X				Andersson Malte, 1994; BALPH MH, 1979, AUK, V96, P78; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; COLE BJ, 1986, BEHAV ECOL SOCIOBIOL, V18, P165, DOI 10.1007/BF00290820; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; EICKWORT KR, 1969, EVOLUTION, V23, P391, DOI 10.1111/j.1558-5646.1969.tb03523.x; Gobin B, 2003, J INSECT PHYSIOL, V49, P747, DOI 10.1016/S0022-1910(03)00111-2; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; HOLBERTON RL, 1989, ANIM BEHAV, V37, P681, DOI 10.1016/0003-3472(89)90047-X; HORRIDGE GA, 1995, J INSECT PHYSIOL, V41, P681, DOI 10.1016/0022-1910(95)00021-L; JOHNSTONE RA, 1993, BEHAV ECOL SOCIOBIOL, V32, P127, DOI 10.1007/BF00164045; McGraw KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P116, DOI 10.1007/s00265-002-0558-z; OWENS IPF, 1991, AM NAT, V138, P1187, DOI 10.1086/285277; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; Pereboom JJM, 2003, OECOLOGIA, V137, P42, DOI 10.1007/s00442-003-1324-2; Pryke SR, 2003, BEHAV ECOL SOCIOBIOL, V53, P393, DOI 10.1007/s00265-003-0587-2; Reeve H.K., 1991, P99; ROHWER S, 1975, EVOLUTION, V29, P593, DOI 10.1111/j.1558-5646.1975.tb00853.x; ROHWER S, 1978, ANIM BEHAV, V26, P1012, DOI 10.1016/0003-3472(78)90090-8; Roseler P.-F., 1991, P309; Senar JC., 1999, P INT ORNITHOLOGICAL, V22, P1669; SHIELDS WM, 1977, EVOLUTION, V31, P905, DOI 10.1111/j.1558-5646.1977.tb01086.x; Sledge MF, 2001, BEHAV ECOL SOCIOBIOL, V49, P401, DOI 10.1007/s002650000311; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Strassmann Joan E., 1996, P190; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; WATT DJ, 1986, ANIM BEHAV, V34, P1, DOI 10.1016/0003-3472(86)90001-1; WHITFIELD DP, 1987, TRENDS ECOL EVOL, V2, P13; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	30	301	309	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2004	432	7014					218	222		10.1038/nature02949	http://dx.doi.org/10.1038/nature02949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538369				2022-12-24	WOS:000225020200046
J	Lamb, NE; Hassold, TJ				Lamb, NE; Hassold, TJ			Nondisjunction - A view from ringside	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Emory University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Lamb, NE (corresponding author), Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.							Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391	2	26	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2004	351	19					1931	1934		10.1056/NEJMp048118	http://dx.doi.org/10.1056/NEJMp048118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867OG	15525719				2022-12-24	WOS:000224851300003
J	Peters, A; von Klot, S; Heier, M; Trentinaglia, I; Hormann, A; Wichmann, HE; Lowel, H				Peters, A; von Klot, S; Heier, M; Trentinaglia, I; Hormann, A; Wichmann, HE; Lowel, H		Cooperative Hlth Res Region Augsbu	Exposure to traffic and the onset of myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARTICULATE AIR-POLLUTION; HEART-RATE-VARIABILITY; HEAVY PHYSICAL EXERTION; CASE-CROSSOVER; BLOOD MARKERS; CAR DRIVERS; MORTALITY; RISK; ASSOCIATION; DISEASE	BACKGROUND: An association between exposure to vehicular traffic in urban areas and the exacerbation of cardiovascular disease has been suggested in previous studies. This study was designed to assess whether exposure to traffic can trigger myocardial infarction. METHODS: We conducted a case-crossover study in which cases of myocardial infarction were identified with the use of data from the Cooperative Health Research in the Region of Augsburg Myocardial Infarction Registry in Augsburg, in southern Germany, for the period from February 1999 to July 2001. There were 691 subjects for whom the date and time of the myocardial infarction were known who had survived for at least 24 hours after the event, completed the registry's standardized interview, and provided information on factors that may have triggered the myocardial infarction. Data on subjects' activities during the four days preceding the onset of symptoms were collected with the use of patient diaries. RESULTS: An association was found between exposure to traffic and the onset of a myocardial infarction within one hour afterward (odds ratio, 2.92; 95 percent confidence interval, 2.22 to 3.83; P<0.001). The time the subjects spent in cars, on public transportation, or on motorcycles or bicycles was consistently linked with an increase in the risk of myocardial infarction. Adjusting for the level of exercise on a bicycle or for getting up in the morning changed the estimated effect of exposure to traffic only slightly (odds ratio for myocardial infarction, 2.73; 95 percent confidence interval, 2.06 to 3.61; P<0.001). The subject's use of a car was the most common source of exposure to traffic; nevertheless, there was also an association between time spent on public transportation and the onset of a myocardial infarction one hour later. CONCLUSIONS: Transient exposure to traffic may increase the risk of myocardial infarction in susceptible persons.	GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-87564 Neuherberg, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Hlth Econ, D-87564 Neuherberg, Germany; Univ Munich, Fac Med, Dept Epidemiol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Peters, A (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Ingolstadter Landstr 1, D-87564 Neuherberg, Germany.	peters@gsf.de	Heier, Margit/AAT-5280-2020; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022	Peters, Annette/0000-0001-6645-0985; 				Adams HS, 2001, SCI TOTAL ENVIRON, V279, P29, DOI 10.1016/S0048-9697(01)00723-9; Akiyama T, 2001, NEW ENGL J MED, V345, P391, DOI 10.1056/NEJM200108093450601; BEVAN MAJ, 1991, ENVIRON SCI TECHNOL, V25, P788, DOI 10.1021/es00016a026; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; FORASTIERE F, 1994, AM J IND MED, V26, P785, DOI 10.1002/ajim.4700260607; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Ising Hartmut, 1999, Noise Health, V1, P37; Liao DP, 1999, ENVIRON HEALTH PERSP, V107, P521, DOI 10.2307/3434393; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Mittleman MA, 2001, CIRCULATION, V103, P2805; MULLER JE, 1994, J AM COLL CARDIOL, V23, P809, DOI 10.1016/0735-1097(94)90772-2; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Pekkanen J, 2000, OCCUP ENVIRON MED, V57, P818, DOI 10.1136/oem.57.12.818; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Peters A, 2001, CIRCULATION, V103, P2810; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Praml G, 2000, INT ARCH OCC ENV HEA, V73, P209, DOI 10.1007/s004200050029; Rank J, 2001, SCI TOTAL ENVIRON, V279, P131, DOI 10.1016/S0048-9697(01)00758-6; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schwartz J, 2001, ENVIRON HEALTH PERSP, V109, P405, DOI 10.2307/3434788; VANWIJNEN JH, 1995, INT ARCH OCC ENV HEA, V67, P187, DOI 10.1007/BF00626351; Verrier Richard L., 1996, Cardiology Clinics, V14, P289; Williams JE, 2000, CIRCULATION, V101, P2034, DOI 10.1161/01.CIR.101.17.2034; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; [No title captured]	38	688	705	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1721	1730		10.1056/NEJMoa040203	http://dx.doi.org/10.1056/NEJMoa040203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15496621				2022-12-24	WOS:000224585200007
J	Lederman, MM; Veazey, RS; Offord, R; Mosier, DE; Dufour, J; Mefford, M; Piatak, M; Lifson, JD; Salkowitz, JR; Rodriguez, B; Blauvelt, A; Hartley, O				Lederman, MM; Veazey, RS; Offord, R; Mosier, DE; Dufour, J; Mefford, M; Piatak, M; Lifson, JD; Salkowitz, JR; Rodriguez, B; Blauvelt, A; Hartley, O			Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; HIV-1 INFECTION; PRIMATE LENTIVIRUSES; LANGERHANS CELLS; RANTES ANALOGS; DC-SIGN; CORECEPTOR; INTERNALIZATION; RESISTANCE; RECEPTORS	Topical agents, such as microbicides, that can protect against human immunodeficiency virus (HIV) transmission are urgently needed. Using a chimeric simian/human immunodeficiency virus (SHIV SF162), which is tropic for the chemokine receptor CCR5, we report that topical application of high doses of PSC-RANTES, an amino terminus-modified analog of the chemokine RANTES, provided potent protection against vaginal challenge in rhesus macaques. These experimental findings have potentially important implications for understanding vaginal transmission of HIV and the design of strategies for its prevention.	Case Western Reserve Univ, Univ Hosp, Dept Med, Cleveland, OH 44106 USA; Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; Univ Geneva, Fac Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva 4, Switzerland; Scripps Res Inst, La Jolla, CA 92037 USA; NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD 21702 USA; NCI, Dermatol Branch, Bethesda, MD 20892 USA	Case Western Reserve University; University Hospitals of Cleveland; Tulane University; University of Geneva; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lederman, MM (corresponding author), Case Western Reserve Univ, Univ Hosp, Dept Med, 2061 Cornell Rd, Cleveland, OH 44106 USA.	MXL6@case.edu	Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; Mefford, Megan/0000-0003-4441-7134	NCI NIH HHS [N01-CO-124000] Funding Source: Medline; NIAID NIH HHS [AI 51649, AI 36219] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051649, P30AI036219] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Davis CW, 2004, J EXP MED, V199, P1037, DOI 10.1084/jem.20040426; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; HARTLEY O, UNPUB; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; MOSIER DE, UNPUB; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Sabbe R, 2001, J VIROL, V75, P661, DOI 10.1128/JVI.75.2.661-671.2001; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; VEAZEY RS, UNPUB; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	33	304	324	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					485	487		10.1126/science.1099288	http://dx.doi.org/10.1126/science.1099288			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486300				2022-12-24	WOS:000224626500053
J	McClure, SM; Laibson, DI; Loewenstein, G; Cohen, JD				McClure, SM; Laibson, DI; Loewenstein, G; Cohen, JD			Separate neural systems value immediate and delayed monetary rewards	SCIENCE			English	Article							FMRI; PREDICTION; BRAIN; ANTICIPATION; CIRCUITRY; TIME	When humans are offered the choice between rewards available at different points in time, the relative values of the options are discounted according to their expected delays until delivery. Using functional magnetic resonance imaging, we examined the neural correlates of time discounting while subjects made a series of choices between monetary reward options that varied by delay to delivery. We demonstrate that two separate systems are involved in such decisions. Parts of the limbic system associated with the midbrain dopamine system, including paralimbic cortex, are preferentially activated by decisions involving immediately available rewards. In contrast, regions of the lateral prefrontal. cortex and posterior parietal cortex are engaged uniformly by intertemporal choices irrespective of delay. Furthermore, the relative engagement of the two systems is directly associated with subjects' choices, with greater relative fronto-parietal activity when subjects choose longer term options.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Harvard University; National Bureau of Economic Research; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McClure, SM (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	smcclure@princeton.edu	Loewenstein, George/G-7616-2014; Laibson, David/AAA-7362-2022	Loewenstein, George/0000-0003-2790-0474; 	NIA NIH HHS [AG05842] Funding Source: Medline; NIMH NIH HHS [MH065214, MH132804] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG005842] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Ainslie G., 1992, PICOECONOMICS; Angeletos GM, 2001, J ECON PERSPECT, V15, P47, DOI 10.1257/jep.15.3.47; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benabou R, 2002, ECON LETT, V77, P419, DOI 10.1016/S0165-1765(02)00158-1; BIEDERMAN J, 2002, J ATTEN DISORD, V6, pS1; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Elster J, 1979, ULYSSES SIRENS STUDI; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Giordano LA, 2002, PSYCHOPHARMACOLOGY, V163, P174, DOI 10.1007/s00213-002-1159-2; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HOEBEL BG, 1985, AM J CLIN NUTR, V42, P1133, DOI 10.1093/ajcn/42.5.1133; Kagel John H., 1995, EC CHOICE THEORY EXP; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; KOOPMANS TC, 1964, ECONOMETRICA, V32, P82, DOI 10.2307/1913736; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; MACMILLAN M, 1992, BRAIN COGNITION, V19, P72, DOI 10.1016/0278-2626(92)90038-N; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; PHELPS ES, 1968, REV ECON STUD, V35, P185, DOI 10.2307/2296547; Rachlin H., 2004, SCI SELF CONTROL, DOI 10.4159/9780674042513; RACHLIN H, 1989, JUDGMENT DECISION CH, pCH7; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHEFRIN HM, 1988, ECON INQ, V26, P609, DOI 10.1111/j.1465-7295.1988.tb01520.x; Smith A., 1984, THEORY MORAL SENTIME; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	41	1889	1946	17	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					503	507		10.1126/science.1100907	http://dx.doi.org/10.1126/science.1100907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486304				2022-12-24	WOS:000224626500058
J	Leman, L; Orgel, L; Ghadiri, MR				Leman, L; Orgel, L; Ghadiri, MR			Carbonyl sulfide-mediated prebiotic formation of peptides	SCIENCE			English	Article							AQUEOUS MEDIUM; AMINO-ACIDS; POLYPHOSPHATES; POLYMERIZATION; ROCKS	Almost all discussions of prebiotic chemistry assume that amino acids, nucleotides, and possibly other monomers were first formed on the Earth or brought to it in comets and meteorites, and then condensed nonenzymatically to form oligomeric products. However, attempts to demonstrate plausibly prebiotic polymerization reactions have met with limited success. We show that carbonyl sulfide (COS), a simple volcanic gas, brings about the formation of peptides from amino acids under mild conditions in aqueous solution. Depending on the reaction conditions and additives used, exposure of alpha-amino acids to COS generates peptides in yields of up to 80% in minutes to hours at room temperature.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Biol Chem, La Jolla, CA 92037 USA; Salk Inst Biol Studies, San Diego, CA 92186 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu		Leman, Luke/0000-0002-1879-5900				Biron JP, 2004, J AM CHEM SOC, V126, P9198, DOI 10.1021/ja048189s; BUNINGH WC, 1970, Patent No. 3507613; DEWEY RS, 1971, J ORG CHEM, V36, P49; FERM RJ, 1957, CHEM REV, V57, P621, DOI 10.1021/cr50016a002; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HERRINGTON DR, 1986, Patent No. 4618723; Hill AR, 1998, ORIGINS LIFE EVOL B, V28, P235; HIRSCHMA.R, 1967, J ORG CHEM, V32, P3415, DOI 10.1021/jo01286a030; Huber C, 2003, SCIENCE, V301, P938, DOI 10.1126/science.1086501; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Kasting James F., 1998, P35; Keefe AD, 1996, ORIGINS LIFE EVOL B, V26, P111, DOI 10.1007/BF01809851; Liu RH, 1997, NATURE, V389, P52, DOI 10.1038/37944; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; RABINOWI.J, 1969, NATURE, V224, P795, DOI 10.1038/224795a0; SYMONDS RB, 1994, REV MINERAL, V30, P1; *US EPA, PUBL EPA; YAMAGATA Y, 1991, NATURE, V352, P516, DOI 10.1038/352516a0	18	257	267	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					283	286		10.1126/science.1102722	http://dx.doi.org/10.1126/science.1102722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	861MC	15472077				2022-12-24	WOS:000224419700042
J	Roth, J				Roth, J			Spectre of Noah - "Tell me a story!"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jesserothmd@hotmail.com							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1530	1530		10.1001/jama.292.13.1530	http://dx.doi.org/10.1001/jama.292.13.1530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467040				2022-12-24	WOS:000224254600001
J	Kusch, T; Florens, L; MacDonald, WH; Swanson, SK; Glaser, RL; Yates, JR; Abmayr, SM; Washburn, MP; Workman, JL				Kusch, T; Florens, L; MacDonald, WH; Swanson, SK; Glaser, RL; Yates, JR; Abmayr, SM; Washburn, MP; Workman, JL			Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions	SCIENCE			English	Article							ACETYLTRANSFERASE COMPLEX; REPAIR; CHROMATIN; DAMAGE; NUCLEOSOME; H2A; APOPTOSIS; YEAST	Phosphorylation of the human histone variant H2A.X and H2Av, its homolog in Drosophila melanogaster, occurs rapidly at sites of DNA double-strand breaks. Little is known about the function of this phosphorylation or its removal during DNA repair. Here, we demonstrate that the Drosophila Tip60 (dTip60) chromatin-remodeling complex acetylates nucleosomal phospho-H2Av and exchanges it with an unmodified H2Av. Both the histone a cetyltransfe rase dTip60 as well as the adenosine triphosphatase Domino/p400 catalyze the exchange of phospho-H2Av. Thus, these data reveal a previously unknown mechanism for selective histone exchange that uses the concerted action of two distinct chromatin-remodeling enzymes within the same multiprotein complex.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	Stowers Institute for Medical Research; Scripps Research Institute; State University of New York (SUNY) System; Wadsworth Center	Kusch, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tnk@stowers-institute.org; jlw@stowers-institute.org		Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Allard S, 2004, BBA-GENE STRUCT EXPR, V1677, P158, DOI 10.1016/j.bbaexp.2003.10.016; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; KUSCH T, UNPUB; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Scherthan H, 2003, CYTOGENET GENOME RES, V103, P235, DOI 10.1159/000076809; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Wang Yanming, 2004, Novartis Found Symp, V259, P3	28	519	544	5	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2084	2087		10.1126/science.1103455	http://dx.doi.org/10.1126/science.1103455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15528408				2022-12-24	WOS:000225841000060
J	Flo, TH; Smith, KD; Sato, S; Rodriguez, DJ; Holmes, MA; Strong, RK; Akira, S; Aderem, A				Flo, TH; Smith, KD; Sato, S; Rodriguez, DJ; Holmes, MA; Strong, RK; Akira, S; Aderem, A			Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron	NATURE			English	Article							HUMAN NEUTROPHIL GELATINASE; ACUTE-PHASE PROTEIN; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION; MOUSE; ACQUISITION; UTEROCALIN; NGAL	Although iron is required to sustain life, its free concentration and metabolism have to be tightly regulated(1). This is achieved through a variety of iron-binding proteins including transferrin and ferritin(2). During infection, bacteria acquire much of their iron from the host by synthesizing siderophores that scavenge iron and transport it into the pathogen(3,4). We recently demonstrated that enterochelin, a bacterial catecholate siderophore, binds to the host protein lipocalin 2 (ref. 5). Here, we show that this event is pivotal in the innate immune response to bacterial infection. Upon encountering invading bacteria the Toll-like receptors on immune cells stimulate the transcription, translation and secretion of lipocalin 2; secreted lipocalin 2 then limits bacterial growth by sequestrating the iron-laden siderophore. Our finding represents a new component of the innate immune system and the acute phase response to infection.	Inst Syst Biol, Seattle, WA 98103 USA; Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7489 Trondheim, Norway; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Japan Sci & Technol Corp, ERATO, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Institute for Systems Biology (ISB); Norwegian University of Science & Technology (NTNU); University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST); Osaka University; Fred Hutchinson Cancer Center	Aderem, A (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	aaderem@systemsbiology.org	Flo, Trude Helen/E-1311-2013; Akira, Shizuo/C-3134-2009	Flo, Trude Helen/0000-0002-2569-0381; Sato, Shintaro/0000-0001-5156-3354				Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FLOWER DR, 1991, BIOCHEM BIOPH RES CO, V180, P69, DOI 10.1016/S0006-291X(05)81256-2; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hou ZG, 1997, INORG CHIM ACTA, V263, P341, DOI 10.1016/S0020-1693(97)05664-8; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu QS, 1997, MOL REPROD DEV, V46, P507, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;507::AID-MRD9&gt;3.0.CO;2-S; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Suire S, 2001, BIOCHEM J, V356, P369, DOI 10.1042/0264-6021:3560369; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	24	1276	1328	5	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					917	921		10.1038/nature03104	http://dx.doi.org/10.1038/nature03104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15531878				2022-12-24	WOS:000225733500057
J	Egan, KM; Lawson, JA; Fries, S; Koller, B; Rader, DJ; Smyth, EM; FitzGerald, GA				Egan, KM; Lawson, JA; Fries, S; Koller, B; Rader, DJ; Smyth, EM; FitzGerald, GA			COX-2-derived prostacyclin confers atheroprotection on female mice	SCIENCE			English	Article							NITRIC-OXIDE; IN-VIVO; ATHEROSCLEROSIS; DEFICIENT; ROLES; 17-BETA-ESTRADIOL; CYCLOOXYGENASE-2; SUPEROXIDE; LACKING	Female gender affords relative protection from cardiovascular disease until the menopause. We report that estrogen acts on estrogen receptor subtype alpha to up-regulate the production of atheroprotective prostacyclin, PGI(2), by activation of cyclooxygenase 2 (COX-2). This mechanism restrained both oxidant stress and platelet activation that contribute to atherogenesis in female mice. Deletion of the PGI(2) receptor removed the atheroprotective effect of estrogen in ovariectomized female mice. This suggests that chronic treatment of patients with selective inhibitors of COX-2 could undermine protection from cardiovascular disease in premenopausal females.	Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010		NHLBI NIH HHS [HL62250, HL70128] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL070128, P01HL062250] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akarasereenont P, 2000, INFLAMM RES, V49, P460, DOI 10.1007/s000110050617; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; COLLINS P, 1995, CIRCULATION, V92, P24, DOI 10.1161/01.CIR.92.1.24; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; GODSLAND IF, 1987, AM HEART J, V114, P1467, DOI 10.1016/0002-8703(87)90552-7; GRYGLEWSKI RJ, 1995, ANN NY ACAD SCI, V748, P194; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; KOWALA MC, 1993, ARTERIOSCLER THROMB, V13, P435, DOI 10.1161/01.ATV.13.3.435; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; SINZINGER H, 1979, THROMB HAEMOSTASIS, V42, P803; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; ZHONGHUA Q, 2002, J CLIN INVEST, V110, P61; ZHONGHUA Q, 2002, J CLIN INVEST, V110, P1	22	336	369	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1954	1957		10.1126/science.1103333	http://dx.doi.org/10.1126/science.1103333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15550624				2022-12-24	WOS:000225695600050
J	De Wals, P; Deceuninck, G; Boulianne, N; De Serres, G				De Wals, P; Deceuninck, G; Boulianne, N; De Serres, G			Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	11th International Congress on Infectious Diseases	MAR 04-07, 2004	Cancun, MEXICO				DISEASE	Context Meningococcal polysaccharide vaccines are of limited effectiveness. New protein-polysaccharide conjugate vaccines have yet to be evaluated in field conditions. Objective To assess the effectiveness of a serogroup C conjugate meningococcal vaccine in an outbreak setting. Design, Setting, and Participants Population-based observational study of cases of invasive serogroup C meningococcal disease from 1996 through 2002 in Quebec identified from the provincial registry of notifiable diseases and from the provincial reference laboratory. In 2001, a mass immunization campaign with a conjugate vaccine was conducted to control an emerging epidemic. The number of vaccinated individuals was extracted from meningococcal immunization registries. Main Outcome Measures Incidence of invasive meningococcal disease before and 1 year after the campaign in vaccinated and unvaccinated individuals. Results Vaccination coverage of those 2 months to 20 years was 82.1%. After the campaign, the number of cases of serogroup C disease decreased from 58 in 2001 to 27 in 2002, and the incidence from 7.8 per million to 3.6 per million. Vaccine effectiveness was found to be 96.8% (95% confidence interval, 75.0%-99.9%). There was no observed increase in the incidence of the other serogroups. Conclusion The new conjugate vaccine was effective in controlling an emerging epidemic of serogroup C meningococcal disease, as well as providing short-term protection across a wide age range.	Univ Laval, Dept Prevent & Social Med, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Quebec Natl Publ Hlth Inst, Quebec City, PQ G1K 7P4, Canada; Univ Quebec, Ctr Hosp, Publ Hlth Res Unit, Quebec City, PQ, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); Laval University; Laval University; University of Quebec	De Wals, P (corresponding author), Univ Laval, Dept Prevent & Social Med, Pavillon Est,2180 Chemin St Foy, Quebec City, PQ G1K 7P4, Canada.	Philippe.De.Wals@ssss.gouv.qc.ca						ASHTON FE, 1991, J CLIN MICROBIOL, V29, P2489, DOI 10.1128/JCM.29.11.2489-2493.1991; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Bose A, 2003, LANCET, V361, P675, DOI 10.1016/S0140-6736(03)12563-9; *CYTEL SOFTW CORP, 1999, STATXACT 4 WIND; De Wals P, 2001, JAMA-J AM MED ASSOC, V285, P177, DOI 10.1001/jama.285.2.177; DeWals P, 1996, B WORLD HEALTH ORGAN, V74, P407; DEWALS P, 2004, P 44 INT C ANT AG CH; FARRINGTON P, 2001, MENINGOCOCCAL VACCIN; Lavigne P, 1992, Can Commun Dis Rep, V18, P113; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; *MIN SANT SERV SOC, 1994, PROT IINT INF MEN; *NAT ADV COMM IMM, 2001, CAN COMMUN DIS REP, V27, P2; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Rivest D, 1999, CAN J PUBLIC HEALTH, V90, P250, DOI 10.1007/BF03404126; Squires S G, 2004, Can Commun Dis Rep, V30, P17; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tsang RSW, 2003, CAN J MICROBIOL, V49, P633, DOI 10.1139/W03-074	17	71	73	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2004	292	20					2491	2494		10.1001/jama.292.20.2491	http://dx.doi.org/10.1001/jama.292.20.2491			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	873TD	15562128	Bronze			2022-12-24	WOS:000225303000024
J	Fox, CS; Coady, S; Sorlie, PD; Levy, D; Meigs, JB; D'Agostino, RB; Wilson, PWF; Savage, PJ				Fox, CS; Coady, S; Sorlie, PD; Levy, D; Meigs, JB; D'Agostino, RB; Wilson, PWF; Savage, PJ			Trends in cardiovascular complications of diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; UNITED-STATES; DEATH CERTIFICATES; TEMPORAL TRENDS; SEX-DIFFERENCES; MEDICAL-CARE; EVENT RATES; US ADULTS; MORTALITY	Context Despite reductions in cardiovascular disease (CVD) mortality over the past few decades, it is unclear whether adults with and without diabetes have experienced similar declines in CVD risk. Objective To determine whether adults with and without diabetes experienced similar declines in incident CVD in 1950-1995. Design, Setting, and Participants Participants aged 45-64 years from the Framingham Heart Study original and offspring cohorts who attended examinations in 1950-1966 ("earlier" time period; 4118 participants, 113 with diabetes) and 1977-1995 ("later" time period; 4063 participants, 317 with diabetes). Incidence rates of CVD among those with and without diabetes were compared between the earlier and later periods. Main Outcome Measures Myocardial infarction, coronary heart disease death, and stroke. Results Among participants with diabetes, the age- and sex-adjusted CVD incidence rate was 286.4 per 10000 person-years in the earlier period and 146.9 per 10000 in the later period, a 49.3% (95% confidence interval [Cl], 16.7%-69.4%) decline. Among participants without diabetes, the age- and sex-adjusted incidence rate was 84.6 per 10000 person-years in the earlier period and 54.3 per 10000 person-years in the later period, a 35.4% (95% Cl, 25.3%-45.4%) decline. Hazard ratios for diabetes as a predictor of incident CVD were not different in the earlier vs later periods. Conclusions We report a 50% reduction in the rate of incident CVD events among adults with diabetes, although the absolute risk of CVD is 2-fold greater than among persons without diabetes. Adults with and without diabetes have benefited similarly during the decline in CVD rates over the last several decades. More aggressive treatment of CVD risk factors and further research on diabetes-specific factors contributing to CVD, risk are needed to further reduce the high absolute risk of CVD still experienced by persons with diabetes.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Endocrinol Diabet & Hypertens, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Med Univ S Carolina, Dept Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Boston University; Medical University of South Carolina	Fox, CS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	foxca@nhlbi.nih.gov	Meigs, James/P-3927-2019; Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Meigs, James/0000-0002-2439-2657; Levy, Daniel/0000-0003-1843-8724	NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDRESEN EM, 1993, AM J PUBLIC HEALTH, V83, P1021, DOI 10.2105/AJPH.83.7.1021; [Anonymous], 2001, SAS STAT US GUID VER; BILD DE, 1992, J CLIN EPIDEMIOL, V45, P275, DOI 10.1016/0895-4356(92)90087-4; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; CUPPLES LA, 1987, NIH PUBLICATION; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2000, LANCET, V355, P253; GILLUM RF, 1983, NEW ENGL J MED, V309, P1353, DOI 10.1056/NEJM198312013092203; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Guidry UC, 1999, CIRCULATION, V100, P2054, DOI 10.1161/01.CIR.100.20.2054; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; LIAO YL, 1993, DIABETES CARE, V16, P708, DOI 10.2337/diacare.16.5.708; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lotufo PA, 2001, ARCH INTERN MED, V161, P242, DOI 10.1001/archinte.161.2.242; Lundberg V, 1997, J INTERN MED, V241, P485; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Salomaa V, 1996, CIRCULATION, V94, P3130, DOI 10.1161/01.CIR.94.12.3130; SHURTLEFF D, 1973, DHEW PUBLICATION NIH; Sievers ML, 1996, DIABETES CARE, V19, P107, DOI 10.2337/diacare.19.2.107; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; 1992, MMWR MORB MORTAL WKL, V41, P556; 1997, MMWR MORB MORTAL WKL, V46, P146; 2003, MMWR MORB MORTAL WKL, V52, P1065; 1992, MMWR MORB MORTAL WKL, V41, P548	45	416	440	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2004	292	20					2495	2499		10.1001/jama.292.20.2495	http://dx.doi.org/10.1001/jama.292.20.2495			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873TD	15562129				2022-12-24	WOS:000225303000025
J	Braine, J; Herpin, F				Braine, J; Herpin, F			Molecular hydrogen beyond the optical edge of an isolated spiral galaxy	NATURE			English	Article							MILKY-WAY; GAS; CLOUDS; NGC-4414; ANATOMY; REGIONS; DUST; DISK; M31	Knowledge about the outermost portions of galaxies is limited owing to the small amount of light coming from them. It is known that in many cases atomic hydrogen (H I) extends well beyond the optical radius(1). In the centres of galaxies, however, molecular hydrogen (H-2) usually dominates by a large factor(2-4), raising the question of whether H-2 is also abundant in the outer regions. Here we report the detection of emission from carbon monoxide (CO), the most abundant tracer of H-2, beyond the optical radius of the nearby galaxy NGC 4414. The host molecular clouds probably formed in the regions of relatively high H I column density and in the absence of spiral density waves. The relative strength of the lines from the two lowest rotational levels indicates that both the temperature and density of the H-2 are quite low compared to conditions closer to the centre. The inferred surface density of the molecular material continues the monotonic decrease from the inner regions. We conclude that although molecular clouds can form in the outer region of this galaxy, there is little mass associated with them.	Observ Bordeaux, CNRS, UMR 5804, INSU, F-33270 Floirac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Braine, J (corresponding author), Observ Bordeaux, CNRS, UMR 5804, INSU, BP 89, F-33270 Floirac, France.	braine@obs.u-bordeaux1.fr						Blitz L, 1999, ASTROPHYS J, V514, P818, DOI 10.1086/306963; BRAINE J, 1993, ASTRON ASTROPHYS SUP, V97, P887; BRAINE J, 1993, ASTRON ASTROPHYS, V280, P451; Braine J, 1997, ASTRON ASTROPHYS, V318, P19; Braun R, 1997, ASTROPHYS J, V484, P637, DOI 10.1086/304346; CASERTANO S, 1991, ASTRON J, V101, P1231, DOI 10.1086/115759; COMBES F, 1991, ANNU REV ASTRON ASTR, V29, P195, DOI 10.1146/annurev.aa.29.090191.001211; Cuillandre JC, 2001, ASTROPHYS J, V554, P190, DOI 10.1086/321358; DICKEY JM, 1993, ASTROPHYS J, V405, P153, DOI 10.1086/172348; DICKMAN RL, 1986, ASTROPHYS J, V309, P326, DOI 10.1086/164604; DIGEL S, 1994, ASTROPHYS J, V422, P92, DOI 10.1086/173706; Engargiola G, 2003, ASTROPHYS J SUPPL S, V149, P343, DOI 10.1086/379165; Heyer MH, 1998, ASTROPHYS J, V502, P265, DOI 10.1086/305881; PFENNIGER D, 1994, ASTRON ASTROPHYS, V285, P94; POGGE RW, 1989, ASTROPHYS J SUPPL S, V71, P433, DOI 10.1086/191381; Sodroski TJ, 1997, ASTROPHYS J, V480, P173, DOI 10.1086/303961; Spitzer L., 1978, PHYS PROCESSES INTER, V333; Thornley MD, 1996, ASTROPHYS J, V469, pL45, DOI 10.1086/310250; van Zee L, 1998, ASTRON J, V116, P2805, DOI 10.1086/300647; YOUNG JS, 1991, ANNU REV ASTRON ASTR, V29, P581, DOI 10.1146/annurev.aa.29.090191.003053	20	27	27	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2004	432	7015					369	371		10.1038/nature03054	http://dx.doi.org/10.1038/nature03054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549098				2022-12-24	WOS:000225161400048
J	Murray, AJ; Anderson, RE; Watson, GC; Radda, GK; Clarke, K				Murray, AJ; Anderson, RE; Watson, GC; Radda, GK; Clarke, K			Uncoupling proteins in human heart	LANCET			English	Article								Abnormal energetic activity in heart failure correlates inversely with plasma free-fatty-acid concentrations. However, the link between energetic and metabolic abnormalities is unknown. To investigate this association, we obtained blood samples from 39 patients undergoing coronary artery bypass graft surgery. Patients fasted overnight before samples were taken. When plasma free-fatty-acid concentrations were raised, cardiac mitochondrial uncoupling proteins (UCP) increased (isoform UCP2, p<0.0001; isoform UCP3, p=0.0036) and those of glucose transporter (GLUT4) protein decreased (cardiac, p=0.0001; skeletal muscle, p=0.0006). Consequently, energy deficiency in heart failure might result from increased mitochondrial UCPs (ie, less efficient ATP synthesis) and depleted GLUT4 (ie, reduced glucose uptake). New treatment to correct these energy defects would be to simultaneously lower plasma free fatty acids and provide an alternative energy source.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Karolinska Hosp, Dept Cardiothorac Anesthesia & Intens Care, S-10401 Stockholm, Sweden	University of Oxford; Karolinska Institutet; Karolinska University Hospital	Clarke, K (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	Kieran.Clarke@physiol.ox.ac.uk	Murray, Andrew/B-3130-2010	Murray, Andrew/0000-0002-0929-9315	British Heart Foundation [PS/02/002/14893] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Neubauer S, 1997, CIRCULATION, V96, P2190; Scheuermann-Freestone M, 2003, CIRCULATION, V107, P3040, DOI 10.1161/01.CIR.0000072789.89096.10; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; van Bilsen M, 2002, MOL CELL BIOCHEM, V239, P131, DOI 10.1023/A:1020553428294	5	227	237	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2004	364	9447					1786	1788		10.1016/S0140-6736(04)17402-3	http://dx.doi.org/10.1016/S0140-6736(04)17402-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PQ	15541452				2022-12-24	WOS:000225070600032
J	Driskell, AC; Ane, C; Burleigh, JG; McMahon, MM; O'Meara, BC; Sanderson, MJ				Driskell, AC; Ane, C; Burleigh, JG; McMahon, MM; O'Meara, BC; Sanderson, MJ			Prospects for building the tree of life from large sequence databases	SCIENCE			English	Article							GENE TREES; MISSING DATA; MITOCHONDRIAL; PHYLOGENY	We assess the phylogenetic potential of similar to300,000 protein sequences sampled from Swiss-Prot and GenBank. Although only a small subset of these data was potentially phylogenetically informative, this subset retained a substantial fraction of the original taxonomic diversity. Sampling biases in the databases necessitate building phylogenetic data sets that have large numbers of missing entries. However, an analysis of two "supermatrices" suggests that even data sets with as much as 92% missing data can provide insights into broad sections of the tree of life.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Driskell, AC (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	acdriskell@ucdavis.edu		O'Meara, Brian/0000-0002-0337-5997; Ane, Cecile/0000-0002-4702-8217				ALEXE G, 2002, 200252 DIMACS; Arvestad L, 2003, BIOINFORMATICS, V19, pi7, DOI 10.1093/bioinformatics/btg1000; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Bininda-Emonds O R, 2001, Pac Symp Biocomput, P547; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; DONDOSHANSKY I, 2002, BLASTCLUST VERS 6 1; Duvall MR, 2004, MOL PHYLOGENET EVOL, V30, P97, DOI 10.1016/S1055-7903(03)00187-8; Erdos PL, 1999, RANDOM STRUCT ALGOR, V14, P153, DOI 10.1002/(SICI)1098-2418(199903)14:2<153::AID-RSA3>3.0.CO;2-R; FELSENSTEIN J, 1981, BIOL J LINN SOC, V16, P183, DOI 10.1111/j.1095-8312.1981.tb01847.x; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Kim J, 2001, Pac Symp Biocomput, P571; Kim JH, 1996, SYST BIOL, V45, P363, DOI 10.2307/2413570; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Page RDM, 2000, MOL PHYLOGENET EVOL, V14, P89, DOI 10.1006/mpev.1999.0676; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sanderson MJ, 2003, TRENDS PLANT SCI, V8, P374, DOI 10.1016/S1360-1385(03)00165-1; Sanderson MJ, 2003, MOL BIOL EVOL, V20, P1036, DOI 10.1093/molbev/msg115; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Soltis DE, 1997, ANN MO BOT GARD, V84, P1, DOI 10.2307/2399952; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Zardoya R, 1998, MOL BIOL EVOL, V15, P506, DOI 10.1093/oxfordjournals.molbev.a025950	24	199	206	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1172	1174		10.1126/science.1102036	http://dx.doi.org/10.1126/science.1102036			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539599				2022-12-24	WOS:000225193100045
J	Lu, XW; le Noble, F; Yuan, L; Jiang, QJ; de Lafarge, B; Sugiyama, D; Breant, C; Claes, F; De Smet, F; Thomas, JL; Autiero, M; Carmeliet, P; Tessier-Lavigne, M; Eichmann, A				Lu, XW; le Noble, F; Yuan, L; Jiang, QJ; de Lafarge, B; Sugiyama, D; Breant, C; Claes, F; De Smet, F; Thomas, JL; Autiero, M; Carmeliet, P; Tessier-Lavigne, M; Eichmann, A			The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system	NATURE			English	Article							C-ELEGANS; ENDOTHELIAL-CELLS; CARDIOVASCULAR DEVELOPMENT; BRANCHING MORPHOGENESIS; EXPRESSION PATTERNS; AXON OUTGROWTH; MUTANT MICE; DCC; FAMILY; UNC-5	Blood vessels and nerves are complex, branched structures that share a high degree of anatomical similarity. Guidance of vessels and nerves has to be exquisitely regulated to ensure proper wiring of both systems. Several regulators of axon guidance have been identified and some of these are also expressed in endothelial cells; however, the extent to which their guidance functions are conserved in the vascular system is still incompletely understood. We show here that the repulsive netrin receptor UNC5B is expressed by endothelial tip cells of the vascular system. Disruption of the Unc5b gene in mice, or of Unc5b or netrin-1a in zebrafish, leads to aberrant extension of endothelial tip cell filopodia, excessive vessel branching and abnormal navigation. Netrin-1 causes endothelial filopodial retraction, but only when UNC5B is present. Thus, UNC5B functions as a repulsive netrin receptor in endothelial cells controlling morphogenesis of the vascular system.	Coll France, INSERM, U36, F-75005 Paris, France; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Univ Paris 06, CNRS, UMR 7622, F-75252 Paris, France; Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Univ Paris 06, Hop La Pitie Salpetriere, INSERM,U495, IFR Neurosci, F-75651 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Howard Hughes Medical Institute; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Tessier-Lavigne, M (corresponding author), Coll France, INSERM, U36, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	tessier-lavigne.marc@gene.com; anne.eichmann@college-de.france.fr	le Noble, Ferdinand/L-7867-2017; Carmeliet, Peter/AAQ-5140-2020; De Smet, Frederik/Q-7808-2016	Carmeliet, Peter/0000-0001-7961-1821; De Smet, Frederik/0000-0002-6669-3335				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Barrett C, 2001, MECH DEVELOP, V106, P163, DOI 10.1016/S0925-4773(01)00415-4; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cohen-Cory S, 2002, NAT NEUROSCI, V5, P926, DOI 10.1038/nn1002-926; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Moyon D, 2001, DEVELOPMENT, V128, P3359; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Wang H, 1999, J NEUROSCI, V19, P4938; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Yuan L, 2002, DEVELOPMENT, V129, P4797	48	388	420	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	2004	432	7014					179	186		10.1038/nature03080	http://dx.doi.org/10.1038/nature03080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15510105				2022-12-24	WOS:000225020200036
J	Moscicki, AB; Shiboski, S; Hills, NK; Powell, KJ; Jay, N; Hanson, EN; Miller, S; Canjura-Clayton, LK; Farhat, S; Broering, JM; Darragh, TM				Moscicki, AB; Shiboski, S; Hills, NK; Powell, KJ; Jay, N; Hanson, EN; Miller, S; Canjura-Clayton, LK; Farhat, S; Broering, JM; Darragh, TM			Regression of low-grade squamous intra-epithelial lesions in young women	LANCET			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL DYSPLASIA; NATURAL-HISTORY; SEXUAL FACTORS; NEOPLASIA; COHORT; RISK; ADOLESCENT; DISEASE; AGE	Background The aim of this study was to assess the probability of low-grade squamous intra-epithelial lesion (LSIL) regression in young women, and to examine the factors associated with this regression. Methods In a longitudinal study of human papilloma virus (HPV) infection, female adolescents aged 13-22 years were examined every 4 months by cytology, colposcopy, and HPV DNA status. Both prevalent and incident LSIL cases were included in the analysis, with regression defined as at least three consecutive normal Pap smears. Findings Median follow-up time from baseline (defined as the time of first LSIL diagnosis) for the 187 women with LSIL was 61 months (IQR 34-80). Median time they had been sexually active at diagnosis was 3.2 years (2.6-6.5). Probability of regression for the entire cohort was 61% (95% Cl 53-70) at 12 months and 91% (84-99) at 36 months of follow-up. No associations were found between LSIL regression and HPV status at baseline, sexual behaviour, contraceptive use, substance or cigarette use, incident sexually transmitted infection, or biopsy. Multivariate analysis showed that only HPV status at the current visit was associated with rate of regression, whether infection was caused by one or more viral types (relative hazard=0.3 [95% Cl 0.21-0.42], and 0.14 [0.08-0.25], respectively). Interpretation The high rate of regression recorded in this study lends support to observation by cytology in the management of LSIL in female adolescents. Negative HPV status was associated with regression, suggesting that HPV testing could be helpful in monitoring LSIL.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Moscicki, AB (corresponding author), 3333 Calif St,Suite 245, San Francisco, CA 94118 USA.	annam@itsa.ucsf.edu	Moscicki, Anna-Barbara/AAP-3806-2021	Broering, Jeanette/0000-0002-7580-8931	NCI NIH HHS [R01CA51323, R01CA54053, R01 CA051323, R37 CA051323] Funding Source: Medline; NCRR NIH HHS [M01 RR001271, M01 RR01271] Funding Source: Medline; PHS HHS [MCJ000978, P01A121912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA051323, R01CA054053, R01CA051323] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BACCHETTI P, 1991, BIOMETRICS, V47, P947, DOI 10.2307/2532651; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; DEVET HCW, 1993, INT J EPIDEMIOL, V22, P798, DOI 10.1093/ije/22.5.798; EVANDER M, 1995, J INFECT DIS, V171, P1026, DOI 10.1093/infdis/171.4.1026; Franco ELF, 1996, OBSTET GYN CLIN N AM, V23, P597; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; HOLMES KK, 1981, SCAND J INFECT DIS, P110; Joly P, 1998, BIOMETRICS, V54, P185, DOI 10.2307/2534006; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kurman RJ, 1994, BETHESDA SYSTEM REPO; LAVECCHIA C, 1986, CANCER, V58, P935, DOI 10.1002/1097-0142(19860815)58:4<935::AID-CNCR2820580422>3.0.CO;2-O; MOSCICKI AB, 1993, OBSTET GYNECOL, V82, P578; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Mount SL, 1999, PEDIATRICS, V103, P539, DOI 10.1542/peds.103.3.539; NASH JD, 1987, OBSTET GYNECOL, V69, P160; NASIELL K, 1986, OBSTET GYNECOL, V67, P665, DOI 10.1097/00006250-198605000-00012; OLSEN AO, 1995, INT J CANCER, V61, P312, DOI 10.1002/ijc.2910610306; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; Ries LA, 2002, SEER CANC STAT REV 1; Schlecht NF, 2003, JNCI-J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037; Scott M, 2001, CLIN DIAGN LAB IMMUN, V8, P209, DOI 10.1128/CDLI.8.2.209-220.2001; Smith PJ, 1997, STAT MED, V16, P485, DOI 10.1002/(SICI)1097-0258(19970315)16:5&lt;485::AID-SIM422&gt;3.0.CO;2-#; SYRJANEN K, 1992, OBSTET GYNECOL, V79, P675; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120; WRIGHT VC, 1984, AM J OBSTET GYNECOL, V149, P824, DOI 10.1016/0002-9378(84)90598-2	28	285	299	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 6	2004	364	9446					1678	1683		10.1016/S0140-6736(04)17354-6	http://dx.doi.org/10.1016/S0140-6736(04)17354-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868NZ	15530628				2022-12-24	WOS:000224921600030
J	Challine, D; Pellegrin, B; Bouvier-Alias, M; Rigot, P; Laperche, L; Pawlotsky, JM				Challine, D; Pellegrin, B; Bouvier-Alias, M; Rigot, P; Laperche, L; Pawlotsky, JM			HIV and hepatitis C virus RNA in seronegative organ and tissue donors	LANCET			English	Article							HCV	The objective of our study was to determine whether nucleic acid testing could detect HIV RNA or hepatitis C virus (HCV) RNA in a large series of seronegative organ and tissue donors, and whether this technique should be routinely used to improve viral safety of grafts. We studied 2236 organ donors, 636 tissue donors, and 177 cornea donors. We identified five HCV RNA-positive donors in 2119 HCV-seronegative organ donors, and one HCV RNA-positive donor in 631 HCV-seronegative tissue donors. No HIV-seronegative, HIV RNA-positive donor was identified. Our data suggest that routine nucleic acid testing of organ and tissue donors might increase viral safety in transplantation.	Univ Paris 12, Hop Henri Mondor, Serv Virol,INSERM,U635, Viral Emergency & Organ Tissue & Cell Donoe Scree, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Pawlotsky, JM (corresponding author), Univ Paris 12, Hop Henri Mondor, Serv Virol,INSERM,U635, Viral Emergency & Organ Tissue & Cell Donoe Scree, 51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France.	jean-michel.pawlotsky@hmn.aphp.fr	Bouvier-Alias, Magali/S-5631-2018; Challine, Dominique/U-2652-2018; Pawlotsky, Jean-Michel/R-8159-2018	Bouvier-Alias, Magali/0000-0003-1590-5980; Pawlotsky, Jean-Michel/0000-0003-0745-7559				CIESLAK PR, 2003, MMWR-MORBID MORTAL W, V52, P273; EASTLUND T, 1995, CELL TRANSPLANT, V4, P455, DOI 10.1016/0963-6897(95)00035-V; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Lefrere JJ, 1997, TRANSFUSION, V37, P565, DOI 10.1046/j.1537-2995.1997.37597293892.x; Lelie PN, 2002, TRANSFUSION, V42, P527, DOI 10.1046/j.1537-2995.2002.00101.x	5	25	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 30	2004	364	9445					1611	1612		10.1016/S0140-6736(04)17315-7	http://dx.doi.org/10.1016/S0140-6736(04)17315-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866IQ	15519632				2022-12-24	WOS:000224767600027
J	Krug, EG				Krug, EG			Injury surveillance is key to preventing injuries	LANCET			English	Editorial Material									WHO, Dept Injuries & Violence Prevent, CH-1211 Geneva OK, Switzerland	World Health Organization	Krug, EG (corresponding author), WHO, Dept Injuries & Violence Prevent, CH-1211 Geneva OK, Switzerland.	kruge@who.int						*AD HOC COMM HLTH, 1996, TDRGEN961 WHO AD HOC; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Holder Y, 2001, INJURY SURVEILLANCE; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; Peden M, 2004, WORLD REP ROAD TRAFF; Sethi D., 2004, GUIDELINES CONDUCTIN; Vyrostek Sara B., 2004, Morbidity and Mortality Weekly Report, V53, P1; World Health Organization, 2000, INJ LEAD CAUS GLOB B; World Health Organization, 2002, WORLD REPORT VIOLENC; *WORLD HLTH ASS, 2003, 5624 WHA WHO; *WORLD HLTH ASS, 2004, 5710 WHA WHO	11	56	60	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 30	2004	364	9445					1563	1566		10.1016/S0140-6736(04)17328-5	http://dx.doi.org/10.1016/S0140-6736(04)17328-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866IQ	15519616				2022-12-24	WOS:000224767600007
J	Doebeli, M; Hauert, C; Killingback, T				Doebeli, M; Hauert, C; Killingback, T			The evolutionary origin of cooperators and defectors	SCIENCE			English	Article							CONTINUOUS PRISONERS-DILEMMA	Coexistence of cooperators and defectors is common in nature, yet the evolutionary origin of such social diversification is unclear. Many models have been studied on the basis of the assumption that benefits of cooperative acts only accrue to others. Here, we analyze the continuous snowdrift game, in which cooperative investments are costly but yield benefits to others as well as to the cooperator. Adaptive dynamics of investment levels often result in evolutionary diversification from initially uniform populations to a stable state in which cooperators making large investments coexist with defectors who invest very little. Thus, when individuals benefit from their own actions, large asymmetries in cooperative investments can evolve.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada; Coll William & Mary, Dept Math, Williamsburg, VA 23187 USA	University of British Columbia; University of British Columbia; William & Mary	Doebeli, M (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	doebeli@zoology.ubc.ca	Hauert, Christoph/E-5369-2011; Doebeli, Michael/D-5391-2012	Hauert, Christoph/0000-0002-1239-281X; 				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Doebeli M, 1998, P NATL ACAD SCI USA, V95, P8676, DOI 10.1073/pnas.95.15.8676; Dugatkin L.A., 1997, COOPERATION ANIMALS; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GREIG D, 2004, BIOL LETT, V217, P525; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; HOEKSTRA RF, 1980, J THEOR BIOL, V87, P785, DOI 10.1016/0022-5193(80)90117-4; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Huang A. S., 1977, COMPREHENSIVE VIROLO, V10, P73; Killingback T, 2002, AM NAT, V160, P421, DOI 10.1086/342070; MAIRE N, 2001, SELECTION, V2, P119, DOI DOI 10.1556/SELECT.2.2001.1-2.9; Metz J. A. J., 1996, STOCHASTIC SPATIAL S, P183; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Packer C, 1997, SCI AM, V276, P52, DOI 10.1038/scientificamerican0597-52; PITCHER T, 1992, NETH J ZOOL, V42, P371, DOI 10.1163/156854291X00397; Smith J. M., 1995, MAJOR TRANSITIONS EV; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sober E., 1998, OTHERS EVOLUTION PSY; Sugden R, 1986, EC RIGHTS COOPERATIO; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996	29	224	227	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					859	862		10.1126/science.1101456	http://dx.doi.org/10.1126/science.1101456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514155	Green Submitted			2022-12-24	WOS:000224969400043
J	Kamhawi, S; Ramalho-Ortigao, M; Pham, VM; Kumar, S; Lawyer, PG; Turco, SJ; Barillas-Mury, C; Sacks, DL; Valenzuela, JG				Kamhawi, S; Ramalho-Ortigao, M; Pham, VM; Kumar, S; Lawyer, PG; Turco, SJ; Barillas-Mury, C; Sacks, DL; Valenzuela, JG			A role for insect galectins in parasite survival	CELL			English	Article							LEISHMANIA-MAJOR PROMASTIGOTES; DEVELOPMENTAL MODIFICATION; VECTORIAL COMPETENCE; RHODNIUS-PROLIXUS; LIPOPHOSPHOGLYCAN; LECTIN; IDENTIFICATION; GENES; RECOGNITION; INFECTION	Insect galectins are associated with embryonic development or immunity against pathogens. Here, we show that they can be exploited by parasites for survival in their insect hosts. PpGalec, a tandem repeat galectin expressed in the midgut of the sand fly Phlebotomus papatasi, is used by Leishmania major as a receptor for mediating specific binding to the insect midgut, an event crucial for parasite survival, and accounts for species-specific vector competence. PpGalec is thus identified as a key molecule controlling vector competence for the most widely distributed form of cutaneous leishmaniasis in the Old World. In addition, these studies demonstrate the feasibility of using midgut receptors for parasite ligands as target antigens for transmission-blocking vaccines.	NIAID, Vector Mol Biol Unit, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; NIAID, Mosquito Immun & Vector Competence Unit, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Univ Kentucky, Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40502 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kentucky	Valenzuela, JG (corresponding author), NIAID, Vector Mol Biol Unit, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jvalenzuela@niaid.nih.gov	Ramalho-Ortigao, Marcelo/E-8225-2011	Ramalho-Ortigao, Marcelo/0000-0002-1490-4946; Kumar, Sanjeev/0000-0003-3866-4593	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000256, R01AI020941, R37AI020941, Z01AI000947] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20941] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; Basseri HR, 2002, EXP PARASITOL, V100, P226, DOI 10.1016/S0014-4894(02)00026-7; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BLANCHET MA, 2000, PROTEINS, V40, P378; Butcher BA, 1996, J BIOL CHEM, V271, P20573, DOI 10.1074/jbc.271.34.20573; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Danielsen EM, 1997, MOL BIOL CELL, V8, P2241, DOI 10.1091/mbc.8.11.2241; Dillon RJ, 1999, PARASITOLOGY, V118, P27, DOI 10.1017/S0031182098003588; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dobson DE, 2003, J BIOL CHEM, V278, P28840, DOI 10.1074/jbc.M302728200; Hughes RC, 2001, BIOCHIMIE, V83, P667; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Kamhawi S, 2000, PARASITOLOGY, V121, P25, DOI 10.1017/S0031182099006125; Kamhawi S, 2002, WORLD CL PARASITES, V4, P59; KELLEHER M, 1994, MOL BIOCHEM PARASIT, V66, P187, DOI 10.1016/0166-6851(94)90146-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; MCCONVILLE MJ, 1995, BIOCHEM J, V310, P807, DOI 10.1042/bj3100807; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; Mello CB, 1999, EXP PARASITOL, V91, P289, DOI 10.1006/expr.1998.4385; Moody TN, 2000, FEBS LETT, V470, P305, DOI 10.1016/S0014-5793(00)01347-8; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; Pace KE, 2002, GLYCOCONJUGATE J, V19, P607, DOI 10.1023/B:GLYC.0000014092.86763.2f; Pace KE, 2002, J BIOL CHEM, V277, P13091, DOI 10.1074/jbc.M112105200; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; PIMENTA PFP, 1994, P NATL ACAD SCI USA, V91, P9155, DOI 10.1073/pnas.91.19.9155; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; SVODODOVA M, 1996, ANN TROP MED PARASIT, V90, P329; TESH RB, 1983, J MED ENTOMOL, V20, P199, DOI 10.1093/jmedent/20.2.199; THOMAS JR, 1992, J BIOL CHEM, V267, P6829; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Volf P, 1998, MED VET ENTOMOL, V12, P151, DOI 10.1046/j.1365-2915.1998.00089.x; Volf P, 2002, EUR J BIOCHEM, V269, P6294, DOI 10.1046/j.1432-1033.2002.03349.x; WALLBANKS KR, 1986, TROP MED PARASITOL, V37, P409; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Young AR, 2002, GLYCOCONJUGATE J, V19, P601, DOI 10.1023/B:GLYC.0000014091.00844.0a	51	195	205	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					329	341		10.1016/j.cell.2004.10.009	http://dx.doi.org/10.1016/j.cell.2004.10.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15543683	Bronze			2022-12-24	WOS:000224908300005
J	Feingold, EA; Good, PJ; Guyer, MS; Kamholz, S; Liefer, L; Wetterstrand, K; Collins, FS; Gingeras, TR; Kampa, D; Sekinger, EA; Cheng, J; Hirsch, H; Ghosh, S; Zhu, Z; Pate, S; Piccolboni, A; Yang, A; Tammana, H; Bekiranov, S; Kapranov, P; Harrison, R; Church, G; Struhl, K; Ren, B; Kim, TH; Barrera, LO; Qu, C; Van Calcar, S; Luna, R; Glass, CK; Rosenfeld, MG; Guigo, R; Antonarakis, SE; Birney, E; Brent, M; Pachter, L; Reymond, A; Dermitzakis, ET; Dewey, C; Keefe, D; Denoeud, F; Lagarde, J; Ashurst, J; Hubbard, T; Wesselink, JJ; Castelo, R; Eyras, E; Myers, RM; Sidow, A; Batzoglou, S; Trinklein, ND; Hartman, SJ; Aldred, SF; Anton, E; Schroeder, DI; Marticke, SS; Nguyen, L; Schmutz, J; Grimwood, J; Dickson, M; Cooper, GM; Stone, EA; Asimenos, G; Brudno, M; Dutta, A; Karnani, N; Taylor, CM; Kim, HK; Robins, G; Stamatoyannopoulos, G; Stamatoyannopoulos, JA; Dorschner, M; Sabo, P; Hawrytycz, M; Humbert, R; Wallace, J; Yu, M; Navas, PA; McArthur, M; Noble, WS; Dunham, I; Koch, CM; Andrews, RM; Clelland, GK; Wilcox, S; Fowler, JC; James, KD; Groth, P; Dovey, OM; Ellis, PD; Wraight, VL; Mungall, AJ; Dhami, P; Fiegler, H; Langford, CF; Carter, NP; Vetrie, D; Snyder, M; Euskirchen, G; Urban, AE; Nagalakshmi, U; Rinn, J; Popescu, G; Bertone, P; Hartman, S; Rozowsky, J; Emanuelsson, O; Royce, T; Chung, S; Gerstein, M; Lian, Z; Lian, J; Nakayama, Y; Weissman, S; Stoic, V; Tongprasit, W; Sethi, H; Jones, S; Marra, M; Shin, H; Schein, J; Clamp, M; Lindblad-Toh, K; Chang, J; Jaffe, DB; Kamal, ES; Lander, ES; Mikkelsen, TS; Vinson, J; Zody, MC; de Jong, PJ; Osoegawa, K; Nefedov, M; Zhu, B; Baxevanis, AD; Wolfsberg, TG; Collins, FS; Crawford, GE; Holt, E; Vasicek, TJ; Zhou, D; Luo, S; Green, ED; Bouffard, GG; Margulies, EH; Portnoy, ME; Hansen, NF; Thomas, PJ; Mcdowell, JC; Maskeri, B; Young, AC; Idol, JR; Blakesley, RW; Schuler, G; Miller, W; Hardison, R; Elnitski, L; Shah, P; Salzberg, SL; Pertea, M; Majoros, WH; Haussler, D; Thomas, D; Rosenbloom, KR; Clawson, H; Siepe, A; Kent, WJ; Weng, Z; Jin, S; Halees, A; Burden, H; Karaoz, U; Fu, Y; Yu, Y; Ding, C; Cantor, CR; Kingston, RE; Dennis, J; Green, RD; Singer, MA; Richmond, TA; Norton, JE; Farnham, PJ; Oberley, MJ; Inman, DR; McCormick, MR; Kim, H; Middle, CL; Pirrung, MC; Fu, XD; Kwon, YS; Ye, Z; Dekker, J; Tabuchi, TM; Gheldof, N; Dostie, J; Harvey, SC				Feingold, EA; Good, PJ; Guyer, MS; Kamholz, S; Liefer, L; Wetterstrand, K; Collins, FS; Gingeras, TR; Kampa, D; Sekinger, EA; Cheng, J; Hirsch, H; Ghosh, S; Zhu, Z; Pate, S; Piccolboni, A; Yang, A; Tammana, H; Bekiranov, S; Kapranov, P; Harrison, R; Church, G; Struhl, K; Ren, B; Kim, TH; Barrera, LO; Qu, C; Van Calcar, S; Luna, R; Glass, CK; Rosenfeld, MG; Guigo, R; Antonarakis, SE; Birney, E; Brent, M; Pachter, L; Reymond, A; Dermitzakis, ET; Dewey, C; Keefe, D; Denoeud, F; Lagarde, J; Ashurst, J; Hubbard, T; Wesselink, JJ; Castelo, R; Eyras, E; Myers, RM; Sidow, A; Batzoglou, S; Trinklein, ND; Hartman, SJ; Aldred, SF; Anton, E; Schroeder, DI; Marticke, SS; Nguyen, L; Schmutz, J; Grimwood, J; Dickson, M; Cooper, GM; Stone, EA; Asimenos, G; Brudno, M; Dutta, A; Karnani, N; Taylor, CM; Kim, HK; Robins, G; Stamatoyannopoulos, G; Stamatoyannopoulos, JA; Dorschner, M; Sabo, P; Hawrytycz, M; Humbert, R; Wallace, J; Yu, M; Navas, PA; McArthur, M; Noble, WS; Dunham, I; Koch, CM; Andrews, RM; Clelland, GK; Wilcox, S; Fowler, JC; James, KD; Groth, P; Dovey, OM; Ellis, PD; Wraight, VL; Mungall, AJ; Dhami, P; Fiegler, H; Langford, CF; Carter, NP; Vetrie, D; Snyder, M; Euskirchen, G; Urban, AE; Nagalakshmi, U; Rinn, J; Popescu, G; Bertone, P; Hartman, S; Rozowsky, J; Emanuelsson, O; Royce, T; Chung, S; Gerstein, M; Lian, Z; Lian, J; Nakayama, Y; Weissman, S; Stoic, V; Tongprasit, W; Sethi, H; Jones, S; Marra, M; Shin, H; Schein, J; Clamp, M; Lindblad-Toh, K; Chang, J; Jaffe, DB; Kamal, ES; Lander, ES; Mikkelsen, TS; Vinson, J; Zody, MC; de Jong, PJ; Osoegawa, K; Nefedov, M; Zhu, B; Baxevanis, AD; Wolfsberg, TG; Collins, FS; Crawford, GE; Holt, E; Vasicek, TJ; Zhou, D; Luo, S; Green, ED; Bouffard, GG; Margulies, EH; Portnoy, ME; Hansen, NF; Thomas, PJ; Mcdowell, JC; Maskeri, B; Young, AC; Idol, JR; Blakesley, RW; Schuler, G; Miller, W; Hardison, R; Elnitski, L; Shah, P; Salzberg, SL; Pertea, M; Majoros, WH; Haussler, D; Thomas, D; Rosenbloom, KR; Clawson, H; Siepe, A; Kent, WJ; Weng, Z; Jin, S; Halees, A; Burden, H; Karaoz, U; Fu, Y; Yu, Y; Ding, C; Cantor, CR; Kingston, RE; Dennis, J; Green, RD; Singer, MA; Richmond, TA; Norton, JE; Farnham, PJ; Oberley, MJ; Inman, DR; McCormick, MR; Kim, H; Middle, CL; Pirrung, MC; Fu, XD; Kwon, YS; Ye, Z; Dekker, J; Tabuchi, TM; Gheldof, N; Dostie, J; Harvey, SC		ENCODE Project Consortium	The ENCODE (ENCyclopedia of DNA elements) Project	SCIENCE			English	Editorial Material							INTERNATIONAL HAPMAP PROJECT; HUMAN-GENOME; SEQUENCE; TRANSCRIPTION; ANNOTATION; QUALITY; CDNAS	The ENCyclopedia Of DNA Elements (ENCODE) Project aims to identify all functional elements in the human genome sequence. The pilot phase of the Project is focused on a specified 30 megabases (similar to1%) of the human genome sequence and is organized as an international consortium of computational and laboratory-based scientists working to develop and apply high-throughput approaches for detecting all sequence elements that confer biological function. The results of this pilot phase will guide future efforts to analyze the entire human genome.	NHGRI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Feingold, EA (corresponding author), NHGRI, Bethesda, MD 20892 USA.	elise_feingold@nih.gov	Gasull, Martina/J-4076-2019; Pertea, Mihaela/AAT-2705-2021; Mungall, Andrew J./U-7067-2018; Cooper, Gregory/D-6914-2011; Salzberg, Steven L/F-6162-2011; Grimwood, Jane/ABD-5737-2021; Elnitski, Laura/AAD-3595-2021; Schroeder, Diane/I-2200-2015; Antonarakis, Stylianos E/N-8866-2014; Karaoz, Ulas/J-7093-2014; Oberley, Matthew/I-8107-2019; Hubbard, Tim J.P./AAT-4571-2020; Bertone, Paul/Z-3734-2019; Hardison, Ross C/G-1142-2010; Hubbard, Tim J/C-2567-2008; Clawson, Hiram/ABE-6101-2020; Bertone, Paul/A-6600-2013; Schein, Jacquie E/G-3674-2015; Mikkelsen, Tarjei S/A-1306-2007; Lagarde, Julien/AAI-1686-2020; Popescu, George/N-2193-2019; Guigo, Roderic/D-1303-2010; Salzberg, Steven/Q-6514-2019; Wolfsberg, Tyra/D-8296-2017; Eduardo, Eyras/L-1053-2014; Eyras, Eduardo/ABG-7144-2020; Taylor, Christopher M./AAF-5480-2020; Jin, Shengnan/I-6264-2012; Popescu, George/B-7013-2008; Ding, Chunming/B-2593-2008; Eyras, Eduardo/A-1560-2010; Castelo, Robert/A-4679-2010; Jones, Steven J/C-3621-2009; Dermitzakis, Emmanouil/B-7687-2013; Oberley, Matthew/L-4326-2019; Schmutz, Jeremy/N-3173-2013; Marra, Marco A/B-5987-2008; Brent, Michael/AAK-3702-2020; Karnani, Neerja/G-2539-2012; Sandelin, Albin/G-2881-2011	Pertea, Mihaela/0000-0003-0762-8637; Mungall, Andrew J./0000-0002-0905-2742; Cooper, Gregory/0000-0001-5509-9923; Salzberg, Steven L/0000-0002-8859-7432; Schroeder, Diane/0000-0003-2282-9912; Antonarakis, Stylianos E/0000-0001-8907-5823; Karaoz, Ulas/0000-0002-8238-6757; Oberley, Matthew/0000-0001-6419-2513; Hubbard, Tim J.P./0000-0002-1767-9318; Bertone, Paul/0000-0001-5059-4829; Hardison, Ross C/0000-0003-4084-7516; Hubbard, Tim J/0000-0002-1767-9318; Bertone, Paul/0000-0001-5059-4829; Mikkelsen, Tarjei S/0000-0002-8133-3135; Lagarde, Julien/0000-0002-0290-7445; Popescu, George/0000-0002-7580-6792; Guigo, Roderic/0000-0002-5738-4477; Salzberg, Steven/0000-0002-8859-7432; Wolfsberg, Tyra/0000-0001-5646-9455; Eduardo, Eyras/0000-0003-0793-6218; Eyras, Eduardo/0000-0003-0793-6218; Taylor, Christopher M./0000-0002-7983-5275; Jin, Shengnan/0000-0003-0467-6502; Popescu, George/0000-0002-7580-6792; Ding, Chunming/0000-0002-2063-5594; Castelo, Robert/0000-0003-2229-4508; Jones, Steven J/0000-0003-3394-2208; Schmutz, Jeremy/0000-0001-8062-9172; Marra, Marco A/0000-0001-7146-7175; Brent, Michael/0000-0002-8689-0299; Baxevanis, Andy/0000-0002-5370-0014; Stone, Eric/0000-0002-2725-4209; Gingeras, Thomas/0000-0001-9106-3573; Dunham, Ian/0000-0003-2525-5598; Clawson, Hiram/0000-0002-0480-0545; Siepel, Adam/0000-0002-3557-7219; Halees, Anason/0000-0001-5880-7067; Elnitski, Laura/0000-0003-1065-019X; Rinn, John/0000-0002-7231-7539; Pachter, Lior/0000-0002-9164-6231; Dutta, Anindya/0000-0002-4319-0073; church, george/0000-0001-6232-9969; Koch, Christof/0000-0001-6482-8067; Sandelin, Albin/0000-0002-7109-7378; Cooper, Sara/0000-0002-9627-0309	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200304, R01HG003143] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; *ENCODE CONS, UNPUB; EVANS T, 1990, ANNU REV CELL BIOL, V6, P95, DOI 10.1146/annurev.cellbio.6.1.95; Felsenfeld A, 1999, GENOME RES, V9, P1; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; *INT HUM GEN SEQ C, IN PRESS NATURE; Kapronov Philipp, 2003, Briefings in Functional Genomics & Proteomics, V2, P47, DOI 10.1093/bfgp/2.1.47; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Ren B, 2004, METHOD ENZYMOL, V376, P304; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; SIEPEL A, IN PRESS STAT METHOD; Spellman PT, 2002, GENOME BIOL, V3; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	28	1570	1630	7	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					636	640		10.1126/science.1105136	http://dx.doi.org/10.1126/science.1105136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499007				2022-12-24	WOS:000224756700037
J	Pierard, LA; Lancellotti, P				Pierard, LA; Lancellotti, P			The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; EXERCISE-INDUCED CHANGES; CORONARY-ARTERY-DISEASE; HEART-FAILURE; DETERMINANTS; MECHANISM; HYPERTENSION; INSIGHTS	BACKGROUND: Acute mitral regurgitation may cause pulmonary edema, but the pathogenetic role of chronic ischemic mitral regurgitation, a dynamic condition, has not yet been characterized. METHODS: We prospectively studied 28 patients (mean [+/-SD] age, 65+/-11 years) with acute pulmonary edema and left ventricular systolic dysfunction and 46 patients without a history of acute pulmonary edema. The two groups were matched for all baseline characteristics. Patients underwent quantitative Doppler echocardiography during exercise. Exercise-induced changes in the left ventricular volume, the ejection fraction, the mitral regurgitant volume, the effective regurgitant orifice area, and the transtricuspid pressure gradient were compared in patients with and without acute pulmonary edema. RESULTS: The two groups had similar clinical and baseline echocardiographic characteristics. They also had similar exercise-induced changes in heart rate, systolic blood pressure, and left ventricular volumes. In the univariate analysis, patients with recent pulmonary edema had a much higher increase than did the patients without pulmonary edema in mitral regurgitant volume (26+/-14 ml vs. 5+/-14 ml, P<0.001), the effective regurgitant orifice area (16+/-10 mm(sup 2) vs. 2+/-9 mm(sup 2), P<0.001), and the transtricuspid pressure gradient (29+/-10 mm Hg vs. 13+/-11 mm Hg, P<0.001). In the multivariate analysis, exercise-induced changes in the effective regurgitant orifice area (P<0.001), in the transtricuspid pressure gradient (P=0.001), and in the left ventricular ejection fraction (P=0.02) were independently associated with a history of recent pulmonary edema. CONCLUSIONS: In patients with left ventricular systolic dysfunction, acute pulmonary edema is associated with the dynamic changes in ischemic mitral regurgitation and the resulting increase in pulmonary vascular pressure.	Univ Hosp Liege, Div Cardiol, Liege, Belgium	University of Liege	Pierard, LA (corresponding author), Univ Hosp Sart Tilman, Dept Cardiol, B-4000 Liege, Belgium.	lpierard@chu.ulg.ac.be						Agostoni P, 2003, CIRCULATION, V108, P2666, DOI 10.1161/01.CIR.0000097115.61309.59; Bentancur AG, 2002, AM J MED SCI, V323, P238, DOI 10.1097/00000441-200205000-00002; Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1; EnriquezSarano M, 1997, J AM COLL CARDIOL, V29, P153, DOI 10.1016/S0735-1097(96)00436-6; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; He SQ, 1997, CIRCULATION, V96, P1826, DOI 10.1161/01.CIR.96.6.1826; Hung J, 1999, J AM COLL CARDIOL, V33, P538, DOI 10.1016/S0735-1097(98)00570-1; Irvine T, 2002, HEART, V88, piv11; KEREN G, 1986, AM HEART J, V112, P517, DOI 10.1016/0002-8703(86)90516-8; Lancellotti P, 2003, CIRCULATION, V108, P1713, DOI 10.1161/01.CIR.0000087599.49332.05; Lancellotti P, 2003, J AM COLL CARDIOL, V42, P1921, DOI 10.1016/j.jacc.2003.04.002; Lebrun F, 2001, J AM COLL CARDIOL, V38, P1685, DOI 10.1016/S0735-1097(01)01605-9; Levine RA, 2003, J AM COLL CARDIOL, V42, P1929, DOI 10.1016/j.jacc.2003.09.004; Otsuji Y, 1997, CIRCULATION, V96, P1999, DOI 10.1161/01.CIR.96.6.1999; STONE GW, 1991, AM J CARDIOL, V67, P37, DOI 10.1016/0002-9149(91)90095-3; TCHENG JE, 1992, ANN INTERN MED, V117, P18, DOI 10.7326/0003-4819-117-1-18; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400	18	201	209	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1627	1634		10.1056/NEJMoa040532	http://dx.doi.org/10.1056/NEJMoa040532			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483281	Bronze			2022-12-24	WOS:000224427300009
J	Keeling, L; Anderson, L; Schutz, KE; Kerje, S; Fredriksson, R; Carlborg, O; Cornwallis, CK; Pizzari, T; Jensen, P				Keeling, L; Anderson, L; Schutz, KE; Kerje, S; Fredriksson, R; Carlborg, O; Cornwallis, CK; Pizzari, T; Jensen, P			Chicken genomics: Feather-pecking and victim pigmentation	NATURE			English	Editorial Material							QUANTITATIVE TRAIT LOCI; LAYING HENS; BEHAVIOR		Swedish Univ Agr Sci, Dept Anim Environm & Hlth, S-53223 Skara, Sweden; Uppsala Univ, Dept Med Biochem & Microbiol, S-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75124 Uppsala, Sweden; AgRes Anim Behav & Welf, Hamilton, New Zealand; Linkoping Univ, IFM, Dept Biol, S-58183 Linkoping, Sweden; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Leeds, Sch Biol, Evolut & Ecol Grp, Leeds LS2 9JT, W Yorkshire, England	Swedish University of Agricultural Sciences; Uppsala University; Swedish University of Agricultural Sciences; AgResearch - New Zealand; Linkoping University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Sheffield; University of Leeds	Keeling, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, POB 234, S-53223 Skara, Sweden.	per.jensen@ifm.liu.se	Cornwallis, Charlie/A-6276-2012; Keeling, Linda J/K-6542-2012; Fredriksson, Robert/AAH-3921-2019	Keeling, Linda J/0000-0003-2629-0117; Fredriksson, Robert/0000-0002-2810-3226; Schutz, Karin/0000-0002-2893-3465; Carlborg, Orjan/0000-0002-2722-5264				Blokhuis HJ, 1998, VET QUART, V20, P6, DOI 10.1080/01652176.1998.9694825; Buitenhuis AJ, 2003, POULTRY SCI, V82, P1661, DOI 10.1093/ps/82.11.1661; Buitenhuis AJ, 2003, POULTRY SCI, V82, P1215, DOI 10.1093/ps/82.8.1215; JENSEN P, 2003, ISAE 2003 M JUN 24 2, P68; Johnstone RA, 2004, P ROY SOC B-BIOL SCI, V271, P1917, DOI 10.1098/rspb.2003.2581; KERJE S, IN PRESS GENETICS; Kjaer JB, 1997, BRIT POULTRY SCI, V38, P333, DOI 10.1080/00071669708417999; McAdie TM, 2002, APPL ANIM BEHAV SCI, V75, P147, DOI 10.1016/S0168-1591(01)00182-4; Savory CJ, 1999, BRIT POULTRY SCI, V40, P565, DOI 10.1080/00071669986918; Smyth J.R., 1996, POULTRY BREEDING GEN, P109	10	84	88	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					645	646		10.1038/431645a	http://dx.doi.org/10.1038/431645a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470416				2022-12-24	WOS:000224299300028
J	Boyd, PA; Armstrong, B; Dolk, H; Botting, B; Pattenden, S; Abramsky, L; Rankin, J; Vrijheid, M; Wellesley, D				Boyd, PA; Armstrong, B; Dolk, H; Botting, B; Pattenden, S; Abramsky, L; Rankin, J; Vrijheid, M; Wellesley, D			Congenital anomaly surveillance in England - ascertainment deficiencies in the national system	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NOTIFICATION	Objective Firstly, to assess the completeness of ascertainment in die National Congenital Anomaly System (NCAS), the basis for congenital anomaly surveillance in England and Wales, and its variation by defect geographical area, and socioeconomic deprivation. Secondly, to assess die impact of the lack of data on pregnancies terminated because of fetal anomaly. Design Comparison of the NCAS with four local congenital anomaly registers in England. Setting Four regions in England covering some 109 000 annual births. Participants Cases of congenital anomalies registered in the NCAS (live births and stillbirths) and independently registered in the four local registers (live births, stillbirths, fetal losses from 20 weeks' gestation, and pregnancies terminated after prenatal diagnosis of fetal anomaly). Main outcome measure The ratio of cases identified by the national register to those in local registry files, calculated for different specified anomalies, for whole registry areas, and for hospital catchment areas within registry boundaries. Results Ascertainment by the NCAS (compared with data from local registers, from which terminations of pregnancy were removed) was 40% (34% for chromosomal anomalies and 42% for non-chromosomal anomalies) and varied markedly by defect, by local register, and by hospital catchment area, but not by area deprivation. When terminations of pregnancy were included in the register data, ascertainment-by NCAS was 27% (19% for chromosomal anomalies and 31% for non-chromosomal anomalies),and the geographical variation was of a similar magnitude. Conclusion The surveillance of congenital anomalies in England is currently inadequate because ascertainment to the national register is low and non-uniform and because no data exist on termination of pregnancy resulting from prenatal diagnosis of fetal anomaly.	Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Ulster, Fac Life & Hlth Sci, Newtownabbey BT37 0QB, Antrim, North Ireland; Off Natl Stat, London SW1V 2QQ, England; Northwick Pk Hosp & Clin Res Ctr, N Thames Perinatal Publ Hlth Unit, Harrow HA1 3UJ, Middx, England; Newcastle Univ, Fac Med, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Int Agcy Res Canc, F-69372 Lyon 08, France; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Ulster University; Imperial College London; Newcastle University - UK; World Health Organization; International Agency for Research on Cancer (IARC)	Boyd, PA (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	patricia.boyd@perinat.ox.ac.uk	Vrijheid, Martine/H-2702-2014	Vrijheid, Martine/0000-0002-7090-1758; armstrong, benedict/0000-0003-4407-0409				ABRAMSKY I, 2003, N THAMES PERINATAL P; [Anonymous], 1992, Arch Dis Child, V67, P770; BOTTING B, 2000, HLTH STAT Q, V5, P7; BOYD PA, 2003, REPORT OXFORD CONGEN; Busby A, 1998, ARCH DIS CHILD-FETAL, V79, pF168, DOI 10.1136/fn.79.3.F168; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Dolk H, 2003, STUDY GEOGRAPHICAL V; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; HEY K, 1994, ARCH DIS CHILD-FETAL, V71, pF198, DOI 10.1136/fn.71.3.F198; KNOX EG, 1984, J EPIDEMIOL COMMUN H, V38, P296, DOI 10.1136/jech.38.4.296; *NDSCR, 2003, NAT DOWN SYNDR CYT R; *OFF POP CENS SURV, 1995, 43 OPCS; PAYNE JN, 1992, PUBLIC HEALTH, V106, P437, DOI 10.1016/S0033-3506(05)80458-5; *STAT OFF, 1997, CONG MALF STAT N MB3; TAN KH, 1996, BRIT MED J, V313, P993; Vrijheid M, 2003, OCCUP ENVIRON MED, V60, P543, DOI 10.1136/oem.60.8.543; WELLESLEY D, 2003, WESSEX ANTENATALLY D	17	80	82	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 1	2005	330	7481					27	29		10.1136/bmj.38300.665301.3A	http://dx.doi.org/10.1136/bmj.38300.665301.3A			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15561730	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000226176700017
J	Hamdy, FC; Catto, JWF				Hamdy, FC; Catto, JWF			Less is more: artificial intelligence and gene-expression arrays	LANCET			English	Editorial Material							NEURAL-NETWORKS; CANCER; PREDICTION		Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Hamdy, FC (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England.	f.c.hamdy@sheffield.ac.uk		Hamdy, Freddie/0000-0003-2627-2154; catto, james/0000-0003-2787-8828				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; Catto JWF, 2003, CLIN CANCER RES, V9, P4172; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; SHIMADA H, 1995, J NATL CANCER I, V87, P1470, DOI 10.1093/jnci/87.19.1470; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695	9	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2003	2004		10.1016/S0140-6736(04)17528-4	http://dx.doi.org/10.1016/S0140-6736(04)17528-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582046				2022-12-24	WOS:000225495700008
J	Gussekloo, J; van Exel, E; de Craen, AJM; Meinders, AE; Frolich, M; Westendorp, RGJ				Gussekloo, J; van Exel, E; de Craen, AJM; Meinders, AE; Frolich, M; Westendorp, RGJ			Thyroid status, disability and cognitive function, and survival in old age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; L-THYROXINE THERAPY; SUBCLINICAL HYPOTHYROIDISM; DOUBLE-BLIND; LIFE-SPAN; HEART-DISEASE; DWARF MICE; ALL-CAUSE; DYSFUNCTION; HYPERTHYROIDISM	Context Despite the equivocal outcomes of randomized controlled trials, general clinical opinion favors screening and treatment of elderly individuals with subclinical thyroid disorders. Objectives To determine whether subclinical thyroid dysfunction should be treated in old age and the long-term impact of thyroid dysfunction on performance and survival in old age. Design, Setting, and Participants A prospective, observational, population-based follow-up study within the Leiden 85-Plus Study of 87% of a 2-year birth cohort (1912-1914) in the municipality of Leiden, the Netherlands. A total of 599 participants were followed up from age 85 years through age 89 years (mean [SD] follow-up, 3.7 [1.4] years). Main Outcome Measures Complete thyroid status at baseline; disability in daily life, depressive symptoms, cognitive function, and mortality from age 85 years through 89 years. Results Plasma levels of thyrotropin and free thyroxine were not associated with disability in daily life, depressive symptoms, and cognitive impairment at baseline or during follow-up. Increasing levels of thyrotropin were associated with a lower mortality rate that remained after adjustments were made for baseline disability and health status. The hazard ratio (HR) for mortality per SD increase of 2.71 mIU/L of thyrotropin was 0,77 (95% confidence interval [CI], 0.63-0.94; P=.009). The HR for mortality per SD increase of 0.21 ng/dL (2.67 pmol/L) of free thyroxine increased 1.16-fold (95% Cl, 1.04-1.30; P=.009). Conclusions In the general population of the oldest old, elderly individuals with abnormally, high levels of thyrotropin do not experience adverse effects and may have a prolonged life span. However, evidence for not treating elderly individuals can only come from a well-designed, randomized placebo-controlled clinical trial.	Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Chem, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gussekloo, J (corresponding author), Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, C-2-R Room 133,POB 9600, NL-2300 RC Leiden, Netherlands.	jgussekloo@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021	Gussekloo, Jacobijn/0000-0001-7186-8278; van Exel, Eric/0000-0002-5737-9600				Ayala AR, 2000, ENDOCRIN METAB CLIN, V29, P399, DOI 10.1016/S0889-8529(05)70139-0; Bartke A, 2001, EXP GERONTOL, V36, P21, DOI 10.1016/S0531-5565(00)00205-9; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Blanc S, 2003, J CLIN ENDOCR METAB, V88, P16, DOI 10.1210/jc.2002-020405; Bootsma-van der Wiel A, 2002, J CLIN EPIDEMIOL, V55, P1119, DOI 10.1016/S0895-4356(02)00505-X; Bootsma-van der Wiel A, 2001, J AM GERIATR SOC, V49, P909; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Caraccio N, 2002, J CLIN ENDOCR METAB, V87, P1533, DOI 10.1210/jc.87.4.1533; Cerillo AG, 2003, ANN THORAC SURG, V75, P82, DOI 10.1016/S0003-4975(02)03919-X; Chueire VB, 2003, ARCH GERONTOL GERIAT, V36, P281, DOI 10.1016/S0167-4943(02)00173-5; Col NF, 2004, JAMA-J AM MED ASSOC, V291, P239, DOI 10.1001/jama.291.2.239; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Cooper DS, 2001, NEW ENGL J MED, V345, P260, DOI 10.1056/NEJM200107263450406; Danese MD, 1996, JAMA-J AM MED ASSOC, V276, P285, DOI 10.1001/jama.276.4.285; Davis Jennifer Duncan, 2003, Curr Psychiatry Rep, V5, P384, DOI 10.1007/s11920-003-0073-6; de Craen AJM, 2003, INT J GERIATR PSYCH, V18, P63, DOI 10.1002/gps.773; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Houx PJ, 2002, J NEUROL NEUROSUR PS, V73, P385, DOI 10.1136/jnnp.73.4.385; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Jaeschke R, 1996, J GEN INTERN MED, V11, P744, DOI 10.1007/BF02598988; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; McIver B, 1997, THYROID, V7, P125, DOI 10.1089/thy.1997.7.125; Meier C, 2001, J CLIN ENDOCR METAB, V86, P4860, DOI 10.1210/jc.86.10.4860; Mobbs CV, 2001, J GERONTOL A-BIOL, V56, P34, DOI 10.1093/gerona/56.suppl_1.34; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; NYSTROM E, 1988, CLIN ENDOCRINOL, V29, P63, DOI 10.1111/j.1365-2265.1988.tb00250.x; OLSEN T, 1978, J CLIN ENDOCR METAB, V47, P1111, DOI 10.1210/jcem-47-5-1111; Omar RZ, 1999, STAT MED, V18, P1587, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1587::AID-SIM141>3.0.CO;2-Z; OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5; OOKA H, 1986, MECH AGEING DEV, V33, P275, DOI 10.1016/0047-6374(86)90052-7; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Pollock MA, 2001, BRIT MED J, V323, P891, DOI 10.1136/bmj.323.7318.891; ROBERTSON T. BRAILSFORD, 1928, AUSTRALIAN JOUR EXP BIOL MED SCI, V5, P69, DOI 10.1038/icb.1928.4; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Stathatos N, 2001, BEST PRACT RES CL EN, V15, P465, DOI 10.1053/beem.2001.0164; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Toft AD, 2001, NEW ENGL J MED, V345, P512, DOI 10.1056/NEJMcp010145; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694	45	604	637	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2004	292	21					2591	2599		10.1001/jama.292.21.2591	http://dx.doi.org/10.1001/jama.292.21.2591			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875GU	15572717				2022-12-24	WOS:000225409100022
J	Resneck, JS; Van Beek, M; Furmanski, L; Oyugi, J; LeBoit, PE; Katabira, E; Kambugu, F; Maurer, T; Berger, T; Pletcher, MJ; Machtinger, EL				Resneck, JS; Van Beek, M; Furmanski, L; Oyugi, J; LeBoit, PE; Katabira, E; Kambugu, F; Maurer, T; Berger, T; Pletcher, MJ; Machtinger, EL			Etiology of pruritic papular eruption with HIV infection in Uganda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE; EOSINOPHILIA; MECHANISMS; ANTIGENS; ZAMBIA; SHIFT; AIDS	Context A frequent cause of human immunodeficiency virus (HIV)-related morbidity in sub-Saharan Africa is a commonly occurring, intensely pruritic skin rash. The resulting scars are disfiguring and stigmatizing. Despite the substantial prevalence of pruritic papular eruption (PPE) among HIV-infected Africans, the cause has been elusive. Objective To determine the etiology of PPE occurring in HIV-infected individuals. Design, Setting, and Patients Cross-sectional study of HIV-infected patients with active PPE from clinics in Uganda conducted from May 19 through June 6, 2003. Enrollment occurred in the month preceding May 19. Each participant was clinically examined by 2 dermatologists, had laboratory studies performed, was administered an epidemiologic questionnaire, and had a skin biopsy of a new lesion evaluated by a dermatopathologist. Main Outcome Measures Histological characteristics of new pruritic lesions. Other assessments included CD4 cell count, eosinophil count, and physician-assessed rash severity. Results Of 109 patients meeting inclusion criteria, 102 (93.6%) completed the study. The CD4 cell counts in this study population were generally low (median, 46/muL) and inversely related to increasing rash severity (median CD4 cell counts: 122 for mild, 41 for moderate, and 9 for severe; P<.001 for trend). Eighty-six patients (84%; 95% confidence interval, 77%-91%) had biopsy findings characteristic of arthropod bites. Patients with arthropod bites on biopsy had significantly higher peripheral eosinophil counts (median, 330 vs 180/&mu;L; P=.02) and had a trend toward lower CD4 cell counts (median, 40 vs 99/&mu;L; P=.07) than those without histological evidence of arthropod bites. Conclusions Pruritic papular eruption occurring in HIV-infected individuals may be a reaction to arthropod bites. We hypothesize that this condition reflects an altered and exaggerated immune response to arthropod antigens in a subset of susceptible HIV-infected patients.	Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Iowa, Dept Dermatol, Iowa City, IA USA; Univ Iowa, Dept Epidemiol, Iowa City, IA USA; Reach Out Mbuya Parish AIDS Initiat, Kampala, Uganda; Acad Alliance AIDS Care & Prevent Africa, Kampala, Uganda; Makerere Univ, Kampala, Uganda	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa; University of Iowa; Makerere University	Resneck, JS (corresponding author), Univ Calif San Francisco, Sch Med, Dept Dermatol, Box 0363, San Francisco, CA 94143 USA.	resneck@itsa.ucsf.edu		Van Beek, Marta/0000-0003-2467-5830				ACKERMAN AB, 1997, HISTOLOGIC DIAGNOSIS, P202; Aires JM, 2000, INT J DERMATOL, V39, P903, DOI 10.1046/j.1365-4362.2000.00106.x; ALCOM K, 2004, AIDSMAP NEWS    0218; Barry SM, 2003, JAIDS-J ACQ IMM DEF, V34, P351, DOI 10.1097/00126334-200312010-00001; BASON MM, 1993, INT J DERMATOL, V32, P784, DOI 10.1111/j.1365-4362.1993.tb02762.x; Boonchai W, 1999, INT J DERMATOL, V38, P348, DOI 10.1046/j.1365-4362.1999.00694.x; Broide DH, 2001, J ALLERGY CLIN IMMUN, V108, pS65, DOI 10.1067/mai.2001.116436; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; COLEBUNDERS R, 1987, AIDS, V1, P117; ELGART ML, 1996, CUTANEOUS MED SURG I, P804; FEINGOLD BF, 1968, ANNU REV ENTOMOL, V13, P137, DOI 10.1146/annurev.en.13.010168.001033; GILLET JD, 1972, MOSQUITO ITS LIFE AC; HIRA SK, 1988, J AM ACAD DERMATOL, V19, P451, DOI 10.1016/S0190-9622(88)70197-8; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P87; JASON J, 1995, J ACQ IMMUN DEF SYND, V10, P471, DOI 10.1097/00042560-199512000-00011; Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005; LIAUTAUD B, 1989, ARCH DERMATOL, V125, P629, DOI 10.1001/archderm.125.5.629; MAGNAN A, 1995, REV MAL RESPIR, V12, P177; Mahe A, 1996, J AM ACAD DERMATOL, V34, P1084, DOI 10.1016/S0190-9622(96)90295-9; Milazzo F, 1999, ALLERGY, V54, P266, DOI 10.1034/j.1398-9995.1999.00885.x; Muyinda H, 1997, HEALTH PLACE, V3, P143, DOI 10.1016/S1353-8292(97)00010-5; *NAT I ALL INF DIS, 2001, LESS BLOOD MEAL; Olumide YM, 1997, INT J DERMATOL, V36, P741, DOI 10.1046/j.1365-4362.1997.00338.x; PALLANGYO KJ, 1992, TROP DOCT, V22, P35, DOI 10.1177/00494755920220S107; Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787; PENNEYS NS, 1989, J AM ACAD DERMATOL, V21, P421, DOI 10.1016/S0190-9622(89)80051-9; Pirmohamed M, 2001, CURR OPIN ALLERGY CL, V1, P311, DOI 10.1097/00130832-200108000-00006; Pitche P, 1995, Sante, V5, P349; Rosatelli JB, 2001, ARCH DERMATOL, V137, P672; Simons FER, 1999, J ALLERGY CLIN IMMUN, V104, P705, DOI 10.1016/S0091-6749(99)70348-9; Skiest DJ, 1997, AM J MED, V102, P449, DOI 10.1016/S0002-9343(97)00048-X; Smith KJ, 1997, CLIN EXP DERMATOL, V22, P118, DOI 10.1111/j.1365-2230.1997.tb01038.x	32	43	48	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2004	292	21					2614	2621		10.1001/jama.292.21.2614	http://dx.doi.org/10.1001/jama.292.21.2614			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875GU	15572719	Bronze			2022-12-24	WOS:000225409100024
J	West, S; Gromak, N; Proudfoot, NJ				West, S; Gromak, N; Proudfoot, NJ			Human 5 '-> 3 ' exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites	NATURE			English	Article							RNA-POLYMERASE-II; GENE; REQUIRES; PROTEIN; SIGNAL; END	Eukaryotic protein-encoding genes possess poly(A) signals that define the end of the messenger RNA and mediate downstream transcriptional termination by RNA polymerase II (Pol II)(1). Termination could occur through an 'anti-termination' mechanism whereby elongation factors dissociate when the poly(A) signal is encountered, producing termination-competent Pol II2,3. An alternative 'torpedo' model postulated that poly(A) site cleavage provides an unprotected RNA 5' end that is degraded by 5' --> 3' exonuclease activities ( torpedoes) and so	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk	Gromak, Natalia/F-6475-2014; West, Steven/AAG-4009-2019	Gromak, Natalia/0000-0002-4158-3586; Proudfoot, Nicholas/0000-0001-8646-3222; West, Steven/0000-0002-7622-9050				ADAMS SE, 1988, NUCLEIC ACIDS RES, V16, P4287, DOI 10.1093/nar/16.10.4287; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bauren G, 1998, GENE DEV, V12, P2759, DOI 10.1101/gad.12.17.2759; Cerutti H, 2003, TRENDS GENET, V19, P39, DOI 10.1016/S0168-9525(02)00010-0; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; Hammann C, 2002, CHEMBIOCHEM, V3, P691; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Samarsky DA, 1999, P NATL ACAD SCI USA, V96, P6609, DOI 10.1073/pnas.96.12.6609; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Zhang M, 1999, GENOMICS, V59, P252, DOI 10.1006/geno.1999.5866	25	272	277	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					522	525		10.1038/nature03035	http://dx.doi.org/10.1038/nature03035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565158				2022-12-24	WOS:000225322100051
J	Alessandri, G; Pagano, S; Bez, A; Benetti, A; Pozzi, S; Iannolo, G; Baronio, M; Invernici, G; Caruso, A; Muneretto, C; Bisleri, G; Parati, E				Alessandri, G; Pagano, S; Bez, A; Benetti, A; Pozzi, S; Iannolo, G; Baronio, M; Invernici, G; Caruso, A; Muneretto, C; Bisleri, G; Parati, E			Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages	LANCET			English	Article							BONE-MARROW; PROGENITOR CELLS; SATELLITE CELL; STEM/PROGENITOR CELLS; GENE-THERAPY; SPINAL-CORD; EXPRESSION; MULTIPOTENT; PLURIPOTENT; BLOOD	Background Skeletal-muscle-derived stem cells seem to be a distinct population of immature progenitors of satellite cells, but their functional properties remain unclear, especially in human adult tissue. We investigated their differentiation in samples of skeletal muscle obtained from adults undergoing cardiovascular surgery. Methods Samples were obtained from the brachioradialis muscle of 12 patients in whom the radial artery was the conduit for myocardial revascularisation. The stem cells were isolated by a procedure similar to that used for rat gastrocnemius and cultured in medium optimised for growth of neural stem cells. Cytometry was used for phenotypic characterisation and immunocytochemistry and RT-PCR to assess differentiation. Immunohistochemistry was used to examine engraftment of skeletal-muscle-derived stem cells into injured rat spinal cord. Findings The skeletal-muscle stem cells consisted of two distinct types: one with the typical spindle morphology of satellite cells, the other of rounded cells. Some cultures could be maintained for longer than 6 months. The cells were mainly positive for desmin and to a lesser extent CD105, vimentin, and AC133/CD133, but negative for FLK-1/KDR, CD34, CD31, CD45, von Willebrand factor, Ve-cadherins, and BCL2. After in-vitro differentiation, the cells were able to organise skeletal-muscle fibres and stained positively for striated-muscle actin, smooth-muscle actin, and desmin. Moreover, they differentiated into astrocytes and neurons, as confirmed by positive staining for characteristic proteins. Interpretation Adult human skeletal muscle includes a population of progenitor stem cells that can generate cells of the same lineage and cells with neurogenic properties. Muscle may therefore be a tissue source for the isolation of pluripotent stem cells for development of cell-based therapies for human myogenic and neurogenic diseases.	Ist Nazl Neurol Carlo Besta, Lab Neurobiol & Neuroregenerat, I-20131 Milan, Italy; Univ Brescia, Dept Pathol, Brescia, Italy; Univ Brescia, Microbiol Lab, Brescia, Italy; Univ Brescia, Sch Med, Osped Civile, Div Cardiac Surg, Brescia, Italy	IRCCS Istituto Neurologico Besta; University of Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia	Alessandri, G (corresponding author), Ist Nazl Neurol Carlo Besta, Lab Neurobiol & Neuroregenerat, Via Celoria 11, I-20131 Milan, Italy.	neurofarmacologial@istituto-besta.it	Parati, Eugenio A/G-8765-2011; Bisleri, Gianluigi/AAE-9695-2020; Caruso, Arnaldo/H-7818-2014; Iannolo, Gioacchin/AAC-2375-2022; MUNERETTO, Claudio/ACB-5130-2022; Bisleri, Gianluigi/E-7971-2010; Parati, Eugenio Agostino/AAN-5893-2021	MUNERETTO, Claudio/0000-0003-2656-4544; Parati, Eugenio Agostino/0000-0001-5020-6523; iannolo, gioacchin/0000-0002-7710-4735; alessandri, giulio/0000-0002-1861-8461; CARUSO, Arnaldo/0000-0001-5178-566X; Bisleri, Gianluigi/0000-0002-9816-1480				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; Daley GQ, 2003, ANN NY ACAD SCI, V996, P122, DOI 10.1111/j.1749-6632.2003.tb03240.x; Deasy BM, 2002, CURR OPIN MOL THER, V4, P382; Emery AEH, 1998, BRIT MED J, V317, P991, DOI 10.1136/bmj.317.7164.991; Ferrari G, 2002, NEUROMUSCULAR DISORD, V12, pS7, DOI 10.1016/S0960-8966(02)00102-5; Gerlach M, 2002, J NEUROL S3, V249, piii33, DOI DOI 10.1007/S00415-002-1307-Y; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Gray JA, 2000, CELL TRANSPLANT, V9, P153, DOI 10.1177/096368970000900203; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Houldsworth J, 2002, CELL GROWTH DIFFER, V13, P257; Ishikawa F, 2003, ANN NY ACAD SCI, V996, P174, DOI 10.1111/j.1749-6632.2003.tb03245.x; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; LUCAS PA, 1995, WOUND REPAIR REGEN, V3, P457; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Menasche P, 2003, ANN THORAC SURG, V75, pS20, DOI 10.1016/S0003-4975(03)00462-4; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Orlic D, 2003, ANN NY ACAD SCI, V996, P152, DOI 10.1111/j.1749-6632.2003.tb03243.x; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Peault B, 2003, ANN NY ACAD SCI, V996, P132, DOI 10.1111/j.1749-6632.2003.tb03241.x; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Pomyje J, 2003, EUR J HAEMATOL, V70, P143, DOI 10.1034/j.1600-0609.2003.00040.x; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; RAY C, 1995, ANN THORAC SURG, V60, P12; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; REMOND DE, 2002, NEUROSCIENTIST, V5, P457; Rivier F, 2002, CYTOTHERAPY, V4, P513, DOI 10.1080/146532402761624665; Romero-Ramos M, 2002, J NEUROSCI RES, V69, P894, DOI 10.1002/jnr.10374; Royer CL, 2002, IN VITRO CELL DEV-AN, V38, P512, DOI 10.1290/1071-2690(2002)038<0512:MCPCGR>2.0.CO;2; SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Stewart JD, 2003, J CELL PHYSIOL, V196, P70, DOI 10.1002/jcp.10322; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Torrente Y, 2001, CELL TRANSPLANT, V11, P25; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; Young HE, 2001, ANAT RECORD, V263, P350, DOI 10.1002/ar.1112; Young HE, 1999, P SOC EXP BIOL MED, V221, P63, DOI 10.1046/j.1525-1373.1999.d01-55.x; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zanjani ED, 2003, EXP HEMATOL, V31, P406, DOI 10.1016/S0301-472X(03)00051-1; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	60	155	177	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2004	364	9448					1872	1883		10.1016/S0140-6736(04)17443-6	http://dx.doi.org/10.1016/S0140-6736(04)17443-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873HA	15555667				2022-12-24	WOS:000225269300028
J	Sprague, AL; Boynton, WV; Kerry, KE; Janes, DM; Hunten, DM; Kim, KJ; Reedy, RC; Metzger, AE				Sprague, AL; Boynton, WV; Kerry, KE; Janes, DM; Hunten, DM; Kim, KJ; Reedy, RC; Metzger, AE			Mars' south polar Ar enhancement: A tracer for south polar seasonal meridional mixing	SCIENCE			English	Article							GENERAL-CIRCULATION; MARTIAN ATMOSPHERE; SURFACE	The gamma ray spectrometer on the Mars Odyssey spacecraft measured an enhancement of atmospheric argon over southern high latitudes during autumn followed by dissipation during winter and spring. Argon does not freeze at temperatures normal for southern winter (similar to145 kelvin) and is left in the atmosphere, enriched relative to carbon dioxide (CO2), as the southern seasonal cap of CO2 frost accumulates. Calculations of seasonal transport of argon into and out of southern high latitudes point to meridional (north-south) mixing throughout southern winter and spring.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; University of New Mexico; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sprague, AL (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	sprague@lpl.arizona.edu		Reedy, Robert/0000-0002-2189-1303; Kim, Kyeong J/0000-0001-6220-8411				Banfield D, 2003, ICARUS, V161, P319, DOI 10.1016/S0019-1035(02)00044-1; Boynton WV, 2004, SPACE SCI REV, V110, P37, DOI 10.1023/B:SPAC.0000021007.76126.15; CHAMBERLAIN J.W., 1987, THEORY PLANETARY ATM; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002053; Feldman WC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002101; HABERLE RM, COMMUNICATION; HESS SL, 1979, J GEOPHYS RES, V84, P2969, DOI 10.1029/JB084iB06p02969; KELLY N, 2003, 6 INT C MARS, V3244; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1976, SCIENCE, V193, P780, DOI 10.1126/science.193.4255.780; Litvak ML, 2004, SOLAR SYST RES+, V38, P167, DOI 10.1023/B:SOLS.0000030856.83622.17; MCCONNOCHIE TH, 2003, AAS DIVISION PLANETA, P14; MCCONNOCHIE TH, 2003, 6 INT C MARS, V3249; METZGER AE, 1990, J GEOPHYS RES-SOLID, V95, P14695, DOI 10.1029/JB095iB09p14695; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P1447, DOI 10.1029/JB095iB02p01447; Prettyman TH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002139; PRETTYMAN TH, 2004, 35 LUN PLAN SCI C, V1878; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46; Wilson RJ, 1997, GEOPHYS RES LETT, V24, P123, DOI 10.1029/96GL03814	20	57	57	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1364	1367		10.1126/science.1098496	http://dx.doi.org/10.1126/science.1098496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15472041				2022-12-24	WOS:000225301600049
J	Zavaleta, ES; Hulvey, KB				Zavaleta, ES; Hulvey, KB			Realistic species losses disproportionately reduce grassland resistance to biological invaders	SCIENCE			English	Article							ECOSYSTEM FUNCTION; DIVERSITY; BIODIVERSITY; RICHNESS; INVASION; PATTERNS; SUBSETS	Consequences of progressive biodiversity declines depend on the functional roles of individual species and the order in which species are lost. Most studies of the biodiversity-ecosystem functioning relation tackle only the first of these factors. We used observed variation in grassland diversity to design an experimental test of how realistic species losses affect invasion resistance. Because entire plant functional groups disappeared faster than expected by chance, resistance declined dramatically with progressive species losses. Realistic biodiversity losses, even of rare species, can thus affect ecosystem processes far more than indicated by randomized-loss experiments.	Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Zavaleta, ES (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	zavaleta@ucsc.edu	hulvey, k/L-4227-2019; Hulvey, Kris/B-3730-2011	hulvey, k/0000-0001-9062-4113; 				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Atmar W., 1995, NESTEDNESS TEMPERATU; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Blockstein DE, 1998, SCIENCE, V279, P1831, DOI 10.1126/science.279.5358.1831c; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Dukes JS, 2001, OECOLOGIA, V126, P563, DOI 10.1007/s004420000549; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Fox BJ, 1987, EVOL ECOL, V1, P201, DOI 10.1007/BF02067551; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Hadly EA, 2001, EVOL ECOL RES, V3, P477; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; HOBBS RJ, 1991, ECOLOGY, V72, P59, DOI 10.2307/1938902; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; KADMON R, 1995, ECOLOGY, V76, P458, DOI 10.2307/1941204; Lawler SP, 2002, MG POP BIOL, V33, P294; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Magurran A. E., 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0; MCDONALD KA, 1992, CONSERV BIOL, V6, P409, DOI 10.1046/j.1523-1739.1992.06030409.x; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Synge, 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Watkinson AR, 2001, J APPL ECOL, V38, P233, DOI 10.1046/j.1365-2664.2001.00621.x; Weiher E, 2004, OIKOS, V106, P151, DOI 10.1111/j.0030-1299.2004.12545.x; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469	36	253	266	7	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1175	1177		10.1126/science.1102643	http://dx.doi.org/10.1126/science.1102643			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539600	Green Submitted			2022-12-24	WOS:000225193100046
J	Amrani, N; Ganesan, R; Kervestin, S; Mangus, DA; Ghosh, S; Jacobson, A				Amrani, N; Ganesan, R; Kervestin, S; Mangus, DA; Ghosh, S; Jacobson, A			A faux 3 '-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay	NATURE			English	Article							TRANSLATION TERMINATION; POLY(A)-BINDING PROTEIN; INITIATION; YEAST; SURVEILLANCE; RECOGNITION; EFFICIENCY; SEQUENCES; UPSTREAM; POLY(A)	Nonsense-mediated messenger RNA decay (NMD) is triggered by premature translation termination(1-3), but the features distinguishing premature from normal termination are unknown. One model for NMD suggests that decay-inducing factors bound to mRNAs during early processing events are routinely removed by elongating ribosomes but remain associated with mRNAs when termination is premature, triggering rapid turnover(4). Recent experiments(5-7) challenge this notion and suggest a model that posits that mRNA decay is activated by the intrinsically aberrant nature of premature termination(8,9). Here we use a primer extension inhibition ( toeprinting) assay(10) to delineate ribosome positioning and find that premature translation termination in yeast extracts is indeed aberrant. Ribosomes encountering premature UAA or UGA codons in the CAN1 mRNA fail to release and, instead, migrate to upstream AUGs. This anomaly depends on prior nonsense codon recognition and is eliminated in extracts derived from cells lacking the principal NMD factor, Upf1p, or by flanking the nonsense codon with a normal 3' - untranslated region (UTR). Tethered poly(A)-binding protein (Pab1p), used as a mimic of a normal 3'-UTR, recruits the termination factor Sup35p (eRF3) and stabilizes nonsense-containing mRNAs. These findings indicate that efficient termination and mRNA stability are dependent on a properly configured 3'-UTR.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Jacobson, A (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	allan.jacobson@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027757, R01GM027757] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM027757, R01 GM027757] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Iizuka N, 1997, METHODS, V11, P353, DOI 10.1006/meth.1996.0433; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LeBlanc JJ, 2004, J VIROL, V78, P5139, DOI 10.1128/JVI.78.10.5139-5146.2004; Maderazo AB, 2003, MOL CELL BIOL, V23, P842, DOI 10.1128/MCB.23.3.842-851.2003; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; MAQUAT LE, 1995, RNA, V1, P453; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; PEABODY DS, 1986, MOL CELL BIOL, V6, P2695, DOI 10.1128/MCB.6.7.2695; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Stansfield I, 1997, EUR J BIOCHEM, V245, P557, DOI 10.1111/j.1432-1033.1997.00557.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200	30	367	380	5	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					112	118		10.1038/nature03060	http://dx.doi.org/10.1038/nature03060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525991				2022-12-24	WOS:000224854900051
J	Lickert, H; Takeuchi, JK; von Both, I; Walls, JR; McAuliffe, F; Adamson, SL; Henkelman, RM; Wrana, JL; Rossant, J; Bruneau, BG				Lickert, H; Takeuchi, JK; von Both, I; Walls, JR; McAuliffe, F; Adamson, SL; Henkelman, RM; Wrana, JL; Rossant, J; Bruneau, BG			Baf60c is essential for function of BAF chromatin remodelling complexes in heart development	NATURE			English	Article							MAMMALIAN SWI/SNF COMPLEXES; TRANSCRIPTION FACTORS; MUSCLE DIFFERENTIATION; MUTUAL COFACTORS; MOUSE HEART; IN-VIVO; NKX2-5; PROLIFERATION; CARDIOGENESIS; EXPRESSION	Tissue-specific transcription factors regulate several important aspects of embryonic development. They must function in the context of DNA assembled into the higher-order structure of chromatin. Enzymatic complexes such as the Swi/Snf-like BAF complexes remodel chromatin to allow the transcriptional machinery access to gene regulatory elements(1,2). Here we show that Smarcd3, encoding Baf60c, a subunit of the BAF complexes, is expressed specifically in the heart and somites in the early mouse embryo. Smarcd3 silencing by RNA interference in mouse embryos derived from embryonic stem cells causes defects in heart morphogenesis that reflect impaired expansion of the anterior/secondary heart field, and also results in abnormal cardiac and skeletal muscle differentiation. An intermediate reduction in Smarcd3 expression leads to defects in outflow tract remodelling reminiscent of human congenital heart defects. Baf60c overexpressed in cell culture can mediate interactions between cardiac transcription factors and the BAF complex ATPase Brg1, thereby potentiating the activation of target genes. These results reveal tissue-specific and dose-dependent roles for Baf60c in recruiting BAF chromatin remodelling complexes to heart-specific enhancers, providing a novel mechanism to ensure transcriptional regulation during organogenesis.	Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Coll Dublin, Dept Obstet & Gynaecol, Natl Matern Hosp, Dublin 2, Ireland; Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5G 1L4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; National Maternity Hospital, Dublin; University College Dublin; University of Toronto	Rossant, J (corresponding author), Hosp Sick Children, Mouse Imaging Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	rossant@mshri.on.ca; bbruneau@sickkids.ca	HENKELMAN, MARK/W-6847-2019; Adamson, S. Lee/E-4581-2013; Lickert, Heiko/K-9045-2013; Wrana, Jeffrey/F-8857-2013	Adamson, S. Lee/0000-0002-7340-3041; Bruneau, Benoit/0000-0002-0804-7597				Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Biben C, 1996, DEV BIOL, V173, P200, DOI 10.1006/dbio.1996.0017; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Meilhac SM, 2003, DEVELOPMENT, V130, P3877, DOI 10.1242/dev.00580; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Zhou YQ, 2002, PHYSIOL GENOMICS, V10, P113, DOI 10.1152/physiolgenomics.00119.2001	30	382	394	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					107	112		10.1038/nature03071	http://dx.doi.org/10.1038/nature03071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525990				2022-12-24	WOS:000224854900050
J	Thoma, R; Schulz-Gasch, T; D'Arcy, B; Benz, J; Aebi, J; Dehmlow, H; Hennig, M; Stihle, M; Ruf, A				Thoma, R; Schulz-Gasch, T; D'Arcy, B; Benz, J; Aebi, J; Dehmlow, H; Hennig, M; Stihle, M; Ruf, A			Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase	NATURE			English	Article							LANOSTEROL SYNTHASE; SQUALENE CYCLASE; CRYSTAL-STRUCTURE; 2,3-OXIDOSQUALENE; CATION; REFINEMENT; INHIBITORS	In higher organisms the formation of the steroid scaffold is catalysed exclusively by the membrane-bound oxidosqualene cyclase (OSC; lanosterol synthase). In a highly selective cyclization reaction OSC forms lanosterol with seven chiral centres starting from the linear substrate 2,3-oxidosqualene. Valuable data on the mechanism of the complex cyclization cascade have been collected during the past 50 years using suicide inhibitors, mutagenesis studies and homology modelling. Nevertheless it is still not fully understood how the enzyme catalyses the reaction(1,2). Because of the decisive role of OSC in cholesterol biosynthesis it represents a target for the discovery of novel anticholesteraemic drugs that could complement the widely used statins(3). Here we present two crystal structures of the human membrane protein OSC: the target protein with an inhibitor that showed cholesterol lowering in vivo opens the way for the structure-based design of new OSC inhibitors. The complex with the reaction product lanosterol gives a clear picture of the way in which the enzyme achieves product specificity in this highly exothermic cyclization reaction.	Hoffmann La Roche Ag, Pharma Res Discovery Chem, CH-4070 Basel, Switzerland	Roche Holding	Ruf, A (corresponding author), Hoffmann La Roche Ag, Pharma Res Discovery Chem, CH-4070 Basel, Switzerland.	armin.ruf@roche.com						Abe I, 1998, BIOCHEMISTRY-US, V37, P5779, DOI 10.1021/bi980366c; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Brown GR, 1999, J MED CHEM, V42, P1306, DOI 10.1021/jm990038q; Corey EJ, 1996, BIOCHEM BIOPH RES CO, V219, P327, DOI 10.1006/bbrc.1996.0232; Corey EJ, 1997, J AM CHEM SOC, V119, P1277, DOI 10.1021/ja963227w; Corey EJ, 1997, J AM CHEM SOC, V119, P1289, DOI 10.1021/ja963228o; Dehmlow H, 2003, J MED CHEM, V46, P3354, DOI 10.1021/jm021120f; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; GERBER PR, 1992, BIOPOLYMERS, V32, P1003, DOI 10.1002/bip.360320811; Hoshino T, 2002, CHEM COMMUN, P291, DOI 10.1039/b108995c; Jolidon S., 1993, P223; Lenhart A, 2002, CHEM BIOL, V9, P639, DOI 10.1016/S1074-5521(02)00138-2; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Miklis PC, 1998, J AM CHEM SOC, V120, P10482, DOI 10.1021/ja980505d; Milla P, 2002, EUR J BIOCHEM, V269, P2108, DOI 10.1046/j.1432-1033.2002.02861.x; Morand OH, 1997, J LIPID RES, V38, P373; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PORALLA K, 1994, TRENDS BIOCHEM SCI, V19, P157, DOI 10.1016/0968-0004(94)90276-3; Reinert DJ, 2004, CHEM BIOL, V11, P121, DOI 10.1016/j.chembiol.2003.12.013; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; Ruf A, 2004, BIOCHEM BIOPH RES CO, V315, P247, DOI 10.1016/j.bbrc.2004.01.052; Schulz-Gasch T, 2003, J COMPUT CHEM, V24, P741, DOI 10.1002/jcc.10147; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Zoltewicz JA, 1998, J ORG CHEM, V63, P4985, DOI 10.1021/jo9801465	30	252	261	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					118	122		10.1038/nature02993	http://dx.doi.org/10.1038/nature02993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525992				2022-12-24	WOS:000224854900052
J	Canagarajah, B; Leskow, FC; Ho, JYS; Mischak, H; Saidi, LF; Kazanietz, MG; Hurley, JH				Canagarajah, B; Leskow, FC; Ho, JYS; Mischak, H; Saidi, LF; Kazanietz, MG; Hurley, JH			Structural mechanism for lipid activation of the Rac-specific GAP, beta 2-chimaerin	CELL			English	Article							PROTEIN-KINASE-C; PHORBOL ESTER RECEPTOR; CYSTEINE-RICH REGION; CRYSTAL-STRUCTURE; N-CHIMAERIN; SUBCELLULAR-LOCALIZATION; INDUCED TRANSLOCATION; MEMBRANE-BINDING; NIH 3T3-CELLS; DOMAIN	The lipid second messenger diacylglycerol acts by binding to the C1 domains of target proteins, which translocate to cell membranes and are allosterically activated. Here we report the crystal structure at 3.2 Angstrom resolution of one such protein, beta2-chimaerin, a GTPase-activating protein for the small GTPase Rac, in its inactive conformation. The structure shows that in the inactive state, the N terminus of beta2-chimaerin protrudes into the active site of the RacGAP domain, sterically blocking Rac binding. The diacylglycerol and phospholipid membrane binding site on the C1 domain is buried by contacts with the four different regions of beta2-chimaerin: the N terminus, SH2 domain, RacGAP domain, and the linker between the SH2 and C1 domains. Phospholipid binding to the C1 domain triggers the cooperative dissociation of these interactions, allowing the N terminus to move out of the active site and thereby activating the enzyme.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania; University of Pennsylvania	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Mischak, Harald/E-8685-2011	Mischak, Harald/0000-0003-0323-0306	NCI NIH HHS [R01-CA74197] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; AHMED S, 1993, J BIOL CHEM, V268, P10709; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Hurley James H, 2003, Methods Mol Biol, V233, P289; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Hurley JH, 1997, PROTEIN SCI, V6, P477; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P14679, DOI 10.1074/jbc.270.24.14679; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; LEUNG T, 1994, J BIOL CHEM, V269, P12888; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ORR JW, 1994, J BIOL CHEM, V269, P8383; ORR JW, 1992, J BIOL CHEM, V267, P15263; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Slater SJ, 1999, BIOCHEMISTRY-US, V38, P3804, DOI 10.1021/bi982778r; Soltis SM, 1997, J APPL CRYSTALLOGR, V30, P190, DOI 10.1107/S0021889896012939; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; YUAN SX, 1995, CANCER RES, V55, P3456; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	60	105	106	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					407	418		10.1016/j.cell.2004.10.012	http://dx.doi.org/10.1016/j.cell.2004.10.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507211	Bronze			2022-12-24	WOS:000224908300011
J	Lohrer, AM; Thrush, SF; Gibbs, MM				Lohrer, AM; Thrush, SF; Gibbs, MM			Bioturbators enhance ecosystem function through complex biogeochemical interactions	NATURE			English	Article							BIODIVERSITY; DISTURBANCE; PRODUCTIVITY; DIVERSITY; BIOMASS; IMPACTS; TERM	Predicting the consequences of species loss is critically important, given present threats to biological diversity such as habitat destruction, overharvesting and climate change(1). Several empirical studies have reported decreased ecosystem performance ( for example, primary productivity) coincident with decreased biodiversity(2-4), although the relative influence of biotic effects and confounding abiotic factors has been vigorously debated(5-7). Whereas several investigations focused on single trophic levels ( for example, grassland plants)(8,9), studies of whole systems have revealed multiple layers of feedbacks, hidden drivers and emergent properties(10,11), making the consequences of species loss more difficult to predict(12). Here we report functionally important organisms and considerable biocomplexity in a sedimentary seafloor habitat, one of Earth's most widespread ecosystems. Experimental field measurements demonstrate how the abundance of spatangoid urchins - infaunal ( in seafloor sediment) grazers / deposit feeders - is positively related to primary production, as their activities change nutrient fluxes and improve conditions for production by microphytobenthos (sedimentatry microbes and unicellular algae). Declines of spatangoid urchins after trawling are well documented(13,14), and our research linking these bioturbators to important benthic - pelagic fluxes highlights potential ramifications for productivity in coastal oceans.	Natl Inst Water & Atmospher Res, Hamilton, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Lohrer, AM (corresponding author), Natl Inst Water & Atmospher Res, POB 11-115, Hamilton, New Zealand.	d.lohrer@niwa.co.nz	Ross, Donald J/F-7607-2012	Ross, Donald J/0000-0002-8659-3833; Thrush, Simon/0000-0002-4005-3882				Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; CLARK KR, 2001, PRIMER VERSION 5; Daan R, 1996, ICES J MAR SCI, V53, P1036, DOI 10.1006/jmsc.1996.0129; FALKOWSKI P, 1985, J PLANKTON RES, V7, P715, DOI 10.1093/plankt/7.5.715; Ghiold J., 1989, BIOL OCEANOGRAPHY, V6, P79, DOI DOI 10.1080/01965581.1988.10749524; Grasshoff K., 1999, METHODS SEAWATER ANA; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Hector A, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P36; Hector A, 2002, SCIENCE, V295, P639, DOI 10.1126/science.1064815; Herman PMJ, 1999, ADV ECOL RES, V29, P195; Huston MA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P47; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; LOHRER AM, UNPUB J EXP MAR BIOL; Long BG, 1995, MAR ECOL PROG SER, V129, P127, DOI 10.3354/meps129127; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Raffaelli D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P147; Sartory D.P., 1982, SPECTROPHOTOMETRIC A; Snelgrove P, 1997, AMBIO, V26, P578; Thompson Bruce, 1993, Bulletin Southern California Academy of Sciences, V92, P25; THRUSH S, UNPUB ECOLOGY; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.2307/2641273; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valiela I, 1995, MARINE ECOLOGICAL PR	30	413	433	12	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1092	1095		10.1038/nature03042	http://dx.doi.org/10.1038/nature03042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15470385				2022-12-24	WOS:000224730800039
J	van de Beek, D; de Gans, J; Spanjaard, L; Weisfelt, M; Reitsma, JB; Vermeulen, M				van de Beek, D; de Gans, J; Spanjaard, L; Weisfelt, M; Reitsma, JB; Vermeulen, M			Clinical features and prognostic factors in adults with bacterial meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; PNEUMOCOCCAL MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL THERAPY; LUMBAR PUNCTURE; DEXAMETHASONE; SUSCEPTIBILITY; COMPLICATIONS; NETHERLANDS; CHILDREN	BACKGROUND: We conducted a nationwide study in the Netherlands to determine clinical features and prognostic factors in adults with community-acquired acute bacterial meningitis. METHODS: From October 1998 to April 2002, all Dutch patients with community-acquired acute bacterial meningitis, confirmed by cerebrospinal fluid cultures, were prospectively evaluated. All patients underwent a neurologic examination on admission and at discharge, and outcomes were classified as unfavorable (defined by a Glasgow Outcome Scale score of 1 to 4 points at discharge) or favorable (a score of 5). Predictors of an unfavorable outcome were identified through logistic-regression analysis. RESULTS: We evaluated 696 episodes of community-acquired acute bacterial meningitis. The most common pathogens were Streptococcus pneumoniae (51 percent of episodes) and Neisseria meningitidis (37 percent). The classic triad of fever, neck stiffness, and a change in mental status was present in only 44 percent of episodes; however, 95 percent had at least two of the four symptoms of headache, fever, neck stiffness, and altered mental status. On admission, 14 percent of patients were comatose and 33 percent had focal neurologic abnormalities. The overall mortality rate was 21 percent. The mortality rate was higher among patients with pneumococcal meningitis than among those with meningococcal meningitis (30 percent vs. 7 percent, P<0.001). The outcome was unfavorable in 34 percent of episodes. Risk factors for an unfavorable outcome were advanced age, presence of otitis or sinusitis, absence of rash, a low score on the Glasgow Coma Scale on admission, tachycardia, a positive blood culture, an elevated erythrocyte sedimentation rate, thrombocytopenia, and a low cerebrospinal fluid white-cell count. CONCLUSIONS: In adults presenting with community-acquired acute bacterial meningitis, the sensitivity of the classic triad of fever, neck stiffness, and altered mental status is low, but almost all present with at least two of the four symptoms of headache, fever, neck stiffness, and altered mental status. The mortality associated with bacterial meningitis remains high, and the strongest risk factors for an unfavorable outcome are those that are indicative of systemic compromise, a low level of consciousness, and infection with S. pneumoniae.	Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol H2, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de beek, diederik/A-2935-2010; van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X				Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; Arnold AM, 2003, AM J EPIDEMIOL, V157, P74, DOI 10.1093/aje/kwf156; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Aronin Steven I, 2002, Expert Opin Pharmacother, V3, P121, DOI 10.1517/14656566.3.2.121; Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; Auburtin M, 2002, AM J RESP CRIT CARE, V165, P713, DOI 10.1164/ajrccm.165.5.2105110; BOHR V, 1985, J INFECTION, V10, P143, DOI 10.1016/S0163-4453(85)91585-3; BRUYN GAW, 1989, EUR J CLIN MICROBIOL, V8, P695, DOI 10.1007/BF01963754; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; de Gans J, 2003, NEW ENGL J MED, V348, P955; DODGE PR, 1965, NEW ENGL J MED, V272, P954, DOI 10.1056/NEJM196505062721806; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Flores-Cordero JM, 2003, INTENS CARE MED, V29, P1967, DOI 10.1007/s00134-003-1935-4; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Hoen B, 1993, Eur J Med, V2, P28; Hussein AS, 2000, MEDICINE, V79, P360, DOI 10.1097/00005792-200011000-00002; Jennett B., 1981, MANAGEMENT HEAD INJU; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Kellner JD, 2002, PEDIATR INFECT DIS J, V21, P903, DOI 10.1097/00006454-200210000-00004; KIRKPATRICK B, 1994, J INFECTION, V29, P171, DOI 10.1016/S0163-4453(94)90698-X; KRAGSBJERG P, 1994, SCAND J INFECT DIS, V26, P659, DOI 10.3109/00365549409008633; Little R. J. A., 1987, STAT ANAL MISSING DA; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Magnussen C R, 1980, N Y State J Med, V80, P901; McMillan DA, 2001, CLIN INFECT DIS, V33, P969, DOI 10.1086/322612; *NETH REF LAB BACT, 2003, BACT MEN NETH ANN RE; OLSSON RA, 1961, ANN INTERN MED, V55, P545, DOI 10.7326/0003-4819-55-4-545; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Sigurdardottir B, 1997, ARCH INTERN MED, V157, P425, DOI 10.1001/archinte.157.4.425; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; *STAT METH, 2001, STATL; TAUBER MG, 1992, AM J PATHOL, V141, P53; TUNKEL AR, 2001, BACTERIAL MENINGITIS; van Crevel H, 2002, J NEUROL, V249, P129, DOI 10.1007/PL00007855; van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5; van de Beek D, 2002, J INFECT DIS, V186, P1047, DOI 10.1086/344229; van de Beek D, 2002, J ANTIMICROB CHEMOTH, V49, P661, DOI 10.1093/jac/49.4.661; van de Beek D, 2004, ANN INTERN MED, V141, P327, DOI 10.7326/0003-4819-141-4-200408170-00028; van de Beek D, 1997, J ANTIMICROB CHEMOTH, V40, P895, DOI 10.1093/jac/40.6.895; WEISS W, 1967, ARCH INTERN MED, V120, P517, DOI 10.1001/archinte.120.5.517; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	42	916	932	1	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2004	351	18					1849	1859		10.1056/NEJMoa040845	http://dx.doi.org/10.1056/NEJMoa040845			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865SM	15509818	Green Published			2022-12-24	WOS:000224723100008
J	Tso, A; Harris, L; Littlewood, T				Tso, A; Harris, L; Littlewood, T			Acceptability to a general haematology clinic of written responses to referrals: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England	University of Oxford	Littlewood, T (corresponding author), John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England.	tim.littlewood@orh.nhs.uk						Wright D, 1992, Health Trends, V24, P145	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					946	947		10.1136/bmj.38253.703553.F7	http://dx.doi.org/10.1136/bmj.38253.703553.F7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15465846	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000224773200016
J	Berggren, PO; Yang, SN; Murakami, M; Efanov, AM; Uhles, S; Kohler, M; Moede, T; Fernstrom, A; Appelskog, LB; Aspinwall, CA; Zaitsev, SV; Larsson, O; de Vargas, LM; Fecher-Trost, C; Weissgerber, P; Ludwig, A; Leibiger, B; Juntti-Berggren, L; Barker, CJ; Gromada, J; Freichel, M; Leibiger, IB; Flockerzi, V				Berggren, PO; Yang, SN; Murakami, M; Efanov, AM; Uhles, S; Kohler, M; Moede, T; Fernstrom, A; Appelskog, LB; Aspinwall, CA; Zaitsev, SV; Larsson, O; de Vargas, LM; Fecher-Trost, C; Weissgerber, P; Ludwig, A; Leibiger, B; Juntti-Berggren, L; Barker, CJ; Gromada, J; Freichel, M; Leibiger, IB; Flockerzi, V			Removal of Ca2+ channel beta(3) Subunit enhances Ca2+ oscillation frequency and insulin exocytosis	CELL			English	Article							PANCREATIC BETA-CELLS; GATED CALCIUM-CHANNELS; INOSITOL 1,4,5-TRISPHOSPHATE; FUNCTIONAL EXPRESSION; SUBUNIT; COMPLEX; GLUCOSE; TRANSCRIPTION; MODULATION; ACTIVATION	An oscillatory increase in pancreatic beta cell cytoplasmic free Ca2+ concentration, [Ca2+](i), is a key feature in glucose-induced insulin release. The role of the voltage-gated Ca2+ channel beta(3) subunit in the molecular regulation of these [Ca2+](i) oscillations has now been clarified by using beta(3) subunit-deficient beta cells. beta(3) knockout mice showed a more efficient glucose homeostasis compared to wild-type mice due to increased glucose-stimulated insulin secretion. This resulted from an increased glucose-induced [Ca2+](i) oscillation frequency in beta cells lacking the beta(3) subunit, an effect accounted for by enhanced formation of inositol 1,4,5-trisphosphate (InsP(3)) and increased Ca2+ mobilization from intracellular stores. Hence, the beta(3) subunit negatively modulated InsP(3)-induced Ca2+ release, which is not paralleled by any effect on the voltage-gated L type Ca2+ channel. Since the increase in insulin release was manifested only at high glucose concentrations, blocking the beta(3) subunit in the beta cell may constitute the basis for a novel diabetes therapy.	Karolinska Univ Hosp SOlna, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-17176 Stockholm, Sweden; Univ Saarland, D-66421 Homburg, Germany; Lilly Res Labs, D-22419 Hamburg, Germany; Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia; Boston Univ, Sch Med, Evans BIomed Res Ctr, Boston, MA 02118 USA; Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Karolinska Institutet; Karolinska University Hospital; Saarland University; Eli Lilly; Lilly Deutschland GmbH; Lomonosov Moscow State University; Boston University; Technical University of Munich	Berggren, PO (corresponding author), Karolinska Univ Hosp SOlna, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-17176 Stockholm, Sweden.	per-olof.berggren@molmed.ki.se	Tuluc, Petronel/C-2527-2011; Efanov, Alexander/R-3630-2019	Efanov, Alexander/0000-0002-8630-1503; Berggren, Per-Olof/0000-0001-8991-413X; Uhles, Sabine/0000-0002-2836-8726; Kohler, Martin/0000-0001-6487-4303; Aspinwall, Craig/0000-0002-4359-5812; Moede, Tilo/0000-0002-2045-9244	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058508] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK58508] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMMALA C, 1991, NATURE, V353, P849, DOI 10.1038/353849a0; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BARKER CJ, 1995, BIOCHEM J, V306, P557, DOI 10.1042/bj3060557; BARKER CJ, 1994, BIOCHEM J, V297, P265, DOI 10.1042/bj2970265; Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; ROE MW, 1993, J BIOL CHEM, V268, P9953; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; STADDON JM, 1991, J BIOL CHEM, V266, P4840; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; Yu J, 2003, J BIOL CHEM, V278, P46210, DOI 10.1074/jbc.M303743200; Zaitsev SV, 2001, DIABETES, V50, pS70, DOI 10.2337/diabetes.50.2007.S70	34	89	97	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 15	2004	119	2					273	284		10.1016/j.cell.2004.09.033	http://dx.doi.org/10.1016/j.cell.2004.09.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479643	Bronze			2022-12-24	WOS:000224577200014
J	Ozcan, U; Cao, Q; Yilmaz, E; Lee, AH; Iwakoshi, NN; Ozdelen, E; Tuncman, G; Gorgun, C; Glimcher, LH; Hotamisligil, GS				Ozcan, U; Cao, Q; Yilmaz, E; Lee, AH; Iwakoshi, NN; Ozdelen, E; Tuncman, G; Gorgun, C; Glimcher, LH; Hotamisligil, GS			Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTOR; MESSENGER-RNA; ER STRESS; KINASE; RESISTANCE; XBP-1; IRE1; JNK	Obesity contributes to the development of type 2 diabetes, but the underlying mechanisms are poorly understood. Using cell culture and mouse models, we show that obesity causes endoplasmic reticulum (ER) stress. This stress in turn leads to suppression of insulin receptor signaling through hyperactivation of c-Jun N-terminal kinase (JNK) and subsequent serine phosphorylation of insulin receptor substrate-1 (IRS-1). Mice deficient in X-box-binding protein-1 (XBP-1), a transcription factor that modulates the ER stress response, develop insulin resistance. These findings demonstrate that ER stress is a central feature of peripheral insulin resistance and type 2 diabetes at the molecular, cellular, and organismal levels. Pharmacologic manipulation of this pathway may offer novel opportunities for treating these common diseases.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Longo, Kenneth A/A-5631-2010; YILMAZ, ERKAN/O-1592-2014	YILMAZ, ERKAN/0000-0001-7355-3878	NCI NIH HHS [P05-CA100707] Funding Source: Medline; NIAID NIH HHS [AI32412] Funding Source: Medline; NIDDK NIH HHS [DK52539, T32-DK07703] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703, R01DK052539] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligin G. S., 2003, DIABETES MELLITUS, P953; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; KHARROUBI I, 2004, ENDOCRINOLOGY   0805, DOI DOI 10.1210/EN.2004-0478; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; OZCAN U, UNPUB; Reimold AM, 2000, GENE DEV, V14, P152; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	26	2805	2968	12	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					457	461		10.1126/science.1103160	http://dx.doi.org/10.1126/science.1103160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486293				2022-12-24	WOS:000224626500044
J	Potter, BK				Potter, BK			The prince and the professor - With respect, professor, the Prince of Wales is not so wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Asda Hulme, Manchester M15, England; Univ Nottingham, Nottingham NG7 2RD, England	University of Nottingham	Potter, BK (corresponding author), Asda Hulme, Manchester M15, England.	ldyxrkp@nottingham.ac.uk						Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					858	859		10.1136/bmj.329.7470.858-b	http://dx.doi.org/10.1136/bmj.329.7470.858-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472281	Green Published			2022-12-24	WOS:000224472800041
J	Remondes, M; Schuman, EM				Remondes, M; Schuman, EM			Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory	NATURE			English	Article							SLOW-WAVE SLEEP; PLACE; PLASTICITY; LESIONS; AMNESIA; CELLS	A dialogue between the hippocampus and the neocortex is thought to underlie the formation, consolidation and retrieval of episodic memories(1-4), although the nature of this corticohippocampal communication is poorly understood. Using selective electrolytic lesions in rats, here we examined the role of the direct entorhinal projection (temporoammonic, TA) to the hippocampal area CA1 in short-term (24 hours) and long-term (four weeks) spatial memory in the Morris water maze. When short-term memory was examined, both sham- and TA-lesioned animals showed a significant preference for the target quadrant. When re-tested four weeks later, sham- lesioned animals exhibited long-term memory; in contrast, the TA-lesioned animals no longer showed target quadrant preference. Many long-lasting memories require a process called consolidation, which involves the exchange of information between the cortex and hippocampus(3,5,6). The disruption of long-term memory by the TA lesion could reflect a requirement for TA input during either the acquisition or consolidation of long-term memory. To distinguish between these possibilities, we trained animals, verified their spatial memory 24 hours later, and then subjected trained animals to TA lesions. TA-lesioned animals still exhibited a deficit in long-term memory, indicating a disruption of consolidation. Animals in which the TA lesion was delayed by three weeks, however, showed a significant preference for the target quadrant, indicating that the memory had already been adequately consolidated at the time of the delayed lesion. These results indicate that, after learning, ongoing cortical input conveyed by the TA path is required to consolidate long-term spatial memory.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 114-96, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011	Remondes, Miguel/0000-0001-9321-3985				Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; El-Ghundi M, 1999, EUR J PHARMACOL, V383, P95, DOI 10.1016/S0014-2999(99)00573-7; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; JARRARD LE, 1983, BEHAV NEUROSCI, V97, P873, DOI 10.1037/0735-7044.97.6.873; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SKELTON RW, 1992, HIPPOCAMPUS, V2, P73, DOI 10.1002/hipo.450020110; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	27	282	291	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					699	703		10.1038/nature02965	http://dx.doi.org/10.1038/nature02965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470431				2022-12-24	WOS:000224299300043
J	Nemeth, E; Tuttle, MS; Powelson, J; Vaughn, MB; Donovan, A; Ward, DM; Ganz, T; Kaplan, J				Nemeth, E; Tuttle, MS; Powelson, J; Vaughn, MB; Donovan, A; Ward, DM; Ganz, T; Kaplan, J			Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization	SCIENCE			English	Article							INFLAMMATION; TRANSPORTER; EXPRESSION; PROTEIN-2; MEDIATOR; HORMONE; ANEMIA	Hepcidin is a peptide hormone secreted by the liver in response to iron loading and inflammation. Decreased hepcidin leads to tissue iron overload, whereas hepcidin overproduction leads to hypoferremia and the anemia of inflammation. Ferroportin is an iron exporter present on the surface of absorptive enterocytes, macrophages, hepatocytes, and placental cells. Here we report that hepcidin bound to ferroportin in tissue culture cells. After binding, ferroportin was internalized and degraded, leading to decreased export of cellular iron. The posttranslational regulation of ferroportin by hepcidin may thus complete a homeostatic loop: Iron regulates the secretion of hepcidin, which in turn controls the concentration of ferroportin on the cell surface.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; Childrens Hosp, Dept Hematol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital	Ganz, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA.	TGanz@mednet.ucla.edu; jerry.kaplan@path.utah.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Tuttle, Marie/0000-0003-1198-2727; Nemeth, Elizabeta/0000-0002-3477-2397; Ganz, Tomas/0000-0002-2830-5469	NHLBI NIH HHS [HL26922, T35HL007744] Funding Source: Medline; NIDDK NIH HHS [DK30534, DK065029] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007744, R37HL026922, R01HL026922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534, R01DK065029] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aumelas A, 1996, EUR J BIOCHEM, V237, P575, DOI 10.1111/j.1432-1033.1996.0575p.x; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mok H, 2004, DEVELOPMENT, V131, P1859, DOI 10.1242/dev.01081; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; RYSER HJP, 1967, NATURE, V215, P934, DOI 10.1038/215934a0; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Yeh KY, 2004, AM J PHYSIOL-GASTR L, V286, pG385, DOI 10.1152/ajpgi.00246.2003	19	3372	3572	15	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2090	2093		10.1126/science.1104742	http://dx.doi.org/10.1126/science.1104742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15514116				2022-12-24	WOS:000225841000062
J	Williams, SEJ; Wootton, P; Mason, HS; Bould, J; Iles, DE; Riccardi, D; Peers, C; Kemp, PJ				Williams, SEJ; Wootton, P; Mason, HS; Bould, J; Iles, DE; Riccardi, D; Peers, C; Kemp, PJ			Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel	SCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; CAROTID-BODY; LARGE-CONDUCTANCE; CHEMORECEPTOR CELLS; CYTOSOLIC FACTORS; CARBON-MONOXIDE; CENTRAL NEURONS; CURRENTS; MECHANISM; HEME	Modulation of calcium-sensitive potassium (BK) channels by oxygen is important in several mammalian tissues, and in the carotid body it is crucial to respiratory control. However, the identity of the oxygen sensor remains unknown. We demonstrate that hemoxygenase-2 (HO-2) is part of the BK channel complex and enhances channel activity in normoxia. Knockdown of HO-2 expression reduced channel activity, and carbon monoxide, a product of HO-2 activity, rescued this loss of function. Inhibition of BK channels by hypoxia was dependent on HO-2 expression and was augmented by HO-2 stimulation. Furthermore, carotid body cells demonstrated HO-2-dependent hypoxic BK channel inhibition, which indicates that HO-2 is an oxygen sensor that controls channel activity during oxygen deprivation.	Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; Univ Wales Coll Cardiff, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales	University of Leeds; University of Leeds; University of Leeds; University of Leeds; Cardiff University	Kemp, PJ (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England.	KempPJ@Cardiff.ac.uk	Bould, J/GRX-7488-2022; Riccardi, Daniela/A-4674-2010; Kemp, Paul/A-4634-2010; Bould, Jonathan/H-4536-2015	Riccardi, Daniela/0000-0002-7322-3163; Kemp, Paul/0000-0003-2773-973X; Bould, Jonathan/0000-0003-3615-1938; Peers, Chris/0000-0002-8354-346X				Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; COMFIELD DN, 1996, P NATL ACAD SCI USA, V93, P8089; JIANG C, 1994, P NATL ACAD SCI USA, V91, P7198, DOI 10.1073/pnas.91.15.7198; JIANG C, 1994, J PHYSIOL-LONDON, V481, P15, DOI 10.1113/jphysiol.1994.sp020415; Lewis A, 2002, J PHYSIOL-LONDON, V540, P771, DOI 10.1113/jphysiol.2001.013888; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Peng W, 1999, AM J RESP CELL MOL, V20, P737, DOI 10.1165/ajrcmb.20.4.3390; PRABHAKAR NR, 1995, P NATL ACAD SCI USA, V92, P1994, DOI 10.1073/pnas.92.6.1994; Prabhakar NR, 1999, RESP PHYSIOL, V115, P161, DOI 10.1016/S0034-5687(99)00019-5; Riesco-Fagundo AM, 2001, CIRC RES, V89, P430, DOI 10.1161/hh1701.095632; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Thompson RJ, 1998, J PHYSIOL-LONDON, V512, P421, DOI 10.1111/j.1469-7793.1998.421be.x; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Williams SE, 2004, BIOCHEM BIOPH RES CO, V314, P63, DOI 10.1016/j.bbrc.2003.12.052; WYATT CN, 1995, P NATL ACAD SCI USA, V92, P295, DOI 10.1073/pnas.92.1.295	19	370	379	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2093	2097		10.1126/science.1105010	http://dx.doi.org/10.1126/science.1105010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15528406				2022-12-24	WOS:000225841000063
J	Grutzner, F; Rens, W; Tsend-Ayush, E; El-Mogharbel, N; O'Brien, PCM; Jones, RC; Ferguson-Smith, MA; Graves, JAM				Grutzner, F; Rens, W; Tsend-Ayush, E; El-Mogharbel, N; O'Brien, PCM; Jones, RC; Ferguson-Smith, MA; Graves, JAM			In the platypus a meiotic chain of ten sex chromosomes shares genes with the bird Z and mammal X chromosomes	NATURE			English	Article							DETERMINING REGION; Y-CHROMOSOME; DMRT1; MONOTREMATA; DIFFERENTIATION; MARSUPIALS; EVOLUTION; SYSTEM; MEDAKA; DNA	Two centuries after the duck-billed platypus was discovered, monotreme chromosome systems remain deeply puzzling. Karyotypes of males(1), or of both sexes(2-4), were claimed to contain several unpaired chromosomes ( including the X chromosome) that form a multi-chromosomal chain at meiosis. Such meiotic chains exist in plants(5) and insects(6) but are rare in vertebrates(7). How the platypus chromosome system works to determine sex and produce balanced gametes has been controversial for decades(1-4). Here we demonstrate that platypus have five male-specific chromosomes (Y chromosomes) and five chromosomes present in one copy in males and two copies in females ( X chromosomes). These ten chromosomes form a multivalent chain at male meiosis, adopting an alternating pattern to segregate into XXXXX-bearing and YYYYY-bearing sperm. Which, if any, of these sex chromosomes bears one or more sex-determining genes remains unknown. The largest X chromosome, with homology to the human X chromosome, lies at one end of the chain, and a chromosome with homology to the bird Z chromosome lies near the other end. This suggests an evolutionary link between mammal and bird sex chromosome systems, which were previously thought to have evolved independently.	Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; Univ Cambridge, Dept Vet Med, Ctr Vet Sci, Cambridge CB3 0ES, England; Univ Newcastle, Dept Biol Sci, Newcastle, NSW 2308, Australia	Australian National University; University of Cambridge; University of Newcastle	Grutzner, F (corresponding author), Australian Natl Univ, Res Sch Biol Sci, GPO Box 475, Canberra, ACT 2601, Australia.	frank.gruetzner@anu.edu.au	Graves, Jennifer A.M./A-1387-2008; Grutzner, Frank/AAD-5834-2020; Grutzner, Frank/ABB-2820-2021	Grutzner, Frank/0000-0002-3088-7314; Graves, Jennifer/0000-0001-6480-7856				BICK Y, 1992, MEIOTIC CHAIN CHROMO, P64; BICK YAE, 1975, CYTOBIOS, V14, P17; Brunner B, 2001, GENOMICS, V77, P8, DOI 10.1006/geno.2001.6615; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; CLELAND R, 1962, CYTOGENETICS OENOTHE; Eaker S, 2001, J CELL SCI, V114, P2953; FREDGA K, 1970, PHILOS T R SOC B, V259, P15, DOI 10.1098/rstb.1970.0042; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; GRIFFITHS R, 1991, P ROY SOC B-BIOL SCI, V244, P123, DOI 10.1098/rspb.1991.0060; Grutzner F, 2003, COMP BIOCHEM PHYS A, V136, P867, DOI 10.1016/j.cbpb.2003.09.014; Johannisson R, 1994, CHROMOSOME RES, V2, P137, DOI 10.1007/BF01553492; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mizuno S, 2002, CYTOGENET GENOME RES, V99, P236, DOI 10.1159/000071599; MURTAGH CE, 1977, CHROMOSOMA, V65, P37, DOI 10.1007/BF00293129; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; OHNO S, 1967, CHROMOSOMES SEX LINK; Rahn MI, 1996, CHROMOSOME RES, V4, P350, DOI 10.1007/BF02257270; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Rens W, 1999, CHROMOSOME RES, V7, P461, DOI 10.1023/A:1009249813617; RENS W, IN PRESS P NATL ACAD; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; SYREN RM, 1977, NATURE, V266, P167, DOI 10.1038/266167a0; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Toder R, 1997, MAMM GENOME, V8, P418, DOI 10.1007/s003359900459; Watson J.M., 1992, P53; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; WRIGLEY JM, 1984, IN VITRO CELL DEV B, V20, P321; WRIGLEY JM, 1988, CHROMOSOMA, V96, P231, DOI 10.1007/BF00302363	29	200	205	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2004	432	7019					913	917		10.1038/nature03021	http://dx.doi.org/10.1038/nature03021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15502814				2022-12-24	WOS:000225733500056
J	Atkinson, HDE; Nicol, SG; Purkayastha, S; Paterson-Brown, S				Atkinson, HDE; Nicol, SG; Purkayastha, S; Paterson-Brown, S			Surgical management of inguinal hernia: retrospective cohort study in southeastern Scotland, 1985-2001	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REPAIR		Charing Cross Hosp, Dept Orthopaed & Trauma Surg, London W6 8RF, England; Bristol Royal Infirm & Gen Hosp, Dept Trauma & Orthopaed Surg, Bristol, Avon, England; St Marys Hosp, Dept Gen Surg, London, England; Univ Edinburgh, Royal Infirm Edinburgh, Dept Surg, Edinburgh EH3 9YW, Midlothian, Scotland	Imperial College London; Bristol Royal Infirmary; Imperial College London; Royal Infirmary of Edinburgh; University of Edinburgh	Atkinson, HDE (corresponding author), Charing Cross Hosp, Dept Orthopaed & Trauma Surg, London W6 8RF, England.	duscha@hotmail.com	Atkinson, Henry Dushan Edward/AAB-1735-2019	Atkinson, Henry Dushan Edward/0000-0001-6003-207X				Bay-Nielsen M, 2001, LANCET, V358, P1124, DOI 10.1016/S0140-6736(01)06251-1; Grant A, 2000, BRIT J SURG, V87, P854, DOI 10.1046/j.1365-2168.2000.01539.x; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; McCormack K, 2003, Cochrane Database Syst Rev, pCD001785, DOI 10.1002/14651858.CD001785; SCHUMPELICK V, 1994, LANCET, V344, P375	5	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2004	329	7478					1315	1316		10.1136/bmj.38282.675556.F7	http://dx.doi.org/10.1136/bmj.38282.675556.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15546894	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000225657800017
J	Vaugelade, J; Pinchinat, S; Guiella, G; Elguero, E; Simondon, F				Vaugelade, J; Pinchinat, S; Guiella, G; Elguero, E; Simondon, F			Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso	BRITISH MEDICAL JOURNAL			English	Article							WEST-AFRICA; MORTALITY	Objective To study the effect of vaccination on mortality before 2 years of age in a developing country. Design Prospective cohort study. Setting Rural communities in Burkina Faso. Participants 9085 children born in the study area between 1985 and 1993. Main outcome measure Child death rate. Results Mortality before 2 years of age was lower in the group of children who had been vaccinated: those vaccinated with BCG only had significantly lower mortality (0.37, 95% confidence interval 0.29 to 0.48) as did those vaccinated with diphtheria, tetanus, and pertussis only (0.24, 0.13 to 0.43). The second dose of diphtheria, tetanus, and pertussis was not associated with lower mortality (0.80, 0.58 to 1.12). Conclusion Vaccination with diphtheria, tetanus, and pertussis as well as BCG is associated with better survival of children up to 2 years of age.	Inst Rech Dev, Lab Populat Environm & Dev, F-34394 Montpellier 5, France; Biostatem, F-30035 Nimes, France; Unite Etud & Rech Demog, Ouagadougou 03, Burkina Faso	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Vaugelade, J (corresponding author), Inst Rech Dev, Lab Populat Environm & Dev, BP 64501, F-34394 Montpellier 5, France.	vaugelad@ird.fr	Elguero, Eric/J-3014-2012	Simondon, Francois/0000-0003-0395-1314				AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; COX, 1972, J ROY STAT SOC B, P187; FINE P, 2000, BRIT MED J, V321, P1440; GARENNE M, 1991, AM J EPIDEMIOL, V338, P183; HULL HF, 1983, LANCET, V1, P972; JENSEN H, 2002, THESIS U COPENHAGEN; KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; VAUGELADE J, 1988, VARIATIONS MORTALITE; VAUGELADE J, 1997, DEMOGRAPHIC EVALUATI, P123; VAUGELADE J, 2000, PROBLEMATIQUE METHOD	12	73	73	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1309	1311		10.1136/bmj.38261.496366.82	http://dx.doi.org/10.1136/bmj.38261.496366.82			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15550402	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225657800015
J	Mees, A; Klar, T; Gnau, P; Hennecke, U; Eker, APM; Carell, T; Essen, LO				Mees, A; Klar, T; Gnau, P; Hennecke, U; Eker, APM; Carell, T; Essen, LO			Crystal structure of a photolyase bound to a CPD-like DNA lesion after in situ repair	SCIENCE			English	Article							CATALYTIC COFACTOR FADH(-); ELECTRON-TRANSFER; THYMINE DIMERS; MECHANISM; ENZYME; MODEL; RECOGNITION; SUBSTRATE; DAMAGE	DNA photolyases use light energy to repair DNA that comprises ultrarviolet-induced lesions such as the cis-syn cyclobutane pyrimidine dimers (CPDs). Here we report the crystal structure of a DNA photolyase bound to duplex DNA that is bent by 50degrees and comprises a synthetic CPD lesion. This CPD lesion is flipped into the active site and split there into two thymines by synchrotron radiation at 100 K. Although photolyases catalyze blue light-driven CPD cleavage only above 200 K, this structure apparently mimics a structural substate during light-driven DNA repair in which back-flipping of the thymines into duplex DNA has not yet taken place.	Univ Marburg, Dept Chem, D-35032 Marburg, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Erasmus Univ, Dept Cell Biol & Genet, Med Genet Centrum, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Philipps University Marburg; University of Munich; Erasmus University Rotterdam; Erasmus MC	Carell, T (corresponding author), Univ Marburg, Dept Chem, Hans Meerwin Str, D-35032 Marburg, Germany.	thomas.carell@cup.uni-muenchen.de; essen@chemie.uni-marburg.de	Carell, Thomas/G-4799-2012; Essen, Lars-Oliver/L-3862-2016; Hennecke, Ulrich/A-7723-2010	Carell, Thomas/0000-0001-7898-2831; Essen, Lars-Oliver/0000-0003-4272-4026; Hennecke, Ulrich/0000-0002-4904-6793				Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Butenandt J, 2000, CHEM-EUR J, V6, P62, DOI 10.1002/(SICI)1521-3765(20000103)6:1<62::AID-CHEM62>3.3.CO;2-Z; Carell T, 2001, CURR OPIN CHEM BIOL, V5, P491, DOI 10.1016/S1367-5931(00)00239-8; Christine KS, 2002, J BIOL CHEM, V277, P38339, DOI 10.1074/jbc.M206531200; Hahn J, 1999, J PHYS CHEM B, V103, P2001, DOI 10.1021/jp984197h; HUSAIN I, 1987, J BIOL CHEM, V262, P13188; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; KIENER A, 1989, J BIOL CHEM, V264, P13880; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Kort R, 2004, ACTA CRYSTALLOGR D, V60, P1205, DOI 10.1107/S0907444904009321; Langenbacher T, 1997, J AM CHEM SOC, V119, P10532, DOI 10.1021/ja9721024; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Medvedev D, 2001, J THEOR BIOL, V210, P237, DOI 10.1006/jtbi.2001.2291; MIKI K, 1993, J MOL BIOL, V233, P167, DOI 10.1006/jmbi.1993.1492; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pezeshk A, 1996, J PHYS CHEM-US, V100, P19714, DOI 10.1021/jp962196o; Rak J, 1999, J PHYS CHEM A, V103, P3569, DOI 10.1021/jp9901545; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sanders DB, 1999, J AM CHEM SOC, V121, P5127, DOI 10.1021/ja982660y; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Torizawa T, 2004, J BIOL CHEM, V279, P32950, DOI 10.1074/jbc.M404536200; Vande Berg BJ, 1998, J BIOL CHEM, V273, P20276, DOI 10.1074/jbc.273.32.20276; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Weber S, 2001, J AM CHEM SOC, V123, P3790, DOI 10.1021/ja003426m	26	296	301	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1789	1793		10.1126/science.1101598	http://dx.doi.org/10.1126/science.1101598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576622				2022-12-24	WOS:000225630800057
J	Wadsworth, JDF; Asante, EA; Desbruslais, M; Linehan, JM; Joiner, S; Gowland, I; Welch, J; Stone, L; Lloyd, SE; Hill, AF; Brandner, S; Collinge, J				Wadsworth, JDF; Asante, EA; Desbruslais, M; Linehan, JM; Joiner, S; Gowland, I; Welch, J; Stone, L; Lloyd, SE; Hill, AF; Brandner, S; Collinge, J			Human prion protein with valine 129 prevents expression of variant CJD phenotype	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; BLOOD-TRANSFUSION; STRAIN VARIATION; SUSCEPTIBILITY; MICE; BSE; TRANSMISSION; GENOTYPE; VCJD	Variant Creutzfeldt-jpkob disease (vCJD) is a unique and highly distinctive clinicopathological and molecular phenotype of human prion disease associated with infection with bovine spongiform encephalopathy (BSE)-like prions. Here, we found that generation of this phenotype in transgenic mice required expression of human prion protein (PrP) with methionine 129. Expression of human PrP with valine 129 resulted in a distinct phenotype and, remarkably, persistence of a barrier to transmission of BSE-derived prions on subpassage. Polymorphic residue 129 of human PrP dictated propagation of distinct prion strains after BSE prion infection. Thus, primary and secondary human infection with BSE-derived prions may result in sporadic CJD-like or novel phenotypes in addition to vCJD, depending on the genotype of the prion source and the recipient.	UCL, MRC, Prion Unit, London WC1N 3BG, England; UCL, Dept Neurodegenerat Dis, Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL, MRC, Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009	Brandner, Sebastian/0000-0002-9821-0342; Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Wadsworth, Jonathan/0000-0002-4797-2259; Asante, Emmanuel A/0000-0003-3771-4843	Medical Research Council [MC_U123160653, MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; ASANTE EA, UNPUB; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	21	203	207	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1793	1796		10.1126/science.1103932	http://dx.doi.org/10.1126/science.1103932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15539564				2022-12-24	WOS:000225630800058
J	Emerson, SU; Purcell, RH				Emerson, SU; Purcell, RH			Global health - Running like water - The omnipresence of hepatitis E	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAID, Mol Hepatitis Sect, NIH, Bethesda, MD 20892 USA; NIAID, Hepatitis Viruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Emerson, SU (corresponding author), NIAID, Mol Hepatitis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000311, ZIAAI000596, Z01AI000596, ZIAAI000311] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Xing L, 1999, VIROLOGY, V265, P35, DOI 10.1006/viro.1999.0005	1	64	71	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2367	2368		10.1056/NEJMp048285	http://dx.doi.org/10.1056/NEJMp048285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575050				2022-12-24	WOS:000225429000003
J	Alonso, JM; Stepanova, AN				Alonso, JM; Stepanova, AN			The ethylene signaling pathway	SCIENCE			English	Article							RECEPTOR GENE FAMILY; RAF-LIKE KINASE; RESPONSE PATHWAY; ARABIDOPSIS-THALIANA; CTR1; TRANSDUCTION; ETR1; GAS; ETHYLENE-INSENSITIVE3; PERSPECTIVE	Plants use a structurally very simple gas molecule, the hydrocarbon ethylene, to modulate various developmental programs and coordinate responses to a multitude of external stress factors. How this simple molecule generates such a diverse array of effects has been the subject of intense research for the past two decades. A fascinating signaling pathway, with classical as well as novel plant-specific signaling elements, is emerging from these studies. We describe the four main modules that constitute this signaling pathway: a phosphotransfer relay, an EIN2-based unit, a ubiquitin-mediated protein degradation component, and a transcriptional cascade. The canonical and Arabidopsis ethylene signaling pathways in the Signal Transduction Knowledge Environment Connections Maps provide a complete panoramic view of these signaling events in plants.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Alonso, JM (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	jmalonso@unity.ncsu.edu	Alonso, Jose M/K-6826-2014; Stepanova, Anna/P-9575-2019	Alonso, Jose M/0000-0001-7087-1571; Stepanova, Anna/0000-0003-1018-4758				Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Bleecker AB, 1999, TRENDS PLANT SCI, V4, P269, DOI 10.1016/S1360-1385(99)01427-2; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hirayama T, 2000, PLANT CELL PHYSIOL, V41, P548, DOI 10.1093/pcp/41.5.548; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Hyodo H., 1991, PLANT HORMONE ETHYLE; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Klee HJ, 2004, PLANT PHYSIOL, V135, P660, DOI 10.1104/pp.104.040998; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MOUSSATCHE P, 2004, IN PRESS J BIOL 0909; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; STEPANOVA AN, 2004, SCI STKE         NOV; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100	30	147	162	5	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2004	306	5701					1513	1515		10.1126/science.1104812	http://dx.doi.org/10.1126/science.1104812			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567852				2022-12-24	WOS:000225442700046
J	Dorigo, B; Schalch, T; Kulangara, A; Duda, S; Schroeder, RR; Richmond, TJ				Dorigo, B; Schalch, T; Kulangara, A; Duda, S; Schroeder, RR; Richmond, TJ			Nucleosome arrays reveal the two-start organization of the chromatin fiber	SCIENCE			English	Article							HIGHER-ORDER STRUCTURE; HISTONE H1; METAPHASE CHROMOSOMES; ANGSTROM RESOLUTION; LINKER HISTONES; CORE PARTICLE; IN-VIVO; LENGTH	Chromatin folding determines the accessibility of DNA constituting eukaryotic genomes and consequently is profoundly important in the mechanisms of nuclear processes such as gene regulation. Nucleosome arrays compact to form a 30-nanometer chromatin fiber of hitherto disputed structure. Two competing classes of models have been proposed in which nucleosomes are either arranged linearly in a one-start higher order helix or zigzag back and forth in a two-start helix. We analyzed compacted nucleosome arrays stabilized by introduction of disulfide cross-links and show that the chromatin fiber comprises two stacks of nucleosomes in accord with the two-start model.	ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Max Planck Inst Med Res, Dept Biomed Mech, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Richmond, TJ (corresponding author), ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	richmond@mot.biol.ethz.ch	Schalch, Thomas/E-7507-2010; Schröder, Rasmus R/S-6220-2016; Schalch, Thomas/A-6007-2014	Schalch, Thomas/0000-0002-0758-3013				Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DORIGO B, UNPUB; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; RATTNER JB, 1978, CHROMOSOMA, V69, P363, DOI 10.1007/BF00332139; Richmond TJ, 2000, CHROMATIN STRUCTURE, P1; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Van Holde KE, 1988, SPRINGER SERIES MOL; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; WORCEL A, 1981, P NATL ACAD SCI-BIOL, V78, P1461, DOI 10.1073/pnas.78.3.1461	22	412	426	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1571	1573		10.1126/science.1103124	http://dx.doi.org/10.1126/science.1103124			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567867				2022-12-24	WOS:000225442700064
J	Shapiro, B; Drummond, AJ; Rambaut, A; Wilson, MC; Matheus, PE; Sher, AV; Pybus, OG; Gilbert, MTP; Barnes, I; Binladen, J; Willerslev, E; Hansen, AJ; Baryshnikov, GF; Burns, JA; Davydov, S; Driver, JC; Froese, DG; Harington, CR; Keddie, G; Kosintsev, P; Kunz, ML; Martin, LD; Stephenson, RO; Storer, J; Tedford, R; Zimov, S; Cooper, A				Shapiro, B; Drummond, AJ; Rambaut, A; Wilson, MC; Matheus, PE; Sher, AV; Pybus, OG; Gilbert, MTP; Barnes, I; Binladen, J; Willerslev, E; Hansen, AJ; Baryshnikov, GF; Burns, JA; Davydov, S; Driver, JC; Froese, DG; Harington, CR; Keddie, G; Kosintsev, P; Kunz, ML; Martin, LD; Stephenson, RO; Storer, J; Tedford, R; Zimov, S; Cooper, A			Rise and fall of the Beringian steppe bison	SCIENCE			English	Article							ICE-FREE CORRIDOR; EUROPEAN CATTLE; EXTINCTION; PALEOENVIRONMENTS; LAURENTIDE; OVERKILL; ORIGINS; HISTORY; MAMMALS; CANADA	The widespread extinctions of large mammals at the end of the Pleistocene epoch have often been attributed to the depredations of humans; here we present genetic evidence that questions this assumption. We used ancient DNA and Bayesian techniques to reconstruct a detailed genetic history of bison throughout the late Pleistocene and Holocene epochs. Our analyses depict a large diverse population living throughout Beringia until around 37,000 years before the present, when the population's genetic diversity began to decline dramatically. The timing of this decline correlates with environmental changes associated with the onset of the last glacial cycle, whereas archaeological evidence does, not support the presence of large populations of humans in Eastern Beringia until more than 15,000 years later.	Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Douglas Coll, Dept Geol, New Westminster, BC V3L 5B2, Canada; Douglas Coll, Dept Anthropol, New Westminster, BC V3L 5B2, Canada; Univ Alaska Fairbanks, Alaska Quaternary Ctr, Fairbanks, AK 99775 USA; Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; UCL, Dept Biol, Ctr Genet Anthropol, London WC1E 6BT, England; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen, Denmark; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; Prov Museum Alberta, Edmonton, AB T5N 0M6, Canada; Russian Acad Sci, NE Sci Stn, Cherskii, Republic Sakha, Russia; Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Canadian Museum Nat Paleobiol, Ottawa, ON K1P 6P4, Canada; Royal British Columbia Museum, Dept Archaeol, Victoria, BC V8V 1X4, Canada; Russian Acad Sci, Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; Bur Land Management, Fairbanks, AK 99708 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Alaska Dept Fish & Game, Fairbanks, AK 99701 USA; Yukon Dept Tourism & Culture, Heritage Resources, Whitehorse, YT Y1A 2C6, Canada; Amer Museum Nat Hist, Dept Paleontol, New York, NY 10024 USA	University of Oxford; University of Oxford; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; University of London; University College London; University of Copenhagen; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Russian Academy of Sciences; Simon Fraser University; University of Alberta; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Kansas; Alaska Department of Fish & Game; American Museum of Natural History (AMNH)	Cooper, A (corresponding author), Univ Oxford, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	alan.cooper@zoo.ox.ac.uk	Barnes, Ian C/B-8081-2008; Cooper, Alan/E-8171-2012; Gilbert, Marcus TP/A-8936-2013; Zimov, Sergey/K-3009-2018; Willerslev, Eske/AAA-5686-2019; Froese, Duane G/B-6038-2009; Davydov, Sergei P./S-9906-2018; Hansen, Anders Johannes/A-5608-2013; Drummond, Alexei J/A-3209-2010; Rambaut, Andrew/B-2481-2009; Driver, Jonathan/D-1013-2009; Willerslev, Eske/A-9619-2011; Pybus, Oliver G/B-2640-2012; Baryshnikov, Gennady/AAE-1972-2020; Cooper, Andrew/AAH-4251-2020	Barnes, Ian C/0000-0001-8322-6918; Cooper, Alan/0000-0002-7738-7851; Gilbert, Marcus TP/0000-0002-5805-7195; Hansen, Anders Johannes/0000-0002-1890-2702; Drummond, Alexei J/0000-0003-4454-2576; Rambaut, Andrew/0000-0003-4337-3707; Willerslev, Eske/0000-0002-7081-6748; Pybus, Oliver G/0000-0002-8797-2667; Cooper, Andrew/0000-0003-4972-8812; Driver, Jonathan/0000-0002-9782-641X; Shapiro, Beth/0000-0002-2733-7776; Zimov, Sergey/0000-0002-0053-6599; Davydov, Sergei/0000-0003-0820-9426				Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Anderson PH, 2001, QUATERNARY SCI REV, V20, P93, DOI 10.1016/S0277-3791(00)00129-3; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brook BW, 2004, J BIOGEOGR, V31, P517, DOI 10.1046/j.1365-2699.2003.01028.x; Burns JA, 1996, QUATERN INT, V32, P107, DOI 10.1016/1040-6182(95)00057-7; Catto N, 1996, QUATERN INT, V32, P21, DOI 10.1016/S1040-6182(96)90012-9; DRIVER JC, 2001, BRIT ARCHAEOLOGICAL, V0944, P00013; Drummond AJ, 2002, GENETICS, V161, P1307; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Graham RW, 1996, SCIENCE, V272, P1601; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Halsey LA, 1998, CLIMATIC CHANGE, V40, P315, DOI 10.1023/A:1005425124749; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; McDonald JN, 1981, N AM BISON THEIR CLA; Morlan RE, 2003, QUATERNARY RES, V60, P123, DOI 10.1016/S0033-5894(03)00070-X; Pannell JR, 2003, EVOLUTION, V57, P949; Roe F. G., 1970, N AM BUFFALO; SKINNER MF, 1947, B AM MUS NAT HIST, V89, P126; STEPHENSON RO, 2001, BRIT ARCHAEOLOGICAL, V944, P125; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Wilson MC, 1996, QUATERN INT, V32, P97, DOI 10.1016/S1040-6182(96)90017-8; Yesner DR, 2001, QUATERNARY SCI REV, V20, P315, DOI 10.1016/S0277-3791(00)00114-1; Zazula GD, 2003, NATURE, V423, P603, DOI 10.1038/423603a	30	514	531	1	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2004	306	5701					1561	1565		10.1126/science.1101074	http://dx.doi.org/10.1126/science.1101074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567864	Green Published			2022-12-24	WOS:000225442700061
J	Bock-Marquette, I; Saxena, A; White, MD; DiMaio, JM; Srivastava, D				Bock-Marquette, I; Saxena, A; White, MD; DiMaio, JM; Srivastava, D			Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; BETA-THYMOSINS; ACTIN; PROTEINS; PEPTIDE; DOMAIN; B/AKT; SERUM	Heart disease is a leading cause of death in newborn children and in adults. Efforts to promote cardiac repair through the use of stem cells hold promise but typically involve isolation and introduction of progenitor cells. Here, we show that the G-actin sequestering peptide thymosin beta4 promotes myocardial and endothelial cell migration in the embryonic heart and retains this property in postnatal cardiomyocytes. Survival of embryonic and postnatal cardiomyocytes in culture was also enhanced by thymosin beta4. We found that thymosin beta4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt ( also known as protein kinase B). After coronary artery ligation in mice, thymosin beta4 treatment resulted in upregulation of ILK and Akt activity in the heart, enhanced early myocyte survival and improved cardiac function. These findings suggest that thymosin beta4 promotes cardiomyocyte migration, survival and repair and the pathway it regulates may be a new therapeutic target in the setting of acute myocardial damage.	Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA; Childrens Med Ctr Dallas, Dallas, TX 75390 USA; Univ Pecs, Fac Med, Dept Med Genet & Child Dev, H-7624 Pecs, Hungary	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pecs	Srivastava, D (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Deepak.Srivastava@UTSouthwestern.edu		Saxena, Ankur/0000-0001-8646-2887				*AM HEART ASS, 2004, HEART DIS STROK STAT, P11; Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Frohm M, 1996, EUR J BIOCHEM, V237, P86, DOI 10.1111/j.1432-1033.1996.0086n.x; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Garner LB, 2003, AM J PHYSIOL-HEART C, V285, pH2500, DOI 10.1152/ajpheart.00432.2003; GomezMarquez J, 1996, BBA-GENE STRUCT EXPR, V1306, P187, DOI 10.1016/0167-4781(96)00003-6; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huang WQ, 2001, EXP HEMATOL, V29, P12, DOI 10.1016/S0301-472X(00)00634-2; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; LIN SC, 1990, J MOL NEUROSCI, V2, P35, DOI 10.1007/BF02896924; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Mora CA, 1997, INT J IMMUNOPHARMACO, V19, P1, DOI 10.1016/S0192-0561(97)00005-2; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Philp D, 2003, WOUND REPAIR REGEN, V11, P19, DOI 10.1046/j.1524-475X.2003.11105.x; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; SAFER D, 1991, J BIOL CHEM, V266, P4029; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Sun HQ, 1996, J BIOL CHEM, V271, P9223, DOI 10.1074/jbc.271.16.9223; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; van den Hoff MJB, 1999, DEV BIOL, V212, P477, DOI 10.1006/dbio.1999.9366; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; YU FX, 1993, J BIOL CHEM, V268, P502; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	38	531	579	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					466	472		10.1038/nature03000	http://dx.doi.org/10.1038/nature03000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565145				2022-12-24	WOS:000225322100037
J	Kim, M; Krogan, NJ; Vasiljeva, L; Rando, OJ; Nedea, E; Greenblatt, JF; Buratowski, S				Kim, M; Krogan, NJ; Vasiljeva, L; Rando, OJ; Nedea, E; Greenblatt, JF; Buratowski, S			The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II	NATURE			English	Article							SMALL NUCLEOLAR RNAS; KINASE CTDK-I; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; DOMAIN; GENOME; EXORIBONUCLEASE; IDENTIFICATION; COMPONENT; COMPLEXES	The carboxy-terminal domain (CTD) of the RNA polymerase II (RNApII) largest subunit consists of multiple heptapeptide repeats with the consensus sequence YSPTSPS. Different CTD phosphorylation patterns act as recognition sites for the binding of various messenger RNA processing factors, thereby coupling transcription and mRNA processing(1). Polyadenylation factors are co-transcriptionally recruited by phosphorylation of CTD serine 2 (ref. 2) and these factors are also required for transcription termination(3,4). RNApII transcribes past the poly(A) site, the RNA is cleaved by the polyadenylation machinery, and the RNA downstream of the cleavage site is degraded. Here we show that Rtt103 and the Rat1/Rai1 5' --> 3' exonuclease are localized at 3' ends of protein coding genes. In rat1-1 or rai1Delta cells, RNA 3' to polyadenylation sites is greatly stabilized and termination defects are seen at many genes. These findings support a model in which poly(A) site cleavage and subsequent degradation of the 3'-downstream RNA by Rat1 trigger transcription termination(5,6).	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of Toronto; Harvard University	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu	Vasilieva, Lidia/AAU-1473-2020; NEDEA, EDUARD/D-5476-2009	Vasiljeva, Lidia/0000-0002-1244-8772; Rando, Oliver/0000-0003-1516-9397				Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CONNELLY S, 1989, CELL, V57, P561, DOI 10.1016/0092-8674(89)90126-8; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Qu LH, 1999, MOL CELL BIOL, V19, P1144; Scholes DT, 2001, GENETICS, V159, P1449; Skaar DA, 2002, MOL CELL, V10, P1429, DOI 10.1016/S1097-2765(02)00731-1; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Ujvari A, 2002, J BIOL CHEM, V277, P32527, DOI 10.1074/jbc.M201145200; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Yonaha M, 2000, EMBO J, V19, P3770, DOI 10.1093/emboj/19.14.3770; Zhao J, 1999, MOL CELL BIOL, V19, P7733	29	366	374	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					517	522		10.1038/nature03041	http://dx.doi.org/10.1038/nature03041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565157				2022-12-24	WOS:000225322100050
J	Batey, RT; Gilbert, SD; Montange, RK				Batey, RT; Gilbert, SD; Montange, RK			Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine	NATURE			English	Article							RNA-PROTEIN RECOGNITION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; INDUCED FIT; BINDING; RIBOZYMES; SELECTION; SWITCHES; APTAMER; MOTIF	Riboswitches are genetic regulatory elements found in the 50 untranslated region of messenger RNA that act in the absence of protein cofactors(1,2). They are broadly distributed across bacteria and account for the regulation of more than 2% of all genes in Bacillus subtilis, underscoring their importance in the control of cellular metabolism(3). The 5' untranslated region of many mRNAs of genes involved in purine metabolism and transport contain a guanine-responsive riboswitch that directly binds guanine, hypoxanthine or xanthine to terminate transcription(3,4). Here we report the crystal structure at 1.95 Angstrom resolution of the purine-binding domain of the guanine riboswitch from the xpt-pbuX operon of B. subtilis bound to hypoxanthine, a prevalent metabolite in the bacterial purine salvage pathway. This structure reveals a complex RNA fold involving several phylogenetically conserved nucleotides that create a binding pocket that almost completely envelops the ligand. Hypoxanthine functions to stabilize this structure and to promote the formation of a downstream transcriptional terminator element, thereby providing a mechanism for directly repressing gene expression in response to an increase in intracellular concentrations of metabolite.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, 215 UCB, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008759, T32 GM142607] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baugh C, 2000, J MOL BIOL, V301, P117, DOI 10.1006/jmbi.2000.3951; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; Correll CC, 2003, NUCLEIC ACIDS RES, V31, P6806, DOI 10.1093/nar/gkg908; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan P, 1996, J MOL BIOL, V258, P480, DOI 10.1006/jmbi.1996.0263; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Johansen LE, 2003, J BACTERIOL, V185, P5200, DOI 10.1128/JB.185.17.5200-5209.2003; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kieft JS, 2004, RNA, V10, P988, DOI 10.1261/rna.7040604; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Silverman SK, 2003, RNA, V9, P377, DOI 10.1261/rna.2200903; TERWILLIGER T, 2001, J SYNCHROTRON RADIAT, V11, P49; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Zimmermann GR, 1997, NAT STRUCT BIOL, V4, P644, DOI 10.1038/nsb0897-644	28	393	428	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					411	415		10.1038/nature03037	http://dx.doi.org/10.1038/nature03037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549109				2022-12-24	WOS:000225161400060
J	Gershon, D				Gershon, D			Making connections	NATURE			English	Article																			0	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	2004	432	7014					243	+		10.1038/432243a	http://dx.doi.org/10.1038/432243a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538372	Bronze			2022-12-24	WOS:000225020200051
J	Stomp, M; Huisman, J; de Jongh, F; Veraart, AJ; Gerla, D; Rijkeboer, M; Ibelings, BW; Wollenzien, UIA; Stal, LJ				Stomp, M; Huisman, J; de Jongh, F; Veraart, AJ; Gerla, D; Rijkeboer, M; Ibelings, BW; Wollenzien, UIA; Stal, LJ			Adaptive divergence in pigment composition promotes phytoplankton biodiversity	NATURE			English	Article							COMPETITION; MARINE; LIGHT; PHOTOTROPHY	The dazzling diversity of the phytoplankton has puzzled biologists for decades(1-5). The puzzle has been enlarged rather than solved by the progressive discovery of new phototrophic microorganisms in the oceans, including picocyanobacteria(6,7), pico-eukaryotes(8), and bacteriochlorophyll-based(9-11) and rhodopsin-based phototrophic bacteria(12,13). Physiological and genomic studies suggest that natural selection promotes niche differentiation among these phototrophic microorganisms, particularly with respect to their photosynthetic characteristics(14-16). We have analysed competition for light between two closely related picocyanobacteria of the Synechococcus group that we isolated from the Baltic Sea(17). One of these two has a red colour because it contains the pigment phycoerythrin, whereas the other is blue-green because it contains high contents of the pigment phycocyanin. Here we report theory and competition experiments that reveal stable coexistence of the two picocyanobacteria, owing to partitioning of the light spectrum. Further competition experiments with a third marine cyanobacterium, capable of adapting its pigment composition, show that this species persists by investing in the pigment that absorbs the colour not used by its competitors. These results demonstrate the adaptive significance of divergence in pigment composition of phototrophic microorganisms, which allows an efficient utilization of light energy and favours species coexistence.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands; Netherlands Inst Ecol NIOO KNAW, Ctr Limnol, NL-3631 AC Nieuwersluis, Netherlands; Netherlands Inst Ecol NIOO KNAW, Ctr Estuarine & Marine Ecol, NL-4400 AC Yerseke, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Nieuwe Achtergracht 127, NL-1018 WS Amsterdam, Netherlands.	jef.huisman@science.uva.nl	Veraart, Annelies J/E-1927-2014; Stomp, Maayke/J-1484-2012; Gerla, Daan/A-4170-2009; Ibelings, Bas W/B-4237-2011; Stal, Lucas J/B-3334-2011; Huisman, Jef/A-1089-2013	Veraart, Annelies J/0000-0001-6286-7484; Gerla, Daan/0000-0002-2847-5273; Ibelings, Bas W/0000-0002-7213-7407; Huisman, Jef/0000-0001-9598-3211				Abrams PA, 1999, AM NAT, V153, P83, DOI 10.1086/303154; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Ernst A, 2003, MICROBIOL-SGM, V149, P217, DOI 10.1099/mic.0.25475-0; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jonker RR, 1995, WATER SCI TECHNOL, V32, P177, DOI 10.1016/0273-1223(95)00696-6; Kirk J. T. O., 2011, LIGHT PHOTOSYNTHESIS; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; OHKI K, 1985, PLANT PHYSIOL, V79, P943, DOI 10.1104/pp.79.4.943; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SATHYENDRANATH S, 1989, LIMNOL OCEANOGR, V34, P188, DOI 10.4319/lo.1989.34.1.0188; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; Tilman D., 1982, Monographs in Population Biology, pi; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0	28	207	214	9	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					104	107		10.1038/nature03044	http://dx.doi.org/10.1038/nature03044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15475947				2022-12-24	WOS:000224854900049
J	Gill, TM; Allore, HG; Holford, TR; Guo, ZC				Gill, TM; Allore, HG; Holford, TR; Guo, ZC			Hospitalization, restricted activity, and the development of disability among older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; FUNCTIONAL DEPENDENCE; PHYSICAL PERFORMANCE; HOME CARE; SUBSEQUENT DISABILITY; COGNITIVE IMPAIRMENT; CONTROLLED-TRIAL; ELDERLY PERSONS; UNITED-STATES; NURSING-HOME	Context Preventing the development of disability in activities of daily living is an important goal in older adults, yet relatively little is known about the disabling process. Objectives To evaluate the relationship between 2 types of intervening events (hospitalization and restricted activity) and the development of disability and to determine whether this relationship is modified by the presence of physical frailty. Design, Setting, and Participants Prospective cohort study, conducted in the general community in greater New Haven, Conn, from March 1998 to March 2003, of 754 persons aged 70 years or older, who were not disabled (ie, required no personal assistance) in 4 essential activities of daily living: bathing, dressing, walking inside the house, and transferring from a chair. Participants were categorized into 2 groups according to the presence of physical frailty (defined on the basis of slow gait speed) and were followed up with monthly telephone interviews for up to 5 years to ascertain exposure to intervening events and determine the occurrence of disability. Main Outcome Measure Disability, defined as the need for personal assistance in bathing, dressing, walking inside the house, or transferring from a chair. Results During the 5-year follow-up period, disability developed among 417 (55.3%) participants, 372 (49.3%) were hospitalized and 600 (79.6%) had at least 1 episode of restricted activity. The multivariable hazard ratios for the development of disability were 61.8 (95% confidence interval [CI], 49.0-78.0) within a month of hospitalization and 5.54 (95% Cl, 4.27-7.19) within a month of restricted activity. Strong associations were observed for participants who were physically frail and those who were not physically frail. Hospital admissions for falls were most likely to lead to disability. Intervening events occurring more than a month prior to disability onset were not associated with the development of disability. The population-attributable fractions associated with new exposure to hospitalization and restricted activity, respectively, were 0.48 and 0.19; 0.40 and 0.20, respectively, for frail participants and 0.61 and 0.16, respectively, for nonfrail participants. Conclusions Illnesses and injuries leading to either hospitalization or restricted activity represent important sources of disability for older persons living in the community, regardless of the presence of physical frailty. These intervening events may be suitable targets for the prevention of disability.	Yale Univ, Sch Med, Dorothy Adler Geriatr Assessment Ctr, Dept Internal Med, New Haven, CT 06504 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Dorothy Adler Geriatr Assessment Ctr, Dept Internal Med, 20 York St, New Haven, CT 06504 USA.	gill@ynhh.org	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	NATIONAL INSTITUTE ON AGING [K24AG021507, R01AG017560, P30AG021342] Funding Source: NIH RePORTER; NIA NIH HHS [K24AG021507, R01AG17560, P30AG21342] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], TXB GERIATRIC MED GE; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; BRUCE ML, 1994, AM J PUBLIC HEALTH, V84, P1796, DOI 10.2105/AJPH.84.11.1796; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; COUGHLIN TA, 1992, HEALTH SERV RES, V27, P453; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Cronin-Stubbs D, 2000, ARCH INTERN MED, V160, P3074, DOI 10.1001/archinte.160.20.3074; Ebrahim S, 1999, LANCET, V353, P1990, DOI 10.1016/S0140-6736(99)00195-6; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; GILL TM, 1995, J GERONTOL A-BIOL, V50, pM235, DOI 10.1093/gerona/50A.5.M235; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 2004, AM J MED, V117, P484, DOI 10.1016/j.amjmed.2004.05.018; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 2003, ARCH INTERN MED, V163, P1317, DOI 10.1001/archinte.163.11.1317; Gill TM, 2003, J GERONTOL A-BIOL, V58, P70; Gill TM, 1996, J GERONTOL A-BIOL, V51, pM283, DOI 10.1093/gerona/51A.6.M283; Gill TM, 1997, J GEN INTERN MED, V12, P757, DOI 10.1046/j.1525-1497.1997.07161.x; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; Gill TM, 2001, J AM GERIATR SOC, V49, P1039, DOI 10.1046/j.1532-5415.2001.49206.x; Gill TM, 2004, ARCH PHYS MED REHAB, V85, P1043, DOI 10.1016/j.apmr.2003.10.021; Goodwin James S, 2002, Lancet, V359, P1358, DOI 10.1016/S0140-6736(02)08318-6; GRESHAM GE, 1995, CLIN PRACTICE GUIDEL, V16, P1; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 2002, AM J PUBLIC HEALTH, V92, P1244, DOI 10.2105/AJPH.92.8.1244; Hamerman D, 1999, ANN INTERN MED, V130, P945, DOI 10.7326/0003-4819-130-11-199906010-00022; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hoenig H, 1997, J AM GERIATR SOC, V45, P1371, DOI 10.1111/j.1532-5415.1997.tb02939.x; Hosmer D. W., 1999, APPL SURVIVAL ANAL; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736; KEMPER P, 1992, HEALTH SERV RES, V27, P421; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Landefeld CS, 1998, J AM GERIATR SOC, V46, P1314, DOI 10.1111/j.1532-5415.1998.tb04553.x; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lauer MS, 2002, NEW ENGL J MED, V346, P1468, DOI 10.1056/NEJMcp012672; Levine C, 1999, NEW ENGL J MED, V340, P1587, DOI 10.1056/NEJM199905203402013; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; MANTON KG, 1988, J GERONTOL, V43, pS153, DOI 10.1093/geronj/43.5.S153; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; MCKINLAY JB, 1995, J AGING HEALTH, V7, P497, DOI 10.1177/089826439500700403; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; ROCKWOOD K, 1994, CAN MED ASSOC J, V150, P489; Rodgers W, 1997, J GERONTOL B-PSYCHOL, V52, P21, DOI 10.1093/geronb/52B.Special_Issue.21; Rothman K., 1998, MODERN EPIDEMIOLOGY; RUDBERG MA, 1993, J GERONTOL, V48, pM261, DOI 10.1093/geronj/48.6.M261; SALIVE ME, 1994, J AM GERIATR SOC, V42, P287, DOI 10.1111/j.1532-5415.1994.tb01753.x; Sands LP, 2002, J GERONTOL A-BIOL, V57, pM449, DOI 10.1093/gerona/57.7.M449; SCHOLES D, 1991, AM J PUBLIC HEALTH, V81, P485, DOI 10.2105/AJPH.81.4.485; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1396, DOI 10.1001/jama.288.11.1396; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; *US CENS BUR, 2003, AM FACTF	69	424	427	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2004	292	17					2115	2124		10.1001/jama.292.17.2115	http://dx.doi.org/10.1001/jama.292.17.2115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868OC	15523072	Bronze			2022-12-24	WOS:000224921900024
J	Sondermann, H; Soisson, SM; Boykevisch, S; Yang, SS; Bar-Sagi, D; Kuriyan, J				Sondermann, H; Soisson, SM; Boykevisch, S; Yang, SS; Bar-Sagi, D; Kuriyan, J			Structural analysis of autoinhibition in the Ras activator son of sevenless	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; PLECKSTRIN HOMOLOGY DOMAINS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; INTRAMOLECULAR INTERACTIONS; BINDING PROTEINS; N-TERMINUS; GRB2; COMPLEX; GTP	The classical model for the activation of the nucleotide exchange factor Son of sevenless (SOS) involves its recruitment to the membrane, where it engages Ras. The recent discovery that Ras.GTP is an allosteric activator of SOS indicated that the regulation of SOS is more complex than originally envisaged. We now present crystallographic and biochemical analyses of a construct of SOS that contains the DbI homology-pleckstrin homology (DH-PH) and catalytic domains and show that the DH-PH unit blocks the allosteric binding site for Ras and suppresses the activity of SOS. SOS is dependent on Ras binding to the allosteric site for both a lower level of activity, which is a result of Ras.GDP binding, and maximal activity, which requires Ras.GTP. The action of the DH-PH unit gates a reciprocal interaction between Ras and SOS, in which Ras converts SOS from low to high activity forms as Ras.GDP is converted to Ras.GTP by SOS.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		Bar-Sagi, Dafna/0000-0003-2597-8948	NATIONAL CANCER INSTITUTE [R01CA096504, P01CA028146, R37CA055360] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA096504-02, 5P01 CA28146, 5R37CA55360] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Byrne JL, 1996, ONCOGENE, V13, P2055; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Hall BE, 2002, FRONT BIOSCI, V7, pD288, DOI 10.2741/hall; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Kim JH, 1998, ONCOGENE, V16, P2597, DOI 10.1038/sj.onc.1201822; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kraemer A, 2002, J MOL BIOL, V324, P763, DOI 10.1016/S0022-2836(02)01136-1; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Qian XL, 1998, MOL CELL BIOL, V18, P771, DOI 10.1128/MCB.18.2.771; Silver SJ, 2004, GENESIS, V39, P263, DOI 10.1002/gene.20054; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sondermann H, 2003, STRUCTURE, V11, P1583, DOI 10.1016/j.str.2003.10.015; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	34	207	209	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					393	405		10.1016/j.cell.2004.10.005	http://dx.doi.org/10.1016/j.cell.2004.10.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507210	Bronze			2022-12-24	WOS:000224908300010
J	Liao, GC; Wang, JM; Guo, JS; Allard, J; Cheng, J; Ng, A; Shafer, S; Puech, A; McPherson, JD; Foernzler, D; Peltz, G; Usuka, J				Liao, GC; Wang, JM; Guo, JS; Allard, J; Cheng, J; Ng, A; Shafer, S; Puech, A; McPherson, JD; Foernzler, D; Peltz, G; Usuka, J			In silico genetics: Identification of a functional element regulating H2-E alpha gene expression	SCIENCE			English	Article							AH-RECEPTOR; PHENOTYPE; MOUSE; MHC	Computational tools can markedly accelerate the rate at which murine genetic models can be analyzed. We developed a computational method for mapping. phenotypic traits that vary among inbred strains onto haplotypic blocks. This method correctly predicted the genetic basis for strain-specific differences in several biologically important traits. It was also used to identify an allele-specific functional genomic element regulating H2-Ealpha gene expression. This functional element, which contained the binding sites for YY1 and a second transcription factor that is probably serum response factor, is located within the first intron of the H2-Ealpha gene. This computational method will greatly improve our ability to identify the genetic basis for a variety of phenotypic traits, ranging from qualitative trait information to quantitative gene expression data, which vary among inbred mouse strains.	Roche Palo Alto, Dept Genet & Genom, Palo Alto, CA 94304 USA; Stanford Univ, Med Ctr, Dept Anesthesia, Stanford, CA 94305 USA; Ctr Natl Genotypage, F-91057 Evry, France; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Roche Ctr Med Genom F Hoffmann La Roche, CH-4070 Basel, Switzerland	Roche Holding; Stanford University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); Washington University (WUSTL); Roche Holding	Peltz, G (corresponding author), Roche Palo Alto, Dept Genet & Genom, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	gary.peltz@roche.com	Shafer, Steven/AAH-4514-2021; McPherson, John D/D-2633-2017; PUECH, Anne/A-7470-2013	McPherson, John D/0000-0001-8049-9347; Shafer, Steven/0000-0002-0289-7793	NHGRI NIH HHS [1 R01 HG02322-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002322] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; EMA M, 1994, J BIOL CHEM, V269, P27337; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; *JACKS LAB, 1998, 475 JACKS LAB; Maier A, 1998, ENVIRON HEALTH PERSP, V106, P421, DOI 10.2307/3434070; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; NEBERT DW, 1982, GENETICS, V100, P79; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; WANG J, 2004, COMPUTATIONAL GENETI; YANG Y, 1992, J BIOL CHEM, V267, P11669	14	96	97	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					690	695		10.1126/science.1100636	http://dx.doi.org/10.1126/science.1100636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499019				2022-12-24	WOS:000224756700053
J	Cisek, P; Kalaska, JF				Cisek, P; Kalaska, JF			Neural correlates of mental rehearsal in dorsal premotor cortex	NATURE			English	Article							MOTOR IMAGERY; REPRESENTATION; MECHANISMS; MOVEMENTS; NEURONS	Behavioural and imaging studies suggest that when humans mentally rehearse a familiar action they execute some of the same neural operations used during overt motor performance(1-9). Similarly, neural activation is present during action observation in many of the same brain regions normally used for performance, including premotor cortex(6-9). Here we present behavioural evidence that monkeys also engage in mental rehearsal during the observation of sensory events associated with a well-learned motor task. Furthermore, most task-related neurons in dorsal premotor cortex exhibit the same activity patterns during observation as during performance, even during an instructed-delay period before any actual observed motion. This activity might be a single-neuron correlate of covert mental rehearsal.	Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Kalaska, JF (corresponding author), Univ Montreal, Dept Physiol, CP 6128 Succursale Centreville, Montreal, PQ H3C 3J7, Canada.	kalaskaj@physio.umontreal.ca	Cisek, Paul/H-2660-2012					Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fadiga L, 2000, INT J PSYCHOPHYSIOL, V35, P165, DOI 10.1016/S0167-8760(99)00051-3; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Jeannerod M, 1999, Q J EXP PSYCHOL-A, V52, P1, DOI 10.1080/027249899391205; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Ochiai T, 2002, J NEUROPHYSIOL, V88, P2167, DOI 10.1152/jn.2002.88.4.2167; Papaxanthis C, 2002, EXP BRAIN RES, V143, P447, DOI 10.1007/s00221-002-1012-1; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856	23	180	181	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					993	996		10.1038/nature03005	http://dx.doi.org/10.1038/nature03005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863TI	15496925				2022-12-24	WOS:000224585600046
J	Brent, DA				Brent, DA			Treating depression in children: Antidepressants and pediatric depression the risk of doing nothing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUICIDE		Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Brent, DA (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA.							BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Martin A, 2004, ARCH PEDIAT ADOL MED, V158, P773, DOI 10.1001/archpedi.158.8.773; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; WEBSTER DW, 2004, JAMA-J AM MED ASSOC, V292, P1178	6	86	86	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1598	1601						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483276				2022-12-24	WOS:000224427300004
J	Wise, RP; Iskander, J; Pratt, RD; Campbell, S; Ball, R; Pless, RP; Braun, MM				Wise, RP; Iskander, J; Pratt, RD; Campbell, S; Ball, R; Pless, RP; Braun, MM			Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EVENT-REPORTING-SYSTEM; INFANT-DEATH-SYNDROME; ADVERSE EVENTS; IMMUNIZATION; RISK; PERTUSSIS; VAERS; EPIDEMIOLOGY; EFFICACY; PURPURA	Context Clinical trials evaluate a vaccine's safety before approval, but some risks may escape detection or adequate characterization until larger population exposures occur after licensure. Objective To summarize reports of events occurring after vaccination with 7-valent pneumococcal conjugate vaccine (PCV), including those that may warrant further investigation to assess possible causation by PCV. Design Descriptive epidemiology of reports submitted to the Vaccine Adverse Event Reporting System (VAERS), a national passive surveillance database. Setting and Patients United States during first 2 years after licensure of PCV (February 2000 through February 2002). Reports studied were for children younger than 18 years and vaccinated with PCV. Main Outcome Measures Numbers and proportional distributions of reports. Results A total of 4154 reports of events following PCV were submitted to VAERS, for a rate of 13.2 reports per 100000 doses distributed. Multiple vaccines were given in 74.3% of reports. The most frequently reported symptoms and signs included fever, injection site reactions, fussiness, rashes, and urticaria. Serious events were described in 14.6% of reports. There were 117 deaths, 23 reports of positive rechallenges, and 34 cases of invasive pneumococcal infections possibly representing vaccine failure. Immune-mediated events occurred in 31.3% of reports. All 14 patients with anaphylactic or anaphylactoid reactions survived. Thrombocytopenia developed in 14 patients and serum sickness in 6 others. Neurologic symptoms occurred in 38% of reports. Seizures described in 393 reports included 94 febrile seizures. Conclusions The majority of reports to VAERS in the first 2 years after licensure of PCV described generally minor adverse events previously identified in clinical trials. The proportion of reports portraying serious events was similar to that for other vaccines. Although there are important limitations in passive surveillance data, and caution in their interpretation is necessary, symptoms experienced by a few children more than once after successive PCV doses, including allergic reactions, prolonged or abnormal crying, fussiness, dyspnea, and gastrointestinal distress, warrant continued surveillance, as do reports of rare but potentially serious events, such as seizures, anaphylactic or anaphylactoid reactions, serum sickness, and thrombocytopenia.	US FDA, Ctr Biol Evaluat & Res, Div Epidemiol, Off Biostat & Epidemiol, Rockville, MD 20852 USA; US FDA, Ctr Biol Evaluat & Res, Div Vaccines & Related Prod Applicat, Off Vaccines Res & Review, Rockville, MD 20852 USA; Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA USA; Ctr Infect Dis Prevent & Control Hlth Canada, Immunizat Safety Unit, Immunizat & Resp Infect Div, Ottawa, ON, Canada	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Wise, RP (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Epidemiol, Off Biostat & Epidemiol, HFM-225,1401 Rockville Pike, Rockville, MD 20852 USA.	R.P.Wise@cber.fda.gov						[Anonymous], 2002, IMMUNIZATION SAFETY; Ball Robert, 2002, Expert Rev Vaccines, V1, P161, DOI 10.1586/14760584.1.2.161; Beeler J, 1996, PEDIATR INFECT DIS J, V15, P88, DOI 10.1097/00006454-199601000-00020; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P568, DOI 10.1097/00006454-200206000-00018; Braun MM, 1997, J PEDIATR-US, V131, P529, DOI 10.1016/S0022-3476(97)70056-8; Byard RW, 1998, J PAEDIATR CHILD H, V34, P101; Byard RW, 1995, MED J AUSTRALIA, V163, P443, DOI 10.5694/j.1326-5377.1995.tb124675.x; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Cohen AD, 1996, J AUTOIMMUN, V9, P699, DOI 10.1006/jaut.1996.0091; DeStefano F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e112; Ellenberg SS, 1997, PUBLIC HEALTH REP, V112, P10; *FDA PHS, 1995, COD COSTART SYMB THE; GRIFFIN MR, 1988, NEW ENGL J MED, V319, P618, DOI 10.1056/NEJM198809083191006; Halsey Neal A, 2002, Semin Pediatr Infect Dis, V13, P205, DOI 10.1053/spid.2002.125864; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; *I SAF MED PRACT, 2002, ISMP MED SAFETY ALER, V7, P2; Jefferson T, 1998, J EPIDEMIOL COMMUN H, V52, P674, DOI 10.1136/jech.52.10.674; Jonville-Bera AP, 2001, BRIT J CLIN PHARMACO, V51, P271, DOI 10.1046/j.1365-2125.2001.00341.x; Miller E, 2001, ARCH DIS CHILD, V84, P227, DOI 10.1136/adc.84.3.227; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; Shetty AK, 2000, ARCH FAM MED, V9, P553, DOI 10.1001/archfami.9.6.553; Silvers LE, 2001, PHARMACOEPIDEM DR S, V10, P279, DOI 10.1002/pds.619; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; Stratton K, 2003, IMMUNIZATION SAFETY; STRATTON KR, 1994, JAMA-J AM MED ASSOC, V271, P1602, DOI 10.1001/jama.271.20.1602; Verstraeten T, 2001, AM J EPIDEMIOL, V154, P1006, DOI 10.1093/aje/154.11.1006; WEBER RE, 1984, MOL PHYSIOL, V6, P1; Wise RP, 2000, JAMA-J AM MED ASSOC, V284, P1271, DOI 10.1001/jama.284.10.1271; Wise RP, 1997, JAMA-J AM MED ASSOC, V278, P1176, DOI 10.1001/jama.278.14.1176; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1; 1994, FED REG, V59, P54042; 2001, MMWR WEEKLY     1221, V50, P1140	33	53	56	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2004	292	14					1702	1710		10.1001/jama.292.14.1702	http://dx.doi.org/10.1001/jama.292.14.1702			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861JS	15479935	Bronze			2022-12-24	WOS:000224413400029
J	Cottam, R				Cottam, R			Obesity and culture	LANCET			English	Editorial Material									Croydon Primary Care Trust, Surrey CR0 6SR, England		Cottam, R (corresponding author), Croydon Primary Care Trust, Surrey CR0 6SR, England.	rachelcottam@pink2.demon.co.uk						ATKINS R, 2003, ATKINS LIFE; *CAB OFF, 2004, ALC HARM RED STRAT E; Critser G., 2003, FAT LAND AM BECAME F; Furedi F., 2004, THERAPY CULTURE CULT; GROSSMAN M, 2004, EC OBESITY PUBLIC IN; MEEK J, 2002, GUARDIAN        1008; *NAT I CLIN EX, 2002, SELF HARM SHORT TERM; *NAT I CLIN EX, 2004, SCOP CONS DRAFT GUID; *NAT I CLIN EXC, FULL LIST STAK; National Institutes of Health, 2004, STRAT PLAN NIH OB RE; Packard V., 1957, HIDDEN PERSUADERS; SHAPIN S, 2004, LONDON REV BOOK 0805, P16; *UK PARL, 2004, 3 UK PARL SEL COMM H; 2004, GUARDIAN        0729	14	7	7	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1202	1203		10.1016/S0140-6736(04)17159-6	http://dx.doi.org/10.1016/S0140-6736(04)17159-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464169				2022-12-24	WOS:000224254200009
J	Gu, CH; Yoshida, Y; Livet, J; Reimert, DV; Mann, F; Merte, J; Henderson, CE; Jessell, TM; Kolodkin, AL; Ginty, DD				Gu, CH; Yoshida, Y; Livet, J; Reimert, DV; Mann, F; Merte, J; Henderson, CE; Jessell, TM; Kolodkin, AL; Ginty, DD			Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR; CELLS; MORPHOGENESIS; COMPLEXES; GUIDANCE; BINDING	The development of a patterned vasculature is essential for normal organogenesis. We found that signaling by semaphorin 3E (Sema3E) and its receptor plexin-D1 controls endothelial cell positioning and the patterning of the developing vasculature in the mouse. Sema3E is highly expressed in developing somites, where it acts as a repulsive cue for plexin-D1-expressing endotheiial cells of adjacent intersomitic vessels. Sema3E-plexin-D1 signaling did not require neuropilins, which were previously presumed to be obligate Sema3 coreceptors. Moreover, genetic ablation of Sema3E or plexin-D1 but not neuropilin-mediated Sema3 signaling disrupted vascular patterning. These findings reveal an unexpected semaphorin signaling pathway and define a mechanism for controlling vascular patterning.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Dev Biol Inst Marseille, INSERM, UMR623, F-13288 Marseille, France	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Columbia University; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu; dginty@jhmi.edu	Mann, Fanny/G-2786-2016; livet, jean/C-2766-2012	Mann, Fanny/0000-0003-4839-4347; livet, jean/0000-0003-3079-4908; Henderson, Christopher/0000-0002-9936-3279	NCI NIH HHS [CA23767-24] Funding Source: Medline; NIMH NIH HHS [MH59199-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; GU C, UNPUB; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jilani SM, 2003, J HISTOCHEM CYTOCHEM, V51, P597, DOI 10.1177/002215540305100505; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Levine AJ, 2003, DEV BIOL, V254, P50, DOI 10.1016/S0012-1606(02)00029-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Miyazaki N, 1999, NEUROSCI RES, V33, P269, DOI 10.1016/S0168-0102(99)00015-2; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	21	383	406	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					265	268		10.1126/science.1105416	http://dx.doi.org/10.1126/science.1105416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15550623				2022-12-24	WOS:000226361900046
J	Chang, P; Jacobson, MK; Mitchison, TJ				Chang, P; Jacobson, MK; Mitchison, TJ			Poly(ADP-ribose) is required for spindle assembly and structure	NATURE			English	Article							POLYMERASE; TANKYRASE; PROTEIN; DYNAMICS; NUMA; TUBULIN; IRAP; PARP	The mitotic spindle is typically thought of as an array of microtubules, microtubule-associated proteins and motors that self-organizes to align and segregate chromosomes(1). The major spindle components consist of proteins and DNA, the primary structural elements of the spindle(1). Other macromolecules including RNA and lipids also associate with spindles, but their spindle function, if any, is unknown. Poly(ADP-ribose) ( PAR) is a large, branched, negatively charged polymeric macromolecule whose polymerization onto acceptor proteins is catalysed by a family of poly(ADP-ribose) polymerases (PARPs)(2). Several PARPs localize to the spindle in vertebrate cells, suggesting that PARPs and/or PAR have a role in spindle function(2). Here we show that PAR is enriched in the spindle and is required for spindle function-PAR hydrolysis or perturbation leads to rapid disruption of spindle structure, and hydrolysis during spindle assembly blocks the formation of bipolar spindles. PAR exhibits localization dynamics that differ from known spindle proteins and are consistent with a low rate of turnover in the spindle. Thus, PAR is a non-proteinaceous, non-chromosomal component of the spindle required for bipolar spindle assembly and function.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA	Harvard University; Harvard Medical School; University of Arizona; Arizona Center Cancer Care; University of Arizona	Chang, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	paul_chang2@hms.harvard.edu			NIGMS NIH HHS [F32 GM070090] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070090] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 1997, BIOCHEM J, V325, P543, DOI 10.1042/bj3250543; Bakondi E, 2002, J HISTOCHEM CYTOCHEM, V50, P91, DOI 10.1177/002215540205000110; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Dionne MA, 1999, CELL MOTIL CYTOSKEL, V42, P189, DOI 10.1002/(SICI)1097-0169(1999)42:3<189::AID-CM3>3.0.CO;2-X; Earle E, 2000, HUM MOL GENET, V9, P187, DOI 10.1093/hmg/9.2.187; HAAKEYAMA K, 1986, J BIOL CHEM, V261, P14902; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; OLMSTED JB, 1989, J CELL BIOL, V109, P211, DOI 10.1083/jcb.109.1.211; PickettHeaps JD, 1997, CELL MOTIL CYTOSKEL, V37, P1, DOI 10.1002/(SICI)1097-0169(1997)37:1<1::AID-CM1>3.0.CO;2-D; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1999, J CELL SCI, V112, P3649; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; TROLL W, 1990, BASIC LIFE SCI, V52, P225; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	29	183	192	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					645	649		10.1038/nature03061	http://dx.doi.org/10.1038/nature03061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577915				2022-12-24	WOS:000225433200051
J	Bond, GL; Hu, WW; Bond, EE; Robins, H; Lutzker, SG; Arva, NC; Bargonetti, J; Bartel, F; Taubert, H; Wuerl, P; Onel, K; Yip, L; Hwang, SJ; Strong, LC; Lozano, G; Levine, AJ				Bond, GL; Hu, WW; Bond, EE; Robins, H; Lutzker, SG; Arva, NC; Bargonetti, J; Bartel, F; Taubert, H; Wuerl, P; Onel, K; Yip, L; Hwang, SJ; Strong, LC; Lozano, G; Levine, AJ			A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans	CELL			English	Article							SOFT-TISSUE SARCOMAS; TRANSCRIPTION FACTOR; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; BREAST-CANCER; EXPRESSION; GENE; AMPLIFICATION; ACTIVATION; MUTATIONS	The tumor suppressor p53 gene is mutated in minimally half of all cancers. It is therefore reasonable to assume that naturally occurring polymorphic genetic variants in the p53 stress response pathway might determine an individual's susceptibility to cancer. A central node in the p53 pathway is the MDM2 protein, a direct negative regulator of p53. In this report, a single nucleotide polymorphism (SNP309) is found in the MDM2 promoter and is shown to increase the affinity of the transcriptional activator Sp1, resulting in higher levels of MDM2 RNA and protein and the subsequent attenuation of the p53 pathway. In humans, SNP309 is shown to associate with accelerated tumor formation in both hereditary and sporadic cancers. A model is proposed whereby SNP309 serves as a rate-limiting event in carcinogenesis.	Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; Univ Texas, MD Anderson Canc Ctr, Sect Canc Genet, Houston, TX 77030 USA; Univ Halle Wittenberg, Fac Med, Inst Pathol, D-06097 Halle Saale, Germany; Univ Ulm, Surg Clin, D-89075 Ulm, Germany; Cornell Univ, Weill Coll Med, Dept Med, New York, NY 10021 USA; CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; CUNY, Grad Sch, New York, NY 10021 USA	Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Texas System; UTMD Anderson Cancer Center; Martin Luther University Halle Wittenberg; Ulm University; Cornell University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Levine, AJ (corresponding author), Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA.	alevine@ias.edu		Bargonetti, Jill/0000-0003-2692-0991; Taubert, Helge/0000-0002-9077-1727				BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; CORDONCARDO C, 1994, CANCER RES, V54, P794; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Freedman DA, 1999, CANCER RES, V59, P1; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hurtado J, 2002, Expert Opin Pharmacother, V3, P521; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Jin SK, 2001, J CELL SCI, V114, P4139; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Landers JE, 1997, CANCER RES, V57, P3562; LEACH FS, 1993, CANCER RES, V53, P2231; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; Lu WG, 2002, CANCER RES, V62, P1305; LUNA RMD, 1995, NATURE, V378, P203; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Phelps M, 2003, CANCER RES, V63, P2616; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Taubert H, 2000, MOL MED, V6, P50, DOI 10.1007/BF03401934; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584	30	1002	1039	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					591	602		10.1016/j.cell.2004.11.022	http://dx.doi.org/10.1016/j.cell.2004.11.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550242	Green Published, Bronze			2022-12-24	WOS:000225389500006
J	Launay, P; Cheng, H; Srivatsan, S; Penner, R; Fleig, A; Kinet, JP				Launay, P; Cheng, H; Srivatsan, S; Penner, R; Fleig, A; Kinet, JP			TRPM4 regulates calcium oscillations after T cell activation	SCIENCE			English	Article							GENE-EXPRESSION; CHANNELS; LYMPHOCYTES; SYSTEM	TRPM4 has recently been described as a calcium-activated nonselective (CAN) cation channel that mediates membrane depolarization. However, the functional importance of TRPM4 in the context of calcium (Ca2+) signaling and its effect on cellular responses are not known. Here, the molecular inhibition of endogenous TRPM4 in T cells was shown to suppress TRPM4 currents, with a profound influence on receptor-mediated Ca2+ mobilization. Agonist-mediated oscillations in intracellutar Ca2+ concentration ([Ca2+](i)), which are driven by store-operated Ca2+ influx, were transformed into a sustained elevation in [Ca2+](i). This increase in Ca2+ influx enhanced interleukin-2 production. Thus, TRPM4-mediated depolarization modulates Ca2+ oscillations, with downstream effects on cytokine production in T lymphocytes.	Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Harvard University; Beth Israel Deaconess Medical Center	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	jkinet@bidmc.harvard.edu	Launay, Pierre/AAH-7076-2019	Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046734, R01AI050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063954, R01GM065360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI46734, R01-AI50200] Funding Source: Medline; NIGMS NIH HHS [R01-GM65360, R01-GM63954] Funding Source: Medline; NINDS NIH HHS [R01-NS40927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; MINTA A, 1989, J BIOL CHEM, V264, P19449; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Nilius B, 2003, ENDOTHELIUM-J ENDOTH, V10, P5, DOI 10.1080/10623320303356; Petersen OH, 2002, CURR BIOL, V12, pR520, DOI 10.1016/S0960-9822(02)01027-8; VERHEUGEN JAH, 1995, CELL CALCIUM, V17, P287, DOI 10.1016/0143-4160(95)90075-6; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	19	240	252	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1374	1377		10.1126/science.1098845	http://dx.doi.org/10.1126/science.1098845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550671				2022-12-24	WOS:000225301600052
J	Salama, P; Spiegel, P; Talley, L; Waldman, R				Salama, P; Spiegel, P; Talley, L; Waldman, R			Lessons learned from complex emergencies over past decade	LANCET			English	Review							PUBLIC-HEALTH; REFUGEE POPULATIONS; RESIDENT POPULATIONS; SEVERE MALNUTRITION; NUTRITIONAL-STATUS; RWANDAN REFUGEES; MORTALITY-RATES; FAMINE; WAR; SOMALIA	Major advances have been made during the past decade in the way the international community responds to the health and nutrition consequences of complex emergencies. The public health and clinical response to diseases of acute epidemic potential has improved, especially in camps. Case-fatality rates for severely malnourished children have plummeted because of better protocols and products. Renewed focus is required on the major causes of death in conflict-affected societies-particularly acute respiratory infections, diarrhoea, malaria, measles, neonatal causes, and malnutrition-outside camps and often across regions and even political boundaries. in emergencies in sub-Saharan Africa, particularly southern Africa, HIV/AIDS is also an important cause of morbidity and mortality. Stronger coordination, increased accountability, and a more strategic positioning of non-governmental organisations and UN agencies are crucial to achieving lower maternal and child morbidity and mortality rates in complex emergencies and therefore for reaching the UN's Millennium Development Goals.	UNICEF, Kabul, Afghanistan; UNHCR, Geneva, Switzerland; Ctr Dis Control & Prevent, Atlanta, GA USA; Columbia Univ, Mailman Sch Publ Hlth, Ctr Global Hlth & Econ Dev, New York, NY USA	Centers for Disease Control & Prevention - USA; Columbia University	Salama, P (corresponding author), Suite 400,1325 G St, Washington, DC 20005 USA.	psalama@unicef.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; [Anonymous], 1997, REF HLTH APPR EM SIT; Assefa F, 2001, JAMA-J AM MED ASSOC, V286, P2723, DOI 10.1001/jama.286.21.2723; BARTLETT L, IN PRESS LANCET; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; BURKHOLDER BT, 1995, LANCET, V346, P1012, DOI 10.1016/S0140-6736(95)91694-6; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1029; *CDCP, 1992, MMWR-MORBID MORTAL W, P41; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P304; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P104; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P979; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P475; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P363; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P701; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P14; Cheung Edith, 2003, Food and Nutrition Bulletin, V24, P247; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; COLLINS S, 1993, JAMA-J AM MED ASSOC, V270, P637; COLLINS S, 1995, NAT MED, V1, P810, DOI 10.1038/nm0895-810; Creusvaux H, 1999, LANCET, V354, P832, DOI 10.1016/S0140-6736(99)80016-6; de Ville de Goyet C., 1978, MANAGEMENT NUTR EMER; de Waal A, 2002, IDS BULL-I DEV STUD, V33, P120; Deng LB, 2002, IDS BULL-I DEV STUD, V33, P28, DOI 10.1111/j.1759-5436.2002.tb00041.x; Dunston C, 2001, AM J PUBLIC HEALTH, V91, P1574, DOI 10.2105/AJPH.91.10.1574; Ford N, 2002, LANCET, V360, P334, DOI 10.1016/S0140-6736(02)09559-4; Ford N, 2001, LANCET, V358, P1543, DOI 10.1016/S0140-6736(01)06588-6; FRIEDMAN C, 2000, W TIMOR MISSION REPO; GALL C, AFGHAN MOTHERHOOD FI; GESSNER BD, 1994, JAMA-J AM MED ASSOC, V272, P382, DOI 10.1001/jama.272.5.382; GLASS RI, 1980, LANCET, V1, P868; *GLOB IDP PROJ, 2002, INT DISPL PEOPL GLOB; HAKEWILL PA, 1991, TROP DOCT, V21, P24, DOI 10.1177/00494755910210S106; Hammond L, 2002, DISASTERS, V26, P262, DOI 10.1111/1467-7717.00204; Hankins CA, 2002, AIDS, V16, P2245, DOI 10.1097/00002030-200211220-00003; *INT RESC COMM, 2003, MORT DEM REP CONG RE; *INT STAND COMM, 2003, GUID HIV AIDS INT EM; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khaw AJ, 2000, DISASTERS, V24, P181, DOI 10.1111/1467-7717.00141; LAUTZE S, 1997, STRATEGIC HUMANITARI; Lautze S., 2003, RISK VULNERABILITY E; LAUTZE S, 2002, QAHTEPOOL CASH FAMIN; LAUTZE S, IN PRESS LANCET; MACRAE Joanna, 2000, 8 HPG OV DEV I; MAGAN AM, 1983, DISASTERS, V7, P94, DOI 10.1111/j.1467-7717.1983.tb00801.x; MARFIN AA, 1994, JAMA-J AM MED ASSOC, V272, P377, DOI 10.1001/jama.272.5.377; Maxwell D, 2002, IDS BULL-I DEV STUD, V33, P48, DOI 10.1111/j.1759-5436.2002.tb00043.x; MAYER J, 1969, POSTGRAD MED, V45, P236, DOI 10.1080/00325481.1969.11697106; MEARS C, 1994, HLTH CARE REFUGEES D; *MED FRONT, 2001, SEV FOOD CRIS REP CE; *MED FRONT, DEATH RAT ANG CONF E; MOLLICA RF, IN PRESS LANCET; MOORE PS, 1990, B WORLD HEALTH ORGAN, V68, P587; MOORE PS, 1993, LANCET, V341, P935, DOI 10.1016/0140-6736(93)91223-9; MOREN A, 1990, PELLAGRA CASES MOZAM; Nabeth P, 1997, LANCET, V349, P59, DOI 10.1016/S0140-6736(05)62198-8; NEIBERG P, 1988, B WORLD HEALTH ORGAN, V66, P689; Noji EK, 1997, DISASTERS, V21, P366, DOI 10.1111/1467-7717.00068; NUTRISET SA, DIET TREATMENT SEVER; Palmer CA, 1999, SOC SCI MED, V49, P1689, DOI 10.1016/S0277-9536(99)00253-1; PAQUET C, 1994, LANCET, V344, P823, DOI 10.1016/S0140-6736(94)92381-7; *PHYS HUM RIGHTS, 1999, WAR CRIM KOS POP BAS; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; Robinson WC, 1999, LANCET, V354, P291, DOI 10.1016/S0140-6736(99)02266-7; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SALAMA P, 1999, ENN FIELD EXCHANGE, V6, P19; SALAMA P, 1998, ASSESSMENT HUMANITAR; Salignon P, 2000, LANCET, V356, P1762, DOI 10.1016/S0140-6736(00)03217-7; Schofield EC, 1996, DISASTERS, V20, P248, DOI 10.1111/j.1467-7717.1996.tb01037.x; Seal A, 2001, DISASTERS, V25, P136, DOI 10.1111/1467-7717.00166; SEAMAN J, 1987, P SEM MORT SOC SUBS; SEAMAN JA, 1972, LANCET, V2, P866; SIDDIQUE AK, 1995, LANCET, V345, P359, DOI 10.1016/S0140-6736(95)90344-5; Simmonds S., 1983, REFUGEE COMMUNITY HL; *SPHER PROJ, 2004, SPHERE HUM CHART MIN; Spiegel P, 2002, LANCET, V360, P1927, DOI 10.1016/S0140-6736(02)11915-5; SPIEGEL P, 1999, ALBANIAN HLTH SURVEY; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Spiegel PB, 2001, LANCET, V357, P714, DOI 10.1016/S0140-6736(00)04143-X; Talley L., 2001, J REFUG STUD, V14, P412; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; TOOLE MJ, 1993, LANCET, V342, P190, DOI 10.1016/0140-6736(93)92292-2; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; TOOLE MJ, 1993, LANCET, V341, P1193, DOI 10.1016/0140-6736(93)91013-C; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; TOOLE MJ, 1995, INFECT DIS CLIN N AM, V9, P353; U.S. Committee for Refugees, 2000, WORLD REF SURV 2000; U.S. Committee for Refugees, 1992, WORLD REF SURV 1992; *UN HIGH COMM REF, 1999, REPR HLTH REF SIT IN; *UNHCR, 2002, STAT YB 2001 REF AS; *US COMM REF, 1993, WORLD REF SURV 1992; *US COMM REF, 1993, WORLD REF SURV 1993; *US COMM REF, 1995, WORLD REF SURV 1995; US Committee for Refugees, 2002, WORLD REF SURV 2002; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; VARAINE F, 1995, LANCET, V345, P1114, DOI 10.1016/S0140-6736(95)90845-5; *WHO, 1997, TUB CONTR REF SIT IN; World Health Organization, 1993, GUID CHOL CONTR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; YIP R, 1993, JAMA-J AM MED ASSOC, V270, P587, DOI 10.1001/jama.270.5.587; YOUNG H, 1987, DISASTERS, V11, P102, DOI 10.1111/j.1467-7717.1987.tb00622.x; YOUNG H, 1995, DISASTERS, V19, P94, DOI 10.1111/j.1467-7717.1995.tb00361.x	108	170	172	0	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2004	364	9447					1801	1813		10.1016/S0140-6736(04)17405-9	http://dx.doi.org/10.1016/S0140-6736(04)17405-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	870PQ	15541455				2022-12-24	WOS:000225070600035
J	Wang, CY				Wang, CY			Coping with endometriosis	LANCET			English	Editorial Material												wangcyen@yahoo.com							0	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 13	2004	364	9447					1800	1800		10.1016/S0140-6736(04)17404-7	http://dx.doi.org/10.1016/S0140-6736(04)17404-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PQ	15541454				2022-12-24	WOS:000225070600034
J	Solan, M; Cardinale, BJ; Downing, AL; Engelhardt, KAM; Ruesink, JL; Srivastava, DS				Solan, M; Cardinale, BJ; Downing, AL; Engelhardt, KAM; Ruesink, JL; Srivastava, DS			Extinction and ecosystem function in the marine benthos	SCIENCE			English	Article							IN-SITU; SPECIES LOSS; BIODIVERSITY; COMMUNITY; DIVERSITY; RESPONSES; SEDIMENT; PATTERNS; RISK; SEA	Rapid changes in biodiversity are occurring globally, yet the ecological impacts of diversity loss are poorly understood. Here we use data from marine invertebrate communities to parameterize models that predict how extinctions will. affect sediment bioturbation, a process vital to the persistence of aquatic communities. We show that species extinction is generally expected to reduce bioturbation, but the magnitude of reduction depends on how the functional traits of individual species covary with their risk of extinction. As a result, the particular cause of extinction and the order in which species are lost ultimately govern the ecosystem-level consequences of biodiversity loss.	Auburn Univ, Newburgh AB41 6AA, Aberdeen, Scotland; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Ohio Wesleyan Univ, Dept Zool, Delaware, OH 43015 USA; Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of Aberdeen; University of California System; University of California Santa Barbara; Ohio Wesleyan University; University System of Maryland; University of Maryland Center for Environmental Science; University of Washington; University of Washington Seattle; University of British Columbia	Solan, M (corresponding author), Auburn Univ, Main St, Newburgh AB41 6AA, Aberdeen, Scotland.	m.solan@abdn.ac.uk	Solan, Martin/E-9338-2012; Langhamer, Olivia/J-3425-2012; Cardinale, Bradley J/I-7076-2013; Engelhardt, Katharina AM/H-8755-2013	Solan, Martin/0000-0001-9924-5574; 				Biles CL, 2003, J EXP MAR BIOL ECOL, V285, P165, DOI 10.1016/S0022-0981(02)00525-7; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Davies KF, 2004, ECOLOGY, V85, P265, DOI 10.1890/03-0110; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fischer JM, 2001, ECOL APPL, V11, P1060, DOI 10.2307/3061012; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson CN, 1998, NATURE, V394, P272, DOI 10.1038/28385; Johnson KS, 1999, NATURE, V398, P697, DOI 10.1038/19511; Jonsson M, 2002, P ROY SOC B-BIOL SCI, V269, P1047, DOI 10.1098/rspb.2002.1979; Lawton J.H., 1995, POPULATION DYNAMIC P, P147; Malakoff D, 1997, SCIENCE, V277, P486, DOI 10.1126/science.277.5325.486; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; Raffaelli D, 2003, J SEA RES, V49, P133, DOI 10.1016/S1385-1101(02)00200-9; Ruesink JL, 2001, OIKOS, V93, P221, DOI 10.1034/j.1600-0706.2001.930206.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solan M, 2002, MAR ECOL PROG SER, V228, P179, DOI 10.3354/meps228179; Srivastava DS, 2002, OIKOS, V98, P351, DOI 10.1034/j.1600-0706.2002.980216.x; TRACY CR, 1992, AM NAT, V139, P102, DOI 10.1086/285315; TURNER RE, 1994, NATURE, V368, P619, DOI 10.1038/368619a0; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799	32	555	574	6	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1177	1180		10.1126/science.1103960	http://dx.doi.org/10.1126/science.1103960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539601				2022-12-24	WOS:000225193100047
J	Wagner, D; Przybyla, D; Camp, ROD; Kim, C; Landgraf, F; Lee, KP; Wursch, M; Laloi, C; Nater, M; Hideg, E; Apel, K				Wagner, D; Przybyla, D; Camp, ROD; Kim, C; Landgraf, F; Lee, KP; Wursch, M; Laloi, C; Nater, M; Hideg, E; Apel, K			The genetic basis of singlet oxygen-induced stress responses of Arabidopsis thaliana	SCIENCE			English	Article							PHOTOSYSTEM-II; PHOTOSYNTHESIS; LEAVES; LIGHT	Plants under oxidative stress suffer from damages that have been interpreted as unavoidable consequences of injuries inflicted upon plants by toxic levels of reactive oxygen species (ROS). However, this paradigm needs to be modified. Inactivation of a single gene, EXECUTER1, is sufficient to abrogate stress responses of Arabidopsis thaliana caused by the release of singlet oxygen: External conditions under which these stress responses are observed and the amounts of ROS that accumulate in plants exposed to these environmental conditions do not directly cause damages. Instead, seedling lethality and growth inhibition of mature plants result from genetic programs that are activated after the release of singlet oxygen has been perceived by the plant.	Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Apel, K (corresponding author), Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland.	klaus.apel@ipw.biol.ethz.ch	Kim, Chanhong/G-5506-2012; Laloi, Christophe/E-5685-2019; Kim, Chanhong/AAL-4930-2021	Laloi, Christophe/0000-0002-6576-5966; Kim, Chanhong/0000-0003-4133-9070; Lee, Keun Pyo/0000-0002-2025-9269				Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Fufezan C, 2002, FEBS LETT, V532, P407, DOI 10.1016/S0014-5793(02)03724-9; Hideg E, 2002, PLANT CELL PHYSIOL, V43, P1154, DOI 10.1093/pcp/pcf145; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; PRZYBYLA D, UNPUB; Sharma J, 1997, J BIOL CHEM, V272, P3935, DOI 10.1074/jbc.272.7.3935; Trebst A, 2003, Z NATURFORSCH C, V58, P609; Wagner D., UNPUB	14	463	487	6	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1183	1185		10.1126/science.1103178	http://dx.doi.org/10.1126/science.1103178			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539603				2022-12-24	WOS:000225193100049
J	Constancia, M; Kelsey, G; Reik, W				Constancia, M; Kelsey, G; Reik, W			Resourceful imprinting	NATURE			English	Article							GENES; EXPRESSION; METABOLISM; GENOMES; MAMMALS; GROWTH; LOCUS		Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Constancia, M (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England.	miguel.constancia@bbsrc.ac.uk; gavin.kelsey@bbsrc.ac.uk; wolf.reik@bbsrc.ac.uk	Constancia, Miguel/F-6654-2013; Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Constancia, Miguel/0000-0002-8976-1679; Kelsey, Gavin/0000-0002-9762-5634	Biotechnology and Biological Sciences Research Council [BB/B50118X/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; BEECHEY CV, MOUSE IMPRINTING DAT; Brown WM, 2004, MED HYPOTHESES, V63, P377, DOI 10.1016/j.mehy.2004.05.010; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; Isles AR, 2000, TRENDS COGN SCI, V4, P309, DOI 10.1016/S1364-6613(00)01504-7; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Ma D, 2004, J CLIN INVEST, V114, P339, DOI 10.1172/jci200419876; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437	30	211	225	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					53	57		10.1038/432053a	http://dx.doi.org/10.1038/432053a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525980				2022-12-24	WOS:000224854900037
J	Gao, XF; Jiang, L				Gao, XF; Jiang, L			Water-repellent legs of water striders	NATURE			English	Editorial Material							LOCOMOTION		Chinese Acad Sci, Inst Chem, Key Lab Organ Solids, Beijing 100080, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China; Natl Ctr Nanosci & Nanotechnol, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Gao, XF (corresponding author), Chinese Acad Sci, Inst Chem, Key Lab Organ Solids, Beijing 100080, Peoples R China.	jianglei@iccas.ac.cn	, 许永傲/AAC-2581-2019; Jiang, Lei/B-1066-2011; jiang, lei/E-8437-2010	gao, xue feng/0000-0001-6908-1361				CAPONIGRO MA, 1976, AM MIDL NAT, V95, P268, DOI 10.2307/2424392; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Dickinson M, 2003, NATURE, V424, P621, DOI 10.1038/424621a; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Hu DL, 2003, NATURE, V424, P663, DOI 10.1038/nature01793; Tadanaga K, 1997, J AM CERAM SOC, V80, P1040, DOI 10.1111/j.1151-2916.1997.tb02943.x	7	2010	2151	91	1675	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					36	36		10.1038/432036a	http://dx.doi.org/10.1038/432036a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525973	Bronze			2022-12-24	WOS:000224854900030
J	Majumdar, SR; Almasi, EA; Stafford, RS				Majumdar, SR; Almasi, EA; Stafford, RS			Promotion and prescribing of hormone therapy after report of harm by the women's health initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTINUING MEDICAL-EDUCATION; RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; NATIONAL TRENDS; UNITED-STATES; ESTROGEN; PUBLICATION; PHYSICIANS; INDUSTRY	Context Little is known about how the pharmaceutical industry responds to evidence of harm associated with its products, such as the publication in July 2002 of the Women's Health Initiative Estrogen Plus Progestin Trial (WHI E+P) report demonstrating that standard-dose Prempro produced significant harm and lacked net benefits. Objective To examine pharmaceutical industry response to the WHI E+P results by analyzing promotional expenditures for hormone therapy before and after July 2002. Design and Setting Nationally representative and prospectively collected longitudinal data (January 2001 through December 2003) on prescribing and promotion of hormone therapies were obtained from IMS Health and Consumer Media Reports. Main Outcome Measures Trends in quarterly prescriptions for hormone therapy and expenditures on 5 modes of drug promotion: samples, office-based detailing, hospital-based promotion, journal advertisements, and direct-to-consumer advertising. Results Prior to the WHI E+P report, prescribing rates and promotional spending for hormone therapy were stable. In the quarter before the WHI E+P report (April-June 2002), 22.4 million prescriptions for hormone therapy were dispensed and $71 million was spent on promotion (in annual terms, $350 per year per US physician). Within 9 months of the report's publication (quarter 1 of 2003), there was a 32% decrease in hormone therapy prescriptions, and a nadir had been reached for promotional spending (37% decrease compared with pre-WHI E+P levels). Spending decreased for all promotional activities and most hormone therapies. overall, the greatest declines were for samples (36% decrease as of quarter 1 of 2003) and direct-to-consumer advertising (100% decrease). The greatest declines in promotion occurred for standard-dose Prempro (61% decrease as of quarter 1 of 2003), the agent implicated by the WHI E+P report. More recently, promotional efforts have increased, particularly for lower-dose Prempro, a resurgence associated with modestly increased prescriptions for this newer agent. Conclusions Concordant with its widespread use, hormone therapy was among the most heavily promoted medications prior to the WHI E+P report. Following reporting of the evidence of harm from this trial, there was a substantial decline in promotional spending for hormone therapy, particularly for the agents most directly implicated in the trial. Interrelated with the impact of the trial results themselves and the ensuing media coverage, reduced promotion may have contributed to a substantial decline in hormone therapy prescriptions.	Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Stanford, CA 94305 USA; Univ Alberta, Dept Med, Edmonton, AB, Canada	Stanford University; University of Alberta	Stafford, RS (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Hoover Pavil, Stanford, CA 94305 USA.	rstafford@stanford.edu	Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	AHRQ HHS [R01-HS013405] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013405] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Austin PC, 2003, JAMA-J AM MED ASSOC, V289, P3241, DOI 10.1001/jama.289.24.3241; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; GARDNER J, 1992, US NEWS WORLD RE NOV, V8, P71; Herrington DM, 2003, NEW ENGL J MED, V349, P519, DOI 10.1056/NEJMp038108; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Holmer AF, 2001, JAMA-J AM MED ASSOC, V285, P2012, DOI 10.1001/jama.285.15.2012; Katz Anne, 2003, Health Care Women Int, V24, P927, DOI 10.1080/07399330390244167; Lawton B, 2003, BRIT MED J, V327, P845, DOI 10.1136/bmj.327.7419.845; Levy R, 1994, Arch Fam Med, V3, P327, DOI 10.1001/archfami.3.4.327; Ma J, 2003, CLIN THER, V25, P1503, DOI 10.1016/S0149-2918(03)80136-4; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Majumdar SR, 2001, J GEN INTERN MED, V16, P351, DOI 10.1046/j.1525-1497.2001.016006351.x; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; *N AM MEN SOC, 2003, MENOPAUSE, V10, P6; Naylor CD, 2004, JAMA-J AM MED ASSOC, V291, P104, DOI 10.1001/jama.291.1.104; Petersen Melody, 2002, N Y Times Web, pC2; Relman AS, 2001, JAMA-J AM MED ASSOC, V285, P2009, DOI 10.1001/jama.285.15.2009; ROSSDEGNAN D, 1993, JAMA-J AM MED ASSOC, V270, P1937, DOI 10.1001/jama.270.16.1937; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; Stafford RS, 2003, ARCH INTERN MED, V163, P1046, DOI 10.1001/archinte.163.9.1046; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; ZATE M, 2000, VENTURA COUNTY  0826; 1996, ADWEEK          1125, V46, P3	28	119	128	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2004	292	16					1983	1988		10.1001/jama.292.16.1983	http://dx.doi.org/10.1001/jama.292.16.1983			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865DO	15507584				2022-12-24	WOS:000224682900023
J	Hood, L; Heath, JR; Phelps, ME; Lin, BY				Hood, L; Heath, JR; Phelps, ME; Lin, BY			Systems biology and new technologies enable predictive and preventative medicine	SCIENCE			English	Editorial Material							NANOMECHANICAL CANTILEVER ARRAY; LASER-CAPTURE MICRODISSECTION; PROSTATE-CANCER; GENE-EXPRESSION; NANOWIRE NANOSENSORS; PROTEOMIC PATTERNS; MICROCHIP DEVICE; NETWORKS; DNA; BIOSENSORS	Systems approaches to disease are grounded in the idea that disease-perturbed protein and gene regulatory networks differ from their normal counterparts; we have been pursuing the possibility that these differences may be reflected by multiparameter measurements of the blood. Such concepts are transforming current diagnostic and therapeutic approaches to medicine and, together with new technologies, wilt enable a predictive and preventive medicine that will lead to personalized medicine.	Inst Syst Biol, Seattle, WA USA; CALTECH, Dept Chem, Pasadena, CA 91125 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA USA	Institute for Systems Biology (ISB); California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hood, L (corresponding author), Inst Syst Biol, Seattle, WA USA.	lhood@systemsbiology.org	Crozier, Laura/A-7950-2013					Adam BL, 2002, CANCER RES, V62, P3609; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Arntz Y, 2003, NANOTECHNOLOGY, V14, P86, DOI 10.1088/0957-4484/14/1/319; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; BUNIMOVICH Y, IN PRESS LANGMUIR; Carlson RH, 1997, PHYS REV LETT, V79, P2149, DOI 10.1103/PhysRevLett.79.2149; Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; CHURCH JG, 1993, CYTOMETRY, V14, P271, DOI 10.1002/cyto.990140306; Covitz PA, 2003, PHARMACOGENOMICS J, V3, P257, DOI 10.1038/sj.tpj.6500187; Craven RA, 2001, PROTEOMICS, V1, P1200; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Diamandis EP, 2003, CLIN CHEM, V49, P1272, DOI 10.1373/49.8.1272; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330; Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; JOHNSTONHALPERI.E, IN PRESS J APPL PHYS; KARUBE I, 1995, ANN NY ACAD SCI, V750, P101, DOI 10.1111/j.1749-6632.1995.tb19935.x; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klein CA, 2004, CELL CYCLE, V3, P29; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; LIN BC, UNPUB; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McKendry R, 2002, P NATL ACAD SCI USA, V99, P9783, DOI 10.1073/pnas.152330199; Melosh NA, 2003, SCIENCE, V300, P112, DOI 10.1126/science.1081940; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; PANTOJA R, 2004, IN PRESS BIOSEN 0506, DOI DOI 10.1016/J.BIOS.2004.02.020; Petricoin EF, 2002, J NATL CANCER I, V94, P1576; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Phelps ME, 2004, PET MOL IMAGING BIOL; Qu YS, 2002, CLIN CHEM, V48, P1835; Rothenberg EV, 2003, INFEC DIS S, P61; Shah K, 2004, GENE THER, V11, P1175, DOI 10.1038/sj.gt.3302278; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; UTLEG AG, UNPUB; Waters LC, 1998, ANAL CHEM, V70, P158, DOI 10.1021/ac970642d; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Weston AD, 2003, COLD SPRING HARB SYM, V68, P345, DOI 10.1101/sqb.2003.68.345; WHETSELL L, 1992, ONCOGENE, V7, P2355; Wickline SA, 2003, CIRCULATION, V107, P1092, DOI 10.1161/01.CIR.0000059651.17045.77; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827	52	767	837	1	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					640	643		10.1126/science.1104635	http://dx.doi.org/10.1126/science.1104635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499008				2022-12-24	WOS:000224756700038
J	Kassen, R; Llewellyn, M; Rainey, PB				Kassen, R; Llewellyn, M; Rainey, PB			Ecological constraints on diversification in a model adaptive radiation	NATURE			English	Article							DIVERSITY; EVOLUTION; PRODUCTIVITY; FITNESS	Taxonomic diversification commonly occurs through adaptive radiation, the rapid evolution of a single lineage into a range of genotypes or species each adapted to a different ecological niche(1,2). Radiation size (measured as the number of new types) varies widely between phylogenetically distinct taxa(2-4) and between replicate radiations within a single taxon where the ecological opportunities available seem to be identical(5,6). Here we show how variation in energy input (productivity) and environmental disturbance combine to determine the extent of diversification in a single radiating lineage of Pseudomonas fluorescens adapting to laboratory conditions. Diversity peaked at intermediate rates of both productivity and disturbance and declined towards the extremes in a manner reminiscent of well-known ecological patterns(7-9). The mechanism responsible for the decrease in diversity arises from pleiotropic fitness costs associated with niche specialization(10,11), the effects of which are modulated by gradients of productivity and disturbance. Our results indicate that ecological gradients may constrain the size of adaptive radiations, even in the presence of the strong diversifying selection associated with ecological opportunity, by decoupling evolutionary diversification from ecological coexistence.	Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England; Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Oxford; University of Ottawa; University of Ottawa; University of Auckland	Kassen, R (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	rkassen@uottawa.ca	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795				Buckling A, 2003, SCIENCE, V302, P2107, DOI 10.1126/science.1088848; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Day T, 2004, BIOSCIENCE, V54, P101, DOI 10.1641/0006-3568(2004)054[0101:CAFED]2.0.CO;2; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Givnish Thomas J., 1997, P1; Holt RD, 1996, OIKOS, V75, P182, DOI 10.2307/3546242; Huston M.A., 1994, BIOL DIVERSITY; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kawecki TJ, 1997, J EVOLUTION BIOL, V10, P407, DOI 10.1007/s000360050032; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; MEYER W, 1993, HISTOL HISTOPATHOL, V8, P305; Morris SC, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P283; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; RIEBESELL JF, 1974, ECOLOGY, V55, P183, DOI 10.2307/1934634; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Simpson GG, 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SMITH JM, 1980, GENET RES, V35, P45, DOI 10.1017/S0016672300013926; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Tilman D., 1982, Monographs in Population Biology, pi; Travisano M, 2000, AM NAT, V156, pS35, DOI 10.1086/303414; Williams EE., 1972, EVOL BIOL, V6, P47, DOI [DOI 10.1007/978-1-4684-9063-3_3, 10. 1007/978-1-4684-9063-3]; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	30	74	76	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					984	988		10.1038/nature02923	http://dx.doi.org/10.1038/nature02923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15496923				2022-12-24	WOS:000224585600044
J	Joseph, SB; Bradley, MN; Castrillo, A; Bruhn, KW; Mak, PA; Pei, LM; Hogenesch, J; O'Connell, RM; Cheng, GH; Saez, E; Miller, JF; Tontonoz, P				Joseph, SB; Bradley, MN; Castrillo, A; Bruhn, KW; Mak, PA; Pei, LM; Hogenesch, J; O'Connell, RM; Cheng, GH; Saez, E; Miller, JF; Tontonoz, P			LXR-dependent gene expression is important for macrophage survival and the innate immune response	CELL			English	Article							CELL-BINDING CHARACTERISTICS; NUCLEAR RECEPTOR LXR; SCAVENGER RECEPTORS; MOLECULAR-CLONING; MICE LACKING; APOPTOSIS; CHOLESTEROL; LISTERIA; AIM; ATHEROSCLEROSIS	The liver X receptors (LXRs) are nuclear receptors with established roles in the regulation of lipid metabolism. We now show that LXR signaling not only regulates macrophage cholesterol metabolism but also impacts antimicrobial responses. Mice lacking LXRs are highly susceptible to infection with the intracellular bacteria Listeria monocytogenes (LM). Bone marrow transplant studies point to altered macrophage function as the major determinant of susceptibility. LXR-null macrophages undergo accelerated apoptosis when challenged with LM and exhibit defective bacterial clearance in vivo. These defects result, at least in part, from loss of regulation of the antiapoptotic factor SPalpha, a direct target for regulation by LXRalpha. Expression of LXRalpha or SPalpha in macrophages inhibits apoptosis in the setting of LM infection. Our results demonstrate that LXR-dependent gene expression plays an unexpected role in innate immunity and suggest that common nuclear receptor pathways mediate macrophage responses to modified lipoproteins and intracellular pathogens.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Novartis	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Bruhn, Kevin/F-9772-2013	Joseph, Sean/0000-0002-2602-8517	NATIONAL CANCER INSTITUTE [R01CA084008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL030568] Funding Source: NIH RePORTER; NCI NIH HHS [CA 84008] Funding Source: Medline; NHLBI NIH HHS [HL 66088, HL 30568] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Castrillo A, 2000, MOL CELL BIOL, V20, P1692, DOI 10.1128/MCB.20.5.1692-1698.2000; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Fettucciari K, 2000, J IMMUNOL, V165, P3923, DOI 10.4049/jimmunol.165.7.3923; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gebe JA, 2000, IMMUNOLOGY, V99, P78, DOI 10.1046/j.1365-2567.2000.00903.x; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guzman CA, 1996, MOL MICROBIOL, V20, P119, DOI 10.1111/j.1365-2958.1996.tb02494.x; Haruta I, 2001, J BIOL CHEM, V276, P22910, DOI 10.1074/jbc.M100324200; Hilbi H, 1997, INFECT IMMUN, V65, P5165, DOI 10.1128/IAI.65.12.5165-5170.1997; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kuwata K, 2003, AM J PATHOL, V162, P837, DOI 10.1016/S0002-9440(10)63880-1; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; North RJ, 1997, IMMUNOL REV, V158, P27, DOI 10.1111/j.1600-065X.1997.tb00989.x; OCONNELL R, 2004, IN PRESS J EXP MED; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rojas M, 1997, J IMMUNOL, V159, P1352; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Terpstra V, 2000, ARTERIOSCL THROM VAS, V20, P1860, DOI 10.1161/01.ATV.20.8.1860; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; van der Laan LJW, 1999, J IMMUNOL, V162, P939; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	35	431	453	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					299	309		10.1016/j.cell.2004.09.032	http://dx.doi.org/10.1016/j.cell.2004.09.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479645	Bronze			2022-12-24	WOS:000224577200016
J	Grotegut, CA				Grotegut, CA			Ureteral obstruction in pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Grotegut, CA (corresponding author), Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					E14	E14		10.1056/NEJMicm030958	http://dx.doi.org/10.1056/NEJMicm030958			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483272				2022-12-24	WOS:000224427300014
J	Daviglus, ML; Liu, K; Yan, LJL; Pirzada, A; Manheim, L; Manning, W; Garside, DB; Wang, RW; Dyer, AR; Greenland, P; Stamler, J				Daviglus, ML; Liu, K; Yan, LJL; Pirzada, A; Manheim, L; Manning, W; Garside, DB; Wang, RW; Dyer, AR; Greenland, P; Stamler, J			Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ASSOCIATION DETECTION PROJECT; HEALTH-CARE COSTS; CARDIOVASCULAR-DISEASE; UNITED-STATES; RISK-FACTOR; US ADULTS; FOLLOW-UP; OBESITY; OVERWEIGHT	Context Increasing prevalence of overweight/obesity and rapid aging of the US population have raised concerns of increasing health care costs, with important implications for Medicare. However, little is known about the impact of body mass index (BMI) earlier in life on Medicare expenditures (cardiovascular disease [CVD]-related, diabetes-related, and total) in older age. Objective To examine relationships of BMI in young adulthood and middle age to subsequent health care expenditures at ages 65 years and older. Design, Setting, and Participants Medicare data (1984-2002) were linked with baseline data from the Chicago Heart Association Detection Project in Industry (CHA) (1967-1973) for 9978 men (mean age, 46.0 years) and 7623 women (mean age, 48.4 years) (baseline overall age range, 33 to 64 years) who were free of coronary heart disease, diabetes, and major electrocardiographic abnormalities, were not underweight (BMI <18.5), and were Medicare-eligible (&GE;65 years) for at least 2 years during 1984-2002. Participants were classified by their baseline BMI as nonoverweight (BMI, 18.5-24.9), overweight (25.0-29.9), obese (30.0-34.9), and severely obese (&GE;35.0). Main Outcome Measures Cardiovascular disease-related, diabetes-related, and total average annual Medicare charges, and cumulative Medicare charges from age 65 years to death or to age 83 years. Results In multivariate analyses, average annual and cumulative Medicare charges (CVD-related, diabetes-related, and total) were significantly higher by higher baseline BMI for both men and women. Thus, with adjustment for baseline age, race, education, and smoking, total average annual charges for nonoverweight, overweight, obese, and severely obese women were, respectively, $6224, $7653, $9612, and $12342 (P<.001 for trend); corresponding total cumulative,Charges were $76866, $100959, $125470, and $174752 (P<.001 for trend). For nonoverweight, overweight, obese, and severely obese men, total average annual charges were, respectively, $7205, $8390, $10128, and $13674 (P<001 for trend). Corresponding total cumulative charges were $100431, $109098, $119318, and $176947 (P<.001 for trend). Conclusion Overweight/obesity in young adulthood and middle age has long-term adverse consequences for health care costs in older age.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Univ Chicago, Harris Sch Publ Policy Studies, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago	Daviglus, ML (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	daviglus@northwestern.edu	Pirzada, Amber/ABG-6028-2021; Greenland, Philip/ABD-5528-2021	Pirzada, Amber/0000-0003-0526-3611; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010, R01HL062684] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21010, R01 HL62684] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *AM HEART ASS, 2003, HEART STROK STAT 200; Bungum T, 2003, AM J HEALTH BEHAV, V27, P456, DOI 10.5993/AJHB.27.4.17; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cooper R, 2000, CIRCULATION, V102, P3137; Cornier MA, 2002, OBES RES, V10, P1167, DOI 10.1038/oby.2002.158; Daviglus ML, 2003, ARCH INTERN MED, V163, P2448, DOI 10.1001/archinte.163.20.2448; Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foot DK, 2000, J AM COLL CARDIOL, V35, P1067, DOI 10.1016/S0735-1097(00)00561-1; FRIED VM, 2003, CHARTBOOK TRENDS HLT; *GLOB PREV SEC TRE, 1999, OB PREV MAN GLOB EP, P16; Gorsky RD, 1996, AM J PREV MED, V12, P388, DOI 10.1016/S0749-3797(18)30296-4; HLATKY MA, 1990, CIRCULATION, V82, P208; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kuriyama S, 2002, INT J OBESITY, V26, P1069, DOI 10.1038/sj.ijo.0802021; LEVINE JB, 1964, CLIN CHIM ACTA, V10, P381, DOI 10.1016/0009-8981(64)90073-7; *MED PAYM ADV COMM, 2004, REP C MED PAYM POL H; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *NHLBI OB ED IN EX, 1998, NIH PUBL; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; PRINEAS RJ, 1983, HYPERTENSION, V5, P160; PRIYANATH A, 2001, JPN J CARDIOVASC D S, V36, P131; Pronk NP, 1999, JAMA-J AM MED ASSOC, V282, P2235, DOI 10.1001/jama.282.23.2235; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Thompson D, 2001, OBES RES, V9, P210, DOI 10.1038/oby.2001.23; *US BUR CENS, 2002, STAT ABSTR US 2002, P453; *US DEP HHS, 1980, DHHS PUBL; Wang GJ, 2002, AM J PREV MED, V23, P1, DOI 10.1016/S0749-3797(02)00448-8; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461	39	168	172	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2743	2749		10.1001/jama.292.22.2743	http://dx.doi.org/10.1001/jama.292.22.2743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585734	Bronze			2022-12-24	WOS:000225546600023
J	Lemmon, MT; Wolff, MJ; Smith, MD; Clancy, RT; Banfield, D; Landis, GA; Ghosh, A; Smith, PH; Spanovich, N; Whitney, B; Whelley, P; Greeley, R; Thompson, S; Bell, JF; Squyres, SW				Lemmon, MT; Wolff, MJ; Smith, MD; Clancy, RT; Banfield, D; Landis, GA; Ghosh, A; Smith, PH; Spanovich, N; Whitney, B; Whelley, P; Greeley, R; Thompson, S; Bell, JF; Squyres, SW			Atmospheric imaging results from the Mars exploration rovers: Spirit and Opportunity	SCIENCE			English	Article							GUSEV CRATER; MARTIAN ATMOSPHERE; MERIDIANI-PLANUM; PATHFINDER; DUST; IMAGER; TES; LOCALIZATION; AEROSOLS	A visible atmospheric optical depth of 0.9 was measured by the Spirit rover at Gusev crater and by the Opportunity rover at Meridiani Planum. Optical depth decreased by about 0.6 to 0.7% per sol through both 90-sol primary missions. The vertical distribution of atmospheric dust at Gusev crater was consistent with uniform mixing, with a measured scale height of 11.56+/-0.62 kilometers. The dust's cross section weighted mean radius was 1.47+/-0.21 micrometers (mum) at Gusev and 1.52+/-0.18 pm at Meridiani. Comparison of visible optical depths with 9-mum optical depths shows a visible-to-infrared optical depth ratio of 2.0+/-0.2 for comparison with previous monitoring of infrared optical depths.	Texas A&M Univ, College Stn, TX 77843 USA; Space Sci Inst, Boulder, CO 80301 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Cornell Univ, Ithaca, NY 14853 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Univ Arizona, Tucson, AZ 85721 USA; Arizona State Univ, Tempe, AZ 85287 USA	Texas A&M University System; Texas A&M University College Station; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cornell University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University of Arizona; Arizona State University; Arizona State University-Tempe	Lemmon, MT (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	lemmon@tamu.edu	Lemmon, Mark/X-2333-2019; Smith, Michael/C-8875-2012; Whelley, Patrick/B-9560-2012; Lemmon, Mark T/E-9983-2010; Banfield, Don J/I-3523-2018	Lemmon, Mark/0000-0002-4504-5136; Whelley, Patrick/0000-0003-3266-9772; Lemmon, Mark T/0000-0002-4504-5136; Banfield, Don J/0000-0003-2664-0164				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Balme MR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002096; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clancy RT, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002058; COLBURN DS, 1989, ICARUS, V79, P159, DOI 10.1016/0019-1035(89)90114-0; Ferri F, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2000JE001421; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002006; Johnson JR, 2003, ICARUS, V163, P330, DOI 10.1016/S0019-1035(03)00084-8; Kahn R. A., 1992, MARS, P1017; LIVINGSTON WC, 2000, ALLENS ASTROPHYSICAL; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; Markiewicz WJ, 1999, J GEOPHYS RES-PLANET, V104, P9009, DOI 10.1029/1998JE900033; POLLACK JB, 1995, J GEOPHYS RES-PLANET, V100, P5235, DOI 10.1029/94JE02640; POLLACK JB, 1980, J ATMOS SCI, V37, P868, DOI 10.1175/1520-0469(1980)037<0868:SBNPOS>2.0.CO;2; POLLACK JB, 1977, J GEOPHYS RES, V82, P8064; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith PH, 1999, J GEOPHYS RES-PLANET, V104, P8975, DOI 10.1029/1998JE900017; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016; Wolff MJ, 1999, J GEOPHYS RES-PLANET, V104, P9027, DOI 10.1029/98JE01967	25	182	184	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1753	1756		10.1126/science.1104474	http://dx.doi.org/10.1126/science.1104474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576613				2022-12-24	WOS:000225630800045
J	Allen, MR; Lord, R				Allen, MR; Lord, R			The blame game	NATURE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Brick Court Chambers, London WC2R 3LD, England	University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.		Allen, Myles R/A-5172-2012		Natural Environment Research Council [NER/T/S/2001/00968, NER/A/S/2002/00881] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Black E., 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; CAMPBELL P, 2004, NATURE, V421, P1; COGAN D, 2003, CORPORATE GOVERNANCE; *EUR, 2004, ICRC WORLD DIS REP, pCH2; Grossman David A., 2003, COLUM J ENV L, V28, P1; Schar C, 2004, NATURE, V432, P559, DOI 10.1038/432559a; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089	9	44	44	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2004	432	7017					551	552		10.1038/432551a	http://dx.doi.org/10.1038/432551a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577882				2022-12-24	WOS:000225433200016
J	Stott, PA; Stone, DA; Allen, MR				Stott, PA; Stone, DA; Allen, MR			Human contribution to the European heatwave of 2003	NATURE			English	Article							20TH-CENTURY TEMPERATURE-CHANGE; CLIMATE-CHANGE; PART I; VARIABILITY; TRENDS; MODEL	The summer of 2003 was probably the hottest in Europe since at latest AD 1500(1-4), and unusually large numbers of heat-related deaths were reported in France, Germany and Italy(5). It is an ill-posed question whether the 2003 heatwave was caused, in a simple deterministic sense, by a modification of the external influences on climate-for example, increasing concentrations of greenhouse gases in the atmosphere-because almost any such weather event might have occurred by chance in an unmodified climate. However, it is possible to estimate by how much human activities may have increased the risk of the occurrence of such a heatwave(6-8). Here we use this conceptual framework to estimate the contribution of human-induced increases in atmospheric concentrations of greenhouse gases and other pollutants to the risk of the occurrence of unusually high mean summer temperatures throughout a large region of continental Europe. Using a threshold for mean summer temperature that was exceeded in 2003, but in no other year since the start of the instrumental record in 1851, we estimate it is very likely (confidence level > 90%)(9) that human influence has at least doubled the risk of a heatwave exceeding this threshold-magnitude.	Univ Reading, Hadley Ctr Climate Predict & Res, Reading Unit, Met Off, Reading RG6 6BB, Berks, England; Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Met Office - UK; Hadley Centre; University of Reading; University of Oxford; University of Oxford	Stott, PA (corresponding author), Univ Reading, Hadley Ctr Climate Predict & Res, Reading Unit, Met Off, Meteorol Bldg, Reading RG6 6BB, Berks, England.	peter.stott@metoffice.gov.uk	Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016; Allen, Myles R/A-5172-2012	Stott, Peter/0000-0003-4853-7686; Stone, Daithi/0000-0002-2518-100X	Natural Environment Research Council [NER/A/S/2002/00881, NER/T/S/2001/00968] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Allen MR, 2003, CLIM DYNAM, V21, P477, DOI 10.1007/s00382-003-0313-9; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Beniston M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018857; Black E., 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; Coles S, 2001, INTRO STAT MODELING; Colman A, 1999, INT J CLIMATOL, V19, P513, DOI 10.1002/(SICI)1097-0088(199904)19:5<513::AID-JOC370>3.0.CO;2-D; Giorgi F, 2002, CLIM DYNAM, V18, P675, DOI 10.1007/s00382-001-0204-x; Grossman David A., 2003, COLUM J ENV L, V28, P1; Houghton J.T., 2001, IPCC CLIMATE CHANGE; *I VEILL SAN, 2003, IMP SAN VAG CHAL AOU; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Karoly DJ, 2003, SCIENCE, V302, P1200, DOI 10.1126/science.1089159; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; NAKICEOVIC N, 2000, SPECIAL REPORT EMISS; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; STONE DA, IN PRESS CLIM CHANGE; Stott PA, 2003, J CLIMATE, V16, P4079, DOI 10.1175/1520-0442(2003)016<4079:DMUTSC>2.0.CO;2; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Stott PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017324; Stott PA, 2001, CLIM DYNAM, V17, P1, DOI 10.1007/PL00007924; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; TETT SFB, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2000JD00028; Zwiers FW, 2003, J CLIMATE, V16, P793, DOI 10.1175/1520-0442(2003)016<0793:TRSCCD>2.0.CO;2	28	1047	1074	10	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					610	614		10.1038/nature03089	http://dx.doi.org/10.1038/nature03089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577907				2022-12-24	WOS:000225433200043
J	Graham, DJ; Staffa, JA; Shatin, D; Andrade, SE; Schech, SD; La Grenade, L; Gurwitz, JH; Chan, KA; Goodman, MJ; Platt, R				Graham, DJ; Staffa, JA; Shatin, D; Andrade, SE; Schech, SD; La Grenade, L; Gurwitz, JH; Chan, KA; Goodman, MJ; Platt, R			Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COA REDUCTASE INHIBITORS; PLASMA-CONCENTRATIONS; GEMFIBROZIL; CERIVASTATIN; MYOPATHY; STATINS; ACID	Context Lipid-lowering agents are widely prescribed in the United States. Reliable estimates of rhabdomyolysis risk with various lipid-lowering agents are not available. Objective To estimate the incidence of rhabdomyolysis in patients treated with different statins and fibrates, alone and in combination, in the ambulatory setting. Design, Setting, and Patients Drug-specific inception cohorts of statin and fibrate users were established using claims data from 11 managed care health plans across the United States. Patients with at least 180 days of prior health plan enrollment were entered into the cohorts between January 1, 1998, and June 30, 2001. Person-time was classified as monotherapy or combined statin-fibrate therapy. Main Outcome Measure Incidence rates of rhabdomyolysis per 10000 person-years of treatment, number needed to treat, and relative risk of rhabdomyolysis. Results In 252460 patients treated with lipid-lowering agents, 24 cases of hospitalized rhabdomyolysis occurred during treatment. Average incidence per 10000 person-years for monotherapy with atorvastatin, pravastatin, or simvastatin was 0.44 (95% confidence interval [CI], 0.20-0.84); for cerivastatin, 5.34 (95% Cl, 1.46-13.68); and for fibrate, 2.82 (95% Cl, 0.58-8.24). By comparison,. the incidence during unexposed person-time was 0 (95% Cl, 0-0.48; P=.056). The incidence increased to 5.98 (95% Cl, 0.72-216.0) for combined therapy of atorvastatin, pravastatin, or simvastatin with a fibrate, and to 1035 (95% Cl, 389-2117) for combined cerivastatin-fibrate use. Per year of therapy, the number needed to treat to observe 1 case of rhabdomyolysis was 22 727 for statin monotherapy, 484 for older patients with diabetes mellitus who were treated with both a statin and fibrate, and ranged from 9.7 to 12.7 for patients who were treated with cerivastatin plus fibrate. Conclusions Rhabdomyolysis risk was similar and low for monotherapy with atorvastatin, pravastatin, and simvastatin; combined statin-fibrate use increased risk, especially in older patients with diabetes mellitus. Cerivastatin combined with fibrate conferred a risk of approximately 1 in 10 treated patients per year.	US FDA, Off Drug Safety, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; Ctr Hlth Care Policy & Evaluat, Eden Prairie, MN USA; Fallon Fdn, Meyers Primary Care Inst, Worcester, MA USA; Univ Massachusetts, Sch Med, Amherst, MA 01003 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; HealthPartners Res Fdn, Minneapolis, MN USA	US Food & Drug Administration (FDA); University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health; HealthPartners Institute for Education & Research	Graham, DJ (corresponding author), US FDA, Off Drug Safety, Ctr Drug Evaluat & Res, 5600 Fishers Ln,HFD-400, Rockville, MD 20857 USA.	grahamd@cder.fda.gov		Chan, Kinwei/0000-0001-8161-1986	FDA HHS [FD-U-002067, FD-U-002068] Funding Source: Medline	FDA HHS		Backman JT, 2002, CLIN PHARMACOL THER, V72, P685, DOI 10.1067/mcp.2002.128469; Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Baker SK, 2001, CLIN INVEST MED, V24, P258; BALALNTYNE CM, 2003, ARCH INTERN MED, V163, P553; Barker BJ, 2003, DIABETES CARE, V26, P2482, DOI 10.2337/diacare.26.8.2482; Black C, 2002, PHARMACOTHERAPY, V22, P1524, DOI 10.1592/phco.22.17.1524.34130; Chan KA, 2000, PHARMACOEPIDEM DR S, P285; Clouatre Y, 1999, NEPHROL DIAL TRANSPL, V14, P1047, DOI 10.1093/ndt/14.4.1047; Cottrell DA, 2003, CURR OPIN CARDIOL, V18, P301, DOI 10.1097/00001573-200307000-00010; Evans M, 2002, DRUG SAFETY, V25, P649, DOI 10.2165/00002018-200225090-00004; Furberg CD, 2001, CURR CONTR TRIALS C, V2, P205, DOI 10.1186/CVM-2-5-205; Gaist D, 2001, EPIDEMIOLOGY, V12, P565, DOI 10.1097/00001648-200109000-00017; Gorriz JL, 1996, NEPHRON, V74, P437, DOI 10.1159/000189355; Kolata Gina, 2004, N Y Times Web, pA15; Kyrklund C, 2001, CLIN PHARMACOL THER, V69, P340, DOI 10.1067/mcp.2001.115542; Layne RD, 2004, ANN PHARMACOTHER, V38, P232, DOI 10.1345/aph.1D282; McAlister FA, 2000, JAMA-J AM MED ASSOC, V283, P2829, DOI 10.1001/jama.283.21.2829; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Omar MA, 2001, ANN PHARMACOTHER, V35, P1096, DOI 10.1345/aph.10228; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P1280, DOI 10.1124/dmd.30.11.1280; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P505, DOI 10.1124/dmd.30.5.505; Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033; SHATIN D, 2000, PHARMACOEPIDEM DR S, P295; Shek A, 2001, ANN PHARMACOTHER, V35, P908, DOI 10.1345/aph.10315; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; THOMPSON PDR, 2004, ZOCOR PHYS DESK REFE, P2113; THOMPSON PDR, 2004, LIPITOR PHYS DESK RE, P2543; Ucar M, 2000, DRUG SAFETY, V22, P441, DOI 10.2165/00002018-200022060-00003	30	627	660	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2004	292	21					2585	2590		10.1001/jama.292.21.2585	http://dx.doi.org/10.1001/jama.292.21.2585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875GU	15572716	Bronze			2022-12-24	WOS:000225409100021
J	Pascal, JM; O'Brien, PJ; Tomkinson, AE; Ellenberger, T				Pascal, JM; O'Brien, PJ; Tomkinson, AE; Ellenberger, T			Human DNA ligase I completely encircles and partially unwinds nicked DNA	NATURE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; DOMAIN; REPLICATION; FIDELITY; PCNA; CRYSTALLOGRAPHY; IDENTIFICATION; SPECIFICITY	The end-joining reaction catalysed by DNA ligases is required by all organisms and serves as the ultimate step of DNA replication, repair and recombination processes. One of three well characterized mammalian DNA ligases, DNA ligase I, joins Okazaki fragments during DNA replication. Here we report the crystal structure of human DNA ligase I ( residues 233 to 919) in complex with a nicked, 5' adenylated DNA intermediate. The structure shows that the enzyme redirects the path of the double helix to expose the nick termini for the strand-joining reaction. It also reveals a unique feature of mammalian ligases: a DNA-binding domain that allows ligase I to encircle its DNA substrate, stabilizes the DNA in a distorted structure, and positions the catalytic core on the nick. Similarities in the toroidal shape and dimensions of DNA ligase I and the proliferating cell nuclear antigen sliding clamp are suggestive of an extensive protein-protein interface that may coordinate the joining of Okazaki fragments.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Maryland, Sch Med, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Harvard University; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ellenberger, T (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	tome@hms.harvard.edu						BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bhagwat AS, 1999, NUCLEIC ACIDS RES, V27, P4028, DOI 10.1093/nar/27.20.4028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Dimitriadis EK, 1998, J BIOL CHEM, V273, P20540, DOI 10.1074/jbc.273.32.20540; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Doherty AJ, 1999, J MOL BIOL, V285, P63, DOI 10.1006/jmbi.1998.2301; Doherty AJ, 2000, J MOL BIOL, V296, P43, DOI 10.1006/jmbi.1999.3423; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; Grawunder U, 1998, CURR BIOL, V8, P873, DOI 10.1016/S0960-9822(07)00349-1; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Harrison C, 2002, CANCER RES, V62, P4065; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; LEHMAN IR, 1974, SCIENCE, V186, P790; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Luo JY, 1996, NUCLEIC ACIDS RES, V24, P3079, DOI 10.1093/nar/24.15.3079; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Martin IV, 2002, GENOME BIOL, V3; MONTECUCCO A, 1995, EMBO J, V14, P5379, DOI 10.1002/j.1460-2075.1995.tb00222.x; MONTECUCCO A, 1988, NUCLEIC ACIDS RES, V16, P7369, DOI 10.1093/nar/16.15.7369; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Robinet E, 1998, J HEMATOTHER, V7, P205, DOI 10.1089/scd.1.1998.7.205; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Sekiguchi J, 1997, BIOCHEMISTRY-US, V36, P9073, DOI 10.1021/bi970705m; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Singleton MR, 1999, STRUCTURE, V7, P35, DOI 10.1016/S0969-2126(99)80007-0; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, J BIOL CHEM, V277, P9695, DOI 10.1074/jbc.M111164200; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; TERAOKA H, 1993, J BIOL CHEM, V268, P24156; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R	50	251	256	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016					473	478		10.1038/nature03082	http://dx.doi.org/10.1038/nature03082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15565146				2022-12-24	WOS:000225322100038
J	Lyon, BE; Eadie, JM				Lyon, BE; Eadie, JM			An obligate brood parasite trapped in the intraspecific arms race of its hosts	NATURE			English	Article							CONSPECIFIC NEST PARASITISM; CUCULUS-CANORUS; EGGS; DISCRIMINATION; RECOGNITION; COEVOLUTION; REJECTION; MIMICRY; ACCEPT; CHOICE	Reciprocal selection pressures often lead to close and adaptive matching of traits in coevolved species. A failure of one species to match the evolutionary trajectories of another is often attributed to evolutionary lags(1,2) or to differing selection pressures across a geographic mosaic(3,4). Here we show that mismatches in adaptation of interacting species-an obligate brood parasitic duck and each of its two main hosts-are best explained by the evolutionary dynamics within the host species. Rejection of the brood parasite's eggs was common by both hosts, despite a lack of detectable cost of parasitism to the hosts. Egg rejection markedly reduced parasite fitness, but egg mimicry experiments revealed no phenotypic natural selection for more mimetic parasitic eggs. These paradoxical results were resolved by the discovery of intraspecific brood parasitism and conspecific egg rejection within the hosts themselves. The apparent arms race between species seems instead to be an incidental by-product of within-species conflict, with little recourse for evolutionary response by the parasite.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Santa Cruz; University of California System; University of California Davis	Lyon, BE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	lyon@biology.ucsc.edu	Eadie, John/E-4820-2011; Lyon, Bruce E/E-8491-2011	Eadie, John/0000-0001-9573-2703				ARNOLD TW, 1990, FOOD LIMITATION ADAP; BROOKE MD, 1988, NATURE, V335, P630; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; FREDERICK PC, 1986, J FIELD ORNITHOL, V57, P225; FREEMAN S, 1988, OSTRICH, V59, P49, DOI 10.1080/00306525.1988.9633694; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Jackson WM, 1998, OX ORN SER, V9, P407; Jamieson IG, 2000, AUK, V117, P250, DOI 10.1642/0004-8038(2000)117[0250:HROCBP]2.0.CO;2; Lahti DC, 2002, ANIM BEHAV, V63, P1135, DOI 10.1006/anbe.2002.3009; LOTEM A, 1992, BEHAV ECOL, V3, P128, DOI 10.1093/beheco/3.2.128; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; LYON BE, 1994, NATURE, V371, P240, DOI 10.1038/371240a0; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; LYON BE, 1991, BEHAV ECOL, V2, P309, DOI 10.1093/beheco/2.4.309; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MASON P, 1987, AM NAT, V130, P161, DOI 10.1086/284703; McRae SB, 1997, IBIS, V139, P701; PAYNE RB, 1977, ANNU REV ECOL SYST, V8, P1, DOI 10.1146/annurev.es.08.110177.000245; ROSKAFT E, 1990, EVOL ECOL, V4, P35, DOI 10.1007/BF02270713; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Sorenson MD, 1997, BEHAV ECOL, V8, P153, DOI 10.1093/beheco/8.2.153; SORENSON MD, 1995, CONDOR, V97, P819, DOI 10.2307/1369192; Thompson JN, 2002, INTEGR COMP BIOL, V42, P381, DOI 10.1093/icb/42.2.381; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Todd, 1996, NATURAL HIST WATERFO; WELLER M W, 1968, Living Bird, V7, P169; WELLER MW, 1971, AUK, V88, P108, DOI 10.2307/4083965	30	35	37	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					390	393		10.1038/nature03036	http://dx.doi.org/10.1038/nature03036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549105				2022-12-24	WOS:000225161400055
J	Koropatnick, TA; Engle, JT; Apicella, MA; Stabb, EV; Goldman, WE; McFall-Ngai, MJ				Koropatnick, TA; Engle, JT; Apicella, MA; Stabb, EV; Goldman, WE; McFall-Ngai, MJ			Microbial factor-mediated development in a host-bacterial mutualism	SCIENCE			English	Article							BORDETELLA-PERTUSSIS; TRACHEAL CYTOTOXIN; LIGHT ORGAN; SOLUBLE PEPTIDOGLYCAN; VIBRIO-FISCHERI; LIPOPOLYSACCHARIDE; MORPHOGENESIS; RECOGNITION; ENDOTOXIN; SYMBIOSIS	Tracheal cytotoxin (TCT), a fragment of the bacterial surface molecule peptidoglycan (PGN), is the factor responsible for the extensive tissue damage characteristic of whooping cough and gonorrhea infections. Here, we report that Vibrio fischeri also releases TCT, which acts in synergy with lipopolysaccharide (LPS) to trigger tissue development in its mutualistic symbiosis with the squid Euprymna scolopes. As components of PGN and LIDS have commonly been linked with pathogenesis in animals, these findings demonstrate that host interpretation of these bacterial signal molecules is context dependent. Therefore, such differences in interpretation can lead to either inflammation and disease or to the establishment of a mutually beneficial animal-microbe association.	Univ Hawaii, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96813 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Hawaii System; Washington University (WUSTL); University of Iowa; University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison	McFall-Ngai, MJ (corresponding author), Univ Hawaii, Kewalo Marine Lab, Pacific Biomed Res Ctr, 41 Ahui St, Honolulu, HI 96813 USA.	mjmcfallngai@wisc.edu		Goldman, William/0000-0002-1551-6718	NCRR NIH HHS [NCRR12294] Funding Source: Medline; NIAID NIH HHS [R01-AI50661] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050661] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COOKSON BT, 1989, INFECT IMMUN, V57, P2223, DOI 10.1128/IAI.57.7.2223-2229.1989; COOKSON BT, 1989, BIOCHEMISTRY-US, V28, P1744, DOI 10.1021/bi00430a048; Doino JA, 1995, BIOL BULL, V189, P347, DOI 10.2307/1542152; Flak TA, 2000, INFECT IMMUN, V68, P1235, DOI 10.1128/IAI.68.3.1235-1242.2000; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; GOLDMAN WE, 1982, INFECT IMMUN, V36, P782, DOI 10.1128/IAI.36.2.782-794.1982; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Karl David M., 1998, P29; Liu ZQ, 2001, ARTHRITIS RES, V3, P375, DOI 10.1186/ar330; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; MCFALLNGAI MJ, UNPUB; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MELLY MA, 1984, J INFECT DIS, V149, P378, DOI 10.1093/infdis/149.3.378; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Nyholm SV, 2002, APPL ENVIRON MICROB, V68, P5113, DOI 10.1128/AEM.68.10.5113-5122.2002; Pabst MJ, 1999, NEUROIMMUNOMODULAT, V6, P261, DOI 10.1159/000026384; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; ROSENTHAL RS, 1979, INFECT IMMUN, V24, P869, DOI 10.1128/IAI.24.3.869-878.1979; ROSENTHAL RS, 1987, INFECT IMMUN, V55, P2117, DOI 10.1128/IAI.55.9.2117-2120.1987; RUBY EG, 1977, APPL ENVIRON MICROB, V34, P164, DOI 10.1128/AEM.34.2.164-169.1977; Traub S, 2004, J BIOL CHEM, V279, P8694, DOI 10.1074/jbc.M310556200; Wray GM, 2001, SHOCK, V15, P135, DOI 10.1097/00024382-200115020-00010; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100	25	267	274	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2004	306	5699					1186	1188		10.1126/science.1102218	http://dx.doi.org/10.1126/science.1102218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539604				2022-12-24	WOS:000225193100050
J	Tapper, AR; McKinney, SL; Nashmi, R; Schwarz, J; Deshpande, P; Labarca, C; Whiteaker, P; Marks, MJ; Collins, AC; Lester, HA				Tapper, AR; McKinney, SL; Nashmi, R; Schwarz, J; Deshpande, P; Labarca, C; Whiteaker, P; Marks, MJ; Collins, AC; Lester, HA			Nicotine activation of alpha 4*receptors: Sufficient for reward, tolerance, and sensitization	SCIENCE			English	Article							CONDITIONED PLACE-PREFERENCE; VENTRAL TEGMENTAL AREA; ACETYLCHOLINE-RECEPTORS; UP-REGULATION; MICE; DOPAMINE; EXPOSURE; NEURONS; INFUSION; BLOCKADE	The identity of nicotinic receptor subtypes sufficient to elicit both the acute and chronic effects of nicotine dependence is unknown. We engineered mutant mice with alpha4 nicotinic subunits containing a single point mutation, Leu(9)' --> Ala(9)' in the pore-forming M2 domain, rendering alpha4* receptors hypersensitive to nicotine. Selective activation of alpha4* nicotinic acetylcholine receptors with low doses of agonist recapitulates nicotine effects thought to be important in dependence, including reinforcement in response to acute nicotine administration, as well as tolerance and sensitization elicited by chronic nicotine administration. These data indicate that activation of alpha4* receptors is sufficient for nicotine-induced reward, tolerance, and sensitization.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Leipzig, Dept Neurol, D-04103 Leipzig, Germany; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	California Institute of Technology; Leipzig University; University of Colorado System; University of Colorado Boulder	Lester, HA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	lester@caltech.edu		Nashmi, Raad/0000-0001-6596-2620	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA015663, R01DA003194] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-15663, DA-3194] Funding Source: Medline; NIMH NIH HHS [MH-49716] Funding Source: Medline; NINDS NIH HHS [NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACQUAS E, 1989, PSYCHOPHARMACOLOGY, V99, P151, DOI 10.1007/BF00442800; Berrendero F, 2002, J NEUROSCI, V22, P10935; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Damaj MI, 1996, J PHARMACOL EXP THER, V277, P454; FUDALA PJ, 1985, PHARMACOL BIOCHEM BE, V22, P237, DOI 10.1016/0091-3057(85)90384-3; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P887, DOI 10.1016/0091-3057(83)90099-0; Konu O, 2001, BRAIN RES, V909, P194, DOI 10.1016/S0006-8993(01)02685-3; KSIR C, 1985, NEUROPHARMACOLOGY, V24, P527, DOI 10.1016/0028-3908(85)90058-9; KSIR C, 1987, PSYCHOPHARMACOLOGY, V92, P25, DOI 10.1007/BF00215474; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Laviolette SR, 2003, PSYCHOPHARMACOLOGY, V166, P306, DOI 10.1007/s00213-002-1317-6; Li MD, 2002, MOL NEUROBIOL, V25, P265, DOI 10.1385/MN:25:3:265; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; MARKS MJ, 1991, J PHARMACOL EXP THER, V259, P392; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268; Marubio LM, 2003, EUR J NEUROSCI, V17, P1329, DOI 10.1046/j.1460-9568.2003.02564.x; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Nashmi R, 2003, J NEUROSCI, V23, P11554; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; Partridge JG, 2002, J NEUROSCI, V22, P2541, DOI 10.1523/JNEUROSCI.22-07-02541.2002; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; TAPPER A, UNPUB; WONNACOTT S, 1990, TRENDS PHARMACOL SCI, V11, P216, DOI 10.1016/0165-6147(90)90242-Z; Yates SL, 1995, BIOCHEM PHARMACOL, V50, P2001, DOI 10.1016/0006-2952(95)02100-0	28	523	539	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1029	1032		10.1126/science.1099420	http://dx.doi.org/10.1126/science.1099420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528443				2022-12-24	WOS:000225001100042
J	Matsumoto, Y; Maller, JL				Matsumoto, Y; Maller, JL			A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; MAMMALIAN-CELLS; CDK2; TRANSITION; PROGRESSION; CDK2-CYCLIN; DUPLICATION; PROTEIN; KINASE; MICE	Excess cyclin E-Cdk2 accelerates entry into S phase of the cell cycle and promotes polyploidy, which may contribute to genomic instability in cancer cells. We identified 20 amino acids in cyclin E as a centrosomal localization signal (CLS) essential for both centrosomal targeting and promoting DNA synthesis. Expressed wild-type, but not mutant, CLS peptides localized on the centrosome, prevented endogenous cyclin E and cyclin A from localizing to the centrosome, and inhibited DNA synthesis. Ectopic cyclin E localized to the centrosome and accelerated S phase entry even with mutations that abolish Cdk2 binding, but not with a mutation in the CLS. These results suggest that cyclin E has a modular centrosomal-targeting domain essential for promoting S phase entry in a Cdk2-independent manner.	Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA.	Jim.Maller@uchsc.edu						Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y., UNPUB; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rialland M, 2002, J CELL SCI, V115, P1435; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; TSAI LH, 1993, ONCOGENE, V8, P1593; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468	22	158	162	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					885	888		10.1126/science.1103544	http://dx.doi.org/10.1126/science.1103544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514162				2022-12-24	WOS:000224969400051
J	Pighin, JA; Zheng, HQ; Balakshin, LJ; Goodman, IP; Western, TL; Jetter, R; Kunst, L; Samuels, AL				Pighin, JA; Zheng, HQ; Balakshin, LJ; Goodman, IP; Western, TL; Jetter, R; Kunst, L; Samuels, AL			Plant cuticular lipid export requires an ABC transporter	SCIENCE			English	Article							CANCER RESISTANCE PROTEIN; ARABIDOPSIS-THALIANA; MUTANTS	A waxy protective cuticle coats all primary aerial plant tissues. Its synthesis requires extensive export of lipids from epidermal cells to the plant surface. Arabidopsis cer5 mutants had reduced stem cuticular wax loads and accumulated sheetlike inclusions in the cytoplasm of wax-secreting cells. These inclusions represented abnormal deposits of cuticular wax and resembled inclusions found in a human disorder caused by a defective peroxisomal adenosine triphosphate binding cassette (ABC) transporter. We found that the CER5 gene encodes an ABC transporter localized in the plasma membrane of epidermal cells and conclude that it is required for wax export to the cuticle.	Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Samuels, AL (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	lsamuels@interchange.ubc.ca	zheng, Huanquan/G-4739-2011; Samuels, Anne Lacey/C-9767-2012	Samuels, Anne Lacey/0000-0002-0606-8933; Zheng, Huanquan/0000-0003-2986-725X				Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; KOORNNEEF M, 1989, J HERED, V80, P118, DOI 10.1093/oxfordjournals.jhered.a110808; Otsu CT, 2004, J EXP BOT, V55, P1643, DOI 10.1093/jxb/erh195; POWELL H, 1975, ARCH NEUROL-CHICAGO, V32, P250, DOI 10.1001/archneur.1975.00490460066009; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; REA PA, 2003, ABC PROTEINS BACTERI, P335; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Scheffer GL, 2000, CANCER RES, V60, P2589	10	380	421	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					702	704		10.1126/science.1102331	http://dx.doi.org/10.1126/science.1102331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499022				2022-12-24	WOS:000224756700056
J	Dayan, L; Donovan, B				Dayan, L; Donovan, B			Chlamydia, gonorrhoea, and injectable progesterone	LANCET			English	Editorial Material							CONTRACEPTIVE USE; UNITED-STATES; DEPO-PROVERA; INFECTIONS; STORY		Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; Royal N Shore Hosp, Sexual Hlth Serv, St Leonards, NSW 2065, Australia; Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	University of Sydney; Royal North Shore Hospital	Dayan, L (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	ldayan@doh.health.nsw.gov.au	Donovan, Basil J/K-1246-2012	Donovan, Basil J/0000-0001-8851-4126				Cromer BA, 1998, J ADOLESCENT HEALTH, V23, P74, DOI 10.1016/S1054-139X(98)00030-5; Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415; KLITSCH M, 1993, FAM PLANN PERSPECT, V25, P37, DOI 10.2307/2135992; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Oddens BJ, 1997, J BIOSOC SCI, V29, P437, DOI 10.1017/S0021932097004379; RICHARD BW, 1987, ANN INTERN MED, V106, P886, DOI 10.7326/0003-4819-106-6-886; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726	7	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1387	1388		10.1016/S0140-6736(04)17239-5	http://dx.doi.org/10.1016/S0140-6736(04)17239-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488203				2022-12-24	WOS:000224485300008
J	Friesema, ECH; Grueters, A; Biebermann, H; Krude, H; von Moers, A; Reeser, M; Barrett, TG; Mancilla, EE; Svensson, J; Kester, MHA; Kuiper, GGJM; Balkassmi, S; Uitterlinden, AG; Koehrle, J; Rodien, P; Halestrap, AP; Visser, T				Friesema, ECH; Grueters, A; Biebermann, H; Krude, H; von Moers, A; Reeser, M; Barrett, TG; Mancilla, EE; Svensson, J; Kester, MHA; Kuiper, GGJM; Balkassmi, S; Uitterlinden, AG; Koehrle, J; Rodien, P; Halestrap, AP; Visser, T			Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation	LANCET			English	Article								Monocarboxylate transporter 8 (MCT8) is a thyroid hormone transporter, the gene of which is located on the X chromosome. We tested whether mutations in MCT8 cause severe psychomotor retardation and high serum triiodothyronine (T,) concentrations in five unrelated young boys. The coding sequence of MCT8 was analysed by PCR and direct sequencing of its six exons. In two patients, gene deletions of 2.4 kb and 24 kb were recorded and in three patients missense mutations Ala150Va1, Arg171stop, and Leu397Pro were identified. We suggest that this novel syndrome of X-linked psychomotor retardation is due to a defect in T-3 entry into neurons through MCT8, resulting in impaired T-3 action and metabolism.	Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; Humboldt Univ, Dept Paediat Endocrinol, Charite Childrens Hosp, Berlin, Germany; Juliana Childrens Hosp, Dept Paediat, The Hague, Netherlands; Birmingham Childrens Hosp, Dept Endocrinol, Birmingham, W Midlands, England; Univ Chile, Inst Biomed Sci, Santiago, Chile; Malmo Univ Hosp, Dept Paediat, Malmo, Sweden; Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; CHU Angers, INSERM, U0018, EMI, Angers, France; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Birmingham; Universidad de Chile; Lund University; Skane University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Bristol	Visser, T (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	t.j.visser@erasmusmc.nl	Visser, Theo J/C-8059-2013; Halestrap, Andrew P/G-7275-2011; Rodien, Patrice/AAT-7909-2021; Köhrle, Josef/AAH-6438-2020; Barrett, Timothy/F-1682-2010	Visser, Theo J/0000-0002-6997-284X; Köhrle, Josef/0000-0002-9187-9078; Barrett, Timothy/0000-0002-6873-0750; Halestrap, Andrew/0000-0001-5374-2778; Biebermann, Heike/0000-0002-2024-7778; Svensson, Johan/0000-0003-4313-1521				Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; de Escobar GM, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI 10.1210/jc.85.11.3975; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; LAFRENIERE RG, 1994, HUM MOL GENET, V3, P1133, DOI 10.1093/hmg/3.7.1133; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0	7	471	485	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1435	1437		10.1016/S0140-6736(04)17226-7	http://dx.doi.org/10.1016/S0140-6736(04)17226-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488219				2022-12-24	WOS:000224485300030
J	Goodman, MB				Goodman, MB			Deconstructing C-elegans sensory mechanotransduction	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; SENSITIVITY; CHANNEL; NEURONS		Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Goodman, MB (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272				Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Brown A, UNPUB; *CDCP, 2004, NAT DIAB FACT SHEET; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hardie RC, 2001, J EXP BIOL, V204, P3403; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; MENDELSON M, 1964, SCIENCE, V144, P554, DOI 10.1126/science.144.3618.554; OHAGAN R, UNPUB; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015	14	1	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					427	428		10.1126/science.1105624	http://dx.doi.org/10.1126/science.1105624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486284				2022-12-24	WOS:000224626500036
J	Hall, DA; Zhu, H; Zhu, XW; Royce, T; Gerstein, M; Snyder, M				Hall, DA; Zhu, H; Zhu, XW; Royce, T; Gerstein, M; Snyder, M			Regulation of gene expression by a metabolic enzyme	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; BUDDING YEAST; COMPLEX; IDENTIFICATION; TRANSCRIPTION; PROMOTER; PROTEINS; PROTEOME; BINDING	Gene expression in eukaryotes is normally believed to be controlled by transcriptional regulators that activate genes encoding structural proteins and enzymes. To identify previously unrecognized DNA binding activities, a yeast proteome microarray was screened with DNA probes; Arg5,6, a well-characterized mitochondrial enzyme involved in arginine biosynthesis, was identified. Chromatin immunoprecipitation experiments revealed that Arg5,6 is associated with specific nuclear and mitochondrial loci in vivo, and Arg5,6 binds to specific fragments in vitro. Deletion of Arg5,6 causes altered transcript levels of both nuclear and mitochondrial target genes. These results indicate that metabolic enzymes can directly regulate eukaryotic gene expression.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	michael.snyder@yale.edu		Snyder, Michael/0000-0003-0784-7987; Zhu, Xiaowei/0000-0002-5731-3177				Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; Bateman JM, 2002, GENETICS, V161, P1043; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Guillamon JM, 2001, FEMS YEAST RES, V1, P169, DOI 10.1111/j.1567-1364.2001.tb00031.x; HICKE BJ, 1989, EMBO J, V8, P3843, DOI 10.1002/j.1460-2075.1989.tb08562.x; Hirose Y, 2000, GENE DEV, V14, P1415; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; MacIver FH, 1997, CURR GENET, V31, P119, DOI 10.1007/s002940050184; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; SCHMIDT WM, 1994, J MOL BIOL, V243, P157, DOI 10.1006/jmbi.1994.1642; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Turner BM, 2003, NAT CELL BIOL, V5, P390, DOI 10.1038/ncb0503-390; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; [No title captured]	22	179	197	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					482	484		10.1126/science.1096773	http://dx.doi.org/10.1126/science.1096773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486299				2022-12-24	WOS:000224626500052
J	Muni, NI; Gross, TP				Muni, NI; Gross, TP			Problems with drug-eluting coronary stents - The FDA perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Muni, NI (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.							*FOOD DRUG ADM, 2004, TAXUS EXPR 2 PACL EL; *FOOD DRUG ADM, 2003, CYPHER SIR EL COR ST	2	40	46	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1593	1595		10.1056/NEJMp048262	http://dx.doi.org/10.1056/NEJMp048262			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483274				2022-12-24	WOS:000224427300002
J	Hu, D; Hook, EW; Goldie, SJ				Hu, D; Hook, EW; Goldie, SJ			Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PELVIC-INFLAMMATORY-DISEASE; SEXUALLY-TRANSMITTED-DISEASES; DIRECT MEDICAL COST; UNITED-STATES; ASYMPTOMATIC WOMEN; YOUNG-WOMEN; FOLLOW-UP; INFECTION; PREVALENCE; TESTS	Background: Clinical guidelines have traditionally advised annual Chlamydia trachomatis screening for women younger than 25 years of age. Objective: To assess the cost-effectiveness of recently proposed strategies for chlamyclia screening. Design: State transition simulation model; cost-effectiveness analysis. Data Sources: Published literature. Target Population: Sexually active U.S. women 15 to 29 years of age. Time Horizon: Lifetime. Perspective: Modified societal. Interventions: Four strategies targeted to 3 specific age groups (15 to 19 years, 15 to 24 years, and 15 to 29 years): 1) no screening, 2) annual screening for all women, 3) annual screening followed by 1 repeated test within 3 to 6 months after a positive test result, and 4) annual screening followed by selective semiannual screening for women with a history of infection. Outcome Measures: Clinical events (for example, pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and infertility), lifetime costs, quality-adjusted life expectancy, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection was the most effective and cost-effective strategy. It consistently had an incremental cost-effectiveness ratio less than $25 000 per quality-adjusted life-year (QALY) compared with the next most effective strategy. When the indirect transmission effects of a 10-year screening program on the probability of infection in uninfected women (that is, per-susceptible rate of infection) were considered, all strategies became more cost-effective. Results of Sensitivity Analysis: Results were sensitive to the annual incidence of chlamyclia, probability of persistent infection, screening test costs, and costs of treating long-term complications. Each variable was associated with threshold values beyond which screening became cost-saving. In probabilistic analysis, annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection had an incremental cost-effectiveness ratio less than $50 000 per QALY in 99% of simulations. Limitations: Uncertainty about the natural history of chlamydial infection and consideration of only the indirect transmission effects of C. trachomatis screening. Conclusions: Annual C. trachomatis screening for all women 15 to 29 years of age and selective targeting of those with a history of infection for semiannual screening is very cost-effective compared with other well-accepted clinical interventions.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Univ Alabama Birmingham, Birmingham, AL USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Alabama System; University of Alabama Birmingham	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.							Abma J C, 1997, Vital Health Stat 23, P1; Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; ARAL SO, 1991, JAMA-J AM MED ASSOC, V266, P2570, DOI 10.1001/jama.266.18.2570; Bachmann LH, 2003, SEX TRANSM DIS, V30, P20, DOI 10.1097/00007435-200301000-00005; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; Black CM, 2002, J CLIN MICROBIOL, V40, P3757, DOI 10.1128/JCM.40.10.3757-3763.2002; BRIHMER C, 1989, EUR J OBSTET GYN R B, V30, P263, DOI 10.1016/0028-2243(89)90011-7; Britton T F, 1992, Am J Gynecol Health, V6, P80; BUHAUG H, 1990, BRIT J GEN PRACT, V40, P142; BUHAUG H, 1989, MED CARE, V27, P833, DOI 10.1097/00005650-198908000-00007; Burstein GR, 2001, SEX TRANSM INFECT, V77, P26, DOI 10.1136/sti.77.1.26; Burstein GR, 1998, JAMA-J AM MED ASSOC, V280, P521, DOI 10.1001/jama.280.6.521; *CDCP, 2001, CHL PREV MON PROJ S; *CDCP, 2001, TRACK HIDD EP TRENDS; *CDCP, 1996, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2016, DEV WAT MAN PROGR RE; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Dean D, 1998, J CLIN MICROBIOL, V36, P94, DOI 10.1128/JCM.36.1.94-99.1998; Edmunds WJ, 1999, STAT MED, V18, P3263, DOI 10.1002/(SICI)1097-0258(19991215)18:23&lt;3263::AID-SIM315&gt;3.0.CO;2-3; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gift TL, 2002, SEX TRANSM DIS, V29, P542, DOI 10.1097/00007435-200209000-00009; Goeree R, 2001, SEX TRANSM DIS, V28, P701, DOI 10.1097/00007435-200112000-00007; Gold MR, 1996, COST EFFECTIVENESS H; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; GOLDSMITH MF, 1986, JAMA-J AM MED ASSOC, V255, P1665, DOI 10.1001/jama.255.13.1665; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; HALVORSEN L E, 1988, Tidsskrift for den Norske Laegeforening, V108, P2706; HAMMERSCHLAG MR, 1999, SEXUALLY TRANSMITTED, P1155; HILLIS SD, 1995, FAM PLANN PERSPECT, V27, P108, DOI 10.2307/2136107; HILLIS SD, 1994, AM J OBSTET GYNECOL, V170, P801, DOI 10.1016/S0002-9378(94)70286-1; HILLIS SD, 1995, 11 M INT SOC STD RES, V267, P156; *HLTH CAR FIN ADM, 2000, MED B; Howell MR, 1999, SEX TRANSM DIS, V26, P519, DOI 10.1097/00007435-199910000-00007; Howell MR, 1998, ANN INTERN MED, V128, P277, DOI 10.7326/0003-4819-128-4-199802150-00005; KATZ BP, 1988, SEX TRANSM DIS, V15, P11, DOI 10.1097/00007435-198801000-00003; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lawrence RS., 2000, VACCINES 21 CENTURY, P149; Low W., 1999, SEX TRANSM DIS, P407; Magid D, 1996, ANN INTERN MED, V124, P389, DOI 10.7326/0003-4819-124-4-199602150-00002; MARDH PA, 1977, NEW ENGL J MED, V296, P1377, DOI 10.1056/NEJM197706162962403; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; MCCORMACK WM, 1979, NEW ENGL J MED, V300, P123, DOI 10.1056/NEJM197901183000305; *MED EC, 2000, DRUG TOP RED BOOK; Mertz KJ, 2002, SEX TRANSM DIS, V29, P271, DOI 10.1097/00007435-200205000-00004; Mertz KJ, 2001, AM J PUBLIC HEALTH, V91, P1287, DOI 10.2105/AJPH.91.8.1287; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Nsuami M, 2000, SEX TRANSM DIS, V27, P473, DOI 10.1097/00007435-200009000-00010; Oh MK, 1996, J ADOLESCENT HEALTH, V18, P270, DOI 10.1016/1054-139X(95)00232-H; Ostergaard L, 1998, BRIT MED J, V317, P26, DOI 10.1136/bmj.317.7150.26; PAAVONEN J, 1985, AM J OBSTET GYNECOL, V152, P280, DOI 10.1016/S0002-9378(85)80210-6; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Richey CM, 1999, SEX TRANSM DIS, V26, P4, DOI 10.1097/00007435-199901000-00002; Rietmeijer CA, 2002, SEX TRANSM DIS, V29, P65, DOI 10.1097/00007435-200202000-00001; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; Shafer MAB, 1999, ARCH PEDIAT ADOL MED, V153, P119; *SIG HLTH CAR INF, 1994, MED REG GEP GEG 1993; SMITH TW, 1991, FAM PLANN PERSPECT, V23, P102, DOI 10.2307/2135820; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; STEECE R, 1997, NATL PRICING CHLAMYD; Stephen EH, 2000, FAM PLANN PERSPECT, V32, P132, DOI 10.2307/2648162; Tao G, 2002, SEX TRANSM DIS, V29, P703, DOI 10.1097/00007435-200211000-00014; TEISALA K, 1987, OBSTET GYNECOL, V69, P343; *US CENS BUR, 2000, STAT ABSTR US  2000; *US DEP LAB BUR LA, 2003, 952 US DEP LAB BUR L; VISCIDI RP, 1993, J INFECT DIS, V168, P488, DOI 10.1093/infdis/168.2.488; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2565, DOI 10.1001/jama.266.18.2565; WASHINGTON AE, 1984, JAMA-J AM MED ASSOC, V251, P2529, DOI 10.1001/jama.251.19.2529; WASHINGTON AE, 1986, JAMA-J AM MED ASSOC, V255, P1735, DOI 10.1001/jama.255.13.1735; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; WESTROM LV, 1994, SEX TRANSM DIS, V21, pS32; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; WOLNERHANSSEN P, 1983, OBSTET GYNECOL, V61, P702; Yeh JM, 2003, SEX TRANSM DIS, V30, P369, DOI 10.1097/00007435-200305000-00001; 1997, MMWR MORB MORTAL WKL, V46, P193	86	102	103	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					501	513		10.7326/0003-4819-141-7-200410050-00006	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466767				2022-12-24	WOS:000224467800002
J	Tzedakis, PC; Roucoux, KH; de Abreu, L; Shackleton, NJ				Tzedakis, PC; Roucoux, KH; de Abreu, L; Shackleton, NJ			The duration of forest stages in southern Europe and interglacial climate variability	SCIENCE			English	Article							SEA-LEVEL; MARINE; LONG; TERRESTRIAL; RECORDS; TEMPERATURE; VEGETATION; CYCLES; PHASE	Foraminiferal oxygen isotope and pollen analyses from a deep-sea sequence off southwest Portugal show that the duration of temperate stages on land over the past 350,000 years varied considerably. The record shows forest contractions during intervals of low ice volume, coeval with declines in atmospheric methane, after which tree populations did not always recover. What emerges is that, although the broad timing of interglacials is consistent with orbital theory, their specific duration may be dictated by millennial. variability. This complicates the prediction of the natural duration of interglacials, at least until the origin of this climate variability is understood.	Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Cambridge, Dept Earth Sci, Godwin Lab, Cambridge CB2 3SA, England	University of Leeds; University of Cambridge	Tzedakis, PC (corresponding author), Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England.	P.C.Tzedakis@teeds.ac.uk	Tzedakis, Polychronis/J-1894-2012	Roucoux, Katherine/0000-0001-6757-7267; Tzedakis, Polychronis/0000-0001-6072-1166				Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; Brook EJ, 1999, GEOPH MONOG SERIES, V112, P165; de Beaulieu JL, 2001, QUATERNARY SCI REV, V20, P1593, DOI 10.1016/S0277-3791(01)00027-0; Delmotte M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004417; FOLLIERI M, 1988, Pollen et Spores, V30, P329; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; Kukla G, 1997, QUATERNARY SCI REV, V16, P605, DOI 10.1016/S0277-3791(96)00114-X; Parrenin F, 2003, EARTH PLANET SC LETT, V214, P243, DOI 10.1016/S0012-821X(03)00363-7; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Reille M, 1998, QUATERNARY SCI REV, V17, P1107, DOI 10.1016/S0277-3791(97)00093-0; REILLE M, 1995, QUATERNARY RES, V44, P205, DOI 10.1006/qres.1995.1065; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Roucoux KH, 2001, QUATERNARY RES, V56, P128, DOI 10.1006/qres.2001.2218; SHACKLETON NJ, 1969, PROC R SOC SER B-BIO, V174, P135, DOI 10.1098/rspb.1969.0085; Shackleton NJ, 2003, GLOBAL PLANET CHANGE, V36, P151, DOI 10.1016/S0921-8181(02)00181-9; Shackleton NJ, 2002, QUATERNARY RES, V58, P14, DOI 10.1006/qres.2001.2312; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Turner C, 1998, QUATERN INT, V47-8, P41, DOI 10.1016/S1040-6182(97)00069-4; Tzedakis PC, 1997, EARTH PLANET SC LETT, V150, P171, DOI 10.1016/S0012-821X(97)00078-2; Tzedakis PC, 2003, EARTH PLANET SC LETT, V212, P197, DOI 10.1016/S0012-821X(03)00233-4; Tzedakis PC, 2002, QUATERNARY RES, V58, P53, DOI 10.1006/qres.2002.2328; Tzedakis PC, 2001, QUATERNARY SCI REV, V20, P1583, DOI 10.1016/S0277-3791(01)00025-7; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525; WIJMSTRA TA, 1976, ACTA BOT NEERL, V25, P297, DOI 10.1111/j.1438-8677.1976.tb00241.x	26	134	135	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2231	2235		10.1126/science.1102398	http://dx.doi.org/10.1126/science.1102398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15576573				2022-12-24	WOS:000225950000039
J	Corey, DP; Garcia-Anoveros, J; Holt, JR; Kwan, KY; Lin, SY; Vollrath, MA; Amalfitano, A; Cheung, ELM; Derfler, BH; Duggan, A; Geleoc, GSG; Gray, PA; Hoffman, MP; Rehm, HL; Tamasauskas, D; Zhang, DS				Corey, DP; Garcia-Anoveros, J; Holt, JR; Kwan, KY; Lin, SY; Vollrath, MA; Amalfitano, A; Cheung, ELM; Derfler, BH; Duggan, A; Geleoc, GSG; Gray, PA; Hoffman, MP; Rehm, HL; Tamasauskas, D; Zhang, DS			TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells	NATURE			English	Article							ION CHANNELS; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; MECHANOTRANSDUCER CHANNEL; TIP LINKS; ADAPTATION; MUTATIONS; GENE; CADHERIN-23; ADENOVIRUS	Mechanical deflection of the sensory hair bundles of receptor cells in the inner ear causes ion channels located at the tips of the bundle to open, thereby initiating the perception of sound. Although some protein constituents of the transduction apparatus are known, the mechanically gated transduction channels have not been identified in higher vertebrates. Here, we investigate TRP ( transient receptor potential) ion channels as candidates and find one, TRPA1 ( also known as ANKTM1), that meets criteria for the transduction channel. The appearance of TRPA1 messenger RNA expression in hair cell epithelia coincides developmentally with the onset of mechanosensitivity. Antibodies to TRPA1 label hair bundles, especially at their tips, and tip labelling disappears when the transduction apparatus is chemically disrupted. Inhibition of TRPA1 protein expression in zebrafish and mouse inner ears inhibits receptor cell function, as assessed with electrical recording and with accumulation of a channel-permeant fluorescent dye. TRPA1 is probably a component of the transduction channel itself.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Northwestern Univ, Inst Neurosci, Dept Anesthesiol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Physiol, Chicago, IL 60611 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Partners Genome Ctr, Mol Med Lab, Cambridge, MA 02139 USA; Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27705 USA; NIDCR, Matrix & Morphogenesis Unit, CDBRB, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Northwestern University; Northwestern University; Northwestern University; University of Virginia; University of Virginia; Massachusetts Institute of Technology (MIT); Harvard University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Corey, DP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	dcorey@hms.harvard.edu		Kwan, Kelvin/0000-0002-8617-5543; Garcia-Anoveros, Jaime/0000-0001-6561-9048; Rehm, Heidi L./0000-0002-6025-0015; Corey, David/0000-0003-4497-6016	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000707] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Duggan A, 2000, CURR BIOL, V10, pR384, DOI 10.1016/S0960-9822(00)00478-4; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hodges BL, 2000, J GENE MED, V2, P250, DOI 10.1002/1521-2254(200007/08)2:4<250::AID-JGM113>3.0.CO;2-3; Holt JR, 1999, J NEUROPHYSIOL, V81, P1881, DOI 10.1152/jn.1999.81.4.1881; Holt JR, 2002, AUDIOL NEURO-OTOL, V7, P157, DOI 10.1159/000058302; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Luebke AE, 2001, GENE THER, V8, P789, DOI 10.1038/sj.gt.3301445; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Starr CJ, 2004, P NATL ACAD SCI USA, V101, P2572, DOI 10.1073/pnas.0308474100; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUKHAREV S, 2004, SCI STKE, pRE4; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	42	497	559	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					723	730		10.1038/nature03066	http://dx.doi.org/10.1038/nature03066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15483558				2022-12-24	WOS:000225597200040
J	Huber, TL; Kouskoff, V; Fehling, HJ; Palis, J; Keller, G				Huber, TL; Kouskoff, V; Fehling, HJ; Palis, J; Keller, G			Haemangioblast commitment is initiated in the primitive streak of the mouse embryo	NATURE			English	Article							DEFINITIVE HEMATOPOIESIS; CELL-DIFFERENTIATION; EXPRESSION PATTERN; COMMON PRECURSOR; MESODERMAL CELLS; SMOOTH-MUSCLE; YOLK-SAC; GENE; FLK-1; ERYTHROPOIESIS	Haematopoietic and vascular cells are thought to arise from a common progenitor called the haemangioblast. Support for this concept has been provided by embryonic stem (ES) cell differentiation studies that identified the blast colony-forming cell (BL-CFC), a progenitor with both haematopoietic and vascular potential(1,2). Using conditions that support the growth of BL-CFCs, we identify comparable progenitors that can form blast cell colonies (displaying haematopoietic and vascular potential) in gastrulating mouse embryos. Cell mixing and limiting dilution analyses provide evidence that these colonies are clonal, indicating that they develop from a progenitor with haemangioblast potential. Embryo-derived haemangioblasts are first detected at the mid-streak stage of gastrulation and peak in number during the neural plate stage. Analysis of embryos carrying complementary DNA of the green fluorescent protein targeted to the brachyury locus demonstrates that the haemangioblast is a subpopulation of mesoderm that co-expresses brachyury ( also known as T) and Flk-1 (also known as Kdr). Detailed mapping studies reveal that haemangioblasts are found at highest frequency in the posterior region of the primitive streak, indicating that initial stages of haematopoietic and vascular commitment occur before blood island development in the yolk sac.	CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; Univ Clin, Fac Med, Dept Immunol, D-89081 Ulm, Germany; Univ Rochester, Med Ctr, Dept Pediat, Ctr Canc, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Human Genet & Mol Pediat Dis, Rochester, NY 14642 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Paterson Institute for Cancer Research; Ulm University; University of Rochester; University of Rochester	Keller, G (corresponding author), CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	james_palis@urmc.rochester.edu; gordon.keller@mssm.edu		Palis, James/0000-0001-7324-1049; Keller, Gordon/0000-0001-9309-9297				Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Kabrun N, 1997, DEVELOPMENT, V124, P2039; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; ORKIN SH, 1992, BLOOD, V80, P575; Palis J, 1999, DEVELOPMENT, V126, P5073; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Saga Y, 1996, DEVELOPMENT, V122, P2769; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Sitzmann J, 1995, ONCOGENE, V11, P2273; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	28	480	505	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					625	630		10.1038/nature03122	http://dx.doi.org/10.1038/nature03122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577911				2022-12-24	WOS:000225433200047
J	Francis, NJ; Kingston, RE; Woodcock, CL				Francis, NJ; Kingston, RE; Woodcock, CL			Chromatin compaction by a polycomb group protein complex	SCIENCE			English	Article							STRUCTURAL BASIS; ACCESSIBILITY; DNA; MECHANISMS; REPRESSION; MOTIF	Polycomb group proteins preserve body patterning through development by maintaining transcriptional silencing of homeotic genes. A long-standing hypothesis is that silencing involves creating chromatin structure that is repressive to gene transcription. We demonstrate by electron microscopy that core components of Polycomb Repressive Complex 1 induce compaction of defined nucleosomal arrays. Compaction by Polycomb proteins requires nucleosomes but not histone tails. Each Polycomb complex can compact about three nucleosomes. A region of Posterior Sex Combs that is important for gene silencing in vivo is also important for chromatin compaction, linking the two activities. This mechanism of chromatin compaction might be central to stable gene silencing by the Polycomb group.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043786] Funding Source: NIH RePORTER; NCRR NIH HHS [NIH-P41-RR01777] Funding Source: Medline; NIGMS NIH HHS [GM43786] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Beuchle D, 2001, DEVELOPMENT, V128, P993; Boivin A, 1998, GENETICS, V150, P1539; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KING I, UNPUB; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; Porter IM, 2004, CURR BIOL, V14, pR554, DOI 10.1016/j.cub.2004.07.009; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	26	602	620	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1574	1577		10.1126/science.1100576	http://dx.doi.org/10.1126/science.1100576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567868				2022-12-24	WOS:000225442700065
J	Nagoshi, E; Saini, C; Bauer, C; Laroche, T; Naef, F; Schibler, U				Nagoshi, E; Saini, C; Bauer, C; Laroche, T; Naef, F; Schibler, U			Circadian gene expression in individual fibroblasts: Cell-autonomous and self-sustained oscillators pass time to daughter cells	CELL			English	Article							PERIPHERAL-TISSUES; CLOCK; RHYTHMS; RECEPTOR; LIGHT; CYCLE; LIMB	The mammalian circadian timing system is composed of a central pacemaker in the suprachiasmatic nucleus (SCN) of the brain and subsidiary oscillators in most peripheral cell types. While oscillators in SCN neurons are known to function in a self-sustained fashion, peripheral oscillators have been thought to damp rapidly when disconnected from the control exerted by the SCN. Using two reporter systems, we monitored circadian gene expression in NIH3T3 mouse fibroblasts in real time and in individual cells. In conjunction with mathematical modeling and cell co-culture experiments, these data demonstrated that in vitro cultured fibroblasts harbor self-sustained and cell-autonomous circadian clocks similar to those operative in SCN neurons. Circadian gene expression in fibroblasts continues during cell division, and our experiments unveiled unexpected interactions between the circadian clock and the cell division clock. Specifically, the circadian oscillator gates cytokinesis to defined time windows, and mitosis elicits phase shifts in circadian cycles.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Frontiers Genet Sci 2, CH-1211 Geneva 4, Switzerland; ISREC, CH-1066 Epalinges, Switzerland; NCCR Mol Oncol, CH-1066 Epalinges, Switzerland	University of Geneva; University of Geneva; University of Geneva; Swiss Institute Experimental Cancer Research	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	ueli.schibler@molbio.unige.ch	Jansen, Heiko T./A-5770-2008; Naef, Felix/C-9527-2011	Jansen, Heiko T./0000-0003-0178-396X; Naef, Felix/0000-0001-9786-3037; Nagoshi, Emi/0000-0002-6365-4074				Akashi M, 2000, GENE DEV, V14, P645; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Biederbick A, 1998, CELL TISSUE RES, V291, P277, DOI 10.1007/s004410050997; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; DAAN S, 1976, J COMP PHYSIOL, V106, P267, DOI 10.1007/BF01417858; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shen HM, 1997, J NEUROSCI, V17, P5221; Smaaland R, 2002, CHRONOBIOL INT, V19, P101, DOI 10.1081/CBI-120002594; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	36	735	760	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2004	119	5					693	705		10.1016/j.cell.2004.11.015	http://dx.doi.org/10.1016/j.cell.2004.11.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	874ZP	15550250	Bronze			2022-12-24	WOS:000225389500014
J	Balachandran, S; Thomas, E; Barber, GN				Balachandran, S; Thomas, E; Barber, GN			A FADD-dependent innate immune mechanism in mammalian cells	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; VIRAL-INFECTION; SIGNALING PATHWAY; TRANSCRIPTION FACTORS; ANTIVIRAL RESPONSES; DENDRITIC CELLS; DEATH DOMAIN; KINASE; ACTIVATION	Vertebrate innate immunity provides a first line of defence against pathogens such as viruses and bacteria. Viral infection activates a potent innate immune response, which can be triggered by double-stranded (ds) RNA produced during viral replication(1-3). Here, we report that mammalian cells lacking the death-domain-containing protein FADD(4,5) are defective in intracellular dsRNA-activated gene expression, including production of type I (a/b) interferons, and are thus very susceptible to viral infection. The signalling pathway incorporating FADD is largely independent of Toll-like receptor 3 and the dsRNA-dependent kinase PKR, but seems to require receptor interacting protein 1 as well as Tank-binding kinase 1-mediated activation of the transcription factor IRF-3. The requirement for FADD in mammalian host defence is evocative of innate immune signalling in Drosophila, in which a FADD-dependent pathway responds to bacterial infection by activating the transcription of antimicrobial genes(6). These data therefore suggest the existence of a conserved pathogen recognition pathway in mammalian cells that is essential for the optimal induction of type I interferons and other genes important for host defence.	Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	gbarber@med.miami.edu						Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	30	236	248	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					401	405		10.1038/nature03124	http://dx.doi.org/10.1038/nature03124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549108				2022-12-24	WOS:000225161400058
J	Wilson, RJ; Thomas, CD; Fox, R; Roy, DB; Kunin, WE				Wilson, RJ; Thomas, CD; Fox, R; Roy, DB; Kunin, WE			Spatial patterns in species distributions reveal biodiversity change	NATURE			English	Article							BRITISH BUTTERFLIES; GEOGRAPHIC RANGE; RED LIST; CONSERVATION; EXTINCTION; ABUNDANCE; HABITAT; CLIMATE; DECLINE; SCALE	Interpretation of global biodiversity change is hampered by a lack of information on the historical status of most species in most parts of the world(1-5). Here we show that declines and increases can be deduced from current species distributions alone, using spatial patterns of occupancy combined with distribution size. Declining species show sparse, fragmented distributions for their distribution size, reflecting the extinction process; expanding species show denser, more aggregated distributions, reflecting colonization. Past distribution size changes for British butterflies were deduced successfully from current distributions, and former distributions had some power to predict future change. What is more, the relationship between distribution pattern and change in British butterflies independently predicted distribution change for butterfly species in Flanders, Belgium, and distribution change in British rare plant species is similarly related to spatial distribution pattern. This link between current distribution patterns and processes of distribution change could be used to assess relative levels of threat facing different species, even for regions and taxa lacking detailed historical and ecological information.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Butterfly Conservat, Wareham BH20 5QP, Dorset, England; NERC, Ctr Ecol & Hydrol, Huntingdon PE28 2LS, Cambs, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Wilson, RJ (corresponding author), Univ Rey Juan Carlos, Escuela Super Ciencias Expt & Tecnol, Area Biodiversidad & Conservac, Tulipan S-N, E-28933 Madrid, Spain.	rwilson@escet.urjc.es	Roy, David/A-6619-2009; Thomas, Chris D/A-1894-2012; Wilson, Robert J/I-8726-2014; Thomas, Chris D/A-1460-2014	Roy, David/0000-0002-5147-0331; Thomas, Chris D/0000-0003-2822-1334; Wilson, Robert J/0000-0003-4477-7068; Thomas, Chris D/0000-0003-2822-1334; Fox, Richard/0000-0001-6992-3522				Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Asher J, 2001, MILLENNIUM ATLAS BUT; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cowley MJR, 1999, P ROY SOC B-BIOL SCI, V266, P1587, DOI 10.1098/rspb.1999.0819; Groombridge B, 2002, WORLD ATLAS BIODIVER; Hanski I., 1999, METAPOPULATION ECOLO; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT VE; Johnson CN, 1998, NATURE, V394, P272, DOI 10.1038/28385; Keith DA, 2000, BIOL CONSERV, V94, P311, DOI 10.1016/S0006-3207(99)00194-9; Kunin WE, 1998, SCIENCE, V281, P1513, DOI 10.1126/science.281.5382.1513; Linder ET, 2000, ECOGRAPHY, V23, P678, DOI 10.1034/j.1600-0587.2000.230605.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MARTINS EP, 2004, COMPARE VERSION 4 6; Ostling A, 2000, Science, V290, P671; Ridgeway Cecilia, U PENN LAW REV, V70, P367, DOI [10.2307/1907187, 10.2307/2580244, DOI 10.2307/3313062]; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; Shigesada N, 1997, BIOL INVASIONS THEOR; THOMAS CD, 1995, BIOL CONSERV, V73, P59, DOI 10.1016/0006-3207(95)90065-9; Warren MS, 1997, BIOL CONSERV, V82, P317, DOI 10.1016/S0006-3207(97)00037-2; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; World Conservation Monitoring Centre, 1992, GLOBAL BIODIVERSITY	30	162	170	7	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2004	432	7015					393	396		10.1038/nature03031	http://dx.doi.org/10.1038/nature03031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549106				2022-12-24	WOS:000225161400056
J	Gershon, D				Gershon, D			Quantum dots show their true colors	NATURE			English	Article																			0	4	4	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	2004	432	7014					247	247		10.1038/432247a	http://dx.doi.org/10.1038/432247a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869YG	15538374	Bronze			2022-12-24	WOS:000225020200053
J	An, SJ; Almers, W				An, SJ; Almers, W			Tracking SNARE complex formation in live endocrine cells	SCIENCE			English	Article							SENSITIVE FUSION PROTEIN; FLUORESCENT PROTEIN; PLASMA-MEMBRANE; CRYSTAL-STRUCTURE; SYNTAXIN; EXOCYTOSIS; SNAP-25; DOMAIN; RESONANCE; CALCIUM	Syntaxin, synaptosome-associated protein of 25 kD (SNAP25), and vesicle-associated membrane protein/synaptobrevin are collectively called SNAP receptor (SNARE) proteins, and they catalyze neuronal exocytosis by forming a "core complex." The steps in core complex formation are unknown. Here, we monitored SNARE complex formation in vivo with the use of a fluorescent version of SNAP25. In PC12 cells, we found evidence for a syntaxin-SNAP25 complex that formed with high affinity, required only the amino-terminal SNARE motif of SNAP25, tolerated a mutation that blocks formation of other syntaxin-SNAP25 complexes, and assembled reversibly when Ca2+ entered cells during depolarization. The complex may represent a precursor to the core complex formed during a Ca2+-dependent priming step of exocytosis.	Oregon Hlth Sci Univ, Vollum Inst L474, Portland, OR 97201 USA	Oregon Health & Science University	Almers, W (corresponding author), Oregon Hlth Sci Univ, Vollum Inst L474, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	almersw@ohsu.edu			NIMH NIH HHS [MH60600] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Huang XH, 2001, AM J PHYSIOL-CELL PH, V281, pC740, DOI 10.1152/ajpcell.2001.281.3.C740; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P5449, DOI 10.1021/bi0256476; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Lu XH, 2003, CELL CALCIUM, V33, P267, DOI 10.1016/S0143-4160(03)00009-5; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174	26	106	111	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1042	1046		10.1126/science.1102559	http://dx.doi.org/10.1126/science.1102559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528447				2022-12-24	WOS:000225001100046
J	Shelton, JD; Peterson, EA				Shelton, JD; Peterson, EA			The imperative for family planning in ART in Africa	LANCET			English	Editorial Material							ANTIRETROVIRAL NUCLEOSIDE; MATERNAL HIV; PREGNANCY; NEVIRAPINE; INFECTION; THERAPY; MALARIA		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002; DESCHAMPS MD, 2004, 15 INT AIDS C BANK; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Minkoff H, 2003, AM J OBSTET GYNECOL, V189, P552, DOI 10.1067/S0002-9378(03)00467-8; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Newell ML, 2003, JAIDS-J ACQ IMM DEF, V32, P380, DOI 10.1097/00126334-200304010-00006; Poirier MC, 2004, TOXICOL APPL PHARM, V199, P151, DOI 10.1016/j.taap.2003.11.034; Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010; Powderly WG, 2002, J ACQ IMMUN DEF SYND, V29, pS28, DOI 10.1097/00126334-200202011-00005; SINGH S, 2004, ADD IT BEN INV SEX R; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; *UNAIDS, 2002, REP GLOB HIV AIDS EP; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wainberg MA, 2003, JAIDS-J ACQ IMM DEF, V34, pS2, DOI 10.1097/00126334-200309011-00002; WESTOFF CF, 2001, UNMET NEED END CENTU; WHO UNICEF and UNFPA (World Health Organization United Nations Children's Fund and United Nations Population Fund), 2003, MAT MORT 2000 EST DE; World Health Organization, 2003, ENTR POINTS ANT TREA; World Health Organization, 2003, SCAL ANT THER RES LT; 2003, LANCET, V362, P179	21	19	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2004	364	9449					1916	1918		10.1016/S0140-6736(04)17489-8	http://dx.doi.org/10.1016/S0140-6736(04)17489-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874BX	15566991				2022-12-24	WOS:000225327000005
J	Shachaf, CM; Kopelman, AM; Arvanitis, C; Karlsson, A; Beer, S; Mandl, S; Bachmann, MH; Borowsky, AD; Ruebner, B; Cardiff, RD; Yang, QW; Bishop, JM; Contag, CH; Felsher, DW				Shachaf, CM; Kopelman, AM; Arvanitis, C; Karlsson, A; Beer, S; Mandl, S; Bachmann, MH; Borowsky, AD; Ruebner, B; Cardiff, RD; Yang, QW; Bishop, JM; Contag, CH; Felsher, DW			MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer	NATURE			English	Article							LIVER-REGENERATION; STEM-CELLS; GROWTH; TUMORIGENESIS; ONCOGENES; NEOPLASIA	Hepatocellular carcinoma is generally refractory to clinical treatment(1). Here, we report that inactivation of the MYC oncogene is sufficient to induce sustained regression of invasive liver cancers. MYC inactivation resulted en masse in tumour cells differentiating into hepatocytes and biliary cells forming bile duct structures, and this was associated with rapid loss of expression of the tumour marker alpha-fetoprotein, the increase in expression of liver cell markers cytokeratin 8 and carcinoembryonic antigen, and in some cells the liver stem cell marker cytokeratin 19. Using in vivo bioluminescence imaging we found that many of these tumour cells remained dormant as long as MYC remain inactivated; however, MYC reactivation immediately restored their neoplastic features. Using array comparative genomic hybridization we confirmed that these dormant liver cells and the restored tumour retained the identical molecular signature and hence were clonally derived from the tumour cells. Our results show how oncogene inactivation may reverse tumorigenesis in the most clinically difficult cancers. Oncogene inactivation uncovers the pluripotent capacity of tumours to differentiate into normal cellular lineages and tissue structures, while retaining their latent potential to become cancerous, and hence existing in a state of tumour dormancy.	Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Univ Calif Davis, Med Ctr, Dept Pathol, Davis, CA 95616 USA; Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco	Felsher, DW (corresponding author), Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA.	dfelsher@stanford.edu	Borowsky, Alexander D/S-5404-2017; Bachmann, Michael Hubertus/N-9339-2016; Arvanitis, Constadina/C-5975-2013	Bachmann, Michael Hubertus/0000-0002-0204-3720; Arvanitis, Constadina/0000-0002-6311-0974; Contag, Christopher/0000-0002-1011-8278				Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Fausto N, 1990, CURR OPIN CELL BIOL, V2, P1036, DOI 10.1016/0955-0674(90)90153-6; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Felsher DW, 2003, NAT REV CANCER, V3, P375, DOI 10.1038/nrc1070; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Hardy J, 2001, EXP HEMATOL, V29, P1353, DOI 10.1016/S0301-472X(01)00756-1; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LEFFERT KS, 1984, CELL CULTURE METHODS, P43; Lotem J, 2002, SEMIN CANCER BIOL, V12, P339, DOI 10.1016/S1044-579X(02)00054-8; MURAKAMI H, 1993, CANCER RES, V53, P1719; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riethmuller G, 2001, SEMIN CANCER BIOL, V11, P307, DOI 10.1006/scbi.2001.0386; SANDGREN EP, 1989, ONCOGENE, V4, P715; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; UHR JW, 1991, CANCER RES, V51, pS5045; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Venook A P, 2000, Curr Treat Options Oncol, V1, P407, DOI 10.1007/s11864-000-0068-z; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu YF, 2002, ONCOGENE, V21, P1518, DOI 10.1038/sj.onc.1205208	30	673	712	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1112	1117		10.1038/nature03043	http://dx.doi.org/10.1038/nature03043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15475948				2022-12-24	WOS:000224730800044
J	Wennberg, DE; Lucas, FL; Siewers, AE; Kellett, MA; Malenka, DJ				Wennberg, DE; Lucas, FL; Siewers, AE; Kellett, MA; Malenka, DJ			Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; SITE CARDIAC-SURGERY; GLYCOPROTEIN IIB/IIIA RECEPTOR; ON-SITE; PRIMARY ANGIOPLASTY; THROMBOLYTIC THERAPY; BALLOON ANGIOPLASTY; SURGICAL BACKUP; UNITED-KINGDOM; EXPERIENCE	Context An ongoing debate focuses on whether institutions should perform percutaneous coronary interventions (PCIs) without an onsite coronary artery bypass graft (CABG) surgery program. Objective To compare patient outcomes following PCI at US institutions performing this procedure without and with onsite cardiac surgery. Design, Setting, and Patients Medicare hospital (part A) data were used to identify PCIs performed on fee-for-service Medicare enrollees (n=625854) aged at least 65 years at acute care facilities between January 1, 1999, and December 1, 2001. Hospitals without and with onsite cardiac surgery were identified based on the presence of claims for CABG surgery. Patients were characterized as undergoing primary/rescue PCI, defined as an emergency procedure performed on the same day of admission for an acute myocardial infarction (MI), vs all other PCIs. Main Outcome Measures Post-PCI CABG surgery and combined in-hospital and 30-day mortality. Results A total of 178 hospitals performed PCIs without onsite cardiac surgery and 943 hospitals performed PCIs with onsite cardiac surgery. Patients undergoing PCIs in hospitals without onsite cardiac surgery were similar to those with onsite cardiac surgery with respect to age, sex, race, and measurable comorbidities; however, patients undergoing PCIs in hospitals without onsite cardiac surgery were more likely to have a primary/rescue PCI (22.0% vs 5.6%, P<.001). Patients undergoing PCIs in hospitals without cardiac surgery were more likely to die (6.0% vs 3.3%; adjusted odds ratio [OR], 1.29; 95% confidence interval [CI], 1.14-1.47; P<.001). After accounting for baseline differences, mortality for patients with primary/rescue PCI was similar in institutions without and with cardiac surgery (adjusted OR, 0.93; 95% Cl, 0.80-1.08; P=34). However, for the larger non-primary/rescue PCI population, mortality was higher in hospitals without onsite cardiac surgery (adjusted OR, 1.38; 95% Cl, 1.14-1.67; P=.001). This increase in mortality was primarily confined to hospitals performing 50 or less Medicare PCIs per year. Conclusions Percutaneous coronary interventions in hospitals without onsite cardiac surgery are often performed for reasons other than immediate treatment of an MI and are associated with a higher risk of adverse outcomes. Policies aimed at increasing access to primary/rescue PCI through promoting PCI in hospitals without cardiac surgery may inadvertently lead to an overall increase in mortality related to PCI.	Ctr Outcomes Res & Evaluat, Portland, ME 04101 USA; Maine Med Ctr, Dept Med, Portland, ME 04102 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Dept Cardiol, Lebanon, NH 03766 USA	Maine Medical Center; Dartmouth College; Dartmouth College	Wennberg, DE (corresponding author), Ctr Outcomes Res & Evaluat, 139 Forest Ave, Portland, ME 04101 USA.	dwennberg@healthdialog.com						*AM HEART ASS, 2002, HEART DIS STROK STAT; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], 1999, INT CLASS DIS; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Brush JE, 1996, J INVASIVE CARDIOL, V8, P91; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Cannon CP, 2002, JAMA-J AM MED ASSOC, V287, P1987, DOI 10.1001/jama.287.15.1987; DELLAVALLE A, 1995, CORONARY ARTERY DIS, V6, P513; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; GEORGE J, 1998, PHILADELPHIA BU 0227; Gray HH, 2000, HEART, V83, P224; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; IANNONE LA, 1993, TEX HEART I J, V20, P99; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; KIMMEL SE, 1995, JAMA-J AM MED ASSOC, V274, P1137, DOI 10.1001/jama.274.14.1137; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; KLINKE WP, 1992, AM J CARDIOL, V70, P1520, DOI 10.1016/0002-9149(92)90451-4; Loubeyre C, 1999, CATHETER CARDIO INTE, V47, P441, DOI 10.1002/(SICI)1522-726X(199908)47:4<441::AID-CCD12>3.0.CO;2-S; Malenka DJ, 2002, J AM COLL CARDIOL, V40, P2092, DOI 10.1016/S0735-1097(02)02605-0; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; RAMSDALE DR, 1995, BRIT HEART J, V73, P414; RICHARDSON SG, 1990, BRIT MED J, V300, P355, DOI 10.1136/bmj.300.6721.355; Ritchie JL, 1999, AM HEART J, V138, P437, DOI 10.1016/S0002-8703(99)70144-4; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Seshadri N, 2002, CIRCULATION, V106, P2346, DOI 10.1161/01.CIR.0000036595.92742.69; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Smyth DW, 1997, J INVASIVE CARDIOL, V9, P324; SOWTON E, 1991, BRIT HEART J, V66, P325; Ting HH, 2003, AM HEART J, V145, P278, DOI 10.1067/mhj.2003.61; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Vogt A, 1999, Semin Interv Cardiol, V4, P43; WEAVER WD, 1993, CIRCULATION, V88, P2067, DOI 10.1161/01.CIR.88.5.2067; Wennberg D, 1997, J Health Serv Res Policy, V2, P75; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wharton TP, 2004, J AM COLL CARDIOL, V43, P1943, DOI 10.1016/j.jacc.2004.03.013; Wharton TP, 1999, J AM COLL CARDIOL, V33, P1257, DOI 10.1016/S0735-1097(99)00009-1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	41	87	88	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2004	292	16					1961	1968		10.1001/jama.292.16.1961	http://dx.doi.org/10.1001/jama.292.16.1961			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865DO	15507581	Bronze			2022-12-24	WOS:000224682900020
J	Burwinkel, M; Holtkamp, N; Baier, M				Burwinkel, M; Holtkamp, N; Baier, M			Biology of infectious proteins: lessons from yeast prions	LANCET			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; GENETIC-VARIATION; MECHANISM		Robert Koch Inst, Project Neurodegenerat Dis, D-13353 Berlin, Germany; Humboldt Univ, Inst Neuropathol, D-13353 Berlin, Germany	Robert Koch Institute; Humboldt University of Berlin	Baier, M (corresponding author), Robert Koch Inst, Project Neurodegenerat Dis, D-13353 Berlin, Germany.	baierm@rki.de		Burwinkel, Michael/0000-0003-4811-7323				Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Oidtmann B, 2003, FEBS LETT, V538, P96, DOI 10.1016/S0014-5793(03)00149-2; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	12	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2004	364	9444					1471	1472		10.1016/S0140-6736(04)17290-5	http://dx.doi.org/10.1016/S0140-6736(04)17290-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864PN	15500875				2022-12-24	WOS:000224645500008
J	Kong, M; Fox, CJ; Mu, J; Solt, L; Xu, A; Cinalli, RM; Birnbaum, MJ; Lindsten, T; Thompson, CB				Kong, M; Fox, CJ; Mu, J; Solt, L; Xu, A; Cinalli, RM; Birnbaum, MJ; Lindsten, T; Thompson, CB			The PP2A-associated protein alpha 4 is an essential inhibitor of apoptosis	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; PHOSPHATASE 2A; REGULATORY SUBUNIT; CATALYTIC SUBUNIT; OPITZ-SYNDROME; BINDING; GENE; ASSOCIATION; SURVIVAL; TAP42	Despite evidence that protein kinases are regulators of apoptosis, a specific role for phosphatases in regulating cell survival has not been established. Here we show that alpha4, a noncatalytic subunit of protein phosphatase 2A (PP2A), is required to repress apoptosis in murine cells. alpha4 is a nonredundant regulator of the dephosphorylation of the transcription factors c-jun and p53. As a result of alpha4 deletion, multiple proapoptotic genes were transcribed. Either inhibition of new protein synthesis or Bcl-x(L) overexpression Suppressed apoptosis initiated by alpha4 deletion. Thus, mammalian cell viability depends on repression of transcription-initiated apoptosis mediated by a component of PP2A.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu		Mu, James/0000-0001-8081-2401; Birnbaum, Morris/0000-0001-9972-8680				Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Everett AD, 2002, DEV DYNAM, V224, P461, DOI 10.1002/dvdy.10125; Hua DR, 2003, EUR J IMMUNOL, V33, P1899, DOI 10.1002/eji.200323720; INUI S, 1995, J IMMUNOL, V154, P2714; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Inui S, 2002, INT IMMUNOL, V14, P177, DOI 10.1093/intimm/14.2.177; LINDSTEN T, UNPUB; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	23	131	138	4	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					695	698		10.1126/science.1100537	http://dx.doi.org/10.1126/science.1100537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499020				2022-12-24	WOS:000224756700054
J	Bird, SM				Bird, SM			Prescribing sentence: time for evidence-based justice	LANCET			English	Editorial Material							MANDATORY DRUGS TESTS; PRISONS; SCOTLAND; DEATHS; NEED		MRC, Biostat Unit, Cambridge CB2 2SR, England; Univ Strathclyde, Dept Stat & Modeling Sci, Glasgow, Lanark, Scotland	MRC Biostatistics Unit; University of Strathclyde	Bird, SM (corresponding author), MRC, Biostat Unit, Cambridge CB2 2SR, England.	Sheila.bird@mrc-bsu.cam.ac.uk						Bird SM, 2003, DRUG-EDUC PREV POLIC, V10, P396, DOI 10.1080/0968763031000111626-131; Bird SM, 2003, LANCET, V362, P941, DOI 10.1016/S0140-6736(03)14362-0; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; BIRD SM, 2004, HERALD          0217, P15; BIRD SM, 2004, HERALD GLASGOW  0226, P19; Blunkett D., 2004, REDUCING CRIME CHANG; Bourn J., 2004, DRUG TREATMENT TESTI; Carter P., 2004, MANAGING OFFENDERS R; Committee on Data and Research for Policy on Illegal Drugs, 2001, INF AM POL ILL DRUGS; ELERY S, 2002, DRUG TREATMENT TESTI; Fitz-Gibbon C, 2004, J R STAT SOC A STAT, V167, P1, DOI 10.1046/j.0964-1998.2003.02047.x; GOGGINS P, 2004, POLICY REV       MAR, P10; Gore SM, 1998, BRIT MED J, V316, P1256, DOI 10.1136/bmj.316.7140.1256; Gore SM, 1996, BRIT MED J, V312, P1411; Gore SM, 1996, LANCET, V348, P1124, DOI 10.1016/S0140-6736(96)06318-0; GORE SM, 1995, BRIT MED J, V310, P595, DOI 10.1136/bmj.310.6979.595; *HOM OFF, 2004, ON CHARG DRUG TEST E; Hough M, 2003, IMPACT DRUG TREATMEN; KAY J, 2004, POLICY REV MAG   MAR, P14; NAYSMITH S, 2004, SUNDAY HERALD G 0229, P16; *ROYAL STAT SOC WO, PERF IND GOOD BAD UG; Singleton N., 2003, DRUG RELATED MORTALI; Smith AFM, 1996, J ROY STAT SOC A STA, V159, P367, DOI 10.2307/2983324; Turnbull PJ, 2000, DRUG TREATMENT TESTI	24	13	13	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1457	1459		10.1016/S0140-6736(04)17230-9	http://dx.doi.org/10.1016/S0140-6736(04)17230-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488223				2022-12-24	WOS:000224485300034
J	Schaub, B; von Mutius, E				Schaub, B; von Mutius, E			The marketing of asthma and allergies	LANCET			English	Editorial Material							HOUSE-DUST MITE; CLINICAL MANAGEMENT; CHILDHOOD ASTHMA; SOLUBLE CD14; EXPOSURE; CHILDREN; PREVENTION; POLYMORPHISM; AVOIDANCE; ENCASINGS		Univ Childrens Hosp, D-80337 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Schaub, B (corresponding author), Univ Childrens Hosp, D-80337 Munich, Germany.	bianca.schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515				*AM CAT FANC ASS, SPHINX CAT; Arshad SH, 2004, CURR OPIN ALLERGY CL, V4, P119, DOI [10.1097/00130832-200404000-00009, 10.1097/01.all.0000123971.96233.65]; Asher I, 2004, INT ARCH ALLERGY IMM, V135, P83, DOI 10.1159/000080524; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bender BG, 2003, J ALLERGY CLIN IMMUN, V111, P936, DOI 10.1067/mai.2003.1475; Bergquist P, 2001, EUR RESPIR J, V18, P248, DOI 10.1183/09031936.01.00239601; Bukstein DA, 2003, ANN ALLERG ASTHMA IM, V90, P543, DOI 10.1016/S1081-1206(10)61848-0; Cabana MD, 2004, J ALLERGY CLIN IMMUN, V114, P352, DOI 10.1016/j.jaci.2004.04.047; Capristo C, 2004, ALLERGY, V59, P53, DOI 10.1111/j.1398-9995.2004.00652.x; Celedon JC, 2002, LANCET, V360, P781, DOI 10.1016/S0140-6736(02)09906-3; Cullinan P, 2004, THORAX, V59, P855, DOI 10.1136/thx.2003.019877; Halken S, 2003, J ALLERGY CLIN IMMUN, V111, P169, DOI 10.1067/mai.2003.5; Horak F, 2004, CLIN EXP ALLERGY, V34, P1220, DOI 10.1111/j.1365-2222.2004.02024.x; Juniper EF, 2003, CURR OPIN PULM MED, V9, pS8, DOI 10.1097/00063198-200304001-00003; Kabesch M, 2004, ALLERGY, V59, P520, DOI 10.1111/j.1398-9995.2004.00439.x; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Maziak W, 2002, EUR RESPIR J, V20, P1476, DOI 10.1183/09031936.02.00281102; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Robinson AR, 2004, ARCH INTERN MED, V164, P427, DOI 10.1001/archinte.164.4.427; Terreehorst I, 2003, NEW ENGL J MED, V349, P237, DOI 10.1056/NEJMoa023171; Vercelli D, 2003, CLIN EXP ALLERGY, V33, P153, DOI 10.1046/j.1365-2222.2003.01606.x	22	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1389	1390		10.1016/S0140-6736(04)17241-3	http://dx.doi.org/10.1016/S0140-6736(04)17241-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488205				2022-12-24	WOS:000224485300010
J	Marcus, GF				Marcus, GF			Before the word - Language evolution: evolutionary vestiges may provide clues to the ultimate origins of human language.	NATURE			English	Editorial Material									NYU, Dept Psychol, New York, NY 10003 USA	New York University	Marcus, GF (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.							Christiansen M.H., 2003, LANGUAGE EVOLUTION; Gould Stephen J., 1980, PANDAS THUMB; Jackendoff R., 2002, FDN LANGUAGE BRAIN M; Marcus G., 2004, BIRTH MIND; McElree B, 2003, J MEM LANG, V48, P67, DOI 10.1016/S0749-596X(02)00515-6	5	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					745	745		10.1038/431745a	http://dx.doi.org/10.1038/431745a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483585				2022-12-24	WOS:000224435500020
J	Alexander, LN; Seward, JF; Santibanez, TA; Pallansch, MA; Kew, OM; Prevots, DR; Strebel, PM; Cono, J; Wharton, M; Orenstein, WA; Sutter, RW				Alexander, LN; Seward, JF; Santibanez, TA; Pallansch, MA; Kew, OM; Prevots, DR; Strebel, PM; Cono, J; Wharton, M; Orenstein, WA; Sutter, RW			Vaccine policy changes and epidemiology of poliomyelitis in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INACTIVATED POLIOVIRUS VACCINE; PARALYTIC POLIOMYELITIS; IMPACT; IDENTIFICATION; SCHEDULE	Context The last case of poliomyelitis in the United States due to indigenously acquired wild poliovirus occurred in 1979; however, as a consequence of oral poliovirus vaccine (OPV) use that began in 1961, an average of 9 cases of vaccine-associated paralytic poliomyelitis (VAPP) were confirmed each year from 1961 through 1989. To reduce the VAPP burden, national vaccination policy changed in 1997 from reliance on OPV to options for a sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV. In 2000, an exclusive IPV schedule was adopted. Objective To review the epidemiology of paralytic poliomyelitis and document the association between the vaccine schedule changes and VAPP in the United States. Design and Setting Review of national surveillance data from 1990 through 2003 for cases of confirmed paralytic poliomyelitis. Main Outcome Measures Number of confirmed paralytic poliomyelitis cases, including VAPP, and ratio of VAPP cases to number of doses of OPV distributed that occurred before, during, and after implementation of policy changes. Results From 1990 through 1999, 61 cases of paralytic poliomyelitis were reported; 59 (97%) of these were VAPP (1 case per 2.9 million OPV doses distributed), 1 case was imported, and 1 case was indeterminate. Thirteen cases occurred during the 19971999 transitional policy period and were associated with the all-OPV schedule; none occurred with the IPV-OPV schedule. No cases occurred after the United States implemented the all-IPV policy in 2000. The last imported poliomyelitis case occurred in 1993 and the last case of VAPP occurred in 1999. Conclusion The change in polio vaccination policy from OPV to exclusive use of IPV was successfully implemented; this change led to the elimination of VAPP in the United States.	Ctr Dis Control & Prevent, Natl Immunizat Program, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Alexander, LN (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, Natl Ctr Infect Dis, 1600 Clifton Rd,MS E-61, Atlanta, GA 30333 USA.	lalexander@cdc.gov		Prevots, D Rebecca/0000-0003-0339-9873; Santibanez, Tammy A./0000-0002-5784-7427				Abramson JS, 1999, PEDIATRICS, V104, P1404, DOI 10.1542/peds.104.6.1404; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; CDC, 1981, CDC ANN SUMM REP MOR; Centers for Disease Control and Prevention, NAT IMM SURV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P107; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1017; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P180; DE L, 1995, J CLIN MICROBIOL, V33, P562, DOI 10.1128/JCM.33.3.562-571.1995; ESTEVES K, 1988, B WORLD HEALTH ORGAN, V66, P739; Halsey NA, 1999, PEDIATRICS, V103, P171, DOI 10.1542/peds.103.1.171; Halsey NA, 1997, PEDIATRICS, V99, P300, DOI 10.1542/peds.99.2.300; HENDERSON DA, 1964, JAMA-J AM MED ASSOC, V190, P41; *I MED, 1996, VACC SAF FOR OPT POL; *I MED, 1977, EV POL VACC, P75; *I MED, 1988, EV POL VACC POL VACC; JOCE R, 1992, BRIT MED J, V305, P79, DOI 10.1136/bmj.305.6845.79; KOHBERGER RC, 1995, I MED POL WORKSH JUN; Kolasa MS, 2001, PUBLIC HEALTH REP, V116, P282, DOI 10.1093/phr/116.4.282; Lindegren Mary Lou, 2004, Morbidity and Mortality Weekly Report, V53, P1; LUTHER T, 1962, ASS CASES POLIOMYELI, P1; Marwick C, 1996, JAMA-J AM MED ASSOC, V275, P827, DOI 10.1001/jama.275.11.827; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; NOTTAY BK, 1981, VIROLOGY, V108, P405, DOI 10.1016/0042-6822(81)90448-7; Polich T., 1997, J CLIN GEROPSYCHOLOG, V3, P1; PREVOTS DR, 1994, ARCH PEDIAT ADOL MED, V148, P479, DOI 10.1001/archpedi.1994.02170050037007; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE, V6th, P51; Schonberger L B, 1978, Adv Neurol, V19, P217; SCHONBERGER LB, 1976, AM J EPIDEMIOL, V104, P202, DOI 10.1093/oxfordjournals.aje.a112290; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; Sutter R. W. C. S., 1999, VACCINES, P364; SUTTER RW, 1989, AM J PUBLIC HEALTH, V79, P495, DOI 10.2105/AJPH.79.4.495; SUTTER RW, 1994, INFECT MED, V11, P429; Sutter RW, 1994, INFECT MED, V11, P426; SUTTER RW, 1994, INFECT MED, V11, P435; Taylor JA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e90; VARUGHESE PV, 1989, CAN J PUBLIC HEALTH, V80, P363; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; Wattigney WA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e83; Weibel RE, 1996, AM J PUBLIC HEALTH, V86, P734, DOI 10.2105/AJPH.86.5.734; YANG CF, 1991, VIRUS RES, V20, P159; Zimmerman RK, 1999, AM FAM PHYSICIAN, V59, P113; 1998, MMWR MORB MORTAL WKL, V46, P79	44	149	168	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2004	292	14					1696	1701		10.1001/jama.292.14.1696	http://dx.doi.org/10.1001/jama.292.14.1696			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861JS	15479934	Bronze			2022-12-24	WOS:000224413400028
J	Shahmanesh, M; Wayal, S				Shahmanesh, M; Wayal, S			Targeting commercial sex-workers in Goa, India: time for a strategic rethink?	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED-DISEASES; CONDOM PROMOTION; HIV; PREVENTION; PREVALENCE; INFECTION; DECLINE; IMPACT		UCL Royal Free & Univ Coll Med Sch, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England; Posit People, Panaji, Goa, India	University of London; University College London; UCL Medical School	Shahmanesh, M (corresponding author), UCL Royal Free & Univ Coll Med Sch, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England.	bamaryjoon@yahoo.co.uk		Shahmanesh, Maryam/0000-0001-7129-8535; Wayal, Sonali/0000-0002-5878-7665				Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; BHAVE G, 1995, AIDS, V9, pS21; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Egger M, 2000, LANCET, V355, P2101, DOI 10.1016/S0140-6736(00)02376-X; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Jana S, 1998, AIDS, V12 Suppl B, pS101; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; SHARMA R, 2004, FRONTLINE       0717; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001	13	18	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1297	1299		10.1016/S0140-6736(04)17206-1	http://dx.doi.org/10.1016/S0140-6736(04)17206-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474122				2022-12-24	WOS:000224349700009
J	Lan, Q; Zhang, LP; Li, GL; Vermeulen, R; Weinberg, RS; Dosemeci, M; Rappaport, SM; Shen, M; Alter, BP; Wu, YJ; Kopp, W; Waidyanatha, S; Rabkin, C; Guo, WH; Chanock, S; Hayes, RB; Linet, M; Kim, S; Yin, SN; Rothman, N; Smith, MT				Lan, Q; Zhang, LP; Li, GL; Vermeulen, R; Weinberg, RS; Dosemeci, M; Rappaport, SM; Shen, M; Alter, BP; Wu, YJ; Kopp, W; Waidyanatha, S; Rabkin, C; Guo, WH; Chanock, S; Hayes, RB; Linet, M; Kim, S; Yin, SN; Rothman, N; Smith, MT			Hematotoxicity in workers exposed to low levels of benzene	SCIENCE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; TOXICITY; BLOOD; RISK; NQ01	Benzene is known to have toxic effects on the blood and bone marrow, but its impact at levels below the U.S. occupational standard of 1 part per million (ppm) remains uncertain. in a study of 250 workers exposed to benzene, white blood cell and platelet counts were significantly lower than in 140 controls, even for exposure below 1 ppm in air. Progenitor cell colony formation significantly declined with increasing benzene exposure and was more sensitive to the effects of benzene than was the number of mature blood cells. Two genetic variants in key metabolizing enzymes, myeloperoxidase and NAD(P)H:quinone oxidoreductase, influenced susceptibility to benzene hematotoxicity. Thus, hematotoxicity from exposure to benzene occurred at air levels of 1 ppm or less and may be particularly evident among genetically susceptible subpopulations.	Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; New York Blood Ctr, Clin Serv, White Plains, NY 10605 USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Peking Union Med Coll, Beijing, Peoples R China; SAIC Frederick Inc, Frederick, MD 21702 USA; NCI, Ctr Canc Res, NIH, US Dept HHS, Bethesda, MD 20892 USA	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Center for Disease Control & Prevention; New York Blood Center; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, MT (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	martynts@berkeley.edu	Vermeulen, Roel/F-8037-2011; Weinberg, Rona/M-8637-2019	Vermeulen, Roel/0000-0003-4082-8163; Kim, Sungkyoon/0000-0002-1378-8795; Hayes, Richard/0000-0002-0918-661X	NIEHS NIH HHS [P30ES10126, P30ES01896, R01ES06721, P42ES05948, P42 ES004705, P42ES04705] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01CP010121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896, P42ES004705, R01ES006721, P42ES005948, P30ES010126] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; AKSOY M, 1989, ENVIRON HEALTH PERSP, V82, P193, DOI 10.2307/3430775; Bauer AK, 2003, CANCER RES, V63, P929; COLLINS JJ, 1991, J OCCUP ENVIRON MED, V33, P619; Collins JJ, 1997, J OCCUP ENVIRON MED, V39, P232, DOI 10.1097/00043764-199703000-00013; Gist GL, 1997, TOXICOL IND HEALTH, V13, P661, DOI 10.1177/074823379701300601; Kreja L, 1999, INT J RADIAT BIOL, V75, P1241, DOI 10.1080/095530099139395; Qu QS, 2002, AM J IND MED, V42, P275, DOI 10.1002/ajim.10121; Ross D, 1996, EUR J HAEMATOL, V57, P111; Rothman N, 1997, CANCER RES, V57, P2839; Simon V, 2004, SCI TOTAL ENVIRON, V334, P177, DOI 10.1016/j.scitotenv.2004.04.065; Smith MT, 2000, CARCINOGENESIS, V21, P1485, DOI 10.1093/carcin/21.8.1485; Tsai SP, 2004, REGUL TOXICOL PHARM, V40, P67, DOI 10.1016/j.yrtph.2004.05.010; Vermeulen R, 2004, ANN OCCUP HYG, V48, P105, DOI 10.1093/annhyg/meh005; Wan JX, 2002, ENVIRON HEALTH PERSP, V110, P1213, DOI 10.1289/ehp.021101213; Ward E, 1996, AM J IND MED, V29, P247, DOI 10.1002/(SICI)1097-0274(199603)29:3<247::AID-AJIM4>3.0.CO;2-N; Winterbourn CC, 2000, CURR OPIN HEMATOL, V7, P53, DOI 10.1097/00062752-200001000-00010; Xu Jian-ning, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P86; Yoon BI, 2001, EXP HEMATOL, V29, P278, DOI 10.1016/S0301-472X(00)00671-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang Ben, 1996, Zhonghua Yufang Yixue Zazhi, V30, P164	21	461	507	5	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1774	1776		10.1126/science.1102443	http://dx.doi.org/10.1126/science.1102443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576619	Green Submitted, Green Accepted			2022-12-24	WOS:000225630800052
J	Zhou, DP; Mattner, J; Cantu, C; Schrantz, N; Yin, N; Gao, Y; Sagiv, Y; Hudspeth, K; Wu, YP; Yamashita, T; Teneberg, S; Wang, DC; Proia, RL; Levery, SB; Savage, PB; Teyton, L; Bendelac, A				Zhou, DP; Mattner, J; Cantu, C; Schrantz, N; Yin, N; Gao, Y; Sagiv, Y; Hudspeth, K; Wu, YP; Yamashita, T; Teneberg, S; Wang, DC; Proia, RL; Levery, SB; Savage, PB; Teyton, L; Bendelac, A			Lysosomal glycosphingolipid recognition by NKT cells	SCIENCE			English	Article							MICE LACKING; ANTIGEN PRESENTATION; SPECIFICITY; LYMPHOCYTE; ACTIVATION; EXPRESSION; SYNTHASE; CD1D	NKT Celts represent a distinct lineage of T cells that coexpress a conserved alphabeta T cell receptor (TCR) and natural killer (NK) receptors. Although the TCR of NKT cells is characteristically autoreactive to CD1d, a lipid-presenting molecule, endogenous ligands for these cells have not been identified. We show that a lysosomal glycosphingolipid of previously unknown function, isoglobotrihexosylceramide (iGb3), is recognized both by mouse and human NKT cells. Impaired generation of lysosomal iGb3 in mice lacking beta-hexosaminidase b results in severe NKT cell deficiency, suggesting that this lipid also mediates development of NKT cells in the mouse. We suggest that expression of iGb3 in peripheral tissues may be involved in controlling NKT cell responses to infections and malignancy and in autoimmunity.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; Univ New Hampshire, Dept Chem, Durham, NH 03824 USA	University of Chicago; Scripps Research Institute; Brigham Young University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Gothenburg; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System Of New Hampshire; University of New Hampshire	Zhou, DP (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dzhou@midway.uchicago.edu; abendela@bsd.uchicago.edu	Savage, Paul B/HGB-3414-2022; Yin, NIng/C-8991-2011; Mattner, Jochen/AAT-7866-2021; Savage, Paul B/E-1448-2011; Proia, Richard L/A-7908-2012; zhou, dapeng/GXG-9715-2022; Zhou, Dapeng/A-6446-2019	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; Zhou, Dapeng/0000-0003-1347-3811; Proia, Richard/0000-0003-0456-1270	NCRR NIH HHS [P20RR16459] Funding Source: Medline; NIAID NIH HHS [R01 AI38339, AI053725, AI50847] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050847, R01AI038339, P01AI053725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056000] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Bendelac A, 2004, NAT IMMUNOL, V5, P557, DOI 10.1038/ni0604-557; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Conzelmann E, 1980, Adv Exp Med Biol, V125, P295; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Galili U, 1999, Subcell Biochem, V32, P79; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honey K, 2002, NAT IMMUNOL, V3, P1069, DOI 10.1038/ni844; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Smyth MJ, 2000, NAT IMMUNOL, V1, P459, DOI 10.1038/82698; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Teneberg S, 1996, GLYCOBIOLOGY, V6, P599, DOI 10.1093/glycob/6.6.599; Teneberg S, 2004, GLYCOBIOLOGY, V14, P187, DOI 10.1093/glycob/cwh015; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Xu H, 2002, TRANSPLANTATION, V73, P1549, DOI 10.1097/00007890-200205270-00006; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhou D., UNPUB; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	32	783	837	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1786	1789		10.1126/science.1103440	http://dx.doi.org/10.1126/science.1103440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15539565				2022-12-24	WOS:000225630800056
J	Nioche, P; Berka, V; Vipond, J; Minton, N; Tsai, AL; Raman, CS				Nioche, P; Berka, V; Vipond, J; Minton, N; Tsai, AL; Raman, CS			Femtomolar sensitivity of a NO sensor from Clostridium botulinum	SCIENCE			English	Article							SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE; OXYGEN-BINDING; BOVINE LUNG; HEME; RESONANCE; PROTEINS; FNR	Nitric oxide (NO) is extremely toxic to Clostridium botulinum, but its molecular targets are unknown. Here, we identify a heme protein sensor (SONO) that displays femtomolar affinity for NO. The crystal structure of the SONO heme domain reveals a previously undescribed fold and a strategically placed tyrosine residue that modulates heme-nitrosyl coordination. Furthermore, the domain architecture of a SONO ortholog cloned from Chlamydomonas reinhardtii indicates that NO signaling through cyclic guanosine monophosphate arose before the origin of multicellular eukaryotes. Our findings have broad implications for understanding bacterial responses to NO, as well as for the activation of mammalian NO-sensitive guanylyl cyclase.	Univ Texas, Sch Med, Struct Biol Res Ctr, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Div Hematol, Houston, TX 77030 USA; Hlth Protect Agcy, Salisbury SP4 0JG, Wilts, England; Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England	University of Texas System; University of Texas System; University of Texas System; Health Protection Agency; University of Nottingham; University of Nottingham	Raman, CS (corresponding author), Univ Texas, Sch Med, Struct Biol Res Ctr, Houston, TX 77030 USA.	c.s.raman@uth.tmc.edu		Minton, Nigel/0000-0002-9277-1261; Raman, C. S./0000-0002-1036-3193	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054444] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054444, R01 AI054444-05] Funding Source: Medline; PHS HHS [AY343540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CAMILLI A, COMMUNICATION; Cammack R, 1999, BBA-BIOENERGETICS, V1411, P475, DOI 10.1016/S0005-2728(99)00033-X; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Davidson M., 2001, FOOD MICROBIOLOGY FU, P593; FERGUSON SJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P17, DOI 10.1016/S0005-2728(05)80259-2; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA, P3; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Knoll AH, 1999, SCIENCE, V285, P1025, DOI 10.1126/science.285.5430.1025; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; OLSON JS, COMMUNICATION; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thomas MR, 2001, BIOCHEMISTRY-US, V40, P15047, DOI 10.1021/bi011440l; TIMKOVICH R, COMMUNICATION; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; WILLIAMS RJP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P71, DOI 10.1016/S0005-2728(05)80272-5; Wyllie GRA, 2002, CHEM REV, V102, P1067, DOI 10.1021/cr000080p; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323; Zumft WG, 2002, J MOL MICROB BIOTECH, V4, P277	33	169	177	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1550	1553		10.1126/science.1103596	http://dx.doi.org/10.1126/science.1103596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15472039				2022-12-24	WOS:000225442700057
J	Iizuka, N; Hamamoto, Y; Oka, M				Iizuka, N; Hamamoto, Y; Oka, M			Predicting individual outcomes in hepatocellular carcinoma	LANCET			English	Editorial Material							GENE-EXPRESSION PROFILES; OLIGONUCLEOTIDE MICROARRAY; RECURRENCE		Yamaguchi Univ, Sch Med, Dept Surg 2, Yamaguchi 7558505, Japan; Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Iizuka, N (corresponding author), Yamaguchi Univ, Sch Med, Dept Surg 2, Yamaguchi 7558505, Japan.	iizuka@yamaguchi-u.ac.jp						Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Iizuka N, 2002, CANCER RES, V62, P3939; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Kurokawa Y, 2004, J HEPATOL, V41, P284, DOI 10.1016/j.jhep.2004.04.031; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2004, J HEPATOL, V41, P336, DOI 10.1016/j.jhep.2004.06.002; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Locker J, 2004, HEPATOLOGY, V40, P521, DOI 10.1002/hep.20368; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	11	25	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2004	364	9448					1837	1839		10.1016/S0140-6736(04)17455-2	http://dx.doi.org/10.1016/S0140-6736(04)17455-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873HA	15555651				2022-12-24	WOS:000225269300007
J	Zimmermann, R; Strauss, JG; Haemmerle, G; Schoiswohl, G; Birner-Gruenberger, R; Riederer, M; Lass, A; Neuberger, G; Eisenhaber, F; Hermetter, A; Zechner, R				Zimmermann, R; Strauss, JG; Haemmerle, G; Schoiswohl, G; Birner-Gruenberger, R; Riederer, M; Lass, A; Neuberger, G; Eisenhaber, F; Hermetter, A; Zechner, R			Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase	SCIENCE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOCYTE; DEFICIENCY; METABOLISM; PROTEIN; OBESITY	Mobilization of fatty acids from triglyceride stores in adipose tissue requires lipolytic enzymes. Dysfunctional lipolysis affects energy homeostasis and may contribute to the pathogenesis of obesity and insulin resistance. Until now, hormone-sensitive lipase (HSL) was the only enzyme known to hydrolyze triglycerides in mammalian adipose tissue. Here, we report that a second enzyme, adipose triglyceride lipase (ATGL), catalyzes the initial step in triglyceride hydrolysis. It is interesting that ATGL contains a "patatin domain" common to plant acyl-hydrolases. ATGL is highly expressed in adipose tissue of mice and humans. It exhibits high substrate specificity for triacylglycerol and is associated with lipid droplets. Inhibition of ATGL markedly decreases total adipose acyl-hydrolase activity. Thus, ATGL and HSL coordinately catabolize stored triglycerides in adipose tissue of mammals.	Graz Univ, Inst Mol Biosci, Graz, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria; Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Graz University of Technology	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	rudolf.zechner@uni-graz.at	Adiels, Martin/C-9278-2011; Birner-Gruenberger, Ruth/E-8623-2010; Lass, Achim/C-3332-2008; Birner-Gruenberger, Ruth/X-9433-2019	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Lass, Achim/0000-0002-8190-7151; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Bogner-Strauss, Juliane/0000-0003-2459-0124; Zechner, Rudolf/0000-0001-5483-1182; Schoiswohl, Gabriele/0000-0002-7346-2834; Zimmermann, Robert/0000-0002-7354-870X; Haemmerle, Guenter/0000-0001-9900-5896				ALTHENSTAEDT K, 2003, J BIOL CHEM, V278, P23317; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; Bergman RN, 2001, J INVEST MED, V49, P119, DOI 10.2310/6650.2001.34108; Blaak EE, 2003, P NUTR SOC, V62, P753, DOI 10.1079/PNS2003290; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Oskolkova OV, 2003, CHEM PHYS LIPIDS, V125, P103, DOI 10.1016/S0009-3084(03)00085-9; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; YEAMAN SJ, 1994, ADV ENZYME REGUL, V34, P355, DOI 10.1016/0065-2571(94)90022-1; ZIMMERMAN R, UNPUB; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	23	1447	1562	6	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1383	1386		10.1126/science.1100747	http://dx.doi.org/10.1126/science.1100747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550674				2022-12-24	WOS:000225301600055
J	Singh, SK; Hawkins, C; Clarke, ID; Squire, JA; Bayani, J; Hide, T; Henkelman, RM; Cusimano, MD; Dirks, PB				Singh, SK; Hawkins, C; Clarke, ID; Squire, JA; Bayani, J; Hide, T; Henkelman, RM; Cusimano, MD; Dirks, PB			Identification of human brain tumour initiating cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; GROWTH-FACTOR RECEPTOR; STEM-LIKE CELLS; CANCER; HIERARCHY; ANTIGEN	The cancer stem cell (CSC) hypothesis suggests that neoplastic clones are maintained exclusively by a rare fraction of cells with stem cell properties(1,2). Although the existence of CSCs in human leukaemia is established(3,4), little evidence exists for CSCs in solid tumours, except for breast cancer(5). Recently, we prospectively isolated a CD133(+) cell subpopulation from human brain tumours that exhibited stem cell properties in vitro(6). However, the true measures of CSCs are their capacity for self renewal and exact recapitulation of the original tumour(1,2,7). Here we report the development of a xenograft assay that identified human brain tumour initiating cells that initiate tumours in vivo. Only the CD133(+) brain tumour fraction contains cells that are capable of tumour initiation in NOD-SCID (non-obese diabetic, severe combined immunodeficient) mouse brains. Injection of as few as 100 CD133(+) cells produced a tumour that could be serially transplanted and was a phenocopy of the patient's original tumour, whereas injection of 10 5 CD133(-) cells engrafted but did not cause a tumour. Thus, the identification of brain tumour initiating cells provides insights into human brain tumour pathogenesis, giving strong support for the CSC hypothesis as the basis for many solid tumours(5), and establishes a previously unidentified cellular target for more effective cancer therapies.	Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Integrat Biol Program, Toronto, ON M5G 1X8, Canada; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Toronto, ON M5G 2M9, Canada; St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Dirks, PB (corresponding author), Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt brain Tumor Res Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	peter.dirks@sickkids.ca	Cusimano, Michael/GWR-1025-2022; Singh, Sheila K/W-2799-2018; Cusimano, Michael/X-4059-2019; Squire, Jeremy/A-9352-2012	Singh, Sheila K/0000-0003-1272-5300; Cusimano, Michael/0000-0002-9989-0650; Squire, Jeremy/0000-0002-9863-468X				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; HOUCHENS DP, 1983, EUR J CANCER CLIN ON, V19, P799, DOI 10.1016/0277-5379(83)90012-3; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Potgens AJG, 2001, PLACENTA, V22, P639, DOI 10.1053/plac.2001.0701; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Russell D.S., 1989, PATHOLOGY TUMORS CEN; Singh SK, 2003, CANCER RES, V63, P5821; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720	28	5585	6027	13	647	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					396	401		10.1038/nature03128	http://dx.doi.org/10.1038/nature03128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15549107				2022-12-24	WOS:000225161400057
J	Stoll, BJ; Hansen, NI; Adams-Chapman, I; Fanaroff, AA; Hintz, SR; Vohr, B; Higgins, RD				Stoll, BJ; Hansen, NI; Adams-Chapman, I; Fanaroff, AA; Hintz, SR; Vohr, B; Higgins, RD			Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WHITE-MATTER DAMAGE; CEREBRAL-PALSY; BRAIN-DAMAGE; PERIVENTRICULAR LEUKOMALACIA; INTRAUTERINE INFECTION; PERINATAL INFECTION; PRETERM INFANT; NECROTIZING ENTEROCOLITIS; NATIONAL-INSTITUTE; RESEARCH NETWORK	Context Neonatal infections are frequent complications of extremely low-birth-weight (ELBW) infants receiving intensive care. Objective To determine if neonatal infections in ELBW infants are associated with increased risks of adverse neurodevelopmental and growth sequelae in early childhood. Design, Setting, and Participants Infants weighing 401 to 1000 g at birth (born in 1993-2001) were enrolled in a prospectively collected very low-birth-weight registry at academic medical centers participating in the National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth outcomes were assessed at a comprehensive follow-up visit at 18 to 22 months of corrected gestational age and compared by infection group. Eighty percent of survivors completed the follow-up visit and 6093 infants were studied. Registry data were used to classify infants by type of infection: uninfected (n=2161), clinical infection alone (n=1538), sepsis (n=1922), sepsis and necrotizing enterocolitis (n=279), or meningitis with or without sepsis (n=193). Main Outcome Measures Cognitive and neuromotor development, neurologic status, vision and hearing, and growth (weight, length, and head circumference) were assessed at follow-up. Results The majority of ELBW survivors (65%) had at least 1 infection during their hospitalization after birth. Compared with uninfected infants, those in each of the 4 infection groups were significantly more likely to have adverse neurodevelopmental outcomes at follow-up, including cerebral palsy (range of significant odds ratios [ORs], 1.4-1.7), low Bayley Scales of Infant Development II scores on the mental development index (ORs, 1.3-1.6) and psychomotor development index (ORs, 1.5-2.4), and vision impairment (ORs, 1.3-2.2). Infection in the neonatal period was also associated with impaired head growth, a known predictor of poor neurodevelopmental outcome. Conclusions This large cohort study suggests that neonatal infections among ELBW infants are associated with poor neurodevelopmental and growth outcomes in early childhood. Additional studies are needed to elucidate the pathogenesis of brain injury in infants with infection so that novel interventions to improve these outcomes can be explored.	Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Res Triangle Inst, Res Triangle Pk, NC 27709 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Stanford Univ, Med Ctr, Div Neonatol, Palo Alto, CA 94304 USA; Brown Univ, Dept Pediat, Providence, RI 02912 USA; NICHHD, Bethesda, MD 20892 USA	Emory University; Research Triangle Institute; Case Western Reserve University; Stanford University; Brown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stoll, BJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.			Hintz, Susan/0000-0001-7023-4433; Hansen, Nellie/0000-0003-4794-9646	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD040689, U10HD021364, U10HD040461, U10HD040492, U10HD034216, U10HD027904, U10HD027856, U10HD021385, U10HD027871, U10HD027853, U10HD027880, U10HD021373, U10HD027851] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021415, U10HD027881, U10HD034167, U10HD040521, U10HD040498, U10HD021397, U01HD036790, U01HD019897] Funding Source: NIH RePORTER; NICHD NIH HHS [U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U01 HD19897, U01 HD36790, U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD21415, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27871, U10 HD27880, U10 HD27881, U10 HD27904, U10 HD34167, U10 HD34216] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; BAYLEY N, 1993, BAYLEY SCALES INFANT, V2; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Boylan GB, 2000, PEDIATR RES, V48, P12, DOI 10.1203/00006450-200007000-00005; Dammann O, 2000, J PEDIATR-US, V136, P433, DOI 10.1016/S0022-3476(00)90004-0; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dammann O, 2001, TRENDS NEUROSCI, V24, P320, DOI 10.1016/S0166-2236(00)01811-7; Dammann O, 2000, CURR OPIN PEDIATR, V12, P99, DOI 10.1097/00008480-200004000-00002; Deguchi K, 1996, PEDIATR NEUROL, V14, P13, DOI 10.1016/0887-8994(95)00223-5; Dommergues MA, 2000, ANN NEUROL, V47, P54, DOI 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.3.CO;2-P; Dusick AM, 2003, SEMIN PERINATOL, V27, P302, DOI 10.1016/S0146-0005(03)00044-2; Dusick Anna, 1998, Pediatric Research, V43, p213A; Eschenbach DA, 1997, JAMA-J AM MED ASSOC, V278, P247, DOI 10.1001/jama.278.3.247; FAIX RG, 1985, PEDIATRICS, V76, P415; Fanaroff AA, 1999, NEW ENGL J MED, V341, P1229, DOI 10.1056/NEJM199910143411611; Fischel-Ghodsian N, 1999, ANN NY ACAD SCI, V884, P99, DOI 10.1111/j.1749-6632.1999.tb08639.x; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; HACK M, 1991, PEDIATRICS, V87, P587; HACK M, 1989, AM J DIS CHILD, V143, P63, DOI 10.1001/archpedi.1989.02150130073018; HACK M, 1991, NEW ENGL J MED, V325, P231, DOI 10.1056/NEJM199107253250403; Jeohn GH, 1998, J NEUROIMMUNOL, V85, P1, DOI 10.1016/S0165-5728(97)00204-X; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Leviton A, 2002, ACTA PAEDIATR, V91, P9, DOI 10.1080/080352502753457851; Leviton A, 2002, NEUROPEDIATRICS, V33, P281, DOI 10.1055/s-2002-37089; LEVITON A, 1973, J NEUROL SCI, V18, P53, DOI 10.1016/0022-510X(73)90020-8; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Msall M E, 1994, J Perinatol, V14, P41; Murphy DJ, 1997, BMJ-BRIT MED J, V314, P404, DOI 10.1136/bmj.314.7078.404; Nelson KB, 2002, MENT RETARD DEV D R, V8, P1, DOI 10.1002/mrdd.10010; O'Shea TM, 1998, PAEDIATR PERINAT EP, V12, P72; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; O'Shea TM, 2002, MENT RETARD DEV D R, V8, P135, DOI 10.1002/mrdd.10032; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Perlman JM, 1998, EARLY HUM DEV, V53, P99, DOI 10.1016/S0378-3782(98)00037-1; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schendel DE, 2002, MENT RETARD DEV D R, V8, P39, DOI 10.1002/mrdd.10011; Stoll BJ, 2004, PEDIATRICS, V113, P1181, DOI 10.1542/peds.113.5.1181; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Tang HY, 2002, GENET MED, V4, P336, DOI 10.1097/00125817-200209000-00004; Thomas P, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e21; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wheater M, 2000, DEV MED CHILD NEUROL, V42, P364, DOI 10.1017/S0012162200000670; WILLOUGHBY RE, 1994, CLIN PERINATOL, V21, P307, DOI 10.1016/S0095-5108(18)30347-6; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6	51	1026	1076	1	48	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2004	292	19					2357	2365		10.1001/jama.292.19.2357	http://dx.doi.org/10.1001/jama.292.19.2357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PL	15547163	Bronze			2022-12-24	WOS:000225070100024
J	Fang, MC; Chang, YC; Hylek, EM; Rosand, J; Greenberg, SM; Go, AS; Singer, DE				Fang, MC; Chang, YC; Hylek, EM; Rosand, J; Greenberg, SM; Go, AS; Singer, DE			Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Article							BLEEDING COMPLICATIONS; ORAL ANTICOAGULATION; PHYSICIAN ATTITUDES; STROKE PREVENTION; THERAPY; METAANALYSIS; PREVALENCE; PREDICTION; ASPIRIN; OUTPATIENTS	Background: The risk for atrial fibrillation-associated stroke increases at low anticoagulation intensities. However, higher intensities increase hemorrhage risk. Optimal use of warfarin for atrial fibrillation requires precise information on the risk for intracranial hemorrhage as a function of patient age and anticoagulation intensity. Objective: To examine the relationship of age, anticoagulation intensity, and risk for intracranial hemorrhage. Design: Case-control study. Setting: Academic medical center. Patients: 170 case-patients who developed intracranial hemorrhage during warfarin therapy and 1020 matched controls who did not; both case-patients and controls were taking warfarin for atrial fibrillation. Measurements: The authors performed multivariable conditional logistic regression to determine the odds of intracranial hemorrhage with regard to age and international normalized ratio (INR), controlling for comorbid conditions and aspirin use. Results: Case-patients were older than controls (median age, 78 years vs. 75 years; P < 0.001) and had higher median INRs (2.7 vs. 2.3; P < 0.001). The risk for intracranial hemorrhage increased at 85 years of age or older (adjusted odds ratio, 2.5 [95% CI, 1.3 to 4.7]; referent age, 70 to 74 years) and at an INR range of 3.5 to 3.9 (adjusted odds ratio, 4.6 [CI, 2.3 to 9.4]; referent INR, 2.0 to 3.0). The risk for intracranial hemorrhage at INRs less than 2.0 did not differ statistically from the risk at INRs of 2.0 to 3.0 (adjusted odds ratio, 1.3 [CI, 0.8 to 2.2]). Limitations: Although duration of anticoagulation has been associated with hemorrhage in other studies, the current study could not control for this potential confounder. Conclusions: The risk for intracranial hemorrhage increases at age 85 years. International normalized ratios less than 2.0 were not associated with lower risk for intracranial hemorrhage compared with INRs between 2.0 and 3.0. Therefore, anticoagulation management should focus on maintaining INRs in the 2.0 to 3.0 range, even in elderly patients with atrial fibrillation, rather than targeting INRs less than 2.0. Similarly, INRs of 3.5 or greater should be avoided.	Univ Calif San Francisco, Div Gen Internal Med, Hospitalist Grp, San Francisco, CA 94143 USA; Kaiser Permanente, Oakland, CA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of California System; University of California San Francisco; Kaiser Permanente; Harvard University; Massachusetts General Hospital	Fang, MC (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, Hospitalist Grp, 533 Parnassus Ave,Box 0131, San Francisco, CA 94143 USA.	mfang@medicine.ucsf.edu	Hug, Balthasar L./G-1568-2010; Go, Alan S./AAE-7745-2019; Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [AG15478] Funding Source: Medline; PHS HHS [5T32-HP-11001-14] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Antani MR, 1996, J GEN INTERN MED, V11, P713, DOI 10.1007/BF02598984; Arboix A, 2002, J AM GERIATR SOC, V50, P449, DOI 10.1046/j.1532-5415.2002.50109.x; Berwaerts J, 2000, STROKE, V31, P2558, DOI 10.1161/01.STR.31.11.2558; Berwaerts J, 2000, QJM-MON J ASSOC PHYS, V93, P513, DOI 10.1093/qjmed/93.8.513; Beyth RJ, 1996, J GEN INTERN MED, V11, P721, DOI 10.1007/BF02598985; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Fang MC, 2004, ARCH INTERN MED, V164, P55, DOI 10.1001/archinte.164.1.55; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Franke CL, 1997, ANN NEUROL, V42, P857; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gorter JW, 1999, NEUROLOGY, V53, P1319, DOI 10.1212/WNL.53.6.1319; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Hylek EM, 2001, ANN INTERN MED, V135, P393, DOI 10.7326/0003-4819-135-6-200109180-00008; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; Kronmal RA, 1998, STROKE, V29, P887, DOI 10.1161/01.STR.29.5.887; Lackie CL, 2002, ANN PHARMACOTHER, V36, P200; LANDEFELD CS, 1989, AM J MED, V87, P144; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; MCBRIDE R, 1994, LANCET, V343, P687; MCCRORY DC, 1995, ARCH INTERN MED, V155, P277, DOI 10.1001/archinte.155.3.277; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; Palareti G, 2000, ARCH INTERN MED, V160, P470, DOI 10.1001/archinte.160.4.470; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; ROSENBAUM PR, 1991, BIOMETRICS, V47, P87, DOI 10.2307/2532498; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Segal JB, 2000, J GEN INTERN MED, V15, P56, DOI 10.1046/j.1525-1497.2000.04329.x; Smith EE, 2002, NEUROLOGY, V59, P193, DOI 10.1212/WNL.59.2.193; Thrift AG, 1996, STROKE, V27, P2020, DOI 10.1161/01.STR.27.11.2020; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	47	388	409	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 16	2004	141	10					745	752		10.7326/0003-4819-141-10-200411160-00005	http://dx.doi.org/10.7326/0003-4819-141-10-200411160-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872KU	15545674				2022-12-24	WOS:000225206900001
J	Perez, F; Orne-Gliemann, J; Mukotekwa, T; Miller, A; Glenshaw, M; Mahomva, A; Dabis, F				Perez, F; Orne-Gliemann, J; Mukotekwa, T; Miller, A; Glenshaw, M; Mahomva, A; Dabis, F			Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe	BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CONTROLLED-TRIAL; COTE-DIVOIRE; DOUBLE-BLIND; ZIDOVUDINE; NEVIRAPINE; AFRICA; INTRAPARTUM; LAMIVUDINE; EFFICACY	Problem Zimbabwe has one of the highest rates of HIV seroprevalence in the world. In 2001 only 4% of women and children in need of services for prevention of mother to child transmission of HIV were receiving them. Design Pilot implementation of the first programme for prevention of mother to child transmission of HIV in rural Zimbabwe. Setting 120 bed district hospital in Buhera district (285 000 inhabitants), Manicaland, Zimbabwe. Key measures for improvement Programme uptake indicators monitored for 18 months; impact of policy evaluated by assessing up-scaling of programme. Strategies for change Voluntary counselling and testing services for HIV were provided in the hospital antenatal clinic. Women identified as HIV positive and informed of their serostatus and their newborn were offered a single dose antiretroviral treatment of nevirapine; mother-child pairs were followed up through routine health services. Nursing staff and social workers were trained, and community mobilisation was conducted. Effects of change No services for prevention of mother to child transmission of HIV were available at baseline. Within 18 months, 2298 pregnant women had received pretest counselling, and the acceptance of HIV testing reached 93.0%. Of all 2137 women who had an HIV test, 1588 (74.3%) returned to collect their result; 326 of the 437 HIV positive women diagnosed had post-test counselling, and 104 (24%) mother-child pairs received nevirapine prophylaxis. Lessons learnt Minimum staffing, an enhanced training programme, and involvement of district health authorities are needed for the implementation and successful integration of services for prevention of mother to child transmission of HIV. Voluntary counselling and testing services are important entry points for HIV prevention and care and for referral to community networks and medical HIV care services. A district approach is critical to extend programmes for prevention of mother to child transmission of HIV in rural settings. The lessons learnt from this pilot programme have contributed to the design of the national expansion strategy for prevention of mother to child transmission of HIV in Zimbabwe.	Univ Bordeaux 2, ISPED, F-33076 Bordeaux, France; Minist Hlth & Child Welf, PMTCT Unit, AIDS & TB Programme, Harare, Zimbabwe	UDICE-French Research Universities; Universite de Bordeaux	Perez, F (corresponding author), Univ Bordeaux 2, ISPED, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	Freddy.Perez@isped.u-bordeaux2.fr	Orne-Gliemann, Joanna/T-2787-2019; Perez, Freddy/AAN-3893-2020; DABIS, FRANCOIS/S-9298-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Perez, Freddy/0000-0003-2001-0057				Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Gregson S., 2001, Zimbabwe Science News, V35, P27; Horwood C, 2003, B WORLD HEALTH ORGAN, V81, P858; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; *MIN HLTH CHILD WE, 2003, PREV MOTH CHILD TRAN; *MIN HLTH CHILD WE, 2001, REP CONS PROV MED DI; *MIN HLTH CHILD WE, 2001, NAT ACT PLAN US NEV; *MIN HLTH CHILD WE, 2003, ZIMB NAT HIV AIDS ES; Mitka M, 2002, JAMA-J AM MED ASSOC, V288, P153, DOI 10.1001/jama.288.2.153; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Msellati P, 2001, B WORLD HEALTH ORGAN, V79, P641; Olliaro PL, 1995, B WORLD HEALTH ORGAN, V73, P735; Perez-Then E, 2003, JAIDS-J ACQ IMM DEF, V34, P506, DOI 10.1097/00126334-200312150-00010; Saba J, 2002, LANCET, V359, P1178; Saman M, 2002, AIDS, V16, P950, DOI 10.1097/00002030-200204120-00025; Songok EM, 2003, AM J TROP MED HYG, V69, P8, DOI 10.4269/ajtmh.2003.69.8; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2003, LANCET, V362, P1850, DOI 10.1016/S0140-6736(03)14907-0; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; UNAIDS, 2003, REP GLOB HIV AIDS EP; *WHO, 2001, HLTH SECT RESP HIV A; *WHO, 2004, ANT DRUGS PREV MOTH	23	57	57	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 13	2004	329	7475					1147	1150		10.1136/bmj.329.7475.1147	http://dx.doi.org/10.1136/bmj.329.7475.1147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	871XJ	15539670	Green Published			2022-12-24	WOS:000225169600021
J	Fleming, A; Osley, MA				Fleming, A; Osley, MA			Silence of the rings	CELL			English	Editorial Material							TRANSCRIPTIONAL ACTIVATION; H2B UBIQUITYLATION; HISTONE H2B; PROTEIN; UBIQUITINATION		Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico	Fleming, A (corresponding author), Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.							Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; FANG J, 2004, IN PRESS J BIOL CHEM; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	14	5	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2004	119	4					449	451		10.1016/j.cell.2004.11.001	http://dx.doi.org/10.1016/j.cell.2004.11.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	872CI	15537534	Bronze			2022-12-24	WOS:000225183200003
J	AbdAlla, S; Lother, H; Langer, A; el Faramawy, Y; Quitterer, U				AbdAlla, S; Lother, H; Langer, A; el Faramawy, Y; Quitterer, U			Factor XIIIA transglutaminase crosslinks AT(1) receptor dimers of monocytes at the onset of atherosclerosis	CELL			English	Article							PERIPHERAL-BLOOD MONOCYTES; ANGIOTENSIN-II; MEMBRANE; HETERODIMERS; EXPRESSION; DIMERIZATION; RECRUITMENT; ACTIVATION; DEFICIENT; PRESSURE	Many G protein-coupled receptors form dimers in cells. However, underlying mechanisms are barely understood. We report here that intracellular factor XIIIA transglutaminase crosslinks agonist-induced AT(1) receptor homodimers via glutamine(315) in the carboxyl-terminal tail of the AT(1) receptor. The crosslinked dimers displayed enhanced signaling and desensitization in vitro and in vivo. Inhibition of angiotensin II release or of factor XIIIA activity prevented formation of crosslinked AT(1) receptor dimers. In agreement with this finding, factor XIIIA-deficient individuals lacked crosslinked AT(1) dimers. Elevated levels of crosslinked AT(1) dimers were present on monocytes of patients with the common atherogenic risk factor hypertension and correlated with an enhanced angiotensin II-dependent monocyte adhesion to endothelial cells. Elevated levels of crosslinked AT(1) receptor dimers on monocytes could sustain the process of atherogenesis, because inhibition of angiotensin II generation or of intracellular factor XIIIA activity suppressed the appearance of crosslinked AT(1) receptors and symptoms of atherosclerosis in ApoE-deficient mice.	Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Inst Pharmakol, D-97078 Wurzburg, Germany	Heinrich Pette Institute; University of Wurzburg	Quitterer, U (corresponding author), Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.	toph029@rzbox.uni-wuerzburg.de						AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; ACHYUTHAN KE, 1993, J BIOL CHEM, V268, P21284; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Caimi G., 1997, Artery, V22, P328; Cayatte AJ, 2000, ARTERIOSCL THROM VAS, V20, P1724, DOI 10.1161/01.ATV.20.7.1724; Dinauer MC, 1999, BLOOD, V94, P914, DOI 10.1182/blood.V94.3.914.415a11_914_922; Dorffel Y, 1999, HYPERTENSION, V34, P113, DOI 10.1161/01.HYP.34.1.113; Dorffel Y, 2001, ATHEROSCLEROSIS, V157, P151, DOI 10.1016/S0021-9150(00)00674-2; DUGGAN J, 1992, AM J HYPERTENS, V5, P687; DUTTON A, 1975, P NATL ACAD SCI USA, V72, P2568, DOI 10.1073/pnas.72.7.2568; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Franco R, 2003, TRENDS BIOCHEM SCI, V28, P238, DOI 10.1016/S0968-0004(03)00065-3; GERRITY RG, 1985, ARTERIOSCLEROSIS, V5, P55, DOI 10.1161/01.ATV.5.1.55; GORMAN JJ, 1980, J BIOL CHEM, V255, P419; Gosgnach W, 2000, CARDIOVASC RES, V45, P486, DOI 10.1016/S0008-6363(99)00269-2; Hayek T, 1998, J CARDIOVASC PHARM, V31, P540, DOI 10.1097/00005344-199804000-00011; Ishiguro H, 2001, J BIOL CHEM, V276, P36742, DOI 10.1074/jbc.M106027200; Kim CJ, 2000, ARTERIOSCL THROM VAS, V20, P1976, DOI 10.1161/01.ATV.20.8.1976; LAZARUS DS, 1994, BBA-MOL BASIS DIS, V1226, P12, DOI 10.1016/0925-4439(94)90052-3; LJUNGMAN S, 1983, HYPERTENSION, V5, P368, DOI 10.1161/01.HYP.5.3.368; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; MUSZBEK L, 1988, THROMB HAEMOSTASIS, V59, P231; MUSZBEK L, 1995, THROMB HAEMOSTASIS, V73, P702; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; POLGAR J, 1990, BIOCHEM J, V267, P557, DOI 10.1042/bj2670557; POSTNOV YV, 1985, PHYSIOL REV, V65, P904, DOI 10.1152/physrev.1985.65.4.904; Quitterer U, 1999, J BIOL CHEM, V274, P14773, DOI 10.1074/jbc.274.21.14773; Quitterer U, 2004, SEMIN NEPHROL, V24, P115, DOI 10.1016/j.semnephrol.2003.11.007; Schiffrin EL, 2002, AM J HYPERTENS, V15, p115S, DOI 10.1016/S0895-7061(02)03006-6; SCHUNKERT H, 1990, J CLIN INVEST, V86, P1913, DOI 10.1172/JCI114924; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; WIDGREN BR, 1992, AM J HYPERTENS, V5, P167, DOI 10.1093/ajh/5.3.167; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288	40	154	160	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2004	119	3					343	354		10.1016/j.cell.2004.10.006	http://dx.doi.org/10.1016/j.cell.2004.10.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	868IW	15507206	Bronze			2022-12-24	WOS:000224908300006
J	Mukherjee, S				Mukherjee, S			Becoming a physician: A precarious exchange	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dana Farber Partners Canc Care, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mukherjee, S (corresponding author), Dana Farber Partners Canc Care, Boston, MA 02115 USA.							Halsted WS, 1904, J HOPKINS HOSP B, V15, P267; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008	3	57	58	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2004	351	18					1822	1824		10.1056/NEJMp048085	http://dx.doi.org/10.1056/NEJMp048085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865SM	15509813				2022-12-24	WOS:000224723100003
J	Laheij, RJF; Sturkenboom, MCJM; Hassing, RJ; Dieleman, J; Stricker, BHC; Jansen, JBMJ				Laheij, RJF; Sturkenboom, MCJM; Hassing, RJ; Dieleman, J; Stricker, BHC; Jansen, JBMJ			Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BACTERIAL OVERGROWTH; PATIENT RECORDS; OMEPRAZOLE; CIMETIDINE; COLONIZATION; INFECTIONS; RANITIDINE; DYSPEPSIA; THERAPY; MUCOSA	Context Reduction of gastric acid secretion by acid-suppressive therapy allows pathogen colonization from the upper gastrointestinal tract. The bacteria and viruses in the contaminated stomach have been identified as species from the oral cavity. Objective To examine the association between the use of acid-suppressive drugs and occurrence of community-acquired pneumonia. Design, Setting, and Participants Incident acid-suppressive drug users with at least 1 year of valid database history were identified from the Integrated Primary Care Information database between January 1, 1995, and December 31, 2002. Incidence rates for pneumonia were calculated for unexposed and exposed individuals. To reduce confounding by indication, a case-control analysis was conducted nested in a cohort of incident users of acid-suppressive drugs. Cases were all individuals with incident pneumonia during or after stopping use of acid-suppressive drugs. Up to 10 controls were matched to each case for practice, year of birth, sex, and index date. Conditional logistic regression was used to compare the risk of community-acquired pneumonia between use of proton pump inhibitors (PPIs) and H-2-receptor antagonists. Main Outcome Measure Community-acquired pneumonia defined ascertain (proven by radiography or sputum culture) or probable (clinical symptoms consistent with pneumonia). Results The study population comprised 364683 individuals who developed 5551 first occurrences of pneumonia during follow-up. The incidence rates of pneumonia in non-acid-suppressive drug users and acid-suppressive drug users were 0.6 and 2.45 per 100 person-years, respectively. The adjusted relative risk for pneumonia among persons currently using PPIs compared with those who stopped using PPIs was 1.89 (95% confidence interval, 1.36-2.62). Current users of H-2-receptor antagonists had a 1.63-fold increased risk of pneumonia (95% confidence interval, 1.07-2.48) compared with those who stopped use. For current PPI users, a significant positive dose-response relationship was observed. For H-2-receptor antagonist users, the variation in dose was restricted. Conclusion Current use of gastric acid-suppressive therapy was associated with an increased risk of community-acquired pneumonia.	Radboud Univ Nijmegen Med Ctr, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands; Erasmus MC Univ, Med Ctr Rotterdam, Dept Med Informat, Rotterdam, Netherlands; Erasmus MC Univ, Med Ctr Rotterdam, Dept Epidemiol & Biostat, Pharmacoepidemiol Unit, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Laheij, RJF (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Gastroenterol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	R.Laheij@mdl.umcn.nl						*AM GASTR ASS, 1998, GASTROENTEROLOGY, V114, P579; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Brummer RJM, 1996, DIGEST DIS SCI, V41, P2048, DOI 10.1007/BF02093609; DELANEY BC, 2000, COCHRANE DB SYST REV; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; Hayase Y, 2002, J GASTROENTEROL, V37, P101, DOI 10.1007/s005350200003; HOWDEN CW, 1987, GUT, V28, P96, DOI 10.1136/gut.28.1.96; Hurst AF, 1934, BRIT MED J, V1934, P665, DOI 10.1136/bmj.2.3849.665; INGLIS TJJ, 1993, LANCET, V341, P911, DOI 10.1016/0140-6736(93)91208-4; JONES R, 1989, BRIT MED J, V298, P30, DOI 10.1136/bmj.298.6665.30; Laheij RJF, 2003, ALIMENT PHARM THER, V18, P847, DOI 10.1046/j.1365-2036.2003.01744.x; LAMBERTS H, 1992, FAM PRACT, V9, P330, DOI 10.1093/fampra/9.3.330; LITTMAN A, 1990, LANCET, V335, P222, DOI 10.1016/0140-6736(90)90308-R; Martinez AC, 2000, EUR J CLIN MICROBIOL, V19, P96; Mikawa K, 1999, ANESTH ANALG, V89, P218, DOI 10.1097/00000539-199907000-00040; RUDDELL WSJ, 1980, LANCET, V1, P672; Ruhl CE, 2001, ANN EPIDEMIOL, V11, P477, DOI 10.1016/S1047-2797(01)00236-8; Sanduleanu S, 2001, ALIMENT PHARM THER, V15, P379, DOI 10.1046/j.1365-2036.2001.00888.x; Scaringi L, 1996, SCAND J IMMUNOL, V44, P204, DOI 10.1046/j.1365-3083.1996.d01-300.x; SIMMS HH, 1991, J TRAUMA, V31, P531, DOI 10.1097/00005373-199104000-00013; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; van Bommel MJJ, 2001, POSTGRAD MED J, V77, P514, DOI 10.1136/pmj.77.910.514; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vlug AE, 1999, METHOD INFORM MED, V38, P339; *WHO COLL CTR DRUG, 2002, ATC IND DDDS; WICKRAMASINGHE LSP, 1984, BRIT MED J, V289, P1272; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	29	602	633	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2004	292	16					1955	1960		10.1001/jama.292.16.1955	http://dx.doi.org/10.1001/jama.292.16.1955			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865DO	15507580	Bronze			2022-12-24	WOS:000224682900019
J	Cai, DS; Frantz, JD; Tawa, NE; Melendez, PA; Oh, BC; Lidov, HGW; Hasselgren, PO; Frontera, WR; Lee, J; Glass, DJ; Shoelson, SE				Cai, DS; Frantz, JD; Tawa, NE; Melendez, PA; Oh, BC; Lidov, HGW; Hasselgren, PO; Frontera, WR; Lee, J; Glass, DJ; Shoelson, SE			IKK beta/NF-kappa B activation causes severe muscle wasting in mice	CELL			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FOXO TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR; SKELETAL-MUSCLE; TNF-ALPHA; PROTEIN BREAKDOWN; ATROPHY; KINASE; CACHEXIA; EXPRESSION	Muscle wasting,accompanies aging and pathological conditions ranging from cancer, cachexia, and diabetes to denervation and immobilization. We show that activation of NF-kappaB, through muscle-specific transgenic expression of activated IkappaB kinase beta (MIKK), causes profound muscle wasting that resembles clinical cachexia. In contrast, no overt phenotype was seen upon muscle-specific inhibition of NF-kappaB through expression of IkappaBalpha superrepressor (MISR). Muscle loss was due to accelerated protein breakdown through ubiquitin-dependent proteolysis. Expression of the E3 ligase MuRF1, a mediator of muscle atrophy, was increased in MIKK mice. Pharmacological or genetic inhibition of the IKKbeta/NF-kappaB/MuRF1 pathway reversed muscle atrophy. Denervation- and tumor-induced muscle loss were substantially reduced and survival rates improved by NF-kappaB inhibition in MISR mice, consistent with a critical role for NF-kappaB in the pathology of muscle wasting and establishing it as an important clinical target for the treatment of muscle atrophy.	Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Regeneron Pharmaceut Inc, Muscle Program, Tarrytown, NY 10591 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Spaulding Rehabilitation Hospital; Regeneron; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	steven.shoelson@joslin.harvard.edu	Glass, David/AAI-3910-2021; Lee, Jongsoon/AAG-1674-2020; Glass, David/C-4782-2012	Lee, Jongsoon/0000-0002-0891-5059; Oh, Byung-Chul/0000-0002-4277-7083; Glass, David/0000-0001-6187-4164	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051729, R01DK045943, R37DK051729, P30DK036836] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK051729-09, R01 DK051729-08, R01 DK051729-07, R01 DK045943-08, R01 DK045943-07, DK45943, DK36836, DK51729] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carpenter S, 2001, PATHOLOGY SKELETAL M; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Fanelli FR, 1995, NUTRITION, V11, P595; Fang CH, 1998, INT J MOL MED, V1, P163; Fiorucci S, 2002, P NATL ACAD SCI USA, V99, P15770, DOI 10.1073/pnas.232583599; FONG Y, 1989, AM J PHYSIOL, V256, pR659, DOI 10.1152/ajpregu.1989.256.3.R659; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; LopezSoriano J, 1996, MOL CELL BIOCHEM, V165, P17; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pC766, DOI 10.1152/ajpcell.1987.253.6.C766; MORA M, 1989, EUR HEART J, V10, P103, DOI 10.1093/eurheartj/10.suppl_D.103; MULLEN BJ, 1990, P SOC EXP BIOL MED, V193, P318; Penner CG, 2001, BIOCHEM BIOPH RES CO, V281, P1331, DOI 10.1006/bbrc.2001.4497; ROTHWARF DM, 2000, SCI STKE; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sylla BS, 1998, P NATL ACAD SCI USA, V95, P10106, DOI 10.1073/pnas.95.17.10106; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; VAN AD, 1996, SCIENCE, V274, P787; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	45	993	1038	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					285	298		10.1016/j.cell.2004.09.027	http://dx.doi.org/10.1016/j.cell.2004.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479644	Bronze			2022-12-24	WOS:000224577200015
J	Debiec, H; Nauta, J; Coulet, F; van der Burg, M; Guigonis, V; Schurmans, T; de Heer, E; Soubrier, F; Janssen, F; Ronco, P				Debiec, H; Nauta, J; Coulet, F; van der Burg, M; Guigonis, V; Schurmans, T; de Heer, E; Soubrier, F; Janssen, F; Ronco, P			Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies	LANCET			English	Article							LYMPHOBLASTIC-LEUKEMIA ANTIGEN; NEUTRAL ENDOPEPTIDASE; MEMBRANOUS NEPHROPATHY; NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; GLOMERULONEPHRITIS; ANTIBODIES; ENKEPHALINASE; ONTOGENESIS; NEPRILYSIN	Background Membranous glomerulonephritis is an immune-mediated disease. In a recent case of antenatal membranous glomerulonephritis, we identified neutral endopeptidase (NEP) as the podocyte target antigen of circulating antibodies produced by the mother who failed to express NEP on granulocytes. We aimed to investigate whether the disease could affect other families, to search for mutations in the metallomembrane endopeptidase (MME) gene for NEP, and to analyse the outcome of the antenatal renal insult. Methods From three families with a case of neonatal membranous glomerulopathy, we detected mutations by direct sequencing of genomic PCR products. Single nucleotide polymorphism (SNP) analysis was undertaken with five SNPs located in the MME gene. IgG subclasses with anti-NEP activity were determined by western blotting. Findings In five mothers, we identified two compound heterozygous or homozygous mutations in the MME gene. The first, a 1342C-->T nonsense mutation, was detected in one family. The second, 446delC, was detected in all three families; all chromosomes bearing this mutation had the same alleles for the five SNPs. Severity of neonatal renal disease was determined by the mothers' IgG response to fetal NEP antigens expressed on glomerular podocytes. The oldest affected individual, now aged 20 years, has developed severe chronic renal failure. Interpretation Truncating mutations in the MME gene are the cause of alloimmunisation during pregnancy. idiopathic renal failure in early adulthood might be caused by immune-mediated fetal nephron loss. We show that disease caused by fetomaternal alloimmunisation secondary to a genetic defect is not restricted to blood cells. Relevance to clinical practice During pregnancy, the absence of the NEP protein induces an alloimmunisation process against NEP presented by fetal cells, including syncytiotrophoblasts. The fetal podocyte insult and ensuing nephron loss could lead to chronic renal failure in early adulthood. Alloimmunisation against NEP should be considered as a leading cause of membranous glomerulopathy early in life. Concentrations of circulating anti-NEP antibodies should be carefully monitored during subsequent pregnancies, and specific therapeutic approaches developed. This new disease might also account for idiopathic chronic renal failure detected during adolescence, in individuals who can be identified by searching for anti-NEP antibodies in their mother and by MME gene mutation analysis. NEP deficiency should also be considered in patients developing de-novo membranous glomerulopathy after renal transplantation.	Tenon Hosp, APHP, INSERM, U489, F-75020 Paris, France; Tenon Hosp, APHP, Dept Human Genet, Paris, France; Univ Paris 06, Paris, France; Armand Trousseau Hosp, APHP, Dept Pediat Nephrol, Paris, France; Erasmus MC, Sophia Childrens Hosp, Rotterdam, Netherlands; Erasmus MC, Sophia Childrens Hosp, Dept Immunol, Rotterdam, Netherlands; Free Univ Brussels, Dept Pediat Nephrol, Brussels, Belgium; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Debiec, H (corresponding author), Tenon Hosp, APHP, INSERM, U489, F-75020 Paris, France.	hanna.debiec@tnn.ap-hop-paris.fr	De Heer, Emile/C-1110-2009; Ronco, Pierre/AAC-8390-2022; Debiec, Hanna/AAL-8144-2021; Guigonis, Vincent/O-8863-2016	Debiec, Hanna/0000-0002-8946-8245; Guigonis, Vincent/0000-0002-2529-0919				APPAY MD, 1985, CLIN IMMUNOL IMMUNOP, V37, P103, DOI 10.1016/0090-1229(85)90141-2; ARDAILLOU N, 1992, J CELL PHYSIOL, V152, P599, DOI 10.1002/jcp.1041520320; Bonvouloir N, 2001, DNA CELL BIOL, V20, P493, DOI 10.1089/104454901316976127; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bowman John M., 1994, P553; Clark MR, 1997, CHEM IMMUNOL, V65, P88; CYBULSKY AV, 2000, KIDNEY PHYSL PATHOPH, P2645; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Glassock RJ, 2003, SEMIN NEPHROL, V23, P324, DOI 10.1016/S0270-9295(03)00049-4; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Horl WH, 2000, J NEPHROL, V13, P291; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JOHNSON AR, 1984, PEPTIDES, V5, P789, DOI 10.1016/0196-9781(84)90023-8; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2000, J NEPHROL, V13, pS96; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; METZGAR RS, 1981, J EXP MED, V154, P1249, DOI 10.1084/jem.154.4.1249; NAUTA J, 1990, PEDIATR NEPHROL, V4, P111, DOI 10.1007/BF00858820; PLATT JL, 1983, J EXP MED, V157, P155, DOI 10.1084/jem.157.1.155; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; RONCO P, 1988, LAB INVEST, V58, P210; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Squarer A, 1998, J AM SOC NEPHROL, V9, P1389; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Usmani BA, 2000, CLIN CANCER RES, V6, P1664; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664	34	142	156	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1252	1259		10.1016/S0140-6736(04)17142-0	http://dx.doi.org/10.1016/S0140-6736(04)17142-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464186				2022-12-24	WOS:000224254200032
J	Bertone, P; Stolc, V; Royce, TE; Rozowsky, JS; Urban, AE; Zhu, XW; Rinn, JL; Tongprasit, W; Samanta, M; Weissman, S; Gerstein, M; Snyder, M				Bertone, P; Stolc, V; Royce, TE; Rozowsky, JS; Urban, AE; Zhu, XW; Rinn, JL; Tongprasit, W; Samanta, M; Weissman, S; Gerstein, M; Snyder, M			Global identification of human transcribed sequences with genome tiling arrays	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVITY; HUMAN-CHROMOSOME-22; CHROMOSOME-22; PSEUDOGENES; MICROARRAY; RESOURCES; COVERAGE; ENSEMBL; RNAS; DNA	Elucidating the transcribed regions of the genome constitutes a fundamental aspect of human biology, yet this remains an outstanding problem. To comprehensively identify coding sequences, we constructed a series of high-density oligonucleotide tiling arrays representing sense and antisense strands of the entire nonrepetitive sequence of the human genome. Transcribed sequences were located across the genome via hybridization to complementary DNA samples, reverse-transcribed from polyadenylated RNA obtained from human liver tissue. In addition to identifying many known and predicted genes, we found 10,595 transcribed sequences not detected by other methods. A large fraction of these are located in intergenic regions distal. from previously annotated genes and exhibit significant, homology to other mammalian proteins.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; NASA, Ames Res Ctr, Ctr Nanotechnol, Moffett Field, CA 94035 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Eloret Corp, Sunnyvale, CA 94087 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Yale University; Yale University	Gerstein, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	mark.gerstein@yale.edu; michael.snyder@yale.edu	Bertone, Paul/Z-3734-2019; Bertone, Paul/A-6600-2013	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Snyder, Michael/0000-0003-0784-7987; Rinn, John/0000-0002-7231-7539; Zhu, Xiaowei/0000-0002-5731-3177; Rozowsky, Joel/0000-0002-3565-0762	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG02357] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albert TJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng035; ATTSCHUL SF, 1990, J MOL BIOL, V215, P403; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Buckley PG, 2002, HUM MOL GENET, V11, P3221, DOI 10.1093/hmg/11.25.3221; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	21	807	882	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2242	2246		10.1126/science.1103388	http://dx.doi.org/10.1126/science.1103388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15539566				2022-12-24	WOS:000225950000042
J	Sloan, FA; Berman, S; Rosenbaum, S; Chalk, RA; Giffin, RB				Sloan, FA; Berman, S; Rosenbaum, S; Chalk, RA; Giffin, RB			The fragility of the US vaccine supply	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; INSURANCE; CHILDREN; CLINICS; POLICY; COST		Duke Univ, Dept Econ, Durham, NC 27706 USA; Univ Colorado, Sch Med, Childrens Outcomes Res Program, Denver, CO USA; Childrens Hosp, Denver, CO 80218 USA; George Washington Univ, Med Ctr, Dept Hlth Policy, Washington, DC 20037 USA; Natl Acad, Div Behav & Social Sci & Educ, Washington, DC USA; Natl Acad, Inst Med, Washington, DC USA	Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; George Washington University; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Sloan, FA (corresponding author), Duke Univ, Dept Econ, Durham, NC 27706 USA.							[Anonymous], SUPPLYING VACCINES E; Carpenter DP, 2004, HEALTH AFFAIR, V23, P52, DOI 10.1377/hlthaff.23.1.52; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; Finkelstein A, 2004, Q J ECON, V119, P527, DOI 10.1162/0033553041382166; Fontanesi J, 2001, AM J MED QUAL, V16, P196, DOI 10.1177/106286060101600603; FOULKES MA, 2002, JORDAN REPORT ACCELE, P50; FREED GL, 2003, PEDIATRICS, V2, P399; *GEN ACC OFF, 2002, GAO02987; Glazner JE, 2001, PUBLIC HEALTH REP, V116, P219, DOI 10.1093/phr/116.3.219; GRABOWSKI HG, 1997, SEARCH NEW VACCINES; HINMAN AR, 2004, I MED REPORT FINANCI; Holahan John, 2003, CHANGES HLTH CARE CO; *I MED, 2003, FIN VACC 21 CENT ASS; Jacobs RJ, 2001, PREV MED, V33, P639, DOI 10.1006/pmed.2001.0938; KREMER M, 2003, W9833 NAT BUR EC RES; LIEU TA, 1994, PEDIATRICS, V93, P373; McGuire Thomas G, 2003, Int J Health Care Finance Econ, V3, P207, DOI 10.1023/A:1025336903645; Peter G, 2003, JAMA-J AM MED ASSOC, V290, P3122; Wiktorowicz ME, 2003, J HEALTH POLIT POLIC, V28, P615, DOI 10.1215/03616878-28-4-615; Zimmerman RK, 1997, JAMA-J AM MED ASSOC, V278, P996, DOI 10.1001/jama.278.12.996; 2002, MMWR MORB MORTAL WKL, V51, P664; 2002, MMWR MORB MORTAL WKL, V51, P1019; [No title captured]; 2004, MMWR MORB MORTAL WKL, V53, P177	24	23	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2443	2447		10.1056/NEJMsb033394	http://dx.doi.org/10.1056/NEJMsb033394			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575064				2022-12-24	WOS:000225429000018
J	Westfall, PJ; Ballon, DR; Thorner, J				Westfall, PJ; Ballon, DR; Thorner, J			When the stress of your environment makes you go HOG wild	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; RESPONSE REGULATOR; OSMOTIC-STRESS; KINASE PATHWAY; MAPK PATHWAY; YEAST; ACTIVATION; OSMOSTRESS; OSMOSENSOR; COMPONENTS	When exposed to increased dissolved solute in their environment (hyperosmotic stress), all eukaryotic cells respond by rapidly activating a conserved mitogen-activated protein kinase cascade, known in budding yeast Saccharomyces cerevisiae as the high osmolarity glycerol (HOG) pathway. Intensive genetic and biochemical analysis in this organism has revealed the presumptive osmosensors, downstream signaling components, and metabolic and transcriptional changes that allow cells to cope with this stressful condition. These findings have had direct application to understanding stress sensing and control of transcription by stress-activated mitogen-activated protein kinases in mammalian cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA.	jeremy@socrates.berkeley.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021841, R01GM021841, F32GM068343] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-21841, GM-68343] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; WESTFALL PJ, 2004, SCI STKE         NOV; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; Zarrinpar A, 2004, MOL CELL, V14, P825, DOI 10.1016/j.molcel.2004.06.011	22	98	103	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1511	1512		10.1126/science.1104879	http://dx.doi.org/10.1126/science.1104879			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15567851				2022-12-24	WOS:000225442700045
J	Gao, LZ; Innan, H				Gao, LZ; Innan, H			Very low gene duplication rate in the yeast genome	SCIENCE			English	Article							CONVERSION; RECOMBINATION; MODEL	The gene duplication rate in the yeast genome is estimated without assuming the molecular clock model to be similar to0.01 to 0.06 per gene per billion years; this rate is two orders of magnitude lower than a previous estimate based on the molecular clock model. This difference is explained by extensive concerted evolution via gene conversion between duplicated genes, which violates the assumption of the molecular clock in the analyses of duplicated genes. The average length of the period of concerted evolution and the gene conversion rate are estimated to be similar to25 million years and similar to28 times the mutation rate, respectively.	Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Innan, H (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, 1200 Hermann Pressler, Houston, TX 77030 USA.	hideki.innan@uth.tmc.edu		Innan, Hideki/0000-0001-6375-9231				Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hurles ME, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r55; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Innan H, 2003, GENETICS, V163, P803; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Langley CH, 2000, GENETICS, V156, P1837; Li W-H, 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P3251, DOI 10.1073/pnas.79.10.3251; Ohta T., 1980, EVOLUTION VARIATION, V37, DOI [10.1007/978-3-642-93138-3, DOI 10.1007/978-3-642-93138-3]; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Walsh B, 2003, GENETICA, V118, P279, DOI 10.1023/A:1024194802441; Wang W, 2004, GENETICS, V166, P1783, DOI 10.1534/genetics.166.4.1783; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; ZUCKERKANDL EMILE, 1965, P97	26	117	123	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1367	1370		10.1126/science.1102033	http://dx.doi.org/10.1126/science.1102033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550669				2022-12-24	WOS:000225301600050
J	Koo, B; Nottenburg, C; Pardey, PG				Koo, B; Nottenburg, C; Pardey, PG			Intellectual property - Plants and intellectual property: An international appraisal	SCIENCE			English	Article									Int Food Policy Res Inst, Washington, DC 20006 USA; Cougar Patent Law, Seattle, WA 98144 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	CGIAR; International Food Policy Research Institute (IFPRI); University of Minnesota System; University of Minnesota Twin Cities	Koo, B (corresponding author), Int Food Policy Res Inst, Washington, DC 20006 USA.	b.koo@cgiar.org; c.nottenburg@cougarlaw.com; ppardey@apec.umn.edu						Atkinson RC, 2003, SCIENCE, V301, P174, DOI 10.1126/science.1085553; Beachy RN, 2003, SCIENCE, V299, P473, DOI 10.1126/science.299.5606.473; Binenbaum E, 2003, ECON DEV CULT CHANGE, V51, P309, DOI 10.1086/346177; Brahmi P, 2004, CURR SCI INDIA, V86, P392; *CPVO, 2002, ANN REP; Fowler C, 1990, SHATTERING FOOD POLI; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Kennedy D, 2003, SCIENCE, V302, P357, DOI 10.1126/science.302.5644.357; KOO B, 2003, P038 U MINN DEP APPL; Pardey P. G., 2001, SLOW MAGIC AGR R D C	10	33	34	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2004	306	5700					1295	1297		10.1126/science.1106760	http://dx.doi.org/10.1126/science.1106760			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15550646				2022-12-24	WOS:000225301600025
J	Politi, Y; Arad, T; Klein, E; Weiner, S; Addadi, L				Politi, Y; Arad, T; Klein, E; Weiner, S; Addadi, L			Sea urchin spine calcite forms via a transient amorphous calcium carbonate phase	SCIENCE			English	Article							ECHINOID EUCIDARIS-TRIBULOIDES; PRECURSOR; BIOMINERALIZATION; CRYSTALS; PROTEINS; SPICULES; EMBRYOS; TISSUES; FILMS	The skeletons of adult echinoderms comprise large single crystals of calcite with smooth convoluted fenestrated morphologies, raising many questions about how they form. By using water etching, infrared spectroscopy, electron diffraction, and environmental scanning electron microscopy, we show that sea urchin spine regeneration proceeds via the initial deposition of amorphous calcium carbonate. Because most echinoderms produce the same type of skeletal material, they probably all use this same mechanism. Deposition of transient amorphous phases as a strategy for producing single crystals with complex morphology may have interesting implications for the development of sophisticated materials.	Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Chem Res Support Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Addadi, L (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	lia.addadi@weizmann.ac.il						Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Beniash E, 1999, J STRUCT BIOL, V125, P50, DOI 10.1006/jsbi.1998.4081; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Carpenter W.B., 1847, BR ASS ADV SCI, V15, P93; Dubois P, 2001, MICROSC RES TECHNIQ, V55, P427, DOI 10.1002/jemt.1188; Dubois P., 1989, Echinoderm Studies, V3, P109; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; HEATFIELD BM, 1971, J EXP ZOOL, V178, P233, DOI 10.1002/jez.1401780208; LIPPMANN F, 1973, SEDIMENTARY CARBOATE; Loste E, 2001, CHEM COMMUN, P901, DOI 10.1039/b101563j; Lowenstam HA, 1989, BIOMINERALIZATION; MARKEL K, 1983, ZOOMORPHOLOGY, V103, P25, DOI 10.1007/BF00312056; MARKEL K, 1989, ZOOMORPHOLOGY, V109, P79, DOI 10.1007/BF00312313; MARKEL K, 1983, ZOOMORPHOLOGY, V103, P43, DOI 10.1007/BF00312057; OKAZAKI KAYO, 1960, EMBRYOLOGIA, V5, P283, DOI 10.1111/j.1440-169X.1960.tb00096.x; PILKINGTON JB, 1969, J MAR BIOL ASSOC UK, V49, P857, DOI 10.1017/S0025315400037991; RAUP DM, 1959, J GEOL, V67, P661, DOI 10.1086/626624; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; Simkiss K, 1989, BIOMINERALIZATION CE; TOWE KM, 1967, SCIENCE, V157, P1048, DOI 10.1126/science.157.3792.1048; Tsountas C., 1892, SVEN VETENSK AKAD HA, P1; Weiner S, 2000, MAT SCI ENG C-BIO S, V11, P1, DOI 10.1016/S0928-4931(00)00141-7; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wilt FH, 2002, ZOOL SCI, V19, P253, DOI 10.2108/zsj.19.253; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108	28	766	784	12	371	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2004	306	5699					1161	1164		10.1126/science.1102289	http://dx.doi.org/10.1126/science.1102289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15539597				2022-12-24	WOS:000225193100041
J	Thorpe, LE; Frieden, TR; Laserson, KF; Wells, C; Khatri, GR				Thorpe, LE; Frieden, TR; Laserson, KF; Wells, C; Khatri, GR			Seasonality of tuberculosis in India: is it real and what does it tell us?	LANCET			English	Article								India has a third of the world's tuberculosis cases. Large-scale expansion of a national programme in 1998 has allowed for population-based analyses of data from tuberculosis registries. We assessed seasonal trends using quarterly reports from districts with stable tuberculosis control programmes (population 115 million). In northern India, tuberculosis diagnoses peaked between April and June, and reached a nadir between October and December, whereas no seasonality was reported in the south. Overall, rates of new smear-positive tuberculosis cases were 57 per 100000 population in peak seasons versus 46 per 100000 in trough seasons. General health-seeking behaviour artifact was ruled out. Seasonality was highest in paediatric cases, suggesting variation in recent transmission.	NYC Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY 10013 USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Adult Community Hlth, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, Atlanta, GA USA; WHO, Reg Off SE Asia, Stop TB Unit, Delhi, India; Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, New Delhi, India	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Thorpe, LE (corresponding author), NYC Dept Hlth & Mental Hyg, Div Epidemiol, CN6,125 Worth St, New York, NY 10013 USA.	lthorpe@health.nyc.gov		Frieden, Thomas/0000-0002-4759-2256				Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Schaaf HS, 1996, TUBERCLE LUNG DIS, V77, P43, DOI 10.1016/S0962-8479(96)90074-X; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6	5	90	94	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 30	2004	364	9445					1613	1614		10.1016/S0140-6736(04)17316-9	http://dx.doi.org/10.1016/S0140-6736(04)17316-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866IQ	15519633	Green Submitted			2022-12-24	WOS:000224767600028
J	Friml, J; Yang, X; Michniewicz, M; Weijers, D; Quint, A; Tietz, O; Benjamins, R; Ouwerkerk, PBF; Ljung, K; Sandberg, G; Hooykaas, PJJ; Palme, K; Offringa, R				Friml, J; Yang, X; Michniewicz, M; Weijers, D; Quint, A; Tietz, O; Benjamins, R; Ouwerkerk, PBF; Ljung, K; Sandberg, G; Hooykaas, PJJ; Palme, K; Offringa, R			A PINOID-dependent binary switch in apical-basal PIN polar targeting directs auxin efflux	SCIENCE			English	Article							ARABIDOPSIS; TRANSPORT; GRADIENTS; GNOM; MORPHOGENESIS	Polar transport-dependent local accumulation of auxin provides positional cues for multiple plant patterning processes. This directional auxin flow depends on the polar subcellular localization of the PIN auxin efflux regulators. Overexpression of the PINOID protein kinase induces a basal-to-apical shift in PIN localization, resulting in the toss of auxin gradients and strong defects in embryo and seedling roots. Conversely, pid loss of function induces an apical-to-basal. shift in PIN1 polar targeting at the inflorescence apex, accompanied by defective organogenesis. Our results show that a PINOID-dependent binary switch controls PIN polarity and mediates changes in auxin flow to create local gradients for patterning processes.	Leiden Univ, Clusius Lab, Inst Biol, NL-2333 AL Leiden, Netherlands; Univ Tubingen, Ctr Mol Biol Plants, D-72076 Tubingen, Germany; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; Univ Freiburg, D-79104 Freiburg, Germany; Swedish Univ Agr Sci, Dept Forest & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; BOKU Univ Nat Resources & Appl Life Sci, Inst Appl Genet & Cell Biol, A-1190 Vienna, Austria	Leiden University; Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; Peking University; University of Freiburg; Swedish University of Agricultural Sciences; Umea University; University of Natural Resources & Life Sciences, Vienna	Offringa, R (corresponding author), Leiden Univ, Clusius Lab, Inst Biol, Wassenaarseweg 64, NL-2333 AL Leiden, Netherlands.	offringa@rulbim.leidenuniv.nl	Hooykaas, Paul JJ/S-4256-2017; Weijers, Dolf/A-2076-2010; Weijers, Dolf/ABI-1332-2020; Friml, Jiri/D-9511-2012; Ljung, Karin/AAE-8691-2019; Palme, Klaus/A-9524-2013	Hooykaas, Paul JJ/0000-0002-9736-6927; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Friml, Jiri/0000-0002-8302-7596; Ljung, Karin/0000-0003-2901-189X; Palme, Klaus/0000-0002-2728-3835				Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Weijers D, 2001, DEVELOPMENT, V128, P4289; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a	19	557	599	5	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					862	865		10.1126/science.1100618	http://dx.doi.org/10.1126/science.1100618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15514156				2022-12-24	WOS:000224969400044
J	Levrard, B; Forget, F; Montmessin, F; Laskar, J				Levrard, B; Forget, F; Montmessin, F; Laskar, J			Recent ice-rich deposits formed at high latitudes on Mars by sublimation of unstable equatorial ice during low obliquity	NATURE			English	Article							CHAOTIC OBLIQUITY; NEAR-SURFACE; CIRCULATION; HYDROGEN	Observations from the gamma-ray spectrometer instrument suite on the Mars Odyssey spacecraft have been interpreted as indicating the presence of vast reservoirs of near-surface ice in high latitudes of both martian hemispheres(1-5). Ice concentrations are estimated to range from 70 per cent at 60degrees latitude to 100 per cent near the poles, possibly overlain by a few centimetres of ice-free material in most places(4). This result is supported by morphological evidence of metres-thick layered deposits that are rich in water-ice(6-9) and periglacial-like features(10,11) found only difficult to accommodate with such processes(9,13,14). Alternatively, there are suggestions that ice-rich deposits form by transport of ice from polar reservoirs and direct redeposition in high latitudes during periods of higher obliquity(9,13), but these results have been difficult to reproduce with other models. Here we propose instead that, during periods of low obliquity ( less than 25degrees), high-latitude ice deposits form in both hemispheres by direct deposition of ice, as a result of sublimation from an equatorial ice reservoir that formed earlier, during a prolonged high-obliquity excursion. Using the ice accumulation rates estimated from global climate model simulations we show that, over the past ten million years, large variations of Mars' obliquity have allowed the formation of such metres-thick, sedimentary layered deposits in high latitude and polar regions.	IMC, CNRS, UMR 8028, F-75014 Paris, France; Univ Paris 06, Meteorol Dynam Lab, F-75005 Paris, France; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Levrard, B (corresponding author), ENS Lyon, UCBL, UMR 5570, Lab Planetol & Teledetect, 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France.	blevrard@imcce.fr	Laskar, Jacques/E-1098-2011	Laskar, Jacques/0000-0003-2634-789X; Montmessin, Franck/0000-0002-4187-1457				Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; BOYNTON WV, 2003, AGU ALL M; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; HABERLE RM, 2000, LUN PLAN SCI C 31; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HOURDIN F, 1993, J ATMOS SCI, V50, P3625, DOI 10.1175/1520-0469(1993)050<3625:MVATAS>2.0.CO;2; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; Kreslavsky MA, 2000, J GEOPHYS RES-PLANET, V105, P26695, DOI 10.1029/2000JE001259; Kreslavsky MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015392; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; MANGOLD N, 2003, 3 MARS POL SCI C; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; Milliken RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002005; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MISCHNA MA, 2003, 6 INT MARS C; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Montmessin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002284; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; Richardson MI, 2002, NATURE, V416, P298, DOI 10.1038/416298a; SHEAN DE, 2004, LUN PLAN SCI C 35; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; [No title captured], DOI DOI 10.1029/2001JE001522	30	161	162	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1072	1075		10.1038/nature03055	http://dx.doi.org/10.1038/nature03055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15510141				2022-12-24	WOS:000224730800033
J	Olson, LE; Richtsmeier, JT; Leszl, J; Reeves, RH				Olson, LE; Richtsmeier, JT; Leszl, J; Reeves, RH			A chromosome 21 critical region does not cause specific down syndrome phenotypes	SCIENCE			English	Article								The "Down syndrome critical region" (DSCR) is a chromosome 21 segment purported to contain genes responsible for many features of Down syndrome (DS), including craniofacial dysmorphology. We used chromosome engineering to create mice that were trisomic or monosomic for only the mouse chromosome segment orthologous to the DSCR and assessed dysmorphologies of the craniofacial skeleton that show direct parallels with DS in mice with a larger segmental trisomy. The DSCR genes were not sufficient and were largely not necessary to produce the facial phenotype. These results refute specific predictions of the prevailing hypothesis of gene action in DS.	Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Genet Program, University Pk, PA 16802 USA	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Reeves, RH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rreeves@jhmi.edu	Olson, Lisa Erin/AGX-7480-2022	Olson, Lisa Erin/0000-0003-0710-7583; Richtsmeier, Joan/0000-0002-0239-5822	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038384] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F33DE005706] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD024605, HD24605, HD38384, R01 HD038384] Funding Source: Medline; NIDCR NIH HHS [F33 DE005706] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		COHEN WI, 1999, DOWN SYNDROME Q, V4, P3; DAVISSON MT, COMMUNICATION; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Kisling E, 1966, CRANIAL MORPHOLOGY D; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; Olson LE, 2003, CANCER RES, V63, P6602; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reeves RH, 2001, TRENDS GENET, V17, P83, DOI 10.1016/S0168-9525(00)02172-7; Richtsmeier J. T., 2001, INTER DISC; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; SHAPIRO BL, 1983, AM J MED GENET, V14, P241, DOI 10.1002/ajmg.1320140206	17	216	221	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					687	690		10.1126/science.1098992	http://dx.doi.org/10.1126/science.1098992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15499018	Green Accepted			2022-12-24	WOS:000224756700052
J	Hess, HA; Roper, JC; Grill, SW; Koelle, MR				Hess, HA; Roper, JC; Grill, SW; Koelle, MR			RGS-7 completes a receptor-independent heterotrimeric G protein regulate mitotic spindle positioning in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; G-ALPHA; POLARITY CUES; ORIENTATION; ASSOCIATION; MECHANISMS; SYNEMBRYN; DIVISIONS; G(O)ALPHA; PARTNER	Heterotrimeric G proteins promote microtubule forces that position mitotic spindles during asymmetric cell division in C. elegans embryos. While all previously studied G protein functions require activation by seven-transmembrane receptors, this function appears to be receptor independent. We found that mutating a regulator of G protein signaling, RGS-7, resulted in hyperasymmetric spindle movements due to decreased force on one spindle pole. RGS-7 is localized at the cell cortex, and its effects require two redundant Galpha(o)-related G proteins and their nonreceptor activators RIC-8 and GPR-1/2. Using recombinant proteins, we found that RIC-8 stimulates GTP binding by Galpha(o) and that the FIGS domain of RGS-7 stimulates GTP hydrolysis by Galpha(o), demonstrating that Galpha(o) passes through the GTP bound state during its activity cycle. While GTPase activators typically inactivate G proteins, RGS-7 instead appears to promote G protein function asymmetrically in the cell, perhaps acting as a G protein effector.	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Max Planck Society; Yale University; Yale University	Koelle, MR (corresponding author), Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany.	michael.koelle@yale.edu	Grill, Stephan/D-9427-2012					Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; CARTY DJ, 1994, METHOD ENZYMOL, V237, P38; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Dong MQ, 2000, GENE DEV, V14, P2003; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Edgley M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf051; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Honda A, 2002, J BIOL CHEM, V277, P20234, DOI 10.1074/jbc.M112080200; Kehrl JH, 2002, GENOMICS, V79, P860, DOI 10.1006/geno.2002.6773; Kelly WG, 1997, GENETICS, V146, P227; Knust E, 2001, CELL, V107, P125, DOI 10.1016/S0092-8674(01)00534-7; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Miller KG, 2000, GENETICS, V156, P1649; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rose LS, 1998, DEVELOPMENT, V125, P1337; Sato M, 2003, LIFE SCI, V73, P917, DOI 10.1016/S0024-3205(03)00355-2; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Tsou MFB, 2002, DEVELOPMENT, V129, P4469; WU HC, 1994, LAB INVEST, V71, P175; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	38	84	87	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					209	218		10.1016/j.cell.2004.09.025	http://dx.doi.org/10.1016/j.cell.2004.09.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479638	Bronze			2022-12-24	WOS:000224577200009
J	Newman, TB				Newman, TB			Treating depression in children: A black-box warning for antidressants in children?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Newman, TB (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.							March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	2	62	63	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1595	1598						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483275				2022-12-24	WOS:000224427300003
J	Stoleru, D; Peng, Y; Agosto, J; Rosbash, M				Stoleru, D; Peng, Y; Agosto, J; Rosbash, M			Coupled oscillators control morning and evening locomotor behaviour of Drosophila	NATURE			English	Article							SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; PACEMAKER NEURONS; CLOCK GENES; PERIOD; BRAIN; MELANOGASTER; NEUROPEPTIDE; LIGHT; PROJECTIONS	Daily rhythms of physiology and behaviour are precisely timed by an endogenous circadian clock(1,2). These include separate bouts of morning and evening activity, characteristic of Drosophila melanogaster and many other taxa, including mammals(3-5). Whereas multiple oscillators have long been proposed to orchestrate such complex behavioural programmes(6), their nature and interplay have remained elusive. By using cell-specific ablation, we show that the timing of morning and evening activity in Drosophila derives from two distinct groups of circadian neurons: morning activity from the ventral lateral neurons that express the neuropeptide PDF, and evening activity from another group of cells, including the dorsal lateral neurons. Although the two oscillators can function autonomously, cell-specific rescue experiments with circadian clock mutants indicate that they are functionally coupled.	Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA.	rosbash@brandeis.edu			NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; HALLIBURTON IW, 1980, J GEN VIROL, V48, P1, DOI 10.1099/0022-1317-48-1-1; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	30	508	518	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					862	868		10.1038/nature02926	http://dx.doi.org/10.1038/nature02926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483615				2022-12-24	WOS:000224435500051
J	Vaniman, DT; Bish, DL; Chipera, SJ; Fialips, CI; Carey, JW; Feldman, WC				Vaniman, DT; Bish, DL; Chipera, SJ; Fialips, CI; Carey, JW; Feldman, WC			Magnesium sulphate salts and the history of water on Mars	NATURE			English	Article							MINERALS; ROCKS	Recent reports of similar to30 wt% of sulphate within saline sediments onMars(1,2)-probably occurring in hydrated form(3)-suggest a role for sulphates in accounting for equatorial H2O observed in a global survey by the Odyssey spacecraft(4). Among salt hydrates likely to be present(3), those of the MgSO4.nH(2)O series have many hydration states. Here we report the exposure of several of these phases to varied temperature, pressure and humidity to constrain their possible H2O contents under martian surface conditions. We found that crystalline structure and H2O content are dependent on temperature-pressure history, that an amorphous hydrated phase with slow dehydration kinetics forms at <1% relative humidity, and that equilibrium calculations may not reflect the true H2O-bearing potential of martian soils. Mg sulphate salts can retain sufficient H2O to explain a portion of the Odyssey observations(5). Because phases in the MgSO4 center dot nH(2)O system are sensitive to temperature and humidity, they can reveal much about the history of water on Mars. However, their ease of transformation implies that salt hydrates collected on Mars will not be returned to Earth unmodified, and that accurate in situ analysis is imperative.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Indiana Univ, Bloomington, IN 47405 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Indiana University System; Indiana University Bloomington	Vaniman, DT (corresponding author), Los Alamos Natl Lab, MS D462, Los Alamos, NM 87545 USA.	vaniman@lanl.gov	Bish, David/AAY-7618-2020; Carey, James/B-4421-2011					Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bish D. L., 2003, 6 INT C MARS; Bish DL, 2003, ICARUS, V164, P96, DOI 10.1016/S0019-1035(03)00140-4; BRUECKNER J, 2004, EOS S, V85; Chipera S.J., 1997, ADV X-RAY ANAL, V39, P713, DOI [10.1154/S0376030800023168, DOI 10.1154/S0376030800023168]; Chou IM, 2003, ASTROBIOLOGY, V3, P619, DOI 10.1089/153110703322610708; CHRISTENSEN PR, 1982, J GEOPHYS RES, V87, P9985, DOI 10.1029/JB087iB12p09985; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1978, ICARUS, V34, P645, DOI 10.1016/0019-1035(78)90052-0; CLARK BC, 1976, SCIENCE, V194, P1283, DOI 10.1126/science.194.4271.1283; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020181; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; FOLEY CN, 2003, J GEOPHYS RES, V108, DOI DOI 10.1019/2002JE002019; Gounelle M, 2001, METEORIT PLANET SCI, V36, P1321, DOI 10.1111/j.1945-5100.2001.tb01827.x; Hawthorne FC, 2000, REV MINERAL GEOCHEM, V40, P1, DOI 10.2138/rmg.2000.40.1; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; SAVIJARVI H, 1995, ICARUS, V117, P120, DOI 10.1006/icar.1995.1146; TAYLOR LA, 1973, P LUNAR PLANET SCI C, P829; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; [No title captured]	23	241	245	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					663	665		10.1038/nature02973	http://dx.doi.org/10.1038/nature02973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470421				2022-12-24	WOS:000224299300033
J	Willer, CJ; Dyment, DA; Sadovnick, AD; Rothwell, PM; Murray, TJ; Ebers, GC				Willer, CJ; Dyment, DA; Sadovnick, AD; Rothwell, PM; Murray, TJ; Ebers, GC		Canadian Collaborative Study Grp	Timing of birth and risk of multiple sclerosis: population based study.	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; SEASON; SKIN; EPIDEMIOLOGY; IMMIGRANTS; BORN; MS	Objectives To determine if risk of multiple sclerosis (MS) is associated with month of birth in countries in the northern hemisphere and if factors related to month of birth interact with genetic risk. Design Population based study with population and family based controls and a retrospective cohort identified from death certificates. A post hoc pooled analysis was carried out for large northern datasets including Sweden and Denmark. Setting 19 MS clinics in major cities across Canada (Canadian collaborative project on the genetic susceptibility to multiple sclerosis); incident cases of MS from a population based study in the Lothian and Border regions of Scotland; and death records from the UK Registrar General. Populations 17 874 Canadian patients mid 11 502 British patients with multiple sclerosis. Main outcome measure Diagnosis of multiple sclerosis. Results In Canada (n = 17 874) significantly fewer patients with MS Were born in November compared with controls from the population census and unaffected siblings. These observations were confirmed in a dataset of British patients (n = 11502), in which there was also an increase in the number of births in May. A pooled analysis of datasets from Canada, Great Britain, Denmark, and Sweden (n = 42 045) showed that significantly fewer (805%) people with MS were born in November mid significantly more (9.1%) were born in May. For recent incident data, the effect of month of birth was most evident in Scotland, where MS prevalence is the highest. Conclusions Month of birth and risk of MS are associated, more so in familial cases, implying interactions between genes and environment that are related to climate. Such interactions may act during gestation or shortly after birth in individuals born in the northern countries studied.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC V6T 2B5, Canada; Dalhousie Univ, Halifax, NS B3H 4R2, Canada	Radcliffe Infirmary; University of Oxford; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; University of British Columbia; University of British Columbia; Dalhousie University	Ebers, GC (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England.	george.ebers@cineuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211; Sadovnick, Dessa/0000-0003-2987-2008; Ebers, George/0000-0003-4771-4177; Willer, Cristen/0000-0001-5645-4966				ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; BRANDA RF, 1978, SCIENCE, V201, P625, DOI 10.1126/science.675247; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; DEAN G, 1967, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.5554.724; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; ELIAN M, 1987, J NEUROL NEUROSUR PS, V50, P327, DOI 10.1136/jnnp.50.3.327; FAWCETT J, 1988, NEUROLOGY, V38, P416, DOI 10.1212/WNL.38.3.416; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; HOLICK MF, 1987, ARCH DERMATOL, V123, P1677, DOI 10.1001/archderm.123.12.1677; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; McGrath JJ, 2004, J STEROID BIOCHEM, V89-90, P557, DOI 10.1016/j.jsbmb.2004.03.070; MCLEOD JG, 1994, MED J AUSTRALIA, V160, P117, DOI 10.5694/j.1326-5377.1994.tb126553.x; Rothwell PM, 1998, J NEUROL NEUROSUR PS, V64, P730, DOI 10.1136/jnnp.64.6.730; Sadovnick AD, 1998, CAN J NEUROL SCI, V25, P216, DOI 10.1017/S0317167100034041; SADOVNICK AD, 1994, ACTA NEUROL SCAND, V89, P190; Salemi G, 2000, ACTA NEUROL SCAND, V101, P381, DOI 10.1034/j.1600-0404.2000.90336.x; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Vieth R, 2001, EUR J CLIN NUTR, V55, P1901; Wiberg MA, 1994, J ORTHOMOL MED, V9, P71; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	25	335	343	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2005	330	7483					120	123		10.1136/bmj.38301.686030.63	http://dx.doi.org/10.1136/bmj.38301.686030.63			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15585537	Green Published, Bronze			2022-12-24	WOS:000226454900016
J	Khunti, K; Samani, NJ				Khunti, K; Samani, NJ			Coronary heart disease in people of south-Asian origin	LANCET			English	Editorial Material							TYPE-2 DIABETES-MELLITUS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HYPERTENSION; CHILDREN		Univ Leicester, Dept Hlth Sci, Leicester LE5 4PW, Leics, England	University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE5 4PW, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099				Anand S S, 2000, Indian Heart J, V52, pS35; BHATNAGAR D, 1995, LANCET, V345, P405; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; PETERSEN S, 2004, CORONARY HEAT DIS ST; *S AS HLTH FDN UK, 2004, PREV TREATM REH CARD; Saxena S, 2004, ARCH DIS CHILD, V89, P30; SHAUKAT N, 1995, FIBRINOLYSIS, V9, P55, DOI 10.1016/S0268-9499(08)80046-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; WILLIAMS B, 1995, LANCET, V345, P401, DOI 10.1016/S0140-6736(95)90394-1	12	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2077	2078		10.1016/S0140-6736(04)17563-6	http://dx.doi.org/10.1016/S0140-6736(04)17563-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589295				2022-12-24	WOS:000225742300006
J	Frank, MJ; Seeberger, LC; O'Reilly, RC				Frank, MJ; Seeberger, LC; O'Reilly, RC			By carrot or by stick: Cognitive reinforcement learning in Parkinsonism	SCIENCE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DOPAMINERGIC MEDICATION; DISEASE; REWARD; STRIATUM; INHIBITION; RECEPTORS; HUMANS	To what extent do we learn from the positive versus negative outcomes of our decisions? The neuromodulator dopamine plays a key role in these reinforcement learning processes. Patients with Parkinson's disease, who have depleted dopamine in the basal ganglia, are impaired in tasks that require learning from trial and error. Here, we show, using two cognitive procedural learning tasks, that Parkinson's patients off medication are better at learning to avoid choices that lead to negative outcomes than they are at learning from positive outcomes. Dopamine medication reverses this bias, making patients more sensitive to positive than negative outcomes. This pattern was predicted by our biologically based computational model of basal ganglia-dopamine interactions in cognition, which has separate pathways for "Go" and "NoGo" responses that are differentially modulated by positive and negative reinforcement.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; Colorado Neurol Inst, Movement Disorders Ctr, Englewood, CO 80113 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Frank, MJ (corresponding author), Univ Colorado, Dept Psychol, Boulder, CO 80309 USA.	frankmj@psych.colorado.edu; oreilly@psych.colorado.edu	O'Reilly, Randall/A-5819-2008; Frank, Michael J/B-2979-2008		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069597] Funding Source: NIH RePORTER; NIMH NIH HHS [MH069597-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Aubert I, 2000, J COMP NEUROL, V418, P22; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delius JD, 1998, BEHAV PROCESS, V42, P107, DOI 10.1016/S0376-6357(97)00072-7; FRANK M, IN PRESS J COGNIT NE; FRANK M, IN PRESS MEM COGNIT; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2003, HIPPOCAMPUS, V13, P341, DOI 10.1002/hipo.10084; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.ne.15.030192.001441; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Kaasinen V, 2001, P NATL ACAD SCI USA, V98, P13272, DOI 10.1073/pnas.231313198; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nishi A, 1997, J NEUROSCI, V17, P8147; OREILLY RC, 2004, ICS TECH REP U COLOR; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Shohamy D, 2004, BRAIN, V127, P851, DOI 10.1093/brain/awh100; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Tomer R, 2004, J NEUROL NEUROSUR PS, V75, P972, DOI 10.1136/jnnp.2003.024885; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; VONFERSEN L, 1991, J EXP PSYCHOL ANIM B, V17, P334, DOI 10.1037/0097-7403.17.3.334; Wickens J, 1997, NETWORK-COMP NEURAL, V8, pR77, DOI 10.1088/0954-898X/8/4/001; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WYNNE CDL, 1995, ANIM LEARN BEHAV, V23, P207, DOI 10.3758/BF03199936; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	34	1308	1322	7	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1940	1943		10.1126/science.1102941	http://dx.doi.org/10.1126/science.1102941			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	879DC	15528409	Green Submitted			2022-12-24	WOS:000225695600046
J	Smith, MD; Wolff, MJ; Lemmon, MT; Spanovich, N; Banfield, D; Budney, CJ; Clancy, RT; Ghosh, A; Landis, GA; Smith, P; Whitney, B; Christensen, PR; Squyres, SW				Smith, MD; Wolff, MJ; Lemmon, MT; Spanovich, N; Banfield, D; Budney, CJ; Clancy, RT; Ghosh, A; Landis, GA; Smith, P; Whitney, B; Christensen, PR; Squyres, SW			First atmospheric science results from the Mars exploration rovers Mini-TES	SCIENCE			English	Article							THERMAL EMISSION SPECTROMETER; ATMOSPHERIC TEMPERATURES; AEROBRAKING	Thermal infrared spectra of the martian atmosphere taken by the Miniature Thermal Emission Spectrometer (Mini-TES) were used to determine the atmospheric temperatures in the planetary boundary layer and the column-integrated optical depth of aerosols. Mini-TES observations show the diurnal variation of the martian boundary layer thermal structure, including a near-surface superadiabatic layer during the afternoon and an inversion layer at night. Upward-looking Mini-TES observations show warm and cool parcels of air moving through the Mini-TES field of view on a time scale of 30 seconds. The retrieved dust optical depth shows a downward trend at both sites.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Boulder, CO 80301 USA; Texas A&M Univ, College Stn, TX 77843 USA; Univ Arizona, Tucson, AZ 85721 USA; Cornell Univ, Ithaca, NY 14853 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Arizona State Univ, Tempe, AZ 85287 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Texas A&M University System; Texas A&M University College Station; University of Arizona; Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Arizona State University; Arizona State University-Tempe	Smith, MD (corresponding author), NASA, Goddard Space Flight Ctr, Code 661, Greenbelt, MD 20771 USA.	Michael.D.Smith@nasa.gov	Lemmon, Mark T/E-9983-2010; Banfield, Don J/I-3523-2018; Lemmon, Mark/X-2333-2019; Smith, Michael/C-8875-2012	Lemmon, Mark T/0000-0002-4504-5136; Banfield, Don J/0000-0003-2664-0164; Lemmon, Mark/0000-0002-4504-5136; 				Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Conrath BJ, 2000, J GEOPHYS RES-PLANET, V105, P9509, DOI 10.1029/1999JE001095; Hess S. L., 1977, Journal of Geophysical Research, V82, P4559, DOI 10.1029/JS082i028p04559; Murphy JR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015214; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Smith MD, 2000, J GEOPHYS RES-PLANET, V105, P9539, DOI 10.1029/1999JE001097; Smith MD, 1996, ICARUS, V124, P586, DOI 10.1006/icar.1996.0232; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001522; Wolff MJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002057	10	90	90	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1750	1753		10.1126/science.1104257	http://dx.doi.org/10.1126/science.1104257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576612				2022-12-24	WOS:000225630800044
J	Stuart, SN; Chanson, JS; Cox, NA; Young, BE; Rodrigues, ASL; Fischman, DL; Waller, RW				Stuart, SN; Chanson, JS; Cox, NA; Young, BE; Rodrigues, ASL; Fischman, DL; Waller, RW			Status and trends of amphibian declines and extinctions worldwide	SCIENCE			English	Article							POPULATION DECLINES; CENTRAL-AMERICA; CLIMATE; TOAD; BIODIVERSITY; MORTALITY; DISEASE; FROGS	The first global assessment of amphibians provides new context for the well-publicized phenomenon of amphibian declines. Amphibians are more threatened and are declining more rapidly than either birds or mammals. Although many declines are due to habitat loss and overutilization, other, unidentified processes threaten 48% of rapidly declining species and are driving species most quickly to extinction. Declines are nonrandom in terms of species' ecological preferences, geographic ranges, and taxonomic associations and are most prevalent among Neotropicai montane, stream-associated species. The lack of conservation remedies for these poorly understood declines means that hundreds of amphibian species now face extinction.	IUCN Species Survival Commiss Conservat, Int Ctr Appl Biodivers Sci, Biodivers Assessment Unit, Washington, DC 20036 USA; Natureserve, Monteverde, Puntarenas, Costa Rica; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA	Conservation International	Stuart, SN (corresponding author), IUCN Species Survival Commiss Conservat, Int Ctr Appl Biodivers Sci, Biodivers Assessment Unit, 1919 M St NW, Washington, DC 20036 USA.	s.stuart@conservation.org	Fapesp, Biota/F-8655-2017; Rodrigues, Ana/GYQ-6273-2022; Rodrigues, Ana S.L./A-5914-2009	Fapesp, Biota/0000-0002-9887-8449; Rodrigues, Ana S.L./0000-0003-4775-0127				Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BirdLife International, 2004, STAT WORLDS BIRDS IN; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; CZECHURA G V, 1990, Memoirs of the Queensland Museum, V29, P361; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; DROST CA, 1996, CONSERV BIOL, V10, P415; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; IUCN CONSERVATION INTERNATIONAL AND NATURESERVE, 2004, GLOB AMPH ASS; *IUCN WORLD CONS U, 2003, 2003 IUCN RED LIST T; IUCN - The World Conservation Union, 2001, IUCN RED LIST CAT CR; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lynch John D., 1998, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V22, P149; Magin C, 2003, ORYX, V37, P406; MANZANILLA J, 2004, MEM FUND LA SALLE CI, V62, P5; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; Ron SR, 2003, J HERPETOL, V37, P116, DOI 10.1670/0022-1511(2003)037[0116:PDOTJT]2.0.CO;2; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	30	2998	3322	30	1316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1783	1786		10.1126/science.1103538	http://dx.doi.org/10.1126/science.1103538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15486254	Green Submitted			2022-12-24	WOS:000225630800055
J	Hofman, PL; Regan, F; Jackson, WE; Jefferies, C; Knight, DB; Robinson, EM; Cutfield, WS				Hofman, PL; Regan, F; Jackson, WE; Jefferies, C; Knight, DB; Robinson, EM; Cutfield, WS			Premature birth and later insulin resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADULT DISEASE; FETAL-GROWTH; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; PRENATAL EXPOSURE; BLOOD-PRESSURE; SYNDROME-X; CHILDREN; WEIGHT; SENSITIVITY	Background: Term infants who are small for gestational age appear prone to the development of insulin resistance during childhood. We hypothesized that insulin resistance, a marker of type 2 diabetes mellitus, would be prevalent among children who had been born prematurely, irrespective of whether they were appropriate for gestational age or small for gestational age. Methods: Seventy-two healthy prepubertal children 4 to 10 years of age were studied: 50 who had been born prematurely (32 weeks' gestation or less), including 38 with a birth weight that was appropriate for gestational age (above the 10th percentile) and 12 with a birth weight that was low (i.e., who were small) for gestational age, and 22 control subjects (at least 37 weeks' gestation, with a birth weight above the 10th percentile). Insulin sensitivity was measured with the use of paired insulin and glucose data obtained by frequent measurements during intravenous glucose-tolerance tests. Results: Children who had been born prematurely, whether their weight was appropriate or low for gestational age, had an isolated reduction in insulin sensitivity as compared with controls (appropriate-for-gestational-age group, 14.2 x 10(-4) per minute per milliunit per liter [95 percent confidence interval, 11.5 to 16.2]; small-for-gestational-age group, 12.9 x 10(-4) per minute per milliunit per liter [95 percent confidence interval, 9.7 to 17.4]; and control group, 21.6 x 10(-4) per minute per milliunit per liter [95 percent confidence interval, 17.1 to 27.4]; P=0.002). There were no significant differences in insulin sensitivity between the two premature groups (P=0.80). As compared with controls, both groups of premature children had a compensatory increase in acute insulin release (appropriate-for-gestational-age group, 2002 pmol per liter [95 percent confidence interval, 2153 to 2432]; small-for-gestational-age group, 2253 pmol per liter [95 percent confidence interval, 1622 to 3128]; and control group, 1148 pmol per liter [95 percent confidence interval, 875 to 1500]; P<0.001). Conclusions: Like children who were born at term but who were small for gestational age, children who were born prematurely have an isolated reduction in insulin sensitivity, which may be a risk factor for type 2 diabetes mellitus.	Univ Auckland, Fac Med & Hlth Sci, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Dept Community Hlth, Hlth Res Council Biostat Unit, Auckland 1, New Zealand; Natl Womens Hosp Neonatal Unit, Auckland, New Zealand	University of Auckland; University of Auckland	Hofman, PL (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Liggins Inst, Private Bag 92019, Auckland 1, New Zealand.	p.hofman@auckland.ac.nz	Knight, David B/F-7437-2011; Jefferies, craig/ABA-1921-2021	Jackson, Wendy/0000-0001-5723-1131; Jefferies, Craig/0000-0002-0541-6094				*AUCKL DISTR HLTH, 2004, NEWB SERV NAT WOM AN; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Barker DJP, 1997, CLIN OBSTET GYNECOL, V40, P853, DOI 10.1097/00003081-199712000-00019; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Bazaes RA, 2004, J CLIN ENDOCR METAB, V89, P1267, DOI 10.1210/jc.2003-031239; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Boyko EJ, 2000, DIABETES CARE, V23, P1260, DOI 10.2337/diacare.23.9.1260; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CUTFIELD WS, 1990, J CLIN ENDOCR METAB, V70, P1644, DOI 10.1210/jcem-70-6-1644; DURANT RH, 1981, J AM DIET ASSOC, V78, P35; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Gray IP, 2002, J CLIN ENDOCR METAB, V87, P4252, DOI 10.1210/jc.2001-011961; GRUNFELD B, 1994, HYPERTENSION S1, V23, P12; GUARAN RL, 1994, AUST NZ J OBSTET GYN, V34, P39, DOI 10.1111/j.1479-828X.1994.tb01037.x; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; MCLAREN DS, 1975, LANCET, V2, P219; Nyirenda MJ, 2001, J ENDOCRINOL, V170, P653, DOI 10.1677/joe.0.1700653; Petry CJ, 2000, HORM METAB RES, V32, P233, DOI 10.1055/s-2007-978627; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Scherrer U, 1997, CIRCULATION, V96, P4104; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83	32	438	457	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2004	351	21					2179	2186		10.1056/NEJMoa042275	http://dx.doi.org/10.1056/NEJMoa042275			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	871UU	15548778				2022-12-24	WOS:000225160600008
J	Austin, CP; Brady, LS; Insel, TR; Collins, FS				Austin, CP; Brady, LS; Insel, TR; Collins, FS			NIH Molecular Libraries Initiative	SCIENCE			English	Editorial Material							DRUG DISCOVERY; HUMAN GENOME; INNOVATION; BIOLOGY		NHGRI, NIH, Bethesda, MD 20892 USA; NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Austin, CP (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	austinc@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319, ZIAHG200319, Z01HG200319] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Austin CP, 2003, CURR OPIN CHEM BIOL, V7, P511, DOI 10.1016/S1367-5931(03)00083-8; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2004, NAT REV DRUG DISCOV, V3, P640, DOI 10.1038/nrd1488; Couzin J, 2003, SCIENCE, V302, P218, DOI 10.1126/science.302.5643.218; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; JANSSEN D, 2004, BIO IT WORLD, V3, P1; Kaiser J, 2004, SCIENCE, V304, P1728; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Savchuk NP, 2004, CURR OPIN CHEM BIOL, V8, P412, DOI 10.1016/j.cbpa.2004.06.003; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	13	286	296	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2004	306	5699					1138	1139		10.1126/science.1105511	http://dx.doi.org/10.1126/science.1105511			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872FM	15542455				2022-12-24	WOS:000225193100031
J	Chamberlain, JS				Chamberlain, JS			Cachexia in cancer - Zeroing in on myosin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Sch Med, Senator Paul D Wellstone Muscular Dystrophy Coope, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chamberlain, JS (corresponding author), Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA.			Chamberlain, Jeffrey/0000-0001-5299-0059				Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Rubin H, 2003, P NATL ACAD SCI USA, V100, P5384, DOI 10.1073/pnas.0931260100; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3	4	37	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2004	351	20					2124	2125		10.1056/NEJMcibr042889	http://dx.doi.org/10.1056/NEJMcibr042889			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	869TM	15537911				2022-12-24	WOS:000225007200017
J	Garner, EC; Campbell, CS; Mullins, RD				Garner, EC; Campbell, CS; Mullins, RD			Dynamic instability in a DNA-segregating prokaryotic actin homolog	SCIENCE			English	Article							FORMIN-INDUCED NUCLEATION; PLASMID R1; ESCHERICHIA-COLI; MECHANISM; PARM; POLYMERIZATION; HYDROLYSIS; FILAMENTS; PROTEIN; ATP	Dynamic instability-the switching of a two-state polymer between phases of steady elongation and rapid shortening-is essential to the cellular function of eukaryotic microtubules, especially during chromosome segregation. Since the discovery of dynamic instability 20 years ago, no other biological polymer has been found to exhibit this behavior. Using total internal reflection fluorescence microscopy and fluorescence resonance energy transfer, we observe that the prokaryotic actin homolog ParM, whose assembly is required for the segregation of large, low-copy number plasmids, displays both dynamic instability and symmetrical, bidirectional polymerization. The dynamic instability of ParM is regulated by adenosine triphosphate (ATP) hydrolysis, and filaments are stabilized by a cap of ATP-bound monomers. ParM is not related to tubulin, so its dynamic instability must have arisen by convergent evolution driven by a set of common constraints on polymer-based segregation of,DNA.	Univ Calif San Francisco, San Francisco, CA 94107 USA	University of California System; University of California San Francisco	Mullins, RD (corresponding author), Univ Calif San Francisco, 600 16th St, San Francisco, CA 94107 USA.	dyche@muttinslab.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555; Campbell, Christopher/0000-0002-3927-344X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061010] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61010-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Jensen RB, 1999, EMBO J, V18, P4076, DOI 10.1093/emboj/18.14.4076; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; MANDELKOW EM, 1988, EMBO J, V7, P357, DOI 10.1002/j.1460-2075.1988.tb02821.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; NORDSTROM K, 1972, J BACTERIOL, V110, P562; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Panda D, 2002, BIOCHEMISTRY-US, V41, P1609, DOI 10.1021/bi011767m; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; WENDEL H, 1987, BIOCHIM BIOPHYS ACTA, V915, P199, DOI 10.1016/0167-4838(87)90300-1; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	27	217	220	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1021	1025		10.1126/science.1101313	http://dx.doi.org/10.1126/science.1101313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15528442				2022-12-24	WOS:000225001100040
J	Smetacek, V; Mechsner, F				Smetacek, V; Mechsner, F			Making sense	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Inst Occupat Physiol, D-44139 Dortmund, Germany; Inst Adv Study, Delmenhorst, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Cole J., 1995, PRIDE DAILY MARATHON; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Smetacek V, 2002, NATURE, V415, P481, DOI 10.1038/415481a	4	20	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					21	21		10.1038/432021a	http://dx.doi.org/10.1038/432021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15525964	Bronze			2022-12-24	WOS:000224854900022
J	Singh, JA				Singh, JA			Why AIDS in South Africa threatens stability and economic growth in other parts of Africa	LANCET			English	Editorial Material									Ctr AIDS Programme Res S Africa CAPRISA, Durban, South Africa; Univ KwaZulu Natal, Howard Coll Sch Law, ZA-4041 Durban, South Africa; Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	University of Kwazulu Natal; University of Toronto	Singh, JA (corresponding author), Ctr AIDS Programme Res S Africa CAPRISA, Durban, South Africa.	singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					*DEP DEF S AFR, 2004, PROJ PHID UPD B; *DEP DEF S AFR, 2002, CURR STAT HIV EP SA; *DEP DEF S AFR, MAS CAMP; *DEP HLTH S AFR, 2003, NAT HIV SYPH ANT SER; *PIC HEADL, 2004, HLTH ED ENV DEC DEM; *S AFR PRESS ASS, 2004, AFR BREEDS TERR SAYS; *STAT S AFR, CENS 2001; *UN POP FUND, 2004, UNFPA STAT WORLD POP; VERMUELEN A, 2004, S AFRICA CORPORATE F	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV-DEC	2004	364	9449					1919	1920		10.1016/S0140-6736(04)17491-6	http://dx.doi.org/10.1016/S0140-6736(04)17491-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874BX	15566993				2022-12-24	WOS:000225327000007
J	Viner, R; Hotopf, M				Viner, R; Hotopf, M			Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; HISTORY; ILLNESS; CARE	Objective To study childhood risk factors for chronic fatigue syndrome in adult life. Design Examination of data from the 1970 British birth cohort Participants 16 567 babies born 5-11 April 1970, followed up at 5, 10, 16, and 29-30 years. Main outcome measures Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) identified by self report at age 30 years. Data from childhood from questionnaires given to parents and teachers. Maternal mental health assessed with the malaise inventory. Results 93 (0.8%. 95% confidence interval 0.7 to 1.0) of 11261 participants reported ever having CFS/ME, and 48 (0.4%, 0.3 to 0.6) had the condition currently. Higher risk of CFS/ME was associated with having a limiting longstanding condition in childhood (odds ratio 2.3, 1.4 to 3.9), female sex (2.3, 1.4 to 2.6), and high social class in childhood (2.2, 1.4 to 3.5). Higher levels of exercise in childhood were associated with lower risk (0.5, 0.2 to 0.9). Maternal psychological disorder, psychological problems in childhood, birth weight, birth order, atopy, obesity, school absence, academic ability. and parental illness were not associated with risk of CFS/ME. Conclusions We identified no association between maternal or child psychological distress, academic ability, parental illness, atopy, or birth order and increasing risk of lifetime CFS/ME. Sedentary behaviour increased the risk.	Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Paediat, London W1T 3AA, England; Inst Psychiat, Dept Psychol Med, London SE5 8AF, England	University of London; University College London; University of London; King's College London	Viner, R (corresponding author), Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Paediat, London W1T 3AA, England.	R.Viner@ich.ucl.ac.uk	Hotopf, Matthew/E-4971-2010; Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247; Hotopf, Matthew/0000-0002-3980-4466				Brimacombe M, 2002, HUM BIOL, V74, P615, DOI 10.1353/hub.2002.0038; BYNNER J, 2002, 1 CLS I ED; Chalder T, 2003, BRIT MED J, V327, P654, DOI 10.1136/bmj.327.7416.654; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Elliot C. D., 1983, BRIT ABILITY SCALES; Endicott NA, 1998, PSYCHOSOM MED, V60, P744, DOI 10.1097/00006842-199811000-00017; Euba R, 1996, BRIT J PSYCHIAT, V168, P121, DOI 10.1192/bjp.168.1.121; Fisher L, 2003, J PSYCHOSOM RES, V54, P439, DOI 10.1016/S0022-3999(02)00458-0; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Garralda E, 1999, J AM ACAD CHILD PSY, V38, P1515, DOI 10.1097/00004583-199912000-00012; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hall GJ, 1998, J ROY COLL PHYS LOND, V32, P44; HART JG, 1982, BR J ED PSYCHOL, V22, P167; Hotopf M, 1996, J NEUROL NEUROSUR PS, V60, P504, DOI 10.1136/jnnp.60.5.504; Irving B, 2002, PREDICTING ADOLESCEN; Krilov LR, 1998, PEDIATRICS, V102, P360, DOI 10.1542/peds.102.2.360; Levine PH, 1997, J PSYCHIATR RES, V31, P7, DOI 10.1016/S0022-3956(96)00058-1; MacDonald KL, 1996, AM J MED, V100, P548, DOI 10.1016/S0002-9343(96)00017-4; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; Salit IE, 1997, J PSYCHIATR RES, V31, P59, DOI 10.1016/S0022-3956(96)00050-7; Sullivan PF, 2003, PSYCHOL MED, V33, P263, DOI 10.1017/S0033291702007031; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6	23	70	72	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 23	2004	329	7472					941	943		10.1136/bmj.38258.507928.55	http://dx.doi.org/10.1136/bmj.38258.507928.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15469945	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000224773200014
J	Ahlgren, M; Melbye, M; Wohlfahrt, J; Sorensen, TIA				Ahlgren, M; Melbye, M; Wohlfahrt, J; Sorensen, TIA			Growth patterns and the risk of breast cancer in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH CHARACTERISTICS; DANISH MEASUREMENTS; SEXED TWINS; YOUNG-WOMEN; HEIGHT; WEIGHT; CHILDHOOD; POPULATION; COHORT; NORWAY	BACKGROUND: Adult height and body-mass index influence the risk of breast cancer in women. Whether these associations reflect growth patterns of the fetus or growth during childhood and adolescence is unknown. METHODS: We investigated the association between growth during childhood and the risk of breast cancer in a cohort of 117,415 Danish women. Birth weight, age at menarche, and annual measurements of height and weight were obtained from school health records. We used the data to model individual growth curves. Information on vital status, age at first childbirth, parity, and diagnosis of breast cancer was obtained through linkages to national registries. RESULTS: During 3,333,359 person-years of follow-up, 3340 cases of breast cancer were diagnosed. High birth weight, high stature at 14 years of age, low body-mass index (BMI) at 14 years of age, and peak growth at an early age were independent risk factors for breast cancer. Height at 8 years of age and the increase in height during puberty (8 to 14 years of age) were also associated with breast cancer. The attributable risks of birth weight, height at 14 years of age, BMI at 14 years of age, and age at peak growth were 7 percent, 15 percent, 15 percent, and 9 percent, respectively. No effect of adjusting for age at menarche, age at first childbirth, and parity was observed. CONCLUSIONS: Birth weight and growth during childhood and adolescence influence the risk of breast cancer.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Copenhagen Univ Hosp, Inst Prevent Med, Danish Epidemiol Sci Ctr, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Aarhus University; University of Copenhagen	Ahlgren, M (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	abk@ssi.dk		melbye, mads/0000-0001-8264-6785				Ahlgren M, 2003, INT J CANCER, V107, P997, DOI 10.1002/ijc.11481; Andersson SW, 2001, BRIT J CANCER, V84, P1193, DOI 10.1054/bjoc.2000.1738; De Stavola BL, 2000, BRIT J CANCER, V83, P964, DOI 10.1054/bjoc.2000.1370; Ekbom A, 1997, JNCI-J NATL CANCER I, V89, P71, DOI 10.1093/jnci/89.1.71; EKBOM A, 1992, LANCET, V340, P1015, DOI 10.1016/0140-6736(92)93019-J; Friedenreich CM, 2001, EUR J CANCER PREV, V10, P15, DOI 10.1097/00008469-200102000-00003; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; Herrinton LJ, 2001, AM J EPIDEMIOL, V154, P618, DOI 10.1093/aje/154.7.618; Hilakivi-Clarke L, 2001, BRIT J CANCER, V85, P1680, DOI 10.1054/bjoc.2001.2109; Howard BA, 2000, J MAMMARY GLAND BIOL, V5, P119, DOI 10.1023/A:1026487120779; Hubinette A, 2001, INT J CANCER, V91, P248, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1025>3.3.CO;2-H; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; Kaijser M, 2001, J NATL CANCER I, V93, P60, DOI 10.1093/jnci/93.1.60; KVALE G, 1988, CANCER-AM CANCER SOC, V62, P1625, DOI 10.1002/1097-0142(19881015)62:8<1625::AID-CNCR2820620828>3.0.CO;2-K; LEMARCHAND L, 1988, BRIT J CANCER, V57, P437, DOI 10.1038/bjc.1988.99; LEMARCHAND L, 1988, AM J EPIDEMIOL, V128, P137; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Petersen Tove Anne-Grete, 2002, Ugeskr Laeger, V164, P5006; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Rasmussen Soren, 2002, Ugeskr Laeger, V164, P5011; Rostgaard K, 2000, CANCER CAUSE CONTROL, V11, P669, DOI 10.1023/A:1008928204121; Russo J, 1999, ONCOL RES, V11, P169; Sanderson M, 1998, PAEDIATR PERINAT EP, V12, P397; Sanderson M, 2002, BRIT J CANCER, V86, P84, DOI 10.1038/sj.bjc.6600009; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; SAS Institute, 2003, SAS STAT US GUID VER; Storm HH, 1997, DAN MED BULL, V44, P535; Titus-Ernstoff L, 2002, CANCER EPIDEM BIOMAR, V11, P207; TRETLI S, 1989, INT J CANCER, V44, P23, DOI 10.1002/ijc.2910440105; Vatten LJ, 2002, BRIT J CANCER, V86, P89, DOI 10.1038/sj.bjc.6600011; 2003, STATA BASE REFERENCE	35	294	303	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1619	1626		10.1056/NEJMoa040576	http://dx.doi.org/10.1056/NEJMoa040576			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483280				2022-12-24	WOS:000224427300008
J	Briffa, JP				Briffa, JP			The prince and the professor - Which emperor is naked?	BRITISH MEDICAL JOURNAL			English	Letter												drjbriffa@aol.com						Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118; VARMAN S, 2004, BRAVO ELECT RESPONSE	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					858	858		10.1136/bmj.329.7470.858	http://dx.doi.org/10.1136/bmj.329.7470.858			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472283	Green Published			2022-12-24	WOS:000224472800039
J	Espagne, E; Dupuy, C; Huguet, E; Cattolico, L; Provost, B; Martins, N; Poirie, M; Periquet, G; Drezen, JM				Espagne, E; Dupuy, C; Huguet, E; Cattolico, L; Provost, B; Martins, N; Poirie, M; Periquet, G; Drezen, JM			Genome sequence of a polydnavirus: Insights into symbiotic virus evolution	SCIENCE			English	Article							KAPPA-B; GENE; WASP; PARASITOIDS; INHIBITION; RESISTANCE; PROTEINS; FAMILIES; ORIGINS	Little is known of the fate of viruses involved in long-term obligatory associations with eukaryotes. For example, many species of parasitoid wasps have symbiotic viruses to manipulate host defenses and to allow development of parasitoid larvae. The complete nucleotide sequence of the DNA enclosed in the virus particles injected by a parasitoid wasp revealed a complex organization, resembling a eukaryote genomic region more than a viral genome. Although endocellular symbiont genomes have undergone a dramatic loss of genes, the evolution of symbiotic viruses appears to be characterized by extensive duplication of virulence genes coding for truncated versions of cellular proteins.	UFR Sci & Tech, Inst Rech Biol Insecte, CNRS, UMR 6035,UFR Sci & Tech, F-37200 Tours, France; Natl Ctr Sequencage, Genoscope, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS)	Dupuy, C (corresponding author), UFR Sci & Tech, Inst Rech Biol Insecte, CNRS, UMR 6035,UFR Sci & Tech, Parc Grandrnont, F-37200 Tours, France.	catherine.dupuy@univ-tours.fr	Dupuy, Catherine/AFK-5583-2022; martins, natalia florencio/AAE-7875-2019; Espagne, Eric/GMX-2417-2022; Espagne, Eric/AAF-9794-2019; POIRIE, MARYLENE/A-2909-2009; Huguet, Elisabeth/D-3321-2009	Dupuy, Catherine/0000-0002-3947-3580; Huguet, Elisabeth/0000-0002-0096-0330; Espagne, Eric/0000-0002-5813-498X; Drezen, Jean-Michel/0000-0001-7578-635X				Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BECKAGE NE, 1993, INSECT BIOCHEM MOLEC, V23, P643, DOI 10.1016/0965-1748(93)90038-T; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Belle E, 2002, J VIROL, V76, P5793, DOI 10.1128/JVI.76.11.5793-5796.2002; CLEM RJ, 1994, J VIROL, V68, P6759, DOI 10.1128/JVI.68.10.6759-6762.1994; Dahlman DL, 2003, INSECT MOL BIOL, V12, P527, DOI 10.1046/j.1365-2583.2003.00439.x; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Deng LQ, 2000, VIROLOGY, V269, P440, DOI 10.1006/viro.2000.0248; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Einerwold J, 2001, BIOCHEMISTRY-US, V40, P14404, DOI 10.1021/bi011499s; ESPAGNE E, UNPUB; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; PROVOST B, IN PRESS J VIROL; Revilla Y, 1998, J BIOL CHEM, V273, P5405, DOI 10.1074/jbc.273.9.5405; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Stasiak K, 2000, J GEN VIROL, V81, P3059, DOI 10.1099/0022-1317-81-12-3059; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; Teramato T, 2003, J INSECT PHYSIOL, V49, P463, DOI 10.1016/S0022-1910(03)00063-5; Turnbull M, 2002, ADV VIRUS RES, V58, P203, DOI 10.1016/S0065-3527(02)58006-4; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; WEBB BA, 2002, VIRUS TAXONOMY, P253; Whitfield JB, 1997, NATURWISSENSCHAFTEN, V84, P502, DOI 10.1007/s001140050434; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; WHITFIELD JB, 1990, PARASITOL TODAY, V6, P381, DOI 10.1016/0169-4758(90)90146-U	33	200	215	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					286	289		10.1126/science.1103066	http://dx.doi.org/10.1126/science.1103066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472078				2022-12-24	WOS:000224419700043
J	Coleman, EA; Berenson, RA				Coleman, EA; Berenson, RA			Lost in transition: Challenges and opportunities for improving the quality of transitional care	ANNALS OF INTERNAL MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; OLDER PATIENTS; HOSPITAL-CARE; FOLLOW-UP; DISCHARGE; INTERVENTION; NEEDS	Transitional care has been defined as a set of actions designed to ensure the coordination and continuity of health care as patients transfer between different locations or different levels of care in the same location. Transitional care, which primarily concerns the relatively brief time interval that begins with preparing a patient to leave one setting and concludes when the patient is received in the next setting, poses challenges that distinguish it from other types of care. Many transitions are unplanned, result from unanticipated medical problems, occur in "real time" during nights and on weekends, involve clinicians who may not have an ongoing relationship with the patient, and happen so quickly that formal and informal support mechanisms cannot respond in a timely manner. This article describes the challenges involved in and potential solutions for improving the quality of transitional care.	Univ Colorado, Div Hlth Care Policy & Res, Hlth Sci Ctr, Aurora, CO 80011 USA; Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Urban Institute	Coleman, EA (corresponding author), Univ Colorado, Div Hlth Care Policy & Res, Hlth Sci Ctr, 13611 E Colfax,Suite 100, Aurora, CO 80011 USA.	Eric.Coleman@uchsc.edu						*AG HEALTHC RES QU, 2000, MED ERR SCOP PROBL; *ASTM INT MASS MED, CONT CAR REC CCR CON; Bazzoli GJ, 2003, HEALTH AFFAIR, V22, P40, DOI 10.1377/hlthaff.22.6.40; BEERS MH, 1992, HOSP FORMUL, V27, P720; BREWSTER L, EMERGENCY ROOM DIVER; Burns LR, 2002, HEALTH AFFAIR, V21, P128, DOI 10.1377/hlthaff.21.4.128; *CAL HLTH CAR FDN, RES PAT EV PERF PEP; Centers for Medicare and Medicaid Services, HEALTHC COMM PROC CO; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Coleman EA, 2004, J AM GERIATR SOC, V52, pS1; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; COLEMAN EA, 2004, IN PRESS HLTH SERV R; COLEMAN EA, 2004, IN PRESS MED CARE; COLEMAN EA, 2002, ASP TRANS CAR C P; COLEMAN EA, 2002, DEV TESTING MEASURE; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Einstadter D, 1996, J GEN INTERN MED, V11, P684, DOI 10.1007/BF02600160; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Harrison A, 2002, HEALTH SERV RES, V37, P1031, DOI 10.1034/j.1600-0560.2002.64_2.x; *HMO CAR MAN WORKG, ON PAT MAN PLAC MAN; *I MED COMM DAT ST, 2001, KEY CAP EL HLTH REC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; *JOINT COMM ACCR H, 2001, STAND INT STAT 1, P69; Katz T.F., 2000, ANN LONG TERM CARE, V8, P51; KRAMER A, 2003, SUMMARY STATUS ELECT, P1; LEVINE C, 1998, CROSSINGS FAMILY CAR; *MED PAYM ADV COMM, 2003, US MARK COMP FEE FOR, P131; *MED PAYM ADV COMM, US INC IMPR QUAL CAR; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Partnership for Solutions, 2002, CHRON COND MAK CAS O; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; *US DEP HHS OFF IN, 1997, US DEP HLTH HUM SERV; vom Eigen KA, 1999, MED CARE, V37, P33, DOI 10.1097/00005650-199901000-00006; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Weaver F M, 1998, Home Health Care Serv Q, V17, P27; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008	40	454	458	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					533	535		10.7326/0003-4819-141-7-200410050-00009	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466770				2022-12-24	WOS:000224467800005
J	Verma, R; Peters, NR; D'Onofrio, M; Tochtrop, GP; Sakamoto, KM; Varadan, R; Zhang, MS; Coffino, P; Fushman, D; Deshaies, RJ; King, RW				Verma, R; Peters, NR; D'Onofrio, M; Tochtrop, GP; Sakamoto, KM; Varadan, R; Zhang, MS; Coffino, P; Fushman, D; Deshaies, RJ; King, RW			Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; 26S PROTEASOME; DEUBIQUITINATION; RECONSTITUTION; RECOGNITION; PROTEOMICS; SUBSTRATE; PROTEINS; MITOSIS; SYSTEM	To identify previously unknown small molecules that inhibit cell cycle machinery, we performed a chemical genetic screen in Xenopus extracts. One class of inhibitors, termed ubistatins, blocked cell cycle progression by inhibiting cyclin B proteolysis and inhibited degradation of ubiquitinated Sic1 by purified proteasomes. Ubistatins blocked the binding of ubiquitinated substrates to the proteasome by targeting the ubiquitin-ubiquitin interface of Lys(48)-linked chains. The same interface is recognized by ubiquitin-chain receptors of the proteasome, indicating that ubistatins act by disrupting a critical protein-protein interaction in the ubiquitin-proteasome system.	Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Mattel Childrens Hosp, Div Hematol Oncol,David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute; University System of Maryland; University of Maryland College Park; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	King, RW (corresponding author), Harvard Univ, Sch Med, Inst Chem & Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; D'ONOFRIO, Mariapina/0000-0002-8699-0847; Sakamoto, Kathleen/0000-0003-0494-8838	NCI NIH HHS [CA78048, R21CA108545, P50 CA92131] Funding Source: Medline; NIGMS NIH HHS [GM068276, GM65334, GM66492, R01 GM-45335] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078048, R21CA108545, P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068276, R56GM066492, R01GM045335, R01GM065334, R01GM066492] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; COOK WJ, 1992, J BIOL CHEM, V267, P16467; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; FUSHMAN D, UNPUB; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Mayer TU, 2003, TRENDS CELL BIOL, V13, P270, DOI 10.1016/S0962-8924(03)00077-1; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; PETERS N, UNPUB; Pfleger CM, 2000, GENE DEV, V14, P655; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walling LA, 2001, J CELL BIOCHEM, V84, P7, DOI 10.1002/jcb.10075; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	26	153	158	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					117	120		10.1126/science.1100946	http://dx.doi.org/10.1126/science.1100946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459393	Green Accepted			2022-12-24	WOS:000224304000050
J	Coghill, D; Markovitch, H				Coghill, D; Markovitch, H			Use of stimulants for attention deficit hyperactivity disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Definitive diagnosis of attention deficit hyperactivity disorder is complex. David Coghill believes the condition is undertreated, but Harvey Markovitch argues that cut rent uncertainties about diagnosis and treatment mean doctors should be cautious	Univ Dundee, Ctr Child Hlth, Div Pathol & Neurosci Psychiat, Dundee DD3 6HH, Scotland	University of Dundee	Coghill, D (corresponding author), Univ Dundee, Ctr Child Hlth, Div Pathol & Neurosci Psychiat, Dundee DD3 6HH, Scotland.	david.coghill@tpct.scot.nhs.uk; h.marcovitch@btinternet.com	Coghill, David R/B-7244-2009; Coghill, David/ABF-5213-2020; Coghill, David R/X-6449-2018	Coghill, David R/0000-0003-3017-9737; Coghill, David/0000-0003-3017-9737; Coghill, David R/0000-0003-3017-9737				CASTELLANOS FX, 2002, HYPERACTIVITY ATTENT, P336; Hill P, 2001, ARCH DIS CHILD, V84, P404, DOI 10.1136/adc.84.5.404; Huss M, 2002, J Atten Disord, V6 Suppl 1, pS65; Jadad AR, 1999, CAN J PSYCHIAT, V44, P1025, DOI 10.1177/070674379904401009; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; National Institute for Clinical Excellence, 13 NAT I CLIN EXC; Perrin JM, 2001, PEDIATRICS, V108, P1033; Rey JM, 2003, BRIT J PSYCHIAT, V182, P284, DOI 10.1192/bjp.182.4.284; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; *SCOTT INT GUID NE, 2001, ATT DEF HYP DIS CHIL; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Taylor E, 1996, J AM ACAD CHILD PSY, V35, P1213, DOI 10.1097/00004583-199609000-00019	13	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2004	329	7471					907	909		10.1136/bmj.329.7471.907	http://dx.doi.org/10.1136/bmj.329.7471.907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863MU	15485976	Green Published			2022-12-24	WOS:000224566800027
